<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31226545</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Multiple sclerosis and related disorders</Title><ISOAbbreviation>Mult Scler Relat Disord</ISOAbbreviation></Journal><ArticleTitle>Emotional expressions associated with therapeutic inertia in multiple sclerosis care.</ArticleTitle><Pagination><MedlinePgn>17-28</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-0348(19)30233-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msard.2019.05.029</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Emotions play a critical role in our daily decisions. However, it remains unclear how and what sort of emotional expressions are associated with therapeutic decisions in multiple sclerosis (MS) care. Our goal was to evaluate the relationship between emotions and affective states (as captured by muscle facial activity and emotional expressions) and TI amongst neurologists caring for MS patients when making therapeutic decisions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">38 neurologists with expertise in MS were invited to participate in a face-to-face study across Canada. Participants answered questions regarding their clinical practice, aversion to ambiguity, and the management of 10 simulated case-scenarios. TI was defined as lack of treatment initiation or escalation when there was clear evidence of clinical and radiological disease activity. We recorded facial muscle activations and their associated emotional expressions during the study, while participants made therapeutic choices. We used a validated machine learning algorithm of the AFFDEX software to code for facial muscle activations and a predefined mapping to emotional expressions (disgust, fear, surprise, etc.). Mixed effects models and mediation analyses were used to evaluate the relationship between ambiguity aversion, facial muscle activity/emotional expressions and TI measured as a binary variable and a continuous score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">34 (89.4%) neurologists completed the study. The mean age [standard deviation (SD)] was 44.6 (11.5) years; 38.3% were female and 58.8% self-identified as MS specialists. Overall, 17 (50%) participants showed TI in at least one case-scenario and the mean (SD) TI score was 0.74 (0.90). Nineteen (55.9%) participants had aversion to ambiguity in the financial domain. The multivariate analysis adjusted for age, sex and MS expertise showed that aversion to ambiguity in the financial domain (OR 1.56, 95%CI 1.32-1.86) was associated with TI. Most common muscle activations included mouth open (23.4%), brow furrow (20.9%), brow raise (17.6%), and eye widening (13.1%). Most common emotional expressions included fear (5.1%), disgust (3.2%), sadness (2.9%), and surprise (2.8%). After adjustment for age, sex, and physicians' expertise, the multivariate analysis revealed that brow furrow (OR 1.04; 95%CI 1.003-1.09) and lip suck (OR 1.06; 95%CI 1.01-1.11) were associated with an increase in TI prevalence, whereas upper lip raise (OR 0.30; 95%CI 0.15-0.59), and chin raise (OR 0.90; 95%CI 0.83-0.98) were associated with lower likelihood of TI. Disgust and surprise were associated with a lower TI score (disgust: p..&lt; 0.001; surprise: p...=...0.008) and lower prevalence of TI (OR<sub>disgust</sub>: 0.14, 95%CI 0.03-0.65; OR<sub>surprise</sub>: 0.66, 94%CI 0.47-0.92) after adjusting for covariates. The mediation analysis showed that brow furrow was a partial mediator explaining 21.2% (95%CI 14.9%-38.9%) of the association between aversion to ambiguity and TI score, followed by nose wrinkle 12.8% (95%CI 8.9%-23.4%). Similarly, disgust was the single emotional expression (partial mediator) that attenuated (-13.2%, 95%CI -9.2% to -24.3%) the effect of aversion to ambiguity on TI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">TI was observed in half of participants in at least one case-scenario. Our data suggest that facial metrics (e.g. brow furrow, nose wrinkle) and emotional expressions (e.g. disgust) are associated with physicians' choices and partially mediate the effect of aversion to ambiguity on TI.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saposnik</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Decision Neuroscience Unit, Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario M5C 1R6, Canada; Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Switzerland; Decision Neuroscience Unit, St Michael's Hospital, University of Toronto, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Canada. Electronic address: saposnikg@smh.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Decision Neuroscience Unit, Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario M5C 1R6, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terzaghi</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Decision Neuroscience Unit, Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario M5C 1R6, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostyrko</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Decision Neuroscience Unit, Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, 55 Queen St E, Toronto, Ontario M5C 1R6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakdache</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical Affairs Neuroscience, Hoffmann-La Roche, Mississauga, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoya</LastName><ForeName>Alonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Affairs Neuroscience, Hoffmann-La Roche, Mississauga, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaja</LastName><ForeName>Blessing N R</ForeName><Initials>BNR</Initials><AffiliationInfo><Affiliation>Decision Neuroscience Unit, St Michael's Hospital, University of Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nisenbaum</LastName><ForeName>Rosane</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Canada; Applied Health Research Centre, Centre for Urban Health Solutions, St Michael's Hospital, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruff</LastName><ForeName>Christian C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobler</LastName><ForeName>Philippe N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mult Scler Relat Disord</MedlineTA><NlmUniqueID>101580247</NlmUniqueID><ISSNLinking>2211-0348</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="Y">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005149" MajorTopicYN="Y">Facial Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072141" MajorTopicYN="N">Neurologists</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013038" MajorTopicYN="N">Specialization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035501" MajorTopicYN="N">Uncertainty</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Decision making</Keyword><Keyword MajorTopicYN="N">Disease-modifying therapy</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Neuroeconomics</Keyword><Keyword MajorTopicYN="N">Risk</Keyword><Keyword MajorTopicYN="N">Therapeutic inertia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31226545</ArticleId><ArticleId IdType="pii">S2211-0348(19)30233-0</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2019.05.029</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31206931</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0193</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>14</Issue><PubDate><Year>2019</Year><Month>10</Month><Day>01</Day></PubDate></JournalIssue><Title>Human brain mapping</Title><ISOAbbreviation>Hum Brain Mapp</ISOAbbreviation></Journal><ArticleTitle>Accurate, rapid and reliable, fully automated MRI brainstem segmentation for application in multiple sclerosis and neurodegenerative diseases.</ArticleTitle><Pagination><MedlinePgn>4091-4104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/hbm.24687</ELocationID><Abstract><AbstractText>Neurodegenerative disorders, such as Alzheimer's disease (AD) and progressive forms of multiple sclerosis (MS), can affect the brainstem and are associated with atrophy that can be visualized by MRI. Anatomically accurate, large-scale assessments of brainstem atrophy are challenging due to lack of automated, accurate segmentation methods. We present a novel method for brainstem volumetry using a fully-automated segmentation approach based on multi-dimensional gated recurrent units (MD-GRU), a deep learning based semantic segmentation approach employing a convolutional adaptation of gated recurrent units. The neural network was trained on 67 3D-high resolution T1-weighted MRI scans from MS patients and healthy controls (HC) and refined using segmentations of 20 independent MS patients' scans. Reproducibility was assessed in MR test-retest experiments in 33 HC. Accuracy and robustness were examined by Dice scores comparing MD-GRU to FreeSurfer and manual brainstem segmentations in independent MS and AD datasets. The mean %-change/SD between test-retest brainstem volumes were 0.45%/0.005 (MD-GRU), 0.95%/0.009 (FreeSurfer), 0.86%/0.007 (manually edited segmentations). Comparing MD-GRU to manually edited segmentations the mean Dice scores/SD were: 0.97/0.005 (brainstem), 0.95/0.013 (mesencephalon), 0.98/0.006 (pons), 0.95/0.015 (medulla oblongata). Compared to the manual gold standard, MD-GRU brainstem segmentations were more accurate than FreeSurfer segmentations (p &lt;....001). In the multi-centric acquired AD data, the mean Dice score/SD for the MD-GRU-manual segmentation comparison was 0.97/0.006. The fully automated brainstem segmentation method MD-GRU provides accurate, highly reproducible, and robust segmentations in HC and patients with MS and AD in 200 s/scan on an Nvidia GeForce GTX 1080 GPU and shows potential for application in large and longitudinal datasets.</AbstractText><CopyrightInformation>.. 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pezold</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for medical Image Analysis &amp; Navigation (CIAN), Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andermatt</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for medical Image Analysis &amp; Navigation (CIAN), Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amann</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Basel and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Basel and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendebourg</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinnecker</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Basel and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radue</LastName><ForeName>Ernst-Wilhelm</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naegelin</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granziera</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappos</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuerfel</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Basel and qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattin</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for medical Image Analysis &amp; Navigation (CIAN), Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlaeger</LastName><ForeName>Regina</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2056-5765</Identifier><AffiliationInfo><Affiliation>Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Imaging in Neurology (ThINK) Basel, Department of Medicine and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Schweizerische Multiple Sklerose Gesellschaft</Agency><Country>International</Country></Grant><Grant><GrantID>MHV program; PMPDP3 171391</GrantID><Agency>Schweizerischer Nationalfonds zur F..rderung der Wissenschaftlichen Forschung</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Brain Mapp</MedlineTA><NlmUniqueID>9419065</NlmUniqueID><ISSNLinking>1065-9471</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MD-GRU</Keyword><Keyword MajorTopicYN="Y">atrophy</Keyword><Keyword MajorTopicYN="Y">brainstem</Keyword><Keyword MajorTopicYN="Y">deep learning</Keyword><Keyword MajorTopicYN="Y">multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">segmentation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31206931</ArticleId><ArticleId IdType="doi">10.1002/hbm.24687</ArticleId><ArticleId IdType="pmc">PMC6865769</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurol Sci. 2010 Feb 15;289(1-2):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19758601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):798-800</Citation><ArticleIdList><ArticleId IdType="pubmed">12023429</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2016 Jul 1;134:281-294</Citation><ArticleIdList><ArticleId IdType="pubmed">27039700</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2001 May;22(5):896-904</Citation><ArticleIdList><ArticleId IdType="pubmed">11337335</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropathol Appl Neurobiol. 2009 Aug;35(4):406-16</Citation><ArticleIdList><ArticleId IdType="pubmed">19508444</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2009 Mar 1;45(1):60-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19013533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2009 Mar;8(3):270-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19233037</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2008 Sep;29(8):1465-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18556361</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2013 Oct;32(10):1840-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23744673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2019 Oct 1;40(14):4091-4104</Citation><ArticleIdList><ArticleId IdType="pubmed">31206931</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2004;23 Suppl 1:S69-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15501102</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimaging. 2018 Mar;28(2):162-172</Citation><ArticleIdList><ArticleId IdType="pubmed">29134725</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Case Rep. 2017 Feb 14;2017:</Citation><ArticleIdList><ArticleId IdType="pubmed">28196825</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurosci. 2018 Jan;47:6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">29102236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jan 22;9(1):e86916</Citation><ArticleIdList><ArticleId IdType="pubmed">24466290</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 May 23;11(5):e0156123</Citation><ArticleIdList><ArticleId IdType="pubmed">27213683</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2015 Jun;113:184-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25776214</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jun 1;56(3):907-22</Citation><ArticleIdList><ArticleId IdType="pubmed">21352927</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Sep 28;343(13):938-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11006371</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1095-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10871021</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2002 Jan 31;33(3):341-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31202936</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Early detection and risk assessment for chronic disease with irregular longitudinal data analysis.</ArticleTitle><Pagination><MedlinePgn>103231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30150-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103231</ELocationID><Abstract><AbstractText>Early detection and risk assessment of complex chronic disease based on longitudinal clinical data is helpful for doctors to make early diagnosis and monitor the disease progression. Disease diagnosis with computer-aided methods has been extensively studied. However, early detection and contemporaneous risk assessment based on partially labeled irregular longitudinal measurements is relatively unexplored. In this paper, we propose a flexible mixed-kernel framework for training a contemporaneous disease risk detector to predict the onset of disease and monitor the disease progression. Moreover, we address the label insufficiency problem by identifying the pattern of disease-induced progression over time with longitudinal data. Our method is based on a Structured Output Support Vector Machine (SOSVM), extended to longitudinal data analysis. Extensive experiments are conducted on several datasets of varying complexity, including the contemporaneous risk assessment with simulated irregular longitudinal data; the identification of the onset of Type 1 Diabetes (T1D) with irregularly sampled longitudinal RNA-Seq gene expression dataset; as well as the monitoring of the drug long-term effects on patients using longitudinal RNA-Seq dataset containing missing time points, demonstrating that our method enhances the accuracy in both early diagnosis and risk estimation with partially labeled irregular longitudinal clinical data.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Electrical &amp; Computer Engineering, Texas A&amp;M University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Industrial &amp; Systems Engineering, University of Washington, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Xiaoning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Electrical &amp; Computer Engineering, Texas A&amp;M University, United States. Electronic address: xqian@ece.tamu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="Y">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="N">RNA-Seq</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Early diagnosis</Keyword><Keyword MajorTopicYN="Y">Longitudinal measurements</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Risk monitoring</Keyword><Keyword MajorTopicYN="Y">Structured output</Keyword><Keyword MajorTopicYN="Y">Support Vector Machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31202936</ArticleId><ArticleId IdType="pii">S1532-0464(19)30150-9</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103231</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">31200978</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Machine Learning in Glomerular Diseases: Promise for Precision Medicine.</ArticleTitle><Pagination><MedlinePgn>290-292</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(19)30714-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2019.04.011</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nadkarni</LastName><ForeName>Girish N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: girish.nadkarni@mountsinai.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhary</LastName><ForeName>Kumardeep</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coca</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: steven.coca@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK096549</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK115562</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK106962</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Am J Kidney Dis. 2019 Sep;74(3):300-309</RefSource><PMID Version="1">31031086</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005922" MajorTopicYN="Y">Glomerulonephritis, IGA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31200978</ArticleId><ArticleId IdType="pii">S0272-6386(19)30714-0</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2019.04.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31195880</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-2811</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>03</Month></PubDate></JournalIssue><Title>Health informatics journal</Title><ISOAbbreviation>Health Informatics J</ISOAbbreviation></Journal><ArticleTitle>Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning.</ArticleTitle><Pagination><MedlinePgn>703-718</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1460458219850682</ELocationID><Abstract><AbstractText>Tight blood glucose control reduces the risk of microvascular and macrovascular complications in patients with type 1 diabetes. However, this is very difficult due to the large intra-individual variability and other factors that affect glycaemic control. The main limiting factor to achieve strict control of glucose levels in patients on intensive insulin therapy is the risk of severe hypoglycaemia. Therefore, hypoglycaemia is the main safety problem in the treatment of type 1 diabetes, negatively affecting the quality of life of patients suffering from this disease. Decision support tools based on machine learning methods have become a viable way to enhance patient safety by anticipating adverse glycaemic events. This study proposes the application of four machine learning algorithms to tackle the problem of safety in diabetes management: (1) grammatical evolution for the mid-term continuous prediction of blood glucose levels, (2) support vector machines to predict hypoglycaemic events during postprandial periods, (3) artificial neural networks to predict hypoglycaemic episodes overnight, and (4) data mining to profile diabetes management scenarios. The proposal consists of the combination of prediction and classification capabilities of the implemented approaches. The resulting system significantly reduces the number of episodes of hypoglycaemia, improving safety and providing patients with greater confidence in decision-making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veh..</LastName><ForeName>Josep</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6884-9789</Identifier><AffiliationInfo><Affiliation>Universitat de Girona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Iv..n</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universitat de Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biagi</LastName><ForeName>Lyvia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3356-8375</Identifier></Author><Author ValidYN="Y"><LastName>Bertachi</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universitat de Girona, Spain; Federal University of Technology - Paran.. (UTFPR), Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Informatics J</MedlineTA><NlmUniqueID>100883604</NlmUniqueID><ISSNLinking>1460-4582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">blood glucose prediction</Keyword><Keyword MajorTopicYN="Y">decision support systems</Keyword><Keyword MajorTopicYN="Y">diabetes management</Keyword><Keyword MajorTopicYN="Y">hypoglycaemia</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type-1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31195880</ArticleId><ArticleId IdType="doi">10.1177/1460458219850682</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31180553</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-3004</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular medicine reports</Title><ISOAbbreviation>Mol Med Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing...remitting multiple sclerosis to natalizumab treatment.</ArticleTitle><Pagination><MedlinePgn>678-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2019.10283</ELocationID><Abstract><AbstractText>Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon..... are administered as first...line treatments for this disease. In non...responsive patients, several second...line therapies are available, including natalizumab; however, a percentage of MS patients does not respond, or respond partially. Therefore, it is of the utmost importance to develop a diagnostic test for the prediction of drug response in patients suffering from complex diseases, such as MS, where several therapeutic options are already available. By a machine learning approach, the UnCorrelated Shrunken Centroid algorithm was applied to identify a subset of genes of CD4+ T cells that may predict the pharmacological response of relapsing...remitting MS patients to natalizumab, before the initiation of therapy. The results from the present study may provide a basis for the design of personalized therapeutic strategies for patients with MS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fagone</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, I...95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzon</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi 'Bonino...Pulejo', I...98124 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammana</LastName><ForeName>Santa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi 'Bonino...Pulejo', I...98124 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Marco</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine and Health Sciences, University of Molise, I...86100 Campobasso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinasanta</LastName><ForeName>Flaminia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, I...95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basile</LastName><ForeName>Maria Sofia</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, I...95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petralia</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi 'Bonino...Pulejo', I...98124 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bramanti</LastName><ForeName>Placido</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Centro Neurolesi 'Bonino...Pulejo', I...98124 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, I...95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangano</LastName><ForeName>Katia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, I...95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Mol Med Rep</MedlineTA><NlmUniqueID>101475259</NlmUniqueID><ISSNLinking>1791-2997</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054316">Biomarkers, Pharmacological</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069442">Natalizumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D054316" MajorTopicYN="N">Biomarkers, Pharmacological</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069442" MajorTopicYN="N">Natalizumab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31180553</ArticleId><ArticleId IdType="doi">10.3892/mmr.2019.10283</ArticleId><ArticleId IdType="pmc">PMC6580020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6745-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10359783</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1999 Oct 1;238(2):375-85</Citation><ArticleIdList><ArticleId IdType="pubmed">10570965</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Feb 3;403(6769):503-11</Citation><ArticleIdList><ArticleId IdType="pubmed">10676951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2000 Mar;24(3):227-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10700174</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13790-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11707567</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54</Citation><ArticleIdList><ArticleId IdType="pubmed">11742071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2002 Jan;8(1):68-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11786909</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Jan 31;415(6871):530-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11823860</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12011421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2003 Apr 1;63(7):1602-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12670911</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Mar 2;354(9):899-910</Citation><ArticleIdList><ArticleId IdType="pubmed">16510744</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2007 Jan;8(1):118-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16632515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Oct 25;372(9648):1502-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18970977</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2009 Jan;37(1):1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2009;4(1):44-57</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2010 May 15;292(1-2):28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20236661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20576703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2011 Jul 06;3(7):43</Citation><ArticleIdList><ArticleId IdType="pubmed">21745417</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(4):e32994</Citation><ArticleIdList><ArticleId IdType="pubmed">22539942</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2013 Feb;19(2 Suppl):S15-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23544716</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2014 Feb 26;6(2):17</Citation><ArticleIdList><ArticleId IdType="pubmed">24571673</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Relat Outcome Meas. 2014 Apr 04;5:25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">24741337</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Apr 20;43(7):e47</Citation><ArticleIdList><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav. 2015 Sep;5(9):e00362</Citation><ArticleIdList><ArticleId IdType="pubmed">26445701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2017 Aug;23(9):1289-1296</Citation><ArticleIdList><ArticleId IdType="pubmed">27811338</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2017 Apr 29;18(5):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28468254</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol Appl Pharmacol. 2017 Sep 1;330:93-99</Citation><ArticleIdList><ArticleId IdType="pubmed">28733203</ArticleId></ArticleIdList></Reference><Reference><Citation>J Alzheimers Dis. 2017;59(4):1187-1202</Citation><ArticleIdList><ArticleId IdType="pubmed">28759965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 May;24(6):777-785</Citation><ArticleIdList><ArticleId IdType="pubmed">29685071</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Oct 31;13(10):e0206511</Citation><ArticleIdList><ArticleId IdType="pubmed">30379917</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31136028</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>08</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov Disord</ISOAbbreviation></Journal><ArticleTitle>Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>1192-1202</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.27723</ELocationID><Abstract><AbstractText Label="BACKGROUND">Parkinson's disease is an intractable disorder with heterogeneous clinical presentation that may reflect different underlying pathogenic mechanisms. Surrogate indicators of pathogenic processes correlating with clinical measures may assist in better patient stratification. Mitochondrial function, which is impaired in and central to PD pathogenesis, may represent one such surrogate indicator.</AbstractText><AbstractText Label="METHODS">Mitochondrial function was assessed by respirometry experiment in fibroblasts derived from idiopathic patients (n = 47) in normal conditions and in experimental settings that do not permit glycolysis and therefore force energy production through mitochondrial function. Respiratory parameters and clinical measures were correlated with bivariate analysis. Machine-learning-based classification and regression trees were used to classify patients on the basis of biochemical and clinical measures. The effects of mitochondrial respiration on ..-synuclein stress were assessed monitoring the protein phosphorylation in permitting versus restrictive glycolysis conditions.</AbstractText><AbstractText Label="RESULTS">Bioenergetic properties in peripheral fibroblasts correlate with clinical measures in idiopathic patients, and the correlation is stronger with predominantly nondopaminergic signs. Bioenergetic analysis under metabolic stress, in which energy is produced solely by mitochondria, shows that patients' fibroblasts can augment respiration, therefore indicating that mitochondrial defects are reversible. Forcing energy production through mitochondria, however, favors ..-synuclein stress in different cellular experimental systems. Machine-learning-based classification identified different groups of patients in which increasing disease severity parallels higher mitochondrial respiration.</AbstractText><AbstractText Label="CONCLUSION">The suppression of mitochondrial activity in PD may be an adaptive strategy to cope with concomitant pathogenic factors. Moreover, mitochondrial measures in fibroblasts are potential peripheral biomarkers to follow disease progression. .. 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</AbstractText><CopyrightInformation>.. 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pay..n-G..mez</LastName><ForeName>C..sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Natural Sciences and Mathematics, Universidad del Rosario, Bogot.., Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvani</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molano Gonz..lez</LastName><ForeName>Nicol..s</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogot.., Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tresini</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nait Abdellah</LastName><ForeName>Soraya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Roon-Mom</LastName><ForeName>Willeke M C</ForeName><Initials>WMC</Initials><AffiliationInfo><Affiliation>Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figini</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Political and Social Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinus</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hilten</LastName><ForeName>Jacobus J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroberardino</LastName><ForeName>Pier G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>X2RN3Q8DNE</RegistryNumber><NameOfSubstance UI="D005690">Galactose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005690" MajorTopicYN="N">Galactose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Parkinson's disease</Keyword><Keyword MajorTopicYN="Y">clinical phenotyping</Keyword><Keyword MajorTopicYN="Y">mitochondria</Keyword><Keyword MajorTopicYN="Y">..-synuclein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31136028</ArticleId><ArticleId IdType="doi">10.1002/mds.27723</ArticleId><ArticleId IdType="pmc">PMC6771759</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hum Mol Genet. 2012 Oct 1;21(19):4201-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22736029</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2014 Sep;1842(9):1385-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24854107</ArticleId></ArticleIdList></Reference><Reference><Citation>Redox Biol. 2014 Jan 10;2:206-10</Citation><ArticleIdList><ArticleId IdType="pubmed">24494194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2010 Nov 15;25(15):2649-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21069833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2012 Aug;46(1):20-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22350618</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Dec 6;17(10):2522-2531</Citation><ArticleIdList><ArticleId IdType="pubmed">27926857</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</Citation><ArticleIdList><ArticleId IdType="pubmed">2841426</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2017 Mar 27;40(6):583-594.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">28350990</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinsonism Relat Disord. 2016 Mar;24:113-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26774535</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hum Genet. 2010 Mar;55(3):175-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20139917</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem J. 2009 Oct 23;424(1):99-107</Citation><ArticleIdList><ArticleId IdType="pubmed">19740075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley Interdiscip Rev Data Min Knowl Discov. 2011 Jan;1(1):55-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2015 Sep 8;85(10):846-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26253449</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Physiol. 2015 Jan 14;5:522</Citation><ArticleIdList><ArticleId IdType="pubmed">25642192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1989 Jun 3;1(8649):1269</Citation><ArticleIdList><ArticleId IdType="pubmed">2566813</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2010 Nov 30;75(22):2017-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21115957</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Aging. 2012 Aug;33(8):1843.e1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22296644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2008 Nov 15;23(15):2129-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19025984</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2008 Dec;33(12):2565-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18473170</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2014 Feb 4;82(5):412-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24391163</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Med Metab Biol. 1992 Oct;48(2):122-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1329873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Aug 8;7(1):7495</Citation><ArticleIdList><ArticleId IdType="pubmed">28790323</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2015 Mar 11;6:78</Citation><ArticleIdList><ArticleId IdType="pubmed">25815004</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Aging Neurosci. 2017 Oct 06;9:329</Citation><ArticleIdList><ArticleId IdType="pubmed">29056906</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):409-15</Citation><ArticleIdList><ArticleId IdType="pubmed">22952329</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2003 Nov 11;61(9):1222-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14610124</ArticleId></ArticleIdList></Reference><Reference><Citation>Antioxid Redox Signal. 2018 Jan 1;28(1):44-61</Citation><ArticleIdList><ArticleId IdType="pubmed">28816057</ArticleId></ArticleIdList></Reference><Reference><Citation>Biogerontology. 2012 Dec;13(6):583-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23086530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Nov 05;5:5244</Citation><ArticleIdList><ArticleId IdType="pubmed">25370169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1996 Oct 1;125(7):605-13</Citation><ArticleIdList><ArticleId IdType="pubmed">8815760</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinsonism Relat Disord. 2016 Apr;25:39-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26922004</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2008 Nov;64(5):555-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19067348</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Health Perspect. 2011 Jun;119(6):866-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21269927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2000 Dec;3(12):1301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2006 Oct 6;281(40):29739-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16847063</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31092710</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0315-162X</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>The Journal of rheumatology</Title><ISOAbbreviation>J Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Development and Validation of a MicroRNA Panel to Differentiate Between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.</ArticleTitle><Pagination><MedlinePgn>188-196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3899/jrheum.181029</ELocationID><Abstract><AbstractText Label="OBJECTIVE">MicroRNA (miRNA) are short noncoding RNA that regulate genes and are both biomarkers and mediators of disease. We used small RNA (sRNA) sequencing and machine learning methodology to develop an miRNA panel to reliably differentiate between rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) and control subjects.</AbstractText><AbstractText Label="METHODS">Plasma samples from 167 RA and 91 control subjects who frequency-matched for age, race, and sex were used for sRNA sequencing. TIGER was used to analyze miRNA. DESeq2 and random forest analyses were used to identify a prioritized list of miRNA differentially expressed in patients with RA. Prioritized miRNA were validated by quantitative PCR, and lasso and logistic regression were used to select the final panel of 6 miRNA that best differentiated RA from controls. The panel was validated in a separate cohort of 12 SLE, 32 RA, and 32 control subjects. Panel efficacy was assessed by area under the receiver operative characteristic curve (AUC) analyses.</AbstractText><AbstractText Label="RESULTS">The final panel included miR-22-3p, miR-24-3p, miR-96-5p, miR-134-5p, miR-140-3p, and miR-627-5p. The panel differentiated RA from control subjects in discovery (AUC = 0.81) and validation cohorts (AUC = 0.71), seronegative RA (AUC = 0.84), RA remission (AUC = 0.85), and patients with SLE (AUC = 0.80) versus controls. Pathway analysis showed upstream regulators and targets of panel miRNA are associated with pathways implicated in RA pathogenesis.</AbstractText><AbstractText Label="CONCLUSION">An miRNA panel identified by a bioinformatic approach differentiated between RA or SLE patients and control subjects. The panel may represent an autoimmunity signature, perhaps related to inflammatory arthritis, which is not dependent on active disease or seropositivity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ormseth</LastName><ForeName>Michelle J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-3734-3309</Identifier><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA. michelle.ormseth@vumc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center. michelle.ormseth@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solus</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Quanhu</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-8951-9295</Identifier><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-6472-5076</Identifier><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5252-3960</Identifier><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeser</LastName><ForeName>Annette M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-8057-3436</Identifier><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vickers</LastName><ForeName>Kasey C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>C Michael</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>From the Tennessee Valley Healthcare System, US Department of Veterans Affairs; Department of Medicine, Vanderbilt University Medical Center; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Bioinformatics, University of New Mexico, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>M.J. Ormseth, MD, Tennessee Valley Healthcare System, US Department of Veterans Affairs, and Department of Medicine, Vanderbilt University Medical Center; J.F. Solus, PhD, Department of Medicine, Vanderbilt University Medical Center; Q. Sheng, PhD, Department of Biostatistics, Vanderbilt University Medical Center; F. Ye, PhD, Department of Biostatistics, Vanderbilt University Medical Center; Q. Wu, PhD, Department of Medicine, Vanderbilt University Medical Center; Y. Guo, PhD, Department of Bioinformatics, University of New Mexico; A.M. Oeser, BA, MLAS, CCRP, Department of Medicine, Vanderbilt University Medical Center; R.M. Allen, PhD, Department of Medicine, Vanderbilt University Medical Center; K.C. Vickers, PhD, Department of Medicine, Vanderbilt University Medical Center; C.M. Stein, MBChB, Department of Medicine, Vanderbilt University Medical Center.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL127173</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL128996</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IK2 CX001269</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL116263</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR056116</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K22 HL113039</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Rheumatol</MedlineTA><NlmUniqueID>7501984</NlmUniqueID><ISSNLinking>0315-162X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">AUTOIMMUNITY</Keyword><Keyword MajorTopicYN="Y">BIOLOGICAL MARKERS</Keyword><Keyword MajorTopicYN="Y">DISEASE ACTIVITY</Keyword><Keyword MajorTopicYN="Y">RHEUMATOID ARTHRITIS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31092710</ArticleId><ArticleId IdType="pii">jrheum.181029</ArticleId><ArticleId IdType="doi">10.3899/jrheum.181029</ArticleId><ArticleId IdType="pmc">PMC6856415</ArticleId><ArticleId IdType="mid">NIHMS1528480</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Inflamm Res. 2013 Oct;62(10):871-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23942573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Clin Oncol. 2014 Mar;11(3):145-56</Citation><ArticleIdList><ArticleId IdType="pubmed">24492836</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2009;10(3):R25</Citation><ArticleIdList><ArticleId IdType="pubmed">19261174</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):E1629-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22615393</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21383194</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2015 Nov;16(11):1185-94</Citation><ArticleIdList><ArticleId IdType="pubmed">26437241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2009 Jan 23;136(2):215-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Ther Med. 2018 Jan;15(1):338-344</Citation><ArticleIdList><ArticleId IdType="pubmed">29250154</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Jan;66(1):49-59</Citation><ArticleIdList><ArticleId IdType="pubmed">24449575</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2017 Dec 22;19(1):288</Citation><ArticleIdList><ArticleId IdType="pubmed">29273071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2010 Jul;6(7):391-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20517293</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2015 Oct;42(10):1746-1751</Citation><ArticleIdList><ArticleId IdType="pubmed">26233505</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2016 Feb;68(2):370-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26473405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2011 Apr;13(4):423-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21423178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med Rep. 2017 Aug;16(2):1590-1595</Citation><ArticleIdList><ArticleId IdType="pubmed">28627619</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2018 Aug;45(8):1078-1084</Citation><ArticleIdList><ArticleId IdType="pubmed">29657146</ArticleId></ArticleIdList></Reference><Reference><Citation>J Extracell Vesicles. 2018 Aug 13;7(1):1506198</Citation><ArticleIdList><ArticleId IdType="pubmed">30128086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Prev Res (Phila). 2012 Mar;5(3):492-497</Citation><ArticleIdList><ArticleId IdType="pubmed">22158052</ArticleId></ArticleIdList></Reference><Reference><Citation>J Steroid Biochem Mol Biol. 2017 Oct;173:13-22</Citation><ArticleIdList><ArticleId IdType="pubmed">28167299</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2014 Oct 31;5:5214</Citation><ArticleIdList><ArticleId IdType="pubmed">25358394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Sep;38(17):5919-28</Citation><ArticleIdList><ArticleId IdType="pubmed">20466808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jan 1;26(1):139-40</Citation><ArticleIdList><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26545825</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2007 Jun;9(6):654-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17486113</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2013 Aug;145(2):437-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23619147</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2016 Aug;68(8):1839-48</Citation><ArticleIdList><ArticleId IdType="pubmed">26882526</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Epigenetics. 2018 Apr 23;10:59</Citation><ArticleIdList><ArticleId IdType="pubmed">29713393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2014 Jul 23;6(246):246ra99</Citation><ArticleIdList><ArticleId IdType="pubmed">25101889</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Lett. 2018 Aug 1;428:90-103</Citation><ArticleIdList><ArticleId IdType="pubmed">29680223</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2407-15</Citation><ArticleIdList><ArticleId IdType="pubmed">14681506</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1982 Nov;25(11):1271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics J. 2016 Apr;16(2):141-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25939484</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Markers. 2018 May 15;2018:6292396</Citation><ArticleIdList><ArticleId IdType="pubmed">29887920</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2013 Nov;43(11):3028-37</Citation><ArticleIdList><ArticleId IdType="pubmed">23934711</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Oct;52(10):3045-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16200609</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1995 Jan;38(1):44-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7818570</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2010;12(3):R86</Citation><ArticleIdList><ArticleId IdType="pubmed">20470394</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Carcinog. 2015 Nov;54(11):1442-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25256312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Sep 4;455(7209):64-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18668037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther Nucleic Acids. 2017 Mar 17;6:140-149</Citation><ArticleIdList><ArticleId IdType="pubmed">28325280</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008;3(11):e3694</Citation><ArticleIdList><ArticleId IdType="pubmed">19002258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2004 Oct;43(10):1252-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15238643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31075042</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0250-832X</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Dento maxillo facial radiology</Title><ISOAbbreviation>Dentomaxillofac Radiol</ISOAbbreviation></Journal><ArticleTitle>Preliminary study on the application of deep learning system to diagnosis of Sj..gren's syndrome on CT images.</ArticleTitle><Pagination><MedlinePgn>20190019</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1259/dmfr.20190019</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study estimated the diagnostic performance of a deep learning system for detection of Sj..gren's syndrome (SjS) on CT, and compared it with the performance of radiologists.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">CT images were assessed from 25 patients confirmed to have SjS based on the both Japanese criteria and American-European Consensus Group criteria and 25 control subjects with no parotid gland abnormalities who were examined for other diseases. 10 CT slices were obtained for each patient. From among the total of 500 CT images, 400 images (200 from 20 SjS patients and 200 from 20 control subjects) were employed as the training data set and 100 images (50 from 5 SjS patients and 50 from 5 control subjects) were used as the test data set. The performance of a deep learning system for diagnosing SjS from the CT images was compared with the diagnoses made by six radiologists (three experienced and three inexperienced radiologists).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The accuracy, sensitivity, and specificity of the deep learning system were 96.0%, 100% and 92.0%, respectively. The corresponding values of experienced radiologists were 98.3%, 99.3% and 97.3% being equivalent to the deep learning, while those of inexperienced radiologists were 83.5%, 77.9% and 89.2%. The area under the curve of inexperienced radiologists were significantly different from those of the deep learning system and the experienced radiologists.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The deep learning system showed a high diagnostic performance for SjS, suggesting that it could possibly be used for diagnostic support when interpreting CT images.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kise</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Haruka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuda</LastName><ForeName>Motoki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariji</LastName><ForeName>Yoshiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Electrical, Electronic and Computer Faculty of Engineering, Gifu University, Gifu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsumata</LastName><ForeName>Akitoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oral Radiology, Asahi University School of Dentistry, Mizuho, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariji</LastName><ForeName>Eiichiro</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Radiology, Aichi Gakuin University, Nagoya, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dentomaxillofac Radiol</MedlineTA><NlmUniqueID>7609576</NlmUniqueID><ISSNLinking>0250-832X</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010306" MajorTopicYN="N">Parotid Gland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sj..gren's syndrome</Keyword><Keyword MajorTopicYN="N">Tomography</Keyword><Keyword MajorTopicYN="N">X-ray computed</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31075042</ArticleId><ArticleId IdType="doi">10.1259/dmfr.20190019</ArticleId><ArticleId IdType="pmc">PMC6747436</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Rheum Dis. 2002 Jun;61(6):554-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12006334</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2005 May;26(5):1207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15891185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentomaxillofac Radiol. 1991 Aug;20(3):147-51</Citation><ArticleIdList><ArticleId IdType="pubmed">1807998</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Radiol. 2012 Oct;81(10):2702-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22285605</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2012 Apr;39(4):804-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22337248</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87</Citation><ArticleIdList><ArticleId IdType="pubmed">22563590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Rheumatol. 2004 Dec;14(6):425-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24387718</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2015 Aug 23;17:223</Citation><ArticleIdList><ArticleId IdType="pubmed">26298875</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Dis. 2017 Jan;23(1):84-90</Citation><ArticleIdList><ArticleId IdType="pubmed">27580143</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2017 Jan;69(1):35-45</Citation><ArticleIdList><ArticleId IdType="pubmed">27785888</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2017 Jan;138:49-56</Citation><ArticleIdList><ArticleId IdType="pubmed">27886714</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2017 Nov;46(5):1409-1417</Citation><ArticleIdList><ArticleId IdType="pubmed">28323371</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2017 Aug;90(1077):20160704</Citation><ArticleIdList><ArticleId IdType="pubmed">28707990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Healthc Eng. 2017;2017:8314740</Citation><ArticleIdList><ArticleId IdType="pubmed">29065651</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2018 Feb;91(1083):20170576</Citation><ArticleIdList><ArticleId IdType="pubmed">29215311</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Radiol. 2018 May;91(1085):20170671</Citation><ArticleIdList><ArticleId IdType="pubmed">29376736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J Dent Res. 2018;21(1):63-68</Citation><ArticleIdList><ArticleId IdType="pubmed">29507913</ArticleId></ArticleIdList></Reference><Reference><Citation>Insights Imaging. 2018 Aug;9(4):611-629</Citation><ArticleIdList><ArticleId IdType="pubmed">29934920</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2018 Dec;289(3):688-697</Citation><ArticleIdList><ArticleId IdType="pubmed">30179104</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2018 Nov;6(11):837-845</Citation><ArticleIdList><ArticleId IdType="pubmed">30232049</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 May;127(5):458-463</Citation><ArticleIdList><ArticleId IdType="pubmed">30497907</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 1996 Apr;166(4):935-41</Citation><ArticleIdList><ArticleId IdType="pubmed">8610577</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Mar;83(3):400-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9084205</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 1997 May;18(5):951-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9159376</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Oral Sci. 1997 Jun;105(3):228-33</Citation><ArticleIdList><ArticleId IdType="pubmed">9249189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31059539</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Swept source optical coherence tomography to early detect multiple sclerosis disease. The use of machine learning techniques.</ArticleTitle><Pagination><MedlinePgn>e0216410</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0216410</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To compare axonal loss in ganglion cells detected with swept-source optical coherence tomography (SS-OCT) in eyes of patients with multiple sclerosis (MS) versus healthy controls using different machine learning techniques. To analyze the capability of machine learning techniques to improve the detection of retinal nerve fiber layer (RNFL) and the complex Ganglion Cell Layer-Inner plexiform layer (GCL+) damage in patients with multiple sclerosis and to use the SS-OCT as a biomarker to early predict this disease.</AbstractText><AbstractText Label="METHODS">Patients with relapsing-remitting MS (n = 80) and age-matched healthy controls (n = 180) were enrolled. Different protocols from the DRI SS-OCT Triton system were used to obtain the RNFL and GCL+ thicknesses in both eyes. Macular and peripapilar areas were analyzed to detect the zones with higher thickness decrease. The performance of different machine learning techniques (decision trees, multilayer perceptron and support vector machine) for identifying RNFL and GCL+ thickness loss in patients with MS were evaluated. Receiver-operating characteristic (ROC) curves were used to display the ability of the different tests to discriminate between MS and healthy eyes in our population.</AbstractText><AbstractText Label="RESULTS">Machine learning techniques provided an excellent tool to predict MS disease using SS-OCT data. In particular, the decision trees obtained the best prediction (97.24%) using RNFL data in macular area and the area under the ROC curve was 0.995, while the wide protocol which covers an extended area between macula and papilla gave an accuracy of 95.3% with a ROC of 0.998. Moreover, it was obtained that the most significant area of the RNFL to predict MS is the macula just surrounding the fovea. On the other hand, in our study, GCL+ did not contribute to predict MS and the different machine learning techniques performed worse in this layer than in RNFL.</AbstractText><AbstractText Label="CONCLUSIONS">Measurements of RNFL thickness obtained with SS-OCT have an excellent ability to differentiate between healthy controls and patients with MS. Thus, the use of machine learning techniques based on these measures can be a reliable tool to help in MS diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P..rez Del Palomar</LastName><ForeName>Amaya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0669-777X</Identifier><AffiliationInfo><Affiliation>Group of Biomaterials, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cego..ino</LastName><ForeName>Jos..</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Group of Biomaterials, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montol..o</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Group of Biomaterials, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orduna</LastName><ForeName>Elvira</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2710-1875</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GIMSO Research and Innovative Group, Aragon Institute for Health Research (IIS Arag..n), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilades</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GIMSO Research and Innovative Group, Aragon Institute for Health Research (IIS Arag..n), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebasti..n</LastName><ForeName>Berta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pablo</LastName><ForeName>Luis E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GIMSO Research and Innovative Group, Aragon Institute for Health Research (IIS Arag..n), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Martin</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GIMSO Research and Innovative Group, Aragon Institute for Health Research (IIS Arag..n), University of Zaragoza, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="Y">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008266" MajorTopicYN="N">Macula Lutea</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="Y">Tomography, Optical Coherence</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31059539</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0216410</ArticleId><ArticleId IdType="pii">PONE-D-18-34805</ArticleId><ArticleId IdType="pmc">PMC6502323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurol. 2016 Jul;263(7):1323-31</Citation><ArticleIdList><ArticleId IdType="pubmed">27142714</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Treat Options Neurol. 2018 Mar 21;20(4):9</Citation><ArticleIdList><ArticleId IdType="pubmed">29564662</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2018 Feb;17(2):162-173</Citation><ArticleIdList><ArticleId IdType="pubmed">29275977</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2017 Sep;264(9):1837-1853</Citation><ArticleIdList><ArticleId IdType="pubmed">28567539</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Apr 5;12(4):e0174866</Citation><ArticleIdList><ArticleId IdType="pubmed">28379999</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2520-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10509645</ArticleId></ArticleIdList></Reference><Reference><Citation>Eye Brain. 2018 Jul 31;10:47-63</Citation><ArticleIdList><ArticleId IdType="pubmed">30104912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2018 May;22:77-82</Citation><ArticleIdList><ArticleId IdType="pubmed">29605802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2011 Jul;17(7):830-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21300734</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Neurosci. 2011 Nov;18(11):1469-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21917458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2012 Oct;131(10):1639-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22752090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophthalmic Physiol Opt. 2013 Jan;33(1):7-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23252852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2013 Jan;9(1):44-53</Citation><ArticleIdList><ArticleId IdType="pubmed">23165340</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Ophthalmol. 2015 Jan;30(1):11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23952910</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Ophthalmol. 1993 Jun;111(6):831-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8512486</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2019 Jan;27:260-268</Citation><ArticleIdList><ArticleId IdType="pubmed">30423530</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ophthalmol. 2016;2016:8503859</Citation><ArticleIdList><ArticleId IdType="pubmed">27840739</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Ophthalmol. 2013 Dec;91(8):e628-34</Citation><ArticleIdList><ArticleId IdType="pubmed">23647619</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Struct Biotechnol J. 2014 Nov 15;13:8-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25750696</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(5):e19843</Citation><ArticleIdList><ArticleId IdType="pubmed">21611198</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Apr 4;12(4):e0174944</Citation><ArticleIdList><ArticleId IdType="pubmed">28376093</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Res Notes. 2014 Dec 15;7:910</Citation><ArticleIdList><ArticleId IdType="pubmed">25512202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2016 May;15(6):574-84</Citation><ArticleIdList><ArticleId IdType="pubmed">27011339</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2001 Sep;124(Pt 9):1813-20</Citation><ArticleIdList><ArticleId IdType="pubmed">11522583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2017 Oct;16(10):797-812</Citation><ArticleIdList><ArticleId IdType="pubmed">28920886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophthalmology. 2014 Feb;121(2):573-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24268855</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurol. 2017 Dec 13;8:675</Citation><ArticleIdList><ArticleId IdType="pubmed">29326643</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Inform. 2007 Feb 11;2:59-77</Citation><ArticleIdList><ArticleId IdType="pubmed">19458758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2011 Dec;17(12):1449-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21865411</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2009 May;66(5):587-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19433658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31042157</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>05</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>e11030</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/11030</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diabetes mellitus is a chronic metabolic disorder that results in abnormal blood glucose (BG) regulations. The BG level is preferably maintained close to normality through self-management practices, which involves actively tracking BG levels and taking proper actions including adjusting diet and insulin medications. BG anomalies could be defined as any undesirable reading because of either a precisely known reason (normal cause variation) or an unknown reason (special cause variation) to the patient. Recently, machine-learning applications have been widely introduced within diabetes research in general and BG anomaly detection in particular. However, irrespective of their expanding and increasing popularity, there is a lack of up-to-date reviews that materialize the current trends in modeling options and strategies for BG anomaly classification and detection in people with diabetes.</AbstractText><AbstractText Label="OBJECTIVE">This review aimed to identify, assess, and analyze the state-of-the-art machine-learning strategies and their hybrid systems focusing on BG anomaly classification and detection including glycemic variability (GV), hyperglycemia, and hypoglycemia in type 1 diabetes within the context of personalized decision support systems and BG alarm events applications, which are important constituents for optimal diabetes self-management.</AbstractText><AbstractText Label="METHODS">A rigorous literature search was conducted between September 1 and October 1, 2017, and October 15 and November 5, 2018, through various Web-based databases. Peer-reviewed journals and articles were considered. Information from the selected literature was extracted based on predefined categories, which were based on previous research and further elaborated through brainstorming.</AbstractText><AbstractText Label="RESULTS">The initial results were vetted using the title, abstract, and keywords and retrieved 496 papers. After a thorough assessment and screening, 47 articles remained, which were critically analyzed. The interrater agreement was measured using a Cohen kappa test, and disagreements were resolved through discussion. The state-of-the-art classes of machine learning have been developed and tested up to the task and achieved promising performance including artificial neural network, support vector machine, decision tree, genetic algorithm, Gaussian process regression, Bayesian neural network, deep belief network, and others.</AbstractText><AbstractText Label="CONCLUSIONS">Despite the complexity of BG dynamics, there are many attempts to capture hypoglycemia and hyperglycemia incidences and the extent of an individual's GV using different approaches. Recently, the advancement of diabetes technologies and continuous accumulation of self-collected health data have paved the way for popularity of machine learning in these tasks. According to the review, most of the identified studies used a theoretical threshold, which suffers from inter- and intrapatient variation. Therefore, future studies should consider the difference among patients and also track its temporal change over time. Moreover, studies should also give more emphasis on the types of inputs used and their associated time lag. Generally, we foresee that these developments might encourage researchers to further develop and test these systems on a large-scale basis.</AbstractText><CopyrightInformation>..Ashenafi Zebene Woldaregay, Eirik ..rsand, Taxiarchis Botsis, David Albers, Lena Mamykina, Gunnar Hartvigsen. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 01.05.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woldaregay</LastName><ForeName>Ashenafi Zebene</ForeName><Initials>AZ</Initials><Identifier Source="ORCID">0000-0002-9464-3407</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>..rsand</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9520-1408</Identifier><AffiliationInfo><Affiliation>Norwegian Centre for E-health Research, University Hospital of North Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botsis</LastName><ForeName>Taxiarchis</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7848-2570</Identifier><AffiliationInfo><Affiliation>The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5369-526X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamykina</LastName><ForeName>Lena</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5203-274X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartvigsen</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8771-9867</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, University of Troms.. - The Arctic University of Norway, Troms.., Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012734</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">anomalies detection</Keyword><Keyword MajorTopicYN="Y">blood glucose dynamics</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31042157</ArticleId><ArticleId IdType="pii">v21i5e11030</ArticleId><ArticleId IdType="doi">10.2196/11030</ArticleId><ArticleId IdType="pmc">PMC6658321</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):117-122</Citation><ArticleIdList><ArticleId IdType="pubmed">24876547</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2011 Mar;15(2):308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21349796</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2013;192:38-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23920511</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4843-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25571076</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2017 Jun;128:40-50</Citation><ArticleIdList><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2005 Jul;43(4):501-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16255433</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Nov 01;7(6):1575-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24351184</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5666-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22255625</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jul 01;7(4):871-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23911168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2018 May 30;20(5):e10775</Citation><ArticleIdList><ArticleId IdType="pubmed">29848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1897-901</Citation><ArticleIdList><ArticleId IdType="pubmed">22699297</ArticleId></ArticleIdList></Reference><Reference><Citation>ISA Trans. 2016 Sep;64:440-446</Citation><ArticleIdList><ArticleId IdType="pubmed">27311357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerontology. 2013;59(2):99-104</Citation><ArticleIdList><ArticleId IdType="pubmed">23182884</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2013;2013:5386-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24110953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430</Citation><ArticleIdList><ArticleId IdType="pubmed">28456416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2013 Dec 17;13(12):17472-500</Citation><ArticleIdList><ArticleId IdType="pubmed">24351646</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3503-3506</Citation><ArticleIdList><ArticleId IdType="pubmed">28269053</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7961-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22256187</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2012 Jul;55(3):177-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22698854</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1311-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19162908</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:6053-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17945929</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jul;15(7):538-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23631608</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:4475-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25570985</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Cybern. 2014 Aug;44(8):1338-49</Citation><ArticleIdList><ArticleId IdType="pubmed">24122616</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2010;2010:4930-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21096665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Jul 01;5(4):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21880228</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3297-300</Citation><ArticleIdList><ArticleId IdType="pubmed">19163412</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Jan 01;7(1):135-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23439169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 24;7(1):6232</Citation><ArticleIdList><ArticleId IdType="pubmed">28740090</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 Mar;12(2):303-310</Citation><ArticleIdList><ArticleId IdType="pubmed">28539087</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3515-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23366685</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Metab J. 2015 Aug;39(4):273-82</Citation><ArticleIdList><ArticleId IdType="pubmed">26301188</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3140-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18002661</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2014;2014:302-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25569957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2012 Apr;40(4):934-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22012087</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2012;2012:6325-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23367375</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1:S27-36</Citation><ArticleIdList><ArticleId IdType="pubmed">22701840</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2010;2010:618-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21096769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33323237</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-7500</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>The Lancet. Digital health</Title><ISOAbbreviation>Lancet Digit Health</ISOAbbreviation></Journal><ArticleTitle>Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.</ArticleTitle><Pagination><MedlinePgn>e17-e25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2589-7500(19)30003-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2589-7500(19)30003-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted pump therapy.</AbstractText><AbstractText Label="METHODS">In this multicentre, open-label, randomised, crossover trial, we recruited adults (aged ...18 years) with at least a 2 year history of type 1 diabetes, who had been treated with external insulin pump therapy for at least 6 months, had glycated haemoglobin (HbA<sub>1c</sub>) of 10% or less (86 mmol/mol), and preserved hypoglycaemia awareness. After a 2-week run-in period, patients were randomly assigned (1:1) with a web-based system in randomly permuted blocks of two, to receive insulin via the hybrid closed-loop system (DBLG1; using a machine-learning-based algorithm) or sensor-assisted pump therapy over 12 weeks of free living, followed by an 8-week washout period and then the other intervention for 12 weeks. The primary outcome was the proportion of time that the sensor glucose concentration was within the target range (3..9-10..0 mmol/L) during the 12 week study period. Efficacy analyses were done in the modified intention-to-treat population, which included all randomly assigned patients who completed both 12 week treatment periods. Safety analyses were done in all patients who were exposed to either of the two treatments at least once during the study. This trial is registered with ClinicalTrials.gov, number NCT02987556.</AbstractText><AbstractText Label="FINDINGS">Between March 3, 2017, and June 19, 2017, 71 patients were screened, and 68 eligible patients were randomly assigned to the DBLG1 group (n=33) or the sensor-assisted pump therapy group (n=35), of whom five dropped out in the washout period (n=1 pregnancy; n=4 withdrew consent). 63 patients completed both 12 week treatment periods and were included in the modified intention-to-treat analysis. The proportion of time that the glucose concentration was within the target range was significantly higher in the DBLG1 group (68..5% [SD 9..4] than the sensor-assisted pump group (59..4% [10..2]; mean difference 9..2% [95% CI 6..4 to 11..9]; p&lt;0..0001). Five severe hypoglycaemic episodes occurred in the DBLG1 group and three episodes occurred in the sensor-assisted pump therapy group, which were associated with hardware malfunctions or human error.</AbstractText><AbstractText Label="INTERPRETATION">The DBLG1 system improves glucose control compared with sensor-assisted insulin pumps. This finding supports the use of closed-loop technology combined with appropriate health care organisation in adults with type 1 diabetes.</AbstractText><AbstractText Label="FUNDING">French Innovation Fund, Diabeloop.</AbstractText><CopyrightInformation>Copyright .. 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benhamou</LastName><ForeName>Pierre-Yves</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France. Electronic address: pybenhamou@chu-grenoble.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franc</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reznik</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, University of Caen C..te de Nacre Regional Hospital Center, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thivolet</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaepelynck</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Marseille University Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renard</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerci</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre L..s Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaillous</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukas-Croisier</LastName><ForeName>Celine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeandidier</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanaire</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borot</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Nutrition and Diabetes, Besan..on University Hospital and Franche-Comt.. University, Besan..on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doron</LastName><ForeName>Maeva</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire d'..lectronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jallon</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire d'..lectronique des technologies de l'information, F-38000, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xhaard</LastName><ForeName>Ilham</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melki</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology and Nutrition, Strasbourg University Hospital, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delemer</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Reims University Hospital, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillouche</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Nutrition, L'Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoumacker-Ley</LastName><ForeName>Laurene</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Lorraine University Hospital, Vandoeuvre L..s Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farret</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, UMR CNRS 5203, INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raccah</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Diabetology, Marseille University Hospital, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lablanche</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Grenoble University Hospital, INSERM U1055, Grenoble Alpes University, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joubert</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, University of Caen C..te de Nacre Regional Hospital Center, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penfornis</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Paris Sud University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charpentier</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Study and Research for Improvement of the Treatment of Diabetes, Bioparc-Genopole Evry-Corbeil, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DIABELOOP WP7 Trial Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02987556</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Digit Health</MedlineTA><NlmUniqueID>101751302</NlmUniqueID><ISSNLinking>2589-7500</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Digit Health. 2019 May;1(1):e2-e3</RefSource><PMID Version="1">33323238</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>16</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33323237</ArticleId><ArticleId IdType="pii">S2589-7500(19)30003-2</ArticleId><ArticleId IdType="doi">10.1016/S2589-7500(19)30003-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31031086</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.</ArticleTitle><Pagination><MedlinePgn>300-309</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(19)30618-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2019.02.016</ELocationID><Abstract><AbstractText Label="RATIONALE &amp; OBJECTIVE">Immunoglobulin A nephropathy (IgAN) is common worldwide and has heterogeneous phenotypes. Predicting long-term outcomes and stratifying risk are important for clinical decision making and designing future clinical trials.</AbstractText><AbstractText Label="STUDY DESIGN">Multicenter retrospective cohort study of 2,047 patients with IgAN.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS">Derivation and validation cohorts composed of 1,022 Chinese patients with IgAN from a single center and 1,025 patients..with IgAN from 18 renal centers, respectively.</AbstractText><AbstractText Label="PREDICTORS">36 characteristics, including demographic, clinical, and pathologic variables.</AbstractText><AbstractText Label="OUTCOMES">Combined event of end-stage kidney disease or 50% reduction in estimated glomerular filtration rate within 5 years after diagnostic kidney biopsy.</AbstractText><AbstractText Label="ANALYTICAL APPROACH">A gradient tree boosting method implemented in the eXtreme Gradient Boosting (XGBoost) system was used to select the 10 most important variables from 36 candidate variables. Stepwise Cox regression analysis was used to derive a simplified scoring scale model (SSM) based on these 10 variables. Model discrimination and calibration were assessed using the C statistic and Hosmer-Lemeshow test. Risk stratification of the SSM was evaluated using Kaplan-Meier analysis.</AbstractText><AbstractText Label="RESULTS">In the derivation and validation cohorts, 74 and 114 patients reached the outcome, respectively. XGBoost predicted the outcome with a C statistic of 0.84 (95% CI, 0.80-0.88) for the validation cohort. The SSM included 3 variables: urine protein excretion, global sclerosis, and tubular atrophy/interstitial fibrosis. Using Kaplan-Meier analysis, the SSM identified significant risk stratification (P..&lt; 0.001).</AbstractText><AbstractText Label="LIMITATIONS">Retrospective study design, application for other ethnic groups needs to be verified.</AbstractText><AbstractText Label="CONCLUSIONS">A prediction model using routinely available characteristics and based on the combination of a machine learning algorithm and survival analysis can stratify risk for kidney disease progression in the setting of IgAN. An online calculator, the Nanjing IgAN Risk Stratification System, permits easy implementation of this model.</AbstractText><CopyrightInformation>Copyright .. 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tingyu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China; National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>IBM Research-China, Beijing, China; Ping An Healthcare Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yingxue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>IBM Research-China, Beijing, China; Ping An Healthcare Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Eryu</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IBM Research-China, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>IBM Research-China, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shaoshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Caihong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. Electronic address: zengch_nj@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhihong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Clinical Research Center of Kidney Diseases, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China; National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. Electronic address: zhihong-liu@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Kidney Dis. 2019 Sep;74(3):290-292</RefSource><PMID Version="1">31200978</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005922" MajorTopicYN="N">Glomerulonephritis, IGA</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">China</Keyword><Keyword MajorTopicYN="Y">IgA nephropathy (IgAN)</Keyword><Keyword MajorTopicYN="Y">Oxford classification</Keyword><Keyword MajorTopicYN="Y">decision support</Keyword><Keyword MajorTopicYN="Y">disease progression</Keyword><Keyword MajorTopicYN="Y">kidney biopsy</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">model derivation</Keyword><Keyword MajorTopicYN="Y">model validation</Keyword><Keyword MajorTopicYN="Y">online risk calculator</Keyword><Keyword MajorTopicYN="Y">prediction model</Keyword><Keyword MajorTopicYN="Y">primary glomerulonephritis</Keyword><Keyword MajorTopicYN="Y">prognosis prediction</Keyword><Keyword MajorTopicYN="Y">risk stratification</Keyword><Keyword MajorTopicYN="Y">stepwise Cox regression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31031086</ArticleId><ArticleId IdType="pii">S0272-6386(19)30618-3</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2019.02.016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31029250</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2019</Year><Month>06</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Risk-based postprandial hypoglycemia forecasting using supervised learning.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(18)30497-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2019.03.008</ELocationID><Abstract><AbstractText Label="BACKGROUND">Predicting insulin-induced postprandial hypoglycemic events is critical for the safety of type 1 diabetes patients because an early warning of hypoglycemia facilitates correction of the insulin bolus before its administration. The postprandial hypoglycemic event counts can be lowered by reducing the size of the bolus based on a reliable prediction but at the cost of increasing the average blood glucose.</AbstractText><AbstractText Label="METHODS">We developed a method for predicting postprandial hypoglycemia using machine learning techniques personalized to each patient. The proposed system enables on-line therapeutic decision making for patients using a sensor augmented pump therapy. Two risk-based approaches were developed for a window of 240 min after the meal/bolus, and they were tested based on real retrospective data from 10 patients using 70 mg/dL and 54 mg/dL as thresholds according to the consensus for Level 1 and Level 2 hypoglycemia, respectively. Due to the small size of the patient cohort, we trained personalized models for each patient.</AbstractText><AbstractText Label="RESULTS">The median specificity and sensitivity were 79% and 71% for Level 1 hypoglycemia, respectively, and 81% and 77% for Level 2.</AbstractText><AbstractText Label="CONCLUSIONS">The results demonstrated that it is feasible to anticipate hypoglycemic events with a reasonable false-positive rate. The accuracy of the results and the trade-off between performance metrics allow its use in decision support systems for patients who wear insulin pumps.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oviedo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: silvia.oviedo@udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain. Electronic address: ivancontrerasfd@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quir..s</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog..a y Nutrici..n. Hospital Universitari Mutua de Terrassa, Terrassa, Spain. Electronic address: cmquiros@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gim..nez</LastName><ForeName>Marga</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biomdiques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: gimenez@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conget</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Diabetes Unit. Endocrinology and Nutrition Dpt. IDIBAPS (Institut d'investigacions biomdiques August Pi I Sunyer), Barcelona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: iconget@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehi</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d'Informatica i Aplicacions. Universitat de Girona, Spain; Centro de Investigaci..n Biom..dica en Red de Diabetes y Enfermedades Metab..licas Asociadas (CIBERDEM), Spain. Electronic address: josep.vehi@udg.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019518" MajorTopicYN="Y">Postprandial Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Blood glucose</Keyword><Keyword MajorTopicYN="Y">Bolus calculation</Keyword><Keyword MajorTopicYN="Y">Hypoglycemia prediction</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Postprandial hypoglycemia</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31029250</ArticleId><ArticleId IdType="pii">S1386-5056(18)30497-0</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.03.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31027048</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9964</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><MedlineDate>2020 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>IEEE/ACM transactions on computational biology and bioinformatics</Title><ISOAbbreviation>IEEE/ACM Trans Comput Biol Bioinform</ISOAbbreviation></Journal><ArticleTitle>Data-Driven Robust Control for a Closed-Loop Artificial Pancreas.</ArticleTitle><Pagination><MedlinePgn>1981-1993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TCBB.2019.2912609</ELocationID><Abstract><AbstractText>We present a fully closed-loop design for an artificial pancreas (AP) that regulates the delivery of insulin for the control of Type I diabetes. Our AP controller operates in a fully automated fashion, without requiring any manual interaction with the patient (e.g., in the form of meal announcements). A major obstacle to achieving closed-loop insulin control are the "unknown disturbances" related to various aspects of a patient's daily behavior, especially meals and physical activity. Such disturbances can significantly affect the patient's blood glucose levels. To handle such uncertainties, we present a data-driven, robust, model-predictive control framework in which we capture a wide range of individual meal and exercise patterns using uncertainty sets learned from historical data. These uncertainty sets are then used in the insulin controller to achieve automated, precise, and personalized insulin therapy. We provide an extensive in silico evaluation of our robust AP design, demonstrating the potential of the approach. In particular, without the benefit of explicit meal announcements, our approach can regulate glucose levels for large clusters of meal profiles learned from population-wide survey data and cohorts of virtual patients, even in the presence of high carbohydrate disturbances.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paoletti</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kin Sum</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hongkai</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Smolka</LastName><ForeName>Scott A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE/ACM Trans Comput Biol Bioinform</MedlineTA><NlmUniqueID>101196755</NlmUniqueID><ISSNLinking>1545-5963</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31027048</ArticleId><ArticleId IdType="doi">10.1109/TCBB.2019.2912609</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31017534</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2041-3033</ISSN><JournalIssue CitedMedium="Internet"><Volume>233</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine</Title><ISOAbbreviation>Proc Inst Mech Eng H</ISOAbbreviation></Journal><ArticleTitle>Automatic localization of anatomical regions in medical ultrasound images of rheumatoid arthritis using deep learning.</ArticleTitle><Pagination><MedlinePgn>657-667</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0954411919845747</ELocationID><Abstract><AbstractText>The pace of population aging is growing faster worldwide. The quality of life of the aging population is mostly affected by rheumatic diseases. With the increasing rate of rheumatoid arthritis in the aging population, technological advances in the field of automatic image processing and analysis have paved way for automatic detection and diagnosis of arthritis based on how the grade of the synovial region is designed. The proposed method is based on spatial analysis using intensity-based approach to segment the skin border, thresholding and connectivity algorithm for bone region segmentation, hit-or-miss transform for bone line segmentation and distance measure with image profile to detect the joint region. After this process of localization, the synovial region is determined using the active contour technique. In arthritis condition, synovitis also occurs which is categorized into four different grades based on the fluid expansion in the synovial region. The different grades are defined and analyzed through deep learning. Convolutional neural network in a deep learning algorithm is used to diagnose the particular grade of synovitis to describe the nature of arthritis. With these results, a module to detect the nature of arthritis automatically is defined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hemalatha</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4712-7482</Identifier><AffiliationInfo><Affiliation>1 Sathyabama University, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijaybaskar</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>2 Department of Electronics and Telecommunication Engineering, Sathyabama University, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thamizhvani</LastName><ForeName>T R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>3 Department of Biomedical Engineering, Vels Institute of Science, Technology and Advanced Studies, Chennai, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Proc Inst Mech Eng H</MedlineTA><NlmUniqueID>8908934</NlmUniqueID><ISSNLinking>0954-4119</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="N">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Localization</Keyword><Keyword MajorTopicYN="N">active contour</Keyword><Keyword MajorTopicYN="N">arthritis</Keyword><Keyword MajorTopicYN="N">bone and joint region</Keyword><Keyword MajorTopicYN="N">convolutional neural network</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31017534</ArticleId><ArticleId IdType="doi">10.1177/0954411919845747</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30997154</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2056-5933</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>RMD open</Title><ISOAbbreviation>RMD Open</ISOAbbreviation></Journal><ArticleTitle>Neural networks for automatic scoring of arthritis disease activity on ultrasound images.</ArticleTitle><Pagination><MedlinePgn>e000891</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2018-000891</ELocationID><Abstract><AbstractText Label="Background">The development of standardised methods for ultrasound (US) scanning and evaluation of synovitis activity by the OMERACT-EULAR Synovitis Scoring (OESS) system is a major step forward in the use of US in the diagnosis and monitoring of patients with inflammatory arthritis. The variation in interpretation of disease activity on US images can affect diagnosis, treatment and outcomes in clinical trials. We, therefore, set out to investigate if we could utilise neural network architecture for the interpretation of disease activity on Doppler US images, using the OESS scoring system.</AbstractText><AbstractText Label="Methods">Two state-of-the-art neural networks were used to extract information from 1342 Doppler US images from patients with rheumatoid arthritis (RA). One neural network divided images as either healthy (Doppler OESS score 0 or 1) or diseased (Doppler OESS score 2 or 3). The other to score images across all four of the OESS systems Doppler US scores (0-3). The neural networks were hereafter tested on a new set of RA Doppler US images (n=176). Agreement between rheumatologist's scores and network scores was measured with the kappa statistic.</AbstractText><AbstractText Label="Results">For the neural network assessing healthy/diseased score, the highest accuracies compared with an expert rheumatologist were 86.4% and 86.9% with a sensitivity of 0.864 and 0.875 and specificity of 0.864 and 0.864, respectively. The other neural network developed to four class Doppler OESS scoring achieved an average per class accuracy of 75.0% and a quadratically weighted kappa score of 0.84.</AbstractText><AbstractText Label="Conclusion">This study is the first to show that neural network technology can be used in the scoring of disease activity on Doppler US images according to the OESS system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Jakob Kristian Holm</ForeName><Initials>JKH</Initials><AffiliationInfo><Affiliation>The Maersk Mc-Kinney Moller Institute, Syddansk Universitet, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Jannik Skyttegaard</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>The Maersk Mc-Kinney Moller Institute, Syddansk Universitet, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laursen</LastName><ForeName>Martin Sundahl</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>The Maersk Mc-Kinney Moller Institute, Syddansk Universitet, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtz</LastName><ForeName>Kathrine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Maersk Mc-Kinney Moller Institute, Syddansk Universitet, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grauslund</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Unit of Ophthalmology, Department of Opthalmology, Odense Universitetshospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savarimuthu</LastName><ForeName>Thiusius Rajeeth</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>The Maersk Mc-Kinney Moller Institute, Syddansk Universitet, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Just</LastName><ForeName>S..ren Andreas</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-3946-5919</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Odense Universitetshospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>RMD Open</MedlineTA><NlmUniqueID>101662038</NlmUniqueID><ISSNLinking>2056-5933</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013585" MajorTopicYN="N">Synovitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="Y">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018608" MajorTopicYN="N">Ultrasonography, Doppler</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">OMERACT-EULAR Synovitis Scoring system</Keyword><Keyword MajorTopicYN="Y">artificial intelligence</Keyword><Keyword MajorTopicYN="Y">automatic scoring</Keyword><Keyword MajorTopicYN="Y">convolutional neural networks</Keyword><Keyword MajorTopicYN="Y">deep learning</Keyword><Keyword MajorTopicYN="Y">disease activity</Keyword><Keyword MajorTopicYN="Y">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="Y">ultrasound</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30997154</ArticleId><ArticleId IdType="doi">10.1136/rmdopen-2018-000891</ArticleId><ArticleId IdType="pii">rmdopen-2018-000891</ArticleId><ArticleId IdType="pmc">PMC6443126</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Res Ther. 2017 Oct 4;19(1):221</Citation><ArticleIdList><ArticleId IdType="pubmed">28978340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Nov;70(11):1995-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21784724</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 2015 May;34(5):819-29</Citation><ArticleIdList><ArticleId IdType="pubmed">25501633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2018 Oct;77(10):1421-1425</Citation><ArticleIdList><ArticleId IdType="pubmed">29934373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jun 10;389(10086):2328-2337</Citation><ArticleIdList><ArticleId IdType="pubmed">28612747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2005 Jul;64(7):1043-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15640263</ArticleId></ArticleIdList></Reference><Reference><Citation>RMD Open. 2017 Jul 11;3(1):e000428</Citation><ArticleIdList><ArticleId IdType="pubmed">28948983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 May 28;521(7553):436-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Mar;56(3):722-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17328042</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Feb;67(2):386-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25370843</ArticleId></ArticleIdList></Reference><Reference><Citation>RMD Open. 2017 Jul 11;3(1):e000427</Citation><ArticleIdList><ArticleId IdType="pubmed">28948984</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30972099</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Identification of Target Genes at Juvenile Idiopathic Arthritis GWAS Loci in Human Neutrophils.</ArticleTitle><Pagination><MedlinePgn>181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2019.00181</ELocationID><Abstract><AbstractText>Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease among children which could cause severe disability. Genomic studies have discovered substantial number of risk loci for JIA, however, the mechanism of how these loci affect JIA development is not fully understood. Neutrophil is an important cell type involved in autoimmune diseases. To better understand the biological function of genetic loci in neutrophils during JIA development, we took an integrated multi-omics approach to identify target genes at JIA risk loci in neutrophils and constructed a protein-protein interaction network via a machine learning approach. We identified genes likely to be JIA risk loci targeted genes in neutrophils which could contribute to JIA development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Junyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xiucheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>March</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xueming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakonarson</LastName><ForeName>Hakon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Qianghua</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epigenetic regulation</Keyword><Keyword MajorTopicYN="N">juvenile idiopathic arthritis</Keyword><Keyword MajorTopicYN="N">pathway enrichment</Keyword><Keyword MajorTopicYN="N">protein-protein interaction</Keyword><Keyword MajorTopicYN="N">target gene identification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30972099</ArticleId><ArticleId IdType="doi">10.3389/fgene.2019.00181</ArticleId><ArticleId IdType="pmc">PMC6445851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1999 Nov;42(11):2261-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10555018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2000 Dec;59(12):1001</Citation><ArticleIdList><ArticleId IdType="pubmed">11153478</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2002 Jan 1;30(1):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2002 Apr;61(4):354-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11874841</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2003 Apr;4(2):249-64</Citation><ArticleIdList><ArticleId IdType="pubmed">12925520</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2004 Feb;75(2):358-72</Citation><ArticleIdList><ArticleId IdType="pubmed">14634056</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2004 Feb;31(2):390-2</Citation><ArticleIdList><ArticleId IdType="pubmed">14760812</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Mar;52(3):722-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15751097</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv4-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16980723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Nov 15;22(22):2825-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16982708</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2008 Aug;38(1):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18191989</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jul;58(7):2206-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18576341</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Dec 1;181(11):8053-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19017998</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Dec 15;59(12):1690-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19035419</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jan;60(1):258-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19116933</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Genomics. 2009 Feb 23;2:9</Citation><ArticleIdList><ArticleId IdType="pubmed">19236715</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2009 Jun;15(6):623-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 May 25;107(21):9813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20439745</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Nov;63(11):3305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21769851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22064851</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2012 Jan 18;242(1-2):60-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22169406</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2012 Mar 30;143(1):9-19</Citation><ArticleIdList><ArticleId IdType="pubmed">22342996</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Aug;64(8):2781-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22354554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2012 Apr;9(4):345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">22453911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2013 Jul;52(7):1163-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23502074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Jun;45(6):664-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23603761</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Mar 20;507(7492):371-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24646999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics J. 2014 Aug;14(4):356-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24709693</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jul;42(Web Server issue):W167-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24861621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2014 Dec 18;159(7):1665-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2016 Jan;75(1):183-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25498119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 Feb 19;518(7539):317-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 May 26;6:7213</Citation><ArticleIdList><ArticleId IdType="pubmed">26007630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 Jul;11(7):384</Citation><ArticleIdList><ArticleId IdType="pubmed">26009294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Sep;21(9):1018-27</Citation><ArticleIdList><ArticleId IdType="pubmed">26301688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Oct 09;6:8442</Citation><ArticleIdList><ArticleId IdType="pubmed">26450413</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2016 Jan 20;17 Suppl 2:15</Citation><ArticleIdList><ArticleId IdType="pubmed">26821531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res. 2016 Oct;112:84-98</Citation><ArticleIdList><ArticleId IdType="pubmed">26826283</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Genet. 2016 Mar 22;17:24</Citation><ArticleIdList><ArticleId IdType="pubmed">27005825</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk J Pediatr. 2015 Jul-Aug;57(4):324-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27186693</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biotechnol. 2016 Aug;34(8):605-608</Citation><ArticleIdList><ArticleId IdType="pubmed">27212022</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Biol Toxicol. 2017 Feb;33(1):15-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27495116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Sep 28;7:12792</Citation><ArticleIdList><ArticleId IdType="pubmed">27677580</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Nov 15;17(8):2042-2059</Citation><ArticleIdList><ArticleId IdType="pubmed">27851967</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361</Citation><ArticleIdList><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901</Citation><ArticleIdList><ArticleId IdType="pubmed">27899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 May;76(5):906-913</Citation><ArticleIdList><ArticleId IdType="pubmed">27927641</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 2017 Aug;69(8-9):605-616</Citation><ArticleIdList><ArticleId IdType="pubmed">28695286</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 28;12(11):e0188402</Citation><ArticleIdList><ArticleId IdType="pubmed">29182645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Nov 28;8(1):1826</Citation><ArticleIdList><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Dis Primers. 2018 Feb 08;4:18001</Citation><ArticleIdList><ArticleId IdType="pubmed">29417936</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2018 Jul;70(7):1155-1165</Citation><ArticleIdList><ArticleId IdType="pubmed">29513936</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2018 Oct 4;19(1):151</Citation><ArticleIdList><ArticleId IdType="pubmed">30286773</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2019 Mar;68(3):665-675</Citation><ArticleIdList><ArticleId IdType="pubmed">30552108</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Rheumatol. 1988;27 Suppl 1:66-71</Citation><ArticleIdList><ArticleId IdType="pubmed">3277687</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr Scand. 1983 May;72(3):345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">6880720</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 1996 Dec;26(3):575-91</Citation><ArticleIdList><ArticleId IdType="pubmed">8989803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30953518</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>04</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Are innovation and new technologies in precision medicine paving a new era in patients centric care?</ArticleTitle><Pagination><MedlinePgn>114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-019-1864-9</ELocationID><Abstract><AbstractText>Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support the advent of precision medicine (PM). Recent scientific breakthroughs and technological advancements have improved our understanding of disease pathogenesis and changed the way we diagnose and treat disease leading to more precise, predictable and powerful health care that is customized for the individual patient. Genetic, genomics, and epigenetic alterations appear to be contributing to different diseases. Deep clinical phenotyping, combined with advanced molecular phenotypic profiling, enables the construction of causal network models in which a genomic region is proposed to influence the levels of transcripts, proteins, and metabolites. Phenotypic analysis bears great importance to elucidat the pathophysiology of networks at the molecular and cellular level. Digital biomarkers (BMs) can have several applications beyond clinical trials in diagnostics-to identify patients affected by a disease or to guide treatment. Digital BMs present a big opportunity to measure clinical endpoints in a remote, objective and unbiased manner. However, the use of "omics" technologies and large sample sizes have generated massive amounts of data sets, and their analyses have become a major bottleneck requiring sophisticated computational and statistical methods. With the wealth of information for different diseases and its link to intrinsic biology, the challenge is now to turn the multi-parametric taxonomic classification of a disease into better clinical decision-making by more precisely defining a disease. As a result, the big data revolution has provided an opportunity to apply artificial intelligence (AI) and machine learning algorithms to this vast data set. The advancements in digital health opportunities have also arisen numerous questions and concerns on the future of healthcare practices in particular with what regards the reliability of AI diagnostic tools, the impact on clinical practice and vulnerability of algorithms. AI, machine learning algorithms, computational biology, and digital BMs will offer an opportunity to translate new data into actionable information thus, allowing earlier diagnosis and precise treatment options. A better understanding and cohesiveness of the different components of the knowledge network is a must to fully exploit the potential of it.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seyhan</LastName><ForeName>Attila A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Division of Biology and Medicine, Brown University, Providence, RI, 02903, USA. Attila_Seyhan@brown.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fox Chase Cancer Center, Temple University Temple Health, Philadelphia, PA, 19111, USA. Attila_Seyhan@brown.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carini</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences &amp; Medicine, King's College London, London, SE1 8WA, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062069" MajorTopicYN="Y">Inventions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018802" MajorTopicYN="Y">Patient-Centered Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Artificial intelligence</Keyword><Keyword MajorTopicYN="Y">Autoimmune and inflammatory diseases</Keyword><Keyword MajorTopicYN="Y">Biomarkers</Keyword><Keyword MajorTopicYN="Y">Cancer</Keyword><Keyword MajorTopicYN="Y">Deep phenotyping</Keyword><Keyword MajorTopicYN="Y">Diabetes</Keyword><Keyword MajorTopicYN="Y">Digital biomarkers</Keyword><Keyword MajorTopicYN="Y">Epigenetics</Keyword><Keyword MajorTopicYN="Y">Genetics</Keyword><Keyword MajorTopicYN="Y">Genomics</Keyword><Keyword MajorTopicYN="Y">Immuno-oncology</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Modeling and simulation</Keyword><Keyword MajorTopicYN="Y">Personalized medicine</Keyword><Keyword MajorTopicYN="Y">Precision medicine</Keyword><Keyword MajorTopicYN="Y">Proteomics</Keyword><Keyword MajorTopicYN="Y">Transcriptomics</Keyword><Keyword MajorTopicYN="Y">miRNAs</Keyword><Keyword MajorTopicYN="Y">microRNAs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30953518</ArticleId><ArticleId IdType="doi">10.1186/s12967-019-1864-9</ArticleId><ArticleId IdType="pii">10.1186/s12967-019-1864-9</ArticleId><ArticleId IdType="pmc">PMC6451233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brief Bioinform. 2009 Jul;10(4):367-77</Citation><ArticleIdList><ArticleId IdType="pubmed">19276200</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 20;357(12):1199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Apr;60(4):1065-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19333922</ArticleId></ArticleIdList></Reference><Reference><Citation>Dement Neuropsychol. 2018 Apr-Jun;12(2):143-151</Citation><ArticleIdList><ArticleId IdType="pubmed">29988333</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2006 Oct 17;48(8):1618-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17045897</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2012 May;33(5):777-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22504886</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2009 May-Jun;32(3-4):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19345069</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007 Jul 11;2(7):e610</Citation><ArticleIdList><ArticleId IdType="pubmed">17622355</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2019 Feb;18(1):97-98</Citation><ArticleIdList><ArticleId IdType="pubmed">30600619</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2015 Jan 6;112(1):103-11</Citation><ArticleIdList><ArticleId IdType="pubmed">25349977</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2018 Oct;24(10):1559-1567</Citation><ArticleIdList><ArticleId IdType="pubmed">30224757</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Jan 13;469(7329):156-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21228852</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Nov;83(5):610-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18950739</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2012 Apr;8(5):1553-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22446932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nutr Biochem. 2017 Nov;49:117-122</Citation><ArticleIdList><ArticleId IdType="pubmed">28945992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2009 May;29(7):749-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18998140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2010 Jul;6(7):391-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20517293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc Res. 2006 Feb 15;69(3):666-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16426590</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2012 Jul;11(9):636-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22100329</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2010 Mar;40(3):888-98</Citation><ArticleIdList><ArticleId IdType="pubmed">20148420</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Endocrinol (Lausanne). 2019 Jan 08;9:779</Citation><ArticleIdList><ArticleId IdType="pubmed">30671023</ArticleId></ArticleIdList></Reference><Reference><Citation>Online J Public Health Inform. 2014 Feb 05;5(3):229</Citation><ArticleIdList><ArticleId IdType="pubmed">24683442</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomedicines. 2018 Feb 02;6(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">29393888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Aug 25;6:31479</Citation><ArticleIdList><ArticleId IdType="pubmed">27558530</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007 Dec 19;2(12):e1347</Citation><ArticleIdList><ArticleId IdType="pubmed">18094754</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2008;9(3):172-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17886169</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Apr 15;182(8):5088-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19342689</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomark Cancer. 2016 Jun 06;8:89-99</Citation><ArticleIdList><ArticleId IdType="pubmed">27279751</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 6;357(10):977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17804842</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2009 Dec;10(12):1252-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19838199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Metab. 2019 Feb;20:63-78</Citation><ArticleIdList><ArticleId IdType="pubmed">30503831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2002 Jun;1(6):469-75</Citation><ArticleIdList><ArticleId IdType="pubmed">12119749</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 May;60(5):1294-304</Citation><ArticleIdList><ArticleId IdType="pubmed">19404929</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Endocrinol. 2018 Mar 12;2018:7351902</Citation><ArticleIdList><ArticleId IdType="pubmed">29721017</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Obes (Lond). 2017 Jul;41(7):1121-1130</Citation><ArticleIdList><ArticleId IdType="pubmed">28344345</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 May;58(5):1284-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18438844</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2008;10(4):R101</Citation><ArticleIdList><ArticleId IdType="pubmed">18759964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Mar 22;555(7697):469-474</Citation><ArticleIdList><ArticleId IdType="pubmed">29539639</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2011 Jun;7(6):1974-89</Citation><ArticleIdList><ArticleId IdType="pubmed">21487605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Oct 12;20(15):2479-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15073010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2016 Dec 20;13(1):106-121</Citation><ArticleIdList><ArticleId IdType="pubmed">27869909</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2013 Mar;41:6-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23306098</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2017 May 26;14(5):e1002309</Citation><ArticleIdList><ArticleId IdType="pubmed">28552987</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2015 May;11(5):1217-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25765998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2012 May;33(5):797-802</Citation><ArticleIdList><ArticleId IdType="pubmed">22392843</ArticleId></ArticleIdList></Reference><Reference><Citation>Obesity (Silver Spring). 2017 Apr;25(4):697-703</Citation><ArticleIdList><ArticleId IdType="pubmed">28240822</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Jan 18;541(7637):321-330</Citation><ArticleIdList><ArticleId IdType="pubmed">28102259</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Apr;82(4):949-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18371930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2008 Dec 23;6:81</Citation><ArticleIdList><ArticleId IdType="pubmed">19105846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 2010;260(2):70-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19954774</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2008 Apr;18(4):644-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18381899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2017 Sep;17(9):559-572</Citation><ArticleIdList><ArticleId IdType="pubmed">28555670</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomark Insights. 2017 Jun 19;12:1177271917715236</Citation><ArticleIdList><ArticleId IdType="pubmed">28659713</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4323-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18326631</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 May 6;352(6286):658-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27151852</ArticleId></ArticleIdList></Reference><Reference><Citation>Virchows Arch. 2019 Apr;474(4):511-522</Citation><ArticleIdList><ArticleId IdType="pubmed">30470933</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Sep 10;461(7261):218-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19741703</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17502601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Oct;17(10):1386-1395</Citation><ArticleIdList><ArticleId IdType="pubmed">27575023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Oct 1;23(19):2507-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17720704</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2008 Dec;92(6):404-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18595652</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Dec 31;13(12):e0208422</Citation><ArticleIdList><ArticleId IdType="pubmed">30596661</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2010 Jul;9(9):618-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20457282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30946685</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Convolutional Recurrent Neural Networks for Glucose Prediction.</ArticleTitle><Pagination><MedlinePgn>603-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2019.2908488</ELocationID><Abstract><AbstractText>Control of blood glucose is essential for diabetes management. Current digital therapeutic approaches for subjects with type 1 diabetes mellitus such as the artificial pancreas and insulin bolus calculators leverage machine learning techniques for predicting subcutaneous glucose for improved control. Deep learning has recently been applied in healthcare and medical research to achieve state-of-the-art results in a range of tasks including disease diagnosis, and patient state prediction among others. In this paper, we present a deep learning model that is capable of forecasting glucose levels with leading accuracy for simulated patient cases (root-mean-square error (RMSE) = 9.38.. .. 0.71 [mg/dL] over a 30-min horizon, RMSE = 18.87.. .. 2.25 [mg/dL] over a 60-min horizon) and real patient cases (RMSE = 21.07.. .. 2.35 [mg/dL] for 30 min, RMSE = 33.27.. .. 4.79% for 60 min). In addition, the model provides competitive performance in providing effective prediction horizon ([Formula: see text]) with minimal time lag both in a simulated patient dataset ([Formula: see text] = 29.0 .. 0.7 for 30 min and [Formula: see text] = 49.8.. .. 2.9 for 60 min) and in a real patient dataset ([Formula: see text] = 19.3.. .. 3.1 for 30 min and [Formula: see text] = 29.3.. .. 9.4 for 60 min). This approach is evaluated on a dataset of ten simulated cases generated from the UVA/Padova simulator and a clinical dataset of ten real cases each containing glucose readings, insulin bolus, and meal (carbohydrate) data. Performance of the recurrent convolutional neural network is benchmarked against four algorithms. The proposed algorithm is implemented on an Android mobile phone, with an execution time of 6..ms on a phone compared to an execution time of 780..ms on a laptop.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kezhi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Pau</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30946685</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2019.2908488</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30923284</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Automated Rating of Multiple Sclerosis Test Results Using a Convolutional Neural Network.</ArticleTitle><Pagination><MedlinePgn>105-108</MedlinePgn></Pagination><Abstract><AbstractText>This work concerns methods for automated rating of the progression of Multiple Sclerosis (MS). Often, MS patients develop cognitive deficits. The Brief Visuospatial Memory Test-Revised (BVMT-R) is a recognized method to measure optical recognition deficits and their progression. Typically, the test is carried out on paper using geometric figures which the patient should recognize and trace. The results are rated manually by a physician. The goal of this work was to digitize the BVMT-R and to support the interpretation of the test results using a machine learning (ML) algorithm. A convolutional neural network (CNN) was used to rate the drawings of a patient. As a result, the correct point value of the BVMT-R could be determined with an accuracy between 57% and 76% based on a training set of 624 patient drawings obtained from 135 patients. These drawings had been previously physician rated to serve as a gold standard. In our experiment, we obtained reasonable accuracy above 80% when more than 40 drawings were available, but our training sample was too small for more detailed analysis. Conclusion: At the currently achieved classification accuracy, results analysis will remain a physician task, potentially supported with ML based preclassification, but there is hope that ML accuracy can be further improved to enable automated follow-ups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Birchmeier</LastName><ForeName>Martin Eduard</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Bern University of Applied Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Studer</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Bern University of Applied Sciences.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="Y">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BICAMS</Keyword><Keyword MajorTopicYN="N">BVMT-R</Keyword><Keyword MajorTopicYN="N">Convolutional neural network</Keyword><Keyword MajorTopicYN="N">Machine Learning</Keyword><Keyword MajorTopicYN="N">Multiple Sclerosis</Keyword><Keyword MajorTopicYN="N">digitalize</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30923284</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30894435</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-5042</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>03</Month><Day>20</Day></PubDate></JournalIssue><Title>mSphere</Title><ISOAbbreviation>mSphere</ISOAbbreviation></Journal><ArticleTitle>Identification of Differentiating Metabolic Pathways between Infant Gut Microbiome Populations Reveals Depletion of Function-Level Adaptation to Human Milk in the Finnish Population.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00152-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mSphereDirect.00152-19</ELocationID><Abstract><AbstractText>A variety of autoimmune and allergy events are becoming increasingly common, especially in Western countries. Some pieces of research link such conditions with the composition of microbiota during infancy. In this period, the predominant form of nutrition for gut microbiota is oligosaccharides from human milk (HMO). A number of gut-colonizing strains, such as <i>Bifidobacterium</i> and <i>Bacteroides</i>, are able to utilize HMO, but only some <i>Bifidobacterium</i> strains have evolved to digest the specific composition of human oligosaccharides. Differences in the proportions of the two genera that are able to utilize HMO have already been associated with the frequency of allergies and autoimmune diseases in the Finnish and the Russian populations. Our results show that differences in terms of the taxonomic annotation do not explain the reason for the differences in the <i>Bifidobacterium</i>/<i>Bacteroides</i> ratio between the Finnish and the Russian populations. In this paper, we present the results of function-level analysis. Unlike the typical workflow for gene abundance analysis, BiomeScout technology explains the differences in the <i>Bifidobacterium</i>/<i>Bacteroides</i> ratio. Our research shows the differences in the abundances of the two enzymes that are crucial for the utilization of short type 1 oligosaccharides.<b>IMPORTANCE</b> Knowing the limitations of taxonomy-based research, there is an emerging need for the development of higher-resolution techniques. The significance of this research is demonstrated by the novel method used for the analysis of function-level metagenomes. BiomeScout-the presented technology-utilizes proprietary algorithms for the detection of differences between functionalities present in metagenomic samples.</AbstractText><CopyrightInformation>Copyright .. 2019 Majta et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Majta</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9042-754X</Identifier><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Biophysics and Bioinformatics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odrzywolek</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6938-4418</Identifier><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, Faculty of Computer Science, Electronics and Telecommunications, AGH University of Science and Technology, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanovic</LastName><ForeName>Bozena</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7762-8021</Identifier><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubar</LastName><ForeName>Vladyslav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrobel</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7921-2334</Identifier><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Physics, Institute of Physics, Astronomy and Applied Computer Sciences, Jagiellonian University, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strycharz-Angrecka</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojciechowski</LastName><ForeName>Szymon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanowska</LastName><ForeName>Kaja</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2187-7616</Identifier><AffiliationInfo><Affiliation>Ardigen, Krakow, Poland kaja.milanowska@ardigen.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mSphere</MedlineTA><NlmUniqueID>101674533</NlmUniqueID><ISSNLinking>2379-5042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009844">Oligosaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000222" MajorTopicYN="Y">Adaptation, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001439" MajorTopicYN="N">Bacteroides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001644" MajorTopicYN="N">Bifidobacterium</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053858" MajorTopicYN="Y">Metabolic Networks and Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056186" MajorTopicYN="N">Metagenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="N">Milk, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009844" MajorTopicYN="N">Oligosaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bioinformatics</Keyword><Keyword MajorTopicYN="Y">gut microbiome</Keyword><Keyword MajorTopicYN="Y">infant microbiome</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">microbiome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30894435</ArticleId><ArticleId IdType="pii">4/2/e00152-19</ArticleId><ArticleId IdType="doi">10.1128/mSphereDirect.00152-19</ArticleId><ArticleId IdType="pmc">PMC6429046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Agric Food Chem. 2007 Oct 31;55(22):8914-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17915960</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Biotechnol Biochem. 2016;80(4):621-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26838671</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Bioinformatics. 2013 Jun;Chapter 3:Unit3.1</Citation><ArticleIdList><ArticleId IdType="pubmed">23749753</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycobiology. 2012 Mar;22(3):361-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21926104</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Mol Biol Rev. 2017 Nov 8;81(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">29118049</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014 Mar 03;15(3):R46</Citation><ArticleIdList><ArticleId IdType="pubmed">24580807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Clin North Am. 2013 Feb;60(1):49-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23178060</ArticleId></ArticleIdList></Reference><Reference><Citation>mSphere. 2018 Mar 7;3(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29564397</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Mol Biol Rev. 2010 Sep;74(3):378-416</Citation><ArticleIdList><ArticleId IdType="pubmed">20805404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Mar 15;31(6):926-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25398609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2016 Feb;158:52-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26627987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2011 Nov 17;10(5):507-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22036470</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2014 May;80(9):2889-900</Citation><ArticleIdList><ArticleId IdType="pubmed">24584251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Mar 16;46(5):2699</Citation><ArticleIdList><ArticleId IdType="pubmed">29425356</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Jun 28;7:12015</Citation><ArticleIdList><ArticleId IdType="pubmed">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chim Acta. 2015 Dec 7;451(Pt A):97-102</Citation><ArticleIdList><ArticleId IdType="pubmed">25584460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 May 13;17(5):592-602</Citation><ArticleIdList><ArticleId IdType="pubmed">25974301</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2008 Jul;74(13):3996-4004</Citation><ArticleIdList><ArticleId IdType="pubmed">18469123</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2009 Mar 27;387(2):416-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19135455</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):61-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10630441</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Neurol Neurosci Rep. 2014 Oct;14(10):492</Citation><ArticleIdList><ArticleId IdType="pubmed">25204849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2018 Oct;562(7728):589-594</Citation><ArticleIdList><ArticleId IdType="pubmed">30356183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Sep 24;9(1):3891</Citation><ArticleIdList><ArticleId IdType="pubmed">30250208</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D170-D176</Citation><ArticleIdList><ArticleId IdType="pubmed">27899574</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2016 Jun 1;102:3-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27012178</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2010 Apr;160(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20415844</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycobiology. 2012 Sep;22(9):1147-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22513036</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Genomics. 2015;2015:567809</Citation><ArticleIdList><ArticleId IdType="pubmed">26236711</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Gastroenterol. 2015 Jan;31(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25394236</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Perinatol. 2011 Jun;38(2):321-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21645799</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2018 Jan 5;359(6371):104-108</Citation><ArticleIdList><ArticleId IdType="pubmed">29302014</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Nutr. 2012 May 01;3(3):473S-82S</Citation><ArticleIdList><ArticleId IdType="pubmed">22585927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2014 May;146(6):1489-99</Citation><ArticleIdList><ArticleId IdType="pubmed">24560869</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2018 Jan 5;359(6371):97-103</Citation><ArticleIdList><ArticleId IdType="pubmed">29097493</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Pediatr. 2016 Mar;170(3):212-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26752321</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Microbiol Ecol. 2003 Feb 1;43(1):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19719691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Jan;12(1):59-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25402007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584</Citation><ArticleIdList><ArticleId IdType="pubmed">28743984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Feb 28;46(4):e23</Citation><ArticleIdList><ArticleId IdType="pubmed">29194524</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2015 Feb;21(2):109-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25578246</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2018 Jan 5;359(6371):91-97</Citation><ArticleIdList><ArticleId IdType="pubmed">29097494</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2012 Jul;18 Suppl 4:12-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22647041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutr Rev. 2016 Oct;74(10):635-44</Citation><ArticleIdList><ArticleId IdType="pubmed">27634978</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 1996 Mar 15;235(2):202-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8833329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Res. 2015 Jan;77(1-2):229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">25303277</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 May 5;165(4):842-53</Citation><ArticleIdList><ArticleId IdType="pubmed">27133167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30877925</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Multiple sclerosis and related disorders</Title><ISOAbbreviation>Mult Scler Relat Disord</ISOAbbreviation></Journal><ArticleTitle>Metabolome-based signature of disease pathology in MS.</ArticleTitle><Pagination><MedlinePgn>12-21</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-0348(19)30111-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msard.2019.03.006</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diagnostic delays are common for multiple sclerosis (MS) since diagnosis typically depends on the presentation of nonspecific clinical symptoms together with radiologically-determined central nervous system (CNS) lesions. It is important to reduce diagnostic delays as earlier initiation of disease modifying therapies mitigates long-term disability. Developing a metabolomic blood-based MS biomarker is attractive, but prior efforts have largely focused on specific subsets of metabolite classes or analytical platforms. Thus, there are opportunities to interrogate metabolite profiles using more expansive and comprehensive approaches for developing MS biomarkers and for advancing our understanding of MS pathogenesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To identify putative blood-based MS biomarkers, we comprehensively interrogated the metabolite profiles in 12 non-Hispanic white, non-smoking, male MS cases who were drug na..ve for 3 months prior to biospecimen collection and 13 non-Hispanic white, non-smoking male controls who were frequency matched to cases by age and body mass index. We performed untargeted two-dimensional gas chromatography and time-of-flight mass spectrometry (GCxGC-TOFMS) and targeted lipidomic and amino acid analysis on serum. 325 metabolites met quality control and supervised machine learning was used to identify metabolites most informative for MS status. The discrimination potential of these select metabolites were assessed using receiver operator characteristic curves based on logistic models; top candidate metabolites were defined as having area under the curves (AUC) &gt;80%. The associations between whole-genome expression data and the top candidate metabolites were examined, followed by pathway enrichment analyses. Similar associations were examined for 175 putative MS risk variants and the top candidate metabolites.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">12 metabolites were determined to be informative for MS status, of which 6 had AUCs &gt;80%: pyroglutamate, laurate, acylcarnitine C14:1, N-methylmaleimide, and 2 phosphatidylcholines (PC ae 40:5, PC ae 42:5). These metabolites participate in glutathione metabolism, fatty acid metabolism/oxidation, cellular membrane composition, and transient receptor potential channel signaling. Pathway analyses based on the gene expression association for each metabolite suggested enrichment for pathways associated with apoptosis and mitochondrial dysfunction. Interestingly, the predominant MS genetic risk allele HLA-DRB1..15:01 was associated with one of the 6 top metabolites.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our analysis represents the most comprehensive description of metabolic changes associated with MS in serum, to date, with the inclusion of genomic and genetic information. We identified atypical metabolic processes that differed between MS patients and controls, which may enable the development of biological targets for diagnosis and treatment.</AbstractText><CopyrightInformation>Copyright .. 2019. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>S L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Discovery MS, David H. Murdock Research Institute, 150 Research Campus Drive, Kannapolis, NC 28081, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>F B S</ForeName><Initials>FBS</Initials><AffiliationInfo><Affiliation>Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 2103 Cornell Rd, Cleveland, OH 44106, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winnike</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Analytical Sciences Laboratory, David H. Murdock Research Institute, 150 Research Campus Drive, Kannapolis, NC 28081, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natanzon</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 2103 Cornell Rd, Cleveland, OH 44106, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maichle</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical &amp; Translational Science Institute, Duke University, Durham, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knagge</LastName><ForeName>K J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Analytical Sciences Laboratory, David H. Murdock Research Institute, 150 Research Campus Drive, Kannapolis, NC 28081, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>L K</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Discovery MS, David H. Murdock Research Institute, 150 Research Campus Drive, Kannapolis, NC 28081, United States; Duke Molecular Physiology Institute, 300 North Duke Street, Duke University, Durham, NC 27701, United States. Electronic address: simon.gregory@duke.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 CA092049</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001117</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mult Scler Relat Disord</MedlineTA><NlmUniqueID>101580247</NlmUniqueID><ISSNLinking>2211-0348</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="Y">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Gene expression</Keyword><Keyword MajorTopicYN="N">Genotype</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Serum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30877925</ArticleId><ArticleId IdType="pii">S2211-0348(19)30111-7</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2019.03.006</ArticleId><ArticleId IdType="pmc">PMC6548586</ArticleId><ArticleId IdType="mid">NIHMS1524147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Biol Chem. 1999 Mar 26;274(13):8823-31</Citation><ArticleIdList><ArticleId IdType="pubmed">10085124</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2003 Feb 25;60(4):634-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12601105</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2006 Mar 24;124(6):1269-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16564016</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2007 Jan;8(1):118-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16632515</ArticleId></ArticleIdList></Reference><Reference><Citation>Metab Brain Dis. 2007 Mar;22(1):51-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17238006</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007 Jul 04;2(7):e595</Citation><ArticleIdList><ArticleId IdType="pubmed">17611627</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Sci. 2008 Sep;29 Suppl 2:S253-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18690509</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):22-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19057183</ArticleId></ArticleIdList></Reference><Reference><Citation>Metab Brain Dis. 2010 Jun;25(2):145-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20431931</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuromolecular Med. 2010 Dec;12(4):351-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20607622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Aug 5;466(7307):707-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20686565</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biochem Sci. 2010 Dec;35(12):669-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20863707</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2264-76</Citation><ArticleIdList><ArticleId IdType="pubmed">20864672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2011 Sep;17(9):1074-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Int. 2011;2011:167156</Citation><ArticleIdList><ArticleId IdType="pubmed">22096628</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):325-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22108055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2011 Dec 11;15(1):70-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22158513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2012 Aug;259(8):1530-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22278331</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2012 Mar;135(Pt 3):886-99</Citation><ArticleIdList><ArticleId IdType="pubmed">22366799</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Appl Genet Mol Biol. 2011;10(1):32</Citation><ArticleIdList><ArticleId IdType="pubmed">22889876</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transl Res. 2012;4(4):458-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23145214</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Chem. 2013 Feb;51(2):102-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23255426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Jul 15;29(14):1786-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23665844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Apr;20(5):558-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24080986</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Nov;45(11):1274-1283</Citation><ArticleIdList><ArticleId IdType="pubmed">24097068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2014 Jan;13(1):113-26</Citation><ArticleIdList><ArticleId IdType="pubmed">24331797</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E15-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24367103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Sep;20(10):1396-400</Citation><ArticleIdList><ArticleId IdType="pubmed">24468817</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2014 Apr;10(4):225-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24638138</ArticleId></ArticleIdList></Reference><Reference><Citation>Naunyn Schmiedebergs Arch Pharmacol. 2015 Apr;388(4):451-63</Citation><ArticleIdList><ArticleId IdType="pubmed">25640188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2015 Jun;11(6):1563-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25690641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2015 Apr 3;14(4):1810-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25735966</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 Apr 23;520(7548):511-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25855297</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2015 Nov;161(1):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26143623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 2015 Dec;68(2 Pt C):507-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26277274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2015 Nov;16(11):1174-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26414764</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2015 Oct 20;43(4):817-29</Citation><ArticleIdList><ArticleId IdType="pubmed">26488817</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 2016 Dec;64(12):2166-2180</Citation><ArticleIdList><ArticleId IdType="pubmed">27568827</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Test Mol Biomarkers. 2016 Dec;20(12):747-752</Citation><ArticleIdList><ArticleId IdType="pubmed">27611910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2017 May 1;26(9):1770-1784</Citation><ArticleIdList><ArticleId IdType="pubmed">28334899</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2017 Jan 1;2017:</Citation><ArticleIdList><ArticleId IdType="pubmed">28605766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Jun 22;8:15890</Citation><ArticleIdList><ArticleId IdType="pubmed">28639618</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:57-59</Citation><ArticleIdList><ArticleId IdType="pubmed">28651698</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biochem Cell Biol. 2017 Dec;93:148-155</Citation><ArticleIdList><ArticleId IdType="pubmed">28720279</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Jul 26;12(7):e0181758</Citation><ArticleIdList><ArticleId IdType="pubmed">28746356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroinflammation. 2017 Sep 12;14(1):184</Citation><ArticleIdList><ArticleId IdType="pubmed">28899400</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2017 Sep 1;186(5):503-509</Citation><ArticleIdList><ArticleId IdType="pubmed">28911009</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2017 Oct 5;2(19):</Citation><ArticleIdList><ArticleId IdType="pubmed">28978801</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 Nov 28;89(22):2230-2237</Citation><ArticleIdList><ArticleId IdType="pubmed">29079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D1271-D1281</Citation><ArticleIdList><ArticleId IdType="pubmed">29106664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 Jan;24(1):12-16</Citation><ArticleIdList><ArticleId IdType="pubmed">29307296</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2018 Jun;141(6):2286-2289.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">29391256</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2018 Feb 20;137(8):841-853</Citation><ArticleIdList><ArticleId IdType="pubmed">29459470</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2018 May;61(5):1046-1054</Citation><ArticleIdList><ArticleId IdType="pubmed">29556673</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2018 Jul 15;320:1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">29759134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494</Citation><ArticleIdList><ArticleId IdType="pubmed">29762782</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2018 Jun 04;12:226</Citation><ArticleIdList><ArticleId IdType="pubmed">29915533</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1996 Aug 9;271(32):19129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">8702588</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1998 Aug 21;273(34):21926-32</Citation><ArticleIdList><ArticleId IdType="pubmed">9705332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30874779</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>03</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis.</ArticleTitle><Pagination><MedlinePgn>e190606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.0606</ELocationID><Abstract><AbstractText Label="Importance">Knowing the future condition of a patient would enable a physician to customize current therapeutic options to prevent disease worsening, but predicting that future condition requires sophisticated modeling and information. If artificial intelligence models were capable of forecasting future patient outcomes, they could be used to aid practitioners and patients in prognosticating outcomes or simulating potential outcomes under different treatment scenarios.</AbstractText><AbstractText Label="Objective">To assess the ability of an artificial intelligence system to prognosticate the state of disease activity of patients with rheumatoid arthritis (RA) at their next clinical visit.</AbstractText><AbstractText Label="Design, Setting, and Participants">This prognostic study included 820 patients with RA from rheumatology clinics at 2 distinct health care systems with different electronic health record platforms: a university hospital (UH) and a public safety-net hospital (SNH). The UH and SNH had substantially different patient populations and treatment patterns. The UH has records on approximately 1 million total patients starting in January 2012. The UH data for this study were accessed on July 1, 2017. The SNH has records on 65...000 unique individuals starting in January 2013. The SNH data for the study were collected on February 27, 2018.</AbstractText><AbstractText Label="Exposures">Structured data were extracted from the electronic health record, including exposures (medications), patient demographics, laboratories, and prior measures of disease activity. A longitudinal deep learning model was used to predict disease activity for patients with RA at their next rheumatology clinic visit and to evaluate interhospital performance and model interoperability strategies.</AbstractText><AbstractText Label="Main Outcomes and Measures">Model performance was quantified using the area under the receiver operating characteristic curve (AUROC). Disease activity in RA was measured using a composite index score.</AbstractText><AbstractText Label="Results">A total of 578 UH patients (mean [SD] age, 57 [15] years; 477 [82.5%] female; 296 [51.2%] white) and 242 SNH patients (mean [SD] age, 60 [15] years; 195 [80.6%] female; 30 [12.4%] white) were included in the study. Patients at the UH compared with those at the SNH were seen more frequently (median time between visits, 100 vs 180 days) and were more frequently prescribed higher-class medications (biologics) (364 [63.0%] vs 70 [28.9%]). At the UH, the model reached an AUROC of 0.91 (95% CI, 0.86-0.96) in a test cohort of 116 patients. The UH-trained model had an AUROC of 0.74 (95% CI, 0.65-0.83) in the SNH test cohort (n...=...117) despite marked differences in the patient populations. In both settings, baseline prediction using each patients' most recent disease activity score had statistically random performance.</AbstractText><AbstractText Label="Conclusions and Relevance">The findings suggest that building accurate models to forecast complex disease outcomes using electronic health record data is possible and these models can be shared across hospitals with diverse patient populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Norgeot</LastName><ForeName>Beau</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glicksberg</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trupin</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lituiev</LastName><ForeName>Dmytro</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianfrancesco</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskotsky</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmajuk</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>San Francisco Veterans Affairs Medical Center, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdany</LastName><ForeName>Jinoos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-Driven Insights and Innovation, University of California Health, Oakland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AR074534</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM079719</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R18 HS025638</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 LM012381</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA195858</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070155</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AR063770</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AR075085</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30874779</ArticleId><ArticleId IdType="pii">2728001</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.0606</ArticleId><ArticleId IdType="pmc">PMC6484652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Rheum Dis. 2016 Jan;75(1):3-15</Citation><ArticleIdList><ArticleId IdType="pubmed">25969430</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Dec 13;316(22):2402-2410</Citation><ArticleIdList><ArticleId IdType="pubmed">27898976</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2002 Oct-Dec;35(5-6):352-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12968784</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Jan 07;350:g7594</Citation><ArticleIdList><ArticleId IdType="pubmed">25569120</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2018 Sep;22(5):1589-1604</Citation><ArticleIdList><ArticleId IdType="pubmed">29989977</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2017 Mar 1;24(2):361-370</Citation><ArticleIdList><ArticleId IdType="pubmed">27521897</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 Dec;68(12):1866-1873</Citation><ArticleIdList><ArticleId IdType="pubmed">27696755</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26545825</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 Jan 25;8:25</Citation><ArticleIdList><ArticleId IdType="pubmed">17254353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Apr 17;8(1):6085</Citation><ArticleIdList><ArticleId IdType="pubmed">29666385</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 1988 Oct 5;80(15):1198-202</Citation><ArticleIdList><ArticleId IdType="pubmed">3047407</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1988 Sep;44(3):837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Soc Interface. 2018 Apr;15(141):</Citation><ArticleIdList><ArticleId IdType="pubmed">29618526</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:176-83</Citation><ArticleIdList><ArticleId IdType="pubmed">27570666</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Feb 2;542(7639):115-118</Citation><ArticleIdList><ArticleId IdType="pubmed">28117445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 17;6:26094</Citation><ArticleIdList><ArticleId IdType="pubmed">27185194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Oct;64(10):1490-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22623324</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2018 Oct 1;25(10):1419-1428</Citation><ArticleIdList><ArticleId IdType="pubmed">29893864</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2018 Nov 27;19(6):1236-1246</Citation><ArticleIdList><ArticleId IdType="pubmed">28481991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheum Dis Clin North Am. 1990 Aug;16(3):513-37</Citation><ArticleIdList><ArticleId IdType="pubmed">2217956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2014 Mar;73(3):492-509</Citation><ArticleIdList><ArticleId IdType="pubmed">24161836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2019 Jan;25(1):14-15</Citation><ArticleIdList><ArticleId IdType="pubmed">30617337</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30862608</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes.</ArticleTitle><Pagination><MedlinePgn>617-628</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2018-214354</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Juvenile idiopathic arthritis (JIA) is the most common class of childhood rheumatic diseases, with distinct disease subsets that may have diverging pathophysiological origins. Both adaptive and innate immune processes have been proposed as primary drivers, which may account for the observed clinical heterogeneity, but few high-depth studies have been performed.</AbstractText><AbstractText Label="METHODS">Here we profiled the adaptive immune system of 85 patients with JIA and 43 age-matched controls with indepth flow cytometry and machine learning approaches.</AbstractText><AbstractText Label="RESULTS">Immune profiling identified immunological changes in patients with JIA. This immune signature was shared across a broad spectrum of childhood inflammatory diseases. The immune signature was identified in clinically distinct subsets of JIA, but was accentuated in patients with systemic JIA and those patients with active disease. Despite the extensive overlap in the immunological spectrum exhibited by healthy children and patients with JIA, machine learning analysis of the data set proved capable of discriminating patients with JIA from healthy controls with ~90% accuracy.</AbstractText><AbstractText Label="CONCLUSIONS">These results pave the way for large-scale immune phenotyping longitudinal studies of JIA. The ability to discriminate between patients with JIA and healthy individuals provides proof of principle for the use of machine learning to identify immune signatures that are predictive to treatment response group.</AbstractText><CopyrightInformation>.. Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Van Nieuwenhove</LastName><ForeName>Erika</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7933-1800</Identifier><AffiliationInfo><Affiliation>UZ Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lagou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Eyck</LastName><ForeName>Lien</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UZ Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dooley</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodenhofer</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Bioinformatics, Linz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LIT AI Lab, Linz Institute of Technology, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>QUOMATIC.AI, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roca</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandebergh</LastName><ForeName>Marijne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goris</LastName><ForeName>An</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humblet-Baron</LastName><ForeName>St..phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wouters</LastName><ForeName>Carine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UZ Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liston</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6272-4085</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium adrian.liston@babraham.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Babraham Institute, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="N">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">B cells</Keyword><Keyword MajorTopicYN="Y">T cells</Keyword><Keyword MajorTopicYN="Y">autoimmune diseases</Keyword><Keyword MajorTopicYN="Y">juvenile idiopathic arthritis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30862608</ArticleId><ArticleId IdType="pii">annrheumdis-2018-214354</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2018-214354</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30851764</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1715-3360</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>02</Month></PubDate></JournalIssue><Title>Canadian journal of ophthalmology. Journal canadien d'ophtalmologie</Title><ISOAbbreviation>Can J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Support Vector Machines and logistic regression to predict temporal artery biopsy outcomes.</ArticleTitle><Pagination><MedlinePgn>116-118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0008-4182(18)30228-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcjo.2018.05.006</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Support vector machines (SVM) is a newer statistical method that has been reported to be advantageous to traditional logistic regression for clinical classification. We determine if SVM can better predict the results of temporal artery biopsy (TABx) for giant cell arteritis compared to logistic regression.</AbstractText><AbstractText Label="METHOD">A database of 530 TABx patients with 10 covariates was used and randomly split into training and test sets. The area under the receiving operating curve (AUC), misclassification rate (MCR), and false negative rate (FN) were compared for SVM and logistic regression. AUC and MCR were used to tune the SVM.</AbstractText><AbstractText Label="RESULTS">The SVM model with optimal AUC had gamma...=...0.01267 and cost...=...26.466, with 133 support vectors. The AUC/MCR/FN for logistic regression and SVM respectively were 0.827/0.184/0.524 and 0.825/0.168/0.571.</AbstractText><AbstractText Label="CONCLUSION">In our dataset of 530 TABx subjects, SVM did not offer any distinct advantage over the logistic regression prediction model.</AbstractText><CopyrightInformation>Copyright .. 2018 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ing</LastName><ForeName>Edsel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ont.; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ont.. Electronic address: edingLidStrab@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Wanhua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, MacEwan University, Edmonton, Alta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schonlau</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torun</LastName><ForeName>Nurhan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ont.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Ophthalmol</MedlineTA><NlmUniqueID>0045312</NlmUniqueID><ISSNLinking>0008-4182</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013700" MajorTopicYN="N">Giant Cell Arteritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013699" MajorTopicYN="N">Temporal Arteries</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30851764</ArticleId><ArticleId IdType="pii">S0008-4182(18)30228-X</ArticleId><ArticleId IdType="doi">10.1016/j.jcjo.2018.05.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30831253</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-7035</ISSN><JournalIssue CitedMedium="Internet"><Volume>202</Volume><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>Clinical immunology (Orlando, Fla.)</Title><ISOAbbreviation>Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Compendium of synovial signatures identifies pathologic characteristics for predicting treatment response in rheumatoid arthritis patients.</ArticleTitle><Pagination><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1521-6616(18)30733-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2019.03.002</ELocationID><Abstract><AbstractText>Rheumatoid arthritis (RA) is therapeutically challenging due to patient heterogeneity and variability. Herein we describe a novel integration of RA synovial genome-scale transcriptomic profiling of different patient cohorts that can be used to provide predictive insights on drug responses. A normalized compendium consisting of 256 RA synovial samples that cover an intersection of 11,769 genes from 11 datasets was build and compared with similar datasets derived from OA patients and healthy controls. Differentially expression genes (DEGs) that were identified in three independent methods were fed into functional network analysis, with subsequent grouping of the samples based on a non-negative matrix factorization method. RA-relevant pathway activation scores and four machine learning classification techniques supported the generation of a predictive model of patient treatment response. We identified 876 up-regulated DEGs including 24 known genetic risk factors and 8 drug targets. DEG-based subgrouping revealed 3 distinct RA patient clusters with distinct activity signatures for RA-relevant pathways. In the case of infliximab, we constructed a classifier of drug response that was highly accurate with an AUC/AUPR of 0.92/0.86. The most informative pathways in achieving this performance were the NF..B-, Fc..RI- TCR-, and TNF signaling pathways. Similarly, the expression of the HMMR, PRPF4B, EVI2A, RAB27A, MALT1, SNX6, and IFIH1 genes contributed in predicting the patient outcome. Construction and analysis of normalized synovial transcriptomic compendia can provide useful insights for understanding RA-related pathway involvement and drug responses for individual patients.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ki-Jo</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Computer Science, University of California at Davis, California, United States; Genome Center, University of California at Davis, California, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minseung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California at Davis, California, United States; Genome Center, University of California at Davis, California, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamopoulos</LastName><ForeName>Iannis E</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California at Davis, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tagkopoulos</LastName><ForeName>Ilias</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California at Davis, California, United States; Genome Center, University of California at Davis, California, United States. Electronic address: itagkopoulos@ucdavis.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR062173</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Immunol</MedlineTA><NlmUniqueID>100883537</NlmUniqueID><ISSNLinking>1521-6616</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013583" MajorTopicYN="N">Synovial Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Clustering</Keyword><Keyword MajorTopicYN="Y">Drug responsiveness</Keyword><Keyword MajorTopicYN="Y">Gene expression</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Rheumatoid arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30831253</ArticleId><ArticleId IdType="pii">S1521-6616(18)30733-2</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2019.03.002</ArticleId><ArticleId IdType="pmc">PMC7605311</ArticleId><ArticleId IdType="mid">NIHMS1018093</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Autoimmun Rev. 2010 Feb;9(4):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19683077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2009;4(1):44-57</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2013 Jan;9(1):24-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23147896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D833-D839</Citation><ArticleIdList><ArticleId IdType="pubmed">27924018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2004 Jan 1;32(Database issue):D497-501</Citation><ArticleIdList><ArticleId IdType="pubmed">14681466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v3-11</Citation><ArticleIdList><ArticleId IdType="pubmed">22718924</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jun 25;5(6):e11310</Citation><ArticleIdList><ArticleId IdType="pubmed">20593016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Jan;69 Suppl 1:i37-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19995742</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 04;10(3):e0118432</Citation><ArticleIdList><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 May;11(5):276-89</Citation><ArticleIdList><ArticleId IdType="pubmed">25687177</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Dec;62(12):3607-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20722020</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 May;67(5):1214-1220</Citation><ArticleIdList><ArticleId IdType="pubmed">25605621</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2014 Apr 01;16(2):R84</Citation><ArticleIdList><ArticleId IdType="pubmed">24690414</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(12):e51508</Citation><ArticleIdList><ArticleId IdType="pubmed">23240033</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2011 Mar;7(3):e1001095</Citation><ArticleIdList><ArticleId IdType="pubmed">21390271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 Jun;11(6):375-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25668139</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4164-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15016911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 Aug;66(8):1008-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17223656</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Aug;62(8):2272-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20506326</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Jun;62(6):1602-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20178127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Signal. 2013 Oct;25(10):2069-78</Citation><ArticleIdList><ArticleId IdType="pubmed">23602936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D358-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24234451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16381927</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Aug;48(8):2132-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12905466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2004 Apr;43(4):405-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14679296</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Sep 29;375(13):1216-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27682033</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2006;7(10):R93</Citation><ArticleIdList><ArticleId IdType="pubmed">17044931</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Nov 15;5(11):e13984</Citation><ArticleIdList><ArticleId IdType="pubmed">21085593</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Feb 16;376(7):652-662</Citation><ArticleIdList><ArticleId IdType="pubmed">28199814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Sep 15;358(9285):903-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11567728</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18081-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15596723</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1986 Aug;29(8):1039-49</Citation><ArticleIdList><ArticleId IdType="pubmed">3741515</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2015 Apr;36(4):189-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25732812</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2012 May;41(3):170-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22401175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Jan;66(1):15-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24449571</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26656494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361</Citation><ArticleIdList><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Dis Primers. 2018 Feb 08;4:18001</Citation><ArticleIdList><ArticleId IdType="pubmed">29417936</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Jan;39(1):34-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8546736</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2002 Jul;2(7):527-35</Citation><ArticleIdList><ArticleId IdType="pubmed">12094227</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 Jul;34(3):267-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2016 Sep 1;76(17):4948-58</Citation><ArticleIdList><ArticleId IdType="pubmed">27302169</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics J. 2014 Apr;14(2):93-106</Citation><ArticleIdList><ArticleId IdType="pubmed">24589910</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Nov;64(11):3553-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22833339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368</Citation><ArticleIdList><ArticleId IdType="pubmed">27924014</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Regul Syst Bio. 2008 May 15;2:193-201</Citation><ArticleIdList><ArticleId IdType="pubmed">19787083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2005 Jun;64(6):834-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15576415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2013 Jul;52(7):1155-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23297340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30815180</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Integrated machine learning pipeline for aberrant biomarker enrichment (i-mAB): characterizing clusters of differentiation within a compendium of systemic lupus erythematosus patients.</ArticleTitle><Pagination><MedlinePgn>1358-1367</MedlinePgn></Pagination><Abstract><AbstractText>Clusters of differentiation (<b>CD</b>) are cell surface biomarkers that denote key biological differences between cell types and disease state. CD-targeting therapeutic monoclonal antibodies (<b>mABs</b>) afford rich trans-disease repositioning opportunities. Within a compendium of systemic lupus erythematous (<b>SLE</b>) patients, we applied the Integrated machine learning pipeline for aberrant biomarker enrichment (<b>i-mAB</b>) to profile <i>de novo</i> gene expression features affecting CD20, CD22 and CD30 gene aberrance. First, a novel Relief-based algorithm identified interdependent features(p=681) predicting treatment-na..ve SLE patients (balanced accuracy=0.822). We then compiled CD-associated expression profiles using regularized logistic regression and pathway enrichment analyses. On an independent general cell line model system data, we replicated associations (<i>in silico</i>) of <i>BCL7A</i> (p<sub>adj</sub>=1.69e-9) and <i>STRBP</i>(p<sub>adj</sub>=4.63e-8) with CD22; <i>NCOA2</i>(p<sub>adj</sub>=7.00e-4), <i>ATN1</i> (p<sub>adj</sub>=1.71e-2), and <i>HOXC4</i>(p<sub>adj</sub>=3.34e-2) with CD30; and <i>PHOSPHO1</i>, a phosphatase linked to bone mineralization, with both CD22(p<sub>adj</sub>=4.37e-2) and CD30(p<sub>adj</sub>=7.40e-3). Utilizing carefully aggregated secondary data and leveraging <i>a priori</i> hypotheses, i-mAB fostered robust biomarker profiling among interdependent biological features.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Trang T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackwood</LastName><ForeName>Nigel O</ForeName><Initials>NO</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taroni</LastName><ForeName>Jaclyn N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Weixuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Pharmacology and Translational Therapeutics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breitenstein</LastName><ForeName>Matthew K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Informatics.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 CA092049</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018951">Antigens, CD20</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017730">Ki-1 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051918">Sialic Acid Binding Ig-like Lectin 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018951" MajorTopicYN="N">Antigens, CD20</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017730" MajorTopicYN="N">Ki-1 Antigen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051918" MajorTopicYN="N">Sialic Acid Binding Ig-like Lectin 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Relief-based machine learning; systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="Y">clusters of differentiation</Keyword><Keyword MajorTopicYN="Y">data re-use</Keyword><Keyword MajorTopicYN="Y">trans-disease biomarker profile</Keyword><Keyword MajorTopicYN="Y">transcriptomics</Keyword><Keyword MajorTopicYN="Y">translational bioinformatics pipeline</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815180</ArticleId><ArticleId IdType="pmc">PMC6371296</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Gen Intern Med. 2011 Aug;26(8):920-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21301985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Res. 2015;165:27-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25655605</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2011 Jan 30;134(2):137-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20923685</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2014 Feb;1843(2):398-435</Citation><ArticleIdList><ArticleId IdType="pubmed">24188867</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Mar;5(3):e1000432</Citation><ArticleIdList><ArticleId IdType="pubmed">19300503</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2010 Jul;9(7):519-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20531273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2001 Sep;2(9):764-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11526379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2015 Sep;24(10):1057-66</Citation><ArticleIdList><ArticleId IdType="pubmed">25736140</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2008 Jul 18;29(1):150-64</Citation><ArticleIdList><ArticleId IdType="pubmed">18631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Immunology. 2015 Nov 13;4(11):e50</Citation><ArticleIdList><ArticleId IdType="pubmed">26682057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2001 Jun 1;61(11):4483-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11389079</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2012 Dec;100(6):337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22959562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2013 Apr;131(4):959-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23465663</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 May 26;356(6340):</Citation><ArticleIdList><ArticleId IdType="pubmed">28495876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2008 Jul;122(1):12-9; quiz 20-1</Citation><ArticleIdList><ArticleId IdType="pubmed">18547629</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2001 Nov 1;125(1-2):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11682119</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2013 Feb;65(2):447-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23203821</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Oct;67(10):2713-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26138472</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2014 Nov;13(11):1094-101</Citation><ArticleIdList><ArticleId IdType="pubmed">25149393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Nov 15;195(10):4555-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26546687</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Jun;66(6):1583-95</Citation><ArticleIdList><ArticleId IdType="pubmed">24644022</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2012 Mar 22;12(4):278-87</Citation><ArticleIdList><ArticleId IdType="pubmed">22437872</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanet J Rare Dis. 2008 Dec 16;3:33</Citation><ArticleIdList><ArticleId IdType="pubmed">19087348</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Apr 21;165(3):551-65</Citation><ArticleIdList><ArticleId IdType="pubmed">27040498</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013 Mar 22;14:106</Citation><ArticleIdList><ArticleId IdType="pubmed">23522326</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2018 Dec 05;2018:1358-1367</Citation><ArticleIdList><ArticleId IdType="pubmed">30815180</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30811739</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-2586</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>10</Month></PubDate></JournalIssue><Title>Journal of magnetic resonance imaging : JMRI</Title><ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation></Journal><ArticleTitle>Automated image quality evaluation of structural brain MRI using an ensemble of deep learning networks.</ArticleTitle><Pagination><MedlinePgn>1260-1267</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.26693</ELocationID><Abstract><AbstractText Label="BACKGROUND">Deep learning (DL) is a promising methodology for automatic detection of abnormalities in brain MRI.</AbstractText><AbstractText Label="PURPOSE">To automatically evaluate the quality of multicenter structural brain MRI images using an ensemble DL model based on deep convolutional neural networks (DCNNs).</AbstractText><AbstractText Label="STUDY TYPE">Retrospective.</AbstractText><AbstractText Label="POPULATION">The study included 1064 brain images of autism patients and healthy controls from the Autism Brain Imaging Data Exchange (ABIDE) database. MRI data from 110 multiple sclerosis patients from the CombiRx study were included for independent testing.</AbstractText><AbstractText Label="SEQUENCE">T<sub>1</sub> -weighted MR brain images acquired at 3T.</AbstractText><AbstractText Label="ASSESSMENT">The ABIDE data were separated into training (60%), validation (20%), and testing (20%) sets. The ensemble DL model combined the results from three cascaded networks trained separately on the three MRI image planes (axial, coronal, and sagittal). Each cascaded network consists of a DCNN followed by a fully connected network. The quality of image slices from each plane was evaluated by the DCNN and the resultant image scores were combined into a volumewise quality rating using the fully connected network. The DL predicted ratings were compared with manual quality evaluation by two experts.</AbstractText><AbstractText Label="STATISTICAL TESTS">Receiver operating characteristic (ROC) curve, area under ROC curve (AUC), sensitivity, specificity, accuracy, and positive (PPV) and negative (NPV) predictive values.</AbstractText><AbstractText Label="RESULTS">The AUC, sensitivity, specificity, accuracy, PPV, and NPV for image quality evaluation of the ABIDE test set using the ensemble model were 0.90, 0.77, 0.85, 0.84, 0.42, and 0.96, respectively. On the CombiRx set the same model achieved performance of 0.71, 0.41, 0.84, 0.73, 0.48, and 0.80.</AbstractText><AbstractText Label="DATA CONCLUSION">This study demonstrated the high accuracy of DL in evaluating image quality of structural brain MRI in multicenter studies.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:1260-1267.</AbstractText><CopyrightInformation>.. 2019 International Society for Magnetic Resonance in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sujit</LastName><ForeName>Sheeba J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-8302-7046</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronado</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamali</LastName><ForeName>Arash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayana</LastName><ForeName>Ponnada A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabr</LastName><ForeName>Refaat E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 NS105857</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Magn Reson Imaging</MedlineTA><NlmUniqueID>9105850</NlmUniqueID><ISSNLinking>1053-1807</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001321" MajorTopicYN="N">Autistic Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">brain MRI</Keyword><Keyword MajorTopicYN="Y">deep learning</Keyword><Keyword MajorTopicYN="Y">postprocessing</Keyword><Keyword MajorTopicYN="Y">quality assessment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30811739</ArticleId><ArticleId IdType="doi">10.1002/jmri.26693</ArticleId><ArticleId IdType="pmc">PMC6711839</ArticleId><ArticleId IdType="mid">NIHMS1012069</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuroinformatics. 2006 Summer;4(3):243-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16943630</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging. 2007 Oct;25(8):1196-202</Citation><ArticleIdList><ArticleId IdType="pubmed">17442523</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2008 Jun;35(6):2541-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18649487</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2009 Aug;62(2):365-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19526493</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2011 Apr;65(4):1053-61</Citation><ArticleIdList><ArticleId IdType="pubmed">21413069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2013 Mar;73(3):327-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23424159</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2014 Jun;19(6):659-67</Citation><ArticleIdList><ArticleId IdType="pubmed">23774715</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2012 Nov 30;2:120-31</Citation><ArticleIdList><ArticleId IdType="pubmed">24179765</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2015 Feb 15;107:107-115</Citation><ArticleIdList><ArticleId IdType="pubmed">25498430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2016 Jul;37(7):2385-97</Citation><ArticleIdList><ArticleId IdType="pubmed">27004471</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2016 Dec 19;10:52</Citation><ArticleIdList><ArticleId IdType="pubmed">28066227</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2018 Mar;47(3):723-728</Citation><ArticleIdList><ArticleId IdType="pubmed">28577329</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2017 Dec;42:60-88</Citation><ArticleIdList><ArticleId IdType="pubmed">28778026</ArticleId></ArticleIdList></Reference><Reference><Citation>MAGMA. 2018 Apr;31(2):243-256</Citation><ArticleIdList><ArticleId IdType="pubmed">28932991</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Sep 25;12(9):e0184661</Citation><ArticleIdList><ArticleId IdType="pubmed">28945803</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2018 Feb 1;166:400-424</Citation><ArticleIdList><ArticleId IdType="pubmed">29079522</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging. 2018 Nov;53:134-147</Citation><ArticleIdList><ArticleId IdType="pubmed">30036653</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Transl Eng Health Med. 2018 Aug 23;6:1800915</Citation><ArticleIdList><ArticleId IdType="pubmed">30197842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30807586</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>02</Month></PubDate></JournalIssue><Title>PLoS medicine</Title><ISOAbbreviation>PLoS Med</ISOAbbreviation></Journal><ArticleTitle>Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.</ArticleTitle><Pagination><MedlinePgn>e1002750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1002750</ELocationID><Abstract><AbstractText Label="BACKGROUND">Joint inflammation is the common feature underlying juvenile idiopathic arthritis (JIA). Clinicians recognize patterns of joint involvement currently not part of the International League of Associations for Rheumatology (ILAR) classification. Using unsupervised machine learning, we sought to uncover data-driven joint patterns that predict clinical phenotype and disease trajectories.</AbstractText><AbstractText Label="METHODS AND FINDINGS">We analyzed prospectively collected clinical data, including joint involvement using a standard 71-joint homunculus, for 640 discovery patients with newly diagnosed JIA enrolled in a Canada-wide study who were followed serially for five years, treatment-na..ve except for nonsteroidal anti-inflammatory drugs (NSAIDs) and diagnosed within one year of symptom onset. Twenty-one patients had systemic arthritis, 300 oligoarthritis, 125 rheumatoid factor (RF)-negative polyarthritis, 16 RF-positive polyarthritis, 37 psoriatic arthritis, 78 enthesitis-related arthritis (ERA), and 63 undifferentiated arthritis. At diagnosis, we observed global hierarchical groups of co-involved joints. To characterize these patterns, we developed sparse multilayer non-negative matrix factorization (NMF). Model selection by internal bi-cross-validation identified seven joint patterns at presentation, to which all 640 discovery patients were assigned: pelvic girdle (57 patients), fingers (25), wrists (114), toes (48), ankles (106), knees (283), and indistinct (7). Patterns were distinct from clinical subtypes (P &lt; 0.001 by ..2 test) and reproducible through external data set validation on a 119-patient, prospectively collected independent validation cohort (reconstruction accuracy Q2 = 0.55 for patterns; 0.35 for groups). Some patients matched multiple patterns. To determine whether their disease outcomes differed, we further subdivided the 640 discovery patients into three subgroups by degree of localization-the percentage of their active joints aligning with their assigned pattern: localized (...90%; 359 patients), partially localized (60%-90%; 124), or extended (&lt;60%; 157). Localized patients more often maintained their baseline patterns (P &lt; 0.05 for five groups by permutation test) than nonlocalized patients (P &lt; 0.05 for three groups by permutation test) over a five-year follow-up period. We modelled time to zero joints in the discovery cohort using a multivariate Cox proportional hazards model considering joint pattern, degree of localization, and ILAR subtype. Despite receiving more intense treatment, 50% of nonlocalized patients had zero joints at one year compared to six months for localized patients. Overall, localized patients required less time to reach zero joints (partial: P = 0.0018 versus localized by log-rank test; extended: P = 0.0057). Potential limitations include the requirement for patients to be treatment na..ve (except NSAIDs), which may skew the patient cohorts towards milder disease, and the validation cohort size precluded multivariate analyses of disease trajectories.</AbstractText><AbstractText Label="CONCLUSIONS">Multilayer NMF identified patterns of joint involvement that predicted disease trajectory in children with arthritis. Our hierarchical unsupervised approach identified a new clinical feature, degree of localization, which predicted outcomes in both cohorts. Detailed assessment of every joint is already part of every musculoskeletal exam for children with arthritis. Our study supports both the continued collection of detailed joint involvement and the inclusion of patterns and degrees of localization to stratify patients and inform treatment decisions. This will advance pediatric rheumatology from counting joints to realizing the potential of using data available from uncovering patterns of joint involvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eng</LastName><ForeName>Simon W M</ForeName><Initials>SWM</Initials><Identifier Source="ORCID">0000-0001-5495-0157</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vector Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aeschlimann</LastName><ForeName>Florence A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Veenendaal</LastName><ForeName>Mira</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6475-8193</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berard</LastName><ForeName>Roberta A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Children's Hospital, London Health Sciences Centre.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Schulich School of Medicine &amp; Dentistry, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Alan M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Quaid</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Vector Institute, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Rae S M</ForeName><Initials>RSM</Initials><Identifier Source="ORCID">0000-0003-2361-725X</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ReACCh-Out Research Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82517 </GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>QNT-69301</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>MOP-125894</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Med</MedlineTA><NlmUniqueID>101231360</NlmUniqueID><ISSNLinking>1549-1277</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="N">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007596" MajorTopicYN="N">Joints</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30807586</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002750</ArticleId><ArticleId IdType="pii">PMEDICINE-D-18-01990</ArticleId><ArticleId IdType="pmc">PMC6390994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Rheumatol. 2004 Feb;31(2):390-2</Citation><ArticleIdList><ArticleId IdType="pubmed">14760812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Mar 3;369(9563):767-778</Citation><ArticleIdList><ArticleId IdType="pubmed">17336654</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2005 Aug;44(8):1002-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15827044</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Jan;63(1):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20936630</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30</Citation><ArticleIdList><ArticleId IdType="pubmed">28416023</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Jul;29(7):1531-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12136915</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Sep;19(9):1639-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19541911</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Mar;52(3):826-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15751057</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Apr;62(4):527-36</Citation><ArticleIdList><ArticleId IdType="pubmed">20391508</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Dec;66(12):3463-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25200124</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2018 Jan;70(1):7-17</Citation><ArticleIdList><ArticleId IdType="pubmed">29024575</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1989 May;32(5):531-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2719728</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1994 Apr;37(4):470-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8147923</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2015 Sep-Oct;33(5):751-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26213158</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4164-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15016911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1999 Oct 21;401(6755):788-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10548103</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2014 Jul;66(7):1063-72</Citation><ArticleIdList><ArticleId IdType="pubmed">24339215</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21452260</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Jul;40(7):1202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9214419</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2014 Dec;41(12):2466-73</Citation><ArticleIdList><ArticleId IdType="pubmed">25274882</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Sep;32(9):1805-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16142881</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Jul 28;313(5786):504-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16873662</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1995 Jun;38(6):835-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7779128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2003 Feb;30(2):386-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12563700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30798638</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>16</Issue><PubDate><Year>2019</Year><Month>04</Month><Day>16</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.</ArticleTitle><Pagination><MedlinePgn>1900-1912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.118.037454</ELocationID><Abstract><AbstractText Label="BACKGROUND">The strength of association and optimal levels for risk factors related to excess risk of death and cardiovascular outcomes in type 1 diabetes mellitus have been sparsely studied.</AbstractText><AbstractText Label="METHODS">In a national observational cohort study from the Swedish National Diabetes Register from 1998 to 2014, we assessed relative prognostic importance of 17 risk factors for death and cardiovascular outcomes in individuals with type 1 diabetes mellitus. We used Cox regression and machine learning analyses. In addition, we examined optimal cut point levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol. Patients with type 1 diabetes mellitus were followed up until death or study end on December 31, 2013. The primary outcomes were death resulting from all causes, fatal/nonfatal acute myocardial infarction, fatal/nonfatal stroke, and hospitalization for heart failure.</AbstractText><AbstractText Label="RESULTS">Of 32...611 patients with type 1 diabetes mellitus, 1809 (5.5%) died during follow-up over 10.4 years. The strongest predictors for death and cardiovascular outcomes were glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol. Glycohemoglobin displayed ...2% higher risk for each 1-mmol/mol increase (equating to ...22% per 1% glycohemoglobin difference), whereas low-density lipoprotein cholesterol was associated with 35% to 50% greater risk for each 1-mmol/L increase. Microalbuminuria or macroalbuminuria was associated with 2 to 4 times greater risk for cardiovascular complications and death. Glycohemoglobin &lt;53 mmol/mol (7.0%), systolic blood pressure &lt;140 mm...Hg, and low-density lipoprotein cholesterol &lt;2.5 mmol/L were associated with significantly lower risk for outcomes observed.</AbstractText><AbstractText Label="CONCLUSIONS">Glycohemoglobin, albuminuria, duration of diabetes mellitus, systolic blood pressure, and low-density lipoprotein cholesterol appear to be the most important predictors for mortality and cardiovascular outcomes in patients with type 1 diabetes mellitus. Lower levels for glycohemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol than contemporary guideline target levels appear to be associated with significantly lower risk for outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Aidin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Araz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sattar</LastName><ForeName>Naveed</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK (N.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franz..n</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Metrics Unit, Sahlgrenska Academy, University of Gothenburg, Sweden (S.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>Darren K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eliasson</LastName><ForeName>Bj..rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svensson</LastName><ForeName>Ann-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zethelius</LastName><ForeName>Bj..rn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Sweden (B.Z.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miftaraj</LastName><ForeName>Mervete</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosengren</LastName><ForeName>Annika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudbj..rnsdottir</LastName><ForeName>Soffia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (A. Rawshani, A. Rawshani, S.F., B.E., A.-M.S., M.M., S.G.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="N">Cholesterol, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063868" MajorTopicYN="N">Patient Outcome Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">cardiovascular disease</Keyword><Keyword MajorTopicYN="Y">cerebrovascular disorders</Keyword><Keyword MajorTopicYN="Y">diabetes mellitus, type 1</Keyword><Keyword MajorTopicYN="Y">glycated hemoglobin A</Keyword><Keyword MajorTopicYN="Y">heart failure</Keyword><Keyword MajorTopicYN="Y">mortality</Keyword><Keyword MajorTopicYN="Y">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30798638</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.037454</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30723470</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage Inflammation.</ArticleTitle><Pagination><MedlinePgn>10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2019.00010</ELocationID><Abstract><AbstractText>Here, we outline an overview of the mammalian immune system that updates and extends the classical clonal selection paradigm. Rather than focusing on strict self-not-self discrimination, we propose that the system orchestrates variable inflammatory responses that maintain the body and its symbiosis with the microbiome while eliminating the threat from pathogenic infectious agents and from tumors. The paper makes four points: The immune system classifies healthy and pathologic states of the body-including both self and foreign elements-by deploying individual lymphocytes as cellular computing machines; immune cells transform input signals from the body into an output of specific immune reactions.Rather than independent clonal responses, groups of individually activated immune-system cells co-react in lymphoid organs to make collective decisions through a type of self-organizing swarm intelligence or crowd wisdom.Collective choices by swarms of immune cells, like those of schools of fish, are modified by relatively small numbers of individual regulators responding to shifting conditions-such collective inflammatory responses are dynamically responsive.Self-reactive autoantibody and T-cell receptor (TCR) repertoires shared by healthy individuals function in a biological version of experience-based supervised machine learning. Immune system decisions are primed by formative experience with training sets of self-antigens encountered during lymphocyte development; these initially trained T cell and B cell repertoires form a Wellness Profile that then guides immune responses to test sets of antigens encountered later. This experience-based machine learning strategy is analogous to that deployed by supervised machine-learning algorithms. We propose experiments to test these ideas. This overview of the immune system bears clinical implications for monitoring wellness and for treating autoimmune disease, cancer, and allograft reactions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Irun R</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efroni</LastName><ForeName>Sol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055633" MajorTopicYN="Y">Immune System Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="N">Immunity, Humoral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="Y">Immunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">T cells</Keyword><Keyword MajorTopicYN="Y">autoantibodies</Keyword><Keyword MajorTopicYN="Y">autoreactive repertoires</Keyword><Keyword MajorTopicYN="Y">immune computation</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">swarm intelligence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30723470</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.00010</ArticleId><ArticleId IdType="pmc">PMC6349705</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Immunology. 2010 Jul;130(3):427-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20201985</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2007 Mar;117(3):712-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17332892</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2017 Sep 25;27(18):2862-2868.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">28889975</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Jun 1;194(11):5272-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25917091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2014 Nov;54:112-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24924121</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1988 Jan 8;239(4836):181-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2447648</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 2003 Jan 22;270(1511):139-46</Citation><ArticleIdList><ArticleId IdType="pubmed">12590751</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 2000 Jun;21(6):265-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10825737</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2014 Sep 16;5:446</Citation><ArticleIdList><ArticleId IdType="pubmed">25278941</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 1992 Nov;13(11):441-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1476598</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2014 May;44(5):1299-312</Citation><ArticleIdList><ArticleId IdType="pubmed">24497074</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Immunol. 2015 Oct;59(10):573-85</Citation><ArticleIdList><ArticleId IdType="pubmed">26306708</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Clin Immunol. 2014 Jan;10(1):41-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24325346</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2000 Jun;12(3):215-9; discussion 257-344</Citation><ArticleIdList><ArticleId IdType="pubmed">10910742</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Immunol. 1991 Jan;33(1):3-13</Citation><ArticleIdList><ArticleId IdType="pubmed">1996406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Feb 22;482(7386):459-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22358810</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Immunol. 2013 Jan;33 Suppl 1:S27-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23229779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 2018 Sep;331:130-136</Citation><ArticleIdList><ArticleId IdType="pubmed">29929727</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Jul 21;6:</Citation><ArticleIdList><ArticleId IdType="pubmed">28731407</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 Jul;7(7):569-74</Citation><ArticleIdList><ArticleId IdType="pubmed">17558422</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2018 Sep 1;57(9):1632-1640</Citation><ArticleIdList><ArticleId IdType="pubmed">29873771</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2010 Apr;40(4):936-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20309907</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 22;14(11):2733-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26972015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 Oct;7(10):823-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17893695</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2013 Jul 11;4:190</Citation><ArticleIdList><ArticleId IdType="pubmed">23874336</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2018 Dec;104(6):1097-1104</Citation><ArticleIdList><ArticleId IdType="pubmed">30168881</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2016 Dec;43:8-15</Citation><ArticleIdList><ArticleId IdType="pubmed">27504588</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Syst Biol. 2011 Feb 10;5:27</Citation><ArticleIdList><ArticleId IdType="pubmed">21310065</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1989 May 19;244(4906):820-2</Citation><ArticleIdList><ArticleId IdType="pubmed">2471264</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2015 Dec 10;4:e10955</Citation><ArticleIdList><ArticleId IdType="pubmed">26652003</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2000 Jun;12(3):189-95; discussion 257-344</Citation><ArticleIdList><ArticleId IdType="pubmed">10910739</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1993 Nov;23(11):2851-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8223861</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2017 Apr 26;35:85-118</Citation><ArticleIdList><ArticleId IdType="pubmed">28226225</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2009 Sep;128(1):92-102</Citation><ArticleIdList><ArticleId IdType="pubmed">19689739</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Law. 2014 Jul;33(2):33-40</Citation><ArticleIdList><ArticleId IdType="pubmed">27359006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2011 Sep 26;208(10):2043-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21875958</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 1998 Jul 1;216(1-2):117-37</Citation><ArticleIdList><ArticleId IdType="pubmed">9760219</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2015 Sep;125(9):3335-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26325031</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Mar 08;6(3):e17445</Citation><ArticleIdList><ArticleId IdType="pubmed">21408156</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 1975 Sep;53(1):205-14</Citation><ArticleIdList><ArticleId IdType="pubmed">1195756</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 2003 May;223(1):87-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12914762</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 1992 Dec;13(12):490-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1463581</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30714276</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>07</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Classification of radiologically isolated syndrome and clinically isolated syndrome with machine-learning techniques.</ArticleTitle><Pagination><MedlinePgn>1000-1005</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.13923</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">The unanticipated detection by magnetic resonance imaging (MRI) in the brain of asymptomatic subjects of white matter lesions suggestive of multiple sclerosis (MS) has been named radiologically isolated syndrome (RIS). As the difference between early MS [i.e. clinically isolated syndrome (CIS)] and RIS is the occurrence of a clinical event, it is logical to improve detection of the subclinical form without interfering with MRI as there are radiological diagnostic criteria for that. Our objective was to use machine-learning classification methods to identify morphometric measures that help to discriminate patients with RIS from those with CIS.</AbstractText><AbstractText Label="METHODS">We used a multimodal 3-T MRI approach by combining MRI biomarkers (cortical thickness, cortical and subcortical grey matter volume, and white matter integrity) of a cohort of 17 patients with RIS and 17 patients with CIS for single-subject level classification.</AbstractText><AbstractText Label="RESULTS">The best proposed models to predict the diagnosis of CIS and RIS were based on the Naive Bayes, Bagging and Multilayer Perceptron classifiers using only three features: the left rostral middle frontal gyrus volume and the fractional anisotropy values in the right amygdala and right lingual gyrus. The Naive Bayes obtained the highest accuracy [overall classification, 0.765; area under the receiver operating characteristic (AUROC), 0.782].</AbstractText><AbstractText Label="CONCLUSIONS">A machine-learning approach applied to multimodal MRI data may differentiate between the earliest clinical expressions of MS (CIS and RIS) with an accuracy of 78%.</AbstractText><CopyrightInformation>.. 2019 EAN.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mato-Abad</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ISLA, Computer Science Faculty, A Coruna University, A Coru..a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labiano-Fontcuberta</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital '12 de Octubre', Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr..guez-Y....ez</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ISLA, Computer Science Faculty, A Coruna University, A Coru..a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc..a-V..zquez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ISLA, Computer Science Faculty, A Coruna University, A Coru..a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munteanu</LastName><ForeName>C R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>RNASA-IMEDIR, Computer Science Faculty, A Coruna University, A Coru..a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute of A Coru..a (INIBIC), University Hospital Complex of A Coru..a (CHUAC), A Coru..a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade-Garda</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ISLA, Computer Science Faculty, A Coruna University, A Coru..a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domingo-Santos</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital '12 de Octubre', Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gal..n S..nchez-Seco</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital '12 de Octubre', Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aladro</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Getafe University Hospital, Getafe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart..nez-Gin..s</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital 'Gregorio Mara....n', Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuso</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital 'Principe de Asturias', Alcal.. de Henares.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benito-Le..n</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1769-4809</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital '12 de Octubre', Madrid.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci..n Biom..dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Complutense University, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="N">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bagging</Keyword><Keyword MajorTopicYN="Y">Multilayer Perceptron</Keyword><Keyword MajorTopicYN="Y">Naive Bayes classifier</Keyword><Keyword MajorTopicYN="Y">clinically isolated syndrome</Keyword><Keyword MajorTopicYN="Y">diffusion tensor imaging</Keyword><Keyword MajorTopicYN="Y">machine-learning</Keyword><Keyword MajorTopicYN="Y">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="Y">multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">radiologically isolated syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30714276</ArticleId><ArticleId IdType="doi">10.1111/ene.13923</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30706334</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-5447</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Australasian physical &amp; engineering sciences in medicine</Title><ISOAbbreviation>Australas Phys Eng Sci Med</ISOAbbreviation></Journal><ArticleTitle>2-Stage classification of knee joint thermograms for rheumatoid arthritis prediction in subclinical inflammation.</ArticleTitle><Pagination><MedlinePgn>259-277</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13246-019-00726-9</ELocationID><Abstract><AbstractText>Presence of inflammation in knee joint is the early indication of arthritis. In this paper, we performed the inflamed region segmentation from knee joint thermograms for structural feature extraction based knee abnormality prediction. Existing four popular segmentation techniques are investigated, namely K-means, Fuzzy C-means, Otsu, Single seeded region growing. We proposed modified multi-seeded region growing method that generates 98.6% accurate segmentation rate compared to ground truth of inflammation. Based on the spread of the inflammation oriented structural feature analysis, in the first stage of classification we classified arthritis affected knee joint thermograms, and all other types of thermograms (non-arthritis) with 91% accuracy. Among different types of arthritis, the most damaging type that causes disability of joints in long run is known as rheumatoid arthritis (RA). Early diagnosis of RA in subclinical stage enormously helps clinicians to decrease the disease affect. In second stage of classification, we integrated the RA and non-RA categorization by extracting texture, shape and frequency level features. Experiment shows that the combination of all features decreases the accurate detection rate of RA classification. To increase the classification rate, we incorporated the accuracy based feature selection procedure. The RA classification rate obtained with accuracy based feature selection is 73% whereas existing support vector machine-recursive feature elimination (SVM-RFE) and RELIEF methods provide 67% and 71% correct classification rate respectively. The area under the curve (AUC) of accuracy based feature selection, SVM-RFE, and RELIEF for RA classification are 0.72, 0.65 and 0.67, respectively and it indicates better classification outcome of the accuracy based feature selection method.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bardhan</LastName><ForeName>Shawli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computer Science and Engineering, Tripura University, Suryamaninagar, Tripura, 799022, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhowmik</LastName><ForeName>Mrinal Kanti</ForeName><Initials>MK</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3451-191X</Identifier><AffiliationInfo><Affiliation>Computer Science and Engineering, Tripura University, Suryamaninagar, Tripura, 799022, India. mrinalkantibhowmik@tripurauniv.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5/7/1516/2016-RCH</GrantID><Agency>Indian Council of Medical Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Australas Phys Eng Sci Med</MedlineTA><NlmUniqueID>8208130</NlmUniqueID><ISSNLinking>0158-9938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001799" MajorTopicYN="N">Blood Sedimentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007719" MajorTopicYN="N">Knee Joint</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013817" MajorTopicYN="Y">Thermography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthritis</Keyword><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Feature extraction</Keyword><Keyword MajorTopicYN="N">Feature selection</Keyword><Keyword MajorTopicYN="N">RA</Keyword><Keyword MajorTopicYN="N">Segmentation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30706334</ArticleId><ArticleId IdType="doi">10.1007/s13246-019-00726-9</ArticleId><ArticleId IdType="pii">10.1007/s13246-019-00726-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30685040</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4324</ISSN><JournalIssue CitedMedium="Internet"><Volume>1052</Volume><PubDate><Year>2019</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Analytica chimica acta</Title><ISOAbbreviation>Anal Chim Acta</ISOAbbreviation></Journal><ArticleTitle>Non-invasive prediction of blood glucose trends during hypoglycemia.</ArticleTitle><Pagination><MedlinePgn>37-48</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0003-2670(18)31444-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aca.2018.12.009</ELocationID><Abstract><AbstractText>Over the last four decades, there has been a pursuit for a non-invasive solution for glucose measurement, but there is not yet any viable product released. Of the many sensor modalities tried, the combination of electrical and optical measurement is among the most promising for continuous measurements. Although non-invasive prediction of exact glucose levels may seem futile, prediction of their trends may be useful for certain applications. Hypoglycemia is the most serious of the acute complications in type-1 diabetes highlighting the need for a reliable alarm, but little is known about the performance of this technology in predicting hypoglycemic glucose levels and associated trends. We aimed to assess such performance on the way to develop a multisensor system for detection of hypoglycemia, based on near-infrared (NIR), bioimpedance and skin temperature measurements taken during hypoglycemic and euglycemic glucose clamps in 20 subjects with type-1 diabetes. Performance of blood glucose prediction was assessed by global partial least squares and neural network regression models using repeated double cross-validation. Best trend prediction was obtained by including all measurements in a neural network model. Prediction of glucose level was inaccurate for threshold-based detection of hypoglycemia, but the trend predictions may provide useful information in a multisensor system. Comparing NIR and bioimpedance measurements, NIR seems to be the main predictor of blood glucose while bioimpedance may act as correction for individual confounding properties.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tronstad</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway. Electronic address: chrton@ous-hf.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elvebakk</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staal</LastName><ForeName>Odd Martin</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Prediktor Medical AS, Fredrikstad, Norway; Norwegian University of Science and Technology, Department of Engineering Cybernetics, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalv..y</LastName><ForeName>H..vard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H..getveit</LastName><ForeName>Jan Olav</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenssen</LastName><ForeName>Trond Geir</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway; Metabolic and Renal Research Group, UiT The Arctic University of Norway, Troms.., Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birkeland</LastName><ForeName>K..re Inge</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinsen</LastName><ForeName>..rjan G</ForeName><Initials>..G</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biomedical Engineering, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Anal Chim Acta</MedlineTA><NlmUniqueID>0370534</NlmUniqueID><ISSNLinking>0003-2670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="N">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016018" MajorTopicYN="N">Least-Squares Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012881" MajorTopicYN="N">Skin Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013057" MajorTopicYN="N">Spectrum Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glucose</Keyword><Keyword MajorTopicYN="N">Hypoglycemia</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multisensor</Keyword><Keyword MajorTopicYN="N">Neural network</Keyword><Keyword MajorTopicYN="N">Non invasive</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30685040</ArticleId><ArticleId IdType="pii">S0003-2670(18)31444-2</ArticleId><ArticleId IdType="doi">10.1016/j.aca.2018.12.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30684090</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>01</Month><Day>25</Day></PubDate></JournalIssue><Title>Current atherosclerosis reports</Title><ISOAbbreviation>Curr Atheroscler Rep</ISOAbbreviation></Journal><ArticleTitle>Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.</ArticleTitle><Pagination><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11883-019-0766-x</ELocationID><Abstract><AbstractText Label="PURPOSE OF THE REVIEW">Rheumatoid arthritis (RA) is a chronic, autoimmune disease which may result in a higher risk of cardiovascular (CV) events and stroke. Tissue characterization and risk stratification of patients with rheumatoid arthritis are a challenging problem. Risk stratification of RA patients using traditional risk factor-based calculators either underestimates or overestimates the CV risk. Advancements in medical imaging have facilitated early and accurate CV risk stratification compared to conventional cardiovascular risk calculators.</AbstractText><AbstractText Label="RECENT FINDING">In recent years, a link between carotid atherosclerosis and rheumatoid arthritis has been widely discussed by multiple studies. Imaging the carotid artery using 2-D ultrasound is a noninvasive, economic, and efficient imaging approach that provides an atherosclerotic plaque tissue-specific image. Such images can help to morphologically characterize the plaque type and accurately measure vital phenotypes such as media wall thickness and wall variability. Intelligence-based paradigms such as machine learning- and deep learning-based techniques not only automate the risk characterization process but also provide an accurate CV risk stratification for better management of RA patients. This review provides a brief understanding of the pathogenesis of RA and its association with carotid atherosclerosis imaged using the B-mode ultrasound technique. Lacunas in traditional risk scores and the role of machine learning-based tissue characterization algorithms are discussed and could facilitate cardiovascular risk assessment in RA patients. The key takeaway points from this review are the following: (i) inflammation is a common link between RA and atherosclerotic plaque buildup, (ii) carotid ultrasound is a better choice to characterize the atherosclerotic plaque tissues in RA patients, and (iii) intelligence-based paradigms are useful for accurate tissue characterization and risk stratification of RA patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Narendra N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Indraprastha Apollo Hospitals, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamthikar</LastName><ForeName>Ankush D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Electronics and Communication Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Deep</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Electronics and Communication Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piga</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, University Clinic and AOU of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carcassi</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Argiris A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolaides</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Diagnostic Center, University of Cyprus, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laird</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suri</LastName><ForeName>Harman S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mavrogeni</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Clinic, Onassis Cardiac Surgery Center, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protogerou</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Cardiovascular Prevention Unit, Department of Pathophysiology, NKU of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sfikakis</LastName><ForeName>Petros</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Laikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, National Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitas</LastName><ForeName>George D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Arthritis Research UK Centre for Epidemiology, Manchester University, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Development, Academic Affairs, Dudley Group NHS Foundation Trust, Dudley, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suri</LastName><ForeName>Jasjit S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Stroke Monitoring and Diagnostic Division, AtheroPoint..., Roseville, CA, USA. Jasjit.Suri@atheropoint.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Atheroscler Rep</MedlineTA><NlmUniqueID>100897685</NlmUniqueID><ISSNLinking>1523-3804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002340" MajorTopicYN="N">Carotid Artery Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="N">Plaque, Atherosclerotic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Atherosclerosis</Keyword><Keyword MajorTopicYN="Y">Cardiovascular risk assessment</Keyword><Keyword MajorTopicYN="Y">Carotid ultrasound</Keyword><Keyword MajorTopicYN="Y">Deep learning</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Optical coherence tomography</Keyword><Keyword MajorTopicYN="Y">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="Y">Tissue characterization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30684090</ArticleId><ArticleId IdType="doi">10.1007/s11883-019-0766-x</ArticleId><ArticleId IdType="pii">10.1007/s11883-019-0766-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Med Syst. 2017 Jun;41(6):98</Citation><ArticleIdList><ArticleId IdType="pubmed">28501967</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2018 Jan 24;360:j5855</Citation><ArticleIdList><ArticleId IdType="pubmed">29367388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2010 Aug;6(8):445-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20647995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2017 Nov 1;56(11):1837-1846</Citation><ArticleIdList><ArticleId IdType="pubmed">28181650</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):188-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19238083</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2015 Mar 29;17:86</Citation><ArticleIdList><ArticleId IdType="pubmed">25890172</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2005 Jul 25;165(14):1624-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16043681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jan;76(1):17-28</Citation><ArticleIdList><ArticleId IdType="pubmed">27697765</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2003 Dec 16;108(24):2957-63</Citation><ArticleIdList><ArticleId IdType="pubmed">14676136</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 May;67(8):1995-2003</Citation><ArticleIdList><ArticleId IdType="pubmed">25989470</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2008;10(3):R59</Citation><ArticleIdList><ArticleId IdType="pubmed">18492239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Nov;69(11):1996-2001</Citation><ArticleIdList><ArticleId IdType="pubmed">20551156</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23058065</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Dev Immunol. 2013;2013:623036</Citation><ArticleIdList><ArticleId IdType="pubmed">24027590</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2008 Feb 12;117(6):743-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18212285</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2009;11(2):R36</Citation><ArticleIdList><ArticleId IdType="pubmed">19284547</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2017 Oct 16;207(8):357-361</Citation><ArticleIdList><ArticleId IdType="pubmed">29020908</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Nov 15;61(11):1571-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19877093</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 2013 Sep;46(3):299-305</Citation><ArticleIdList><ArticleId IdType="pubmed">23849798</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2009 Dec 14;169(22):2071-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20008689</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Jul;46(7):1714-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12124853</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2017 May 23;357:j2099</Citation><ArticleIdList><ArticleId IdType="pubmed">28536104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jul;76(7):1169-1175</Citation><ArticleIdList><ArticleId IdType="pubmed">27895040</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Bras Reumatol Engl Ed. 2016 Mar-Apr;56(2):138-44</Citation><ArticleIdList><ArticleId IdType="pubmed">27267527</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1997 Mar;24(3):445-51</Citation><ArticleIdList><ArticleId IdType="pubmed">9058647</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2010 May;37(5):890-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20360191</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Mar;67(3):626-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25504899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2000 Mar;27(3):630-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10743800</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Nov;50(11):3450-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15529378</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Atheroscler Rep. 2012 Oct;14(5):429-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22872371</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2015 Jan;46(1):91-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25406150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2016 Apr;75(4):674-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25691119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2015 Apr;74(4):668-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24389293</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38</Citation><ArticleIdList><ArticleId IdType="pubmed">25051948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Mar;50(3):450-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20959355</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumatologia. 2016;54(3):128-35</Citation><ArticleIdList><ArticleId IdType="pubmed">27504023</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2010 Nov;39(6):447-53</Citation><ArticleIdList><ArticleId IdType="pubmed">20604674</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2009 Apr;38(5):366-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18336869</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24222018</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biomed Eng. 2017 Jun 21;19:221-248</Citation><ArticleIdList><ArticleId IdType="pubmed">28301734</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Med. 2018 Jul 1;98:100-117</Citation><ArticleIdList><ArticleId IdType="pubmed">29778925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2012 Jun;71(6):796-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22562981</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Clin Pract Rheumatol. 2006 Aug;2(8):425-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16932734</ArticleId></ArticleIdList></Reference><Reference><Citation>Endothelium. 2008 Jul-Aug;15(4):203-12</Citation><ArticleIdList><ArticleId IdType="pubmed">18663623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ultrasound Med Biol. 2012 Jun;38(6):899-915</Citation><ArticleIdList><ArticleId IdType="pubmed">22502883</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2008 May;28(5):812-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18276911</ArticleId></ArticleIdList></Reference><Reference><Citation>Diab Vasc Dis Res. 2007 Jun;4(2):130-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17654447</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 May 1;103(17):2171-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11331258</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2017 Oct 13;121(9):1092-1101</Citation><ArticleIdList><ArticleId IdType="pubmed">28794054</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2013 Oct 02;15(5):R142</Citation><ArticleIdList><ArticleId IdType="pubmed">24286134</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Med. 2017 Jan 1;80:77-96</Citation><ArticleIdList><ArticleId IdType="pubmed">27915126</ArticleId></ArticleIdList></Reference><Reference><Citation>Open Rheumatol J. 2016 Sep 30;10:49-59</Citation><ArticleIdList><ArticleId IdType="pubmed">27857821</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2011 Apr;40(5):389-97</Citation><ArticleIdList><ArticleId IdType="pubmed">20889191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Jul;69(7):1310-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19854708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Jan;69(1):70-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19174392</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2018 Jan;153:19-32</Citation><ArticleIdList><ArticleId IdType="pubmed">29157451</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian Heart J. 2018 Sep - Oct;70(5):649-664</Citation><ArticleIdList><ArticleId IdType="pubmed">30392503</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Apr 24;12(4):e0176291</Citation><ArticleIdList><ArticleId IdType="pubmed">28437445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Oct 22;388(10055):2023-2038</Citation><ArticleIdList><ArticleId IdType="pubmed">27156434</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Bone Spine. 2011 Mar;78(2):179-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20851020</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Cardiovasc Interv. 2009 Nov;2(11):1035-46</Citation><ArticleIdList><ArticleId IdType="pubmed">19926041</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Bioinformatics. 2014;2014:708279</Citation><ArticleIdList><ArticleId IdType="pubmed">25332717</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiology. 2011 Feb;62(2):167-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20682616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2015 May;54(5):808-15</Citation><ArticleIdList><ArticleId IdType="pubmed">25305139</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2009 Mar 30;7:12</Citation><ArticleIdList><ArticleId IdType="pubmed">19331649</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2003 Jun;24(11):987-1003</Citation><ArticleIdList><ArticleId IdType="pubmed">12788299</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2007 Feb;28(4):398-406</Citation><ArticleIdList><ArticleId IdType="pubmed">17277033</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2012 Aug 1;110(3):420-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22521305</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis. 2013 Oct;230(2):399-405</Citation><ArticleIdList><ArticleId IdType="pubmed">24075774</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Atheroscler Rep. 2016 Jun;18(6):30</Citation><ArticleIdList><ArticleId IdType="pubmed">27108163</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2008 Oct;121(10 Suppl 1):S21-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18926166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2015 Mar;74(3):579-86</Citation><ArticleIdList><ArticleId IdType="pubmed">24297382</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 1999 Jan;30(1):61-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9880389</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Comput Tomogr. 2009 Nov-Dec;3(6):403-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19717355</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Feb 17;10(2):e0117952</Citation><ArticleIdList><ArticleId IdType="pubmed">25689371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2015;2015:718329</Citation><ArticleIdList><ArticleId IdType="pubmed">25960621</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2003 Jul;22(7):902-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12906244</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1999 Dec;26(12):2562-71</Citation><ArticleIdList><ArticleId IdType="pubmed">10606363</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2011 Jan;15(1):130-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21075733</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Jan;54(1):38-46</Citation><ArticleIdList><ArticleId IdType="pubmed">16385494</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2015 Nov;278(5):483-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26260307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2008 Jan;67(1):64-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17517756</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ultrasound Med. 2010 Dec;29(12):1759-68</Citation><ArticleIdList><ArticleId IdType="pubmed">21098848</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging Clin N Am. 2003 Feb;11(1):101-13</Citation><ArticleIdList><ArticleId IdType="pubmed">12797513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934</Citation><ArticleIdList><ArticleId IdType="pubmed">24239923</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2004 Nov;90(11):1286-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15486123</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2018 Sep;143:322-331</Citation><ArticleIdList><ArticleId IdType="pubmed">30059757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2014;2014:793628</Citation><ArticleIdList><ArticleId IdType="pubmed">25525305</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 Jan;20(1):256-67</Citation><ArticleIdList><ArticleId IdType="pubmed">25561598</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:1261582</Citation><ArticleIdList><ArticleId IdType="pubmed">27648442</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2012 Jun;36(3):1861-71</Citation><ArticleIdList><ArticleId IdType="pubmed">21243411</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Oct 4;12(10):e0185261</Citation><ArticleIdList><ArticleId IdType="pubmed">28977008</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2014 Dec;66(12):1818-27</Citation><ArticleIdList><ArticleId IdType="pubmed">24942650</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ultrasound Med. 2016 Oct;35(10):2253-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27582533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jan 15;59(1):42-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18163412</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Aug;52(8):2293-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16052597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2008 Sep;47(9):1286-98</Citation><ArticleIdList><ArticleId IdType="pubmed">18467370</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2017 Dec;42:60-88</Citation><ArticleIdList><ArticleId IdType="pubmed">28778026</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2013 Apr;110(1):66-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23122720</ArticleId></ArticleIdList></Reference><Reference><Citation>JACC Cardiovasc Imaging. 2011 Jan;4(1):50-61</Citation><ArticleIdList><ArticleId IdType="pubmed">21232704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 Jul;11(7):390-400</Citation><ArticleIdList><ArticleId IdType="pubmed">25825281</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2018 Apr;39:9-18</Citation><ArticleIdList><ArticleId IdType="pubmed">29202375</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2003 Feb 6;91(3A):3A-6A</Citation><ArticleIdList><ArticleId IdType="pubmed">12645637</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Organs. 2017 Sep;41(9):E103-E117</Citation><ArticleIdList><ArticleId IdType="pubmed">28150399</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2007;9(6):R116</Citation><ArticleIdList><ArticleId IdType="pubmed">17986352</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Mar 1;13(3):e0193690</Citation><ArticleIdList><ArticleId IdType="pubmed">29494666</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 Jan;21(1):48-55</Citation><ArticleIdList><ArticleId IdType="pubmed">27893402</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2015 Mar;204(3):W249-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25714309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2017 Sep;37(9):1551-1557</Citation><ArticleIdList><ArticleId IdType="pubmed">28455559</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2012 Apr;41(5):676-88</Citation><ArticleIdList><ArticleId IdType="pubmed">22000818</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Atheroscler Rep. 2018 May 21;20(7):33</Citation><ArticleIdList><ArticleId IdType="pubmed">29781047</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Mar 5;105(9):1135-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11877368</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 Feb;69(2):166-174</Citation><ArticleIdList><ArticleId IdType="pubmed">27159164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Jun;70(6):929-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21389043</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Oct;50(10):3085-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15476204</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Mar;32(3):435-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15742434</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Sep 10;106(11):1368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12221054</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2016 Aug 15;217:135-48</Citation><ArticleIdList><ArticleId IdType="pubmed">27179903</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2006 Jul;27(14):1732-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16787955</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110</Citation><ArticleIdList><ArticleId IdType="pubmed">28339992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2007 Sep;46(9):1477-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17704521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16631505</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Feb 14;297(6):611-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17299196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2018 Jan;77(1):48-54</Citation><ArticleIdList><ArticleId IdType="pubmed">28877868</ArticleId></ArticleIdList></Reference><Reference><Citation>J Glob Health. 2015 Jun;5(1):010409</Citation><ArticleIdList><ArticleId IdType="pubmed">25969732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Feb;69(2):325-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19773290</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2008 Jun 28;336(7659):1475-82</Citation><ArticleIdList><ArticleId IdType="pubmed">18573856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Mar;70(3):482-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21216812</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2013 May;51(5):513-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23292291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Jan;70(1):8-14</Citation><ArticleIdList><ArticleId IdType="pubmed">21109513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1994 Jun;93(6):2379-86</Citation><ArticleIdList><ArticleId IdType="pubmed">8200971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Nov;50(11):2005-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21859698</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Jul;32(7):1219-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15996055</ArticleId></ArticleIdList></Reference><Reference><Citation>Maedica (Buchar). 2010 Apr;5(2):147</Citation><ArticleIdList><ArticleId IdType="pubmed">21977142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2014 Apr;73(4):722-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23505241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jun;76(6):978-991</Citation><ArticleIdList><ArticleId IdType="pubmed">28087505</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 2016 Feb;35(2):315-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26614535</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 1994 Jan 24;338(1):43-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8307154</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2011 Sep-Oct;29(5):850-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22011672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30665626</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-866X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>08</Month></PubDate></JournalIssue><Title>Seminars in arthritis and rheumatism</Title><ISOAbbreviation>Semin Arthritis Rheum</ISOAbbreviation></Journal><ArticleTitle>Identifying lupus patients in electronic health records: Development and validation of machine learning algorithms and application of rule-based algorithms.</ArticleTitle><Pagination><MedlinePgn>84-90</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0049-0172(18)30651-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semarthrit.2019.01.002</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To utilize electronic health records (EHRs) to study SLE, algorithms are needed to accurately identify these patients. We used machine learning to generate data-driven SLE EHR algorithms and assessed performance of existing rule-based algorithms.</AbstractText><AbstractText Label="METHODS">We randomly selected subjects with.........1 SLE ICD-9/10 codes from our EHR and identified gold standard definite and probable SLE cases by chart review, based on 1997 ACR or 2012 SLICC Classification Criteria. From a training set, we extracted coded and narrative concepts using natural language processing and generated algorithms using penalized logistic regression to classify definite or definite/probable SLE. We assessed predictive characteristics in internal and external cohort validations. We also tested performance characteristics of published rule-based algorithms with pre-specified permutations of ICD-9 codes, laboratory tests and medications in our EHR.</AbstractText><AbstractText Label="RESULTS">At a specificity of 97%, our machine learning coded algorithm for definite SLE had 90% positive predictive value (PPV) and 64% sensitivity and for definite/probable SLE, 92% PPV and 47% sensitivity. In the external validation, at 97% specificity, the definite/probable algorithm had 94% PPV and 60% sensitivity. Adding NLP concepts did not improve performance metrics. The PPVs of published rule-based algorithms ranged from 45-79% in our EHR.</AbstractText><AbstractText Label="CONCLUSION">Our machine learning SLE algorithms performed well in internal and external validation. Rule-based SLE algorithms did not transport as well to our EHR. Unique EHR characteristics, clinical practices and research goals regarding the desired sensitivity and specificity of the case definition must be considered when applying algorithms to identify SLE patients.</AbstractText><CopyrightInformation>Copyright .. 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jorge</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Bulfinch 165, Boston, MA 02114, United States. Electronic address: AMJorge@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Research Information Systems and Computing, Partners Healthcare, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnado</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Immunology, Vanderbilt University Medical Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Information Systems and Computing, Partners Healthcare, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Tianxi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Information Systems and Computing, Partners Healthcare, United States; Department of Biomedical Informatics, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Tianrun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States; Department of Biomedical Informatics, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crofford</LastName><ForeName>Leslie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Immunology, Vanderbilt University Medical Center, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costenbader</LastName><ForeName>Karen H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Katherine P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States; Department of Biomedical Informatics, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlson</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldman</LastName><ForeName>Candace H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070253</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR052403</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AR072757</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR057327</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008685</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR072577</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007258</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR066109</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM010685</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AR071500</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Semin Arthritis Rheum</MedlineTA><NlmUniqueID>1306053</NlmUniqueID><ISSNLinking>0049-0172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Algorithms</Keyword><Keyword MajorTopicYN="Y">Bioinformatics</Keyword><Keyword MajorTopicYN="Y">Electronic health records</Keyword><Keyword MajorTopicYN="Y">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30665626</ArticleId><ArticleId IdType="pii">S0049-0172(18)30651-6</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6609504</ArticleId><ArticleId IdType="mid">NIHMS1519139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Inform Assoc. 2015 Sep;22(5):993-1000</Citation><ArticleIdList><ArticleId IdType="pubmed">25929596</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2017 Apr 1;24(e1):e143-e149</Citation><ArticleIdList><ArticleId IdType="pubmed">27632993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Med. 2016 Feb 26;6(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">26927184</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Apr 24;350:h1885</Citation><ArticleIdList><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Aug;64(8):2677-86</Citation><ArticleIdList><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2008 Sep;84(3):362-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18500243</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2006;:931</Citation><ArticleIdList><ArticleId IdType="pubmed">17238550</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Dec 30;31 Suppl 10:K62-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24331075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e162-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2014 Apr 07;2014:37-42</Citation><ArticleIdList><ArticleId IdType="pubmed">25954575</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2019 Jan 1;26(1):61-65</Citation><ArticleIdList><ArticleId IdType="pubmed">30476175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Ophthalmol. 2012 Apr;130(4):461-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22159170</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2011 Aug;38(8):1612-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21532057</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Jan-Feb;17(1):19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20064797</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 May;69(5):687-693</Citation><ArticleIdList><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30650997</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>09</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>919-927</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818823792</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fear of exercise related hypoglycemia is a major reason why people with type 1 diabetes (T1D) do not exercise. There is no validated prediction algorithm that can predict hypoglycemia at the start of aerobic exercise.</AbstractText><AbstractText Label="METHODS">We have developed and evaluated two separate algorithms to predict hypoglycemia at the start of exercise. Model 1 is a decision tree and model 2 is a random forest model. Both models were trained using a meta-data set based on 154 observations of in-clinic aerobic exercise in 43 adults with T1D from 3 different studies that included participants using sensor augmented pump therapy, automated insulin delivery therapy, and automated insulin and glucagon therapy. Both models were validated using an entirely new validation data set with 90 exercise observations collected from 12 new adults with T1D.</AbstractText><AbstractText Label="RESULTS">Model 1 identified two critical features predictive of hypoglycemia during exercise: heart rate and glucose at the start of exercise. If heart rate was greater than 121 bpm during the first 5 min of exercise and glucose at the start of exercise was less than 182 mg/dL, it predicted hypoglycemia with 79.55% accuracy. Model 2 achieved a higher accuracy of 86.7% using additional features and higher complexity.</AbstractText><AbstractText Label="CONCLUSIONS">Models presented here can assist people with T1D to avoid exercise related hypoglycemia. The simple model 1 heuristic can be easily remembered (the 180/120 rule) and model 2 is more complex requiring computational resources, making it suitable for automated artificial pancreas or decision support systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resalat</LastName><ForeName>Navid</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Leah M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-3634-481X</Identifier><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>Jessica R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Youssef</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon, Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>1 Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101044</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK120367</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="Y">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="N">Pancreas, Artificial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial pancreas</Keyword><Keyword MajorTopicYN="Y">exercise</Keyword><Keyword MajorTopicYN="Y">hypoglycemia</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30650997</ArticleId><ArticleId IdType="doi">10.1177/1932296818823792</ArticleId><ArticleId IdType="pmc">PMC6955453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Spectr. 2015 Jan;28(1):32-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25717276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2016 Dec;59(12):2561-2571</Citation><ArticleIdList><ArticleId IdType="pubmed">27704167</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26438720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 May;8(3):498-507</Citation><ArticleIdList><ArticleId IdType="pubmed">24876613</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2015 Dec;17(12):1150-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26264812</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Apr 26;366(17):1616-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22533577</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2017 Mar;60(3):574-580</Citation><ArticleIdList><ArticleId IdType="pubmed">28013340</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Nov;18(7):540-546</Citation><ArticleIdList><ArticleId IdType="pubmed">27734563</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Med. 1998;49:235-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9509261</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Med (Lond). 2014 Dec;14(6):673-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25468857</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Nov 15;316(19):1957</Citation><ArticleIdList><ArticleId IdType="pubmed">27838705</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Diabetes. 2016 Dec;40(6):503-508</Citation><ArticleIdList><ArticleId IdType="pubmed">27212045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jun 30;9(6):1236-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26134831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Nov;39(11):2065-2079</Citation><ArticleIdList><ArticleId IdType="pubmed">27926890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2016 Oct;91:138-143</Citation><ArticleIdList><ArticleId IdType="pubmed">27527572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2007 Mar;92(3):963-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17118993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Med. 2017 May 24;7(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">28538708</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2002 Aug;93(2):782-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12133892</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2013 Jul;98(7):2908-14</Citation><ArticleIdList><ArticleId IdType="pubmed">23780373</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2018 Feb;20(2):443-447</Citation><ArticleIdList><ArticleId IdType="pubmed">28718987</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(6):370-378</Citation><ArticleIdList><ArticleId IdType="pubmed">28613947</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Nov;31(11):2108-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18689694</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2018 Jul;41(7):1471-1477</Citation><ArticleIdList><ArticleId IdType="pubmed">29752345</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 Jan 25;8:25</Citation><ArticleIdList><ArticleId IdType="pubmed">17254353</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2129-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">26379095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2016 Nov;18(11):1110-1119</Citation><ArticleIdList><ArticleId IdType="pubmed">27333970</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25231116</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Endocrinol Metab. 2011 Jan 1;6(1):93-108</Citation><ArticleIdList><ArticleId IdType="pubmed">21339838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30638593</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>Computer Aided Diagnosis System for multiple sclerosis disease based on phase to amplitude coupling in covert visual attention.</ArticleTitle><Pagination><MedlinePgn>9-18</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(18)31031-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2018.11.006</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Computer Aided Diagnosis (CAD) techniques have widely been used in research to detect the neurological abnormalities and improve the consistency of diagnosis and treatment in medicine. In this study, a new CAD system based on EEG signals was developed. The motivation for the development of the CAD system was to diagnose multiple sclerosis (MS) disease during covert visual attention tasks. It is worth noting that research of this kind on the efficacy of attention tasks is limited in scope for MS patients; therefore, it is vital to develop a feature of EEG to characterize the patient's state with high sensitivity and specificity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated the use of phase-amplitude coupling (PAC) of EEG signals to diagnose MS. It is assumed that the role of PAC for information encoding during visual attention in MS is greatly unknown; therefore, we made an attempt to investigate it via CAD systems. The EEG signals were recorded from healthy and MS patients while performing new visual attention tasks. Machine learning algorithms were also used to identify the EEG signals as to whether the disease existed or not. The challenge regarding the dimensionality of the extracted features was addressed through selecting the relevant and efficient features using T-test and Bhattacharyya distance criteria, and the validity of the system was assessed through leave-one-subject-out cross-validation method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our findings indicated that online sequential extreme learning machine (OS-ELM) classifier with T-test feature selection method yielded peak accuracy, sensitivity and specificity in both color and direction tasks. These values were 91%, 83% and 96% for color task, and 90%, 82% and 96% for the direction task.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the results, it can be concluded that this procedure can be used for the automatic diagnosis of early MS, and can also facilitate the treatment assessment in patients.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Amirmasoud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Neuroengineering Research Lab., Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, 16846-13114, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davoudi</LastName><ForeName>Saeideh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Neuroengineering Research Lab., Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, 16846-13114, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daliri</LastName><ForeName>Mohammad Reza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Neuroscience &amp; Neuroengineering Research Lab., Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, 16846-13114, Tehran, Iran. Electronic address: daliri@iust.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="Y">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="Y">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012815" MajorTopicYN="N">Signal Processing, Computer-Assisted</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Computer Aided Diagnosis</Keyword><Keyword MajorTopicYN="N">Extreme learning machine</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Phase to amplitude coupling</Keyword><Keyword MajorTopicYN="N">Visual attention task</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30638593</ArticleId><ArticleId IdType="pii">S0169-2607(18)31031-9</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2018.11.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30615300</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.</ArticleTitle><Pagination><MedlinePgn>678-684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.40810</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Approximately 30-40% of rheumatoid arthritis (RA) patients who are initially started on low-dose methotrexate (MTX) will not benefit from the treatment. To date, no reliable biomarkers of MTX inefficacy in RA have been identified. The aim of this study was to analyze whole blood samples from RA patients at 2 time points (pretreatment and 4 weeks following initiation of MTX), to identify gene expression biomarkers of the MTX response.</AbstractText><AbstractText Label="METHODS">RA patients who were about to commence treatment with MTX were selected from the Rheumatoid Arthritis Medication Study. Using European League Against Rheumatism (EULAR) response criteria, 42 patients were categorized as good responders and 43 as nonresponders at 6 months following the initation of MTX treatment. Data on whole blood transcript expression were generated, and supervised machine learning methods were used to predict a EULAR nonresponse. Models in which transcript levels were included were compared to models in which clinical covariates alone (e.g., baseline disease activity, sex) were included. Gene network and ontology analysis was also performed.</AbstractText><AbstractText Label="RESULTS">Based on the ratio of transcript values (i.e., the difference in log<sub>2</sub> -transformed expression values between 4 weeks of treatment and pretreatment), a highly predictive classifier of MTX nonresponse was developed using L2-regularized logistic regression (mean .. SEM area under the receiver operating characteristic [ROC] curve [AUC] 0.78 .. 0.11). This classifier was superior to models that included clinical covariates (ROC AUC 0.63 .. 0.06). Pathway analysis of gene networks revealed significant overrepresentation of type I interferon signaling pathway genes in nonresponders at pretreatment (P = 2.8 .. 10<sup>-25</sup> ) and at 4 weeks after treatment initiation (P = 4.9 .. 10<sup>-28</sup> ).</AbstractText><AbstractText Label="CONCLUSION">Testing for changes in gene expression between pretreatment and 4 weeks post-treatment initiation may provide an early classifier of the MTX treatment response in RA patients who are unlikely to benefit from MTX over 6 months. Such patients should, therefore, have their treatment escalated more rapidly, which would thus potentially impact treatment pathways. These findings emphasize the importance of a role for early treatment biomarker monitoring in RA patients started on MTX.</AbstractText><CopyrightInformation>.. 2019 The Authors. Arthritis &amp; Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Plant</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maciejewski</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pfizer, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Maximising Therapeutic Utility in Rheumatoid Arthritis Consortium, the RAMS Study Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Hyrich</LastName><ForeName>Kimme</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziemek</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pfizer, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verstappen</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID> 20385</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K015346/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>I-CRP</GrantID><Agency>Pfizer</Agency><Country>International</Country></Grant><Grant><GrantID>20670</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>20380</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>YL5FZ2Y5U1</RegistryNumber><NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30615300</ArticleId><ArticleId IdType="doi">10.1002/art.40810</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30587115</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2164</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC genomics</Title><ISOAbbreviation>BMC Genomics</ISOAbbreviation></Journal><ArticleTitle>ACES: a machine learning toolbox for clustering analysis and visualization.</ArticleTitle><Pagination><MedlinePgn>964</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12864-018-5300-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies that aim at explaining phenotypes or disease susceptibility by genetic or epigenetic variants often rely on clustering methods to stratify individuals or samples. While statistical associations may point at increased risk for certain parts of the population, the ultimate goal is to make precise predictions for each individual. This necessitates tools that allow for the rapid inspection of each data point, in particular to find explanations for outliers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ACES is an integrative cluster- and phenotype-browser, which implements standard clustering methods, as well as multiple visualization methods in which all sample information can be displayed quickly. In addition, ACES can automatically mine a list of phenotypes for cluster enrichment, whereby the number of clusters and their boundaries are estimated by a novel method. For visual data browsing, ACES provides a 2D or 3D PCA or Heat Map view. ACES is implemented in Java, with a focus on a user-friendly, interactive, graphical interface.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ACES has been proven an invaluable tool for analyzing large, pre-filtered DNA methylation data sets and RNA-Sequencing data, due to its ease to link molecular markers to complex phenotypes. The source code is available from https://github.com/GrabherrGroup/ACES .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden. jiangning.gao@imbim.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundstr..m</LastName><ForeName>G..rel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Ume.., Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghadam</LastName><ForeName>Behrooz Torabi</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of immunology, genetics, and pathology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamani</LastName><ForeName>Neda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabherr</LastName><ForeName>Manfred G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of medical biochemistry and microbiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genomics</MedlineTA><NlmUniqueID>100965258</NlmUniqueID><ISSNLinking>1471-2164</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077230" MajorTopicYN="N">Internet Access</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Centroid detection</Keyword><Keyword MajorTopicYN="N">Clustering</Keyword><Keyword MajorTopicYN="N">Data visualization</Keyword><Keyword MajorTopicYN="N">Discriminative power prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30587115</ArticleId><ArticleId IdType="doi">10.1186/s12864-018-5300-y</ArticleId><ArticleId IdType="pii">10.1186/s12864-018-5300-y</ArticleId><ArticleId IdType="pmc">PMC6307290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2004 Jun 12;20(9):1453-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14871861</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biotechnol. 2005 Sep;31(1):55-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16118415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W444-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18524799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 1;25(15):1994-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19454618</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Mar 09;11:121</Citation><ArticleIdList><ArticleId IdType="pubmed">20214778</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2010 Apr;20(4):440-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20219944</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2010;3:120-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22275205</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2013 May 24;14:347</Citation><ArticleIdList><ArticleId IdType="pubmed">23706020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Oct 10;155(2):462-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24120142</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 May;64(5):1682-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2015 Jul;64(7):2506-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25677915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25969447</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Jun 25;372(26):2481-98</Citation><ArticleIdList><ArticleId IdType="pubmed">26061751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Jan 28;164(3):550-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26824661</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychometrika. 1967 Sep;32(3):241-54</Citation><ArticleIdList><ArticleId IdType="pubmed">5234703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30582502</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0392-856X</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>6 Suppl 115</Issue><PubDate><MedlineDate>2018 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>Clinical and experimental rheumatology</Title><ISOAbbreviation>Clin Exp Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering.</ArticleTitle><Pagination><MedlinePgn>74-79</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To perform unbiased analysis of fever patterns and to investigate their association with clinical manifestations and outcome of patients with adult-onset Still's disease (AOSD).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">AOSD patients who were treated as in-patients from 2004 through 2015 were grouped according to 24-hour body temperature (BT) by hierarchical clustering using a Euclidean distance metric with complete linkage. The clinical and laboratory characteristics of the groups were then examined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Hierarchical clustering partitioned 70 AOSD patients into three distinct groups. Group 1 (n=14) had the highest mean BT (38.1.. 0.4..C) and the widest variation in BT (2.7..0.9..C). Group 2 (n=35) had a lower mean BT (37.4..0.3..C) and a smaller variation (2.1..0.7..C). Group 3 (n=21) had the lowest mean BT (36.7..0.3..C) and the smallest variation (1.5..0.6..C). Clinical features and extent of organ involvement did not differ significantly between groups. However, Group 1 had lower platelet counts and higher lactate dehydrogenase, ferritin levels, and prothrombin time than the other groups. In addition, Group 1 exhibited higher risk of having a macrophage activation syndrome (MAS) and tended to require more intense treatment with corticosteroids and immunosuppressant to achieve clinical remission as compared to other groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hierarchical clustering identified three distinct fever patterns in patients with AOSD. Higher BT was associated with wider variations in diurnal temperature, higher risk of developing MAS, more intense treatment, and longer time to clinical remission, suggesting that fever pattern is a prognostic factor for AOSD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Jung</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Eun Young</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Woochang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Data Science for Knowledge Creation Research Centre, Seoul National University, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Youngjo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Data Science for Knowledge Creation Research Centre, Seoul National University, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun Young</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun Bong</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yeong Wook</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jin Kyun</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Korea. jinkyunpark@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Exp Rheumatol</MedlineTA><NlmUniqueID>8308521</NlmUniqueID><ISSNLinking>0392-856X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001833" MajorTopicYN="Y">Body Temperature Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="Y">Circadian Rhythm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055501" MajorTopicYN="N">Macrophage Activation Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016706" MajorTopicYN="N">Still's Disease, Adult-Onset</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069558" MajorTopicYN="N">Unsupervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30582502</ArticleId><ArticleId IdType="pii">12714</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30571648</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>11</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>A Dual Mode Adaptive Basal-Bolus Advisor Based on Reinforcement Learning.</ArticleTitle><Pagination><MedlinePgn>2633-2641</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2018.2887067</ELocationID><Abstract><AbstractText>Self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) are commonly used by type 1 diabetes (T1D) patients to measure glucose concentrations. The proposed adaptive basal-bolus algorithm (ABBA) supports inputs from either SMBG or CGM devices to provide personalised suggestions for the daily basal rate and prandial insulin doses on the basis of the patients' glucose level on the previous day. The ABBA is based on reinforcement learning, a type of artificial intelligence, and was validated in silico with an FDA-accepted population of 100 adults under different realistic scenarios lasting three simulated months. The scenarios involve three main meals and one bedtime snack per day, along with different variabilities and uncertainties for insulin sensitivity, mealtime, carbohydrate amount, and glucose measurement time. The results indicate that the proposed approach achieves comparable performance with CGM or SMBG as input signals, without influencing the total daily insulin dose. The results are a promising indication that AI algorithmic approaches can provide personalised adaptive insulin optimization and achieve glucose control-independent of the type of glucose monitoring technology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qingnan</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Jankovic</LastName><ForeName>Marko V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Budzinski</LastName><ForeName>Joao</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Brett</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Diem</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Stettler</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Mougiakakou</LastName><ForeName>Stavroula G</ForeName><Initials>SG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30571648</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2018.2887067</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30562343</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus.</ArticleTitle><Pagination><MedlinePgn>e0208132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0208132</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is characterized by abnormalities in B cell and T cell function, but the role of disturbances in the activation status of macrophages (M..) has not been well described in human patients. To address this, gene expression profiles from isolated lymphoid and myeloid populations were analyzed to identify differentially expressed (DE) genes between healthy controls and patients with either inactive or active SLE. While hundreds of DE genes were identified in B and T cells of active SLE patients, there were no DE genes found in B or T cells from patients with inactive SLE compared to healthy controls. In contrast, large numbers of DE genes were found in myeloid cells (MC) from both active and inactive SLE patients. Among the DE genes were several known to play roles in M.. activation and polarization, including the M1 genes STAT1 and SOCS3 and the M2 genes STAT3, STAT6, and CD163. M1-associated genes were far more frequent in data sets from active versus inactive SLE patients. To characterize the relationship between M.. activation and disease activity in greater detail, weighted gene co-expression network analysis (WGCNA) was used to identify modules of genes associated with clinical activity in SLE patients. Among these were disease activity-correlated modules containing activation signatures of predominantly M1-associated genes. No disease activity-correlated modules were enriched in M2-associated genes. Pathway and upstream regulator analysis of DE genes from both active and inactive SLE MC were cross-referenced with high-scoring hits from the drug discovery Library of Integrated Network-based Cellular Signatures (LINCS) to identify new strategies to treat both stages of SLE. A machine learning approach employing MC gene modules and a generalized linear model was able to predict the disease activity status in unrelated gene expression data sets. In summary, altered MC gene expression is characteristic of both active and inactive SLE. However, disease activity is associated with an alteration in the activation of MC, with a bias toward the M1 proinflammatory phenotype. These data suggest that while hyperactivity of B cells and T cells is associated with active SLE, MC potentially direct flare-ups and remission by altering their activation status toward the M1 state.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Labonte</LastName><ForeName>Adam C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-7378-2638</Identifier><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kegerreis</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraci</LastName><ForeName>Nicholas S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachali</LastName><ForeName>Prathyusha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madamanchi</LastName><ForeName>Sushma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robl</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalina</LastName><ForeName>Michelle D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipsky</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grammer</LastName><ForeName>Amrie C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RILITE Research Institute, Charlottesville, Virginia, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008262" MajorTopicYN="N">Macrophage Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067251" MajorTopicYN="N">Symptom Flare Up</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors are employed by AMPEL BioSolutions, LLC or by the RILITE Research Institute. This does not alter our adherence to PLoS One policies on data sharing and materials. The work presented in this study is not part of any patents or marketed products.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30562343</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0208132</ArticleId><ArticleId IdType="pii">PONE-D-18-22756</ArticleId><ArticleId IdType="pmc">PMC6298676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Front Immunol. 2014 Sep 02;5:420</Citation><ArticleIdList><ArticleId IdType="pubmed">25228902</ArticleId></ArticleIdList></Reference><Reference><Citation>ScientificWorldJournal. 2011;11:2391-402</Citation><ArticleIdList><ArticleId IdType="pubmed">22194670</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Med (Berl). 2012 Nov;90(11):1295-309</Citation><ArticleIdList><ArticleId IdType="pubmed">22610275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Feb 15;30(4):523-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Nov 15;177(10):7303-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17082649</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2016 Jun 02;7:204</Citation><ArticleIdList><ArticleId IdType="pubmed">27313577</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Biosci. 2008 Jan 01;13:453-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17981560</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2008 Feb;28(2):206-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18275831</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2008 Dec 29;9:559</Citation><ArticleIdList><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2012 Mar;122(3):787-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22378047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Apr 21;165(3):551-65</Citation><ArticleIdList><ArticleId IdType="pubmed">27040498</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2004 Sep;76(3):509-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15218057</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2014 Oct 07;5:491</Citation><ArticleIdList><ArticleId IdType="pubmed">25339958</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Apr 16;9(4):e95432</Citation><ArticleIdList><ArticleId IdType="pubmed">24740015</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxid Med Cell Longev. 2016;2016:2795090</Citation><ArticleIdList><ArticleId IdType="pubmed">27143992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2009 Jan;9(1):15-27</Citation><ArticleIdList><ArticleId IdType="pubmed">19079135</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Spectr. 2016 Jun;4(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">27337485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Life Sci. 2015 Nov;72(21):4111-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26210152</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2015 Mar;11(3):714-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25609570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2011 Oct 19;12(11):1035-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22012443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2016 Sep;25(10):1150-70</Citation><ArticleIdList><ArticleId IdType="pubmed">27497259</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2014 Nov 26;5:603</Citation><ArticleIdList><ArticleId IdType="pubmed">25505468</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2016 Oct;55(10):1901-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27354683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2007 Jan;117(1):175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17200717</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2015 Dec;161(2):209-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26209923</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2018 Apr;189:63-74</Citation><ArticleIdList><ArticleId IdType="pubmed">27094466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Nov 10;33(20):e175</Citation><ArticleIdList><ArticleId IdType="pubmed">16284200</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Immunol. 2014;124:207-47</Citation><ArticleIdList><ArticleId IdType="pubmed">25175777</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Feb;7(2):e1001311</Citation><ArticleIdList><ArticleId IdType="pubmed">21379322</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 31;8(12):e83776</Citation><ArticleIdList><ArticleId IdType="pubmed">24391825</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2014 Sep 1;547(2):300-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24992030</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2008 Dec;8(12):958-69</Citation><ArticleIdList><ArticleId IdType="pubmed">19029990</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2017 Mar 1;56(3):477-487</Citation><ArticleIdList><ArticleId IdType="pubmed">28031441</ArticleId></ArticleIdList></Reference><Reference><Citation>Redox Biol. 2017 Aug;12:50-57</Citation><ArticleIdList><ArticleId IdType="pubmed">28212523</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cells. 2014 Apr;37(4):275-85</Citation><ArticleIdList><ArticleId IdType="pubmed">24625576</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2011;29:163-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21219184</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1120-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23640492</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2004 Dec;25(12):677-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15530839</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2011 Jul 1;187(1):538-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2016 May 20;34:93-119</Citation><ArticleIdList><ArticleId IdType="pubmed">26735697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wound Repair Regen. 2016 Jul;24(4):613-29</Citation><ArticleIdList><ArticleId IdType="pubmed">27196106</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2013 Feb;65(2):447-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23203821</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2016 Aug;22(8):1992-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27243595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus Sci Med. 2015 Mar 28;2(1):e000080</Citation><ArticleIdList><ArticleId IdType="pubmed">25861459</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(9):e44362</Citation><ArticleIdList><ArticleId IdType="pubmed">23028528</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2002 Feb;14(1):136-45</Citation><ArticleIdList><ArticleId IdType="pubmed">11790544</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jul 1;175(1):342-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15972667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2015 Apr;15(4):203-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25720354</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2014 Dec;26(6):559-77</Citation><ArticleIdList><ArticleId IdType="pubmed">25311810</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(9):e45466</Citation><ArticleIdList><ArticleId IdType="pubmed">23029029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Physiol Biochem. 2016;38(1):330-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26824452</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1722-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27386937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Nephrol. 2015 Jun;11(6):329-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25825084</ArticleId></ArticleIdList></Reference><Reference><Citation>Discov Med. 2015 Jul-Aug;20(108):43-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26321086</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2010 Apr;22(2):231-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20144856</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Nov 16;43(20):9680-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26476451</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Nov 18;9(11):e112545</Citation><ArticleIdList><ArticleId IdType="pubmed">25405351</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2011 May 30;9:65</Citation><ArticleIdList><ArticleId IdType="pubmed">21624134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30545401</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-2618</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>12</Month><Day>13</Day></PubDate></JournalIssue><Title>Microbiome</Title><ISOAbbreviation>Microbiome</ISOAbbreviation></Journal><ArticleTitle>A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?</ArticleTitle><Pagination><MedlinePgn>221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40168-018-0603-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable knowledge has emerged regarding the plausible role of the gut microbiome in IMIDs. This study used 16S rRNA gene amplicon sequencing to compare the gut microbiota of patients with Crohn's disease (CD; N...=...20), ulcerative colitis (UC; N...=...19), multiple sclerosis (MS; N...=...19), and rheumatoid arthritis (RA; N...=...21) versus healthy controls (HC; N...=...23). Biological replicates were collected from participants within a 2-month interval. This study aimed to identify common (or unique) taxonomic biomarkers of IMIDs using both differential abundance testing and a machine learning approach.</AbstractText><AbstractText Label="RESULTS">Significant microbial community differences between cohorts were observed (pseudo F...=...4.56; p...=...0.01). Richness and diversity were significantly different between cohorts (pFDR &lt;...0.001) and were lowest in CD while highest in HC. Abundances of Actinomyces, Eggerthella, Clostridium III, Faecalicoccus, and Streptococcus (pFDR &lt;...0.001) were significantly higher in all disease cohorts relative to HC, whereas significantly lower abundances were observed for Gemmiger, Lachnospira, and Sporobacter (pFDR &lt;...0.001). Several taxa were found to be differentially abundant in IMIDs versus HC including significantly higher abundances of Intestinibacter in CD, Bifidobacterium in UC, and unclassified Erysipelotrichaceae in MS and significantly lower abundances of Coprococcus in CD, Dialister in MS, and Roseburia in RA. A machine learning approach to classify disease versus HC was highest for CD (AUC...=...0.93 and AUC...=...0.95 for OTU and genus features, respectively) followed by MS, RA, and UC. Gemmiger and Faecalicoccus were identified as important features for classification of subjects to CD and HC. In general, features identified by differential abundance testing were consistent with machine learning feature importance.</AbstractText><AbstractText Label="CONCLUSIONS">This study identified several gut microbial taxa with differential abundance patterns common to IMIDs. We also found differentially abundant taxa between IMIDs. These taxa may serve as biomarkers for the detection and diagnosis of IMIDs and suggest there may be a common component to IMID etiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Forbes</LastName><ForeName>Jessica D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chih-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knox</LastName><ForeName>Natalie C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrie</LastName><ForeName>Ruth-Ann</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Gabalawy</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Kievit</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfa</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernstein</LastName><ForeName>Charles N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Domselaar</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada. Gary.vandomselaar@canada.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada. Gary.vandomselaar@canada.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada. Gary.vandomselaar@canada.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microbiome</MedlineTA><NlmUniqueID>101615147</NlmUniqueID><ISSNLinking>2049-2618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004269">DNA, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004275">DNA, Ribosomal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="N">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="N">Crohn Disease</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004269" MajorTopicYN="N">DNA, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004275" MajorTopicYN="N">DNA, Ribosomal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="N">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056186" MajorTopicYN="N">Metagenomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">16S rRNA gene amplicon sequencing</Keyword><Keyword MajorTopicYN="Y">Bacteria</Keyword><Keyword MajorTopicYN="Y">Gut microbiota</Keyword><Keyword MajorTopicYN="Y">Immune-mediated inflammatory disease</Keyword><Keyword MajorTopicYN="Y">Inflammatory bowel disease</Keyword><Keyword MajorTopicYN="Y">Machine learning classifiers</Keyword><Keyword MajorTopicYN="Y">Multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="Y">Taxonomic biomarkers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30545401</ArticleId><ArticleId IdType="doi">10.1186/s40168-018-0603-4</ArticleId><ArticleId IdType="pii">10.1186/s40168-018-0603-4</ArticleId><ArticleId IdType="pmc">PMC6292067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Gastroenterol. 2008 Nov;103(11):2925-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18775018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 Oct 14;18(4):489-500</Citation><ArticleIdList><ArticleId IdType="pubmed">26468751</ArticleId></ArticleIdList></Reference><Reference><Citation>mBio. 2016 Sep 20;7(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">27651359</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Clin Immunol. 2013 Apr;9(4):297-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23557265</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10713-10718</Citation><ArticleIdList><ArticleId IdType="pubmed">28893978</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2011 Jun 24;12(6):R60</Citation><ArticleIdList><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Aug;21(8):895-905</Citation><ArticleIdList><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2017 Sep;83:51-61</Citation><ArticleIdList><ArticleId IdType="pubmed">28431796</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucosal Immunol. 2017 Jan;10(1):18-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27554295</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2016 Apr 21;8(1):43</Citation><ArticleIdList><ArticleId IdType="pubmed">27102666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2017 May;66(5):813-822</Citation><ArticleIdList><ArticleId IdType="pubmed">28179361</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2006 Aug;74(8):4841-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16861672</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2012 Oct;18(10):1799-808</Citation><ArticleIdList><ArticleId IdType="pubmed">22170749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2015 Mar;14(3):263-73</Citation><ArticleIdList><ArticleId IdType="pubmed">25662901</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiome. 2015 Aug 12;3:33</Citation><ArticleIdList><ArticleId IdType="pubmed">26269741</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Sep 19;12(9):e0184624</Citation><ArticleIdList><ArticleId IdType="pubmed">28926599</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Apr 22;8(4):e61217</Citation><ArticleIdList><ArticleId IdType="pubmed">23630581</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiome. 2017 Mar 3;5(1):27</Citation><ArticleIdList><ArticleId IdType="pubmed">28253908</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2011 Nov;96(11):1042-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21903597</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Microbiol. 2011 May;6(5):595-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21585265</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2016 Apr;22(4):817-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26937623</ArticleId></ArticleIdList></Reference><Reference><Citation>Case Rep Gastroenterol. 2017 Jun 14;11(2):377-381</Citation><ArticleIdList><ArticleId IdType="pubmed">28690491</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Aug 02;6:30594</Citation><ArticleIdList><ArticleId IdType="pubmed">27481047</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Sep 14;10(9):e0137429</Citation><ArticleIdList><ArticleId IdType="pubmed">26367776</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Jul 11;12(7):e1004977</Citation><ArticleIdList><ArticleId IdType="pubmed">27400279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2007 Aug;73(16):5261-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17586664</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2930-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25964341</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Mol Med. 2017 May 26;49(5):e340</Citation><ArticleIdList><ArticleId IdType="pubmed">28546563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2013 Dec;7(11):e558-68</Citation><ArticleIdList><ArticleId IdType="pubmed">23643066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 8;500(7461):232-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23842501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2007;35(21):7188-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17947321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jun 27;6:28484</Citation><ArticleIdList><ArticleId IdType="pubmed">27346372</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiome. 2015 Oct 05;3:47</Citation><ArticleIdList><ArticleId IdType="pubmed">26437943</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1725-32</Citation><ArticleIdList><ArticleId IdType="pubmed">10555354</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2016 Feb 21;22(7):2195-205</Citation><ArticleIdList><ArticleId IdType="pubmed">26900284</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2017 Feb;11(2):191-203</Citation><ArticleIdList><ArticleId IdType="pubmed">27466174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Sep 15;32(18):2847-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastroenterol. 2018 Jan;53(1):95-106</Citation><ArticleIdList><ArticleId IdType="pubmed">28852861</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Oct 4;490(7418):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">23023125</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A</Citation><ArticleIdList><ArticleId IdType="pubmed">16151544</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2006 Feb;55(2):205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16188921</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastroenterol Hepatol. 2018 Feb 20;:</Citation><ArticleIdList><ArticleId IdType="pubmed">29462845</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Microbiol. 2017 Feb;12:157-170</Citation><ArticleIdList><ArticleId IdType="pubmed">28139139</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Dis Sci. 2015 Feb;60(2):290-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25204669</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Nutr. 2018 Jun;37(3):797-807</Citation><ArticleIdList><ArticleId IdType="pubmed">28410921</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2017 Feb 13;2:17004</Citation><ArticleIdList><ArticleId IdType="pubmed">28191884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Dec;10(12):1200-2</Citation><ArticleIdList><ArticleId IdType="pubmed">24076764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jun 10;389(10086):2328-2337</Citation><ArticleIdList><ArticleId IdType="pubmed">28612747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Sep 13;489(7415):220-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22972295</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2009 Jan;37(Database issue):D141-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19004872</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonie Van Leeuwenhoek. 2008 Jun;94(1):35-50</Citation><ArticleIdList><ArticleId IdType="pubmed">18338233</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Oct 25;8:1391</Citation><ArticleIdList><ArticleId IdType="pubmed">29118761</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Feb;12(2):115-21</Citation><ArticleIdList><ArticleId IdType="pubmed">25633503</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Res Opin. 2006 May;22(5):989-1000</Citation><ArticleIdList><ArticleId IdType="pubmed">16709321</ArticleId></ArticleIdList></Reference><Reference><Citation>Case Rep Infect Dis. 2012;2012:517637</Citation><ArticleIdList><ArticleId IdType="pubmed">23346432</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2005 Sep;129(3):827-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16143122</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2007 Jul;102(7):1429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17437504</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Dec 5;8(1):1784</Citation><ArticleIdList><ArticleId IdType="pubmed">29209090</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2017 Jul 27;18(1):142</Citation><ArticleIdList><ArticleId IdType="pubmed">28750650</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Syst Evol Microbiol. 2015 Mar;65(Pt 3):805-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25481294</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Syst Evol Microbiol. 2014 Nov;64(Pt 11):3877-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25180093</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2014 Mar 12;15(3):382-392</Citation><ArticleIdList><ArticleId IdType="pubmed">24629344</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G327-G339</Citation><ArticleIdList><ArticleId IdType="pubmed">28039159</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Sep 5;2(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">28904997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Aug 15;27(16):2194-200</Citation><ArticleIdList><ArticleId IdType="pubmed">21700674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Sep;76(9):1614-1622</Citation><ArticleIdList><ArticleId IdType="pubmed">28606969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30537719</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0143</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Kidney &amp; blood pressure research</Title><ISOAbbreviation>Kidney Blood Press Res</ISOAbbreviation></Journal><ArticleTitle>Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.</ArticleTitle><Pagination><MedlinePgn>1852-1864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000495818</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIMS" NlmCategory="OBJECTIVE">There is an increasing risk of end-stage renal disease (ESRD) among Asian people with immunoglobulin A nephropathy (IgAN). A computer-aided system for ESRD prediction in Asian IgAN patients has not been well studied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively reviewed biopsy-proven IgAN patients treated at the Department of Nephrology of the Second Xiangya Hospital from January 2009 to November 2013. Demographic and clinicopathological data were obtained within 1 month of renal biopsy. A random forest (RF) model was employed to predict the ESRD status in IgAN patients. All cases were initially trained and validated, taking advantage of the out-of-bagging(OOB) error. Predictors used in the model were selected according to the Gini impurity index in the RF model and verified by logistic regression analysis. The area under the receiver operating characteristic(ROC) curve (AUC) and F-measure were used to evaluate the RF model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 262 IgAN patients were enrolled in this study with a median follow-up time of 4.66 years. The importance rankings of predictors of ESRD in the RF model were first obtained, indicating some of the most important predictors. Logistic regression also showed that these factors were statistically associated with ESRD status. We first trained an initial RF model using gender, age, hypertension, serum creatinine, 24-hour proteinuria and histological grading suggested by the Clinical Decision Support System for IgAN (CDSS, www.IgAN.net). This 6-predictor model achieved a F-measure of 0.8 and an AUC of 92.57%. By adding Oxford-MEST scores, this model outperformed the initial model with an improved AUC (96.1%) and F-measure (0.823). When C3 staining was incorporated, the AUC was 97.29% and F-measure increased to 0.83. Adding the estimated glomerular filtration rate (eGFR) improved the AUC to 95.45%. We also observed improved performance of the model with additional inputs of blood urea nitrogen (BUN), uric acid, hemoglobin and albumin.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In addition to the predictors in the CDSS, Oxford-MEST scores, C3 staining and eGFR conveyed additional information for ESRD prediction in Chinese IgAN patients using a RF model.</AbstractText><CopyrightInformation>.. 2018 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yexin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Robotics for Infrastructure Management Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaofang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guochun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Liyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Letian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xuejing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Xiangya Hospital, Central South University, Key laboratory of Kidney disease and Blood Purification in Hunan Province, Changsha, China, liuhong618@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Kidney Blood Press Res</MedlineTA><NlmUniqueID>9610505</NlmUniqueID><ISSNLinking>1420-4096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="Y">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005922" MajorTopicYN="N">Glomerulonephritis, IGA</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="N">Supervised Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complement</Keyword><Keyword MajorTopicYN="N">End-stage renal disease(ESRD)</Keyword><Keyword MajorTopicYN="N">Estimated glomerular filtration rate (eGFR)</Keyword><Keyword MajorTopicYN="N">IgA nephropathy (IgAN)</Keyword><Keyword MajorTopicYN="N">Logistic regression</Keyword><Keyword MajorTopicYN="N">Random forest model</Keyword><Keyword MajorTopicYN="N">pathological grading</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30537719</ArticleId><ArticleId IdType="pii">000495818</ArticleId><ArticleId IdType="doi">10.1159/000495818</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30532769</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1687-5273</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Computational intelligence and neuroscience</Title><ISOAbbreviation>Comput Intell Neurosci</ISOAbbreviation></Journal><ArticleTitle>A Predictive Model for Guillain-Barr.. Syndrome Based on Ensemble Methods.</ArticleTitle><Pagination><MedlinePgn>1576927</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/1576927</ELocationID><Abstract><AbstractText>Nowadays, Machine Learning methods have proven to be highly effective on the identification of various types of diseases, in the form of predictive models. Guillain-Barr.. syndrome (GBS) is a potentially fatal autoimmune neurological disorder that has barely been studied with computational techniques and few predictive models have been proposed. In a previous study, single classifiers were successfully used to build a predictive model. We believe that a predictive model is imperative to carry out adequate treatment in patients promptly. We designed three classification experiments: (1) using all four GBS subtypes, (2) One versus All (OVA), and (3) One versus One (OVO). These experiments use a real-world dataset with 129 instances and 16 relevant features. Besides, we compare five state-of-the-art ensemble methods against 15 single classifiers with 30 independent runs. Standard performance measures were used to obtain the best classifier in each experiment. Derived from the experiments, we conclude that Random Forest showed the best results in four GBS subtypes classification, no ensemble method stood out over the rest in OVA classification, and single classifiers outperformed ensemble methods in most cases in OVO classification. This study presents a novel predictive model for classification of four subtypes of Guillain-Barr.. syndrome. Our model identifies the best method for each classification case. We expect that our model could assist specialized physicians as a support tool and also could serve as a basis to improved models in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canul-Reich</LastName><ForeName>Juana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1893-1332</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Tabasco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern..ndez-Torruco</LastName><ForeName>Jos..</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3146-9349</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Tabasco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ch..vez-Bosquez</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-0324-9886</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Tabasco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern..ndez-Oca..a</LastName><ForeName>Betania</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5700-7615</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Tabasco, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Intell Neurosci</MedlineTA><NlmUniqueID>101279357</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30532769</ArticleId><ArticleId IdType="doi">10.1155/2018/1576927</ArticleId><ArticleId IdType="pmc">PMC6247730</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Neurol. 1998 Nov;44(5):780-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9818934</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2012 Aug;123(8):1487-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22480600</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 2004;64(6):597-610</Citation><ArticleIdList><ArticleId IdType="pubmed">15018590</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Math Methods Med. 2017;2017:8424198</Citation><ArticleIdList><ArticleId IdType="pubmed">28487747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 Jun;67(6):781-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20517939</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:3025057</Citation><ArticleIdList><ArticleId IdType="pubmed">27847810</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol India. 2012 Mar-Apr;60(2):150-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22626694</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2014 Aug;10(8):469-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25023340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):115-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24816419</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2017 Jul;128(7):1176-1183</Citation><ArticleIdList><ArticleId IdType="pubmed">28521265</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2011 Mar 15;76(11):968-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21403108</ArticleId></ArticleIdList></Reference><Reference><Citation>J Peripher Nerv Syst. 2014 Mar;19(1):36-43</Citation><ArticleIdList><ArticleId IdType="pubmed">24456386</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscle Nerve. 2013 Jan;47(1):68-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23042578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Inform. 2010 Mar 10;9:39-48</Citation><ArticleIdList><ArticleId IdType="pubmed">20458360</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2007 Jul;6(7):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17537676</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurologia. 2016 Jul-Aug;31(6):389-94</Citation><ArticleIdList><ArticleId IdType="pubmed">25542501</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand. 2011 Mar;123(3):181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20497128</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2015;16 Suppl 5:S3</Citation><ArticleIdList><ArticleId IdType="pubmed">26040557</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jul 22;10(7):e0133520</Citation><ArticleIdList><ArticleId IdType="pubmed">26200903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2017 Mar;264(3):564-569</Citation><ArticleIdList><ArticleId IdType="pubmed">28091723</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30529925</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Multiple sclerosis and related disorders</Title><ISOAbbreviation>Mult Scler Relat Disord</ISOAbbreviation></Journal><ArticleTitle>Multiple sclerosis risk factors contribute to onset heterogeneity.</ArticleTitle><Pagination><MedlinePgn>11-16</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-0348(18)30535-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msard.2018.12.007</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The phenotypic presentation of multiple sclerosis (MS) may predict long-term outcomes and little is known about factors contributing to heterogeneity at MS onset. Given temporality, it is likely MS risk factors also influence presentation of the disease near onset.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using a retrospective cross-sectional study of MS cases, we investigated: age of onset (AOO), number of impaired functional domains (NIFDs), time to second relapse (TT2R), and early relapse activity (ERA). Machine learning variable selection was applied to epidemiologic data for each outcome, followed by multivariable regression models. The models were further adjusted for HLA-DRB1*15:01 carrier status and a MS genetic risk score (GRS). The TT2R and ERA analyses were restricted to relapsing remitting MS cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">HLA-DRB1*15:01, GRS, and smoking were associated with earlier AOO. Cases who were male, obese, had lower education, or had primary progressive MS were older at onset. For NIFDs, those with relapsing remitting MS and of lower SES had increased NIFDs. Among relapsing remitting cases, those who were older at onset, obese, and had polyfocal presentation had shorter TT2R, while ERA was greater among those younger at onset and who were obese.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Individual characteristics including age, genetic profiles, obesity, and smoking status contribute to heterogeneity in disease presentation and modulate early disease course evolution.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Farren B S</ForeName><Initials>FBS</Initials><AffiliationInfo><Affiliation>Neuroimmunological Disorders Gene-Environment Epidemiology Laboratory, Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 1312 Wolstein Research Building, 2103 Cornell, Rd, Cleveland, OH 44106, USA. Electronic address: farren.briggs@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Justin C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Neuroimmunological Disorders Gene-Environment Epidemiology Laboratory, Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 1312 Wolstein Research Building, 2103 Cornell, Rd, Cleveland, OH 44106, USA. Electronic address: justin.c.yu@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Mary F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA. Electronic address: mary_davis@byu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiangyang</LastName><ForeName>Jinghong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuroimmunological Disorders Gene-Environment Epidemiology Laboratory, Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 1312 Wolstein Research Building, 2103 Cornell, Rd, Cleveland, OH 44106, USA. Electronic address: jinghong.jiangyang@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroimmunological Disorders Gene-Environment Epidemiology Laboratory, Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, 1312 Wolstein Research Building, 2103 Cornell, Rd, Cleveland, OH 44106, USA. Electronic address: shannon.fu@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrotta</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: parrote@ccf.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunzler</LastName><ForeName>Douglas D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Center for Health Care Research and Policy, Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. Electronic address: dgunzler@metrohealth.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ontaneda</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: ontaned@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mult Scler Relat Disord</MedlineTA><NlmUniqueID>101580247</NlmUniqueID><ISSNLinking>2211-0348</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489631">HLA-DRB1*15:01 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Onset</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30529925</ArticleId><ArticleId IdType="pii">S2211-0348(18)30535-2</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2018.12.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30502078</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Predicting conversion from clinically isolated syndrome to multiple sclerosis-An imaging-based machine learning approach.</ArticleTitle><Pagination><MedlinePgn>101593</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(18)30341-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2018.11.003</ELocationID><Abstract><AbstractText>Magnetic resonance imaging (MRI) scans play a pivotal role in the evaluation of patients presenting with a clinically isolated syndrome (CIS), as these may depict brain lesions suggestive of an inflammatory cause. We hypothesized that it is possible to predict the conversion from CIS to multiple sclerosis (MS) based on the baseline MRI scan by studying image features of these lesions. We analyzed 84 patients diagnosed with CIS from a prospective observational single center cohort. The patients were followed up for at least three years. Conversion to MS was defined according to the 2010 McDonald criteria. Brain lesions were segmented based on 3D FLAIR and 3D T1 images. We generated brain lesion masks by a computer assisted manual segmentation. We also generated a set of automated segmentations using the Lesion Segmentation Toolbox for SPM to assess the influence of different segmentation methods. Shape and brightness features were automatically calculated from the segmented masks and used as input data to train an oblique random forest classifier. Prediction accuracies of the resulting model were validated through a three-fold cross-validation. Conversion from CIS to MS occurred in 66 of 84 patients (79%). The conversion or non-conversion was predicted correctly in 71 patients based on shape features derived from the computer assisted manual segmentation masks (84.5% accuracy). This predictor was more accurate than predicting conversion using dissemination in space at baseline according to the 2010 McDonald criteria (75% accuracy). While shape features strongly contributed to the accuracy of the predictor, including intensity features did not further improve performance. As patients who convert to definite MS benefit from early treatment, an early classification model is highly desirable. Our study shows that shape parameters of lesions can contribute to predicting the future course of CIS patients more accurately.</AbstractText><CopyrightInformation>Copyright .. 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haike</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberts</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pongratz</LastName><ForeName>Viola</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany; TUM-NIC, NeuroImaging Center, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M..hlau</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany; TUM-NIC, NeuroImaging Center, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmer</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiestler</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichinger</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany. Electronic address: Paul.Eichinger@tum.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="N">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Clinically isolated syndrome</Keyword><Keyword MajorTopicYN="Y">MRI</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Multiple sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30502078</ArticleId><ArticleId IdType="pii">S2213-1582(18)30341-3</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2018.11.003</ArticleId><ArticleId IdType="pmc">PMC6505058</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30513105</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.</ArticleTitle><Pagination><MedlinePgn>e0207926</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0207926</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Limited evidences are available on biomarkers to recognize Systemic Lupus erythematosus (SLE) patients at risk to develop erosive arthritis. Anti-citrullinated peptide antibodies (ACPA) have been widely investigated and identified in up to 50% of X-ray detected erosive arthritis; conversely, few studies evaluated anti-carbamylated proteins antibodies (anti-CarP). Here, we considered the application of machine learning models to identify relevant factors in the development of ultrasonography (US)-detected erosive damage in a large cohort of SLE patients with joint involvement.</AbstractText><AbstractText Label="METHODS">We enrolled consecutive SLE patients with arthritis/arthralgia. All patients underwent joint (DAS28, STR) and laboratory assessment (detection of ACPA, anti-CarP, Rheumatoid Factor, SLE-related antibodies). The bone surfaces of metacarpophalangeal and proximal interphalangeal joints were assessed by US: the presence of erosions was registered with a dichotomous value (0/1), obtaining a total score (0-20). Concerning machine learning techniques, we applied and compared Logistic Regression and Decision Trees in conjunction with the feature selection Forward Wrapper method.</AbstractText><AbstractText Label="RESULTS">We enrolled 120 SLE patients [M/F 8/112, median age 47.0 years (IQR 15.0); median disease duration 120.0 months (IQR 156.0)], 73.3% of them referring at least one episode of arthritis. Erosive damage was identified in 25.8% of patients (mean..SD 0.7..1.6), all of them with clinically evident arthritis. We applied Logistic Regression in conjunction with the Forward Wrapper method, obtaining an AUC value of 0.806..0.02. As a result of the learning procedure, we evaluated the relevance of the different factors: this value was higher than 35% for ACPA and anti-CarP.</AbstractText><AbstractText Label="CONCLUSION">The application of Machine Learning Models allowed to identify factors associated with US-detected erosive bone damage in a large SLE cohort and their relevance in determining this phenotype. Although the scope of this study is limited by the small sample size and its cross-sectional nature, the results suggest the relevance of ACPA and anti-CarP antibodies in the development of erosive damage as also pointed out in other studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ceccarelli</LastName><ForeName>Fulvia</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5026-8783</Identifier><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciandrone</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perricone</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvan</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0384-0334</Identifier><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cipriano</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galligari</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8599-642X</Identifier><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4616-8277</Identifier><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colasanti</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massaro</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natalucci</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>Francesca Romana</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessandri</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valesini</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075422">Anti-Citrullinated Protein Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>9009-79-4</RegistryNumber><NameOfSubstance UI="D012217">Rheumatoid Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2019 Jan 30;14(1):e0211791</RefSource><PMID Version="1">30699190</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075422" MajorTopicYN="N">Anti-Citrullinated Protein Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077279" MajorTopicYN="N">Protein Carbamylation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012217" MajorTopicYN="N">Rheumatoid Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30513105</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0207926</ArticleId><ArticleId IdType="pii">PONE-D-18-13195</ArticleId><ArticleId IdType="pmc">PMC6279013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1999 Jun;42(6):1232-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10366117</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2017 Jul-Aug;35(4):674-677</Citation><ArticleIdList><ArticleId IdType="pubmed">28339366</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17372-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21987802</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumatismo. 2015 Sep 16;67(2):62-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26492964</ArticleId></ArticleIdList></Reference><Reference><Citation>EURASIP J Bioinform Syst Biol. 2016 Aug 19;2016(1):12</Citation><ArticleIdList><ArticleId IdType="pubmed">27610127</ArticleId></ArticleIdList></Reference><Reference><Citation>ScientificWorldJournal. 2014;2014:236842</Citation><ArticleIdList><ArticleId IdType="pubmed">25530992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2006;15(8):501-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16942002</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2017 Aug;47(1):53-64</Citation><ArticleIdList><ArticleId IdType="pubmed">28465078</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Feb;29(2):288-91</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2006;8(5):R144</Citation><ArticleIdList><ArticleId IdType="pubmed">16934155</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumatismo. 2012 Dec 11;64(5):321-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23256108</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2018 Jun 14;20(1):126</Citation><ArticleIdList><ArticleId IdType="pubmed">29898764</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2011 Jul-Aug;57(4):300-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21701272</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Dec;32(12):2485-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16331793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2001 Jul;60(7):641-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11406516</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Res. 2015;2015:712490</Citation><ArticleIdList><ArticleId IdType="pubmed">26090496</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2016 Dec 3;18(1):289</Citation><ArticleIdList><ArticleId IdType="pubmed">27912793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2002 Jan;8(1):68-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11786909</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Mar;39(3):363-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Mar 22;12(3):e0174200</Citation><ArticleIdList><ArticleId IdType="pubmed">28329014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2018 Jan;27(1):105-111</Citation><ArticleIdList><ArticleId IdType="pubmed">28592200</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Med. 2008 Aug;38(8):894-912</Citation><ArticleIdList><ArticleId IdType="pubmed">18656182</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2014;43(5):416-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24720480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30476175</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling.</ArticleTitle><Pagination><MedlinePgn>61-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy154</ELocationID><Abstract><AbstractText>Accurate and efficient identification of complex chronic conditions in the electronic health record (EHR) is an important but challenging task that has historically relied on tedious clinician review and oversimplification of the disease. Here we adapt methods that allow for automated "noisy labeling" of positive and negative controls to create a "silver standard" for machine learning to automate identification of systemic lupus erythematosus (SLE). Our final model, which includes both structured data as well as text processing of clinical notes, outperformed all existing algorithms for SLE (AUC 0.97). In addition, we demonstrate how the probabilistic outputs of this model can be adapted to various clinical needs, selecting high thresholds when specificity is the priority and lower thresholds when a more inclusive patient population is desired. Deploying a similar methodology to other complex diseases has the potential to dramatically simplify the landscape of population identification in the EHR.</AbstractText><AbstractText Label="MeSH terms">Electronic Health Records, Machine Learning, Lupus Erythematosus, Phenotype, Algorithms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Sara G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avati</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmajuk</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, San Francisco VA Medical Center, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdany</LastName><ForeName>Jinoos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AR074534</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070155</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS024412</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AR063770</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30476175</ArticleId><ArticleId IdType="pii">5199370</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy154</ArticleId><ArticleId IdType="pmc">PMC6308013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Apr 24;350:h1885</Citation><ArticleIdList><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Syst Man Cybern B Cybern. 2009 Apr;39(2):539-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19095540</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2011 Aug;38(8):1612-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21532057</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Dec 30;31 Suppl 10:K62-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24331075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e162-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2016 Nov;23(6):1166-1173</Citation><ArticleIdList><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 May;69(5):687-693</Citation><ArticleIdList><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30475847</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>eDRAM: Effective early disease risk assessment with matrix factorization on a large-scale medical database: A case study on rheumatoid arthritis.</ArticleTitle><Pagination><MedlinePgn>e0207579</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0207579</ELocationID><Abstract><AbstractText>Recently, a number of analytical approaches for probing medical databases have been developed to assist in disease risk assessment and to determine the association of a clinical condition with others, so that better and intelligent healthcare can be provided. The early assessment of disease risk is an emerging topic in medical informatics. If diseases are detected at an early stage, prognosis can be improved and medical resources can be used more efficiently. For example, if rheumatoid arthritis (RA) is detected at an early stage, appropriate medications can be used to prevent bone deterioration. In early disease risk assessment, finding important risk factors from large-scale medical databases and performing individual disease risk assessment have been challenging tasks. A number of recent studies have considered risk factor analysis approaches, such as association rule mining, sequential rule mining, regression, and expert advice. In this study, to improve disease risk assessment, machine learning and matrix factorization techniques were integrated to discover important and implicit risk factors. A novel framework is proposed that can effectively assess early disease risks, and RA is used as a case study. This framework comprises three main stages: data preprocessing, risk factor optimization, and early disease risk assessment. This is the first study integrating matrix factorization and machine learning for disease risk assessment that is applied to a nation-wide and longitudinal medical diagnostic database. In the experimental evaluations, a cohort established from a large-scale medical database was used that included 1007 RA-diagnosed patients and 921,192 control patients examined over a nine-year follow-up period (2000-2008). The evaluation results demonstrate that the proposed approach is more efficient and stable for disease risk assessment than state-of-the-art methods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Chu-Yu</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-2913-5043</Identifier><AffiliationInfo><Affiliation>Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Sun-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Vincent S</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-4853-1594</Identifier><AffiliationInfo><Affiliation>Computer Science and Information Engineering, National Chiao Tung University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There are no conflicts of interest to declare, although one of the authors is affiliated with a commercial company [Telecommunication Laboratories, Chunghwa Telecom Co., Ltd]. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30475847</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0207579</ArticleId><ArticleId IdType="pii">PONE-D-18-00521</ArticleId><ArticleId IdType="pmc">PMC6261027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2016 May 05;11(5):e0154627</Citation><ArticleIdList><ArticleId IdType="pubmed">27148867</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Oct 14;11(10):e0164880</Citation><ArticleIdList><ArticleId IdType="pubmed">27741311</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2017 Jan;44(1):4-10</Citation><ArticleIdList><ArticleId IdType="pubmed">27744395</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cardiol. 2015 Nov 15;199:25-30</Citation><ArticleIdList><ArticleId IdType="pubmed">26173170</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2011;2011:189-96</Citation><ArticleIdList><ArticleId IdType="pubmed">22195070</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Occup Ther. 2017 Nov;24(6):468-476</Citation><ArticleIdList><ArticleId IdType="pubmed">28052711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1999 Oct 21;401(6755):788-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10548103</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:892-895</Citation><ArticleIdList><ArticleId IdType="pubmed">28268467</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Nov;52(11):3381-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16258899</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Apr 13;10(4):e0122508</Citation><ArticleIdList><ArticleId IdType="pubmed">25875441</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Jan 1;20(1):117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Mar;125:58-65</Citation><ArticleIdList><ArticleId IdType="pubmed">26701199</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Jul;115(3):103-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24835615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jun;76(6):960-977</Citation><ArticleIdList><ArticleId IdType="pubmed">28264816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Jun;70(6):949-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21285117</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 2007;81-82:97-114</Citation><ArticleIdList><ArticleId IdType="pubmed">17540693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dtsch Arztebl Int. 2013 Jul;110(27-28):477-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23964304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 17;6:26094</Citation><ArticleIdList><ArticleId IdType="pubmed">27185194</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Dec 15;51(6):952-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15593102</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 Mar;21(2):303-311</Citation><ArticleIdList><ArticleId IdType="pubmed">28129195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e162-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Mar 22;13(3):e0193377</Citation><ArticleIdList><ArticleId IdType="pubmed">29565986</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 Feb 13;16:43</Citation><ArticleIdList><ArticleId IdType="pubmed">25887585</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2010 Nov 13;2010:857-61</Citation><ArticleIdList><ArticleId IdType="pubmed">21347100</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics Proteomics Bioinformatics. 2014 Feb;12(1):48-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23933456</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2014 Dec;52(12):1729-37</Citation><ArticleIdList><ArticleId IdType="pubmed">24933628</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Pattern Anal Mach Intell. 2011 Aug;33(8):1548-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21173440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Apr 19;7:46445</Citation><ArticleIdList><ArticleId IdType="pubmed">28422144</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Nov;62(11):3161-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20597112</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2012 Dec;18(13 Suppl):S295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">23327517</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2014 Mar-Apr;21(2):221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2012 Feb;31(2):207-16</Citation><ArticleIdList><ArticleId IdType="pubmed">21914569</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs Real World Outcomes. 2016 Mar;3(1):107-114</Citation><ArticleIdList><ArticleId IdType="pubmed">27747810</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomedica. 2009 Mar;29(1):43-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19753838</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 May 09;11(5):e0154837</Citation><ArticleIdList><ArticleId IdType="pubmed">27159635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2013 Feb;33(2):355-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22451027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30442457</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-4436</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Zeitschrift fur medizinische Physik</Title><ISOAbbreviation>Z Med Phys</ISOAbbreviation></Journal><ArticleTitle>Multivariate prediction of multiple sclerosis using robust quantitative MR-based image metrics.</ArticleTitle><Pagination><MedlinePgn>262-271</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0939-3889(18)30068-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.zemedi.2018.10.004</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The current work investigates the performance of different multivariate supervised machine learning models to predict the presence or absence of multiple sclerosis (MS) based on features derived from quantitative MRI acquisitions. The performance of these models was evaluated for images which are significantly degraded due to subject motion, a problem which is often observed in clinical routine diagnostics. Finally, the difference between a true multivariate analysis and the corresponding univariate analysis based on single parameters alone was addressed.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">52 MS patients and 45 healthy controls where scanned on a 3T system. The datasets showed variable degrees of motion-associated artefacts. For each dataset, the average of T<sub>1</sub>, T<sub>2</sub><sup>*</sup>, total and myelin bound water content was determined in white and grey matter. Based on these parameters, different multivariate models were trained and their cross-validated performance to predict the presence of MS was evaluated. Furthermore, the univariate distributions of each quantitative parameter were employed to define optimised cut-offs that differentiate MS patients from healthy controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For data not affected by motion, 83.7% of all subjects were correctly classified using a crossvalidated multivariate model. Inclusion of data with significant artefacts reduces the rate of correct classification to 74.5%. T<sub>1</sub> in grey and myelin water content in white matter where the most discriminating variables in the multivariate analysis. In contrast, the total water content in white matter and the ratio of white and grey matter total water content each resulted in 77% correct classifications in a univariate regression analysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results demonstrate that even simple quantitative MRI-based measures allow for an automated prediction of the presence/absence of multiple sclerosis with good specificity. Importantly, even highly degraded datasets due to motion-artefacts could be correctly classified, especially when pooling features derived from grey and white matter. Finally, the advantage of a multivariate over a univariate analysis of quantitative MR data was shown.</AbstractText><CopyrightInformation>Copyright .. 2018. Published by Elsevier GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neeb</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Multimodal Imaging Physics Group, University of Applied Sciences Koblenz, RheinAhrCampus Remagen, 53424 Remagen, Germany; Institute for Medical Engineering and Information Processing - MTI Mittelrhein, University of Koblenz, 56070 Koblenz, Germany. Electronic address: neeb@hs-koblenz.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenk</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Radiologisches Institut Hohenzollernstrasse, 56068 Koblenz, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Z Med Phys</MedlineTA><NlmUniqueID>100886455</NlmUniqueID><ISSNLinking>0939-3889</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Myelin imaging</Keyword><Keyword MajorTopicYN="N">Quantitative MRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30442457</ArticleId><ArticleId IdType="pii">S0939-3889(18)30068-0</ArticleId><ArticleId IdType="doi">10.1016/j.zemedi.2018.10.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30428956</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1092-8529</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>10</Month></PubDate></JournalIssue><Title>CNS spectrums</Title><ISOAbbreviation>CNS Spectr</ISOAbbreviation></Journal><ArticleTitle>Neuroanatomical features and its usefulness in classification of patients with PANDAS.</ArticleTitle><Pagination><MedlinePgn>533-543</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S1092852918001268</ELocationID><Abstract><AbstractText Label="OBJECTIVE">An obsessive-compulsive disorder (OCD) subtype has been associated with streptococcal infections and is called pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS). The neuroanatomical characterization of subjects with this disorder is crucial for the better understanding of its pathophysiology; also, evaluation of these features as classifiers between patients and controls is relevant to determine potential biomarkers and useful in clinical diagnosis. This was the first multivariate pattern analysis (MVPA) study on an early-onset OCD subtype.</AbstractText><AbstractText Label="METHODS">Fourteen pediatric patients with PANDAS were paired with 14 healthy subjects and were scanned to obtain structural magnetic resonance images (MRI). We identified neuroanatomical differences between subjects with PANDAS and healthy controls using voxel-based morphometry, diffusion tensor imaging (DTI), and surface analysis. We investigated the usefulness of these neuroanatomical differences to classify patients with PANDAS using MVPA.</AbstractText><AbstractText Label="RESULTS">The pattern for the gray and white matter was significantly different between subjects with PANDAS and controls. Alterations emerged in the cortex, subcortex, and cerebellum. There were no significant group differences in DTI measures (fractional anisotropy, mean diffusivity, radial diffusivity, and axial diffusivity) or cortical features (thickness, sulci, volume, curvature, and gyrification). The overall accuracy of 75% was achieved using the gray matter features to classify patients with PANDAS and healthy controls.</AbstractText><AbstractText Label="CONCLUSION">The results of this integrative study allow a better understanding of the neural substrates in this OCD subtype, suggesting that the anatomical gray matter characteristics could have an immune origin that might be helpful in patient classification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Brenda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Rebollar</LastName><ForeName>C..sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroimaging Laboratory, Department of Electrical Engineering, Autonomous Metropolitan University, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim..nez-..ngeles</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departament of Biomedical Systems, Engineering Faculty, National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genis-Mendoza</LastName><ForeName>Alma D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychiatric Care Services, Child Psychiatric Hospital Dr Juan N Navarro, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzagorta</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Carracci Medical Group, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyo</LastName><ForeName>Mar..a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Fuente-Sandoval</LastName><ForeName>Camilo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Institute of Neurology and Neurosurgery "Manuel Velasco Su..rez", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santana</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Carracci Medical Group, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Ba..uelos</LastName><ForeName>Ver..nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neuroimaging Laboratory, Department of Electrical Engineering, Autonomous Metropolitan University, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacrist..n</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroimaging Laboratory, Department of Electrical Engineering, Autonomous Metropolitan University, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolini</LastName><ForeName>Humberto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carracci Medical Group, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>CNS Spectr</MedlineTA><NlmUniqueID>9702877</NlmUniqueID><ISSNLinking>1092-8529</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C537163">Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009771" MajorTopicYN="N">Obsessive-Compulsive Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013290" MajorTopicYN="N">Streptococcal Infections</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MRI</Keyword><Keyword MajorTopicYN="Y">PANDAS</Keyword><Keyword MajorTopicYN="Y">early-onset OCD</Keyword><Keyword MajorTopicYN="Y">gaussian process classifiers</Keyword><Keyword MajorTopicYN="Y">gray matter</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">multivariate pattern analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30428956</ArticleId><ArticleId IdType="pii">S1092852918001268</ArticleId><ArticleId IdType="doi">10.1017/S1092852918001268</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30395877</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7549</ISSN><JournalIssue CitedMedium="Internet"><Volume>359</Volume><PubDate><Year>2019</Year><Month>02</Month><Day>01</Day></PubDate></JournalIssue><Title>Behavioural brain research</Title><ISOAbbreviation>Behav Brain Res</ISOAbbreviation></Journal><ArticleTitle>Understanding and exploiting prediction errors minimization within the brain in pharmacological treatments.</ArticleTitle><Pagination><MedlinePgn>223-233</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0166-4328(18)31029-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbr.2018.10.019</ELocationID><Abstract><AbstractText>The human brain can be conceptualized as an inference machine that actively predicts and explains its sensations and perceptions: it makes predictions through a probabilistic model. Such a model is continuously and implicitly updated by the computation and minimization of weighted prediction errors, as shown by numerous studies and experimental results. Nevertheless, such an algorithmic functioning of the brain has not been exploited in the neuropharmacological practice. In this manuscript, we show by theoretical analysis and model fitting of previously published data in two different contexts, how it is possible to increase the effectiveness of neuropharmacological and immunosuppressive drugs, through the modulation of the weighted prediction errors. Moreover, on the basis of the proposed model, we derive an optimized drug administration schedule able to increase the drug effectiveness of one order of magnitude, in psoriasis treatment. We make important testable predictions, evidencing the impact and the potential benefit of prediction errors modulation within the brain, in the pharmacotherapeutic practice. Finally, our results lead to a novel formal theory of implicit learning, and shed lights on the actual roles of classical conditioning and UCS revaluation in behavioral and pharmacological conditioning experiments. The potential practical implications of our results are many: the reduction of drugs side effects; the maximization of the therapeutic outcome; a more effective treatment for chronic pain, certain neuropsychiatric diseases, autoimmune diseases and allergic diseases.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puviani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Modena and Reggio Emilia, via Vivarelli 10, Modena, Italy. Electronic address: luca.puviani@unimore.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rama</LastName><ForeName>Sidita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Local Medical Unit, Via San Giovanni del Cantone, 23, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Behav Brain Res</MedlineTA><NlmUniqueID>8004872</NlmUniqueID><ISSNLinking>0166-4328</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002491">Central Nervous System Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002491" MajorTopicYN="N">Central Nervous System Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007858" MajorTopicYN="N">Learning</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="Y">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011565" MajorTopicYN="N">Psoriasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Drug effectiveness</Keyword><Keyword MajorTopicYN="Y">Neural gain</Keyword><Keyword MajorTopicYN="Y">Partial reinforcement</Keyword><Keyword MajorTopicYN="Y">Prediction errors</Keyword><Keyword MajorTopicYN="Y">Psychoneuroimmunology</Keyword><Keyword MajorTopicYN="Y">UCS revaluation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30395877</ArticleId><ArticleId IdType="pii">S0166-4328(18)31029-5</ArticleId><ArticleId IdType="doi">10.1016/j.bbr.2018.10.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30353541</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1541-0420</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>03</Month></PubDate></JournalIssue><Title>Biometrics</Title><ISOAbbreviation>Biometrics</ISOAbbreviation></Journal><ArticleTitle>Automated feature selection of predictors in electronic medical records data.</ArticleTitle><Pagination><MedlinePgn>268-277</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/biom.12987</ELocationID><Abstract><AbstractText>The use of Electronic Health Records (EHR) for translational research can be challenging due to difficulty in extracting accurate disease phenotype data. Historically, EHR algorithms for annotating phenotypes have been either rule-based or trained with billing codes and gold standard labels curated via labor intensive medical chart review. These simplistic algorithms tend to have unpredictable portability across institutions and low accuracy for many disease phenotypes due to imprecise billing codes. Recently, more sophisticated machine learning algorithms have been developed to improve the robustness and accuracy of EHR phenotyping algorithms. These algorithms are typically trained via supervised learning, relating gold standard labels to a wide range of candidate features including billing codes, procedure codes, medication prescriptions and relevant clinical concepts extracted from narrative notes via Natural Language Processing (NLP). However, due to the time intensiveness of gold standard labeling, the size of the training set is often insufficient to build a generalizable algorithm with the large number of candidate features extracted from EHR. To reduce the number of candidate predictors and in turn improve model performance, we present an automated feature selection method based entirely on unlabeled observations. The proposed method generates a comprehensive surrogate for the underlying phenotype with an unsupervised clustering of disease status based on several highly predictive features such as diagnosis codes and mentions of the disease in text fields available in the entire set of EHR data. A sparse regression model is then built with the estimated outcomes and remaining covariates to identify those features most informative of the phenotype of interest. Relying on the results of Li and Duan (1989), we demonstrate that variable selection for the underlying phenotype model can be achieved by fitting the surrogate-based model. We explore the performance of our methods in numerical simulations and present the results of a prediction model for Rheumatoid Arthritis (RA) built on a large EHR data mart from the Partners Health System consisting of billing codes and NLP terms. Empirical results suggest that our procedure reduces the number of gold-standard labels necessary for phenotyping thereby harnessing the automated power of EHR data and improving efficiency.</AbstractText><CopyrightInformation>.. 2018 International Biometric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gronsbell</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5360-5869</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Data Science, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minnier</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3527-2757</Identifier><AffiliationInfo><Affiliation>OHSU-PSU School of Public Health, Oregon Health &amp; Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Statistical Science, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Tianxi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 NS048005</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG007963</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 GM119263</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL127118</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biometrics</MedlineTA><NlmUniqueID>0370625</NlmUniqueID><ISSNLinking>0006-341X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="N">Supervised Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Research, Biomedical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">electronic medical records</Keyword><Keyword MajorTopicYN="Y">feature selection</Keyword><Keyword MajorTopicYN="Y">prediction accuracy</Keyword><Keyword MajorTopicYN="Y">regularized regression</Keyword><Keyword MajorTopicYN="Y">risk prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30353541</ArticleId><ArticleId IdType="doi">10.1111/biom.12987</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30342048</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1747</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>03</Month></PubDate></JournalIssue><Title>The Journal of investigative dermatology</Title><ISOAbbreviation>J Invest Dermatol</ISOAbbreviation></Journal><ArticleTitle>Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.</ArticleTitle><Pagination><MedlinePgn>683-691</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0022-202X(18)32680-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jid.2018.09.018</ELocationID><Abstract><AbstractText>Immune-mediated diseases affect more than 20% of the population, and many autoimmune diseases affect the skin. Drug repurposing (or repositioning) is a cost-effective approach for finding drugs that can be used to treat diseases for which they are currently not prescribed. We implemented an efficient bioinformatics approach using word embedding to summarize drug information from more than 20 million articles and applied machine learning to model the drug-disease relationship. We trained our drug repurposing approach separately on nine cutaneous diseases (including psoriasis, atopic dermatitis, and alopecia areata) and eight other immune-mediated diseases and obtained a mean area under the receiver operating characteristic of 0.93 in cross-validation. Focusing in particular on psoriasis, a chronic inflammatory condition of skin that affects more than 100 million people worldwide, we were able to confirm drugs that are known to be effective for psoriasis and to identify potential candidates used to treat other diseases. Furthermore, the targets of drug candidates predicted by our approach were significantly enriched among genes differentially expressed in psoriatic lesional skin from a large-scale RNA sequencing cohort. Although our algorithm cannot be used to determine clinical efficacy, our work provides an approach for suggesting drugs for repurposing to immune-mediated cutaneous diseases.</AbstractText><CopyrightInformation>Copyright .. 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patrick</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raja</LastName><ForeName>Kalpana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA; Morgridge Institute for Research, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Keylonnie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotzen</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudjonsson</LastName><ForeName>Johann E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elder</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA; Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoi</LastName><ForeName>Lam C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan USA; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: alextsoi@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 AR072129</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR042742</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130025</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR054966</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR050511</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR065183</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR063611</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069071</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Dermatol</MedlineTA><NlmUniqueID>0426720</NlmUniqueID><ISSNLinking>0022-202X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007154" MajorTopicYN="N">Immune System Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039781" MajorTopicYN="N">PubMed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012871" MajorTopicYN="N">Skin Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30342048</ArticleId><ArticleId IdType="pii">S0022-202X(18)32680-0</ArticleId><ArticleId IdType="doi">10.1016/j.jid.2018.09.018</ArticleId><ArticleId IdType="pmc">PMC6387843</ArticleId><ArticleId IdType="mid">NIHMS1516703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc AMIA Symp. 2002;:116-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12463798</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2014 May;19(5):637-44</Citation><ArticleIdList><ArticleId IdType="pubmed">24239728</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Aug 17;3(96):96ra76</Citation><ArticleIdList><ArticleId IdType="pubmed">21849664</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2006 Dec;39(6):600-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16442852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 1956 Jun;26(6):435-6</Citation><ArticleIdList><ArticleId IdType="pubmed">13346150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Discov. 2013 Dec;3(12):1364-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24078773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Aug 17;3(96):96ra77</Citation><ArticleIdList><ArticleId IdType="pubmed">21849665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D914-20</Citation><ArticleIdList><ArticleId IdType="pubmed">25326323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Jan 4;44(D1):D1080-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26553801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2017 Jul;175:47-66</Citation><ArticleIdList><ArticleId IdType="pubmed">28223231</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Apr 14;356(6334):133-134</Citation><ArticleIdList><ArticleId IdType="pubmed">28408558</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2016 May;47:20-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2004 Aug;103(2):147-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15369681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2017 Oct;20(10):1342-1349</Citation><ArticleIdList><ArticleId IdType="pubmed">28805813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2003 Jan;9(1):40-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12461524</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2011 Jul;12(4):327-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21715466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Feb 20;506(7488):376-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24390342</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Oncol. 2017 Nov 14;7:273</Citation><ArticleIdList><ArticleId IdType="pubmed">29184849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2017 Oct;74:20-32</Citation><ArticleIdList><ArticleId IdType="pubmed">28838802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2014 Jul 9;6(244):244ra90</Citation><ArticleIdList><ArticleId IdType="pubmed">25009230</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2018 Jan 18;37(3):403-414</Citation><ArticleIdList><ArticleId IdType="pubmed">28967908</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Derm Venereol. 2006;86(5):450-1</Citation><ArticleIdList><ArticleId IdType="pubmed">16955195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2014 Jul;134(7):1828-1838</Citation><ArticleIdList><ArticleId IdType="pubmed">24441097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2015 Apr;33(4):342-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25850054</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2013 Apr;93(4):335-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23443757</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Dermatol. 2002 Mar;146(3):351-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11952534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2012 Apr 10;30(4):317-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22491277</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2013 Apr;18(7-8):350-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22897878</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2015 Jan;22(1):179-91</Citation><ArticleIdList><ArticleId IdType="pubmed">25053577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jun 16;7(1):3690</Citation><ArticleIdList><ArticleId IdType="pubmed">28623363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Jul 15;33(14):i37-i48</Citation><ArticleIdList><ArticleId IdType="pubmed">28881963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082</Citation><ArticleIdList><ArticleId IdType="pubmed">29126136</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2001 Mar;123(3):505-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11298140</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Pharmacol. 2017 Dec 06;8:896</Citation><ArticleIdList><ArticleId IdType="pubmed">29270124</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2015 May;22(3):671-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25755127</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotherapeutics. 2007 Oct;4(4):647-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17920545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2003 May;112(5-6):581-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12607117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30342033</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>02</Month></PubDate></JournalIssue><Title>Gastroenterology</Title><ISOAbbreviation>Gastroenterology</ISOAbbreviation></Journal><ArticleTitle>Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease.</ArticleTitle><Pagination><MedlinePgn>582-591.e1</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0016-5085(18)35156-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.gastro.2018.10.025</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Celiac disease (CeD) has characteristics of an autoimmune disease, such as increased antibody levels to tissue transglutaminase (tTG). However, assays to measure these biomarkers in blood samples do not identify patients with sufficient accuracy for diagnosis or monitoring of CeD. We aimed to discover biomarkers of CeD derived from neoepitopes of deamidated gliadin peptides (DGP) and tTG fragments and to determine if immune reactivity against these epitopes can identify patients with CeD with mucosal healing.</AbstractText><AbstractText Label="METHODS">We analyzed serum samples from 90 patients with biopsy-proven CeD and 79 healthy individuals (controls) for immune reactivity against the tTG-DGP complex (discovery cohort). A fluorescent peptide microarray platform was used to estimate the antibody-binding intensity of each synthesized tTG-DGP epitope. We validated our findings in 82 patients with newly diagnosed CeD and 217 controls. We tested the ability of our peptide panel to identify patients with mucosal healing (based on the histologic analysis) using serum samples from patients with treated and healed CeD (n..= 85), patients with treated but unhealed CeD (n..= 81; villous atrophy despite a adhering a gluten-free diet), patients with untreated CeD (n..= 82) and disease controls (n..= 27), villous atrophy without CeD), and healthy controls (n..= 217). Data were analyzed using principal component analysis followed by machine learning and support vector machine modeling.</AbstractText><AbstractText Label="RESULTS">We identified 172 immunogenic epitopes of the tTG-DGP complex. We found significantly increased immune reactivity against these epitopes vs controls. In the both cohort, the set of neoepitopes derived from the tTG-DGP complex identified patients with CeD with 99% sensitivity and 100% specificity. Serum samples from patients with untreated CeD had the greatest mean antibody-binding intensity against the tTG-DGP complex (32.5 .. 16.4). The average antibody-binding intensity was significantly higher in serum from patients with treated but unhealed CeD mucosa (15.1 .. 7.5) than in patients with treated and healed CeD mucosa (5.5 .. 3.4) (P &lt; .001). The assay identified patients with mucosa healing status with 84% sensitivity and 95% specificity.</AbstractText><AbstractText Label="CONCLUSIONS">We identified immunogenic epitopes of the tTG-DGP complex, and found that an assay to measure the immune response to epitopes accurately identified patients with CeD, as well as patients with mucosal healing. This biomarker assay might be used in detection and monitoring of patients with CeD.</AbstractText><CopyrightInformation>Copyright .. 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choung</LastName><ForeName>Rok Seon</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaleghi Rostamkolaei</LastName><ForeName>Shahryar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ju</LastName><ForeName>Josephine M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marietta</LastName><ForeName>Eric V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Dyke</LastName><ForeName>Carol T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaraman</LastName><ForeName>Vasanth</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianhao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bei</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>Karenah E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamurthy</LastName><ForeName>Hari Krishnan</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Vibrant Sciences LLC, San Carlos, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: murray.joseph@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gastroenterology</MedlineTA><NlmUniqueID>0374630</NlmUniqueID><ISSNLinking>0016-5085</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-90-3</RegistryNumber><NameOfSubstance UI="D005903">Gliadin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.13</RegistryNumber><NameOfSubstance UI="D011503">Transglutaminases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001707" MajorTopicYN="N">Biopsy, Needle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002446" MajorTopicYN="N">Celiac Disease</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="Y">diet therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055050" MajorTopicYN="N">Diet, Gluten-Free</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005903" MajorTopicYN="N">Gliadin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011503" MajorTopicYN="N">Transglutaminases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Diagnostic</Keyword><Keyword MajorTopicYN="Y">Follow-up</Keyword><Keyword MajorTopicYN="Y">Noninvasive Marker</Keyword><Keyword MajorTopicYN="Y">Response to Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30342033</ArticleId><ArticleId IdType="pii">S0016-5085(18)35156-4</ArticleId><ArticleId IdType="doi">10.1053/j.gastro.2018.10.025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30291263</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>10</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy.</ArticleTitle><Pagination><MedlinePgn>14884</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-33077-8</ELocationID><Abstract><AbstractText>Based on increasing evidence suggesting that MS pathology involves alterations in bioactive lipid metabolism, the present analysis was aimed at generating a complex serum lipid-biomarker. Using unsupervised machine-learning, implemented as emergent self-organizing maps of neuronal networks, swarm intelligence and Minimum Curvilinear Embedding, a cluster structure was found in the input data space comprising serum concentrations of d...=...43 different lipid-markers of various classes. The structure coincided largely with the clinical diagnosis, indicating that the data provide a basis for the creation of a biomarker (classifier). This was subsequently assessed using supervised machine-learning, implemented as random forests and computed..ABC analysis-based feature selection. Bayesian statistics-based biomarker creation was used to map the diagnostic classes of either MS patients (n...=...102) or healthy subjects (n...=...301). Eight lipid-markers passed the feature selection and comprised GluCerC16, LPA20:4, HETE15S, LacCerC24:1, C16Sphinganine, biopterin and the endocannabinoids PEA and OEA. A complex classifier or biomarker was developed that predicted MS at a sensitivity, specificity and accuracy of approximately 95% in training and test data sets, respectively. The present successful application of serum lipid marker concentrations to MS data is encouraging for further efforts to establish an MS biomarker based on serum lipidomics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L..tsch</LastName><ForeName>J..rn</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5818-6958</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany. j.loetsch@em.uni-frankfurt.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology - Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany. j.loetsch@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiffmann</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology - Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunkhorst</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe-University Hospital, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerch</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>DataBionics Research Group, University of Marburg, Hans - Meerwein - Stra..e 22, 35032, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreiros</LastName><ForeName>Nerea</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicker</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Occupational Health Service, University Hospital Frankfurt, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegeder</LastName><ForeName>Irmgard</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geisslinger</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology - Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor - Stern - Kai 7, 60590, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ultsch</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DataBionics Research Group, University of Marburg, Hans - Meerwein - Stra..e 22, 35032, Marburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30291263</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-33077-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-33077-8</ArticleId><ArticleId IdType="pmc">PMC6173715</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prostaglandins Leukot Essent Fatty Acids. 2011 Jul;85(1):29-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21530210</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 09;8(12):e81228</Citation><ArticleIdList><ArticleId IdType="pubmed">24349046</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Diagn. 2007 Apr;9(2):197-204</Citation><ArticleIdList><ArticleId IdType="pubmed">17384211</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 04;10(3):e0118432</Citation><ArticleIdList><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Mol Med. 2014 Sep 30;6(11):1398-422</Citation><ArticleIdList><ArticleId IdType="pubmed">25269445</ArticleId></ArticleIdList></Reference><Reference><Citation>Pract Neurol. 2016 Apr;16(2):96-110</Citation><ArticleIdList><ArticleId IdType="pubmed">26764409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2016 Apr;22(4):451-60</Citation><ArticleIdList><ArticleId IdType="pubmed">26754801</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Clin Exp Med. 2016 Jul-Aug;25(4):775-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27629854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2017 Jan;54(1):31-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26732588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2016 Jan;5:53-65</Citation><ArticleIdList><ArticleId IdType="pubmed">26856944</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2006 Feb 23;7:91</Citation><ArticleIdList><ArticleId IdType="pubmed">16504092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Oct 25;372(9648):1502-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18970977</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2012 Jul 15;248(1-2):53-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22579051</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2007 Feb 1;109(3):1077-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17008548</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2017 Feb;66:95-104</Citation><ArticleIdList><ArticleId IdType="pubmed">28040499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Pharmacol. 2005 Aug;68(2):330-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15900018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Oct 1;23(19):2507-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17720704</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2017 Apr 15;375:198-202</Citation><ArticleIdList><ArticleId IdType="pubmed">28320130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Mar 13;7:43946</Citation><ArticleIdList><ArticleId IdType="pubmed">28287094</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Markers. 2006;22(4):183-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17124339</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteomics. 2011 Nov 18;74(12):2826-36</Citation><ArticleIdList><ArticleId IdType="pubmed">21757039</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2000 Dec 22;290(5500):2319-23</Citation><ArticleIdList><ArticleId IdType="pubmed">11125149</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Sep 15;26(18):i531-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20823318</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2015 Oct;130(4):445-68</Citation><ArticleIdList><ArticleId IdType="pubmed">26264608</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2007 Oct;130(Pt 10):2543-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17626034</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2008 May 9;283(19):13320-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18334483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2015 Nov;4(6):515-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26590657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biopharm Stat. 1997 Mar;7(1):171-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9056596</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand. 2013 Nov;128(5):321-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23465040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroinflammation. 2005 Dec 12;2:29</Citation><ArticleIdList><ArticleId IdType="pubmed">16343349</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 Jul 31;329(7460):253</Citation><ArticleIdList><ArticleId IdType="pubmed">15258006</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol Commun. 2017 Jun 2;5(1):42</Citation><ArticleIdList><ArticleId IdType="pubmed">28578681</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2011 May;234(1-2):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21397339</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2015 Oct;93(9):825-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25833068</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2012 Nov 27;79(22):2166-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23077021</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteomics Clin Appl. 2016 Apr;10(4):470-84</Citation><ArticleIdList><ArticleId IdType="pubmed">27061322</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19995978</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rev. 1956 Mar;63(2):81-97</Citation><ArticleIdList><ArticleId IdType="pubmed">13310704</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2005 Jun;140(3):580-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15932522</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2009 Apr;265(4):459-64</Citation><ArticleIdList><ArticleId IdType="pubmed">19019188</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurol. 2016 Mar 31;7:53</Citation><ArticleIdList><ArticleId IdType="pubmed">27065425</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Jul 1;29(13):i199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">23812985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2013 Sep;19(9):1161-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23933981</ArticleId></ArticleIdList></Reference><Reference><Citation>Practitioner. 2015 Sep;259(1785):21-7, 2-3</Citation><ArticleIdList><ArticleId IdType="pubmed">26591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chim Acta. 2013 Jan 16;415:74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">23063960</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2009 Dec 15;287(1-2):212-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19695579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Lipid Res. 2016 Nov;57(11):2028-2039</Citation><ArticleIdList><ArticleId IdType="pubmed">27623848</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Mar 17;12:77</Citation><ArticleIdList><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2016 Jun 15;295-296:148-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27235360</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2016 Feb;12(2):70-2</Citation><ArticleIdList><ArticleId IdType="pubmed">26823149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2014 Aug 15;273(1-2):120-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24984830</ArticleId></ArticleIdList></Reference><Reference><Citation>Q Rev Biol. 2011 Dec;86(4):287-321</Citation><ArticleIdList><ArticleId IdType="pubmed">22384749</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1983 Nov;33(11):1444-52</Citation><ArticleIdList><ArticleId IdType="pubmed">6685237</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 10;10(6):e0129767</Citation><ArticleIdList><ArticleId IdType="pubmed">26061064</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 1982 Jun;7(6):727-35</Citation><ArticleIdList><ArticleId IdType="pubmed">7121719</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Nov 26;4(11):e8080</Citation><ArticleIdList><ArticleId IdType="pubmed">19956653</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2015 May;46:280-92</Citation><ArticleIdList><ArticleId IdType="pubmed">25697397</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2015 Nov;161(1):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26143623</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2011 Mar;25(3):187-201</Citation><ArticleIdList><ArticleId IdType="pubmed">21323391</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2016 Oct;359(1):207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27516465</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 05;10(6):e0129291</Citation><ArticleIdList><ArticleId IdType="pubmed">26046356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Signal. 2010 Oct;22(10):1543-53</Citation><ArticleIdList><ArticleId IdType="pubmed">20566326</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2015 Oct 28;16(10):25897-911</Citation><ArticleIdList><ArticleId IdType="pubmed">26516852</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2017 Jun 07;18(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28590455</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vis Exp. 2016 May 08;(111):</Citation><ArticleIdList><ArticleId IdType="pubmed">27214391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Jan 22;20(2):289-90</Citation><ArticleIdList><ArticleId IdType="pubmed">14734327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jun 14;6:27710</Citation><ArticleIdList><ArticleId IdType="pubmed">27295977</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2016 Aug;10(8):965-78</Citation><ArticleIdList><ArticleId IdType="pubmed">26928964</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 1988 Apr;34(4):764-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3359616</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Aug 28;10(8):e0135434</Citation><ArticleIdList><ArticleId IdType="pubmed">26317430</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2007 Apr;17(2):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17388952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30242992</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2151-4658</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>10</Month></PubDate></JournalIssue><Title>Arthritis care &amp; research</Title><ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation></Journal><ArticleTitle>Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology.</ArticleTitle><Pagination><MedlinePgn>1336-1343</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.23768</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Flares in rheumatoid arthritis (RA) and axial spondyloarthritis (SpA) may influence physical activity. The aim of this study was to assess longitudinally the association between patient-reported flares and activity-tracker-provided steps per minute, using machine learning.</AbstractText><AbstractText Label="METHODS">This prospective observational study (ActConnect) included patients with definite RA or axial SpA. For a 3-month time period, physical activity was assessed continuously by number of steps/minute, using a consumer grade activity tracker, and flares were self-assessed weekly. Machine-learning techniques were applied to the data set. After intrapatient normalization of the physical activity data, multiclass Bayesian methods were used to calculate sensitivities, specificities, and predictive values of the machine-generated models of physical activity in order to predict patient-reported flares.</AbstractText><AbstractText Label="RESULTS">Overall, 155 patients (1,339 weekly flare assessments and 224,952 hours of physical activity assessments) were analyzed. The mean .. SD age for patients with RA (n = 82) was 48.9 .. 12.6 years and was 41.2 .. 10.3 years for those with axial SpA (n = 73). The mean .. SD disease duration was 10.5 .. 8.8 years for patients with RA and 10.8 .. 9.1 years for those with axial SpA. Fourteen patients with RA (17.1%) and 41 patients with axial SpA (56.2%) were male. Disease was well-controlled (Disease Activity Score in 28 joints mean .. SD 2.2 .. 1.2; Bath Ankylosing Spondylitis Disease Activity Index score mean .. SD 3.1 .. 2.0), but flares were frequent (22.7% of all weekly assessments). The model generated by machine learning performed well against patient-reported flares (mean sensitivity 96% [95% confidence interval (95% CI) 94-97%], mean specificity 97% [95% CI 96-97%], mean positive predictive value 91% [95% CI 88-96%], and negative predictive value 99% [95% CI 98-100%]). Sensitivity analyses were confirmatory.</AbstractText><AbstractText Label="CONCLUSION">Although these pilot findings will have to be confirmed, the correct detection of flares by machine-learning processing of activity tracker data provides a framework for future studies of remote-control monitoring of disease activity, with great precision and minimal patient burden.</AbstractText><CopyrightInformation>.. 2018, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gossec</LastName><ForeName>Laure</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4528-310X</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guyard</LastName><ForeName>Fr..d..ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Orange IMT, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leroy</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Orange IMT, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafargue</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Orange IMT, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiler</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Orange Healthcare, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemin</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molto</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cochin Hospital, AP-HP, INSERM U1153, PRES Sorbonne Paris-Cit.., Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sellam</LastName><ForeName>J..r..mie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.., INSERM UMRS 938, Paris, France, St. Antoine Hospital, AP-HP, DHU i2B, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foltz</LastName><ForeName>Violaine</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandjbakhch</LastName><ForeName>Fr..d..rique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudry</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cochin Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrovic</LastName><ForeName>St..phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fautrel</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sorbonne Universit.. and Piti.. Salp..tri..re Hospital, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Servy</LastName><ForeName>Herv..</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sano..a, e-Health services, G..menos, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA><NlmUniqueID>101518086</NlmUniqueID><ISSNLinking>2151-464X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072936" MajorTopicYN="N">Fitness Trackers</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="N">Rheumatology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025241" MajorTopicYN="N">Spondylarthritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067251" MajorTopicYN="Y">Symptom Flare Up</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30242992</ArticleId><ArticleId IdType="doi">10.1002/acr.23768</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Stone MA, Pomeroy E, Keat A, Sengupta R, Hickey S, Dieppe P, et al. Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Rheumatology (Oxford) 2008;47:1213-8.</Citation></Reference><Reference><Citation>Bykerk VP, Bingham CO, Choy EH, Lin D, Alten R, Christensen R, et al. Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set. RMD Open 2016;2:e000225.</Citation></Reference><Reference><Citation>Fautrel B, Morel J, Berthelot JM, Constantin A, De Bandt M, Gaudin P, et al. Validation of FLARE-RA, a self-administered tool to detect recent or current rheumatoid arthritis flare. Arthritis Rheumatol 2017;69:309-19.</Citation></Reference><Reference><Citation>Godfrin-Valnet M, Prati C, Puyraveau M, Toussirot E, Letho-Gyselink H, Wendling D. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients. Joint Bone Spine 2013;80:393-8.</Citation></Reference><Reference><Citation>Cooksey R, Brophy S, Gravenor MB, Brooks CJ, Burrows CL, Siebert S. Frequency and characteristics of disease flares in ankylosing spondylitis. Rheumatology (Oxford) 2010;49:929-32.</Citation></Reference><Reference><Citation>Bykerk VP, Shadick N, Frits M, Bingham CO III, Jeffery I, Iannaccone C, et al. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol 2014;41:227-34.</Citation></Reference><Reference><Citation>Bartlett SJ, Bykerk VP, Cooksey R, Choy EH, Alten R, Christensen R, et al. Feasibility and domain validation of rheumatoid arthritis (RA) flare core domain set: report of the OMERACT 2014 RA Flare Group Plenary. J Rheumatol 2015;42:2185-9.</Citation></Reference><Reference><Citation>Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis 2011;70:935-42.</Citation></Reference><Reference><Citation>Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et..al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 2015;74:830-5.</Citation></Reference><Reference><Citation>Aletaha D, Alasti F, Smolen JS. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression. Ann Rheum Dis 2011;70:1975-80.</Citation></Reference><Reference><Citation>Cooksey R, Brophy S, Dennis M, Davies H, Atkinson M, Irvine E, et..al. Severe flare as a predictor of poor outcome in ankylosing spondylitis: a cohort study using questionnaire and routine data linkage. Rheumatology (Oxford) 2015;54:1563-72.</Citation></Reference><Reference><Citation>Raheel S, Matteson EL, Crowson CS, Myasoedova E. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study. Rheumatology (Oxford) 2017;56:2154-61.</Citation></Reference><Reference><Citation>Gossec L, Portier A, Landew.. R, Etcheto A, Navarro-Comp..n V, Kroon F, et al. Preliminary definitions of ...flare... in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative. Ann Rheum Dis 2016;75:991-6.</Citation></Reference><Reference><Citation>Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, et..al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis - progress at OMERACT 7. J Rheumatol 2005;32:2250-6.</Citation></Reference><Reference><Citation>Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;45:372-7.</Citation></Reference><Reference><Citation>Hewlett S, Sanderson T, May J, Alten R, Bingham CO III, Cross M, et al. ...I'm hurting, I want to kill myself...: rheumatoid arthritis flare is more than a high joint count - an international patient perspective on flare where medical help is sought. Rheumatology (Oxford) 2012;51:69-76.</Citation></Reference><Reference><Citation>Hern..ndez-Hern..ndez V, Ferraz-Amaro I, D..az-Gonz..lez F. Influence of disease activity on the physical activity of rheumatoid arthritis patients. Rheumatology (Oxford) 2014;53:722-31.</Citation></Reference><Reference><Citation>Brophy S, Cooksey R, Davies H, Dennis MS, Zhou SM, Siebert S. The effect of physical activity and motivation on function in ankylosing spondylitis: a cohort study. Semin Arthritis Rheum 2013;42:619-26.</Citation></Reference><Reference><Citation>Van Genderen S, Boonen A, van der Heijde D, Heuft L, Luime J, Spoorenberg A, et al. Accelerometer quantification of physical activity and activity patterns in patients with ankylosing spondylitis and population controls. J Rheumatol 2015;42:2369-75.</Citation></Reference><Reference><Citation>Jacquemin C, Servy H, Molto A, Sellam J, Foltz V, Gandjbakhch F, et..al. Physical activity assessment using an activity tracker in patients with rheumatoid arthritis and axial spondyloarthritis: prospective observational study. JMIR Mhealth Uhealth 2018;6:e1.</Citation></Reference><Reference><Citation>Jacquemin C, Molto A, Servy H, Sellam J, Foltz V, Gandjbakhch F, et..al. Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study. RMD Open 2017;3:e000434.</Citation></Reference><Reference><Citation>Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. Springer Series in Statistics. New York: Springer; 2009.</Citation></Reference><Reference><Citation>Gonz..lez FA. Machine learning models in rheumatology. Rev Colomb Reumatol 2015;22:77-8.</Citation></Reference><Reference><Citation>Quellec G, Lamard M, Erginay A, Chabouis A, Massin P, Cochener B, et al. Automatic detection of referral patients due to retinal pathologies through data mining. Med Image Anal 2016;29:47-64.</Citation></Reference><Reference><Citation>Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist- level classification of skin cancer with deep neural networks. Nature 2017;542:115-8.</Citation></Reference><Reference><Citation>Tomar D, Agarwal S. A survey on data mining approaches for healthcare. International Journal of Bio-Science Bio-Technology 2013;5:241-66.</Citation></Reference><Reference><Citation>Nandy J, Hsu W, Lee ML. An incremental feature extraction framework for referable diabetic retinopathy detection. In: 2016 IEEE 28th International Conference on Tools with Artificial Intelligence (ICTAI); 2016 Nov 6-8; p. 908-12.</Citation></Reference><Reference><Citation>Fergus P, Hussain A, Hignett D, Al-Jumeily D, Abdel-Aziz K, Hamdan H. A machine learning system for automated whole-brain seizure detection. Applied Computing and Informatics 2016;12:70-89.</Citation></Reference><Reference><Citation>Tripoliti EE, Papadopoulos TG, Karanasiou GS, Naka KK, Fotiadis DI. Heart failure: diagnosis, severity estimation and prediction of adverse events through machine learning techniques. Comput Struct Biotechnol J 2017;15:26-47.</Citation></Reference><Reference><Citation>Prevoo ML, van ...t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.</Citation></Reference><Reference><Citation>Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.</Citation></Reference><Reference><Citation>Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F, et..al. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 1997;24:1954-8.</Citation></Reference><Reference><Citation>Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.</Citation></Reference><Reference><Citation>Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005;58:595-602.</Citation></Reference><Reference><Citation>Nokia. Withings activity pop watch. URL: https://support.health.nokia.com/hc/en-us/categories/200208646.</Citation></Reference><Reference><Citation>Gentleman R, Ihaka R. The R project for statistical computing. URL: https://www.r-project.org.</Citation></Reference><Reference><Citation>Boull.. M. Compression-based averaging of selective naive Bayes classifiers. J Mach Learn Res 2007;8:1659-85.</Citation></Reference><Reference><Citation>Boull.. M. Khiops: outil de pr..paration et mod..lisation des donn..es pour la fouille des grandes bases de donn..es [abstract]. Extraction et gestion des connaissances, 2008. p. 229-30.</Citation></Reference><Reference><Citation>Orange Labs. Khiops software for data mining. URL: https://khiops.diod.orange.com/.</Citation></Reference><Reference><Citation>Hastie T, Tibshirani R, Friedman J. Overview of supervised learning. In: The elements of statistical learning. Springer Series in Statistics. 2nd ed. New York: Springer; 2009. p. 9-41.</Citation></Reference><Reference><Citation>Rish I. An empirical study of the na..ve Bayes classifier. IBM Technical Report RC22230. 2001. URL: https://www.cc.gatech.edu/home/isbell/classes/reading/papers/Rish.pdf.</Citation></Reference><Reference><Citation>Boull.. M. MODL: A Bayes optimal discretization method for continuous attributes. Mach Learn 2006;65:131-65.</Citation></Reference><Reference><Citation>Agresti A. Categorical data analysis. 2nd ed. Wiley-Interscience. Hoboken (NJ): John Wiley &amp; Sons; 2002.</Citation></Reference><Reference><Citation>Douglas PK, Harris S, Yuille A, Cohen MS. Performance comparison of machine learning algorithms and number of independent components used in fMRI decoding of belief vs. disbelief. Neuroimage 2011;56:544-53.</Citation></Reference><Reference><Citation>Putrik P, Ramiro S, Hifinger M, Keszei AP, Hmamouchi I, Dougados M, et al. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study. Ann Rheum Dis 2016;75:715-20.</Citation></Reference><Reference><Citation>Dorard L. Machine learning wars: Amazon vs Google vs BigML vs PredicSis. 2015. URL: http://www.kdnuggets.com/2015/05/machine-learning-wars-amazon-google-bigml-predicsis.html.</Citation></Reference><Reference><Citation>Nabi M, Kumar P, Wahid A. Performance analysis of classification algorithms in predicting diabetes. Int J Adv Res Comput Sci 2017;8:456-61.</Citation></Reference><Reference><Citation>Kukreja M, Johnston SA, Stafford P. Comparative study of classification algorithms for immunosignaturing data. BMC Bioinformatics 2012;13:139.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30238916</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Characterization of relapsing-remitting multiple sclerosis patients using support vector machine classifications of functional and diffusion MRI data.</ArticleTitle><Pagination><MedlinePgn>724-730</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(18)30278-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2018.09.002</ELocationID><Abstract><AbstractText>Multiple Sclerosis patients' clinical symptoms do not correlate strongly with structural assessment done with traditional magnetic resonance images. However, its diagnosis and evaluation of the disease's progression are based on a combination of this imaging analysis complemented with clinical examination. Therefore, other biomarkers are necessary to better understand the disease. In this paper, we capitalize on machine learning techniques to classify relapsing-remitting multiple sclerosis patients and healthy volunteers based on machine learning techniques, and to identify relevant brain areas and connectivity measures for characterizing patients. To this end, we acquired magnetic resonance imaging data from relapsing-remitting multiple sclerosis patients and healthy subjects. Fractional anisotropy maps, structural and functional connectivity were extracted from the scans. Each of them were used as separate input features to construct support vector machine classifiers. A fourth input feature was created by combining structural and functional connectivity. Patients were divided in two groups according to their degree of disability and, together with the control group, three group pairs were formed for comparison. Twelve separate classifiers were built from the combination of these four input features and three group pairs. The classifiers were able to distinguish between patients and healthy subjects, reaching accuracy levels as high as 89%........2%. In contrast, the performance was noticeably lower when comparing the two groups of patients with different levels of disability, reaching levels below 63%........5%. The brain regions that contributed the most to the classification were the right occipital, left frontal orbital, medial frontal cortices and lingual gyrus. The developed classifiers based on MRI data were able to distinguish multiple sclerosis patients and healthy subjects reliably. Moreover, the resulting classification models identified brain regions, and functional and structural connections relevant for better understanding of the disease.</AbstractText><CopyrightInformation>Copyright .. 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zurita</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Center, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Department of Electrical Engineering, School of Engineering, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montalba</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Center, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labb..</LastName><ForeName>Tom..s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Interdisciplinary Center of Neurosciences, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Radiology Department, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalboni da Rocha</LastName><ForeName>Josu..</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Language Lab, Department of Clinical Neuroscience, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tejos</LastName><ForeName>Cristi..n</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Center, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Department of Electrical Engineering, School of Engineering, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciampi</LastName><ForeName>Ethel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Interdisciplinary Center of Neurosciences, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Neurology Department, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Neurology, Hospital Dr. S..tero del R..o, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C..rcamo</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Interdisciplinary Center of Neurosciences, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Neurology Department, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitaram</LastName><ForeName>Ranganatha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Biological and Medical Engineering, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Department of Psychiatry, Section of Neuroscience, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Laboratory for Brain-Machine Interfaces and Neuromodulation, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uribe</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Imaging Center, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Radiology Department, School of Medicine, Pontificia Universidad Cat..lica de Chile, Santiago, Chile; Millennium Nucleus for Cardiovascular Magnetic Resonance, Santiago, Chile. Electronic address: suribe@uc.cl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038524" MajorTopicYN="Y">Diffusion Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Classification</Keyword><Keyword MajorTopicYN="Y">DTI</Keyword><Keyword MajorTopicYN="Y">Multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">Resting state</Keyword><Keyword MajorTopicYN="Y">SVM</Keyword><Keyword MajorTopicYN="Y">fMRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30238916</ArticleId><ArticleId IdType="pii">S2213-1582(18)30278-X</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2018.09.002</ArticleId><ArticleId IdType="pmc">PMC6148733</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mult Scler. 2018 Apr;24(4):459-471</Citation><ArticleIdList><ArticleId IdType="pubmed">28294693</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2016 Feb 02;10:14</Citation><ArticleIdList><ArticleId IdType="pubmed">26869873</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Sep;62(3):2021-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22677149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 Sep;18(9):1251-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22307385</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2010 Feb;254(2):541-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20093525</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2016 Dec 6;87(23):2463-2470</Citation><ArticleIdList><ArticleId IdType="pubmed">27807185</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2015 Aug;74(2):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25137340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Feb;20(2):192-201</Citation><ArticleIdList><ArticleId IdType="pubmed">23812284</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Nov 15;8(11):e80713</Citation><ArticleIdList><ArticleId IdType="pubmed">24348913</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Imaging Behav. 2016 Dec;10(4):1117-1126</Citation><ArticleIdList><ArticleId IdType="pubmed">26553579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2009 Mar 4;29(9):2805-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19261876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimaging. 2004 Apr;14(2):150-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15095561</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2017 Feb 28;11:56</Citation><ArticleIdList><ArticleId IdType="pubmed">28293162</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 May 15;12(5):e0177727</Citation><ArticleIdList><ArticleId IdType="pubmed">28505177</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2012 Dec;265(3):864-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22966067</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2011 Jun;259(3):659-81</Citation><ArticleIdList><ArticleId IdType="pubmed">21602503</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Imaging Behav. 2017 Jun;11(3):754-768</Citation><ArticleIdList><ArticleId IdType="pubmed">27146291</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurosci. 2016 Oct 25;10:478</Citation><ArticleIdList><ArticleId IdType="pubmed">27826224</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Mar;60(1):400-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22245259</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1983 Nov;33(11):1444-52</Citation><ArticleIdList><ArticleId IdType="pubmed">6685237</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Oct 13;4(10):e7440</Citation><ArticleIdList><ArticleId IdType="pubmed">19823682</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2009 Apr;5(4):182-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19347020</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Connect. 2012;2(3):125-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22642651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2017 Apr;23(4):546-555</Citation><ArticleIdList><ArticleId IdType="pubmed">27411700</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2005 Oct 15;237(1-2):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16109428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2005 Oct;4(10):618-26</Citation><ArticleIdList><ArticleId IdType="pubmed">16168930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2013 Jul;260(7):1709-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23052604</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2009 Feb 15;44(4):1397-403</Citation><ArticleIdList><ArticleId IdType="pubmed">19027076</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1998 Jan;121 ( Pt 1):103-13</Citation><ArticleIdList><ArticleId IdType="pubmed">9549491</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2010 Apr;31(4):770-88</Citation><ArticleIdList><ArticleId IdType="pubmed">20373420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30231499</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Deep Learning in Drug Discovery and Medicine; Scratching the Surface.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E2384</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules23092384</ELocationID><Abstract><AbstractText>The practice of medicine is ever evolving. Diagnosing disease, which is often the first step in a cure, has seen a sea change from the discerning hands of the neighborhood physician to the use of sophisticated machines to use of information gleaned from biomarkers obtained by the most minimally invasive of means. The last 100 or so years have borne witness to the enormous success story of allopathy, a practice that found favor over earlier practices of medical purgatory and homeopathy. Nevertheless, failures of this approach coupled with the omics and bioinformatics revolution spurred precision medicine, a platform wherein the molecular profile of an individual patient drives the selection of therapy. Indeed, precision medicine-based therapies that first found their place in oncology are rapidly finding uses in autoimmune, renal and other diseases. More recently a new renaissance that is shaping everyday life is making its way into healthcare. Drug discovery and medicine that started with Ayurveda in India are now benefiting from an altogether different artificial intelligence (AI)-one which is automating the invention of new chemical entities and the mining of large databases in health-privacy-protected vaults. Indeed, disciplines as diverse as language, neurophysiology, chemistry, toxicology, biostatistics, medicine and computing have come together to harness algorithms based on transfer learning and recurrent neural networks to design novel drug candidates, a priori inform on their safety, metabolism and clearance, and engineer their delivery but only on demand, all the while cataloging and comparing omics signatures across traditionally classified diseases to enable basket treatment strategies. This review highlights inroads made and being made in directed-drug design and molecular therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dana</LastName><ForeName>Dibyendu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. ddana@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadhiya</LastName><ForeName>Satishkumar V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. sgadhiya@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St Surin</LastName><ForeName>Luce G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. lstsuri1@jhu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. david_li@college.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naaz</LastName><ForeName>Farha</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. fnaaz@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Quaisar</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. qali@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paka</LastName><ForeName>Latha</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. spaka@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamin</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. myamin@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayan</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, The University of Texas, El Paso, TX 79968, USA. manarayan@utep.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Itzhak D</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. igoldberg@angion.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayan</LastName><ForeName>Prakash</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Preclinical Research, Angion Biomedica Corporation, Nassau, NY 11553, USA. pnarayan@angion.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="Y">Drug Discovery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">de novo design</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">drug discovery</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">recurrent neural networks</Keyword><Keyword MajorTopicYN="N">small molecules</Keyword><Keyword MajorTopicYN="N">therapeutics</Keyword><Keyword MajorTopicYN="N">transfer learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30231499</ArticleId><ArticleId IdType="pii">molecules23092384</ArticleId><ArticleId IdType="doi">10.3390/molecules23092384</ArticleId><ArticleId IdType="pmc">PMC6225282</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Med Chem. 2017 Jan 5;125:255-268</Citation><ArticleIdList><ArticleId IdType="pubmed">27688181</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2010 Jan;233(1):34-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20192991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Inform. 2018 Jan;37(1-2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29235269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2007 Aug;4(8):651-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17558387</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Cancer Drug Targets. 2016;16(9):773-788</Citation><ArticleIdList><ArticleId IdType="pubmed">26638884</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Rev Respir Dis. 1992 May;145(5):1009-15</Citation><ArticleIdList><ArticleId IdType="pubmed">1316727</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Biochem. 2010;79:233-69</Citation><ArticleIdList><ArticleId IdType="pubmed">20334529</ArticleId></ArticleIdList></Reference><Reference><Citation>ChemMedChem. 2015 Dec;10(12):1958-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26358802</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2013 May 20;31(15):1803-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23589545</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2009 Jan 15;69(2):583-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19147572</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1973 Oct;33(4):445-53</Citation><ArticleIdList><ArticleId IdType="pubmed">4355038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Feb 13;421(6924):756-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12610629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Pharmacol. 1998 Jul;54(1):105-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9658195</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Alcohol Depend. 2018 Aug 1;189:49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">29879681</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2007 Oct;12(10):1247-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17962618</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Med Chem. 2011 Mar;3(4):451-67</Citation><ArticleIdList><ArticleId IdType="pubmed">21452981</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetrahedron. 2015 Feb 25;71(8):1227-1231</Citation><ArticleIdList><ArticleId IdType="pubmed">25691805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2003 Mar;22(2):151-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12606142</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Feb 26;372(9):793-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25635347</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2010 Jan;55(1):50-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19932542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Sep 6;489(7414):57-74</Citation><ArticleIdList><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 2009 Oct 1;69(14):1911-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19747008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2015 Apr;33(4):325</Citation><ArticleIdList><ArticleId IdType="pubmed">25850042</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Inform. 2018 Jan;37(1-2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29319225</ArticleId></ArticleIdList></Reference><Reference><Citation>Leukemia. 2009 Jun;23(6):1019-28</Citation><ArticleIdList><ArticleId IdType="pubmed">19194470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioorg Med Chem. 2016 May 1;24(9):2060-71</Citation><ArticleIdList><ArticleId IdType="pubmed">27032890</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008;9(9):R137</Citation><ArticleIdList><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cheminform. 2017 Sep 4;9(1):48</Citation><ArticleIdList><ArticleId IdType="pubmed">29086083</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Feb 22;409(6823):1102-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11234024</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2013 May;34(5):267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23582281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Endocrinol. 2010 Dec;6(12):665-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21045787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetrahedron Lett. 2016 May 11;57(19):2090-2092</Citation><ArticleIdList><ArticleId IdType="pubmed">27152055</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteins. 2008 Sep;72(4):1114-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18320590</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2008 Jan 1;177(1):27-34</Citation><ArticleIdList><ArticleId IdType="pubmed">17885264</ArticleId></ArticleIdList></Reference><Reference><Citation>Handb Exp Pharmacol. 2016;232:91-123</Citation><ArticleIdList><ArticleId IdType="pubmed">26408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2006 Apr;11(7-8):326-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16580974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2008 Sep;5(9):829-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19160518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2015 Aug;33(8):831-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26213851</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Cent Sci. 2018 Jan 24;4(1):120-131</Citation><ArticleIdList><ArticleId IdType="pubmed">29392184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2013 Apr;83(4):749-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23325076</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2001 Feb 16;291(5507):1304-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11181995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Dec 15;30(24):3467-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25371479</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Oct;10(10):669-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19736561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Jul 1;31(13):3576-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12824369</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Health Drug Benefits. 2015 Mar;8(Spec Feature):180-3</Citation><ArticleIdList><ArticleId IdType="pubmed">26629287</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2008 Jul 1;123(1):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18425818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 1977 Mar;37(3):646-50</Citation><ArticleIdList><ArticleId IdType="pubmed">837366</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2016 May 12;59(9):4077-86</Citation><ArticleIdList><ArticleId IdType="pubmed">26881908</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 1991;203:613-38</Citation><ArticleIdList><ArticleId IdType="pubmed">1762573</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Stat Assoc. 2011;106(495):891-903</Citation><ArticleIdList><ArticleId IdType="pubmed">26478641</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetol Metab Syndr. 2017 Oct 18;9:84</Citation><ArticleIdList><ArticleId IdType="pubmed">29075332</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2018 Jun;23(6):1241-1250</Citation><ArticleIdList><ArticleId IdType="pubmed">29366762</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Investig Drugs. 2007 Jul;16(7):1111-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17594194</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Jul 02;11:369</Citation><ArticleIdList><ArticleId IdType="pubmed">20598134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jul 1;21(13):2933-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15860560</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Inform. 2016 Jan;35(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27491648</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2002 Aug 23;321(4):591-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12206775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley Interdiscip Rev Syst Biol Med. 2013 Jan-Feb;5(1):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23184638</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2013;2013:635284</Citation><ArticleIdList><ArticleId IdType="pubmed">24286082</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30223787</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2105</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>BMC bioinformatics</Title><ISOAbbreviation>BMC Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>Data-driven human transcriptomic modules determined by independent component analysis.</ArticleTitle><Pagination><MedlinePgn>327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12859-018-2338-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Analyzing the human transcriptome is crucial in advancing precision medicine, and the plethora of over half a million human microarray samples in the Gene Expression Omnibus (GEO) has enabled us to better characterize biological processes at the molecular level. However, transcriptomic analysis is challenging because the data is inherently noisy and high-dimensional. Gene set analysis is currently widely used to alleviate the issue of high dimensionality, but the user-defined choice of gene sets can introduce biasness in results. In this paper, we advocate the use of a fixed set of transcriptomic modules for such analysis. We apply independent component analysis to the large collection of microarray data in GEO in order to discover reproducible transcriptomic modules that can be used as features for machine learning. We evaluate the usability of these modules across six studies, and demonstrate (1) their usage as features for sample classification, and also their robustness in dealing with small training sets, (2) their regularization of data when clustering samples and (3) the biological relevancy of differentially expressed features.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 139 reproducible transcriptomic modules, which we term fundamental components (FCs). In studies with less than 50 samples, FC-space classification model outperformed their gene-space counterparts, with higher sensitivity (p..&lt;...0.01). The models also had higher accuracy and negative predictive value (p..&lt;...0.01) for small data sets (less than 30 samples). Additionally, we observed a reduction in batch effects when data is clustered in the FC-space. Finally, we found that differentially expressed FCs mapped to GO terms that were also identified via traditional gene-based approaches.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 139 FCs provide biologically-relevant summarization of transcriptomic data, and their performance in low sample settings suggest that they should be employed in such studies in order to harness the data efficiently.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weizhuang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Russ B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA. russ.altman@stanford.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Stanford University, Stanford, CA, 94305, USA. russ.altman@stanford.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24 GM061374</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM005652</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM102365</GrantID><Agency>National Institutes of Health</Agency><Country/></Grant><Grant><GrantID>LM05652</GrantID><Agency>National Institutes of Health</Agency><Country/></Grant><Grant><GrantID>U01 GM061374</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM102365</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM61374</GrantID><Agency>National Institutes of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Bioinformatics</MedlineTA><NlmUniqueID>100965194</NlmUniqueID><ISSNLinking>1471-2105</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016172" MajorTopicYN="N">DNA Fingerprinting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007938" MajorTopicYN="N">Leukemia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Functional modules</Keyword><Keyword MajorTopicYN="N">Gene expression</Keyword><Keyword MajorTopicYN="N">Independent component analysis</Keyword><Keyword MajorTopicYN="N">Transcriptome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30223787</ArticleId><ArticleId IdType="doi">10.1186/s12859-018-2338-4</ArticleId><ArticleId IdType="pii">10.1186/s12859-018-2338-4</ArticleId><ArticleId IdType="pmc">PMC6142401</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Negl Trop Dis. 2015 Mar 13;9(3):e0003522</Citation><ArticleIdList><ArticleId IdType="pubmed">25768297</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2008 Dec 1;24(23):2798-800</Citation><ArticleIdList><ArticleId IdType="pubmed">18842599</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2007 Nov 21;1(2):e86</Citation><ArticleIdList><ArticleId IdType="pubmed">18060089</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D1113-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25361974</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2016 Apr 27;2(4):239-250</Citation><ArticleIdList><ArticleId IdType="pubmed">27135536</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Dec 15;10:422</Citation><ArticleIdList><ArticleId IdType="pubmed">20003504</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychometrika. 1965 Jun;30:179-85</Citation><ArticleIdList><ArticleId IdType="pubmed">14306381</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2017 May;79:53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">28118944</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Nov 15;31(22):3718-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26209431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2015 Sep;28(9):1214-24</Citation><ArticleIdList><ArticleId IdType="pubmed">26226845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2015 Dec 23;1(6):417-425</Citation><ArticleIdList><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2010 May 20;28(15):2529-37</Citation><ArticleIdList><ArticleId IdType="pubmed">20406941</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2010 Dec;43(6):932-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20619355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Jun 02;6:25696</Citation><ArticleIdList><ArticleId IdType="pubmed">27254731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Jan 15;25(2):288-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19033274</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008;9(2):R26</Citation><ArticleIdList><ArticleId IdType="pubmed">18248669</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2003;4(11):R76</Citation><ArticleIdList><ArticleId IdType="pubmed">14611662</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Jan 22;19(2):185-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12538238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2017 Jul 26;5(1):63-71.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">28711280</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2014 Nov 20;9(4):1235-45</Citation><ArticleIdList><ArticleId IdType="pubmed">25456126</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Dec 15;12:474</Citation><ArticleIdList><ArticleId IdType="pubmed">22172014</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Apr;41(7):e82</Citation><ArticleIdList><ArticleId IdType="pubmed">23389952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2014 Feb 13;4:4092</Citation><ArticleIdList><ArticleId IdType="pubmed">24522610</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2014 Mar;70(1):224-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24350655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 Jul;34(3):267-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2002 Jan;18(1):51-60</Citation><ArticleIdList><ArticleId IdType="pubmed">11836211</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Pharmacol. 2016 Jun 1;109:83-90</Citation><ArticleIdList><ArticleId IdType="pubmed">27055738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Feb 12;20(3):307-15</Citation><ArticleIdList><ArticleId IdType="pubmed">14960456</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2009 Jun;1792(6):497-505</Citation><ArticleIdList><ArticleId IdType="pubmed">19268705</ArticleId></ArticleIdList></Reference><Reference><Citation>J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):47-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26429394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Apr 20;43(7):e47</Citation><ArticleIdList><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Summit Transl Bioinform. 2009 Mar 01;2009:56-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21347171</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2008 Mar;26(3):303-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18327243</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2007 Aug;3(8):e161</Citation><ArticleIdList><ArticleId IdType="pubmed">17708679</ArticleId></ArticleIdList></Reference><Reference><Citation>Multivariate Behav Res. 2009 May;44(3):362-388</Citation><ArticleIdList><ArticleId IdType="pubmed">20234802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Feb 15;33(4):522-528</Citation><ArticleIdList><ArticleId IdType="pubmed">27797771</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Genomics. 2011 Oct 14;4:73</Citation><ArticleIdList><ArticleId IdType="pubmed">21996057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Jul 1;22(13):1600-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16606683</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Sep 29;313(5795):1929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17008526</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 Apr;28(4):322-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20379172</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10101-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10963673</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Apr;58(4):1001-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18383392</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2016 Jan 19;1(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">27822512</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2008 Oct 16;9:488</Citation><ArticleIdList><ArticleId IdType="pubmed">18925949</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Dermatol. 2015 Jan;24(1):14-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25356957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30209345</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>09</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure.</ArticleTitle><Pagination><MedlinePgn>13650</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-31911-7</ELocationID><Abstract><AbstractText>We present a study of multiple sclerosis segmentation algorithms conducted at the international MICCAI 2016 challenge. This challenge was operated using a new open-science computing infrastructure. This allowed for the automatic and independent evaluation of a large range of algorithms in a fair and completely automatic manner. This computing infrastructure was used to evaluate thirteen methods of MS lesions segmentation, exploring a broad range of state-of-theart algorithms, against a high-quality database of 53 MS cases coming from four centers following a common definition of the acquisition protocol. Each case was annotated manually by an unprecedented number of seven different experts. Results of the challenge highlighted that automatic algorithms, including the recent machine learning methods (random forests, deep learning, ...), are still trailing human expertise on both detection and delineation criteria. In addition, we demonstrate that computing a statistically robust consensus of the algorithms performs closer to human expertise on one score (segmentation) although still trailing on detection scores.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Commowick</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France. Olivier.Commowick@inria.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Istace</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kain</LastName><ForeName>Micha..l</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurent</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>LaTIM, INSERM, UMR 1101, University of Brest, IBSAM, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leray</LastName><ForeName>Florent</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pop</LastName><ForeName>Sorina Camarasu</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-7923-5069</Identifier><AffiliationInfo><Affiliation>Univ Lyon, INSA-Lyon, Universit.. Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, F-69621, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Univ Lyon, INSA-Lyon, Universit.. Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, F-69621, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Am..li</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferr..</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Rennes, Department of Neuroradiology, F-35033, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerbrat</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Rennes, Department of Neurology, F-35033, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tourdias</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU de Bordeaux, Service de Neuro-Imagerie, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervenansky</LastName><ForeName>Fr..d..ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Univ Lyon, INSA-Lyon, Universit.. Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, F-69621, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatard</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Software Engineering, Concordia University, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaumont</LastName><ForeName>J..r..my</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>Senan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pixyl Medical, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forbes</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pixyl Medical, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inria Grenoble Rh..ne-Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0455-5455</Identifier><AffiliationInfo><Affiliation>Image Analysis in Medicine Lab, School of Engineering, University of Guelph, Guelph, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khademi</LastName><ForeName>April</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4932-0385</Identifier><AffiliationInfo><Affiliation>Image Analysis in Medicine Lab (IAMLAB), Ryerson University, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahbod</LastName><ForeName>Amirreza</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5042-1442</Identifier><AffiliationInfo><Affiliation>School of Technology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunliang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Technology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinley</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Franca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muschelli</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6469-1750</Identifier><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roura</LastName><ForeName>Eloy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research institute of Computer Vision and Robotics (VICOROB), University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llad..</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Research institute of Computer Vision and Robotics (VICOROB), University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Michel M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Centro de Inform..tica, Universidade Federal de Pernambuco, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Wellington P</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Depto. de Eng. Biom..dica, Universidade Federal de Pernambuco, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Filho</LastName><ForeName>Abel G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Centro de Inform..tica, Universidade Federal de Pernambuco, Pernambuco, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomas-Fernandez</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Computational Radiology Laboratory, Department of Radiology, Children's Hospital, 300 Longwood Avenue, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urien</LastName><ForeName>H..l..ne</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>LTCI, T..l..com ParisTech, Universit.. Paris-Saclay, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>LTCI, T..l..com ParisTech, Universit.. Paris-Saclay, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valverde</LastName><ForeName>Sergi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research institute of Computer Vision and Robotics (VICOROB), University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabezas</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research institute of Computer Vision and Robotics (VICOROB), University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vera-Olmos</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Lab, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malpica</LastName><ForeName>Norberto</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-4618-7459</Identifier><AffiliationInfo><Affiliation>Medical Image Analysis Lab, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guttmann</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Neurological Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vukusic</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edan</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Rennes, Department of Neurology, F-35033, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dojat</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Inserm U1216, University Grenoble Alpes, CHU Grenoble, GIN, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Styner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warfield</LastName><ForeName>Simon K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Computational Radiology Laboratory, Department of Radiology, Children's Hospital, 300 Longwood Avenue, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotton</LastName><ForeName>Fran..ois</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0046-2478</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barillot</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>VISAGES: INSERM U1228 - CNRS UMR6074 - Inria, University of Rennes I, Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072356" MajorTopicYN="N">Parenchymal Tissue</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30209345</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-31911-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-31911-7</ArticleId><ArticleId IdType="pmc">PMC6135867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Front Neuroinform. 2016 Jul 27;10:30</Citation><ArticleIdList><ArticleId IdType="pubmed">27512372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroradiol. 2015 Jun;42(3):133-40</Citation><ArticleIdList><ArticleId IdType="pubmed">25660217</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2013 Jan;32(1):110-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23014715</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Imaging (Bellingham). 2014 Apr;1(1):014002</Citation><ArticleIdList><ArticleId IdType="pubmed">26158022</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2008 Apr;27(4):425-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18390341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurol. 2006 Jul;13(7):700-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16834700</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2015 Jun;34(6):1349-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25616008</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2013 Jan;17(1):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23084503</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Jul;115(3):147-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24813718</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2015 Oct;57(10):1031-43</Citation><ArticleIdList><ArticleId IdType="pubmed">26227167</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2017 Mar 1;148:77-102</Citation><ArticleIdList><ArticleId IdType="pubmed">28087490</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2012 Apr;54(4):299-320</Citation><ArticleIdList><ArticleId IdType="pubmed">21584674</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2017 Jul 15;155:159-168</Citation><ArticleIdList><ArticleId IdType="pubmed">28435096</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2014 Oct;33(10):1997-2009</Citation><ArticleIdList><ArticleId IdType="pubmed">24951681</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1994 Apr;44(4):635-41</Citation><ArticleIdList><ArticleId IdType="pubmed">8164816</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2009;12(Pt 2):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20426159</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2010 Jul;133(Pt 7):1900-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20423930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2006 Aug;60(2):236-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16786526</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30195164</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><PubDate><Year>2018</Year><Month>10</Month><Day>01</Day></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Predicting hospital readmission for lupus patients: An RNN-LSTM-based deep-learning methodology.</ArticleTitle><Pagination><MedlinePgn>199-209</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(18)30256-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2018.08.029</ELocationID><Abstract><AbstractText>Hospital readmission is one of the critical metrics used for measuring the performance of hospitals. The HITECH Act imposes penalties when patients are readmitted to hospitals if they are diagnosed with one of the six conditions mentioned in the Act. However, patients diagnosed with lupus are the sixth highest in terms of rehospitalization. The heterogeneity in the disease and patient characteristics makes it very hard to predict rehospitalization. This research utilizes deep learning methods to predict rehospitalization within 30 days by extracting the temporal relationships in the longitudinal EHR clinical data. Prediction results from deep learning methods such as LSTM are evaluated and compared with traditional classification methods such as penalized logistic regression and artificial neural networks. The simple recurrent neural network method and its variant, gated recurrent unit network, are also developed and validated to compare their performance against the proposed LSTM model. The results indicated that the deep learning method RNN-LSTM has a significantly better performance (with an AUC of .70) compared to traditional classification methods such as ANN (with an AUC of 0.66) and penalized logistic regression (with an AUC of 0.63). The rationale for the better performance of the deep learning method may be due to its ability to leverage the temporal relationships of the disease state in patients over time and to capture the progression of the disease-relevant clinical information from patients' prior visits is carried forward in the memory, which may have enabled the higher predictability for the deep learning methods.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Bhargava K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>UCB Biosciences, Inc., 8010 Arco Corporate Drive, Suite 100, Raleigh, NC, 27617, USA. Electronic address: Bhargava.Reddy@ucb.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delen</LastName><ForeName>Dursun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Management Science and Information Systems, Spears School of Business, Oklahoma State University, Tulsa, OK, 74106, USA. Electronic address: dursun.delen@okstate.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="Y">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Deep learning</Keyword><Keyword MajorTopicYN="Y">LSTM</Keyword><Keyword MajorTopicYN="Y">Lupus</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Predictive analytics</Keyword><Keyword MajorTopicYN="Y">Readmission</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30195164</ArticleId><ArticleId IdType="pii">S0010-4825(18)30256-7</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2018.08.029</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30155789</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.</ArticleTitle><Pagination><MedlinePgn>1361-1374</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-018-9942-9</ELocationID><Abstract><AbstractText>Neuroanatomical pattern classification using support vector machines (SVMs) has shown promising results in classifying Multiple Sclerosis (MS) patients based on individual structural magnetic resonance images (MRI). To determine whether pattern classification using SVMs facilitates predicting conversion to clinically definite multiple sclerosis (CDMS) from clinically isolated syndrome (CIS). We used baseline MRI data from 364 patients with CIS, randomised to interferon beta-1b or placebo. Non-linear SVMs and 10-fold cross-validation were applied to predict converters/non-converters (175/189) at two years follow-up based on clinical and demographic data, lesion-specific quantitative geometric features and grey-matter-to-whole-brain volume ratios. We applied linear SVM analysis and leave-one-out cross-validation to subgroups of converters (n...=...25) and non-converters (n...=...44) based on cortical grey matter segmentations. Highest prediction accuracies of 70.4% (p...=...8e-5) were reached with a combination of lesion-specific geometric (image-based) and demographic/clinical features. Cortical grey matter was informative for the placebo group (acc.: 64.6%, p...=...0.002) but not for the interferon group. Classification based on demographic/clinical covariates only resulted in an accuracy of 56% (p...=...0.05). Overall, lesion geometry was more informative in the interferon group, EDSS and sex were more important for the placebo cohort. Alongside standard demographic and clinical measures, both lesion geometry and grey matter based information can aid prediction of conversion to CDMS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bendfeldt</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland. kerstin.bendfeldt@unibas.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taschler</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaetano</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madoerin</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller-Lenke</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amann</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrenken</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>VU University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wottschel</LastName><ForeName>Viktor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>VU University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barkhof</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>VU University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institutes of Neurology and Healthcare Engineering, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgwardt</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry (1), University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London, Department of Psychosis Studies, Institute of Psychiatry, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kl..ppel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Freiburg Brain Imaging, University Medical Center Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicklein</LastName><ForeName>Eva-Maria</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Bayer Pharma AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappos</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edan</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CHU-Hopital Pontchaillou, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montalb..n</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartung</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Heinrich-Heine Universit..t, D..sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pohl</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bayer Pharma AG, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit.. University Medicine Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandbrink</LastName><ForeName>Rupert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bayer Pharma AG, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Heinrich-Heine Universit..t, D..sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprenger</LastName><ForeName>Till</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radue</LastName><ForeName>Ernst-Wilhelm</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuerfel</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit.. University Medicine Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>100309</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Clinically isolated syndrome</Keyword><Keyword MajorTopicYN="N">Lesion geometry</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30155789</ArticleId><ArticleId IdType="doi">10.1007/s11682-018-9942-9</ArticleId><ArticleId IdType="pii">10.1007/s11682-018-9942-9</ArticleId><ArticleId IdType="pmc">PMC6733701</ArticleId><ArticleId IdType="mid">EMS82960</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Mar;63(3 Pt 1):031112</Citation><ArticleIdList><ArticleId IdType="pubmed">11308635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microsc. 2001 Sep;203(Pt 3):303-13</Citation><ArticleIdList><ArticleId IdType="pubmed">11555148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2001 Dec;7(6):359-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11795456</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Jan 17;346(3):158-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11796849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2003 May;6(5):448-50</Citation><ArticleIdList><ArticleId IdType="pubmed">12704393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2003 Sep;18(3):291-301</Citation><ArticleIdList><ArticleId IdType="pubmed">12938123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2004 May;127(Pt 5):1101-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14998914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2004 Aug;10(4):402-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15327037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2004 Oct;10(5):562-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15471374</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimaging. 2005 Jan;15(1):27-36</Citation><ArticleIdList><ArticleId IdType="pubmed">15574571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2005 Feb;57(2):210-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15668965</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2005 Jun;128(Pt 6):1454-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15817511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2005 Dec;58(6):840-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16283615</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimaging. 2005;15(4 Suppl):30S-45S</Citation><ArticleIdList><ArticleId IdType="pubmed">16385017</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2006 Mar;129(Pt 3):606-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16415308</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Feb 28;66(4):551-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16505310</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Oct 10;67(7):1242-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16914693</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Sep 26;67(6):968-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17000962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Aug 4;370(9585):389-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17679016</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2007 Sep;64(9):1292-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17846268</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2008 Mar 25;70(13 Pt 2):1079-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17881717</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2008 Apr;255(4):480-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18004635</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2008 Mar;131(Pt 3):808-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18234696</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2008 Aug 1;42(1):315-22</Citation><ArticleIdList><ArticleId IdType="pubmed">18501636</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Stat Data Anal. 2008 Jan 15;53(3):820-833</Citation><ArticleIdList><ArticleId IdType="pubmed">19177180</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2009 Jul 15;282(1-2):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19201003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2009 Nov;8(11):987-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19748319</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2010 Jun;31(6):983-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20019103</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2010 Jul;133(Pt 7):1914-29</Citation><ArticleIdList><ArticleId IdType="pubmed">20534650</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2010 Aug;6(8):438-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20625376</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 Nov;123(2-3):160-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20826078</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2010 Nov;257(2):448-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20858849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1017-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21297149</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2011 Jul 19;77(3):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21613600</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(6):e21138</Citation><ArticleIdList><ArticleId IdType="pubmed">21695053</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2012 Feb 28;31(5):449-69</Citation><ArticleIdList><ArticleId IdType="pubmed">21964585</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2012 Apr;36(4):1140-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22305994</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2012 Apr;11(4):349-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22441196</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 Nov;18(11):1577-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22495945</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2012 Sep;33(8):1573-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22499842</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2013 Apr;136(Pt 4):1012-24</Citation><ArticleIdList><ArticleId IdType="pubmed">23412934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2013 Dec;19(14):1878-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23652215</ArticleId></ArticleIdList></Reference><Reference><Citation>Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):901-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23917093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2013 May 19;2:735-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24179825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Appl Stat. 2014;8(2):1095-1118</Citation><ArticleIdList><ArticleId IdType="pubmed">25431633</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2014 Dec 04;7:281-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25610791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimaging. 2017 Nov;27(6):613-619</Citation><ArticleIdList><ArticleId IdType="pubmed">28488804</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 1994;13(1-2):14-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8190201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 1993 Jul;37(3):185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">8244781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1993 Feb;116 ( Pt 1):135-46</Citation><ArticleIdList><ArticleId IdType="pubmed">8453454</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1998 Mar;121 ( Pt 3):495-503</Citation><ArticleIdList><ArticleId IdType="pubmed">9549525</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30060699</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>09</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Incorporating Unannounced Meals and Exercise in Adaptive Learning of Personalized Models for Multivariable Artificial Pancreas Systems.</ArticleTitle><Pagination><MedlinePgn>953-966</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818789951</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the recent advancements in the modeling of glycemic dynamics for type 1 diabetes mellitus, automatically considering unannounced meals and exercise without manual user inputs remains challenging.</AbstractText><AbstractText Label="METHOD">An adaptive model identification technique that incorporates exercise information and estimates of the effects of unannounced meals obtained automatically without user input is proposed in this work. The effects of the unknown consumed carbohydrates are estimated using an individualized unscented Kalman filtering algorithm employing an augmented glucose-insulin dynamic model, and exercise information is acquired from noninvasive physiological measurements. The additional information on meals and exercise is incorporated with personalized estimates of plasma insulin concentration and glucose measurement data in an adaptive model identification algorithm.</AbstractText><AbstractText Label="RESULTS">The efficacy of the proposed personalized and adaptive modeling algorithm is demonstrated using clinical data involving closed-loop experiments of the artificial pancreas system, and the results demonstrate accurate glycemic modeling with the average root-mean-square error (mean absolute error) of 25.50 mg/dL (18.18 mg/dL) for six-step (30 minutes ahead) predictions.</AbstractText><AbstractText Label="CONCLUSIONS">The approach presented is able to identify reliable time-varying individualized glucose-insulin models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hajizadeh</LastName><ForeName>Iman</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>1 Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Mudassir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turksoy</LastName><ForeName>Kamuran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>2 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadi</LastName><ForeName>Sediqeh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1 Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jianyuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1 Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sevil</LastName><ForeName>Mert</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobbs</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>2 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazaro</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>3 Department of Electrical and Computer Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>Zacharie</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>2 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Littlejohn</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>4 Department of Pediatrics and Medicine, Section of Endocrinology, Kovler Diabetes Center, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101075</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP3 DK101077</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK092949</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial pancreas</Keyword><Keyword MajorTopicYN="Y">biomedical system</Keyword><Keyword MajorTopicYN="Y">linear systems</Keyword><Keyword MajorTopicYN="Y">modeling and identification</Keyword><Keyword MajorTopicYN="Y">recursive identification</Keyword><Keyword MajorTopicYN="Y">subspace methods</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30060699</ArticleId><ArticleId IdType="doi">10.1177/1932296818789951</ArticleId><ArticleId IdType="pmc">PMC6134614</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25434967</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2018 Mar;20(3):235-246</Citation><ArticleIdList><ArticleId IdType="pubmed">29406789</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Sep;61(9):2230-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22688340</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2002 Feb;25(2):347-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11815508</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2016 Nov;18(11):1110-1119</Citation><ArticleIdList><ArticleId IdType="pubmed">27333970</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Jun;19(6):355-362</Citation><ArticleIdList><ArticleId IdType="pubmed">28459603</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2129-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">26379095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2018 Mar 16;18(3):null</Citation><ArticleIdList><ArticleId IdType="pubmed">29547553</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Sep;19(9):527-532</Citation><ArticleIdList><ArticleId IdType="pubmed">28767276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2017 Mar;19(3):155-163</Citation><ArticleIdList><ArticleId IdType="pubmed">28134564</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 May;15(5):386-400</Citation><ArticleIdList><ArticleId IdType="pubmed">23544672</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10(6):1236-1244</Citation><ArticleIdList><ArticleId IdType="pubmed">27464755</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 May;8(3):498-507</Citation><ArticleIdList><ArticleId IdType="pubmed">24876613</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1135-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27289127</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 Jan;20(1):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26087510</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Jul 5;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">27424482</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 Aug;27(8):1922-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15277418</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Aug;18(5):348-355</Citation><ArticleIdList><ArticleId IdType="pubmed">27191182</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2018 May;12(3):639-649</Citation><ArticleIdList><ArticleId IdType="pubmed">29566547</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Process Control. 2017 Dec;60:115-127</Citation><ArticleIdList><ArticleId IdType="pubmed">29403158</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Nov;18(7):540-546</Citation><ArticleIdList><ArticleId IdType="pubmed">27734563</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Aug;40(8):1096-1102</Citation><ArticleIdList><ArticleId IdType="pubmed">28584075</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Chem Eng. 2018 Apr 6;112:57-69</Citation><ArticleIdList><ArticleId IdType="pubmed">30287976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30005356</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Multiple sclerosis and related disorders</Title><ISOAbbreviation>Mult Scler Relat Disord</ISOAbbreviation></Journal><ArticleTitle>Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>135-141</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2211-0348(18)30186-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msard.2018.06.009</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multiple sclerosis (MS) incidence has increased recently, particularly in women, suggesting a possible role of one or more environmental exposures in MS risk. The study objective was to determine if animal, dietary, recreational, or occupational exposures are associated with MS risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Least absolute shrinkage and selection operator (LASSO) regression was used to identify a subset of exposures with potential relevance to disease in a large population-based (Kaiser Permanente Northern California [KPNC]) case-control study. Variables with non-zero coefficients were analyzed in matched conditional logistic regression analyses, adjusted for established environmental risk factors and socioeconomic status (if relevant in univariate screening),.. genetic risk factors, in the KPNC cohort and, for purposes of replication, separately in the Swedish Epidemiological Investigation of MS cohort. These variables were also assessed in models stratified by HLA-DRB1*15:01 status since interactions between risk factors and that haplotype have been described.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a suggestive association of pesticide exposure with having MS among men, but only in those who were positive for HLA-DRB1*15:01 (OR pooled...=...3.11, 95% CI 0.87, 11.16, p...=...0.08).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While this finding requires confirmation, it is interesting given the association between pesticide exposure and other neurological diseases. The study also demonstrates the application of LASSO to identify environmental exposures with reduced multiple statistical testing penalty. Machine learning approaches may be useful for future investigations of concomitant MS risk or prognostic factors.</AbstractText><CopyrightInformation>Copyright .. 2018. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mowry</LastName><ForeName>Ellen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, 600N. Wolfe Street, Pathology 627, Baltimore 21287, MD, USA. Electronic address: Emowry1@jhmi.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedstr..m</LastName><ForeName>Anna K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianfrancesco</LastName><ForeName>Milena A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Division of Research, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Division of Research, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellesis</LastName><ForeName>Kalliope H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Division of Research, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Farren B S</ForeName><Initials>FBS</Initials><AffiliationInfo><Affiliation>Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Karolinska Institutet at Karolinska University Hospital, Solna, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfredsson</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mult Scler Relat Disord</MedlineTA><NlmUniqueID>101580247</NlmUniqueID><ISSNLinking>2211-0348</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489631">HLA-DRB1*15:01 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010575">Pesticides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="Y">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="N">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010575" MajorTopicYN="N">Pesticides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Environmental exposure</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Gene-environment interaction</Keyword><Keyword MajorTopicYN="N">Keywords:</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Occupational exposure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>05</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30005356</ArticleId><ArticleId IdType="pii">S2211-0348(18)30186-X</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2018.06.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29992392</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.</ArticleTitle><Pagination><MedlinePgn>1103-1114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-018-9926-9</ELocationID><Abstract><AbstractText>Machine Learning application on clinical data in order to support diagnosis and prognostic evaluation arouses growing interest in scientific community. However, choice of right algorithm to use was fundamental to perform reliable and robust classification. Our study aimed to explore if different kinds of Machine Learning technique could be effective to support early diagnosis of Multiple Sclerosis and which of them presented best performance in distinguishing Multiple Sclerosis patients from control subjects. We selected following algorithms: Random Forest, Support Vector Machine, Na..ve-Bayes, K-nearest-neighbor and Artificial Neural Network. We applied the Independent Component Analysis to resting-state functional-MRI sequence to identify brain networks. We found 15 networks, from which we extracted the mean signals used into classification. We performed feature selection tasks in all algorithms to obtain the most important variables. We showed that best discriminant network between controls and early Multiple Sclerosis, was the sensori-motor I, according to early manifestation of motor/sensorial deficits in Multiple Sclerosis. Moreover, in classification performance, Random Forest and Support Vector Machine showed same 5-fold cross-validation accuracies (85.7%) using only this network, resulting to be best approaches. We believe that these findings could represent encouraging step toward the translation to clinical diagnosis and prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sacc..</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarica</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Research Council, Institute of Bioimaging and Molecular Physiology (IBFM), Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novellino</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5898-938X</Identifier><AffiliationInfo><Affiliation>National Research Council, Institute of Bioimaging and Molecular Physiology (IBFM), Catanzaro, Italy. fabiana.novellino@cnr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barone</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallarico</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippelli</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granata</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiriaco</LastName><ForeName>Carmelina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Research Council, Institute of Bioimaging and Molecular Physiology (IBFM), Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno Bossio</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Operating Unit Serraspiga, Provincial Health Authority, Cosenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentino</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quattrone</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Research Council, Institute of Bioimaging and Molecular Physiology (IBFM), Catanzaro, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neurology, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063132" MajorTopicYN="N">Connectome</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012146" MajorTopicYN="N">Rest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial neural network</Keyword><Keyword MajorTopicYN="N">K-nearest-neighbor</Keyword><Keyword MajorTopicYN="N">Na..ve Bayes</Keyword><Keyword MajorTopicYN="N">Random Forest</Keyword><Keyword MajorTopicYN="N">Resting state fMRI</Keyword><Keyword MajorTopicYN="N">Support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29992392</ArticleId><ArticleId IdType="doi">10.1007/s11682-018-9926-9</ArticleId><ArticleId IdType="pii">10.1007/s11682-018-9926-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29980727</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>07</Month><Day>06</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Lupus nephritis pathology prediction with clinical indices.</ArticleTitle><Pagination><MedlinePgn>10231</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-28611-7</ELocationID><Abstract><AbstractText>Effective treatment of lupus nephritis and assessment of patient prognosis depend on accurate pathological classification and careful use of acute and chronic pathological indices. Renal biopsy can provide most reliable predicting power. However, clinicians still need auxiliary tools under certain circumstances. Comprehensive statistical analysis of clinical indices may be an effective support and supplementation for biopsy. In this study, 173 patients with lupus nephritis were classified based on histology and scored on acute and chronic indices. These results were compared against machine learning predictions involving multilinear regression and random forest analysis. For three class random forest analysis, total classification accuracy was 51.3% (class II 53.7%, class III&amp;IV 56.2%, class V 40.1%). For two class random forest analysis, class II accuracy reached 56.2%; class III&amp;IV 63.7%; class V 61%. Additionally, machine learning selected out corresponding important variables for each class prediction. Multiple linear regression predicted the index of chronic pathology (CI) (Q<sup>2</sup>...=...0.746, R<sup>2</sup>...=...0.771) and the acute index (AI) (Q<sup>2</sup>...=...0.516, R<sup>2</sup>...=...0.576), and each variable's importance was calculated in AI and CI models. Evaluation of lupus nephritis by machine learning showed potential for assessment of lupus nephritis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Youzhou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Nephropathy &amp; Rheumatology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Weiru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Minfeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nephropathy &amp; Rheumatology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Lingli</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hematology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Zhijiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nephropathy &amp; Rheumatology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China. 2367720750@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Central South University, Changsha, China. oriental-cds@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hematology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China. xybenlu@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29980727</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-28611-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-28611-7</ArticleId><ArticleId IdType="pmc">PMC6035173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1999 Aug;42(8):1644-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10446863</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Immunol. 2000;76:227-324</Citation><ArticleIdList><ArticleId IdType="pubmed">11079100</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2016 Mar 29;16:39</Citation><ArticleIdList><ArticleId IdType="pubmed">27025458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Dec;68(6):2588-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16316334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2000 Sep;58(3):1160-73</Citation><ArticleIdList><ArticleId IdType="pubmed">10972679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron. 1995;69(4):371-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7777099</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1982 Apr;69(4):835-43</Citation><ArticleIdList><ArticleId IdType="pubmed">6804494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 May 5;150(9):604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2011 Jun;31(6):743-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20155421</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2001 Sep;44(9):2097-106</Citation><ArticleIdList><ArticleId IdType="pubmed">11592372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2015 Nov;26(11):2821-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26045090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2007 Sep;1110:433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17911458</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol Immunopathol. 1983 Nov;29(2):223-41</Citation><ArticleIdList><ArticleId IdType="pubmed">6605223</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2015 Jun 17;17:162</Citation><ArticleIdList><ArticleId IdType="pubmed">26081107</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Jun 03;5:10817</Citation><ArticleIdList><ArticleId IdType="pubmed">26039690</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Oct 02;10(10):e0139627</Citation><ArticleIdList><ArticleId IdType="pubmed">26431044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2004 Feb;65(2):521-30</Citation><ArticleIdList><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2011 Dec;20(14):1557-65</Citation><ArticleIdList><ArticleId IdType="pubmed">21993389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 1986 May;29(5):1066-71</Citation><ArticleIdList><ArticleId IdType="pubmed">3723928</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2010 May;77(9):820-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20182417</ArticleId></ArticleIdList></Reference><Reference><Citation>Histol Histopathol. 2014 May;29(5):553-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24288339</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Exp Pathol. 2015 May 01;8(5):4600-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26191151</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Ther Med. 2016 Jul;12(1):147-150</Citation><ArticleIdList><ArticleId IdType="pubmed">27347030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2016 Dec;25(14):1551-1557</Citation><ArticleIdList><ArticleId IdType="pubmed">27075010</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808</Citation><ArticleIdList><ArticleId IdType="pubmed">22556106</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Inf Sci Syst. 2016 Mar 08;4:2</Citation><ArticleIdList><ArticleId IdType="pubmed">26958341</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunopharmacol Immunotoxicol. 2012 Feb;34(1):163-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21651460</ArticleId></ArticleIdList></Reference><Reference><Citation>Reumatol Clin. 2016 Sep-Oct;12(5):256-62</Citation><ArticleIdList><ArticleId IdType="pubmed">26725021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29903493</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>A decision support system for type 1 diabetes mellitus diagnostics based on dual channel analysis of red blood cell membrane fluidity.</ArticleTitle><Pagination><MedlinePgn>263-271</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(17)31207-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2018.05.025</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Investigation of membrane fluidity by metabolic functional imaging opens up a new and important area of translational research in type 1 diabetes mellitus, being a useful and sensitive biomarker for disease monitoring and treatment. We investigate here how data on membrane fluidity can be used for diabetes monitoring.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We present a decision support system that distinguishes between healthy subjects, type 1 diabetes mellitus patients, and type 1 diabetes mellitus patients with complications. It leverages on dual channel data computed from the physical state of human red blood cells membranes by means of features based on first- and second-order statistical measures as well as on rotation invariant co-occurrence local binary patterns. The experiments were carried out on a dataset of more than 1000 images belonging to 27 subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our method shows a global accuracy of 100%, outperforming also the state-of-the-art approach based on the glycosylated hemoglobin.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The proposed recognition approach permits to achieve promising results.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cordelli</LastName><ForeName>Ermanno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, Rome, Italy. Electronic address: e.cordelli@unicampus.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maulucci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Spirito</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitocco</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Computer Systems and Bioinformatics, Department of Engineering, Universit.. Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004910" MajorTopicYN="N">Erythrocyte Membrane</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008560" MajorTopicYN="Y">Membrane Fluidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feature extraction</Keyword><Keyword MajorTopicYN="N">Image processing</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Two-photon microscopy</Keyword><Keyword MajorTopicYN="N">Type 1 Diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29903493</ArticleId><ArticleId IdType="pii">S0169-2607(17)31207-5</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2018.05.025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29771635</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Pathogenesis-based treatments in primary Sjogren's syndrome using artificial intelligence and advanced machine learning techniques: a systematic literature review.</ArticleTitle><Pagination><MedlinePgn>2553-2558</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1475872</ELocationID><Abstract><AbstractText>Big data analysis has become a common way to extract information from complex and large datasets among most scientific domains. This approach is now used to study large cohorts of patients in medicine. This work is a review of publications that have used artificial intelligence and advanced machine learning techniques to study physio pathogenesis-based treatments in pSS. A systematic literature review retrieved all articles reporting on the use of advanced statistical analysis applied to the study of systemic autoimmune diseases (SADs) over the last decade. An automatic bibliography screening method has been developed to perform this task. The program called BIBOT was designed to fetch and analyze articles from the pubmed database using a list of keywords and Natural Language Processing approaches. The evolution of trends in statistical approaches, sizes of cohorts and number of publications over this period were also computed in the process. In all, 44077 abstracts were screened and 1017 publications were analyzed. The mean number of selected articles was 101.0 (S.D. 19.16) by year, but increased significantly over the time (from 74 articles in 2008 to 138 in 2017). Among them only 12 focused on pSS but none of them emphasized on the aspect of pathogenesis-based treatments. To conclude, medicine progressively enters the era of big data analysis and artificial intelligence, but these approaches are not yet used to describe pSS-specific pathogenesis-based treatment. Nevertheless, large multicentre studies are investigating this aspect with advanced algorithmic tools on large cohorts of SADs patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foulquier</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>a LATIM, Laboratoire de Traitement de l'Information M..dicale, Universit.. de Brest, Inserm, CHU Brest , Brest , France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Lymphocytes B et Autoimmunit.. Universit.. de Brest, Inserm, CHU Brest, LabEx IGO , Brest , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redou</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>a LATIM, Laboratoire de Traitement de l'Information M..dicale, Universit.. de Brest, Inserm, CHU Brest , Brest , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Gal</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>a LATIM, Laboratoire de Traitement de l'Information M..dicale, Universit.. de Brest, Inserm, CHU Brest , Brest , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouvi..re</LastName><ForeName>B..n..dicte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>b Lymphocytes B et Autoimmunit.. Universit.. de Brest, Inserm, CHU Brest, LabEx IGO , Brest , France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Internal Medicine Unit, CHU , Brest , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pers</LastName><ForeName>Jacques-Olivier</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>c Internal Medicine Unit, CHU , Brest , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saraux</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>c Internal Medicine Unit, CHU , Brest , France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>d Rheumatology Unit, Centre National de R..f..rence des Maladies Auto-Immunes Rares (CERAINO), CHU , Brest , France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="Y">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="N">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Artificial intelligence</Keyword><Keyword MajorTopicYN="Y">Sjogren's syndrome</Keyword><Keyword MajorTopicYN="Y">advanced machine learning techniques</Keyword><Keyword MajorTopicYN="Y">systematic literature review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29771635</ArticleId><ArticleId IdType="doi">10.1080/21645515.2018.1475872</ArticleId><ArticleId IdType="pmc">PMC6314425</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Medicine (Baltimore). 2016 Jun;95(25):e3766</Citation><ArticleIdList><ArticleId IdType="pubmed">27336863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2015 Nov;76(11):808-11</Citation><ArticleIdList><ArticleId IdType="pubmed">26429306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2016 Aug;12(8):456-71</Citation><ArticleIdList><ArticleId IdType="pubmed">27411907</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2016 Sep;72(3):888-96</Citation><ArticleIdList><ArticleId IdType="pubmed">26845527</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2017 Oct;47(2):222-227</Citation><ArticleIdList><ArticleId IdType="pubmed">28729155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):499-503</Citation><ArticleIdList><ArticleId IdType="pubmed">19627014</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 May 26;12(5):e0177320</Citation><ArticleIdList><ArticleId IdType="pubmed">28552951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Res. 2014;2014:647507</Citation><ArticleIdList><ArticleId IdType="pubmed">24963499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jun;76(6):1042-1050</Citation><ArticleIdList><ArticleId IdType="pubmed">27899373</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2015 Nov;65(3):239-50</Citation><ArticleIdList><ArticleId IdType="pubmed">26303104</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Sex Differ. 2015 Nov 03;6:19</Citation><ArticleIdList><ArticleId IdType="pubmed">26535108</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Jul 6;8(46):80461-80471</Citation><ArticleIdList><ArticleId IdType="pubmed">29113317</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hematol Oncol. 2017 Apr 17;10(1):90</Citation><ArticleIdList><ArticleId IdType="pubmed">28416003</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2010 Jul;9(9):618-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20457282</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Clin Immunol. 2012 Mar;8(3):269-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22390491</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2017 Sep 7;18(1):401</Citation><ArticleIdList><ArticleId IdType="pubmed">28882107</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2015 Aug;14(8):670-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25842074</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2013 Dec;65(12):3218-27</Citation><ArticleIdList><ArticleId IdType="pubmed">23982978</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2015;21(18):2350-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25777752</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2017 Oct;69(10):1612-1616</Citation><ArticleIdList><ArticleId IdType="pubmed">27998024</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Epidemiol. 2017 Nov 02;9:527-535</Citation><ArticleIdList><ArticleId IdType="pubmed">29138598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2017 Aug;37(8):1311-1316</Citation><ArticleIdList><ArticleId IdType="pubmed">28573480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2018 Jan;77(1):133-140</Citation><ArticleIdList><ArticleId IdType="pubmed">28916716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">29752460</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1759-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>07</Month></PubDate></JournalIssue><Title>Nature reviews. Rheumatology</Title><ISOAbbreviation>Nat Rev Rheumatol</ISOAbbreviation></Journal><ArticleTitle>RNA sequencing and machine learning as molecular scalpels.</ArticleTitle><Pagination><MedlinePgn>388-390</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41584-018-0012-x</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Myles J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-9365-5345</Identifier><AffiliationInfo><Affiliation>Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London and Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0001-9097-7381</Identifier><AffiliationInfo><Affiliation>Centre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London and Barts Health NHS Trust, London, UK. m.r.barnes@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016433">News</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Rev Rheumatol</MedlineTA><NlmUniqueID>101500080</NlmUniqueID><ISSNLinking>1759-4790</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Arthritis Rheumatol. 2018 May;70(5):690-701</RefSource><PMID Version="1">29468833</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29752460</ArticleId><ArticleId IdType="doi">10.1038/s41584-018-0012-x</ArticleId><ArticleId IdType="pii">10.1038/s41584-018-0012-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29636690</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>AIPpred: Sequence-Based Prediction of Anti-inflammatory Peptides Using Random Forest.</ArticleTitle><Pagination><MedlinePgn>276</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2018.00276</ELocationID><Abstract><AbstractText>The use of therapeutic peptides in various inflammatory diseases and autoimmune disorders has received considerable attention; however, the identification of anti-inflammatory peptides (AIPs) through wet-lab experimentation is expensive and often time consuming. Therefore, the development of novel computational methods is needed to identify potential AIP candidates prior to <i>in vitro</i> experimentation. In this study, we proposed a random forest (RF)-based method for predicting AIPs, called AIPpred (AIP predictor in primary amino acid sequences), which was trained with 354 optimal features. First, we systematically studied the contribution of individual composition [amino acid-, dipeptide composition (DPC), amino acid index, chain-transition-distribution, and physicochemical properties] in AIP prediction. Since the performance of the DPC-based model is significantly better than that of other composition-based models, we applied a feature selection protocol on this model and identified the optimal features. AIPpred achieved an area under the curve (AUC) value of 0.801 in a 5-fold cross-validation test, which was ...2% higher than that of the control RF predictor trained with all DPC composition features, indicating the efficiency of the feature selection protocol. Furthermore, we evaluated the performance of AIPpred on an independent dataset, with results showing that our method outperformed an existing method, as well as 3 different machine learning methods developed in this study, with an AUC value of 0.814. These results indicated that AIPpred will be a useful tool for predicting AIPs and might efficiently assist the development of AIP therapeutics and biomedical research. AIPpred is freely accessible at www.thegleelab.org/AIPpred.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manavalan</LastName><ForeName>Balachandran</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Physiology, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Tae H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Physiology, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Science and Technology, Ajou University, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myeong O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Division of Life Science and Applied Life Science (BK21 Plus), College of Natural Sciences, Gyeongsang National University, Jinju, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Gwang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Physiology, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Science and Technology, Ajou University, Suwon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIPpred</Keyword><Keyword MajorTopicYN="N">anti-inflammatory peptides</Keyword><Keyword MajorTopicYN="N">hybrid features</Keyword><Keyword MajorTopicYN="N">parameter optimization</Keyword><Keyword MajorTopicYN="N">random forest</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>03</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29636690</ArticleId><ArticleId IdType="doi">10.3389/fphar.2018.00276</ArticleId><ArticleId IdType="pmc">PMC5881105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Neurol. 2000 Oct;48(4):567-79</Citation><ArticleIdList><ArticleId IdType="pubmed">11026440</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2001 May;7(5):563-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11329057</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2001 Feb;34(1):28-36</Citation><ArticleIdList><ArticleId IdType="pubmed">11376540</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2002 Jan;23(1):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11801454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">12379615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Jul 1;31(13):3692-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12824396</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2005 Feb;173(2):630-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15643278</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent Res. 2005 Feb;84(2):149-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15668332</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 2005 Mar 10;48(5):1384-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15743181</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 Jul 23;8:263</Citation><ArticleIdList><ArticleId IdType="pubmed">17645800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jan;36(Database issue):D202-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17998252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 1996;5(5):334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18475727</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18515843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Jul 24;454(7203):428-35</Citation><ArticleIdList><ArticleId IdType="pubmed">18650913</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2009 May;1788(5):1193-203</Citation><ArticleIdList><ArticleId IdType="pubmed">19285481</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Sep 1;25(17):2200-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19549632</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Today. 2009 Oct;14(19-20):926-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19596080</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat Res. 2010 Aug 7;690(1-2):24-39</Citation><ArticleIdList><ArticleId IdType="pubmed">19769993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Mar 1;26(5):680-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20053844</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Struct Biol. 2010 Jan 12;10:1</Citation><ArticleIdList><ArticleId IdType="pubmed">20067617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Pharmacol. 2009;1(1):29-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20333321</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Sep 16;5(9):e12713</Citation><ArticleIdList><ArticleId IdType="pubmed">20877634</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2011 Mar 21;273(1):236-47</Citation><ArticleIdList><ArticleId IdType="pubmed">21168420</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Dec 23;5(12):e15782</Citation><ArticleIdList><ArticleId IdType="pubmed">21203422</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Ther Pat. 2011 Jun;21(6):927-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21406035</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Recognit. 2011 Jul-Aug;24(4):597-607</Citation><ArticleIdList><ArticleId IdType="pubmed">21472811</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23989</Citation><ArticleIdList><ArticleId IdType="pubmed">21897866</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(9):e25118</Citation><ArticleIdList><ArticleId IdType="pubmed">21949866</ArticleId></ArticleIdList></Reference><Reference><Citation>Amino Acids. 2012 Aug;43(2):583-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21993537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2012 Jan 06;18(1):59-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22227674</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W199-204</Citation><ArticleIdList><ArticleId IdType="pubmed">22638580</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pharm Res. 2012 Aug;35(8):1297-316</Citation><ArticleIdList><ArticleId IdType="pubmed">22941474</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Apr 1;41(6):e68</Citation><ArticleIdList><ArticleId IdType="pubmed">23303794</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Jan 11;339(6116):166-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23307734</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(1):e54178</Citation><ArticleIdList><ArticleId IdType="pubmed">23372681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2013;3:2197</Citation><ArticleIdList><ArticleId IdType="pubmed">23852097</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2016 Oct;25(5):1804-1823</Citation><ArticleIdList><ArticleId IdType="pubmed">24047600</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2013 Oct 30;8:27</Citation><ArticleIdList><ArticleId IdType="pubmed">24168386</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2014 Apr;176(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">24313320</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Dev Immunol. 2013;2013:263952</Citation><ArticleIdList><ArticleId IdType="pubmed">24489573</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2014 Apr 28;15:120</Citation><ArticleIdList><ArticleId IdType="pubmed">24776231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2014 Aug;10(8):2229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24931825</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Microbiol Biotechnol. 2014 Oct;98(20):8685-95</Citation><ArticleIdList><ArticleId IdType="pubmed">25056289</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Sep 15;9(9):e106542</Citation><ArticleIdList><ArticleId IdType="pubmed">25222008</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 Mar 21;16:94</Citation><ArticleIdList><ArticleId IdType="pubmed">25886990</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2015;1324:59-69</Citation><ArticleIdList><ArticleId IdType="pubmed">26202262</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2016 Mar 29;7(13):16895-909</Citation><ArticleIdList><ArticleId IdType="pubmed">26942877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Apr 04;6:23990</Citation><ArticleIdList><ArticleId IdType="pubmed">27041353</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2016 Aug 12;477(1):150-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27291150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2016 Aug 16;12(9):2849-58</Citation><ArticleIdList><ArticleId IdType="pubmed">27364688</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:1654623</Citation><ArticleIdList><ArticleId IdType="pubmed">27437396</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2016 Dec 5;17(1):495</Citation><ArticleIdList><ArticleId IdType="pubmed">27919220</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Jan 17;8(3):4208-4217</Citation><ArticleIdList><ArticleId IdType="pubmed">27926534</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Feb 15;33(4):586-588</Citation><ArticleIdList><ArticleId IdType="pubmed">28035027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2017 Jan 6;15(1):7</Citation><ArticleIdList><ArticleId IdType="pubmed">28057002</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE/ACM Trans Comput Biol Bioinform. 2017 Feb 08;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28186907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Feb 17;7:42851</Citation><ArticleIdList><ArticleId IdType="pubmed">28211521</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechnol Adv. 2017 May - Jun;35(3):337-349</Citation><ArticleIdList><ArticleId IdType="pubmed">28216008</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Mar 14;8:278</Citation><ArticleIdList><ArticleId IdType="pubmed">28352270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Aug 15;33(16):2496-2503</Citation><ArticleIdList><ArticleId IdType="pubmed">28419290</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Apr 25;8(17):28169-28175</Citation><ArticleIdList><ArticleId IdType="pubmed">28423655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2017 Oct;178:132-140</Citation><ArticleIdList><ArticleId IdType="pubmed">28435091</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2017 Aug 7;426:96-103</Citation><ArticleIdList><ArticleId IdType="pubmed">28536036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther Nucleic Acids. 2017 Jun 16;7:155-163</Citation><ArticleIdList><ArticleId IdType="pubmed">28624191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther Nucleic Acids. 2017 Jun 16;7:267-277</Citation><ArticleIdList><ArticleId IdType="pubmed">28624202</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2017 Aug 24;18(9):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28837067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biosyst. 2017 Nov 21;13(12):2545-2550</Citation><ArticleIdList><ArticleId IdType="pubmed">28990628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 Nov 15;199(10):3592-3603</Citation><ArticleIdList><ArticleId IdType="pubmed">28993516</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Aug 19;8(44):77121-77136</Citation><ArticleIdList><ArticleId IdType="pubmed">29100375</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Oct 31;8:1430</Citation><ArticleIdList><ArticleId IdType="pubmed">29163505</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Dec 8;9(2):1944-1956</Citation><ArticleIdList><ArticleId IdType="pubmed">29416743</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2018 Mar 16;9:476</Citation><ArticleIdList><ArticleId IdType="pubmed">29616000</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 1982 Apr;143(1):29-36</Citation><ArticleIdList><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8700-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7568000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29568746</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Metagenomics Biomarkers Selected for Prediction of Three Different Diseases in Chinese Population.</ArticleTitle><Pagination><MedlinePgn>2936257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/2936257</ELocationID><Abstract><AbstractText>The dysbiosis of human microbiome has been proven to be associated with the development of many human diseases. Metagenome sequencing emerges as a powerful tool to investigate the effects of microbiome on diseases. Identification of human gut microbiome markers associated with abnormal phenotypes may facilitate feature selection for multiclass classification. Compared with binary classifiers, multiclass classification models deploy more complex discriminative patterns. Here, we developed a pipeline to address the challenging characterization of multilabel samples. In this study, a total of 300 biomarkers were selected from the microbiome of 806 Chinese individuals (383 controls, 170 with type 2 diabetes, 130 with rheumatoid arthritis, and 123 with liver cirrhosis), and then logistic regression prediction algorithm was applied to those markers as the model intrinsic features. The estimated model produced an <i>F</i><sub>1</sub> score of 0.9142, which was better than other popular classification methods, and an average receiver operating characteristic (ROC) of 0.9475 showed a significant correlation between these selected biomarkers from microbiome and corresponding phenotypes. The results from this study indicate that machine learning is a vital tool in data mining from microbiome in order to identify disease-related biomarkers, which may contribute to the application of microbiome-based precision medicine in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Honglong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Wuhan National Laboratory for Optoelectronics, Key Laboratory of Information Storage System, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Binhai Genomics Institute, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Translational Genomics Center, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Lihua</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wuhan National Laboratory for Optoelectronics, Key Laboratory of Information Storage System, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Mathematics and Computer Science, Guangdong Ocean University, Zhanjiang, Guangdong 524088, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dongfang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wuhan National Laboratory for Optoelectronics, Key Laboratory of Information Storage System, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Binhai Genomics Institute, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Translational Genomics Center, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Binhai Genomics Institute, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Translational Genomics Center, BGI-Tianjin, BGI-Shenzhen, Tianjin 300308, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Shancen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>BGI-Shenzhen, Shenzhen 518083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Fuhao</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Computer Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2161-8796</Identifier><AffiliationInfo><Affiliation>Wuhan National Laboratory for Optoelectronics, Key Laboratory of Information Storage System, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asians</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054892" MajorTopicYN="N">Metagenome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056186" MajorTopicYN="N">Metagenomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29568746</ArticleId><ArticleId IdType="doi">10.1155/2018/2936257</ArticleId><ArticleId IdType="pmc">PMC5820663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Host Microbe. 2016 Jan 13;19(1):12-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26764593</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bacteriol. 2010 Oct;192(19):5081-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20675470</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Feb 05;5(2):e9085</Citation><ArticleIdList><ArticleId IdType="pubmed">20140211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Oct 4;490(7418):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">23023125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2015 Mar 11;6:6528</Citation><ArticleIdList><ArticleId IdType="pubmed">25758642</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2015 Sep;9(9):1979-90</Citation><ArticleIdList><ArticleId IdType="pubmed">25647347</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 May 17;5(5):e10667</Citation><ArticleIdList><ArticleId IdType="pubmed">20498852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Aug 29;500(7464):541-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23985870</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2013 May;13(5):321-35</Citation><ArticleIdList><ArticleId IdType="pubmed">23618829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2006 Dec 21;444(7122):1027-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17183312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jun 13;486(7402):207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22699609</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2001 Feb;42(2):116-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11531317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 May 09;486(7402):222-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22699611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Feb 06;5:8310</Citation><ArticleIdList><ArticleId IdType="pubmed">25655524</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2016 Jul 06;535(7610):94-103</Citation><ArticleIdList><ArticleId IdType="pubmed">27383984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2016 Aug;14 (8):508-22</Citation><ArticleIdList><ArticleId IdType="pubmed">27396567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2015 Jun;16(6):321-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25948244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Sep 4;513(7516):59-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25079328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Mar 4;464(7285):59-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2015 Jun 23;15:239</Citation><ArticleIdList><ArticleId IdType="pubmed">26099252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2014 Aug;32(8):834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24997786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Aug;21(8):895-905</Citation><ArticleIdList><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Jul 15;25(14):1754-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 May 13;17(5):690-703</Citation><ArticleIdList><ArticleId IdType="pubmed">25974306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Apr 7;165(2):276-87</Citation><ArticleIdList><ArticleId IdType="pubmed">27058662</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jun 6;498(7452):99-103</Citation><ArticleIdList><ArticleId IdType="pubmed">23719380</ArticleId></ArticleIdList></Reference><Reference><Citation>J Community Hosp Intern Med Perspect. 2016 Feb 17;6(1):30151</Citation><ArticleIdList><ArticleId IdType="pubmed">26908381</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18936492</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Oct 19;10(10):e0140827</Citation><ArticleIdList><ArticleId IdType="pubmed">26479726</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29542348</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>The Promise and Perils of Wearable Physiological Sensors for Diabetes Management.</ArticleTitle><Pagination><MedlinePgn>587-591</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818763228</ELocationID><Abstract><AbstractText>Development of truly useful wearable physiologic monitoring devices for use in diabetes management is still in its infancy. From wearable activity monitors such as fitness trackers and smart watches to contact lenses measuring glucose levels in tears, we are just at the threshold of their coming use in medicine. Ultimately, such devices could help to improve the performance of sense-and-respond insulin pumps, illuminate the impact of physical activity on blood glucose levels, and improve patient safety. This is a summary of our experience attempting to use such devices to enhance continuous glucose monitoring-augmented insulin pump therapy. We discuss the current status and present difficulties with available devices, and review the potential for future use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>1 Center for Diabetes and Endocrine Diseases, West Virginia University Medicine Camden Clark Medical Center, Parkersburg, WV, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 The Diabetes Institute, Ohio University, Athens, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marling</LastName><ForeName>Cynthia R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>2 The Diabetes Institute, Ohio University, Athens, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 School of Electrical Engineering and Computer Science, Russ College of Engineering and Technology, Ohio University, Athens, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunescu</LastName><ForeName>Razvan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>2 The Diabetes Institute, Ohio University, Athens, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 School of Electrical Engineering and Computer Science, Russ College of Engineering and Technology, Ohio University, Athens, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 EB022356</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076251" MajorTopicYN="Y">Wearable Electronic Devices</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">diabetes management</Keyword><Keyword MajorTopicYN="Y">fitness trackers</Keyword><Keyword MajorTopicYN="Y">physiological sensors</Keyword><Keyword MajorTopicYN="Y">wearables</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29542348</ArticleId><ArticleId IdType="doi">10.1177/1932296818763228</ArticleId><ArticleId IdType="pmc">PMC6154251</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2012 Aug;14(8):683-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22690891</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2017 Jul 13;7(7):e016738</Citation><ArticleIdList><ArticleId IdType="pubmed">28710224</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2016 Apr 23;16(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">27120602</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):63-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25305282</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Nov 01;4(6):1563-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21129354</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25231116</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):138-147</Citation><ArticleIdList><ArticleId IdType="pubmed">27530720</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:2887-2891</Citation><ArticleIdList><ArticleId IdType="pubmed">29060501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29527624</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7365</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>08</Month></PubDate></JournalIssue><Title>Metabolic brain disease</Title><ISOAbbreviation>Metab Brain Dis</ISOAbbreviation></Journal><ArticleTitle>Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.</ArticleTitle><Pagination><MedlinePgn>1053-1067</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11011-018-0208-4</ELocationID><Abstract><AbstractText>Deficit schizophrenia is characterized by neurocognitive impairments and changes in the patterning of IgA/IgM responses to plasma tryptophan catabolites (TRYCATs). In the current study, supervised pattern recognition methods, including logistic regression analysis (LRA), Support Vector Machine (SVM), and Soft Independent Modeling of Class Analogy (SIMCA), were used to examine whether deficit schizophrenia is a discrete diagnostic class with respect to Consortium To Establish a Registry for Alzheimer's disease (CERAD) and Cambridge Neuropsychological Test Automated Battery (CANTAB) tests and IgA/IgM responses to noxious (NOX) and generally more protective (PRO) TRYCATs. We recruited patients with (n...=...40) and without (n...=...40) deficit schizophrenia and healthy volunteers (n...=...40). The combined use of TRYCAT and CERAD features strongly segregates deficit from nondeficit schizophrenia and healthy controls. Three out of the top five most important features in LRA, SVM and SIMCA agreed, namely two different NOX/PRO TRYCAT ratios and false memory recall. SIMCA shows that deficit schizophrenia is significantly separated from nondeficit schizophrenia and controls with as top 6 features IgA responses to picolinic acid, IgM responses to 3-OH-kynurenine and kynurenic acid, and impairments in Word List Memory and Verbal Fluency Tests and Mini-Mental State Examination. Nevertheless, nondeficit schizophrenia was not significantly separated from controls. The results show that schizophrenia is not a unitary disease with mere continuous differences in severity of illness between apparent subtypes. Deficit schizophrenia is a qualitatively distinct class defined by neuroimmune (autoimmune responses to TRYCATs) and neurocognitive (episodic and semantic memory) features coupled or not with clinical (negative) symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanchanatawan</LastName><ForeName>Buranee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sriswasdi</LastName><ForeName>Sira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thika</LastName><ForeName>Supaksorn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirivichayakul</LastName><ForeName>Sunee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Andr.. F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Cear.., Fortaleza, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geffard</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Department, IDRPHT, Talence, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GEMAC, Saint Jean d'Illac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubera</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2012-871X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.michaelmaes@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria. dr.michaelmaes@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, Vic, Australia. dr.michaelmaes@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Metab Brain Dis</MedlineTA><NlmUniqueID>8610370</NlmUniqueID><ISSNLinking>0885-7490</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="N">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Compensatory anti-inflammatory reflex system</Keyword><Keyword MajorTopicYN="Y">Cytokines</Keyword><Keyword MajorTopicYN="Y">Immune activation</Keyword><Keyword MajorTopicYN="Y">Inflammation</Keyword><Keyword MajorTopicYN="Y">Schizophrenia</Keyword><Keyword MajorTopicYN="Y">Tryptophan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29527624</ArticleId><ArticleId IdType="doi">10.1007/s11011-018-0208-4</ArticleId><ArticleId IdType="pii">10.1007/s11011-018-0208-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Psychiatr Res. 1992 Jul;26(3):183-96</Citation><ArticleIdList><ArticleId IdType="pubmed">1432845</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2010 May;118(1-3):122-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19887305</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2017 Feb;16(1):14-24</Citation><ArticleIdList><ArticleId IdType="pubmed">28127915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hist Psychiatry. 2004 Sep;15(59 Pt 3):361-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15386868</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Sep 26;67(6):1006-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17000969</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1994 Apr;44(4):609-14</Citation><ArticleIdList><ArticleId IdType="pubmed">8164812</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2018 Feb;55(2):1524-1536</Citation><ArticleIdList><ArticleId IdType="pubmed">28181189</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1990 Oct;34(1):59-75</Citation><ArticleIdList><ArticleId IdType="pubmed">2176296</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2018 Jun;55(6):5184-5201</Citation><ArticleIdList><ArticleId IdType="pubmed">28875464</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2013 May 14;11:126</Citation><ArticleIdList><ArticleId IdType="pubmed">23672542</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1990 Oct;34(1):43-57</Citation><ArticleIdList><ArticleId IdType="pubmed">2267263</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2011;44(6):345-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21847001</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2015 Jul;41(4):879-91</Citation><ArticleIdList><ArticleId IdType="pubmed">25399026</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2012 Dec 30;200(2-3):754-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22521895</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Endocrinol Lett. 2009;30(5):564-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20035251</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2016 Oct;176(2-3):411-416</Citation><ArticleIdList><ArticleId IdType="pubmed">27242067</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21185346</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry Suppl. 1989 Nov;(7):49-58</Citation><ArticleIdList><ArticleId IdType="pubmed">2695141</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2002 Jul;82(2):258-68</Citation><ArticleIdList><ArticleId IdType="pubmed">12124427</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1989 Nov;30(2):119-23</Citation><ArticleIdList><ArticleId IdType="pubmed">2616682</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Endocrinol Lett. 2013;34(3):185-99</Citation><ArticleIdList><ArticleId IdType="pubmed">23685416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2018 Mar;55(3):2214-2226</Citation><ArticleIdList><ArticleId IdType="pubmed">28290151</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2004;30(4):827-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15954193</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Endocrinol Lett. 2015;36(4):320-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26454487</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1990 Oct;34(1):29-41</Citation><ArticleIdList><ArticleId IdType="pubmed">2267262</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Sep 18;10(9):e0138357</Citation><ArticleIdList><ArticleId IdType="pubmed">26381645</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Psychiatry. 2013 Aug 29;4:95</Citation><ArticleIdList><ArticleId IdType="pubmed">24009589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 1987;13(2):261-76</Citation><ArticleIdList><ArticleId IdType="pubmed">3616518</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29517418</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8042</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>04</Month></PubDate></JournalIssue><Title>Pharmacogenomics</Title><ISOAbbreviation>Pharmacogenomics</ISOAbbreviation></Journal><ArticleTitle>SNPs affecting the clinical outcomes of regularly used immunosuppressants.</ArticleTitle><Pagination><MedlinePgn>495-511</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/pgs-2017-0182</ELocationID><Abstract><AbstractText>Recent studies have suggested that genomic diversity may play a key role in different clinical outcomes, and the importance of SNPs is becoming increasingly clear. In this article, we summarize the bioactivity of SNPs that may affect the sensitivity to or possibility of drug reactions that occur among the signaling pathways of regularly used immunosuppressants, such as glucocorticoids, azathioprine, tacrolimus, mycophenolate mofetil, cyclophosphamide and methotrexate. The development of bioinformatics, including machine learning models, has enabled prediction of the proper immunosuppressant dosage with minimal adverse drug reactions for patients after organ transplantation or for those with autoimmune diseases. This article provides a theoretical basis for the personalized use of immunosuppressants in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Huan-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhao-Hui</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wan-Lin</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Cheng-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhi-Bin</ForeName><Initials>ZB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Yuan-Yuan</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yi-En</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Li-Qun</ForeName><Initials>LQ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital of Central South University, Changsha, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacogenomics</MedlineTA><NlmUniqueID>100897350</NlmUniqueID><ISSNLinking>1462-2416</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">SNPs</Keyword><Keyword MajorTopicYN="Y">drug reactions</Keyword><Keyword MajorTopicYN="Y">immunosuppressants</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29517418</ArticleId><ArticleId IdType="doi">10.2217/pgs-2017-0182</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29515569</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires.</ArticleTitle><Pagination><MedlinePgn>224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.00224</ELocationID><Abstract><AbstractText>The adaptive immune system recognizes antigens <i>via</i> an immense array of antigen-binding antibodies and T-cell receptors, the immune repertoire. The interrogation of immune repertoires is of high relevance for understanding the adaptive immune response in disease and infection (e.g., autoimmunity, cancer, HIV). Adaptive immune receptor repertoire sequencing (AIRR-seq) has driven the quantitative and molecular-level profiling of immune repertoires, thereby revealing the high-dimensional complexity of the immune receptor sequence landscape. Several methods for the computational and statistical analysis of large-scale AIRR-seq data have been developed to resolve immune repertoire complexity and to understand the dynamics of adaptive immunity. Here, we review the current research on (i) diversity, (ii) clustering and network, (iii) phylogenetic, and (iv) machine learning methods applied to dissect, quantify, and compare the architecture, evolution, and specificity of immune repertoires. We summarize outstanding questions in computational immunology and propose future directions for systems immunology toward coupling AIRR-seq with the computational discovery of immunotherapeutics, vaccines, and immunodiagnostics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miho</LastName><ForeName>Enkelejda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department for Biosystems Science and Engineering, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>aiNET GmbH, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yermanos</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department for Biosystems Science and Engineering, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>C..dric R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department for Biosystems Science and Engineering, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Christoph T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Immunology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Sai T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department for Biosystems Science and Engineering, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiff</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department for Biosystems Science and Engineering, ETH Z..rich, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">B-cell receptor</Keyword><Keyword MajorTopicYN="Y">T-cell receptor</Keyword><Keyword MajorTopicYN="Y">antibody discovery</Keyword><Keyword MajorTopicYN="Y">artificial intelligence</Keyword><Keyword MajorTopicYN="Y">immunogenomics</Keyword><Keyword MajorTopicYN="Y">networks</Keyword><Keyword MajorTopicYN="Y">phylogenetics</Keyword><Keyword MajorTopicYN="Y">systems immunology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29515569</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.00224</ArticleId><ArticleId IdType="pmc">PMC5826328</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 1996 Apr 5;272(5258):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8600537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 Sep;11(9):1005-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16086024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Comp Immunol. 2017 Oct;75:28-37</Citation><ArticleIdList><ArticleId IdType="pubmed">28259700</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1984 Jul;37(3):1101-10</Citation><ArticleIdList><ArticleId IdType="pubmed">6611207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Apr 1;33(7):951-955</Citation><ArticleIdList><ArticleId IdType="pubmed">28073756</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E862-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25675496</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Nov 8;357(19):1903-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17989383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Jun 15;7:11881</Citation><ArticleIdList><ArticleId IdType="pubmed">27302887</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16161-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22988065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2016 Jul;48(7):725-32</Citation><ArticleIdList><ArticleId IdType="pubmed">27240091</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Aug 11;11(8):e0160853</Citation><ArticleIdList><ArticleId IdType="pubmed">27513338</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Jul 10;388(6638):133-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9217150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W435-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15215425</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26194755</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2015 Aug;35:89-97</Citation><ArticleIdList><ArticleId IdType="pubmed">26172290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2014 Aug 6;6(248):248ra107</Citation><ArticleIdList><ArticleId IdType="pubmed">25100741</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26194749</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2017 Mar 7;18(1):155</Citation><ArticleIdList><ArticleId IdType="pubmed">28264647</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2017 Sep 7;18(1):401</Citation><ArticleIdList><ArticleId IdType="pubmed">28882107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Jul 6;547(7661):94-98</Citation><ArticleIdList><ArticleId IdType="pubmed">28636589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 May;12(5):380-1</Citation><ArticleIdList><ArticleId IdType="pubmed">25924071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Nov 15;33(22):3685-3690</Citation><ArticleIdList><ArticleId IdType="pubmed">28961695</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 May 8;324(5928):807-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19423829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Feb 16;6:20842</Citation><ArticleIdList><ArticleId IdType="pubmed">26880249</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 1995;42(6):455-500</Citation><ArticleIdList><ArticleId IdType="pubmed">8550092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Apr 23;161(3):470-485</Citation><ArticleIdList><ArticleId IdType="pubmed">25865483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2016 Jul 1;32(13):1943-51</Citation><ArticleIdList><ArticleId IdType="pubmed">27153709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D405-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25300482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Jul 6;547(7661):89-93</Citation><ArticleIdList><ArticleId IdType="pubmed">28636592</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2013 Jun 12;13(6):691-700</Citation><ArticleIdList><ArticleId IdType="pubmed">23768493</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 May 3;102(18):6395-400</Citation><ArticleIdList><ArticleId IdType="pubmed">15851683</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Dec 22;8:1834</Citation><ArticleIdList><ArticleId IdType="pubmed">29312330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 Mar;11(3):171-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25536486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2010 Jun 15;184(12):6986-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20495067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2018 Feb 20;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">29474671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2016 Oct;33(10 ):2735-43</Citation><ArticleIdList><ArticleId IdType="pubmed">27343287</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2017 Apr 26;35:229-253</Citation><ArticleIdList><ArticleId IdType="pubmed">28446063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2015 Aug;16(8):880-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26147688</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2622-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24927543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Nov 15;30(22):3181-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25095879</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Syst Biol. 2016 Jul 29;12 (7):878</Citation><ArticleIdList><ArticleId IdType="pubmed">27474269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Jul 13;7(1):5338</Citation><ArticleIdList><ArticleId IdType="pubmed">28706301</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2008 Jan 1;329(1-2):67-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18001765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Oct 15;31(20):3356-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26069265</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2014 Oct 8;35(12):581-590</Citation><ArticleIdList><ArticleId IdType="pubmed">25306219</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2017 Jul;38(7):471-482</Citation><ArticleIdList><ArticleId IdType="pubmed">28566130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 May 25;6:26556</Citation><ArticleIdList><ArticleId IdType="pubmed">27222149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 May 1;198(9):3371-3373</Citation><ArticleIdList><ArticleId IdType="pubmed">28416712</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Aug 12;19(12):1572-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12912839</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2013 Apr 4;92(4):530-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23541343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Pharm. 2016 May 2;13(5):1445-54</Citation><ArticleIdList><ArticleId IdType="pubmed">27007977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Sep 15;33(18):2924-2929</Citation><ArticleIdList><ArticleId IdType="pubmed">28481982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W557-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15980534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 Oct 15;199(8):2985-2997</Citation><ArticleIdList><ArticleId IdType="pubmed">28924003</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Oct 12;8:1267</Citation><ArticleIdList><ArticleId IdType="pubmed">29075258</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2015 Nov;36(11):738-749</Citation><ArticleIdList><ArticleId IdType="pubmed">26508293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2017 Sep;35(9):879-884</Citation><ArticleIdList><ArticleId IdType="pubmed">28829438</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2017 Sep 23;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">29028876</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2015 Nov 24;2(12 ):2070-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26844287</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19875695</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2014 Apr 10;10(4):e1003537</Citation><ArticleIdList><ArticleId IdType="pubmed">24722319</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Biol. 2016 May;65(3):495-507</Citation><ArticleIdList><ArticleId IdType="pubmed">26658901</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6470-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23536288</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Apr 13;8:430</Citation><ArticleIdList><ArticleId IdType="pubmed">28450864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2017 Jan 3;18(1):237-247</Citation><ArticleIdList><ArticleId IdType="pubmed">28052253</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2016 Jun;40:103-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27065089</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2014 Oct;24(10):1603-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25024161</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2016 Jun 16;8(1):68</Citation><ArticleIdList><ArticleId IdType="pubmed">27312086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 Nov 1;199(9):3369-3380</Citation><ArticleIdList><ArticleId IdType="pubmed">28978691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W573-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22675075</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2018 Feb;153(2):145-160</Citation><ArticleIdList><ArticleId IdType="pubmed">29140551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Feb 9;168(4):600-612</Citation><ArticleIdList><ArticleId IdType="pubmed">28187283</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Aug 14;8:910</Citation><ArticleIdList><ArticleId IdType="pubmed">28855898</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2011 May;21(5):790-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21349924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2017 May 16;19(7):1467-1478</Citation><ArticleIdList><ArticleId IdType="pubmed">28514665</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Biomed Eng. 2017 Mar;1:54-62</Citation><ArticleIdList><ArticleId IdType="pubmed">29038795</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2016 Dec;22(12 ):1456-1464</Citation><ArticleIdList><ArticleId IdType="pubmed">27820605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D419-D427</Citation><ArticleIdList><ArticleId IdType="pubmed">28977646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Apr 14;302(5909):575-81</Citation><ArticleIdList><ArticleId IdType="pubmed">6300689</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2017 Jul 21;6:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28731407</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 Nov 30;7:125</Citation><ArticleIdList><ArticleId IdType="pubmed">26620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Oct 16;8:1286</Citation><ArticleIdList><ArticleId IdType="pubmed">29085363</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 May 28;7(1):49</Citation><ArticleIdList><ArticleId IdType="pubmed">26140055</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2017 May;206(1):417-427</Citation><ArticleIdList><ArticleId IdType="pubmed">28315836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2012 Mar 28;13(5):303-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22456349</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 May 18;12 (5):e1004940</Citation><ArticleIdList><ArticleId IdType="pubmed">27191167</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2017 Jul;38(7):459-470</Citation><ArticleIdList><ArticleId IdType="pubmed">28539189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 May 1;30(9):1312-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24451623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Dec 20;7:13642</Citation><ArticleIdList><ArticleId IdType="pubmed">27995928</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2013 Nov 15;4:358</Citation><ArticleIdList><ArticleId IdType="pubmed">24298272</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 2013 Nov;65(11):777-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23974323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2014 Feb;15(2):118-27</Citation><ArticleIdList><ArticleId IdType="pubmed">24448569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2016 Jul;33(7):1870-4</Citation><ArticleIdList><ArticleId IdType="pubmed">27004904</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 Nov 20;7:121</Citation><ArticleIdList><ArticleId IdType="pubmed">26589402</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2259-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24469811</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5405-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20212159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2014 Jul 9;16(1):105-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24981332</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2014 Jun 19;10(6):e1003646</Citation><ArticleIdList><ArticleId IdType="pubmed">24945836</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2015 Apr;33:126-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25797714</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2017 Dec 15;33(24):3938-3946</Citation><ArticleIdList><ArticleId IdType="pubmed">28968873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Feb 15;27(4):592-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21169378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2016 Oct;17 (10 ):1226-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27525369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2015 Oct 1;31(19):3213-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26007226</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2017 Oct 6;358(6359):58-63</Citation><ArticleIdList><ArticleId IdType="pubmed">28983043</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2013 Dec 25;4:466</Citation><ArticleIdList><ArticleId IdType="pubmed">24400005</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Nov 15;8:1500</Citation><ArticleIdList><ArticleId IdType="pubmed">29187849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Apr 1;176(7):4221-34</Citation><ArticleIdList><ArticleId IdType="pubmed">16547259</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26194753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2016 Nov 1;197(9):3566-3574</Citation><ArticleIdList><ArticleId IdType="pubmed">27707999</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20066-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22123975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Aug 24;170(5):828-843</Citation><ArticleIdList><ArticleId IdType="pubmed">28841416</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2017 Nov 16;18(12 ):1274-1278</Citation><ArticleIdList><ArticleId IdType="pubmed">29144493</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2016 Jan 11;12(1):e1004409</Citation><ArticleIdList><ArticleId IdType="pubmed">26751373</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Jun 15;194(12):5703-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25972486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2015;11(2):391-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25692740</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2005 Dec;71(12):8228-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16332807</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2007 Apr 10;321(1-2):182-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17337271</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2017 Feb;214(2):309-317</Citation><ArticleIdList><ArticleId IdType="pubmed">28104812</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 1997 Nov 15;9(8):1735-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2993-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23382245</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2017 May;49(5):659-665</Citation><ArticleIdList><ArticleId IdType="pubmed">28369038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Mar;89(6):3308-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25589639</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 May 10;8:537</Citation><ArticleIdList><ArticleId IdType="pubmed">28539926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Nov;38(21):e193</Citation><ArticleIdList><ArticleId IdType="pubmed">20846958</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biotechnol. 2017 Mar;35(3):203-214</Citation><ArticleIdList><ArticleId IdType="pubmed">28341036</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biotechnol. 2015 Feb;33(2):65-79</Citation><ArticleIdList><ArticleId IdType="pubmed">25466879</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2385-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8460148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 Mar 1;198(5):2202-2210</Citation><ArticleIdList><ArticleId IdType="pubmed">28115530</ArticleId></ArticleIdList></Reference><Reference><Citation>J Math Biol. 2013 Dec;67(6-7):1339-68</Citation><ArticleIdList><ArticleId IdType="pubmed">23007599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Mar 23;7:11112</Citation><ArticleIdList><ArticleId IdType="pubmed">27005435</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Nov 01;8:1418</Citation><ArticleIdList><ArticleId IdType="pubmed">29163494</ArticleId></ArticleIdList></Reference><Reference><Citation>Klin Wochenschr. 1974 Jun 1;52(11):511-5</Citation><ArticleIdList><ArticleId IdType="pubmed">4853392</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26194757</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jan;73(1 Pt 2):016102</Citation><ArticleIdList><ArticleId IdType="pubmed">16486211</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Biol Med. 1960;3:447-58</Citation><ArticleIdList><ArticleId IdType="pubmed">13806209</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2013 Nov;13(11):2842-54</Citation><ArticleIdList><ArticleId IdType="pubmed">24020931</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2013 Feb;31(2):166-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23334449</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 2018 Mar;70(3):143-158</Citation><ArticleIdList><ArticleId IdType="pubmed">29260260</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2018 Jan;153(1):31-41</Citation><ArticleIdList><ArticleId IdType="pubmed">28898398</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 Mar 15;198(6):2489-2499</Citation><ArticleIdList><ArticleId IdType="pubmed">28179494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Jul 27;406(6794):378-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10935628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2012 Feb 1;188(3):1333-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22205028</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2015 Nov 25;11(11):e1004503</Citation><ArticleIdList><ArticleId IdType="pubmed">26606115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2016 May;33(5):1147-57</Citation><ArticleIdList><ArticleId IdType="pubmed">26802217</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2015 Jul 21;43(1):132-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26187412</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol Commun. 2017 Nov 25;5(1):88</Citation><ArticleIdList><ArticleId IdType="pubmed">29178933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 2017 Jul;87:12-22</Citation><ArticleIdList><ArticleId IdType="pubmed">28388445</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9875-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24941953</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2011 Jan 21;269(1):1-15</Citation><ArticleIdList><ArticleId IdType="pubmed">20955715</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 Sep;28(9):965-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20802495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra131</Citation><ArticleIdList><ArticleId IdType="pubmed">26290413</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2017 Sep 7;2(17 ):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28878138</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev E. 2016 May;93(5):052418</Citation><ArticleIdList><ArticleId IdType="pubmed">27300934</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2013 Nov;23(11):1874-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23742949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Jan 22;20(2):289-90</Citation><ArticleIdList><ArticleId IdType="pubmed">14734327</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2016 Sep 21;7:372</Citation><ArticleIdList><ArticleId IdType="pubmed">27708645</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2017 Jan 10;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28077404</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2017 Sep 5;20(10 ):2357-2367</Citation><ArticleIdList><ArticleId IdType="pubmed">28877470</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2012 Nov;42(11):2834-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23108932</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):500-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25535378</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Nov 19;163(5):1124-1137</Citation><ArticleIdList><ArticleId IdType="pubmed">26582132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Nov 1;23(21):2947-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17846036</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2015 May 28;16:175</Citation><ArticleIdList><ArticleId IdType="pubmed">26017500</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Jan 23;347(6220):400-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25477212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Mar 22;14 (11):2733-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26972015</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Oct 02;9(9):e108658</Citation><ArticleIdList><ArticleId IdType="pubmed">25275470</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1105-1110</Citation><ArticleIdList><ArticleId IdType="pubmed">28096374</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26150657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2008 Sep 30;338(1-2):67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18706908</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2012 Feb 21;13:79</Citation><ArticleIdList><ArticleId IdType="pubmed">22353141</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Syst Biol. 2011 Feb 10;5:27</Citation><ArticleIdList><ArticleId IdType="pubmed">21310065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2016 Apr;13(4):329-332</Citation><ArticleIdList><ArticleId IdType="pubmed">26950746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2014 Feb;32(2):158-68</Citation><ArticleIdList><ArticleId IdType="pubmed">24441474</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Lett. 2014 Aug 8;113(6):068102</Citation><ArticleIdList><ArticleId IdType="pubmed">25148352</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2016 Jun 03;8(1):60</Citation><ArticleIdList><ArticleId IdType="pubmed">27255379</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014;15(12):550</Citation><ArticleIdList><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29493356</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>A Neural-Network-Based Approach to Personalize Insulin Bolus Calculation Using Continuous Glucose Monitoring.</ArticleTitle><Pagination><MedlinePgn>265-272</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1932296818759558</ELocationID><Abstract><AbstractText Label="BACKGROUND">In type 1 diabetes (T1D) therapy, the calculation of the meal insulin bolus is performed according to a standard formula (SF) exploiting carbohydrate intake, carbohydrate-to-insulin ratio, correction factor, insulin on board, and target glucose. Recently, some approaches were proposed to account for preprandial glucose rate of change (ROC) in the SF, including those by Scheiner and by Pettus and Edelman. Here, the aim is to develop a new approach, based on neural networks (NN), to optimize and personalize the bolus calculation using continuous glucose monitoring information and some easily accessible patient parameters.</AbstractText><AbstractText Label="METHOD">The UVa/Padova T1D Simulator was used to simulate data of 100 virtual adults in a single-meal noise-free scenario with different conditions in terms of meal amount and preprandial blood glucose and ROC values. An NN was trained to learn the optimal insulin dose using the SF parameters, ROC, body weight, insulin pump basal infusion rate and insulin sensitivity as features. The performance of the NN for meal bolus calculation was assessed by blood glucose risk index (BGRI) and compared to the methods by Scheiner and by Pettus and Edelman.</AbstractText><AbstractText Label="RESULTS">The NN approach brings to a small but statistically significant ( P &lt; .001) reduction of BGRI value, equal to 0.37, 0.23, and 0.20 versus SF, Scheiner, and Pettus and Edelman, respectively.</AbstractText><AbstractText Label="CONCLUSION">This preliminary study showed the potentiality of using NNs for the personalization and optimization of the meal insulin bolus calculation. Future work will deal with more realistic scenarios including technological and physiological/behavioral sources of variability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cappon</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4358-9268</Identifier><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marturano</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Facchinetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparacino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>1 Department of Information Engineering, University of Padova, Padova, PD, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bolus calculator</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword><Keyword MajorTopicYN="Y">neural network</Keyword><Keyword MajorTopicYN="Y">nonadjunctive use</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29493356</ArticleId><ArticleId IdType="doi">10.1177/1932296818759558</ArticleId><ArticleId IdType="pmc">PMC5851237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2014 Jan 1;8(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24876534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jul;11(4):724-735</Citation><ArticleIdList><ArticleId IdType="pubmed">28299958</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Aug;18(8):472-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27512826</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2003;5(3):365-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12828818</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Aug 29;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28866479</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2015 Jan;17(1):1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25531427</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">25416850</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24</Citation><ArticleIdList><ArticleId IdType="pubmed">27979889</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Mar;9(2):209-14</Citation><ArticleIdList><ArticleId IdType="pubmed">25370149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):132-44</Citation><ArticleIdList><ArticleId IdType="pubmed">20167177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Aug 14;10 (1):50-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26275643</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 May;16(5):277-83</Citation><ArticleIdList><ArticleId IdType="pubmed">24758729</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):160-164</Citation><ArticleIdList><ArticleId IdType="pubmed">27630249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Sep 01;6(5):990-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23063023</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2018 Mar;65(3):587-595</Citation><ArticleIdList><ArticleId IdType="pubmed">28541194</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Meas. 2004 Aug;25(4):905-20</Citation><ArticleIdList><ArticleId IdType="pubmed">15382830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1047-57</Citation><ArticleIdList><ArticleId IdType="pubmed">20144418</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2017 Jan;11(1):138-147</Citation><ArticleIdList><ArticleId IdType="pubmed">27530720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2016 Dec 09;16(12 ):</Citation><ArticleIdList><ArticleId IdType="pubmed">27941663</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Pract. 2008 Dec;14(9):1095-101</Citation><ArticleIdList><ArticleId IdType="pubmed">19158048</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Sep;8(5):1035-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24876436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):44-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2016 Nov;18(11):694-704</Citation><ArticleIdList><ArticleId IdType="pubmed">27860496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29486148</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3492</ISSN><JournalIssue CitedMedium="Internet"><Volume>481</Volume><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinica chimica acta; international journal of clinical chemistry</Title><ISOAbbreviation>Clin Chim Acta</ISOAbbreviation></Journal><ArticleTitle>Glycomics meets artificial intelligence - Potential of glycan analysis for identification of seropositive and seronegative rheumatoid arthritis patients revealed.</ArticleTitle><Pagination><MedlinePgn>49-55</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0009-8981(18)30100-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cca.2018.02.031</ELocationID><Abstract><AbstractText>In this study, one hundred serum samples from healthy people and patients with rheumatoid arthritis (RA) were analyzed. Standard immunoassays for detection of 10 different RA markers and analysis of glycan markers on antibodies in 10 different assay formats with several lectins were applied for each serum sample. A dataset containing 2000 data points was data mined using artificial neural networks (ANN). We identified key RA markers, which can discriminate between healthy people and seropositive RA patients (serum containing autoantibodies) with accuracy of 83.3%. Combination of RA markers with glycan analysis provided much better discrimination accuracy of 92.5%. Immunoassays completely failed to identify seronegative RA patients (serum not containing autoantibodies), while glycan analysis correctly identified 43.8% of these patients. Further, we revealed other critical parameters for successful glycan analysis such as type of a sample, format of analysis and orientation of captured antibodies for glycan analysis.</AbstractText><CopyrightInformation>Copyright .. 2018 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chocholova</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertok</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic. Electronic address: tomas.bertok@savba.sk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jane</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorencova</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holazova</LastName><ForeName>Alena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belicka</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belicky</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mislovicova</LastName><ForeName>Danica</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vikartovska</LastName><ForeName>Alica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imrich</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomedical Research Center, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 05, Slovak Republic; National Institute of Rheumatic Diseases, N..bre..ie I. Krasku 4, 921 12 Pie..t'any, Slovak Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasak</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Advanced Materials, Qatar University, Doha 2713, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tkac</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Slovak Academy of Sciences, Dubravska Cesta 9, Bratislava 845 38, Slovak Republic. Electronic address: jan.tkac@savba.sk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>311532</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Chim Acta</MedlineTA><NlmUniqueID>1302422</NlmUniqueID><ISSNLinking>0009-8981</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>9009-79-4</RegistryNumber><NameOfSubstance UI="D012217">Rheumatoid Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054794" MajorTopicYN="Y">Glycomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012217" MajorTopicYN="N">Rheumatoid Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Feedforward artificial neural network</Keyword><Keyword MajorTopicYN="N">Glycan</Keyword><Keyword MajorTopicYN="N">Glycoprotein</Keyword><Keyword MajorTopicYN="N">Immunoassay</Keyword><Keyword MajorTopicYN="N">Lectin</Keyword><Keyword MajorTopicYN="N">Machine learning algorithm</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29486148</ArticleId><ArticleId IdType="pii">S0009-8981(18)30100-1</ArticleId><ArticleId IdType="doi">10.1016/j.cca.2018.02.031</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29468833</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data.</ArticleTitle><Pagination><MedlinePgn>690-701</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.40428</ELocationID><Abstract><AbstractText Label="OBJECTIVE">In this study, we sought to refine histologic scoring of rheumatoid arthritis (RA) synovial tissue by training with gene expression data and machine learning.</AbstractText><AbstractText Label="METHODS">Twenty histologic features were assessed in 129 synovial tissue samples (n = 123 RA patients and n = 6 osteoarthritis [OA] patients). Consensus clustering was performed on gene expression data from a subset of 45 synovial samples. Support vector machine learning was used to predict gene expression subtypes, using histologic data as the input. Corresponding clinical data were compared across subtypes.</AbstractText><AbstractText Label="RESULTS">Consensus clustering of gene expression data revealed 3 distinct synovial subtypes, including a high inflammatory subtype characterized by extensive infiltration of leukocytes, a low inflammatory subtype characterized by enrichment in pathways including transforming growth factor .., glycoproteins, and neuronal genes, and a mixed subtype. Machine learning applied to histologic features, with gene expression subtypes serving as labels, generated an algorithm for the scoring of histologic features. Patients with the high inflammatory synovial subtype exhibited higher levels of markers of systemic inflammation and autoantibodies. C-reactive protein (CRP) levels were significantly correlated with the severity of pain in the high inflammatory subgroup but not in the others.</AbstractText><AbstractText Label="CONCLUSION">Gene expression analysis of RA and OA synovial tissue revealed 3 distinct synovial subtypes. These labels were used to generate a histologic scoring algorithm in which the histologic scores were found to be associated with parameters of systemic inflammation, including the erythrocyte sedimentation rate, CRP level, and autoantibody levels. Comparison of gene expression patterns to clinical features revealed a potentially clinically important distinction: mechanisms of pain may differ in patients with different synovial subtypes.</AbstractText><CopyrightInformation>.. 2018, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orange</LastName><ForeName>Dana E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0001-9859-7199</Identifier><AffiliationInfo><Affiliation>Hospital for Special Surgery, The Rockefeller University, and New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agius</LastName><ForeName>Phaedra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiCarlo</LastName><ForeName>Edward F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robine</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiger</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szymonifka</LastName><ForeName>Jackie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirza</LastName><ForeName>Serene</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figgie</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivashkiv</LastName><ForeName>Lionel B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernis</LastName><ForeName>Alessandra B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Caroline S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>The Rockefeller University Hospital, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Mayu O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>The Rockefeller University and New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darnell</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>The Rockefeller University and New York Genome Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingampali</LastName><ForeName>Nithya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravallese</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Massachusetts Memorial Medical Center, Worcester.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network</CollectiveName></Author><Author ValidYN="Y"><LastName>Bykerk</LastName><ForeName>Vivian P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donlin</LastName><ForeName>Laura T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Hospital for Special Surgery, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UH2 AR067685</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR046713</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM2 AR067678</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI046712</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AR066063</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067681</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067688</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067689</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067690</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067677</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067694</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067679</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI044938</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067676</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH2 AR067691</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Rheumatol. 2018 Jul;14(7):388-390</RefSource><PMID Version="1">29752460</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="Y">Sequence Analysis, RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013583" MajorTopicYN="N">Synovial Membrane</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29468833</ArticleId><ArticleId IdType="doi">10.1002/art.40428</ArticleId><ArticleId IdType="pmc">PMC6336443</ArticleId><ArticleId IdType="mid">NIHMS1005628</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pain. 2014 Mar;155(3):606-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24342464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2003 Apr;62(4):303-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12634226</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Rheumatol. 2010 Sep;69(7):644-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20213088</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1999 Jan 29;274(5):3215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9915862</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(5):e35296</Citation><ArticleIdList><ArticleId IdType="pubmed">22662108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1988 Apr;47(4):300-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3259125</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2003;4(5):P3</Citation><ArticleIdList><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Rheumatol. 2011 Aug;25(4):509-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22137921</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2014;16(2):R90</Citation><ArticleIdList><ArticleId IdType="pubmed">25167216</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2017 Jun;76(6):960-977</Citation><ArticleIdList><ArticleId IdType="pubmed">28264816</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pain. 2014 Feb;15(2):188-96</Citation><ArticleIdList><ArticleId IdType="pubmed">24212069</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4639-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22383561</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2001 May 11;303(3):149-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11323107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Feb 23;9(1):789</Citation><ArticleIdList><ArticleId IdType="pubmed">29476097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2013 Feb;16(2):166-73</Citation><ArticleIdList><ArticleId IdType="pubmed">23292679</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jan;58(1):46-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18163520</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jun;58(6):1582-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18512774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1970 Sep;29(5):524-32</Citation><ArticleIdList><ArticleId IdType="pubmed">4097692</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2013 May;25(3):334-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23492740</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Med (Zagreb). 2012;22(3):276-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23092060</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopade. 2006 Aug;35(8):853-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16819616</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2014;15(12):550</Citation><ArticleIdList><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Jun;62(6):1602-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20178127</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroreport. 2000 May 15;11(7):1417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">10841349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Feb 1;542(7639):110-114</Citation><ArticleIdList><ArticleId IdType="pubmed">28150777</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Mol Neurosci. 2016 Dec 23;9:155</Citation><ArticleIdList><ArticleId IdType="pubmed">28066179</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Nov;58(11):3439-49</Citation><ArticleIdList><ArticleId IdType="pubmed">18975306</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoarthritis Cartilage. 2007 May;15(5):516-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17157039</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurosci. 2008 Feb;27(3):559-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18279309</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1985 Mar;59(3):529-38</Citation><ArticleIdList><ArticleId IdType="pubmed">3886218</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2012 Dec 6;225:88-104</Citation><ArticleIdList><ArticleId IdType="pubmed">22982106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Jan 1;29(1):15-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Histopathology. 2010 Sep;57(3):436-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20840673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Feb 23;9(1):791</Citation><ArticleIdList><ArticleId IdType="pubmed">29476078</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2007 Sep;3(9):1724-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17907809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2012 Nov;71(11):1888-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22736099</ArticleId></ArticleIdList></Reference><Reference><Citation>J Reticuloendothel Soc. 1965 Dec;2(5):420-36</Citation><ArticleIdList><ArticleId IdType="pubmed">5328155</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2015 Aug 27;16:226</Citation><ArticleIdList><ArticleId IdType="pubmed">26311062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 1997;17(4):169-74</Citation><ArticleIdList><ArticleId IdType="pubmed">9440148</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2016 Jan 20;18:19</Citation><ArticleIdList><ArticleId IdType="pubmed">26792343</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Nov;60(11):3217-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19877042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29380079</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6792</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>05</Month></PubDate></JournalIssue><Title>Brain topography</Title><ISOAbbreviation>Brain Topogr</ISOAbbreviation></Journal><ArticleTitle>Machine Learning EEG to Predict Cognitive Functioning and Processing Speed Over a 2-Year Period in Multiple Sclerosis Patients and Controls.</ArticleTitle><Pagination><MedlinePgn>346-363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10548-018-0620-4</ELocationID><Abstract><AbstractText>Event-related potentials (ERPs) show promise to be objective indicators of cognitive functioning. The aim of the study was to examine if ERPs recorded during an oddball task would predict cognitive functioning and information processing speed in Multiple Sclerosis (MS) patients and controls at the individual level. Seventy-eight participants (35 MS patients, 43 healthy age-matched controls) completed visual and auditory 2- and 3-stimulus oddball tasks with 128-channel EEG, and a neuropsychological battery, at baseline (month 0) and at Months 13 and 26. ERPs from 0 to 700..ms and across the whole scalp were transformed into 1728 individual spatio-temporal datapoints per participant. A machine learning method that included penalized linear regression used the entire spatio-temporal ERP to predict composite scores of both cognitive functioning and processing speed at baseline (month 0), and months 13 and 26. The results showed ERPs during the visual oddball tasks could predict cognitive functioning and information processing speed at baseline and a year later in a sample of MS patients and healthy controls. In contrast, ERPs during auditory tasks were not predictive of cognitive performance. These objective neurophysiological indicators of cognitive functioning and processing speed, and machine learning methods that can interrogate high-dimensional data, show promise in outcome prediction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiiski</LastName><ForeName>Hanni</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Psychology and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jollans</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Psychology and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnchadha</LastName><ForeName>Se..n ..</ForeName><Initials>S..</Initials><AffiliationInfo><Affiliation>UCD School of Psychology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Hugh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Engineering, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lonergan</LastName><ForeName>R..is..n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Siobh..n</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Marie Claire</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>UCD School of Psychology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bramham</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UCD School of Psychology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCD School of Psychology, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tubridy</LastName><ForeName>Niall</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>School of Engineering, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trinity Centre for Bioengineering, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2790-7281</Identifier><AffiliationInfo><Affiliation>School of Psychology and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland. robert.whelan@tcd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland. robert.whelan@tcd.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Topogr</MedlineTA><NlmUniqueID>8903034</NlmUniqueID><ISSNLinking>0896-0267</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012535" MajorTopicYN="N">Scalp</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Cognitive function</Keyword><Keyword MajorTopicYN="Y">Electroencephalography</Keyword><Keyword MajorTopicYN="Y">Longitudinal</Keyword><Keyword MajorTopicYN="Y">Machine learning</Keyword><Keyword MajorTopicYN="Y">Multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">Oddball paradigm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29380079</ArticleId><ArticleId IdType="doi">10.1007/s10548-018-0620-4</ArticleId><ArticleId IdType="pii">10.1007/s10548-018-0620-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29373849</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2154-2317</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><MedlineDate>2018 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>IEEE pulse</Title><ISOAbbreviation>IEEE Pulse</ISOAbbreviation></Journal><ArticleTitle>Automated Insulin Delivery: Taking the Guesswork out of Diabetes Management.</ArticleTitle><Pagination><MedlinePgn>8-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/MPUL.2017.2772685</ELocationID><Abstract><AbstractText>For individuals with Type 1 or insulin-requiring Type 2 diabetes, new technology may offer something they desperately need, but is now nigh impossible: the ability to maintain ideal blood glucose levels all day, every day.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mertz</LastName><ForeName>Leslie</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Pulse</MedlineTA><NlmUniqueID>101541727</NlmUniqueID><ISSNLinking>2154-2287</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001698" MajorTopicYN="Y">Biomedical Engineering</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="Y">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007332" MajorTopicYN="Y">Insulin Infusion Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="N">Mobile Applications</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373849</ArticleId><ArticleId IdType="doi">10.1109/MPUL.2017.2772685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">29360996</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1367-4811</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>06</Month><Day>01</Day></PubDate></JournalIssue><Title>Bioinformatics (Oxford, England)</Title><ISOAbbreviation>Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>Feature specific quantile normalization enables cross-platform classification of molecular subtypes using gene expression data.</ArticleTitle><Pagination><MedlinePgn>1868-1874</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/bty026</ELocationID><Abstract><AbstractText Label="Motivation">Molecular subtypes of cancers and autoimmune disease, defined by transcriptomic profiling, have provided insight into disease pathogenesis, molecular heterogeneity and therapeutic responses. However, technical biases inherent to different gene expression profiling platforms present a unique problem when analyzing data generated from different studies. Currently, there is a lack of effective methods designed to eliminate platform-based bias. We present a method to normalize and classify RNA-seq data using machine learning classifiers trained on DNA microarray data and molecular subtypes in two datasets: breast invasive carcinoma (BRCA) and colorectal cancer (CRC).</AbstractText><AbstractText Label="Results">Multiple analyses show that feature specific quantile normalization (FSQN) successfully removes platform-based bias from RNA-seq data, regardless of feature scaling or machine learning algorithm. We achieve up to 98% accuracy for BRCA data and 97% accuracy for CRC data in assigning molecular subtypes to RNA-seq data normalized using FSQN and a support vector machine trained exclusively on DNA microarray data. We find that maximum accuracy was achieved when normalizing RNA-seq datasets that contain at least 25 samples. FSQN allows comparison of RNA-seq data to existing DNA microarray datasets. Using these techniques, we can successfully leverage information from existing gene expression data in new analyses despite different platforms used for gene expression profiling.</AbstractText><AbstractText Label="Availability and implementation">FSQN has been submitted as an R package to CRAN. All code used for this study is available on Github (https://github.com/jenniferfranks/FSQN).</AbstractText><AbstractText Label="Contact">michael.l.whitfield@dartmouth.edu.</AbstractText><AbstractText Label="Supplementary information">Supplementary data are available at Bioinformatics online.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franks</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Molecular and Systems Biology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Guoshuai</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitfield</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Molecular and Systems Biology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, 03756, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AR061271</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AR060780</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioinformatics</MedlineTA><NlmUniqueID>9808944</NlmUniqueID><ISSNLinking>1367-4803</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29360996</ArticleId><ArticleId IdType="pii">4816109</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/bty026</ArticleId><ArticleId IdType="pmc">PMC5972664</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Mach Learn Res. 2012 Apr;13:1059-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">26834510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Aug 04;12:323</Citation><ArticleIdList><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>PeerJ. 2016 Jan 21;4:e1621</Citation><ArticleIdList><ArticleId IdType="pubmed">26844019</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Mar 10;27(8):1160-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19204204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Aug 17;406(6797):747-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10963602</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res. 2015 Feb 26;17:29</Citation><ArticleIdList><ArticleId IdType="pubmed">25849221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2013 Nov 15;29(22):2877-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23958724</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12011421</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Jan 22;19(2):185-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12538238</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2010;11(3):R25</Citation><ArticleIdList><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008 Jul 16;3(7):e2696</Citation><ArticleIdList><ArticleId IdType="pubmed">18648520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Nov;21(11):1350-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26457759</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 May 12;10(5):e0126545</Citation><ArticleIdList><ArticleId IdType="pubmed">25966034</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2012 Sep 12;13:472</Citation><ArticleIdList><ArticleId IdType="pubmed">22971201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Oct 4;490(7418):61-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23000897</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jan 16;9(1):e78644</Citation><ArticleIdList><ArticleId IdType="pubmed">24454679</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 20;8(8):e71462</Citation><ArticleIdList><ArticleId IdType="pubmed">23977046</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11553815</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jun 7;295(21):2492-502</Citation><ArticleIdList><ArticleId IdType="pubmed">16757721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29238346</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Generating a Tolerogenic Cell Therapy Knowledge Graph from Literature.</ArticleTitle><Pagination><MedlinePgn>1656</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2017.01656</ELocationID><Abstract><AbstractText>Tolerogenic cell therapies provide an alternative to conventional immunosuppressive treatments of autoimmune disease and address, among other goals, the rejection of organ or stem cell transplants. Since various methodologies can be followed to develop tolerogenic therapies, it is important to be aware and up to date on all available studies that may be relevant to their improvement. Recently, knowledge graphs have been proposed to link various sources of information, using text mining techniques. Knowledge graphs facilitate the automatic retrieval of information about the topics represented in the graph. The objective of this work was to automatically generate a knowledge graph for tolerogenic cell therapy from biomedical literature. We developed a system, ICRel, based on machine learning to extract relations between cells and cytokines from abstracts. Our system retrieves related documents from PubMed, annotates each abstract with cell and cytokine named entities, generates the possible combinations of cell-cytokine pairs cooccurring in the same sentence, and identifies meaningful relations between cells and cytokines. The extracted relations were used to generate a knowledge graph, where each edge was supported by one or more documents. We obtained a graph containing 647 cell-cytokine relations, based on 3,264 abstracts. The modules of ICRel were evaluated with cross-validation and manual evaluation of the relations extracted. The relation extraction module obtained an F-measure of 0.789 in a reference database, while the manual evaluation obtained an accuracy of 0.615. Even though the knowledge graph is based on information that was already published in other articles about immunology, the system we present is more efficient than the laborious task of manually reading all the literature to find indirect or implicit relations. The ICRel graph will help experts identify implicit relations that may not be evident in published studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamurias</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>LaSIGE, Faculdade de Ci..ncias, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Jo..o D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>LaSIGE, Faculdade de Ci..ncias, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Luka A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>BioISI: Biosystems &amp; Integrative Sciences Institute, Faculdade de Ci..ncias, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couto</LastName><ForeName>Francisco M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>LaSIGE, Faculdade de Ci..ncias, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">knowledge graph</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">text mining</Keyword><Keyword MajorTopicYN="N">tolerogenic therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29238346</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2017.01656</ArticleId><ArticleId IdType="pmc">PMC5712582</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Bioinformatics. 2012 Jan 30;13:17</Citation><ArticleIdList><ArticleId IdType="pubmed">22289351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vet Med Sci. 2015 Aug;77(8):1017-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25819543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2007;2(10):2366-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17947979</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368</Citation><ArticleIdList><ArticleId IdType="pubmed">27924014</ArticleId></ArticleIdList></Reference><Reference><Citation>Histol Histopathol. 2016 Sep;31(9):1011-27</Citation><ArticleIdList><ArticleId IdType="pubmed">26864661</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2006 Sep 1;108(5):1435-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16684955</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2007 Oct;25(10):1119-26</Citation><ArticleIdList><ArticleId IdType="pubmed">17921997</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cheminform. 2015 Jan 19;7(Suppl 1 Text mining for chemistry and the CHEMDNER track):S13</Citation><ArticleIdList><ArticleId IdType="pubmed">25810770</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2017 Jan;187(1):113-123</Citation><ArticleIdList><ArticleId IdType="pubmed">27667787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2005 Jan 1;33(Database issue):D54-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15608257</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2015 Dec;146(4):547-56</Citation><ArticleIdList><ArticleId IdType="pubmed">26458493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2009;:439-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19209721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Immunol Res. 2016 May;4(5):441-51</Citation><ArticleIdList><ArticleId IdType="pubmed">26896171</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D7-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24259429</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2017 May;137(5):1126-1134</Citation><ArticleIdList><ArticleId IdType="pubmed">28132854</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2008 Oct;41(5):706-16</Citation><ArticleIdList><ArticleId IdType="pubmed">18472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Med (Zagreb). 2012;22(3):276-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23092060</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2316-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26404487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 Aug;7(8):610-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17627284</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Jan 05;12:6</Citation><ArticleIdList><ArticleId IdType="pubmed">21208450</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):269-85</Citation><ArticleIdList><ArticleId IdType="pubmed">25990434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Med Libr Assoc. 1990 Jan;78(1):29-37</Citation><ArticleIdList><ArticleId IdType="pubmed">2403828</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Reprod Immunol. 2015 Oct;74(4):333-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26118309</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2016 Apr 15;12(4):e1005553</Citation><ArticleIdList><ArticleId IdType="pubmed">27082754</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2013 May;172(2):148-57</Citation><ArticleIdList><ArticleId IdType="pubmed">23574312</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2015 Nov;45(11):3140-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26179759</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bioinform Comput Biol. 2010 Feb;8(1):163-79</Citation><ArticleIdList><ArticleId IdType="pubmed">20183881</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Mar 6;12 (3):e0171929</Citation><ArticleIdList><ArticleId IdType="pubmed">28263989</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2001 Jan 1;166(1):633-41</Citation><ArticleIdList><ArticleId IdType="pubmed">11123347</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2016 Apr 15;196(8):3341-53</Citation><ArticleIdList><ArticleId IdType="pubmed">26976955</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2015 Sep;64(9):1368-78</Citation><ArticleIdList><ArticleId IdType="pubmed">25134787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29234597</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>A supervised framework with intensity subtraction and deformation field features for the detection of new T2-w lesions in multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>607-615</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(17)30295-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2017.11.015</ELocationID><Abstract><AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Longitudinal magnetic resonance imaging (MRI) analysis has an important role in multiple sclerosis diagnosis and follow-up. The presence of new T2-w lesions on brain MRI scans is considered a prognostic and predictive biomarker for the disease. In this study, we propose a supervised approach for detecting new T2-w lesions using features from image intensities, subtraction values, and deformation fields (DF).</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">One year apart multi-channel brain MRI scans were obtained for 60 patients, 36 of them with new T2-w lesions. Images from both temporal points were preprocessed and co-registered. Afterwards, they were registered using multi-resolution affine registration, allowing their subtraction. In particular, the DFs between both images were computed with the Demons non-rigid registration algorithm. Afterwards, a logistic regression model was trained with features from image intensities, subtraction values, and DF operators. We evaluated the performance of the model following a leave-one-out cross-validation scheme.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">In terms of detection, we obtained a mean Dice similarity coefficient of 0.77 with a true-positive rate of 74.30% and a false-positive detection rate of 11.86%. In terms of segmentation, we obtained a mean Dice similarity coefficient of 0.56. The performance of our model was significantly higher than state-of-the-art methods.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">The performance of the proposed method shows the benefits of using DF operators as features to train a supervised learning model. Compared to other methods, the proposed model decreases the number of false-positives while increasing the number of true-positives, which is relevant for clinical settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain; Computer Science Department, Faculty of Computers and Information, Assiut University, Egypt. Electronic address: msalem@eia.udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabezas</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valverde</LastName><ForeName>Sergi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pareto</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Dept of Radiology, Vall d'Hebron University Hospital, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvi</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovira</LastName><ForeName>..lex</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Dept of Radiology, Vall d'Hebron University Hospital, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llad..</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Research Institute of Computer Vision and Robotics, University of Girona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Automatic new lesion detection</Keyword><Keyword MajorTopicYN="N">Brain</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29234597</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2017.11.015</ArticleId><ArticleId IdType="pii">S2213-1582(17)30295-4</ArticleId><ArticleId IdType="pmc">PMC5716954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuroradiology. 2012 Aug;54(8):787-807</Citation><ArticleIdList><ArticleId IdType="pubmed">22179659</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2016 Oct;37(10):1816-1823</Citation><ArticleIdList><ArticleId IdType="pubmed">27282863</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 1998 Sep;2(3):243-60</Citation><ArticleIdList><ArticleId IdType="pubmed">9873902</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1999 May;18(5):429-41</Citation><ArticleIdList><ArticleId IdType="pubmed">10416804</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroinformatics. 2014 Jul;12(3):365-79</Citation><ArticleIdList><ArticleId IdType="pubmed">24338728</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2013 Sep;9(9):504-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23897407</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2011 Sep;30(9):1617-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21880566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2016 Mar;15(3):292-303</Citation><ArticleIdList><ArticleId IdType="pubmed">26822746</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2013 Jan;34(1):68-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22766673</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2010 Apr;255(1):154-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2009 Feb;250(2):506-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19037018</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Neurol Sci. 2013 May;40(3):307-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23603165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 May;67(5):667-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20437564</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2017 Jan;35:446-457</Citation><ArticleIdList><ArticleId IdType="pubmed">27598104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2015 Aug;11(8):471-82</Citation><ArticleIdList><ArticleId IdType="pubmed">26149978</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2002 Jun;6(2):163-79</Citation><ArticleIdList><ArticleId IdType="pubmed">12045002</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2000 Feb;19(2):143-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10784285</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Jul;115(3):147-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24813718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2009 Jul;15(7):848-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19542263</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2013 Aug;32(8):1490-503</Citation><ArticleIdList><ArticleId IdType="pubmed">23613032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2015 Jan;8(1):3-13</Citation><ArticleIdList><ArticleId IdType="pubmed">25584069</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2003 Oct;20(2):643-56</Citation><ArticleIdList><ArticleId IdType="pubmed">14568441</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2015 Jul;138(Pt 7):1863-74</Citation><ArticleIdList><ArticleId IdType="pubmed">25902415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Apr;20(5):566-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23999607</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2014 May;56(5):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24590302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2013 Apr;19(5):605-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23012253</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2013 Mar 1;70(3):338-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23599930</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29234049</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>12</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A Novel Classification Indicator of Type 1 and Type 2 Diabetes in China.</ArticleTitle><Pagination><MedlinePgn>17420</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-17433-8</ELocationID><Abstract><AbstractText>Because of the differences of treatment, it is extremely important to classify the types of diabetes, especially for the diagnosis made by clinician. In this study, we proposed a novel scheme calculating an indicator of classifying diabetes, which contains two stages: the first is a model of feature extraction, 17 features are automatically extracted from the curve of glucose concentration acquired by continuous glucose monitoring system (CGM); the second is a model of diabetes parameter regression based on an ensemble learning algorithm named double-Class AdaBoost. 1050 curves of glucose concentration of type 1 and type 2 diabetics were acquired at the Department of Endocrinology in People's Hospital of Zhengzhou University China, and an upper threshold .. was set to 7...mmol/L, 8...mmol/L, 9...mmol/L, 10...mmo/L, and 11...mmol/L respectively according to the guideline of WHO. The experiments show that the coincidence rate of our scheme and clinical diagnosis is 90.3%. The novel indicator extends the criteria in diagnosing types of diabetes and provides doctors with a scalar to classify diabetes of type 1 and type 2.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yannian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Information Engineering, Zhengzhou University, 450001, Zhengzhou, Henan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Information Engineering, Zhengzhou University, 450001, Zhengzhou, Henan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ruoxi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Information Engineering, Zhengzhou University, 450001, Zhengzhou, Henan, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhongning</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Arkansas for Medical Sciences, 72205, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Jinlei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Fifth Affiliated Hospital, Zhengzhou University, 450052, Zhengzhou, Henan, P.R. China. yuanjinliea@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Quanzhong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, People's Hospital of Zhengzhou University, 450003, Zhengzhou, Henan, P.R. China. loicdf@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017440" MajorTopicYN="N">Photoperiod</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29234049</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-17433-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-17433-8</ArticleId><ArticleId IdType="pmc">PMC5727131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can J Diabetes. 2013 Oct;37(5):305-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24500556</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2008 Jan;51(1):183-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17994218</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:6837052</Citation><ArticleIdList><ArticleId IdType="pubmed">27314034</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2012 Aug;48(8):1892-1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Ethnopharmacol. 2004 May;92(1):1-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15099842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29163505</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-3224</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>IL17eScan: A Tool for the Identification of Peptides Inducing IL-17 Response.</ArticleTitle><Pagination><MedlinePgn>1430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2017.01430</ELocationID><Abstract><AbstractText>IL-17 cytokines are pro-inflammatory cytokines and are crucial in host defense against various microbes. Induction of these cytokines by microbial antigens has been investigated in the case of ischemic brain injury, gingivitis, candidiasis, autoimmune myocarditis, etc. In this study, we have investigated the ability of amino acid sequence of antigens to induce IL-17 response using machine-learning approaches. A total of 338 IL-17-inducing and 984 IL-17 non-inducing peptides were retrieved from Immune Epitope Database. 80% of the data were randomly selected as training dataset and rest 20% as validation dataset. To predict the IL-17-inducing ability of peptides/protein antigens, different sequence-based machine-learning models were developed. The performance of support vector machine (SVM) and random forest (RF) was compared with different parameters to predict IL-17-inducing epitopes (IIEs). The dipeptide composition-based SVM-model displayed an accuracy of 82.4% with Matthews correlation coefficient...=...0.62 at polynomial (<i>t</i>...=...1) kernel on 10-fold cross-validation and outperformed RF. Amino acid residues Leu, Ser, Arg, Asn, and Phe and dipeptides LL, SL, LK, IL, LI, NL, LR, FK, SF, and LE are abundant in IIEs. The present tool helps in the identification of IIEs using machine-learning approaches. The induction of IL-17 plays an important role in several inflammatory diseases, and identification of such epitopes would be of great help to the immunologists. It is freely available at http://metagenomics.iiserb.ac.in/IL17eScan/ and http://metabiosys.iiserb.ac.in/IL17eScan/.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Sudheer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Laboratory, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittal</LastName><ForeName>Parul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Laboratory, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhu</LastName><ForeName>Midhun K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Laboratory, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vineet K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Laboratory, Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">interleukin-17</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">pro-inflammatory cytokines</Keyword><Keyword MajorTopicYN="N">random forest</Keyword><Keyword MajorTopicYN="N">support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29163505</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2017.01430</ArticleId><ArticleId IdType="pmc">PMC5671494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Rep. 2017 Feb 17;7:42851</Citation><ArticleIdList><ArticleId IdType="pubmed">28211521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Jul 1;177(1):566-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16785554</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2004 Aug 13;22(23-24):3195-204</Citation><ArticleIdList><ArticleId IdType="pubmed">15297074</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Syst Bioinformatics Conf. 2008;7:121-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19642274</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Rheumatol Rep. 2009 Oct;11(5):365-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19772832</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013;14 Suppl 6:S4</Citation><ArticleIdList><ArticleId IdType="pubmed">23735058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D405-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25300482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2016 May;22(5):516-23</Citation><ArticleIdList><ArticleId IdType="pubmed">27019327</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2013 Sep;2(9):e60</Citation><ArticleIdList><ArticleId IdType="pubmed">26038490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16844994</ArticleId></ArticleIdList></Reference><Reference><Citation>Helicobacter. 2008 Dec;13(6):518-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19166417</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v3-11</Citation><ArticleIdList><ArticleId IdType="pubmed">22718924</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2007 Jul 5;363(2):410-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17337285</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2013 Oct 30;8:27</Citation><ArticleIdList><ArticleId IdType="pubmed">24168386</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Sci. 2004 Mar;13(3):596-607</Citation><ArticleIdList><ArticleId IdType="pubmed">14978300</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2013 Dec 05;8:30</Citation><ArticleIdList><ArticleId IdType="pubmed">24304645</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biosci. 2007 Jan;32(1):31-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17426378</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2016 May 20;34:317-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27168241</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 May 07;8(5):e62216</Citation><ArticleIdList><ArticleId IdType="pubmed">23667458</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurobiol. 2013 Dec;22(4):337-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24465150</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2008 Dec;31(4):399-407</Citation><ArticleIdList><ArticleId IdType="pubmed">19008075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2008 May 12;205(5):1063-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18411338</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2002;31(4):205-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12369651</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2014;1184:333-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25048134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 2011;271(2):438-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21939961</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Jun 15;22(12):1536-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16632492</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Dec;68(12):7704-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7525983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Jan 17;201(2):233-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15657292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2010 Oct 6;2(52):52ra72</Citation><ArticleIdList><ArticleId IdType="pubmed">20926833</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 2006 Nov;18(11):1521-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16954167</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2015;1268:143-57</Citation><ArticleIdList><ArticleId IdType="pubmed">25555724</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2012 Dec;86(24):13717-28</Citation><ArticleIdList><ArticleId IdType="pubmed">23055563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Oral Microbiol. 2013 Dec;28(6):452-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23945018</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Nanobioscience. 2004 Dec;3(4):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15631138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W544-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23771147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Jun 5;510(7503):152-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24739972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2005 Nov;6(11):1133-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16200068</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2009 Jan 16;30(1):108-19</Citation><ArticleIdList><ArticleId IdType="pubmed">19144317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2000;9(8):589-93</Citation><ArticleIdList><ArticleId IdType="pubmed">11035433</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2013 Oct;136(Pt 10):2933-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24072484</ArticleId></ArticleIdList></Reference><Reference><Citation>APMIS Suppl. 2013 May;(136):1-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23635385</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2007;409:387-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18450017</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2015 Jul;106(1):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25863333</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2013 Jan 15;190(2):513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23293357</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2009 Aug;157(2):209-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19604260</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Apr 15;9(4):e93907</Citation><ArticleIdList><ArticleId IdType="pubmed">24736651</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2010 Jul 15;185(2):974-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20574004</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2014 Apr;141(4):514-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24138116</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Nov 1;165(9):5332-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11046068</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Infect Dis. 2008 Dec;12(6):526-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19287843</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2012 Jul 02;14(4):R157</Citation><ArticleIdList><ArticleId IdType="pubmed">22747982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29071211</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple..sclerosis..patients and healthy controls.</ArticleTitle><Pagination><MedlinePgn>169-178</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(17)30255-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2017.10.015</ELocationID><Abstract><AbstractText>Myelin imaging is a form of quantitative magnetic resonance imaging (MRI) that measures myelin content and can potentially allow demyelinating diseases such as multiple sclerosis (MS) to be detected earlier. Although focal lesions are the most visible signs of MS pathology on conventional MRI, it has been shown that even tissues that appear normal may exhibit decreased myelin content as revealed by myelin-specific images (i.e., myelin maps). Current methods for analyzing myelin maps typically use global or regional mean myelin measurements to detect abnormalities, but ignore finer spatial patterns that may be characteristic of MS. In this paper, we present a machine learning method to automatically learn, from multimodal MR images, latent spatial features that can potentially improve the detection of MS pathology at early stage. More specifically, 3D image patches are extracted from myelin maps and the corresponding T1-weighted (T1w) MRIs, and are used to learn a latent joint myelin-T1w feature representation via unsupervised deep learning. Using a data set of images from MS patients and healthy controls, a common set of patches are selected via a voxel-wise <i>t</i>-test performed between the two groups. In each MS image, any patches overlapping with focal lesions are excluded, and a feature imputation method is used to fill in the missing values. A feature selection process (LASSO) is then utilized to construct a sparse representation. The resulting normal-appearing features are used to train a random forest classifier. Using the myelin and T1w images of 55 relapse-remitting MS patients and 44 healthy controls in an 11-fold cross-validation experiment, the proposed method achieved an average classification accuracy of 87.9% (SD..=..8.4%), which is higher and more consistent across folds than those attained by regional mean myelin (73.7%, SD..=..13.7%) and T1w measurements (66.7%, SD..=..10.6%), or deep-learned features in either the myelin (83.8%, SD..=..11.0%) or T1w (70.1%, SD..=..13.6%) images alone, suggesting that the proposed method has strong potential for identifying image features that are more sensitive and specific to MS pathology in normal-appearing brain tissues.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Youngjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada; Biomedical Engineering Program, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada. Electronic address: youngjin.yoo@alumni.ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lisa Y W</ForeName><Initials>LYW</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosch</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada; Biomedical Engineering Program, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>David K B</ForeName><Initials>DKB</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolind</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada; Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vavasour</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauscher</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacKay</LastName><ForeName>Alex L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, BC, Canada; Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traboulsee</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Roger C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Program, University of British Columbia, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada; MS/MRI Research Group, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="Y">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Myelin water imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29071211</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2017.10.015</ArticleId><ArticleId IdType="pii">S2213-1582(17)30255-3</ArticleId><ArticleId IdType="pmc">PMC5651626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuroimage. 2014 Nov 1;101:569-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25042445</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1998 Feb;17(1):87-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9617910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2004 Mar;251(3):284-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15015007</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Oct 15;63(1):533-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22776448</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2014 Sep;272(3):832-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24761837</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2006 Jul 1;31(3):968-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322</Citation><ArticleIdList><ArticleId IdType="pubmed">11545704</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2010 Nov;57(11):</Citation><ArticleIdList><ArticleId IdType="pubmed">20601307</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2013;16(Pt 1):614-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24505718</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2014 Jul;18(5):808-18</Citation><ArticleIdList><ArticleId IdType="pubmed">24858570</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 2006 Jul;18(7):1527-54</Citation><ArticleIdList><ArticleId IdType="pubmed">16764513</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2014;17(Pt 2):462-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25485412</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 2012 Jun;67(6):1803-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22012743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 May 28;521(7553):436-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 1994 Jun;31(6):673-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8057820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2014 Apr;35(4):1305-19</Citation><ArticleIdList><ArticleId IdType="pubmed">23417832</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1983 Nov;33(11):1444-52</Citation><ArticleIdList><ArticleId IdType="pubmed">6685237</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2010 Jan;31(1):185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20027586</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Aug 15;62(2):782-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21979382</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Neurol. 2011 Dec 12;11:153</Citation><ArticleIdList><ArticleId IdType="pubmed">22152037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29065906</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study.</ArticleTitle><Pagination><MedlinePgn>244</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-017-1414-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Radiographic progression is reported to be highly heritable in rheumatoid arthritis (RA). However, previous study using genetic loci showed an insufficient accuracy of prediction for radiographic progression. The aim of this study is to identify a biologically relevant prediction model of radiographic progression in patients with RA using a genome-wide association study (GWAS) combined with bioinformatics analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We obtained genome-wide single nucleotide polymorphism (SNP) data for 374 Korean patients with RA using Illumina HumanOmni2.5Exome-8 arrays. Radiographic progression was measured using the yearly Sharp/van der Heijde modified score rate, and categorized in no or severe progression. Significant SNPs for severe radiographic progression from GWAS were mapped on the functional genes and reprioritized by post-GWAS analysis. For robust prediction of radiographic progression, tenfold cross-validation using a support vector machine (SVM) classifier was conducted. Accuracy was used for selection of optimal SNPs set in the Hanyang Bae RA cohort. The performance of our final model was compared with that of other models based on GWAS results and SPOT (one of the post-GWAS analyses) using receiver operating characteristic (ROC) curves. The reliability of our model was confirmed using GWAS data of Caucasian patients with RA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 36,091 significant SNPs with a p value &lt;0.05 from GWAS were reprioritized using post-GWAS analysis and approximately 2700 were identified as SNPs related to RA biological features. The best average accuracy of ten groups was 0.6015 with 85 SNPs, and this increased to 0.7481 when combined with clinical information. In comparisons of the performance of the model, the 0.7872 area under the curve (AUC) in our model was superior to that obtained with GWAS (AUC 0.6586, p value 8.97........10<sup>-5</sup>) or SPOT (AUC 0.7449, p value 0.0423). Our model strategy also showed superior prediction accuracy in Caucasian patients with RA compared with GWAS (p value 0.0049) and SPOT (p value 0.0151).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using various biological functions of SNPs and repeated machine learning, our model could predict severe radiographic progression relevantly and robustly in patients with RA compared with models using only GWAS results or other post-GWAS tools.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Young Bin</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yul</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Youngho</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwangwoo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biology, Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Jeong Ah</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Radiology, Hanyang University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seunghun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Hanyang University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>So-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hye-Soon</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea. lhsberon@hanyang.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Gwan-Su</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. gwansuyi@kaist.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4658-1093</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea. scbae@hanyang.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatic analysis</Keyword><Keyword MajorTopicYN="N">GWAS</Keyword><Keyword MajorTopicYN="N">Post-GWAS analysis</Keyword><Keyword MajorTopicYN="N">Radiographic progression</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29065906</ArticleId><ArticleId IdType="doi">10.1186/s13075-017-1414-x</ArticleId><ArticleId IdType="pii">10.1186/s13075-017-1414-x</ArticleId><ArticleId IdType="pmc">PMC5655942</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Rheum Dis. 2012 May;71(5):707-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22219137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii64-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12379626</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2015 Apr 15;2015:bav028</Citation><ArticleIdList><ArticleId IdType="pubmed">25877637</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2015 May 08;11(5):e1005223</Citation><ArticleIdList><ArticleId IdType="pubmed">25955312</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2000 Jan;27(1):261-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10648051</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(1):e29632</Citation><ArticleIdList><ArticleId IdType="pubmed">22235315</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Oncol. 2010 Nov;49(8):1363-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20192878</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Mar 27;507(7493):462-70</Citation><ArticleIdList><ArticleId IdType="pubmed">24670764</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24411630</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2010 Jan 15;6(1):e1000641</Citation><ArticleIdList><ArticleId IdType="pubmed">20090828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Jan 1;31(1):51-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12519945</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2007 Oct;34(10):3808-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17985626</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Rheum Dis. 2017 Oct;20(10 ):1437-1446</Citation><ArticleIdList><ArticleId IdType="pubmed">28261973</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 20;357(12):1199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e31989</Citation><ArticleIdList><ArticleId IdType="pubmed">22427815</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2006 May;14(5):535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16493445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Jun;45(6):580-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2013 Dec 09;4:280</Citation><ArticleIdList><ArticleId IdType="pubmed">24367376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2017 Jan;13(1):13-24</Citation><ArticleIdList><ArticleId IdType="pubmed">27811914</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2013 Apr 10;518(1):107-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23262349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jul;38(Web Server issue):W201-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20529875</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2008 Nov;35(11):5098-109</Citation><ArticleIdList><ArticleId IdType="pubmed">19070244</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res. 2008;10(2):R34</Citation><ArticleIdList><ArticleId IdType="pubmed">18430221</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2014 Dec;31:51-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25458995</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2015 Feb;27(1):51-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25819567</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(2):e31826</Citation><ArticleIdList><ArticleId IdType="pubmed">22348130</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16381832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Feb 1;28(3):451-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22171328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2015 May;74(5):876-82</Citation><ArticleIdList><ArticleId IdType="pubmed">24431388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2014 Nov;73(11):2038-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23956247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D163-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21071411</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29065657</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2040-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Journal of healthcare engineering</Title><ISOAbbreviation>J Healthc Eng</ISOAbbreviation></Journal><ArticleTitle>Therapy Decision Support Based on Recommender System Methods.</ArticleTitle><Pagination><MedlinePgn>8659460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2017/8659460</ELocationID><Abstract><AbstractText>We present a system for data-driven therapy decision support based on techniques from the field of recommender systems. Two methods for therapy recommendation, namely, <i>Collaborative Recommender</i> and <i>Demographic-based Recommender</i>, are proposed. Both algorithms aim to predict the individual response to different therapy options using diverse patient data and recommend the therapy which is assumed to provide the best outcome for a specific patient and time, that is, consultation. The proposed methods are evaluated using a clinical database incorporating patients suffering from the autoimmune skin disease psoriasis. The <i>Collaborative Recommender</i> proves to generate both better outcome predictions and recommendation quality. However, due to sparsity in the data, this approach cannot provide recommendations for the entire database. In contrast, the <i>Demographic-based Recommender</i> performs worse on average but covers more consultations. Consequently, both methods profit from a combination into an overall recommender system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gr....er</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut f..r Biomedizinische Technik, Technische Universit..t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckert</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Zentrum f..r Evidenzbasierte Gesundheitsversorgung, Universit..tsklinikum Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K..ster</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Zentrum f..r Evidenzbasierte Gesundheitsversorgung, Universit..tsklinikum Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zentrum f..r Evidenzbasierte Gesundheitsversorgung, Universit..tsklinikum Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik f..r Dermatologie, Universit..tsklinikum Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malberg</LastName><ForeName>Hagen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institut f..r Biomedizinische Technik, Technische Universit..t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaunseder</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6114-3142</Identifier><AffiliationInfo><Affiliation>Institut f..r Biomedizinische Technik, Technische Universit..t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Healthc Eng</MedlineTA><NlmUniqueID>101528166</NlmUniqueID><ISSNLinking>2040-2295</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011565" MajorTopicYN="N">Psoriasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>01</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29065657</ArticleId><ArticleId IdType="doi">10.1155/2017/8659460</ArticleId><ArticleId IdType="pmc">PMC5387813</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Environ Res Public Health. 2014 Mar 03;11(3):2580-607</Citation><ArticleIdList><ArticleId IdType="pubmed">24595212</ArticleId></ArticleIdList></Reference><Reference><Citation>JMLR Workshop Conf Proc. 2016 Aug;56:301-318</Citation><ArticleIdList><ArticleId IdType="pubmed">28286600</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Rheumatol. 2014;2014:672714</Citation><ArticleIdList><ArticleId IdType="pubmed">25114683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2012 Feb;27(2):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21789717</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2004 May;31(1):1-27</Citation><ArticleIdList><ArticleId IdType="pubmed">15182844</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2007 Jan-Feb;14(1):29-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17068355</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiss Med Wkly. 2014 Dec 23;144:w14073</Citation><ArticleIdList><ArticleId IdType="pubmed">25668157</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Jt Summits Transl Sci Proc. 2014 Apr 07;2014:206-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25717414</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2015 ;216:300-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26262059</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermatologica. 1978;157(4):238-44</Citation><ArticleIdList><ArticleId IdType="pubmed">357213</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2007 Oct;60(10):1015-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17884595</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2013 Sep;59(1):5-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23684240</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2015 ;210:190-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25991128</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28993124</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2860</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><PubDate><Year>2018</Year><Month>04</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>Learning ensemble classifiers for diabetic retinopathy assessment.</ArticleTitle><Pagination><MedlinePgn>50-63</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0933-3657(17)30059-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.artmed.2017.09.006</ELocationID><Abstract><AbstractText>Diabetic retinopathy is one of the most common comorbidities of diabetes. Unfortunately, the recommended annual screening of the eye fundus of diabetic patients is too resource-consuming. Therefore, it is necessary to develop tools that may help doctors to determine the risk of each patient to attain this condition, so that patients with a low risk may be screened less frequently and the use of resources can be improved. This paper explores the use of two kinds of ensemble classifiers learned from data: fuzzy random forest and dominance-based rough set balanced rule ensemble. These classifiers use a small set of attributes which represent main risk factors to determine whether a patient is in risk of developing diabetic retinopathy. The levels of specificity and sensitivity obtained in the presented study are over 80%. This study is thus a first successful step towards the construction of a personalized decision support system that could help physicians in daily clinical practice.</AbstractText><CopyrightInformation>Copyright .. 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Emran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departament d'Enginyeria Inform..tica i Matem..tiques, Universitat Rovira i Virgili, Tarragona, Spain. Electronic address: emran.saleh@urv.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B..aszczy..ski</LastName><ForeName>Jerzy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Computing Sciences, Pozna.. University of Technology, 60-965 Pozna.., Poland. Electronic address: jerzy.blaszczynski@cs.put.poznan.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departament d'Enginyeria Inform..tica i Matem..tiques, Universitat Rovira i Virgili, Tarragona, Spain. Electronic address: antonio.moreno@urv.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valls</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departament d'Enginyeria Inform..tica i Matem..tiques, Universitat Rovira i Virgili, Tarragona, Spain. Electronic address: aida.valls@urv.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Aroca</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ophthalmic Service, University Hospital Sant Joan de Reus, Institut d'Investigaci.. Sanit..ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus (Tarragona), Spain. Electronic address: pedro.romero@urv.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Riva-Fern..ndez</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ophthalmic Service, University Hospital Sant Joan de Reus, Institut d'Investigaci.. Sanit..ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus (Tarragona), Spain. Electronic address: delariva.sofia@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S..owi..ski</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computing Sciences, Pozna.. University of Technology, 60-965 Pozna.., Poland; Systems Research Institute, Polish Academy of Sciences, 01-447 Warsaw, Poland. Electronic address: roman.slowinski@cs.put.poznan.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="Y">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003930" MajorTopicYN="N">Diabetic Retinopathy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017143" MajorTopicYN="Y">Fuzzy Logic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Class imbalance</Keyword><Keyword MajorTopicYN="Y">Decision support systems</Keyword><Keyword MajorTopicYN="Y">Diabetic retinopathy</Keyword><Keyword MajorTopicYN="Y">Dominance-based rough set approach</Keyword><Keyword MajorTopicYN="Y">Ensemble classifiers</Keyword><Keyword MajorTopicYN="Y">Fuzzy decision trees</Keyword><Keyword MajorTopicYN="Y">Random forest</Keyword><Keyword MajorTopicYN="Y">Rule-based models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28993124</ArticleId><ArticleId IdType="pii">S0933-3657(17)30059-3</ArticleId><ArticleId IdType="doi">10.1016/j.artmed.2017.09.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28973482</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2423</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>12</Month><Day>01</Day></PubDate></JournalIssue><Title>Glycobiology</Title><ISOAbbreviation>Glycobiology</ISOAbbreviation></Journal><ArticleTitle>High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.</ArticleTitle><Pagination><MedlinePgn>1099-1108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/glycob/cwx082</ELocationID><Abstract><AbstractText>Juvenile idiopathic arthritis (JIA) encompasses all forms of chronic idiopathic arthritis that arise before age 16. Previous studies have found JIA to be associated with lower Fc galactosylation of circulating IgG, but the overall spectrum of glycan changes and the net impact on IgG function are unknown. Using ultra performance liquid chromatography (UPLC), we compared IgG glycosylation in 54 subjects with recent-onset untreated JIA with 98 healthy pediatric controls, paired to biophysical profiling of affinity for 20 IgG receptors using a high-throughput multiplexed microsphere assay. Patients with JIA exhibited an increase in hypogalactosylated and hyposialylated IgG glycans, but no change in fucosylation or bisection, together with alteration in the spectrum of IgG ligand binding. Supervised machine learning demonstrated a robust capacity to discriminate JIA subjects from controls using either glycosylation or binding data. The binding signature was driven predominantly by enhanced affinity for Fc receptor like protein 5 (FcRL5), a noncanonical Fc receptor expressed on B cells. Affinity for FcRL5 correlated inversely with galactosylation and sialylation, a relationship confirmed through enzymatic manipulation. These results demonstrate the capacity of combined structural and biophysical IgG phenotyping to define the overall functional impact of IgG glycan changes and implicate FcRL5 as a potential cellular sensor of IgG glycosylation.</AbstractText><CopyrightInformation>.. The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Hao D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Molecular and Cellular Biology Program, Dartmouth College, Hanover, 03755 NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St..ckmann</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin A94 X099, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamczyk</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin A94 X099, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McManus</LastName><ForeName>Ciara A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin A94 X099, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercan</LastName><ForeName>Altan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Ingrid A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudd</LastName><ForeName>Pauline M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin A94 X099, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackerman</LastName><ForeName>Margaret E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Molecular and Cellular Biology Program, Dartmouth College, Hanover, 03755 NH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thayer School of Engineering, Dartmouth College, Hanover, 03755 NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigrovic</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Immunology, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R03 AR061602</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070253</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR065538</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI099435</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 HD051959</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI102691</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Glycobiology</MedlineTA><NlmUniqueID>9104124</NlmUniqueID><ISSNLinking>0959-6658</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C432367">FCRL5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007141">Immunoglobulin Fc Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011961">Receptors, Fc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="Y">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001666" MajorTopicYN="Y">Binding Sites, Antibody</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007141" MajorTopicYN="Y">Immunoglobulin Fc Fragments</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="Y">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011961" MajorTopicYN="Y">Receptors, Fc</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">FcRL5</Keyword><Keyword MajorTopicYN="Y">IgG glycan</Keyword><Keyword MajorTopicYN="Y">IgG receptor binding</Keyword><Keyword MajorTopicYN="Y">juvenile idiopathic arthritis</Keyword><Keyword MajorTopicYN="Y">machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>09</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28973482</ArticleId><ArticleId IdType="pii">4158106</ArticleId><ArticleId IdType="doi">10.1093/glycob/cwx082</ArticleId><ArticleId IdType="pmc">PMC5881781</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>MAbs. 2014 Jul-Aug;6(4):915-27</Citation><ArticleIdList><ArticleId IdType="pubmed">24927273</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2017 Feb 23;2(4):e89703</Citation><ArticleIdList><ArticleId IdType="pubmed">28239652</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Aug 4;313(5787):670-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16888140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1988 Apr 30;1(8592):966-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2896829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 May;37(5):478-85</Citation><ArticleIdList><ArticleId IdType="pubmed">15838509</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2014;382:29-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25116094</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Nov;67(11):2978-89</Citation><ArticleIdList><ArticleId IdType="pubmed">26200652</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1996 Jul;105(1):99-103</Citation><ArticleIdList><ArticleId IdType="pubmed">8697643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Jun 18;377(9783):2138-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21684384</ArticleId></ArticleIdList></Reference><Reference><Citation>Proteomics Clin Appl. 2009 Jan;3(1):106-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21136940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2011 May;10(5):M110.004655</Citation><ArticleIdList><ArticleId IdType="pubmed">21372248</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2012 Mar 05;14(2):R43</Citation><ArticleIdList><ArticleId IdType="pubmed">22390545</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19036920</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13489-94</Citation><ArticleIdList><ArticleId IdType="pubmed">14597715</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1982 May-Jun;9(3):395-401</Citation><ArticleIdList><ArticleId IdType="pubmed">7120235</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2010 Dec 15;185(12):7405-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21068405</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Sep;64(9):3025-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22549726</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1988 May 1;167(5):1731-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3367097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Proteomics. 2011 Oct;10(10):M111.010090</Citation><ArticleIdList><ArticleId IdType="pubmed">21653738</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9770-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17522256</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS. 2005 Mar 4;19(4):381-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15750391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2015 Dec;1362:110-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25964091</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2006 Aug 15;106(2):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16814399</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Nov;54(11):3433-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17075835</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2012 Dec 14;386(1-2):117-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23023091</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Feb;63(2):556-67</Citation><ArticleIdList><ArticleId IdType="pubmed">21280010</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycoconj J. 2012 Jan;29(1):57-66</Citation><ArticleIdList><ArticleId IdType="pubmed">22179780</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 2008 May 1;376(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">18194658</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2007 Mar;92(3):1106-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17200162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Sep 21;3(101):101ra92</Citation><ArticleIdList><ArticleId IdType="pubmed">21937757</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillieres Clin Rheumatol. 1998 May;12(2):191-208</Citation><ArticleIdList><ArticleId IdType="pubmed">9890093</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6123-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8016124</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Sep 15;179(6):4101-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17785849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2016 Jun 3;15(6):1853-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27161864</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):779-89</Citation><ArticleIdList><ArticleId IdType="pubmed">24325898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1991 Sep;50(9):607-10</Citation><ArticleIdList><ArticleId IdType="pubmed">1929582</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmunity. 2002 Sep;35(6):397-401</Citation><ArticleIdList><ArticleId IdType="pubmed">12568120</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Aug;62(8):2239-48</Citation><ArticleIdList><ArticleId IdType="pubmed">20506563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2014 Jun 1;192(11):5031-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24760152</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2012 Jan;91(1):59-67</Citation><ArticleIdList><ArticleId IdType="pubmed">22028333</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Chem. 2013 Sep 17;85(18):8841-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23919734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 2013 Apr;53(4):374-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23070121</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2008 Aug;20(4):471-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18606225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2015 Jan;74(1):234-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24106048</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2015 May 19;11(5):e1004894</Citation><ArticleIdList><ArticleId IdType="pubmed">25993340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2015 Nov 2;125(11):4160-70</Citation><ArticleIdList><ArticleId IdType="pubmed">26436649</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2011;350:89-104</Citation><ArticleIdList><ArticleId IdType="pubmed">20680805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2013 Oct 4;12(10):4522-31</Citation><ArticleIdList><ArticleId IdType="pubmed">24016253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2012 Sep;18(9):1401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22922409</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2006 Apr;1760(4):669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">16413679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2016 Apr 05;7:11205</Citation><ArticleIdList><ArticleId IdType="pubmed">27046227</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Immunol. 2010 May;30 Suppl 1:S9-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20480216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Jun 19;475(7354):110-3</Citation><ArticleIdList><ArticleId IdType="pubmed">21685887</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2012 Feb 1;188(3):1469-78</Citation><ArticleIdList><ArticleId IdType="pubmed">22205026</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2004 Feb;31(2):390-2</Citation><ArticleIdList><ArticleId IdType="pubmed">14760812</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Oct;58(10):3081-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18821684</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2013 May;123(5):2183-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23563315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2012 May 15;188(10):4741-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22491254</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 1991 Oct;4(5):779-94</Citation><ArticleIdList><ArticleId IdType="pubmed">1797027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Nov 1;183(9):5502-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19843936</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Sep;189(1-2):132-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17617473</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 May 15;104(20):8433-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17485663</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3544-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23929778</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Aug;64(8):2451-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22392608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2003 Feb;30(2):394-400</Citation><ArticleIdList><ArticleId IdType="pubmed">12563701</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):E1282-90</Citation><ArticleIdList><ArticleId IdType="pubmed">23509253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1985 Aug 1-7;316(6027):452-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3927174</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2009;11(6):R193</Citation><ArticleIdList><ArticleId IdType="pubmed">20015375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 1995 Mar;1(3):237-43</Citation><ArticleIdList><ArticleId IdType="pubmed">7585040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Aug 1;177(3):1904-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16849503</ArticleId></ArticleIdList></Reference><Reference><Citation>J Proteome Res. 2011 Jan 7;10(1):143-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20672848</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2013 Jun 1;190(11):5739-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23616577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Nov;39(11):1329-37</Citation><ArticleIdList><ArticleId IdType="pubmed">17952073</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2016 Nov 25;18(1):274</Citation><ArticleIdList><ArticleId IdType="pubmed">27887659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2017 Jan;18(1):104-113</Citation><ArticleIdList><ArticleId IdType="pubmed">27820809</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 1997 Dec;160:115-26</Citation><ArticleIdList><ArticleId IdType="pubmed">9476670</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Jul;29(7):1520-30</Citation><ArticleIdList><ArticleId IdType="pubmed">12136914</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2018 Jan;70(1):7-17</Citation><ArticleIdList><ArticleId IdType="pubmed">29024575</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2002 Jul;129(1):183-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12100039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28906437</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Developing Fine-Grained Actigraphies for Rheumatoid Arthritis Patients from a Single Accelerometer Using Machine Learning.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E2113</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s17092113</ELocationID><Abstract><AbstractText>In addition to routine clinical examination, unobtrusive and physical monitoring of Rheumatoid Arthritis (RA) patients provides an important source of information to enable understanding the impact of the disease on quality of life. Besides an increase in sedentary behaviour, pain in RA can negatively impact simple physical activities such as getting out of bed and standing up from a chair. The objective of this work is to develop a method that can generate fine-grained actigraphies to capture the impact of the disease on the daily activities of patients. A processing methodology is presented to automatically tag activity accelerometer data from a cohort of moderate-to-severe RA patients. A study of procesing methods based on machine learning and deep learning is provided. Thirty subjects, 10 RA patients and 20 healthy control subjects, were recruited in the study. A single tri-axial accelerometer was attached to the position of the fifth lumbar vertebra (L5) of each subject with a tag prediction granularity of 3 s. The proposed method is capable of handling unbalanced datasets from tagged data while accounting for long-duration activities such as sitting and lying, as well as short transitions such as sit-to-stand or lying-to-sit. The methodology also includes a novel mechanism for automatically applying a threshold to predictions by their confidence levels, in addition to a logical filter to correct for infeasible sequences of activities. Performance tests showed that the method was able to achieve around 95% accuracy and 81% F-score. The produced actigraphies can be helpful to generate objective RA disease-specific markers of patient mobility in-between clinical site visits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andreu-Perez</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7421-4808</Identifier><AffiliationInfo><Affiliation>The Hamlyn Centre, Imperial College London, London SW7 2AZ, UK. javier.andreu@imperial.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Computer Science and Electronic Engineering, University of Essex, Colchester CO4 3SQ, UK. javier.andreu@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Gancedo</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Innovation &amp; Digital Platforms; Projects, Clinical Platforms &amp; Sciences, GSK, Stevenage SG1 2NY, UK. luis.x.garcia-gancedo@gsk.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinnell</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6593-829X</Identifier><AffiliationInfo><Affiliation>Emerging Platforms, Platform Technology &amp; Science, GSK, Stevenage SG1 2NY, UK. jonathanmckinnell@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van der Drift</LastName><ForeName>Anniek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tessella, Altran's World Class Center for Analytics, Stevenage SG1 3QP, UK. anniek.vanderdrift@tessella.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tessella, Altran's World Class Center for Analytics, Stevenage SG1 3QP, UK. adam.powell@tessella.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamy</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clinical Innovation &amp; Digital Platforms; Projects, Clinical Platforms &amp; Sciences, GSK, Stevenage SG1 2NY, UK. valentin.x.hamy@gsk.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Emerging Platforms, Platform Technology &amp; Science, GSK, Stevenage SG1 2NY, UK. Thomas.h.keller@gsk.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Guang-Zhong</ForeName><Initials>GZ</Initials><AffiliationInfo><Affiliation>The Hamlyn Centre, Imperial College London, London SW7 2AZ, UK. g.z.yang@imperial.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061725" MajorTopicYN="N">Accelerometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011187" MajorTopicYN="N">Posture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">actigraphy</Keyword><Keyword MajorTopicYN="N">continuous monitoring</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28906437</ArticleId><ArticleId IdType="pii">s17092113</ArticleId><ArticleId IdType="doi">10.3390/s17092113</ArticleId><ArticleId IdType="pmc">PMC5620953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Rheum Dis. 2006 Jan;65(1):30-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15901635</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Sci Sports Exerc. 2010 Aug;42(8):1493-501</Citation><ArticleIdList><ArticleId IdType="pubmed">20139792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2014 Jul;73(7):1316-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24550173</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 2002 Jan-Feb;64(1):52-60</Citation><ArticleIdList><ArticleId IdType="pubmed">11818586</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 Apr;68(4):424-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26314559</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Dec 15;57(8):1404-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18050180</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 May;20(3):838-847</Citation><ArticleIdList><ArticleId IdType="pubmed">25850097</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Feb 1;12 (2):e0169649</Citation><ArticleIdList><ArticleId IdType="pubmed">28146576</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Rheumatol. 2004 Apr;18(2):141-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15121036</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2013 Jan 31;15(1):203</Citation><ArticleIdList><ArticleId IdType="pubmed">23369655</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2011;50(5):420-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21206963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2010;10 (2):1154-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22205862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2015 Dec 11;15(12):31314-38</Citation><ArticleIdList><ArticleId IdType="pubmed">26690450</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2015 Dec;62(12):2750-62</Citation><ArticleIdList><ArticleId IdType="pubmed">25879838</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Sleep Med. 2011 Feb 15;7(1):49-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21344040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 1998 Mar;31(3):263-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9645541</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2017 Jul 27;:jap.00366.2017</Citation><ArticleIdList><ArticleId IdType="pubmed">28751371</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Nurs. 2002 Jul;11(4):430-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12100639</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1999 Dec;26(12):2529-33</Citation><ArticleIdList><ArticleId IdType="pubmed">10606358</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Syst Rehabil Eng. 2014 Sep;22(5):926-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25014957</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2005 Nov;4(8):497-502</Citation><ArticleIdList><ArticleId IdType="pubmed">16214085</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2011;11(6):5561-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22163914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheum Dis Clin North Am. 2000 Aug;26(3):517-26</Citation><ArticleIdList><ArticleId IdType="pubmed">10989510</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2000;29(3):177-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10898071</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Methods Instrum Comput. 2001 Aug;33(3):349-56</Citation><ArticleIdList><ArticleId IdType="pubmed">11591066</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2016;2016:3703745</Citation><ArticleIdList><ArticleId IdType="pubmed">26981528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2003;81(9):646-56</Citation><ArticleIdList><ArticleId IdType="pubmed">14710506</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res. 1995 Dec;8(4):272-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8605266</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res. 1997 Jun;10(3):185-93</Citation><ArticleIdList><ArticleId IdType="pubmed">9335630</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28887746</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-5447</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Australasian physical &amp; engineering sciences in medicine</Title><ISOAbbreviation>Australas Phys Eng Sci Med</ISOAbbreviation></Journal><ArticleTitle>Diagnosis of multiple sclerosis from EEG signals using nonlinear methods.</ArticleTitle><Pagination><MedlinePgn>785-797</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13246-017-0584-9</ELocationID><Abstract><AbstractText>EEG signals have essential and important information about the brain and neural diseases. The main purpose of this study is classifying two groups of healthy volunteers and Multiple Sclerosis (MS) patients using nonlinear features of EEG signals while performing cognitive tasks. EEG signals were recorded when users were doing two different attentional tasks. One of the tasks was based on detecting a desired change in color luminance and the other task was based on detecting a desired change in direction of motion. EEG signals were analyzed in two ways: EEG signals analysis without rhythms decomposition and EEG sub-bands analysis. After recording and preprocessing, time delay embedding method was used for state space reconstruction; embedding parameters were determined for original signals and their sub-bands. Afterwards nonlinear methods were used in feature extraction phase. To reduce the feature dimension, scalar feature selections were done by using T-test and Bhattacharyya criteria. Then, the data were classified using linear support vector machines (SVM) and k-nearest neighbor (KNN) method. The best combination of the criteria and classifiers was determined for each task by comparing performances. For both tasks, the best results were achieved by using T-test criterion and SVM classifier. For the direction-based and the color-luminance-based tasks, maximum classification performances were 93.08 and 79.79% respectively which were reached by using optimal set of features. Our results show that the nonlinear dynamic features of EEG signals seem to be useful and effective in MS diseases diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torabi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, Tehran, 16846-13114, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daliri</LastName><ForeName>Mohammad Reza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, Tehran, 16846-13114, Iran. daliri@iust.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabzposhan</LastName><ForeName>Seyyed Hojjat</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Department, School of Electrical Engineering, Iran University of Science and Technology (IUST), Narmak, Tehran, 16846-13114, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>91054195</GrantID><Agency>Iran National Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Australas Phys Eng Sci Med</MedlineTA><NlmUniqueID>8208130</NlmUniqueID><ISSNLinking>0158-9938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001288" MajorTopicYN="N">Attention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004566" MajorTopicYN="N">Electrodes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="Y">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017711" MajorTopicYN="Y">Nonlinear Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012815" MajorTopicYN="Y">Signal Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013647" MajorTopicYN="N">Task Performance and Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Attention task</Keyword><Keyword MajorTopicYN="N">Electroencephalogram (EEG)</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis (MS)</Keyword><Keyword MajorTopicYN="N">Nonlinear features</Keyword><Keyword MajorTopicYN="N">Support vector machine (SVM)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28887746</ArticleId><ArticleId IdType="doi">10.1007/s13246-017-0584-9</ArticleId><ArticleId IdType="pii">10.1007/s13246-017-0584-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28882707</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2215-0374</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>10</Month></PubDate></JournalIssue><Title>The lancet. Psychiatry</Title><ISOAbbreviation>Lancet Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.</ArticleTitle><Pagination><MedlinePgn>768-774</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2215-0366(17)30330-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2215-0366(17)30330-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">In anti-NMDA receptor (NMDAR) encephalitis, antibody-mediated dysfunction of NMDARs causes severe neuropsychiatric symptoms, including psychosis, memory deficits, and movement disorders. However, it remains elusive how antibody-mediated NMDAR dysfunction leads to these symptoms, and whether the symptoms arise from impairment in specific brain regions and the interactions between impaired regions.</AbstractText><AbstractText Label="METHODS">In this observational study, we recruited 43 patients with anti-NMDAR encephalitis from a tertiary university hospital and 43 age-matched and sex-matched healthy controls without a history of neurological or psychiatric disorders, who were recruited from the general population of Berlin. We used structural and resting-state functional MRI to investigate alterations in connectivity in all participants. We did functional connectivity analyses, including large-scale network analysis, whole-brain pair-wise connectivity, and machine-learning classification, and compared the results with patients' functional impairment.</AbstractText><AbstractText Label="FINDINGS">Although structural MRI was normal in 31 (72%) of the 43 patients, we observed widespread alterations of functional connectivity that correlated with clinical measures. These alterations included impaired hippocampal functional connectivity, decoupling of the medial temporal and the default-mode networks, and an overall impairment of frontotemporal connections. Furthermore, functional connectivity was impaired within distributed large-scale networks, including sensorimotor, frontoparietal, lateral-temporal, and visual networks. Memory impairment correlated with hippocampal and medial-temporal-lobe network connectivity, whereas schizophrenia-like symptoms were associated with functional connectivity changes in frontoparietal networks. Machine-learning analyses corroborated these findings and identified frontoparietal and frontotemporal connections as reliably discriminating features between patients and controls, yielding an overall accuracy of 81%.</AbstractText><AbstractText Label="INTERPRETATION">This study reveals a characteristic pattern of whole-brain functional connectivity alterations in anti-NMDAR encephalitis that is well suited to explain the major clinical symptoms of the disorder. These observations advance the pathophysiological understanding of NMDAR dysfunction in the human brain and could be similarly relevant for other neuropsychiatric disorders, such as schizophrenia.</AbstractText><AbstractText Label="FUNDING">Deutsche Forschungsgemeinschaft, Israeli National Science Foundation, Ministry of Science and Technology of Israel, Orion Foundation, and the Agnes Ginges Center for Neurologenetics.</AbstractText><CopyrightInformation>Copyright .. 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computational Neuropsychiatry Laboratory, Department of Medical Neurosciences, Hebrew University of Jerusalem Medical School, Jerusalem, Israel; Department of Neurology, Hadassah Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pr..ss</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit..-Universit..tsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Dayan</LastName><ForeName>Inbal</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Computational Neuropsychiatry Laboratory, Department of Medical Neurosciences, Hebrew University of Jerusalem Medical School, Jerusalem, Israel; Department of Neurology, Hadassah Medical Center, Jerusalem, Israel; The Rachel and Selim Benin School of Computer Science and Engineering, Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Friedemann</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit..-Universit..tsmedizin Berlin, Berlin, Germany; NeuroCure Clinical Research Center, Charit..-Universit..tsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charit..-Universit..tsmedizin Berlin, Berlin, Germany. Electronic address: friedemann.paul@charite.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arzy</LastName><ForeName>Shahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computational Neuropsychiatry Laboratory, Department of Medical Neurosciences, Hebrew University of Jerusalem Medical School, Jerusalem, Israel; Department of Neurology, Hadassah Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit..-Universit..tsmedizin Berlin, Berlin, Germany; Berlin Center for Advanced Neuroimaging Analyses, Charit..-Universit..tsmedizin Berlin, Berlin, Germany; Berlin School of Mind and Brain, Humboldt-Universit..t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Psychiatry</MedlineTA><NlmUniqueID>101638123</NlmUniqueID><ISSNLinking>2215-0366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Psychiatry. 2017 Oct;4(10):737-738</RefSource><PMID Version="1">28882706</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Psychiatry. 2018 Jan;5(1):21-22</RefSource><PMID Version="1">29277208</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Psychiatry. 2018 Jan;5(1):22</RefSource><PMID Version="1">29277209</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Psychiatry. 2018 Jan;5(1):9-10</RefSource><PMID Version="1">29277216</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060426" MajorTopicYN="N">Anti-N-Methyl-D-Aspartate Receptor Encephalitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063132" MajorTopicYN="N">Connectome</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059907" MajorTopicYN="N">Functional Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009415" MajorTopicYN="N">Nerve Net</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28882707</ArticleId><ArticleId IdType="pii">S2215-0366(17)30330-9</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(17)30330-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28882107</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2105</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC bioinformatics</Title><ISOAbbreviation>BMC Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>Statistical classifiers for diagnosing disease from immune repertoires: a case study using multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>401</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12859-017-1814-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deep sequencing of lymphocyte receptor repertoires has made it possible to comprehensively profile the clonal composition of lymphocyte populations. This opens the door for novel approaches to diagnose and prognosticate diseases with a driving immune component by identifying repertoire sequence patterns associated with clinical phenotypes. Indeed, recent studies support the feasibility of this, demonstrating an association between repertoire-level summary statistics (e.g., diversity) and patient outcomes for several diseases. In our own prior work, we have shown that six codons in VH4-containing genes in B cells from the cerebrospinal fluid of patients with relapsing remitting multiple sclerosis (RRMS) have higher replacement mutation frequencies than observed in healthy controls or patients with other neurological diseases. However, prior methods to date have been limited to focusing on repertoire-level summary statistics, ignoring the vast amounts of information in the millions of individual immune receptors comprising a repertoire. We have developed a novel method that addresses this limitation by using innovative approaches for accommodating the extraordinary sequence diversity of immune receptors and widely used machine learning approaches. We applied our method to RRMS, an autoimmune disease that is notoriously difficult to diagnose.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We use the biochemical features encoded by the complementarity determining region 3 of each B cell receptor heavy chain in every patient repertoire as input to a detector function, which is fit to give the correct diagnosis for each patient using maximum likelihood optimization methods. The resulting statistical classifier assigns patients to one of two diagnosis categories, RRMS or other neurological disease, with 87% accuracy by leave-one-out cross-validation on training data (N..=..23) and 72% accuracy on unused data from a separate study (N..=..102).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our method is the first to apply statistical learning to immune repertoires to aid disease diagnosis, learning repertoire-level labels from the set of individual immune repertoire sequences. This method produced a repertoire-based statistical classifier for diagnosing RRMS that provides a high degree of diagnostic capability, rivaling the accuracy of diagnosis by a clinical expert. Additionally, this method points to a diagnostic biochemical motif in the antibodies of RRMS patients, which may offer insight into the disease process.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ostmeyer</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9066, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christley</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9066, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rounds</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9066, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toby</LastName><ForeName>Inimary</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9066, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Benjamin M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9036, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monson</LastName><ForeName>Nancy L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9036, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowell</LastName><ForeName>Lindsay G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9066, USA. lindsay.cowell@utsouthwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI097403</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Bioinformatics</MedlineTA><NlmUniqueID>100965194</NlmUniqueID><ISSNLinking>1471-2105</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022801">Complementarity Determining Regions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022801" MajorTopicYN="N">Complementarity Determining Regions</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibody</Keyword><Keyword MajorTopicYN="N">CDR3</Keyword><Keyword MajorTopicYN="N">Immune repertoire</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Statistical classifier</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28882107</ArticleId><ArticleId IdType="doi">10.1186/s12859-017-1814-6</ArticleId><ArticleId IdType="pii">10.1186/s12859-017-1814-6</ArticleId><ArticleId IdType="pmc">PMC5588725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neuroimmunol. 2009 Aug 18;213(1-2):123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19631394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Jan;20(1):57-63</Citation><ArticleIdList><ArticleId IdType="pubmed">23736535</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2008 Dec;154(3):316-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18811695</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Oct 17;8(10):e76546</Citation><ArticleIdList><ArticleId IdType="pubmed">24146886</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 May 3;102(18):6395-400</Citation><ArticleIdList><ArticleId IdType="pubmed">15851683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2015 Mar;11(3):171-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25536486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2008 Aug 13;199(1-2):126-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18547652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2015 Nov 16;43(20):e135</Citation><ArticleIdList><ArticleId IdType="pubmed">26152304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2014 Jul 1;30(13):1930-2</Citation><ArticleIdList><ArticleId IdType="pubmed">24618469</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2014 Apr-May;13(4-5):518-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24424194</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2015 Nov 10;572(2):191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26172868</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2006 Apr;63(4):614-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16606781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23671333</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2015 Nov 20;7:121</Citation><ArticleIdList><ArticleId IdType="pubmed">26589402</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2014 Feb 07;15:110</Citation><ArticleIdList><ArticleId IdType="pubmed">24507442</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunother Cancer. 2015 Jun 16;3:23</Citation><ArticleIdList><ArticleId IdType="pubmed">26085931</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncoimmunology. 2015 Jan 22;4(4):e1001230</Citation><ArticleIdList><ArticleId IdType="pubmed">26137399</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Nov 1;179(9):6343-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17947712</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2014 Jul 15;20(14):3818-29</Citation><ArticleIdList><ArticleId IdType="pubmed">24916698</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28880900</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.</ArticleTitle><Pagination><MedlinePgn>e0184109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0184109</ELocationID><Abstract><AbstractText>Glycosylation, oxidation and other post-translational modifications of membrane and transmembrane proteins can alter lipid density, packing and interactions, and are considered an important factor that affects fluidity variation in membranes. Red blood cells (RBC) membrane physical state, showing pronounced alterations in Type 1 diabetes mellitus (T1DM), could be the ideal candidate for monitoring the disease progression and the effects of therapies. On these grounds, the measurement of RBC membrane fluidity alterations can furnish a more sensitive index in T1DM diagnosis and disease progression than Glycosylated hemoglobin (HbA1c), which reflects only the information related to glycosylation processes. Here, through a functional two-photon microscopy approach we retrieved fluidity maps at submicrometric scale in RBC of T1DM patients with and without complications, detecting an altered membrane equilibrium. We found that a phase separation between fluid and rigid domains occurs, triggered by systemic effects on membranes fluidity of glycation and oxidation. The phase separation patterns are different among healthy, T1DM and T1DM with complications patients. Blood cholesterol and LDL content are positively correlated with the extent of the phase separation patterns. To quantify this extent a machine learning approach is employed to develop a Decision-Support-System (DSS) able to recognize different fluidity patterns in RBC. Preliminary analysis shows significant differences(p&lt;0.001) among healthy, T1DM and T1DM with complications patients. The development of an assay based on Phase separation of the plasma membrane of the Red Blood cells is a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus, and could allow customization and the selection of medical treatments in T1DM in clinical settings, and enable the early detection of complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maulucci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2154-319X</Identifier><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordelli</LastName><ForeName>Ermanno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Leva</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papi</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciasca</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samengo</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Patologia, Universit.. Cattolica del Sacro Cuore Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pani</LastName><ForeName>Giovambattista</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Patologia, Universit.. Cattolica del Sacro Cuore Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitocco</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghirlanda</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto di Medicina Interna, Fondazione Policlinico Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannello</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit.. di Sistemi di elaborazione e bioinformatica, Facolt.. dipartimentale di Ingegneria, Universit.. Campus Bio-Medico, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Spirito</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto di Fisica, Universit.. Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008077">Lipoproteins, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019937" MajorTopicYN="Y">Diagnostic Techniques and Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004910" MajorTopicYN="N">Erythrocyte Membrane</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008077" MajorTopicYN="N">Lipoproteins, LDL</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008560" MajorTopicYN="N">Membrane Fluidity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021962" MajorTopicYN="N">Membrane Microdomains</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28880900</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0184109</ArticleId><ArticleId IdType="pii">PONE-D-17-22847</ArticleId><ArticleId IdType="pmc">PMC5589169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2009;4(2):e4412</Citation><ArticleIdList><ArticleId IdType="pubmed">19209233</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1995 Aug;44(8):968-83</Citation><ArticleIdList><ArticleId IdType="pubmed">7622004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Aspects Med. 2016 Jun;49:49-77</Citation><ArticleIdList><ArticleId IdType="pubmed">27012748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2008 Oct 28;1(43):pl3</Citation><ArticleIdList><ArticleId IdType="pubmed">18957692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanoscale. 2015 Oct 28;7(40):17030-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26415744</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2014 Feb;29(2):388-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24002631</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Med Sci. 2012 May-Jun;66(5-6):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23806986</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1460-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22499994</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 1988 Dec;67(6):1129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">2848052</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2014 Jul;1840(7):2192-202</Citation><ArticleIdList><ArticleId IdType="pubmed">24735797</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2013 Mar 19;104(6):1238-47</Citation><ArticleIdList><ArticleId IdType="pubmed">23528083</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1983 Jun 10;258(11):6920-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6853509</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(6):e21182</Citation><ArticleIdList><ArticleId IdType="pubmed">21698159</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Feb;38(2):308-15</Citation><ArticleIdList><ArticleId IdType="pubmed">25510400</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Res. 2016 Nov;50(sup1):S40-S50</Citation><ArticleIdList><ArticleId IdType="pubmed">27593084</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9441-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7937786</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2013 Sep;28 Suppl 3:S660-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23797912</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H786-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18586889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18216768</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2015 May 12;112(10):1675-86</Citation><ArticleIdList><ArticleId IdType="pubmed">25880005</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 2007 Dec 15;93(12):4225-36</Citation><ArticleIdList><ArticleId IdType="pubmed">17766354</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Aug;31(8):1473-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18540046</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2013 Feb;1828(2):357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22940500</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2003 Mar 10;1610(2):198-207</Citation><ArticleIdList><ArticleId IdType="pubmed">12648774</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Res. 2010 Oct;44(10):1125-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20836660</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2009 May;13(3):322-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19171521</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1980 Feb;77(2):915-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6987672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Phys Lipids. 1987 Jul-Sep;44(2-4):175-89</Citation><ArticleIdList><ArticleId IdType="pubmed">3311416</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Biochem. 1992 Feb;25(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1312917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Phys Lipids. 2009 Jan;157(1):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18977338</ArticleId></ArticleIdList></Reference><Reference><Citation>Free Radic Biol Med. 2013 Dec;65:978-87</Citation><ArticleIdList><ArticleId IdType="pubmed">23973638</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1996 Oct;45(10):1289-98</Citation><ArticleIdList><ArticleId IdType="pubmed">8826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Clin Biochem. 2008 Jul;23(3):223-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23105758</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28860558</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>31</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.</ArticleTitle><Pagination><MedlinePgn>10189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-10558-w</ELocationID><Abstract><AbstractText>We developed and independently validated a rheumatoid arthritis (RA) mortality prediction model using the machine learning method Random Survival Forests (RSF). Two independent cohorts from Madrid (Spain) were used: the Hospital Cl..nico San Carlos RA Cohort (HCSC-RAC; training; 1,461 patients), and the Hospital Universitario de La Princesa Early Arthritis Register Longitudinal study (PEARL; validation; 280 patients). Demographic and clinical-related variables collected during the first two years after disease diagnosis were used. 148 and 21 patients from HCSC-RAC and PEARL died during a median follow-up time of 4.3 and 5.0..years, respectively. Age at diagnosis, median erythrocyte sedimentation rate, and number of hospital admissions showed the higher predictive capacity. Prediction errors in the training and validation cohorts were 0.187 and 0.233, respectively. A survival tree identified five mortality risk groups using the predicted ensemble mortality. After 1 and 7 years of follow-up, time-dependent specificity and sensitivity in the validation cohort were 0.79-0.80 and 0.43-0.48, respectively, using the cut-off value dividing the two lower risk categories. Calibration curves showed overestimation of the mortality risk in the validation cohort. In conclusion, we were able to develop a clinical prediction model for RA mortality using RSF, providing evidence for further work on external validation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lezcano-Valverde</LastName><ForeName>Jos.. M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salazar</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>International Centre for Numerical Methods in Engineering (CIMNE), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le..n</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledano</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jover</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Gutierrez</LastName><ForeName>Benjam..n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soudah</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>International Centre for Numerical Methods in Engineering (CIMNE), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz..lez-..lvaro</LastName><ForeName>Isidoro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nico Universitario de La Princesa, and IIS-IP, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abasolo</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Rodriguez</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2869-7861</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Cl..nical San Carlos, and IdISSC, Madr..d, Spain. lrrodriguez@salud.madrid.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001799" MajorTopicYN="N">Blood Sedimentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28860558</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-10558-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-10558-w</ArticleId><ArticleId IdType="pmc">PMC5579234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Magn Reson Imaging. 2017 Jan;45(1):103-117</Citation><ArticleIdList><ArticleId IdType="pubmed">27345946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Transl Neurol. 2016 May 17;3(7):482-94</Citation><ArticleIdList><ArticleId IdType="pubmed">27386498</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2011 Jun 29;13(3):R108</Citation><ArticleIdList><ArticleId IdType="pubmed">21714856</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2014 Jul;32(7):644-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24952901</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Jan;29(1):62-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11824973</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1026-1032</Citation><ArticleIdList><ArticleId IdType="pubmed">27749239</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2013 Feb;65(2):334-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23044791</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2014 Mar 19;14:40</Citation><ArticleIdList><ArticleId IdType="pubmed">24645774</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2016 Feb;44(2):368-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26771782</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Mol Biol Transl Sci. 2010;92:121-56</Citation><ArticleIdList><ArticleId IdType="pubmed">20800819</ArticleId></ArticleIdList></Reference><Reference><Citation>Head Neck. 2012 Jan;34(1):50-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21322080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Nov;56(11):3583-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Mar;62(3):362-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20391482</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Med. 2017 Jun;127:51-56</Citation><ArticleIdList><ArticleId IdType="pubmed">28502419</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2016 Jan 30;35(2):214-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26553135</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2015 Dec;58:104-113</Citation><ArticleIdList><ArticleId IdType="pubmed">26453823</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1982 May 14;247(18):2543-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7069920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2015 Oct;30(12 ):1664-72</Citation><ArticleIdList><ArticleId IdType="pubmed">26340420</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2012 Sep;50(11):1-23</Citation><ArticleIdList><ArticleId IdType="pubmed">25317082</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S12-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15552509</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Math Methods Med. 2015;2015:576413</Citation><ArticleIdList><ArticleId IdType="pubmed">26858773</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2014 Sep;66(9):1296-301</Citation><ArticleIdList><ArticleId IdType="pubmed">24497371</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2016 May;68(5):706-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26415107</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 1993 Apr;39(4):561-77</Citation><ArticleIdList><ArticleId IdType="pubmed">8472349</ArticleId></ArticleIdList></Reference><Reference><Citation>Iran J Public Health. 2016 Jan;45(1):27-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27057518</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Apr;58(4):985-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18383358</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychosom Res. 2012 Dec;73(6):408-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23148806</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Jun;48(6):1530-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12794820</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Jul 1;22(13):2567-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15226324</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2013 Jul;33(7):1797-804</Citation><ArticleIdList><ArticleId IdType="pubmed">23306593</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(12):e29492</Citation><ArticleIdList><ArticleId IdType="pubmed">22242124</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2016 Apr;45(5):533-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26639031</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Bone Spine. 2013 Jan;80(1):29-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22459416</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2003 Jul;28(3):323-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12927339</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2012 Jun;99(6):323-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22546560</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Jun 24;11(6):e0157703</Citation><ArticleIdList><ArticleId IdType="pubmed">27340824</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2014 May;66(5):732-40</Citation><ArticleIdList><ArticleId IdType="pubmed">24151254</ArticleId></ArticleIdList></Reference><Reference><Citation>Biom J. 2006 Dec;48(6):1029-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17240660</ArticleId></ArticleIdList></Reference><Reference><Citation>Biom J. 2012 Sep;54(5):657-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22777999</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2005 Mar;61(1):92-105</Citation><ArticleIdList><ArticleId IdType="pubmed">15737082</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2013 Nov 27;310(20):2191-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2016 Feb 23;7(8):8968-78</Citation><ArticleIdList><ArticleId IdType="pubmed">26840268</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Rheumatol Rep. 2010 Oct;12(5):379-85</Citation><ArticleIdList><ArticleId IdType="pubmed">20645137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatogastroenterology. 2014 May;61(131):689-96</Citation><ArticleIdList><ArticleId IdType="pubmed">26176058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2011 Nov;213(5):579-588, 588.e1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">21925905</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2005 May;58(5):475-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15845334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2015 Feb;90(2):176-83</Citation><ArticleIdList><ArticleId IdType="pubmed">25659235</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2000 Nov;50(5):419-25</Citation><ArticleIdList><ArticleId IdType="pubmed">11069436</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):39-45</Citation><ArticleIdList><ArticleId IdType="pubmed">21098782</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2015 Jan;61(1):249-58</Citation><ArticleIdList><ArticleId IdType="pubmed">25348669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Nov;69(11):1946-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20525846</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2015 Aug;67(8):1047-53</Citation><ArticleIdList><ArticleId IdType="pubmed">25623141</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2014 Aug;272(2):484-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24646147</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Radiol. 2017 Jun;52(6):360-366</Citation><ArticleIdList><ArticleId IdType="pubmed">28079702</ArticleId></ArticleIdList></Reference><Reference><Citation>Leukemia. 2016 Oct;30(10 ):2011-2018</Citation><ArticleIdList><ArticleId IdType="pubmed">27109509</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2014 Jan;53(1):186-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24140761</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2016 Mar 15;133(11):1058-66</Citation><ArticleIdList><ArticleId IdType="pubmed">26888765</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Life Res. 2016 Jul;25(7):1713-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26615615</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Math Methods Med. 2016;2016:7087053</Citation><ArticleIdList><ArticleId IdType="pubmed">27818706</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res. 1992 Sep;5(3):119-29</Citation><ArticleIdList><ArticleId IdType="pubmed">1457486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 Jul;66(7):880-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17324968</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Feb 15;55(1):74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16463416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1994 Jan 1;120(1):26-34</Citation><ArticleIdList><ArticleId IdType="pubmed">8250453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Mar;32(3):430-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15742433</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28830409</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Word2Vec inversion and traditional text classifiers for phenotyping lupus.</ArticleTitle><Pagination><MedlinePgn>126</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-017-0518-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identifying patients with certain clinical criteria based on manual chart review of doctors' notes is a daunting task given the massive amounts of text notes in the electronic health records (EHR). This task can be automated using text classifiers based on Natural Language Processing (NLP) techniques along with pattern recognition machine learning (ML) algorithms. The aim of this research is to evaluate the performance of traditional classifiers for identifying patients with Systemic Lupus Erythematosus (SLE) in comparison with a newer Bayesian word vector method.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We obtained clinical notes for patients with SLE diagnosis along with controls from the Rheumatology Clinic (662 total patients). Sparse bag-of-words (BOWs) and Unified Medical Language System (UMLS) Concept Unique Identifiers (CUIs) matrices were produced using NLP pipelines. These matrices were subjected to several different NLP classifiers: neural networks, random forests, na..ve Bayes, support vector machines, and Word2Vec inversion, a Bayesian inversion method. Performance was measured by calculating accuracy and area under the Receiver Operating Characteristic (ROC) curve (AUC) of a cross-validated (CV) set and a separate testing set.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We calculated the accuracy of the ICD-9 billing codes as a baseline to be 90.00% with an AUC of 0.900, the shallow neural network with CUIs to be 92.10% with an AUC of 0.970, the random forest with BOWs to be 95.25% with an AUC of 0.994, the random forest with CUIs to be 95.00% with an AUC of 0.979, and the Word2Vec inversion to be 90.03% with an AUC of 0.905.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results suggest that a shallow neural network with CUIs and random forests with both CUIs and BOWs are the best classifiers for this lupus phenotyping task. The Word2Vec inversion method failed to significantly beat the ICD-9 code classification, but yielded promising results. This method does not require explicit features and is more adaptable to non-binary classification tasks. The Word2Vec inversion is hypothesized to become more powerful with access to more data. Therefore, currently, the shallow neural networks and random forests are the desirable classifiers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Clayton A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0585-3507</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, College of Charleston, 66 George Street, Charleston, 29424, USA. caturner3@g.cofc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Computer Science, College of Charleston, 66 George Street, Charleston, 29424, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Cassios K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Computer Science, College of Charleston, 66 George Street, Charleston, 29424, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oates</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, 29425, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamen</LastName><ForeName>Diane L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, 29425, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Computer Science, College of Charleston, 66 George Street, Charleston, 29424, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obeid</LastName><ForeName>Jihad S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, 29425, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P60 AR062755</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR025005</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017432" MajorTopicYN="N">Unified Medical Language System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Natural language processing</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28830409</ArticleId><ArticleId IdType="doi">10.1186/s12911-017-0518-1</ArticleId><ArticleId IdType="pii">10.1186/s12911-017-0518-1</ArticleId><ArticleId IdType="pmc">PMC5568290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2013;13 Suppl 1:S1</Citation><ArticleIdList><ArticleId IdType="pubmed">23566040</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2007;129(Pt 2):968-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17911859</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2007 Oct 11;:533-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18693893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 1998 Aug;29(8):1602-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9707200</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Serv Res. 2005 Oct;40(5 Pt 2):1620-39</Citation><ArticleIdList><ArticleId IdType="pubmed">16178999</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2014;2014:240403</Citation><ArticleIdList><ArticleId IdType="pubmed">24729964</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2011 Sep-Oct;18(5):614-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21622934</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Mar 17;12:77</Citation><ArticleIdList><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1982 Nov;25(11):1271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Aug;64(8):2677-86</Citation><ArticleIdList><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1997 Sep;49(3):660-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9305319</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Sep-Oct;17(5):507-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2002 Dec 4;67(1-3):75-83</Citation><ArticleIdList><ArticleId IdType="pubmed">12460633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28812204</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1539-0829</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>15</Day></PubDate></JournalIssue><Title>Current diabetes reports</Title><ISOAbbreviation>Curr Diab Rep</ISOAbbreviation></Journal><ArticleTitle>Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11892-017-0920-1</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">The review summarizes the current state of the artificial pancreas (AP) systems and introduces various new modules that should be included in future AP systems.</AbstractText><AbstractText Label="RECENT FINDINGS">A fully automated AP must be able to detect and mitigate the effects of meals, exercise, stress and sleep on blood glucose concentrations. This can only be achieved by using a multivariable approach that leverages information from wearable devices that provide real-time streaming data about various physiological variables that indicate imminent changes in blood glucose concentrations caused by meals, exercise, stress and sleep. The development of a fully automated AP will necessitate the design of multivariable and adaptive systems that use information from wearable devices in addition to glucose sensors and modify the models used in their model-predictive alarm and control systems to adapt to the changes in the metabolic state of the user. These AP systems will also integrate modules for controller performance assessment, fault detection and diagnosis, machine learning and classification to interpret various signals and achieve fault-tolerant control. Advances in wearable devices, computational power, and safe and secure communications are enabling the development of fully automated multivariable AP systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cinar</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering and Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA. cinar@iit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK101075</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP3 DK101077</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Diab Rep</MedlineTA><NlmUniqueID>101093791</NlmUniqueID><ISSNLinking>1534-4827</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062407" MajorTopicYN="N">Meals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019397" MajorTopicYN="Y">Pancreas, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Adaptive control</Keyword><Keyword MajorTopicYN="Y">Artificial pancreas</Keyword><Keyword MajorTopicYN="Y">Multivariable data interpretation</Keyword><Keyword MajorTopicYN="Y">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28812204</ArticleId><ArticleId IdType="doi">10.1007/s11892-017-0920-1</ArticleId><ArticleId IdType="pii">10.1007/s11892-017-0920-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19344194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">25434967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Process Control. 2008;18(3-4):258-265</Citation><ArticleIdList><ArticleId IdType="pubmed">18709180</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2016 Sep;71:237-246</Citation><ArticleIdList><ArticleId IdType="pubmed">27695131</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 1993 Jul-Aug;55(4):380-93</Citation><ArticleIdList><ArticleId IdType="pubmed">8105502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2017 Jun;18(4):262-270</Citation><ArticleIdList><ArticleId IdType="pubmed">27028035</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Nov;33(11):e142</Citation><ArticleIdList><ArticleId IdType="pubmed">20980421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Nov 01;5(6):1352-62</Citation><ArticleIdList><ArticleId IdType="pubmed">22226252</ArticleId></ArticleIdList></Reference><Reference><Citation>J Behav Ther Exp Psychiatry. 2008 Mar;39(1):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">17466262</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Nov;16(11):728-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25259939</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 Jun;31(6):1183-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18299444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 01;9(6):1217-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26428933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-43</Citation><ArticleIdList><ArticleId IdType="pubmed">26850709</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1151-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27208331</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jul;38(7):1205-11</Citation><ArticleIdList><ArticleId IdType="pubmed">26049550</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 18;9(6):1208-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26481641</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Sep;61(9):2230-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22688340</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jul;38(7):1197-204</Citation><ArticleIdList><ArticleId IdType="pubmed">26049549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 May;5(5):377-390</Citation><ArticleIdList><ArticleId IdType="pubmed">28126459</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1091-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20144422</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Jun;38(6):1036-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25998296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26432775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 May 03;10 (3):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26969142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2012 Oct 23;5(247):pt10</Citation><ArticleIdList><ArticleId IdType="pubmed">23092890</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2129-2140</Citation><ArticleIdList><ArticleId IdType="pubmed">26379095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20200307</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Sports Med Rep. 2017 Jan/Feb;16(1):38-44</Citation><ArticleIdList><ArticleId IdType="pubmed">28067740</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2016 Aug;16(8):67</Citation><ArticleIdList><ArticleId IdType="pubmed">27287017</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol Behav Med. 2016 Jan 1;4(1):49-55</Citation><ArticleIdList><ArticleId IdType="pubmed">27081578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Jul;8(4):731-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24876412</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 May 23;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28541890</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):503-15</Citation><ArticleIdList><ArticleId IdType="pubmed">2226381</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2008 May;31(5):934-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18252903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 Nov 1;10 (6):1236-1244</Citation><ArticleIdList><ArticleId IdType="pubmed">27464755</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 May;15(5):386-400</Citation><ArticleIdList><ArticleId IdType="pubmed">23544672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleep. 2012 Jan 01;35(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22215921</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Apr;11(4):243-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19344199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Sep 01;5(5):1137-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22027306</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Diab Rep. 2015 Jan;15(1):562</Citation><ArticleIdList><ArticleId IdType="pubmed">25398202</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 05;9(6):1175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26438720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Psychol. 2016 Jul;41(6):661-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26994852</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2017 Jan 11;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28092515</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Sportsmed. 1981 Jan;9(1):44-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27462744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Feb 27;375(9716):743-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20138357</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2015 Nov;38(11):2115-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26341131</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1224-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24757229</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1990;9(5):516-28</Citation><ArticleIdList><ArticleId IdType="pubmed">2226382</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 May;8(3):498-507</Citation><ArticleIdList><ArticleId IdType="pubmed">24876613</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1180-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27208335</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2004 Dec;66(3):237-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15536020</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1135-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27289127</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2016 Jul;39(7):1143-50</Citation><ArticleIdList><ArticleId IdType="pubmed">27208316</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jun 30;9(6):1236-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26134831</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Apr;35(4):669-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22374639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1224-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20144441</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 Jan;20(1):47-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26087510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 May 01;5(3):804-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21722597</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 Sep 01;7(5):1337-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24124962</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 Aug;28(8):1910-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16043731</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Sep 14;9(6):1253-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26370244</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2017 May;21(3):619-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28278487</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Aug;16(8):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">24702135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Mar;15(2):91-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23944875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 May;9(3):609-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25568144</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Res Nurs. 2012 Jan;14(1):48-54</Citation><ArticleIdList><ArticleId IdType="pubmed">21278167</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2006 Feb;31(2):151-78</Citation><ArticleIdList><ArticleId IdType="pubmed">16139959</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2015 May;17(5):468-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25600304</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 2015 May;34(5):522-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25798545</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 1994 Mar;37(3):247-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8174837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1031-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20144416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604</Citation><ArticleIdList><ArticleId IdType="pubmed">26066705</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 1986;5(5):439-52</Citation><ArticleIdList><ArticleId IdType="pubmed">3757992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Nov 17;10 (2):405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26581881</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2016 May 03;10 (3):762-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26630914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Jan;9(1):80-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25231116</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetologia. 2008 Dec;51(12):2168-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18806995</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24757225</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 Oct 18;9(6):1185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">26481644</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2012 Nov;97(11):4193-200</Citation><ArticleIdList><ArticleId IdType="pubmed">22962428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2017 Apr;5(4):261-270</Citation><ArticleIdList><ArticleId IdType="pubmed">28094136</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1974 May;23(5):389-96</Citation><ArticleIdList><ArticleId IdType="pubmed">4598089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2011 May;96(5):1402-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21367930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Nov;8(6):1091-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25316716</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(3):773-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24170766</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28791547</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Data Based Prediction of Blood Glucose Concentrations Using Evolutionary Methods.</ArticleTitle><Pagination><MedlinePgn>142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-017-0788-2</ELocationID><Abstract><AbstractText>Predicting glucose values on the basis of insulin and food intakes is a difficult task that people with diabetes need to do daily. This is necessary as it is important to maintain glucose levels at appropriate values to avoid not only short-term, but also long-term complications of the illness. Artificial intelligence in general and machine learning techniques in particular have already lead to promising results in modeling and predicting glucose concentrations. In this work, several machine learning techniques are used for the modeling and prediction of glucose concentrations using as inputs the values measured by a continuous monitoring glucose system as well as also previous and estimated future carbohydrate intakes and insulin injections. In particular, we use the following four techniques: genetic programming, random forests, k-nearest neighbors, and grammatical evolution. We propose two new enhanced modeling algorithms for glucose prediction, namely (i) a variant of grammatical evolution which uses an optimized grammar, and (ii) a variant of tree-based genetic programming which uses a three-compartment model for carbohydrate and insulin dynamics. The predictors were trained and tested using data of ten patients from a public hospital in Spain. We analyze our experimental results using the Clarke error grid metric and see that 90% of the forecasts are correct (i.e., Clarke error categories A and B), but still even the best methods produce 5 to 10% of serious errors (category D) and approximately 0.5% of very serious errors (category E). We also propose an enhanced genetic programming algorithm that incorporates a three-compartment model into symbolic regression models to create smoothed time series of the original carbohydrate and insulin time series.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hidalgo</LastName><ForeName>J Ignacio</ForeName><Initials>JI</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3046-6368</Identifier><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain. hidalgo@ucm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colmenar</LastName><ForeName>J Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Universidad Rey Juan Carlos, C/ Tulip..n s/n, 28933, M..stoles, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kronberger</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Heuristic and Evolutionary Algorithms Laboratory, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Stephan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Heuristic and Evolutionary Algorithms Laboratory, University of Applied Sciences Upper Austria, Softwarepark 11, 4232, Hagenberg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garnica</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanchares</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Adaptive and Bioinspired System Group, School of Informatics, Universidad Complutense de Madrid, C/ Profesor Jos.. Garc..a Santesmases 9, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Continuos glucose monitoring</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Evolutionary computation</Keyword><Keyword MajorTopicYN="N">Glucose prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28791547</ArticleId><ArticleId IdType="doi">10.1007/s10916-017-0788-2</ArticleId><ArticleId IdType="pii">10.1007/s10916-017-0788-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Care. 1987 Sep-Oct;10(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3677983</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Nov;60(11):2672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22025773</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2011 Oct;8(10):1395-406</Citation><ArticleIdList><ArticleId IdType="pubmed">21864222</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Apr;26(4):1079-87</Citation><ArticleIdList><ArticleId IdType="pubmed">12663577</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Jan;52(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15651559</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):617-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22768893</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 May;61(5):1577-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24759285</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Numer Method Biomed Eng. 2017 Jun;33(6):null</Citation><ArticleIdList><ArticleId IdType="pubmed">27644067</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Obes Metab. 2013 Dec;15(12):1065-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23602044</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Apr 13;342:d1855</Citation><ArticleIdList><ArticleId IdType="pubmed">21493665</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2000 Aug;23(8):1143-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10937512</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24757226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28785422</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2057-5858</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>04</Month></PubDate></JournalIssue><Title>Microbial genomics</Title><ISOAbbreviation>Microb Genom</ISOAbbreviation></Journal><ArticleTitle>Human genome-microbiome interaction: metagenomics frontiers for the aetiopathology of autoimmune diseases.</ArticleTitle><Pagination><MedlinePgn>e000112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1099/mgen.0.000112</ELocationID><Abstract><AbstractText>A short while ago, the human genome and microbiome were analysed simultaneously for the first time as a multi-omic approach. The analyses of heterogeneous population cohorts showed that microbiome components were associated with human genome variations. In-depth analysis of these results reveals that the majority of those relationships are between immune pathways and autoimmune disease-associated microbiome components. Thus, it can be hypothesized that autoimmunity may be associated with homeostatic disequilibrium of the human-microbiome interactome. Further analysis of human genome-human microbiome relationships in disease contexts with tailored systems biology approaches may yield insights into disease pathogenesis and prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gundogdu</LastName><ForeName>Aycan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1...Erciyes University School of Medicine, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2...Genome and Stem Cell Center (GenKok), Erciyes University, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalbantoglu</LastName><ForeName>Ufuk</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>3...Department of Computer Engineering, Erciyes University, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2...Genome and Stem Cell Center (GenKok), Erciyes University, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microb Genom</MedlineTA><NlmUniqueID>101671820</NlmUniqueID><ISSNLinking>2057-5858</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056186" MajorTopicYN="N">Metagenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">autoimmune disease</Keyword><Keyword MajorTopicYN="Y">genome-microbiome interaction</Keyword><Keyword MajorTopicYN="Y">metagenomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28785422</ArticleId><ArticleId IdType="doi">10.1099/mgen.0.000112</ArticleId><ArticleId IdType="pmc">PMC5506383</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 2014 Aug 29;345(6200):1048-52</Citation><ArticleIdList><ArticleId IdType="pubmed">25170151</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2016 Nov;26(11):1612-1625</Citation><ArticleIdList><ArticleId IdType="pubmed">27803195</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2009 Oct;77(10):4668-78</Citation><ArticleIdList><ArticleId IdType="pubmed">19635824</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Feb 10;470(7333):187-97</Citation><ArticleIdList><ArticleId IdType="pubmed">21307931</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4615-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20660719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jun 13;486(7402):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22699610</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Oct 19;10(10):e0140827</Citation><ArticleIdList><ArticleId IdType="pubmed">26479726</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2015 Sep 15;16:191</Citation><ArticleIdList><ArticleId IdType="pubmed">26374288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2014 Mar 27;157(1):121-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Med. 2013 Jun 28;5(6):55</Citation><ArticleIdList><ArticleId IdType="pubmed">23806069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Oct 4;490(7418):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">23023125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nutr. 2007 Jan;137(1 Suppl):259S-266S</Citation><ArticleIdList><ArticleId IdType="pubmed">17182837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2015 Oct;12(10):902-3</Citation><ArticleIdList><ArticleId IdType="pubmed">26418763</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Dec;60(12):3794-806</Citation><ArticleIdList><ArticleId IdType="pubmed">19950257</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2012;8(12):e1002822</Citation><ArticleIdList><ArticleId IdType="pubmed">23300413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2013 Jan 17;152(1-2):39-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23332745</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(6):e26284</Citation><ArticleIdList><ArticleId IdType="pubmed">22719818</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Microbiol. 2011 Oct;13(10):2667-80</Citation><ArticleIdList><ArticleId IdType="pubmed">21883787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2016 May 11;19(5):731-43</Citation><ArticleIdList><ArticleId IdType="pubmed">27173935</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2016 Jun;68(6):1483-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26749064</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2015 Mar 16;4:</Citation><ArticleIdList><ArticleId IdType="pubmed">25774601</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2015 Sep 22;16:203</Citation><ArticleIdList><ArticleId IdType="pubmed">26395444</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Jul;42(7):558-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20581876</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2010 Jun 25;32(6):815-27</Citation><ArticleIdList><ArticleId IdType="pubmed">20620945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2001 Feb 15;409(6822):860-921</Citation><ArticleIdList><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Apr 02;9(4):e93379</Citation><ArticleIdList><ArticleId IdType="pubmed">24695491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2014 Aug;32(8):834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24997786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut Microbes. 2016;7(2):178-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26939746</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2015 Feb 12;160(4):583-594</Citation><ArticleIdList><ArticleId IdType="pubmed">25640238</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2010 Feb;4(2):232-41</Citation><ArticleIdList><ArticleId IdType="pubmed">19865183</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 May 13;17(5):603-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25974302</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2015 Sep;61(9):1207-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26185218</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Dec;19(12):2317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19819907</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Oct 8;461(7265):747-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19812666</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 May;42(5):426-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20383147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D1001-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24316577</ArticleId></ArticleIdList></Reference><Reference><Citation>C R Biol. 2016 Jul-Aug;339(7-8):319-23</Citation><ArticleIdList><ArticleId IdType="pubmed">27236827</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28751719</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>07</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of non-activated lymphocytes using three-dimensional refractive index tomography and machine learning.</ArticleTitle><Pagination><MedlinePgn>6654</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-06311-y</ELocationID><Abstract><AbstractText>Identification of lymphocyte cell types are crucial for understanding their pathophysiological roles in human diseases. Current methods for discriminating lymphocyte cell types primarily rely on labelling techniques with magnetic beads or fluorescence agents, which take time and have costs for sample preparation and may also have a potential risk of altering cellular functions. Here, we present the identification of non-activated lymphocyte cell types at the single-cell level using refractive index (RI) tomography and machine learning. From the measurements of three-dimensional RI maps of individual lymphocytes, the morphological and biochemical properties of the cells are quantitatively retrieved. To construct cell type classification models, various statistical classification algorithms are compared, and the k-NN (k...=...4) algorithm was selected. The algorithm combines multiple quantitative characteristics of the lymphocyte to construct the cell type classifiers. After optimizing the feature sets via cross-validation, the trained classifiers enable identification of three lymphocyte cell types (B, CD4+ T, and CD8+ T cells) with high sensitivity and specificity. The present method, which combines RI tomography and machine learning for the first time to our knowledge, could be a versatile tool for investigating the pathophysiological roles of lymphocytes in various diseases including cancers, autoimmune diseases, and virus infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jonghee</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KAIST Institute Health Science and Technology, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics, University of Cambridge, Cambridge, CB3 0HE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>YoungJu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KAIST Institute Health Science and Technology, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min-Hyeok</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, KAIST, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyoohyun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KAIST Institute Health Science and Technology, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>SangYun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KAIST Institute Health Science and Technology, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Suk-Jo</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, KAIST, Daejeon, 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>YongKeun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea. yk.park@kaist.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KAIST Institute Health Science and Technology, Daejeon, 34141, Republic of Korea. yk.park@kaist.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tomocube, Inc., Daejeon, 34051, Republic of Korea. yk.park@kaist.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="Y">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012031" MajorTopicYN="N">Refractometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014054" MajorTopicYN="N">Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28751719</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-06311-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-06311-y</ArticleId><ArticleId IdType="pmc">PMC5532204</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Methods. 2017 Jul 16;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28723583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Sep 20;7(1):11943</Citation><ArticleIdList><ArticleId IdType="pubmed">28931937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2010 Jan;11(1):14-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20016505</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Appl. 2014 Feb 27;1:null</Citation><ArticleIdList><ArticleId IdType="pubmed">25419536</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2015;20(11):111208</Citation><ArticleIdList><ArticleId IdType="pubmed">26259511</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2012 Aug;36(4):2259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">21479624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2015 Jun 03;5:10827</Citation><ArticleIdList><ArticleId IdType="pubmed">26039793</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1993 Jun 1;81(11):2844-53</Citation><ArticleIdList><ArticleId IdType="pubmed">8499622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2009 Apr;27(4):378-86</Citation><ArticleIdList><ArticleId IdType="pubmed">19349973</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2006 Apr;53(4):762-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16602586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Aug 24;7(1):9306</Citation><ArticleIdList><ArticleId IdType="pubmed">28839153</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry A. 2017 May;91(5):510-518</Citation><ArticleIdList><ArticleId IdType="pubmed">28426150</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biophotonics. 2013 May;6(5):416-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22927364</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2006 Jan;6(1):24-37</Citation><ArticleIdList><ArticleId IdType="pubmed">16397525</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2014 Apr;19(4):046009</Citation><ArticleIdList><ArticleId IdType="pubmed">24723114</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 May 29;423(6939):506-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12724780</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Dec 21;10(12):e0145327</Citation><ArticleIdList><ArticleId IdType="pubmed">26690915</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2015;20(11):111207</Citation><ArticleIdList><ArticleId IdType="pubmed">26205909</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2014 Jul;18(5):772-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24835183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2004 Mar;5(3):247-53</Citation><ArticleIdList><ArticleId IdType="pubmed">14985712</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS Appl Mater Interfaces. 2017 Mar 8;9(9):7908-7917</Citation><ArticleIdList><ArticleId IdType="pubmed">28198615</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 2014 Apr 1;39(7):2210-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24686713</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry B Clin Cytom. 2007 Nov;72(6):442-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17474131</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17428922</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 2011 Dec 1;36(23):4677-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22139281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab Chip. 2015 Feb 21;15(4):1123-32</Citation><ArticleIdList><ArticleId IdType="pubmed">25537881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Oct 04;6:34257</Citation><ArticleIdList><ArticleId IdType="pubmed">27698484</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2005 Apr 1;105(7):2828-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15572590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Nov 22;6:36815</Citation><ArticleIdList><ArticleId IdType="pubmed">27874018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioessays. 2013 Dec;35(12):1050-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24114984</ArticleId></ArticleIdList></Reference><Reference><Citation>Analyst. 2016 Jun 21;141(12):3756-64</Citation><ArticleIdList><ArticleId IdType="pubmed">27067644</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2015 Jul 27;23(15):18996</Citation><ArticleIdList><ArticleId IdType="pubmed">26367562</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Opt Express. 2015 Sep 09;6(10):3865-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26504637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2014 May 28;4:5090</Citation><ArticleIdList><ArticleId IdType="pubmed">24867385</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(11):e49502</Citation><ArticleIdList><ArticleId IdType="pubmed">23166689</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Feb 3;403(6769):503-11</Citation><ArticleIdList><ArticleId IdType="pubmed">10676951</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2009 Jan 5;17(1):266-77</Citation><ArticleIdList><ArticleId IdType="pubmed">19129896</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2015 Jun 29;23(13):16933-48</Citation><ArticleIdList><ArticleId IdType="pubmed">26191704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2001 Feb;2(2):123-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11175804</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2014 Jan;19(1):011005</Citation><ArticleIdList><ArticleId IdType="pubmed">23797986</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2004;9(3):247-58</Citation><ArticleIdList><ArticleId IdType="pubmed">15169980</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Lett. 2015 Nov 15;40(22):5407-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26565886</ArticleId></ArticleIdList></Reference><Reference><Citation>Opt Express. 2015 Jun 15;23(12):15792-805</Citation><ArticleIdList><ArticleId IdType="pubmed">26193558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatology. 2004 Nov;40(5):1062-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15486925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Adv. 2017 Aug 04;3(8):e1700606</Citation><ArticleIdList><ArticleId IdType="pubmed">28798957</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microsc. 2002 Feb;205(Pt 2):165-76</Citation><ArticleIdList><ArticleId IdType="pubmed">11879431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2013 Mar 28;13(4):4170-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23539026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Mar 15;6:21471</Citation><ArticleIdList><ArticleId IdType="pubmed">26975219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Sep 08;6:33084</Citation><ArticleIdList><ArticleId IdType="pubmed">27605489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Apr 21;7(1):1039</Citation><ArticleIdList><ArticleId IdType="pubmed">28432323</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28740485</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice.</ArticleTitle><Pagination><MedlinePgn>1222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2017.01222</ELocationID><Abstract><AbstractText>Rheumatoid arthritis (RA) is characterized by chronic autoinflammation of the joints, with a prevalence of about 1% in Western populations. Evidence in recent years has linked RA to changes in the gut microbiota (dysbiosis). Interestingly, helminths have been shown to have therapeutic activity in RA. Specifically, a glycoprotein containing phosphorylcholine (PC) extracted from helminths was found to have immunomodulatory activity. We have previously developed a novel chimeric compound composed of tuftsin-PC (TPC) that attenuates the joint destruction in mice with collagen-induced arthritis (CIA). Here, we address the interrelationship between TPC immunomodulatory activity and the gut microbiota in CIA mice. Preventive therapy with TPC in mice with arthritis maintained a physiological arthritis score as well as a steady gut microbial environment, similar to that of healthy controls, in contrast to CIA mice with severe disease. The microbial composition differed significantly between healthy and phosphate-buffered saline-treated CIA mice, enabling classifying test samples by machine learning based on levels of a small number of bacterial species. Using these bacterial biomarkers, all TPC-treated CIA mice were classified as healthy. Thus, we describe a clear correlation between TPC treatment, healthy gut microbial communities, and prevention of arthritis. This is the first study to demonstrate the immunomodulatory effect of helminth derivatives in autoimmune diseases and the link to gut microbiota.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ben-Amram</LastName><ForeName>Hila</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bar-Ilan UniversitySafed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashi</LastName><ForeName>Tomer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv UniversityTel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werbner</LastName><ForeName>Nir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bar-Ilan UniversitySafed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuman</LastName><ForeName>Hadar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bar-Ilan UniversitySafed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fridkin</LastName><ForeName>Mati</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Organic Chemistry, The Weizmann Institute of ScienceRehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blank</LastName><ForeName>Miri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv UniversityTel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoenfeld</LastName><ForeName>Yehuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv UniversityTel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koren</LastName><ForeName>Omry</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bar-Ilan UniversitySafed, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">collagen-induced arthritis</Keyword><Keyword MajorTopicYN="N">helminths</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">tuftsin-phosphorylcholine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28740485</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2017.01222</ArticleId><ArticleId IdType="pmc">PMC5502260</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genome Biol. 2011 Jun 24;12(6):R60</Citation><ArticleIdList><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Peptides. 1999;20(5):645-74</Citation><ArticleIdList><ArticleId IdType="pubmed">10465518</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2016 Feb 17;7:185</Citation><ArticleIdList><ArticleId IdType="pubmed">26925050</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2006 Jul;72(7):5069-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16820507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2014 Jul;73(7):1316-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24550173</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 1973 Dec 10;55(3):616-22</Citation><ArticleIdList><ArticleId IdType="pubmed">4586614</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2013 Nov 05;2:e01202</Citation><ArticleIdList><ArticleId IdType="pubmed">24192039</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2015 Nov 27;7(12):9768-84</Citation><ArticleIdList><ArticleId IdType="pubmed">26633470</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12011421</ArticleId></ArticleIdList></Reference><Reference><Citation>ISME J. 2012 Aug;6(8):1621-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22402401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2008 Apr;67(4):518-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17704067</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rev Allergy Immunol. 2013 Oct;45(2):211-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23325330</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2015 May;59:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25864802</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2017 Jul;29(4):374-377</Citation><ArticleIdList><ArticleId IdType="pubmed">28376066</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2015 Dec 15;6:1408</Citation><ArticleIdList><ArticleId IdType="pubmed">26697002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2010 May;7(5):335-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>mSystems. 2017 Jan 31;2(1):null</Citation><ArticleIdList><ArticleId IdType="pubmed">28168224</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Microbiol. 2016 Aug;32:14-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27116368</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Environ Microbiol. 2005 Dec;71(12):8228-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16332807</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 11;9(7):e95534</Citation><ArticleIdList><ArticleId IdType="pubmed">25014551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Nov 1;195(9):4059-66</Citation><ArticleIdList><ArticleId IdType="pubmed">26477048</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Aug;21(8):895-905</Citation><ArticleIdList><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Oct 1;26(19):2460-1</Citation><ArticleIdList><ArticleId IdType="pubmed">20709691</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2015 Jan;56:111-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25479760</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2016 Sep;15(9):859-69</Citation><ArticleIdList><ArticleId IdType="pubmed">27392501</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Biochem Mol Biol. 1989;24(1):1-40</Citation><ArticleIdList><ArticleId IdType="pubmed">2667894</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2016 Apr;184(1):19-28</Citation><ArticleIdList><ArticleId IdType="pubmed">26618631</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Apr 29;352(6285):608-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27080105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28626972</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5448</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>Pediatric diabetes</Title><ISOAbbreviation>Pediatr Diabetes</ISOAbbreviation></Journal><ArticleTitle>NIRCa: An artificial neural network-based insulin resistance calculator.</ArticleTitle><Pagination><MedlinePgn>231-235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pedi.12551</ELocationID><Abstract><AbstractText Label="BACKGROUND">Direct measurement of insulin sensitivity in children with type 1 diabetes is cumbersome and time consuming.</AbstractText><AbstractText Label="OBJECTIVE">The aim of our study was to develop novel, accurate machine learning-based methods of insulin resistance estimation in children with type 1 diabetes.</AbstractText><AbstractText Label="METHODS">A hyperinsulinemic hyperglycemic clamp study was performed to evaluate the glucose disposal rate (GDR) in a study group consisting of 315 patients aged 7.6 to 19.7 years. The group was randomly divided into a training and independent testing set for model performance assessment. GDR was estimated on the basis of simple clinical variables using 2 non-linear methods: artificial neural networks (ANN) and multivariate adaptive regression splines (MARSplines). The results were compared against the most frequently used predictive model, based on waist circumference, triglyceride (TG), and HbA1c levels.</AbstractText><AbstractText Label="RESULTS">The reference model showed moderate performance ( R <sup>2</sup> = 0.26) with a median absolute percentage error of 49.1%, and with the worst fit observed in young (7-12 years) children ( R <sup>2</sup> = 0.17). Predictions of the MARSplines model were significantly more accurate than those of the reference model (median error 3.6%, R <sup>2</sup> = 0.44 P &lt; .0001). The predictions of the ANN, however, showed significantly lower error than those of the reference model (P &lt; .0001) and MARSplines (P &lt; .0001) and better fit regardless of patient age. ANN-estimated GDRs were within a ..20% error range in 75% of cases with a median error of 0.6% and an R <sup>2</sup> = 0.66. The predictive tool is available at http://link.konsta.com.pl/gdr.</AbstractText><AbstractText Label="CONCLUSIONS">The developed GDR estimation model reliant on ANN allows for an optimized prediction of GDR for research and clinical purposes.</AbstractText><CopyrightInformation>.. 2017 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stawiski</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6550-3384</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietrzak</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M..ynarski</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fendler</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5083-9168</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szadkowska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Pediatr Diabetes</MedlineTA><NlmUniqueID>100939345</NlmUniqueID><ISSNLinking>1399-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003925" MajorTopicYN="N">Diabetic Angiopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015309" MajorTopicYN="N">Glucose Clamp Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058246" MajorTopicYN="N">Prehypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011627" MajorTopicYN="N">Puberty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">artificial neural networks</Keyword><Keyword MajorTopicYN="Y">biomedical statistics</Keyword><Keyword MajorTopicYN="Y">diabetes in childhood</Keyword><Keyword MajorTopicYN="Y">insulin sensitivity and resistance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28626972</ArticleId><ArticleId IdType="doi">10.1111/pedi.12551</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28611016</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2369-2960</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>How Do You #relax When You're #stressed? A Content Analysis and Infodemiology Study of Stress-Related Tweets.</ArticleTitle><Pagination><MedlinePgn>e35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/publichealth.5939</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Stress is a contributing factor to many major health problems in the United States, such as heart disease, depression, and autoimmune diseases. Relaxation is often recommended in mental health treatment as a frontline strategy to reduce stress, thereby improving health conditions. Twitter is a microblog platform that allows users to post their own personal messages (tweets), including their expressions about feelings and actions related to stress and stress management (eg, relaxing). While Twitter is increasingly used as a source of data for understanding mental health from a population perspective, the specific issue of stress-as manifested on Twitter-has not yet been the focus of any systematic study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of our study was to understand how people express their feelings of stress and relaxation through Twitter messages. In addition, we aimed at investigating automated natural language processing methods to (1) classify stress versus nonstress and relaxation versus nonrelaxation tweets, and (2) identify first-hand experience-that is, who is the experiencer-in stress and relaxation tweets.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We first performed a qualitative content analysis of 1326 and 781 tweets containing the keywords "stress" and "relax," respectively. We then investigated the use of machine learning algorithms-in particular naive Bayes and support vector machines-to automatically classify tweets as stress versus nonstress and relaxation versus nonrelaxation. Finally, we applied these classifiers to sample datasets drawn from 4 cities in the United States (Los Angeles, New York, San Diego, and San Francisco) obtained from Twitter's streaming application programming interface, with the goal of evaluating the extent of any correlation between our automatic classification of tweets and results from public stress surveys.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Content analysis showed that the most frequent topic of stress tweets was education, followed by work and social relationships. The most frequent topic of relaxation tweets was rest &amp; vacation, followed by nature and water. When we applied the classifiers to the cities dataset, the proportion of stress tweets in New York and San Diego was substantially higher than that in Los Angeles and San Francisco. In addition, we found that characteristic expressions of stress and relaxation varied for each city based on its geolocation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This content analysis and infodemiology study revealed that Twitter, when used in conjunction with natural language processing techniques, is a useful data source for understanding stress and stress management strategies, and can potentially supplement infrequently collected survey-based stress data.</AbstractText><CopyrightInformation>..Son Doan, Amanda Ritchart, Nicholas Perry, Juan D Chaparro, Mike Conway. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 13.06.2017.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doan</LastName><ForeName>Son</ForeName><Initials>S</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-7284-1306</Identifier><AffiliationInfo><Affiliation>Deparment of Biomedical Informatics, University of California, San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchart</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2476-8052</Identifier><AffiliationInfo><Affiliation>Linguistics Department, University of California, San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3631-301X</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaparro</LastName><ForeName>Juan D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-8073-8894</Identifier><AffiliationInfo><Affiliation>Deparment of Biomedical Informatics, University of California, San Diego, La Jolla, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conway</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3209-8108</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 LM011393</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM011271</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HL108460</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Twitter</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">relaxation</Keyword><Keyword MajorTopicYN="N">social media</Keyword><Keyword MajorTopicYN="N">stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28611016</ArticleId><ArticleId IdType="pii">v3i2e35</ArticleId><ArticleId IdType="doi">10.2196/publichealth.5939</ArticleId><ArticleId IdType="pmc">PMC5487742</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Public Health. 2014 Jul;104(7):e62-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24832138</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 May 04;6(5):e19467</Citation><ArticleIdList><ArticleId IdType="pubmed">21573238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Altern Complement Med. 2009 May;15(5):593-600</Citation><ArticleIdList><ArticleId IdType="pubmed">19432513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Soc Psychol. 2013 Dec;105(6):996-1012</Citation><ArticleIdList><ArticleId IdType="pubmed">24128185</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Cancer. 2013 Oct 29;13:508</Citation><ArticleIdList><ArticleId IdType="pubmed">24168075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Behav Med. 2008 Feb;35(1):26-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18347902</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2015 Dec;128(12):1335-50</Citation><ArticleIdList><ArticleId IdType="pubmed">26159633</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2008 Sep 1;168(5):481-91; discussion 492-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18611955</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2004 May;29(4):448-74</Citation><ArticleIdList><ArticleId IdType="pubmed">14749092</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Clin Psychol. 2005;1:293-319</Citation><ArticleIdList><ArticleId IdType="pubmed">17716090</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Psychol. 1994 May;49(5):389-404</Citation><ArticleIdList><ArticleId IdType="pubmed">8024167</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2009 Jun;36(6):497-505</Citation><ArticleIdList><ArticleId IdType="pubmed">19460657</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Behav Med. 2015 Jun;5(2):160-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26029278</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2014 Oct 15;16(10):e237</Citation><ArticleIdList><ArticleId IdType="pubmed">25591063</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2015 Feb;26(2):159-69</Citation><ArticleIdList><ArticleId IdType="pubmed">25605707</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2014 Oct 06;16(10):e228</Citation><ArticleIdList><ArticleId IdType="pubmed">25289463</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Nov 29;5(11):e14118</Citation><ArticleIdList><ArticleId IdType="pubmed">21124761</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2015 Apr 02;17(4):e84</Citation><ArticleIdList><ArticleId IdType="pubmed">25843553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Dent Res. 2011 Sep;90(9):1047-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21768306</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Internet Res. 2013 Aug 29;15(8):e174</Citation><ArticleIdList><ArticleId IdType="pubmed">23989137</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2013 Apr 29;13:407</Citation><ArticleIdList><ArticleId IdType="pubmed">23627738</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Dent Assoc. 2014 Jul;145(7):737-43</Citation><ArticleIdList><ArticleId IdType="pubmed">24982280</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 2000 May-Jun;62(3):304-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10845343</ArticleId></ArticleIdList></Reference><Reference><Citation>J Consult Clin Psychol. 1991 Dec;59(6):906-15</Citation><ArticleIdList><ArticleId IdType="pubmed">1774375</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1993 Sep 27;153(18):2093-101</Citation><ArticleIdList><ArticleId IdType="pubmed">8379800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28590455</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Machine-Learned Data Structures of Lipid Marker Serum Concentrations in Multiple Sclerosis Patients Differ from Those in Healthy Subjects.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E1217</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms18061217</ELocationID><Abstract><AbstractText>Lipid metabolism has been suggested to be a major pathophysiological mechanism of multiple sclerosis (MS). With the increasing knowledge about lipid signaling, acquired data become increasingly complex making bioinformatics necessary in lipid research. We used unsupervised machine-learning to analyze lipid marker serum concentrations, pursuing the hypothesis that for the most relevant markers the emerging data structures will coincide with the diagnosis of MS. Machine learning was implemented as emergent self-organizing feature maps (ESOM) combined with the U*-matrix visualization technique. The data space consisted of serum concentrations of three main classes of lipid markers comprising eicosanoids (<i>d</i> = 11 markers), ceramides (<i>d</i> = 10), and lyosophosphatidic acids (<i>d</i> = 6). They were analyzed in cohorts of MS patients (<i>n</i> = 102) and healthy subjects (<i>n</i> = 301). Clear data structures in the high-dimensional data space were observed in eicosanoid and ceramides serum concentrations whereas no clear structure could be found in lysophosphatidic acid concentrations. With ceramide concentrations, the structures that had emerged from unsupervised machine-learning almost completely overlapped with the known grouping of MS patients versus healthy subjects. This was only partly provided by eicosanoid serum concentrations. Thus, unsupervised machine-learning identified distinct data structures of bioactive lipid serum concentrations. These structures could be superimposed with the known grouping of MS patients versus healthy subjects, which was almost completely possible with ceramides. Therefore, based on the present analysis, ceramides are first-line candidates for further exploration as drug-gable targets or biomarkers in MS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L..tsch</LastName><ForeName>J..rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, Frankfurt am Main 60590, Germany. j.loetsch@em.uni-frankfurt.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology-Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany. j.loetsch@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thrun</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DataBionics Research Group, University of Marburg, Hans-Meerwein-Strasse 6, Marburg 35032, Germany. mthrun@Mathematik.Uni-Marburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerch</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology-Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany. lerch@Mathematik.Uni-Marburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunkhorst</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe-University Hospital, Schleusenweg 2-16, Frankfurt am Main 60528, Germany. robert.brunkhorst@kgu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiffmann</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, Frankfurt am Main 60590, Germany. susanne.schiffmann@med.uni-frankfurt.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology-Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany. susanne.schiffmann@med.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, Frankfurt am Main 60590, Germany. thomas@med.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegder</LastName><ForeName>Irmgard</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, Frankfurt am Main 60590, Germany. tegeder@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geisslinger</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, Frankfurt am Main 60590, Germany. geisslinger@em.uni-frankfurt.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute of Molecular Biology and Applied Ecology-Project Group Translational Medicine and Pharmacology (IME-TMP), Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany. geisslinger@em.uni-frankfurt.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ultsch</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DataBionics Research Group, University of Marburg, Hans-Meerwein-Strasse 6, Marburg 35032, Germany. ultsch@Mathematik.Uni-Marburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002518">Ceramides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015777">Eicosanoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008246">Lysophospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>PG6M3969SG</RegistryNumber><NameOfSubstance UI="C032881">lysophosphatidic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002518" MajorTopicYN="N">Ceramides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015777" MajorTopicYN="N">Eicosanoids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048088" MajorTopicYN="N">Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="Y">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008246" MajorTopicYN="N">Lysophospholipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">ceramides</Keyword><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">machine-learning</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">prostanoids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28590455</ArticleId><ArticleId IdType="pii">ijms18061217</ArticleId><ArticleId IdType="doi">10.3390/ijms18061217</ArticleId><ArticleId IdType="pmc">PMC5486040</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Lipid Res. 2009 Apr;50 Suppl:S423-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19095631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2016 Jan;5:53-65</Citation><ArticleIdList><ArticleId IdType="pubmed">26856944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2012 Jul 15;248(1-2):53-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22579051</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2017 Feb;66:95-104</Citation><ArticleIdList><ArticleId IdType="pubmed">28040499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Markers. 2006;22(4):183-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17124339</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 09;8(12 ):e81228</Citation><ArticleIdList><ArticleId IdType="pubmed">24349046</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biopharm Stat. 1997 Mar;7(1):171-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9056596</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2015 Oct;93(9):825-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25833068</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2008 Nov;131(Pt 11):3092-102</Citation><ArticleIdList><ArticleId IdType="pubmed">18772223</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1994 Jun 11;308(6943):1552</Citation><ArticleIdList><ArticleId IdType="pubmed">8019315</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2009 Apr;265(4):459-64</Citation><ArticleIdList><ArticleId IdType="pubmed">19019188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2013 Sep;19(9):1161-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23933981</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2016 Aug;10 (8):965-78</Citation><ArticleIdList><ArticleId IdType="pubmed">26928964</ArticleId></ArticleIdList></Reference><Reference><Citation>Q Rev Biol. 2011 Dec;86(4):287-321</Citation><ArticleIdList><ArticleId IdType="pubmed">22384749</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 1982 Jun;7(6):727-35</Citation><ArticleIdList><ArticleId IdType="pubmed">7121719</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2015 May;46:280-92</Citation><ArticleIdList><ArticleId IdType="pubmed">25697397</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscientist. 2011 Feb;17(1):79-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21343408</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRN Neurol. 2013 Sep 24;2013:981070</Citation><ArticleIdList><ArticleId IdType="pubmed">24205443</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Enzymol. 2007;432:247-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17954221</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(2):e55859</Citation><ArticleIdList><ArticleId IdType="pubmed">23409068</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroinflammation. 2011 Oct 04;8:127</Citation><ArticleIdList><ArticleId IdType="pubmed">21970791</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2007 Apr;17(2):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17388952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28570570</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>e0178366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0178366</ELocationID><Abstract><AbstractText>Gait speed is a powerful clinical marker for mobility impairment in patients suffering from neurological disorders. However, assessment of gait speed in coordination with delivery of comprehensive care is usually constrained to clinical environments and is often limited due to mounting demands on the availability of trained clinical staff. These limitations in assessment design could give rise to poor ecological validity and limited ability to tailor interventions to individual patients. Recent advances in wearable sensor technologies have fostered the development of new methods for monitoring parameters that characterize mobility impairment, such as gait speed, outside the clinic, and therefore address many of the limitations associated with clinical assessments. However, these methods are often validated using normal gait patterns; and extending their utility to subjects with gait impairments continues to be a challenge. In this paper, we present a machine learning method for estimating gait speed using a configurable array of skin-mounted, conformal accelerometers. We establish the accuracy of this technique on treadmill walking data from subjects with normal gait patterns and subjects with multiple sclerosis-induced gait impairments. For subjects with normal gait, the best performing model systematically overestimates speed by only 0.01 m/s, detects changes in speed to within less than 1%, and achieves a root-mean-square-error of 0.12 m/s. Extending these models trained on normal gait to subjects with gait impairments yields only minor changes in model performance. For example, for subjects with gait impairments, the best performing model systematically overestimates speed by 0.01 m/s, quantifies changes in speed to within 1%, and achieves a root-mean-square-error of 0.14 m/s. Additional analyses demonstrate that there is no correlation between gait speed estimation error and impairment severity, and that the estimated speeds maintain the clinical significance of ground truth speed in this population. These results support the use of wearable accelerometer arrays for estimating walking speed in normal subjects and their extension to MS patient cohorts with gait impairment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGinnis</LastName><ForeName>Ryan S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8396-6967</Identifier><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Vermont, Burlington, Vermont, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahadevan</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Yaejin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Motor Control Research Laboratory, University of Illinois at Urbana-Champaign, Champaign, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seagers</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Nirav</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>John A</ForeName><Initials>JA</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiCristofaro</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Ikaro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jortberg</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceruolo</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pindado</LastName><ForeName>Jesus A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosnoff</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Motor Control Research Laboratory, University of Illinois at Urbana-Champaign, Champaign, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaffari</LastName><ForeName>Roozbeh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Shyamal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MC10, Inc., Lexington, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="Y">Biosensing Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="Y">Gait</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="Y">Skin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28570570</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0178366</ArticleId><ArticleId IdType="pii">PONE-D-16-26899</ArticleId><ArticleId IdType="pmc">PMC5453431</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Physiol Meas. 2009 Apr;30(4):R1-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19342767</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 1997 Aug;44(8):753-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9254988</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2004;3:2283-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17272183</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurol. 2001 Jun;14(3):271-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11371748</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroeng Rehabil. 2015 Feb 10;12:14</Citation><ArticleIdList><ArticleId IdType="pubmed">25890382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2009 Jan;29(1):138-42</Citation><ArticleIdList><ArticleId IdType="pubmed">18951800</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Neurol. 2012 Dec 27;12:161</Citation><ArticleIdList><ArticleId IdType="pubmed">23270547</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2011 Jun;59(6):1069-73</Citation><ArticleIdList><ArticleId IdType="pubmed">21649615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2012;12 (7):8507-25</Citation><ArticleIdList><ArticleId IdType="pubmed">23012503</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Eng Phys. 1999 Mar;21(2):87-94</Citation><ArticleIdList><ArticleId IdType="pubmed">10426508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 1985;18(1):39-47</Citation><ArticleIdList><ArticleId IdType="pubmed">3980487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2010 Jul;3(4):229-39</Citation><ArticleIdList><ArticleId IdType="pubmed">21179614</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2007 Aug 17;8:83</Citation><ArticleIdList><ArticleId IdType="pubmed">17705860</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2011 Oct;34(4):462-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21807521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2006 Oct;12(5):620-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17086909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2012;12(5):6102-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22778632</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2010 Nov 16;6:767-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21173883</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Med Rehabil Clin N Am. 2013 May;24(2):325-36</Citation><ArticleIdList><ArticleId IdType="pubmed">23598266</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2012 Feb;35(2):192-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21945386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2002 May;35(5):689-99</Citation><ArticleIdList><ArticleId IdType="pubmed">11955509</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2013 Sep;38(4):974-80</Citation><ArticleIdList><ArticleId IdType="pubmed">23810335</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient. 2011;4(3):189-201</Citation><ArticleIdList><ArticleId IdType="pubmed">21766914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2008 Apr;14(3):383-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17942508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2005 Oct;60(10):1304-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16282564</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23080</Citation><ArticleIdList><ArticleId IdType="pubmed">21850254</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J MS Care. 2011 Spring;13(1):4-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24453700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28569238</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1752-7163</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>06</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of breath research</Title><ISOAbbreviation>J Breath Res</ISOAbbreviation></Journal><ArticleTitle>Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs.</ArticleTitle><Pagination><MedlinePgn>026007</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1088/1752-7163/aa6ac6</ELocationID><Abstract><AbstractText>Diabetes is a disease that involves dysregulation of metabolic processes. Patients with type 1 diabetes (T1D) require insulin injections and measured food intake to maintain clinical stability, manually tracking their results by measuring blood glucose levels. Low blood glucose levels, hypoglycemia, can be extremely dangerous and can result in seizures, coma, or even death. Canines trained as diabetes alert dogs (DADs) have demonstrated the ability to detect hypoglycemia from breath, which led us to hypothesize that hypoglycemia, a metabolic dysregulation leading to low blood glucose levels, could be identified through analyzing volatile organic compounds (VOCs) contained within breath. We hoped to replicate the canines' detection ability and success by analytically using gas chromatography/mass spectrometry of VOCs in 128 breath samples collected from 52 youths with T1D at two different diabetes camps. We used different tests for significance including Ranksum, Student's T-test, and difference between means, and found a subset of 56 traces of potential metabolites. Principle component and linear discriminant analysis (LDA) confirmed a hypoglycemic signature likely resides within this group. Supervised machine learning combined with LDA narrowed the list of likely components to seven. The technique of leave one out cross validation demonstrated the model thus developed has a sensitivity of 91% (95% confidence interval (CI) [57.1, 94.7]) and a specificity of 84% (95% CI [73.0, 92.7]) at identifying hypoglycemia. Confidence intervals were obtained by bootstrapping. These results demonstrate that it is possible to differentiate breath samples obtained during hypoglycemic events from all other breath samples by analytical means and could lead to developing a simple analytical monitoring device as an alternative to using DADs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siegel</LastName><ForeName>Amanda P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Integrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, IN, United States of America. Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, IN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daneshkhah</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Dana S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Sudhir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Varahramyan</LastName><ForeName>Kody</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Mangilal</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Breath Res</MedlineTA><NlmUniqueID>101463871</NlmUniqueID><ISSNLinking>1752-7155</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055549">Volatile Organic Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016002" MajorTopicYN="N">Discriminant Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055549" MajorTopicYN="N">Volatile Organic Compounds</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28569238</ArticleId><ArticleId IdType="doi">10.1088/1752-7163/aa6ac6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28487747</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-6718</ISSN><JournalIssue CitedMedium="Internet"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>A Predictive Model for Guillain-Barr.. Syndrome Based on Single Learning Algorithms.</ArticleTitle><Pagination><MedlinePgn>8424198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2017/8424198</ELocationID><Abstract><AbstractText><i>Background</i>. Guillain-Barr.. Syndrome (GBS) is a potentially fatal autoimmune neurological disorder. The severity varies among the four main subtypes, named as Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), Acute Motor Sensory Axonal Neuropathy (AMSAN), and Miller-Fisher Syndrome (MF). A proper subtype identification may help to promptly carry out adequate treatment in patients. <i>Method</i>. We perform experiments with 15 single classifiers in two scenarios: four subtypes' classification and One versus All (OvA) classification. We used a dataset with the 16 relevant features identified in a previous phase. Performance evaluation is made by 10-fold cross validation (10-FCV). Typical classification performance measures are used. A statistical test is conducted in order to identify the top five classifiers for each case. <i>Results</i>. In four GBS subtypes' classification, half of the classifiers investigated in this study obtained an average accuracy above 0.90. In OvA classification, the two subtypes with the largest number of instances resulted in the best classification results. <i>Conclusions</i>. This study represents a comprehensive effort on creating a predictive model for Guillain-Barr.. Syndrome subtypes. Also, the analysis performed in this work provides insight about the best single classifiers for each classification case.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canul-Reich</LastName><ForeName>Juana</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1893-1332</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Km. 1 Carretera Cunduac..n, Jalpa de M..ndez, Col. Esmeralda, CP 86690, Cunduac..n, TAB, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frausto-Sol..s</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Tecnol..gico de Ciudad Madero, Av. 1o. de Mayo esq. Sor Juana In..s de la Cruz s/n, Col. Los Mangos, 89440 Ciudad Madero, TAMPS, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern..ndez-Torruco</LastName><ForeName>Jos..</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3146-9349</Identifier><AffiliationInfo><Affiliation>Divisi..n Acad..mica de Inform..tica y Sistemas, Universidad Ju..rez Aut..noma de Tabasco, Km. 1 Carretera Cunduac..n, Jalpa de M..ndez, Col. Esmeralda, CP 86690, Cunduac..n, TAB, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28487747</ArticleId><ArticleId IdType="doi">10.1155/2017/8424198</ArticleId><ArticleId IdType="pmc">PMC5405364</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Neurophysiol. 2012 Aug;123(8):1487-95</Citation><ArticleIdList><ArticleId IdType="pubmed">22480600</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 2004;64(6):597-610</Citation><ArticleIdList><ArticleId IdType="pubmed">15018590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 Jun;67(6):781-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20517939</ArticleId></ArticleIdList></Reference><Reference><Citation>J Assoc Physicians India. 2005 Sep;53:764-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16334619</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015 :7234-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26737961</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2011 Mar 15;76(11):968-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21403108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2007 Jul;6(7):589-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17537676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28444127</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1367-4811</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>17</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Bioinformatics (Oxford, England)</Title><ISOAbbreviation>Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>HLA class I binding prediction via convolutional neural networks.</ArticleTitle><Pagination><MedlinePgn>2658-2665</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btx264</ELocationID><Abstract><AbstractText Label="Motivation" NlmCategory="UNASSIGNED">Many biological processes are governed by protein-ligand interactions. One such example is the recognition of self and non-self cells by the immune system. This immune response process is regulated by the major histocompatibility complex (MHC) protein which is encoded by the human leukocyte antigen (HLA) complex. Understanding the binding potential between MHC and peptides can lead to the design of more potent, peptide-based vaccines and immunotherapies for infectious autoimmune diseases.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">We apply machine learning techniques from the natural language processing (NLP) domain to address the task of MHC-peptide binding prediction. More specifically, we introduce a new distributed representation of amino acids, name HLA-Vec, that can be used for a variety of downstream proteomic machine learning tasks. We then propose a deep convolutional neural network architecture, name HLA-CNN, for the task of HLA class I-peptide binding prediction. Experimental results show combining the new distributed representation with our HLA-CNN architecture achieves state-of-the-art results in the majority of the latest two Immune Epitope Database (IEDB) weekly automated benchmark datasets. We further apply our model to predict binding on the human genome and identify 15 genes with potential for self binding.</AbstractText><AbstractText Label="Availability and Implementation" NlmCategory="UNASSIGNED">Codes to generate the HLA-Vec and HLA-CNN are publicly available at: https://github.com/uci-cbcl/HLA-bind .</AbstractText><AbstractText Label="Contact" NlmCategory="UNASSIGNED">xhx@ics.uci.edu.</AbstractText><AbstractText Label="Supplementary information" NlmCategory="UNASSIGNED">Supplementary data are available at Bioinformatics online.</AbstractText><CopyrightInformation>.. The Author (2017). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vang</LastName><ForeName>Yeeleng S</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Genomics and Bioinformatics, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioinformatics</MedlineTA><NlmUniqueID>9808944</NlmUniqueID><ISSNLinking>1367-4803</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28444127</ArticleId><ArticleId IdType="pii">3746909</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btx264</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28379999</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Exploration of machine learning techniques in predicting multiple sclerosis disease course.</ArticleTitle><Pagination><MedlinePgn>e0174866</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0174866</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the value of machine learning methods for predicting multiple sclerosis disease course.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">1693 CLIMB study patients were classified as increased EDSS...1.5 (worsening) or not (non-worsening) at up to five years after baseline visit. Support vector machines (SVM) were used to build the classifier, and compared to logistic regression (LR) using demographic, clinical and MRI data obtained at years one and two to predict EDSS at five years follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline data alone provided little predictive value. Clinical observation for one year improved overall SVM sensitivity to 62% and specificity to 65% in predicting worsening cases. The addition of one year MRI data improved sensitivity to 71% and specificity to 68%. Use of non-uniform misclassification costs in the SVM model, weighting towards increased sensitivity, improved predictions (up to 86%). Sensitivity, specificity, and overall accuracy improved minimally with additional follow-up data. Predictions improved within specific groups defined by baseline EDSS. LR performed more poorly than SVM in most cases. Race, family history of MS, and brain parenchymal fraction, ranked highly as predictors of the non-worsening group. Brain T2 lesion volume ranked highly as predictive of the worsening group.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">SVM incorporating short-term clinical and brain MRI data, class imbalance corrective measures, and classification costs may be a promising means to predict MS disease course, and for selection of patients suitable for more aggressive treatment regimens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yijun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Tufts University, Medford, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Healy</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rotstein</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guttmann</LastName><ForeName>Charles R G</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakshi</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Howard L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodley</LastName><ForeName>Carla E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>College of Computer and Information Science, Northeastern, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitnis</LastName><ForeName>Tanuja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Partners MS Center, Brigham and Women's Hospital, Brookline, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28379999</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0174866</ArticleId><ArticleId IdType="pii">PONE-D-16-29571</ArticleId><ArticleId IdType="pmc">PMC5381810</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain. 1993 Feb;116 ( Pt 1):117-34</Citation><ArticleIdList><ArticleId IdType="pubmed">8453453</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2009 Feb;66(2):234-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19204160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2014 Nov;76(5):633-42</Citation><ArticleIdList><ArticleId IdType="pubmed">25263997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2014 Jan;75(1):43-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24006277</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Jun 21;356(25):2603-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17582070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Int. 2013;2013:189624</Citation><ArticleIdList><ArticleId IdType="pubmed">23555057</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurol. 2013 Jul;20(7):995-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23114082</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1989 Dec;112 ( Pt 6):1419-28</Citation><ArticleIdList><ArticleId IdType="pubmed">2597989</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1989 Feb;112 ( Pt 1):133-46</Citation><ArticleIdList><ArticleId IdType="pubmed">2917275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2003 Apr;126(Pt 4):770-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12615637</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):757-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17220286</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Clin. 2011 May;29(2):279-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21439441</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Neurol. 2011 Jun 07;11:67</Citation><ArticleIdList><ArticleId IdType="pubmed">21649880</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2002 Nov 12;59(9):1412-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12427893</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 Mar;18(3):345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21868487</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 1987;6(3):101-15</Citation><ArticleIdList><ArticleId IdType="pubmed">3658079</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Sci. 2000;21(4 Suppl 2):S831-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11205358</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 May 17;8(5):e59042</Citation><ArticleIdList><ArticleId IdType="pubmed">23690916</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):917-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18077480</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Jan 17;346(3):158-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11796849</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2006 Oct;5(8):532-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17027888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2002 Feb;15(2):203-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11836778</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2007 Jun 12;68(24):2059-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17562826</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2006 Mar;129(Pt 3):595-605</Citation><ArticleIdList><ArticleId IdType="pubmed">16415309</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurol. 2013 Jul;20(7):1107-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23379849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2011 May;17(5):541-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21148262</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 1985;4(4):227-39</Citation><ArticleIdList><ArticleId IdType="pubmed">3835484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28329014</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.</ArticleTitle><Pagination><MedlinePgn>e0174200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0174200</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The increased survival in Systemic Lupus Erythematosus (SLE) patients implies the development of chronic damage, occurring in up to 50% of cases. Its prevention is a major goal in the SLE management. We aimed at predicting chronic damage in a large monocentric SLE cohort by using neural networks.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 413 SLE patients (M/F 30/383; mean age .. SD 46.3..11.9 years; mean disease duration .. SD 174.6 .. 112.1 months). Chronic damage was assessed by the SLICC/ACR Damage Index (SDI). We applied Recurrent Neural Networks (RNNs) as a machine-learning model to predict the risk of chronic damage. The clinical data sequences registered for each patient during the follow-up were used for building and testing the RNNs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At the first visit in the Lupus Clinic, 35.8% of patients had an SDI...1. For the RNN model, two groups of patients were analyzed: patients with SDI = 0 at the baseline, developing damage during the follow-up (N = 38), and patients without damage (SDI = 0). We created a mathematical model with an AUC value of 0.77, able to predict damage development. A threshold value of 0.35 (sensitivity 0.74, specificity 0.76) seemed able to identify patients at risk to develop damage.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We applied RNNs to identify a prediction model for SLE chronic damage. The use of the longitudinal data from the Sapienza Lupus Cohort, including laboratory and clinical items, resulted able to construct a mathematical model, potentially identifying patients at risk to develop damage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ceccarelli</LastName><ForeName>Fulvia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciandrone</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perricone</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvan</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dipartimento di Ingegneria dell'Informazione, Universit.. di Firenze, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicente</LastName><ForeName>Luis Nunes</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Departemento de Matematica, Universidade de Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leccese</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massaro</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cipriano</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>Francesca Romana</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessandri</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valesini</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lupus Clinic, Rheumatology, Dipartimento di Medicina Interna e Specialit.. Mediche, Sapienza Universit.. di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28329014</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0174200</ArticleId><ArticleId IdType="pii">PONE-D-16-46364</ArticleId><ArticleId IdType="pmc">PMC5362169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2006 Aug;119(8):700-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16887417</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Clin Pharmacol. 2007 Sep;2(3):217-26</Citation><ArticleIdList><ArticleId IdType="pubmed">18690868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Dec;68(6):2588-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16316334</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Mar;39(3):363-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Dec 1;365(22):2110-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2002;11(8):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12220102</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2016 Aug;68(8):1955-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26867033</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2015 Jan;14(1):75-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25449682</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2016 Jun;25(7):719-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26821965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2004;13(12):900-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15645743</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2013 Dec;43(3):352-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23786872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2001;10(2):93-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11237132</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2016 Jun;43(6):1050-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27084911</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2000 Mar;27(3):680-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10743808</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Feb;29(2):288-91</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2011 Jul-Aug;57(4):300-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21701272</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Dec;64(12):4021-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22932985</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2008 May;32(4):325-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18265411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1995 Oct 28;346(8983):1135-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7475607</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Feb 15;55(1):74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16463416</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2008;458:15-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19065803</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Syst. 2014 Sep;38(9):110</Citation><ArticleIdList><ArticleId IdType="pubmed">25027017</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28284217</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-0003</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>03</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of neuroengineering and rehabilitation</Title><ISOAbbreviation>J Neuroeng Rehabil</ISOAbbreviation></Journal><ArticleTitle>Use of Nintendo Wii Balance Board for posturographic analysis of Multiple Sclerosis patients with minimal balance impairment.</ArticleTitle><Pagination><MedlinePgn>19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12984-017-0230-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Wii Balance Board (WBB) has been proposed as an inexpensive alternative to laboratory-grade Force Plates (FP) for the instrumented assessment of balance. Previous studies have reported a good validity and reliability of the WBB for estimating the path length of the Center of Pressure. Here we extend this analysis to 18 balance related features extracted from healthy subjects (HS) and individuals affected by Multiple Sclerosis (MS) with minimal balance impairment.</AbstractText><AbstractText Label="METHODS">Eighteen MS patients with minimal balance impairment (Berg Balance Scale 53.3........3.1) and 18 age-matched HS were recruited in this study. All subjects underwent instrumented balance tests on the FP and WBB consisting of quiet standing with the eyes open and closed. Linear correlation analysis and Bland-Altman plots were used to assess relations between path lengths estimated using the WBB and the FP. 18 features were extracted from the instrumented balance tests. Statistical analysis was used to assess significant differences between the features estimated using the WBB and the FP and between HS and MS. The Spearman correlation coefficient was used to evaluate the validity and the Intraclass Correlation Coefficient was used to assess the reliability of WBB measures with respect to the FP. Classifiers based on Support Vector Machines trained on the FP and WBB features were used to assess the ability of both devices to discriminate between HS and MS.</AbstractText><AbstractText Label="RESULTS">We found a significant linear relation between the path lengths calculated from the WBB and the FP indicating an overestimation of these parameters in the WBB. We observed significant differences in the path lengths between FP and WBB in most conditions. However, significant differences were not found for the majority of the other features. We observed the same significant differences between the HS and MS populations across the two measurement systems. Validity and reliability were moderate-to-high for all the analyzed features. Both the FP and WBB trained classifier showed similar classification performance (&gt;80%) when discriminating between HS and MS.</AbstractText><AbstractText Label="CONCLUSIONS">Our results support the observation that the WBB, although not suitable for obtaining absolute measures, could be successfully used in comparative analysis of different populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Severini</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2289-9331</Identifier><AffiliationInfo><Affiliation>School of Electrical and Electronic Engineering, University College Dublin, Dublin, Ireland. giacomo.severini@ucd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy. giacomo.severini@ucd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straudi</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavarelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Roit</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinuzzi</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Marco Pizzongolo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basaglia</LastName><ForeName>Nino</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neuroscience and Rehabilitation Department, Ferrara University Hospital, Ferrara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroeng Rehabil</MedlineTA><NlmUniqueID>101232233</NlmUniqueID><ISSNLinking>1743-0003</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004856" MajorTopicYN="Y">Postural Balance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018910" MajorTopicYN="Y">Video Games</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Multiple Sclerosis</Keyword><Keyword MajorTopicYN="Y">Posturographic Analysis</Keyword><Keyword MajorTopicYN="Y">Wii Balance Board</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28284217</ArticleId><ArticleId IdType="doi">10.1186/s12984-017-0230-5</ArticleId><ArticleId IdType="pii">10.1186/s12984-017-0230-5</ArticleId><ArticleId IdType="pmc">PMC5346266</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biomed Res Int. 2015;2015:916478</Citation><ArticleIdList><ArticleId IdType="pubmed">26583146</ArticleId></ArticleIdList></Reference><Reference><Citation>Occup Ther Int. 2014 Mar;21(1):21-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23613154</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2012 Jul;259(7):1413-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22186852</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2000 Feb;81(2):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10668778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Int. 2013;2013:756564</Citation><ArticleIdList><ArticleId IdType="pubmed">23766910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>Games Health J. 2012 Dec;1(6):456-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26192064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2013 Jun;19(7):965</Citation><ArticleIdList><ArticleId IdType="pubmed">23037547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2006 Jan;59(1):4-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16287079</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1999 Oct;80(10 ):1227-33</Citation><ArticleIdList><ArticleId IdType="pubmed">10527078</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Brain Res. 1993;95(2):308-18</Citation><ArticleIdList><ArticleId IdType="pubmed">8224055</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol. 1985 May;40(3):287-95</Citation><ArticleIdList><ArticleId IdType="pubmed">3989241</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Ther. 1996 Jun;76(6):576-83; discussion 584-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8650273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2008 Feb;27(2):223-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17482466</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2010 Mar;31(3):307-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20005112</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2014 May 07;4(5):e005172</Citation><ArticleIdList><ArticleId IdType="pubmed">24812193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1986 Feb 8;1(8476):307-10</Citation><ArticleIdList><ArticleId IdType="pubmed">2868172</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Phys Ther. 2005 Dec;29(4):170-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16388684</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Clin. 1990 May;8(2):407-20</Citation><ArticleIdList><ArticleId IdType="pubmed">2193219</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2006 Sep;38(5):295-301</Citation><ArticleIdList><ArticleId IdType="pubmed">16931459</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurol. 2000 Jun;13(3):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">10871245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Neurol Neurosci Rep. 2010 Sep;10(5):407-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20567946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2014 Sep 29;14(10):18244-67</Citation><ArticleIdList><ArticleId IdType="pubmed">25268919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2015 Dec 15;359(1-2):440-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26490321</ArticleId></ArticleIdList></Reference><Reference><Citation>J Physiol. 1994 Jul 1;478 ( Pt 1):173-86</Citation><ArticleIdList><ArticleId IdType="pubmed">7965833</ArticleId></ArticleIdList></Reference><Reference><Citation>J Phys Ther Sci. 2013 Oct;25(10):1251-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24259769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2014 Jan;39(1):224-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23910725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerontology. 2006;52(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16439819</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 1981 Sep;28(9):668-71</Citation><ArticleIdList><ArticleId IdType="pubmed">7319527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2013 Feb;19(2):209-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22674972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2006 Oct;12(5):620-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17086909</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Rehabil Res. 2011 Mar;34(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20679901</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurorehabil Neural Repair. 2013 Jul-Aug;27(6):516-25</Citation><ArticleIdList><ArticleId IdType="pubmed">23478168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rehabil Med. 2011 Apr;43(5):435-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21394420</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2013 Jul;268(1):181-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23533287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2013 Aug;19(9):1219-21</Citation><ArticleIdList><ArticleId IdType="pubmed">23322502</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rehabil. 2013 Apr;27(4):361-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22960241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2007 Feb;25(2):166-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16624560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroeng Rehabil. 2014 Feb 08;11:12</Citation><ArticleIdList><ArticleId IdType="pubmed">24507245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 1996 Sep;51(5):M239-46</Citation><ArticleIdList><ArticleId IdType="pubmed">8808996</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2006 Feb 13;394(2):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16269212</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1989 Jul;70(7):510-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2742465</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J MS Care. 2011 Spring;13(1):21-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24453702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2009 Apr;29(3):460-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19167891</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Ther. 2008 May;88(5):559-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18292215</ArticleId></ArticleIdList></Reference><Reference><Citation>Somatosens Mot Res. 2007 Mar-Jun;24(1-2):41-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17558922</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2010 Jan;91(1):93-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20103402</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2009 Apr;90(4):602-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19345775</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2006 Jun 30;28(12):789-95</Citation><ArticleIdList><ArticleId IdType="pubmed">16754576</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand Suppl. 2011;(191):79-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21711261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28282431</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Interactions within the MHC contribute to the genetic architecture of celiac disease.</ArticleTitle><Pagination><MedlinePgn>e0172826</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0172826</ELocationID><Abstract><AbstractText>Interaction analysis of GWAS can detect signal that would be ignored by single variant analysis, yet few robust interactions in humans have been detected. Recent work has highlighted interactions in the MHC region between known HLA risk haplotypes for various autoimmune diseases. To better understand the genetic interactions underlying celiac disease (CD), we have conducted exhaustive genome-wide scans for pairwise interactions in five independent CD case-control studies, using a rapid model-free approach to examine over 500 billion SNP pairs in total. We found 14 independent interaction signals within the MHC region that achieved stringent replication criteria across multiple studies and were independent of known CD risk HLA haplotypes. The strongest independent CD interaction signal corresponded to genes in the HLA class III region, in particular PRRC2A and GPANK1/C6orf47, which are known to contain variants for non-Hodgkin's lymphoma and early menopause, co-morbidities of celiac disease. Replicable evidence for statistical interaction outside the MHC was not observed. Both within and between European populations, we observed striking consistency of two-locus models and model distribution. Within the UK population, models of CD based on both interactions and additive single-SNP effects increased explained CD variance by approximately 1% over those of single SNPs. The interactions signal detected across the five cohorts indicates the presence of novel associations in the MHC region that cannot be detected using additive models. Our findings have implications for the determination of genetic architecture and, by extension, the use of human genetics for validation of therapeutic targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goudey</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-2318-985X</Identifier><AffiliationInfo><Affiliation>NICTA Victoria Research Lab, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computing and Information Systems, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IBM Research, Australia, Level 5, Carlton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Systems Genomics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of BioSciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikianty</LastName><ForeName>Eder</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Johannesburg, Auckland Park, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>NICTA Victoria Research Lab, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawlinson</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>NICTA Victoria Research Lab, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>NICTA Victoria Research Lab, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haviv</LastName><ForeName>Izhak</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Bar Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalczyk</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NICTA Victoria Research Lab, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neural Engineering, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inouye</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Systems Genomics, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of BioSciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>147155-45-1</RegistryNumber><NameOfSubstance UI="C092008">PRRC2A protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002446" MajorTopicYN="N">Celiac Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008228" MajorTopicYN="N">Lymphoma, Non-Hodgkin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008285" MajorTopicYN="N">Major Histocompatibility Complex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28282431</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0172826</ArticleId><ArticleId IdType="pii">PONE-D-16-37547</ArticleId><ArticleId IdType="pmc">PMC5345796</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Res. 2010 Jul;20(7):854-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20502444</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2013;14 Suppl 3:S10</Citation><ArticleIdList><ArticleId IdType="pubmed">23819779</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2011 Aug;41(8):2152-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21792875</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 05;8(8):e71203</Citation><ArticleIdList><ArticleId IdType="pubmed">23940718</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr Suppl. 1996 May;412:76-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8783766</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(5):e36926</Citation><ArticleIdList><ArticleId IdType="pubmed">22615847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 Nov;9(11):855-67</Citation><ArticleIdList><ArticleId IdType="pubmed">18852697</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1193-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22223662</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 02;8(8):e70174</Citation><ArticleIdList><ArticleId IdType="pubmed">23936387</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Mar;7(3):e1001338</Citation><ArticleIdList><ArticleId IdType="pubmed">21437271</ArticleId></ArticleIdList></Reference><Reference><Citation>Digestion. 1994;55(4):243-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8063029</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Aug 2;488(7409):96-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22801501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2011 Dec 04;9(2):179-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22138821</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2010 Feb 26;6(2):e1000864</Citation><ArticleIdList><ArticleId IdType="pubmed">20195508</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 07;9(7):e101428</Citation><ArticleIdList><ArticleId IdType="pubmed">24999842</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 1992;9(5):347-65</Citation><ArticleIdList><ArticleId IdType="pubmed">1427023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Sep;47(9):1085-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26258845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Apr;37(4):413-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15793588</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Apr;42(4):295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">20190752</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2012 May 10;13:88</Citation><ArticleIdList><ArticleId IdType="pubmed">22574887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2002 Oct 1;11(20):2463-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12351582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Apr;40(4):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">18311140</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2008 Feb 29;4(2):e1000008</Citation><ArticleIdList><ArticleId IdType="pubmed">18454194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Hered. 2000 Nov-Dec;50(6):334-49</Citation><ArticleIdList><ArticleId IdType="pubmed">10899752</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2001 Jul;69(1):138-47</Citation><ArticleIdList><ArticleId IdType="pubmed">11404819</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Sep 10;87(3):325-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20817139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Jun;10(6):392-404</Citation><ArticleIdList><ArticleId IdType="pubmed">19434077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2012 Jan 22;44(3):260-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22267201</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 20;357(12):1199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2006 Jul 21;241(2):252-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16457852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Feb;45(2):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">23263489</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2014 Feb 13;10(2):e1004137</Citation><ArticleIdList><ArticleId IdType="pubmed">24550740</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2013 Feb;37(2):184-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23203348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2014 Mar;63(3):415-22</Citation><ArticleIdList><ArticleId IdType="pubmed">23704318</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2014 Jan;15(1):22-33</Citation><ArticleIdList><ArticleId IdType="pubmed">24296533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Jun 1;27(11):1462-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21471009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Sep;39(9):1167-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17721534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Aug;47(8):898-905</Citation><ArticleIdList><ArticleId IdType="pubmed">26168013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Nov 6;456(7218):98-101</Citation><ArticleIdList><ArticleId IdType="pubmed">18758442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2010 Jun;11(6):446-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20479774</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Feb;45(2):202-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23291587</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2012 Nov;22(11):2230-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22767386</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Jul 10;43(8):761-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21743469</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Nov;42(11):985-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20953190</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Jun 13;498(7453):232-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23698362</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 May 23;497(7450):517-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23644456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Oct 2;514(7520):E3-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25279928</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2012 Nov 29;120(23 ):4645-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23047821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Nov 1;18(21):4219-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19648293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Oct 8;461(7265):747-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19812666</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19380721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2014 Oct 1;23(19):5061-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24821702</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2014 Nov;46(11):1187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25305756</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Nov 06;43(12):1193-201</Citation><ArticleIdList><ArticleId IdType="pubmed">22057235</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Apr 10;508(7495):249-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24572353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics J. 2014 Apr;14(2):192-200</Citation><ArticleIdList><ArticleId IdType="pubmed">23712092</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e58352</Citation><ArticleIdList><ArticleId IdType="pubmed">23472185</ArticleId></ArticleIdList></Reference><Reference><Citation>Theor Popul Biol. 1975 Oct;8(2):117-26</Citation><ArticleIdList><ArticleId IdType="pubmed">1198348</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2013 Feb;9(2):e1003295</Citation><ArticleIdList><ArticleId IdType="pubmed">23509438</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Dec 25;44(2):178-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22197929</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Jun;5(6):e1000529</Citation><ArticleIdList><ArticleId IdType="pubmed">19543373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2013 Aug;12(8):581-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23868113</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):323-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15925839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Jul;39(7):827-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17558408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28268941</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Blood glucose level prediction based on support vector regression using mobile platforms.</ArticleTitle><Pagination><MedlinePgn>2990-2993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2016.7591358</ELocationID><Abstract><AbstractText>The correct treatment of diabetes is vital to a patient's health: Staying within defined blood glucose levels prevents dangerous short- and long-term effects on the body. Mobile devices informing patients about their future blood glucose levels could enable them to take counter-measures to prevent hypo or hyper periods. Previous work addressed this challenge by predicting the blood glucose levels using regression models. However, these approaches required a physiological model, representing the human body's response to insulin and glucose intake, or are not directly applicable to mobile platforms (smart phones, tablets). In this paper, we propose an algorithm for mobile platforms to predict blood glucose levels without the need for a physiological model. Using an online software simulator program, we trained a Support Vector Regression (SVR) model and exported the parameter settings to our mobile platform. The prediction accuracy of our mobile platform was evaluated with pre-recorded data of a type 1 diabetes patient. The blood glucose level was predicted with an error of 19 % compared to the true value. Considering the permitted error of commercially used devices of 15 %, our algorithm is the basis for further development of mobile prediction algorithms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reymann</LastName><ForeName>Maximilian P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Dorschky</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Groh</LastName><ForeName>Benjamin H</ForeName><Initials>BH</Initials></Author><Author ValidYN="Y"><LastName>Martindale</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Blank</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Eskofier</LastName><ForeName>Bjoern M</ForeName><Initials>BM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28268941</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2016.7591358</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28188915</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9572</ISSN><JournalIssue CitedMedium="Internet"><Volume>150</Volume><PubDate><Year>2017</Year><Month>04</Month><Day>15</Day></PubDate></JournalIssue><Title>NeuroImage</Title><ISOAbbreviation>Neuroimage</ISOAbbreviation></Journal><ArticleTitle>Machine learning based compartment models with permeability for white matter microstructure imaging.</ArticleTitle><Pagination><MedlinePgn>119-135</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1053-8119(17)30117-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroimage.2017.02.013</ELocationID><Abstract><AbstractText>Some microstructure parameters, such as permeability, remain elusive because mathematical models that express their relationship to the MR signal accurately are intractable. Here, we propose to use computational models learned from simulations to estimate these parameters. We demonstrate the approach in an example which estimates water residence time in brain white matter. The residence time ..<sub>i</sub> of water inside axons is a potentially important biomarker for white matter pathologies of the human central nervous system, as myelin damage is hypothesised to affect axonal permeability, and thus ..<sub>i</sub>. We construct a computational model using Monte Carlo simulations and machine learning (specifically here a random forest regressor) in order to learn a mapping between features derived from diffusion weighted MR signals and ground truth microstructure parameters, including ..<sub>i</sub>. We test our numerical model using simulated and in vivo human brain data. Simulation results show that estimated parameters have strong correlations with the ground truth parameters (R<sup>2</sup>={0.88,0.95,0.82,0.99}) for volume fraction, residence time, axon radius and diffusivity respectively), and provide a marked improvement over the most widely used K..rger model (R<sup>2</sup>={0.75,0.60,0.11,0.99}). The trained model also estimates sensible microstructure parameters from in vivo human brain data acquired from healthy controls, matching values found in literature, and provides better reproducibility than the K..rger model on both the voxel and ROI level. Finally, we acquire data from two Multiple Sclerosis (MS) patients and compare to the values in healthy subjects. We find that in the splenium of corpus callosum (CC-S) the estimate of the residence time is 0.57..0.05s for the healthy subjects, while in the MS patient with a lesion in CC-S it is 0.33..0.12s in the normal appearing white matter (NAWM) and 0.19..0.11s in the lesion. In the corticospinal tracts (CST) the estimate of the residence time is 0.52..0.09s for the healthy subjects, while in the MS patient with a lesion in CST it is 0.56..0.05s in the NAWM and 0.13..0.09s in the lesion. These results agree with our expectations that the residence time in lesions would be lower than in NAWM because the loss of myelin should increase permeability. Overall, we find parameter estimates in the two MS patients consistent with expectations from the pathology of MS lesions demonstrating the clinical potential of this new technique.</AbstractText><CopyrightInformation>Copyright .. 2017 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nedjati-Gilani</LastName><ForeName>Gemma L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing and Dept of Computer Science, University College London, Gower Street, London WC1E 6BT, UK; MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Torben</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuroinflammation, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Matt G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Institute of Child Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cawley</LastName><ForeName>Niamh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neuroinflammation, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Ioana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing and Dept of Computer Science, University College London, Gower Street, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccarelli</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neuroinflammation, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drobnjak</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing and Dept of Computer Science, University College London, Gower Street, London WC1E 6BT, UK. Electronic address: i.drobnjak@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheeler-Kingshott</LastName><ForeName>Claudia A M Gandini</ForeName><Initials>CAMG</Initials><AffiliationInfo><Affiliation>Department of Neuroinflammation, Institute of Neurology, University College London, London, UK; Brain MRI 3T Mondino Research Center, C. Mondino National Neurological Institute, Pavia, Italy; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing and Dept of Computer Science, University College London, Gower Street, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M009106/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroimage</MedlineTA><NlmUniqueID>9215515</NlmUniqueID><ISSNLinking>1053-8119</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017352" MajorTopicYN="N">Echo-Planar Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009010" MajorTopicYN="N">Monte Carlo Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010539" MajorTopicYN="N">Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28188915</ArticleId><ArticleId IdType="pii">S1053-8119(17)30117-9</ArticleId><ArticleId IdType="doi">10.1016/j.neuroimage.2017.02.013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28115314</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1468-4357</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Biostatistics (Oxford, England)</Title><ISOAbbreviation>Biostatistics</ISOAbbreviation></Journal><ArticleTitle>Discriminating sample groups with multi-way data.</ArticleTitle><Pagination><MedlinePgn>434-450</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/biostatistics/kxw057</ELocationID><Abstract><AbstractText>High-dimensional linear classifiers, such as distance weighted discrimination (DWD) and versions of the support vector machine (SVM), are commonly used in biomedical research to distinguish groups of subjects based on a large number of features. However, their use is limited to applications where a single vector of features is measured for each subject. In practice, data are often multi-way, or measured over multiple dimensions. For example, metabolite abundance may be measured over multiple regions or tissues, or gene expression may be measured over multiple time points, for the same subjects. We propose a framework for linear classification of high-dimensional multi-way data, in which coefficients can be factorized into weights that are specific to each dimension. More generally, the coefficients for each measurement in a multi-way dataset are assumed to have low-rank structure. This framework extends existing classification techniques from single vector to multi-way features, and we have implemented multi-way versions of SVM and DWD. We describe informative simulation results, and apply multi-way DWD to data for two very different clinical research studies. The first study uses magnetic resonance spectroscopy metabolite data over multiple brain regions to compare participants with and without spinocerebellar ataxia; the second uses publicly available gene expression time-course data to compare degrees of treatment response among patients with multiple sclerosis. Our multi-way method can improve performance and simplify interpretation over naive applications of full rank linear and non-linear classification to multi-way data. The R package is available at https://github.com/lockEF/MultiwayClassification.</AbstractText><CopyrightInformation>.. The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Tianmeng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lock</LastName><ForeName>Eric F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eberly</LastName><ForeName>Lynn E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR000113</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000114</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biostatistics</MedlineTA><NlmUniqueID>100897327</NlmUniqueID><ISSNLinking>1465-4644</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="Y">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Distance weighted discrimination</Keyword><Keyword MajorTopicYN="N">Gene time-course</Keyword><Keyword MajorTopicYN="N">Magnetic resonance spectroscopy</Keyword><Keyword MajorTopicYN="N">Support vector machine</Keyword><Keyword MajorTopicYN="N">Tensors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28115314</ArticleId><ArticleId IdType="pii">kxw057</ArticleId><ArticleId IdType="doi">10.1093/biostatistics/kxw057</ArticleId><ArticleId IdType="pmc">PMC5862387</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neural Comput. 2016 Apr;28(4):686-715</Citation><ArticleIdList><ArticleId IdType="pubmed">26890354</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychometrika. 1966 Sep;31(3):279-311</Citation><ArticleIdList><ArticleId IdType="pubmed">5221127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebellum. 2011 Jun;10(2):208-17</Citation><ArticleIdList><ArticleId IdType="pubmed">20838948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2010 Jul 15;25(9):1253-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20310029</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2005 Jan;3(1):e2</Citation><ArticleIdList><ArticleId IdType="pubmed">15630474</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2004 Aug;127(Pt 8):1785-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15240431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Apr 15;28(8):1182-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22368246</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2013 Jan;14(1):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22926914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2015 Apr 15;30(5):662-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25773989</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Stat Assoc. 2013;108(502):540-552</Citation><ArticleIdList><ArticleId IdType="pubmed">24791032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28057002</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Prediction of anti-inflammatory proteins/peptides: an insilico approach.</ArticleTitle><Pagination><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-016-1103-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">The current therapy for inflammatory and autoimmune disorders involves the use of nonspecific anti-inflammatory drugs and other immunosuppressant, which are often accompanied with potential side effects. As an alternative therapy, anti-inflammatory peptides are recently being exploited as anti-inflammatory agents for treatment of various inflammatory diseases such as Alzheimer's disease and rheumatoid arthritis. Thus, understanding the correlation between amino acid sequence and its potential anti-inflammatory property is of great importance for the discovery of novel and efficient anti-inflammatory peptide-based therapeutics.</AbstractText><AbstractText Label="METHODS">In this study, we have developed a prediction tool for the classification of peptides as anti-inflammatory epitopes or non anti-inflammatory epitopes. The training was performed using experimentally validated epitopes obtained from Immune epitope database and analysis resource database. Different sequence-based features and their hybrids with motif information were employed for development of support vector machine-based machine learning models. Similarly, machine learning models were also constructed using random forest.</AbstractText><AbstractText Label="RESULTS">The composition and terminal residue conservation analysis of peptides revealed the dominance of leucine, serine, tyrosine and arginine residues in anti-inflammatory epitopes as compared to non anti-inflammatory epitopes. Similarly, the anti-inflammatory epitopes specific motifs were found to be rich in hydrophobic and polar residues. The hybrid of tripeptide composition-based support vector machine model and motif yielded the best performance on 10-fold cross validation with an accuracy of 78.1% and MCC of 0.58. The same displayed an accuracy of 72% and MCC of 0.45 on validation dataset, rejecting any possibility of over-fitting. The tripeptide composition-based random forest model displayed an accuracy of 0.8 and MCC of 0.59 on 10-fold cross validation, however, the accuracy (0.68) and MCC (0.31) was lower as compared to support vector machine model on validation dataset. Thus, the support vector machine model is implemented as the default model and an additional option of using the random forest model is provided.</AbstractText><AbstractText Label="CONCLUSION">The prediction models along with tools for epitope mapping and similarity search have been provided as a web server which is freely accessible at http://metagenomics.iiserb.ac.in/antiinflam/ .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Sudheer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ashok K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shastri</LastName><ForeName>Vibhuti</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhu</LastName><ForeName>Midhun K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Vineet K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Metagenomics and Systems Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India. vineetks@iiserb.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030562" MajorTopicYN="N">Databases, Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28057002</ArticleId><ArticleId IdType="doi">10.1186/s12967-016-1103-6</ArticleId><ArticleId IdType="pii">10.1186/s12967-016-1103-6</ArticleId><ArticleId IdType="pmc">PMC5216551</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Mol Med (Berl). 2001 Oct;79(10):552-65</Citation><ArticleIdList><ArticleId IdType="pubmed">11692152</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 04;10(3):e0118432</Citation><ArticleIdList><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Biochem. 2001 Jun;268(12):3399-406</Citation><ArticleIdList><ArticleId IdType="pubmed">11422369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):695-702</Citation><ArticleIdList><ArticleId IdType="pubmed">11502077</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2013 Jun;34(6):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23434408</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2000 Mar;14(3):572-80</Citation><ArticleIdList><ArticleId IdType="pubmed">10698973</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2009 Jun;109(5):1516-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19457161</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2013 Oct 30;8:27</Citation><ArticleIdList><ArticleId IdType="pubmed">24168386</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Investig Drugs. 2001 Oct;2(10):1387-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11890353</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2014;2014:689219</Citation><ArticleIdList><ArticleId IdType="pubmed">25045691</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Direct. 2013 Dec 05;8:30</Citation><ArticleIdList><ArticleId IdType="pubmed">24304645</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 1995;41(4):178-228</Citation><ArticleIdList><ArticleId IdType="pubmed">7890324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 May 1;27(9):1231-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21372086</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2010 Jul;130(3):319-28</Citation><ArticleIdList><ArticleId IdType="pubmed">20408898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 1996;5(5):334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18475727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii70-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17934101</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2014;1184:217-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25048127</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Dev Immunol. 2013;2013:263952</Citation><ArticleIdList><ArticleId IdType="pubmed">24489573</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2008 Nov;22(8):1146-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18598752</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2011 Apr 15;12:192</Citation><ArticleIdList><ArticleId IdType="pubmed">21496229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2001 May;7(5):563-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11329057</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Sep;46(9):2320-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12355479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2000 Oct;48(4):567-79</Citation><ArticleIdList><ArticleId IdType="pubmed">11026440</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2016 Jun 14;14(1):178</Citation><ArticleIdList><ArticleId IdType="pubmed">27301453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2002 May;18(5):689-96</Citation><ArticleIdList><ArticleId IdType="pubmed">12050065</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2011 Jan;89(1):81-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20458336</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):1936-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15554662</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bioinform Comput Biol. 2011 Aug;9(4):489-502</Citation><ArticleIdList><ArticleId IdType="pubmed">21776605</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2015 Jul;106(1):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25863333</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Apr 15;9(4):e93907</Citation><ArticleIdList><ArticleId IdType="pubmed">24736651</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2002 Jun;80(3):248-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12067412</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacol Exp Ther. 2007 Jan;320(1):108-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17015640</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2005 Feb;173(2):630-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15643278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18515843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28011145</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1747</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of investigative dermatology</Title><ISOAbbreviation>J Invest Dermatol</ISOAbbreviation></Journal><ArticleTitle>A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward..Precision Medicine and Combination Therapy.</ArticleTitle><Pagination><MedlinePgn>1033-1041</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0022-202X(16)32794-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jid.2016.12.007</ELocationID><Abstract><AbstractText>Systemic sclerosis is an orphan, systemic autoimmune disease with no FDA-approved treatments. Its heterogeneity and rarity often result in underpowered clinical trials making the analysis and interpretation of associated molecular data challenging. We performed a meta-analysis of gene expression data from skin biopsies of patients with systemic sclerosis treated with five therapies: mycophenolate mofetil, rituximab, abatacept, nilotinib, and fresolimumab. A common clinical improvement criterion of..-20% or..-5 modified Rodnan skin score was applied to each study. We applied a machine learning approach that captured features beyond differential expression and was better at identifying targets of therapies than the differential expression alone. Regardless of treatment mechanism, abrogation of inflammatory pathways accompanied clinical improvement in multiple studies suggesting that high expression of immune-related genes indicates active and targetable disease. Our framework allowed us to compare different trials and ask if patients who failed one therapy would likely improve on a different therapy, based on changes in gene expression. Genes with high expression at baseline in fresolimumab nonimprovers were downregulated in mycophenolate mofetil improvers, suggesting that immunomodulatory or combination therapy may have benefitted these patients. This approach can be broadly applied to increase tissue specificity and sensitivity of differential expression results.</AbstractText><CopyrightInformation>Copyright .. 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taroni</LastName><ForeName>Jaclyn N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martyanov</LastName><ForeName>Viktor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahoney</LastName><ForeName>J Matthew</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitfield</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. Electronic address: Michael.L.Whitfield@Dartmouth.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR061271</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AR060780</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AR068035</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Dermatol</MedlineTA><NlmUniqueID>0426720</NlmUniqueID><ISSNLinking>0022-202X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Invest Dermatol. 2017 May;137(5):1000-1002</RefSource><PMID Version="1">28411830</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28011145</ArticleId><ArticleId IdType="pii">S0022-202X(16)32794-4</ArticleId><ArticleId IdType="doi">10.1016/j.jid.2016.12.007</ArticleId><ArticleId IdType="pmc">PMC8190797</ArticleId><ArticleId IdType="mid">NIHMS1609058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bioinformatics. 2015 Sep 15;31(18):3069-71</Citation><ArticleIdList><ArticleId IdType="pubmed">25990557</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2015 Jun;47(6):569-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25915600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 May;38(5):500-1</Citation><ArticleIdList><ArticleId IdType="pubmed">16642009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2009 Jan;37(Database issue):D767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18988627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2013 Aug;133(8):1979-89</Citation><ArticleIdList><ArticleId IdType="pubmed">23677167</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Syst. 2015 Dec 23;1(6):417-425</Citation><ArticleIdList><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Feb;60(2):578-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19180481</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Sep 29;313(5795):1929-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17008526</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Jun;19(6):1093-106</Citation><ArticleIdList><ArticleId IdType="pubmed">19246570</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Feb;62(2):580-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20112379</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2015 Jul 1;125(7):2795-807</Citation><ArticleIdList><ArticleId IdType="pubmed">26098215</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2015 Sep 15;43(3):605-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26362267</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jul;39(Web Server issue):W307-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21646343</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2015 Aug 18;17:213</Citation><ArticleIdList><ArticleId IdType="pubmed">26283632</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2015 Jun 13;17:159</Citation><ArticleIdList><ArticleId IdType="pubmed">26071192</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008 Jul 16;3(7):e2696</Citation><ArticleIdList><ArticleId IdType="pubmed">18648520</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2015 Jan 08;11(1):e1004005</Citation><ArticleIdList><ArticleId IdType="pubmed">25569146</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2015 Nov;67(11):3004-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26240058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2012 May;132(5):1363-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22318389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2006 Oct;65(10):1325-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16540546</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jan 21;10(1):e0114017</Citation><ArticleIdList><ArticleId IdType="pubmed">25607805</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Feb;60(2):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19180499</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Jun;6(4):319-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15789058</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27994938</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2229-5089</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Journal of pathology informatics</Title><ISOAbbreviation>J Pathol Inform</ISOAbbreviation></Journal><ArticleTitle>The utility of including pathology reports in improving the computational identification of patients.</ArticleTitle><Pagination><MedlinePgn>46</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Celiac disease (CD) is a common autoimmune disorder. Efficient identification of patients may improve chronic management of the disease. Prior studies have shown searching International Classification of Diseases-9 (ICD-9) codes alone is inaccurate for identifying patients with CD. In this study, we developed automated classification algorithms leveraging pathology reports and other clinical data in Electronic Health Records (EHRs) to refine the subset population preselected using ICD-9 code (579.0).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">EHRs were searched for established ICD-9 code (579.0) suggesting CD, based on which an initial identification of cases was obtained. In addition, laboratory results for tissue transglutaminse were extracted. Using natural language processing we analyzed pathology reports from upper endoscopy. Twelve machine learning classifiers using different combinations of variables related to ICD-9 CD status, laboratory result status, and pathology reports were experimented to find the best possible CD classifier. Ten-fold cross-validation was used to assess the results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1498 patient records were used including 363 confirmed cases and 1135 false positive cases that served as controls. Logistic model based on both clinical and pathology report features produced the best results: Kappa of 0.78, F1 of 0.92, and area under the curve (AUC) of 0.94, whereas in contrast using ICD-9 only generated poor results: Kappa of 0.28, F1 of 0.75, and AUC of 0.63.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our automated classification system presented an efficient and reliable way to improve the performance of CD patient identification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Research Information Solutions and Innovation, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, Ohio 43215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yungui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Research Information Solutions and Innovation, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, Ohio 43215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Nationwide Children's Hospital, 700 Children's Dr, Columbus, Ohio 43205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Research Information Solutions and Innovation, Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, Ohio 43215, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Pathol Inform</MedlineTA><NlmUniqueID>101528849</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Celiac</Keyword><Keyword MajorTopicYN="N">classification</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">patient registry</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27994938</ArticleId><ArticleId IdType="doi">10.4103/2153-3539.194838</ArticleId><ArticleId IdType="pii">JPI-7-46</ArticleId><ArticleId IdType="pmc">PMC5139449</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e149-56</Citation><ArticleIdList><ArticleId IdType="pubmed">22493050</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2014 May;133(5):1280-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24589344</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2015 Sep;22(5):993-1000</Citation><ArticleIdList><ArticleId IdType="pubmed">25929596</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Dec;20(e2):e306-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23956016</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2011 Nov;80(11):793-802</Citation><ArticleIdList><ArticleId IdType="pubmed">21917512</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Gastroenterol Hepatol. 2013 Jun;11(6):689-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23313839</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Qual Saf. 2014 Apr;23 Suppl 1:i9-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24443584</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Jan 16;59(2):895-907</Citation><ArticleIdList><ArticleId IdType="pubmed">21992749</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2015 May;110(5):760-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25823767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2012 Apr;129(4):e1030-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22412030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointest Endosc. 2015 Sep;82(3):512-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25910665</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2015 Oct;110(10):1485-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26372508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol Inform. 2015 Jun 23;6:38</Citation><ArticleIdList><ArticleId IdType="pubmed">26167382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2015 Dec;136(6):e1611-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26574591</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2014 Dec;28(12):1474-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25211697</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2012 Oct;107(10):1538-44; quiz 1537, 1545</Citation><ArticleIdList><ArticleId IdType="pubmed">22850429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27871823</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><PubDate><Year>2017</Year><Month>01</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Prediction of microRNAs involved in immune system diseases through network based features.</ArticleTitle><Pagination><MedlinePgn>34-45</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(16)30162-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2016.11.003</ELocationID><Abstract><AbstractText>MicroRNAs are a class of small non-coding regulatory RNA molecules that modulate the expression of several genes at post-transcriptional level and play a vital role in disease pathogenesis. Recent research shows that a range of miRNAs are involved in the regulation of immunity and its deregulation results in immune mediated diseases such as cancer, inflammation and autoimmune diseases. Computational discovery of these immune miRNAs using a set of specific features is highly desirable. In the current investigation, we present a SVM based classification system which uses a set of novel network based topological and motif features in addition to the baseline sequential and structural features to predict immune specific miRNAs from other non-immune miRNAs. The classifier was trained and tested on a balanced set of equal number of positive and negative examples to show the discriminative power of our network features. Experimental results show that our approach achieves an accuracy of 90.2% and outperforms the classification accuracy of 63.2% reported using the traditional miRNA sequential and structural features. The proposed classifier was further validated with two immune disease sub-class datasets related to multiple sclerosis microarray data and psoriasis RNA-seq data with higher accuracy. These results indicate that our classifier which uses network and motif features along with sequential and structural features will lead to significant improvement in classifying immune miRNAs and hence can be applied to identify other specific classes of miRNAs as an extensible miRNA classification system.</AbstractText><CopyrightInformation>Copyright .. 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prabahar</LastName><ForeName>Archana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Data Mining and Text Mining Laboratory, Department of Bioinformatics, Bharathiar University, Coimbatore 641 046, India. Electronic address: archana.prabahar@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Jeyakumar</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Data Mining and Text Mining Laboratory, Department of Bioinformatics, Bharathiar University, Coimbatore 641 046, India. Electronic address: n.jeyakumar@yahoo.co.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007154" MajorTopicYN="Y">Immune System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Classification</Keyword><Keyword MajorTopicYN="Y">Immune diseases</Keyword><Keyword MajorTopicYN="Y">Network</Keyword><Keyword MajorTopicYN="Y">SVM</Keyword><Keyword MajorTopicYN="Y">Topological features</Keyword><Keyword MajorTopicYN="Y">miRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27871823</ArticleId><ArticleId IdType="pii">S1532-0464(16)30162-9</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2016.11.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27809638</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1651-2251</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Acta oto-laryngologica</Title><ISOAbbreviation>Acta Otolaryngol</ISOAbbreviation></Journal><ArticleTitle>A recurrence model for laryngeal cancer based on SVM and gene function clustering.</ArticleTitle><Pagination><MedlinePgn>557-562</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/00016489.2016.1247984</ELocationID><Abstract><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A prognostic model was obtained for LC. Several critical genes were unveiled. They could be potentially applied for LC recurrence prediction.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Gene expression data of laryngeal cancer (LC) were analyzed to identify critical genes associated with recurrence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two gene expression datasets were downloaded from the Gene Expression Omnibus. Dataset GSE27020 is used as the training set, containing 75 non-recurred LC cases and 34 recurred LC cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 725 DEGs were identified from the training set. A total of 4126 gene pairs showed significant correlations in non-recurred LC only, corresponding to 533 genes. A total of 7235 gene pairs showed significant correlations in recurred LC only, corresponding to 608 genes. Besides, 1694 gene pairs showed significant correlations in both non-recurred and recurred LC, corresponding to 322 genes. Functional enrichment analysis was performed for the three groups of DEGs. Seven overlapping biological functions were revealed: positive regulation of chondrocyte differentiation, autoimmune thyroid disease, focal adhesion, linoleic acid metabolism, drug metabolism, organic cation transport, and ECM-receptor interaction. Eight feature genes (PDIA3, MYH11, PDK1, SDC3, RPE65, LAMC3, BTK, and UPK1B) were identified. Their prognostic effect was validated by independent test set as well as survival analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Jili</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>a Department of Otorhinolaryngology, Head and Neck Surgery , The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology , Luoyang City, Henan Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanqiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>b Department of Otorhinolaryngology, Head and Neck Surgery , Xuzhou Cancer Hospital , Xuzhou City , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Haodong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>c Department of Otorhinolaryngology, Head and Neck Surgery , Yongcheng Red Cross Hospital of Henan Province , Yoncheng City , Henan Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chuanhai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>d Department of Otorhinolaryngology, Head and Neck Surgery , The People's Hospital of Jiawang District in Xuzhou City , Xuzhou City , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>e Department of Otorhinolaryngology, Head and Neck Surgery , The Affiliated Hospital of Xuzhou Medical College , Xuzhou City , Jiangsu Province , PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Otolaryngol</MedlineTA><NlmUniqueID>0370354</NlmUniqueID><ISSNLinking>0001-6489</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007822" MajorTopicYN="N">Laryngeal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="Y">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Laryngeal cancer</Keyword><Keyword MajorTopicYN="N">differentially expressed genes</Keyword><Keyword MajorTopicYN="N">feature genes</Keyword><Keyword MajorTopicYN="N">support vector machine</Keyword><Keyword MajorTopicYN="N">survival analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27809638</ArticleId><ArticleId IdType="doi">10.1080/00016489.2016.1247984</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27660190</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>11</Month></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Glycemic Control Indices and Their Aggregation in the Prediction of Nocturnal Hypoglycemia From Intermittent Blood Glucose Measurements.</ArticleTitle><Pagination><MedlinePgn>1245-1250</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">Despite the risk associated with nocturnal hypoglycemia (NH) there are only a few methods aiming at the prediction of such events based on intermittent blood glucose monitoring data. One of the first methods that potentially can be used for NH prediction is based on the low blood glucose index (LBGI) and suggested, for example, in Accu-Chek.. Connect as a hypoglycemia risk indicator. On the other hand, nowadays there are other glucose control indices (GCI), which could be used for NH prediction in the same spirit as LBGI. In the present study we propose a general approach of combining NH predictors constructed from different GCI.</AbstractText><AbstractText Label="METHODS">The approach is based on a recently developed strategy for aggregating ranking algorithms in machine learning. NH predictors have been calibrated and tested on data extracted from clinical trials, performed in EU FP7-funded project DIAdvisor. Then, to show a portability of the method we have tested it on another dataset that was received from EU Horizon 2020-funded project AMMODIT.</AbstractText><AbstractText Label="RESULTS">We exemplify the proposed approach by aggregating NH predictors that have been constructed based on 4 GCI associated with hypoglycemia. Even though these predictors have been preliminary optimized to exhibit better performance on the considered dataset, our aggregation approach allows a further performance improvement. On the dataset, where a portability of the proposed approach has been demonstrated, the aggregating predictor has exhibited the following performance: sensitivity 77%, specificity 83.4%, positive predictive value 80.2%, negative predictive value 80.6%, which is higher than conventionally considered as acceptable.</AbstractText><AbstractText Label="CONCLUSION">The proposed approach shows potential to be used in telemedicine systems for NH prediction.</AbstractText><CopyrightInformation>.. 2016 Diabetes Technology Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sampath</LastName><ForeName>Sivananthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Indian Institute of Technology Delhi, New Delhi, India siva@maths.iitd.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tkachenko</LastName><ForeName>Pavlo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Johann Radon Institute for Computational and Applied Mathematics (RICAM), Austrian Academy of Sciences, Linz, Wien, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renard</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes, Nutrition, and CIC INSERM 1411, Montpellier University Hospital, Montpellier, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereverzev</LastName><ForeName>Sergei V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Johann Radon Institute for Computational and Applied Mathematics (RICAM), Austrian Academy of Sciences, Linz, Wien, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">aggregation</Keyword><Keyword MajorTopicYN="Y">prediction from glycemic control indices</Keyword><Keyword MajorTopicYN="Y">prediction of nocturnal hypoglycemia</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27660190</ArticleId><ArticleId IdType="pii">1932296816670400</ArticleId><ArticleId IdType="doi">10.1177/1932296816670400</ArticleId><ArticleId IdType="pmc">PMC5094347</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S55-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19469679</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 1987 Oct;62(10):1085</Citation><ArticleIdList><ArticleId IdType="pubmed">3674930</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2007 Jun;30(6):1370-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17363757</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20167169</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2016 Jan;73:26-35</Citation><ArticleIdList><ArticleId IdType="pubmed">26519932</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 1987 Apr;62(4):333-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3296962</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2016 Oct;134:179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">27480742</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1998 Nov;21(11):1870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9802735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2014 Nov;8(6):1091-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25316716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27781950</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1996-3181</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>CNS &amp; neurological disorders drug targets</Title><ISOAbbreviation>CNS Neurol Disord Drug Targets</ISOAbbreviation></Journal><ArticleTitle>The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.</ArticleTitle><Pagination><MedlinePgn>36-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1871527315666161024142439</ELocationID><Abstract><AbstractText>Our purpose is to develop a clinical decision support system to classify the patients' diagnostics based on features gathered from Magnetic Resonance Imaging (MRI) and Expanded Disability Status Scale (EDSS). We studied 120 patients and 19 healthy individuals (not afflicted with MS) have been studied for this study. Healthy individuals in the control group do not have any complaint or drug use history. For the kernel trick, efficient performance in non-linear classification, the Convex Combination of Infinite Kernels model was developed to measure the health status of patients based on features gathered from MRI and EDSS. Our calculations show that our proposed model classifies the multiple sclerosis (MS) diagnosis level with better accuracy than single kernel, artificial neural network and other machine learning methods, and it can also be used as a decision support system for identifying MS health status of patients.</AbstractText><CopyrightInformation>Copyright.. Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karaca</LastName><ForeName>Yeliz</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>IEEE Computer Society Membership, on visiting Engineering School (DEIM), Tuscia University, Viterbo,. Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu-Dong</ForeName><Initials>YD</Initials></Author><Author ValidYN="Y"><LastName>Cattani</LastName><ForeName>Carlo</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ayan</LastName><ForeName>Ugur</ForeName><Initials>U</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>CNS Neurol Disord Drug Targets</MedlineTA><NlmUniqueID>101269155</NlmUniqueID><ISSNLinking>1871-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="N">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017711" MajorTopicYN="N">Nonlinear Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical decision support</Keyword><Keyword MajorTopicYN="N">infinite kernel classification</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">patient diagnostic.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27781950</ArticleId><ArticleId IdType="doi">10.2174/1871527315666161024142439</ArticleId><ArticleId IdType="pii">CNSNDDT-EPUB-79190</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27570203</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3840</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Canadian journal of diabetes</Title><ISOAbbreviation>Can J Diabetes</ISOAbbreviation></Journal><ArticleTitle>Improved A1C Levels in Type 1 Diabetes with Smartphone App Use.</ArticleTitle><Pagination><MedlinePgn>33-40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1499-2671(16)30041-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcjd.2016.06.001</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Smartphones are a potentially useful tool in diabetes care. We have developed an application (app) linked to a website, Intelligent Diabetes Management (IDM), which serves as both an insulin bolus calculator and an electronic diabetes diary. We have prospectively studied whether patients using this app improved control of their glucose levels.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with type 1 diabetes were recruited. There was a 4-week observation period, midway during which we offered to review the participants' records. The app was then downloaded and participants' diabetes regimens entered on the synchronized IDM website. At 2, 4, 8, 12 and 16 weeks of the active phase, their records were reviewed online, and feedback was provided electronically. The primary endpoint was change in levels of glycated hemoglobin (A1C).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 31 patients recruited, 18 completed the study. These 18 made 572..98 entries per person on the IDM system over the course of the study (...5.1/day). Their ages were 40.0..13.9 years, the durations of their diabetes were 27.3..14.9 years and 44% used insulin pumps. The median A1C level fell from 8.1% (7.5 to 9.0, IQ range) to 7.8% (6.9 to 8.3; p&lt;0.001). During the observation period, glucose records were reviewed for 50% of the participants. In the active phase, review of the glucose diaries took less time on the IDM website than using personal glucose records in the observation period, median 6 minutes (5 to 7.5 IQ range) vs. 10 minutes (7.5 to 10.5 IQ range; p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our smartphone app enables online review of glucose records, requires less time for clinical staff and is associated with improved glucose control.</AbstractText><CopyrightInformation>Copyright .. 2016 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Edmond A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Divisions of Endocrinology and Metabolism and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: edmond.ryan@ualberta.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holland</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Divisions of Endocrinology and Metabolism and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stroulia</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazelli</LastName><ForeName>Blerina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babwik</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Divisions of Endocrinology and Metabolism and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Haipeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Alberta Innovates Centre for Machine Learning, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senior</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Divisions of Endocrinology and Metabolism and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiner</LastName><ForeName>Russ</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada; Alberta Innovates Centre for Machine Learning, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Diabetes</MedlineTA><NlmUniqueID>101148810</NlmUniqueID><ISSNLinking>1499-2671</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517652">hemoglobin A1c protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="N">Mobile Applications</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ajustement de l'insuline</Keyword><Keyword MajorTopicYN="N">app</Keyword><Keyword MajorTopicYN="N">appli</Keyword><Keyword MajorTopicYN="N">bolus calculator</Keyword><Keyword MajorTopicYN="N">calculateur de bolus</Keyword><Keyword MajorTopicYN="N">diab..te de type 1</Keyword><Keyword MajorTopicYN="N">glucose control</Keyword><Keyword MajorTopicYN="N">insulin adjustment</Keyword><Keyword MajorTopicYN="N">r..gulation de la glyc..mie</Keyword><Keyword MajorTopicYN="N">smartphone</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">t..l..phone intelligent</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27570203</ArticleId><ArticleId IdType="pii">S1499-2671(16)30041-7</ArticleId><ArticleId IdType="doi">10.1016/j.jcjd.2016.06.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27441367</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.</ArticleTitle><Pagination><MedlinePgn>e0158722</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0158722</ELocationID><Abstract><AbstractText>Although reinforcement learning (RL) is suitable for highly uncertain systems, the applicability of this class of algorithms to medical treatment may be limited by the patient variability which dictates individualised tuning for their usually multiple algorithmic parameters. This study explores the feasibility of RL in the framework of artificial pancreas development for type 1 diabetes (T1D). In this approach, an Actor-Critic (AC) learning algorithm is designed and developed for the optimisation of insulin infusion for personalised glucose regulation. AC optimises the daily basal insulin rate and insulin:carbohydrate ratio for each patient, on the basis of his/her measured glucose profile. Automatic, personalised tuning of AC is based on the estimation of information transfer (IT) from insulin to glucose signals. Insulin-to-glucose IT is linked to patient-specific characteristics related to total daily insulin needs and insulin sensitivity (SI). The AC algorithm is evaluated using an FDA-accepted T1D simulator on a large patient database under a complex meal protocol, meal uncertainty and diurnal SI variation. The results showed that 95.66% of time was spent in normoglycaemia in the presence of meal uncertainty and 93.02% when meal uncertainty and SI variation were simultaneously considered. The time spent in hypoglycaemia was 0.27% in both cases. The novel tuning method reduced the risk of severe hypoglycaemia, especially in patients with low SI. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daskalaki</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diem</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital "Inselspital", 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mougiakakou</LastName><ForeName>Stavroula G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Diabetes Technology Research Group, ARTORG Center for Biomedical Engineering Research, University of Bern, Murtenstrasse 50, 3008 Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital "Inselspital", 3010 Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27441367</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0158722</ArticleId><ArticleId IdType="pii">PONE-D-15-41463</ArticleId><ArticleId IdType="pmc">PMC4956312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pac Symp Biocomput. 2000;:418-29</Citation><ArticleIdList><ArticleId IdType="pubmed">10902190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Jan;3(1):44-55</Citation><ArticleIdList><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Mar 01;3(2):269-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20144358</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2009 Sep 01;3(5):1082-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20144421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1174-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20920437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Mar 01;5(2):368-79</Citation><ArticleIdList><ArticleId IdType="pubmed">21527108</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Oct;13(10):983-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21774690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach Learn. 2011 Jul 1;84(1-2):109-136</Citation><ArticleIdList><ArticleId IdType="pubmed">21799585</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2012 Feb;14(2):168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21992270</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2013 Feb;109(2):116-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22502983</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Feb;36(2):222-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23033237</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Control. 2012 Dec;36(2):255-266</Citation><ArticleIdList><ArticleId IdType="pubmed">23175620</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Apr;36(4):838-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23193217</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2014 Dec;83(12):983-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23317809</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 May 31;8(5):e64925</Citation><ArticleIdList><ArticleId IdType="pubmed">23741425</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2014 Mar;15(2):91-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23944875</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Med Devices. 2013 Sep;10(5):661-73</Citation><ArticleIdList><ArticleId IdType="pubmed">23972072</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2013;2013:3487-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24110480</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2013 Dec;36(12):3882-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24170747</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1216-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24319120</ArticleId></ArticleIdList></Reference><Reference><Citation>J Healthc Eng. 2014;5(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">24691384</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1184-90</Citation><ArticleIdList><ArticleId IdType="pubmed">24757225</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014;37(5):1191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24757226</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2014 Sep;16(9):550-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24801544</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24835122</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jul;37(7):1789-96</Citation><ArticleIdList><ArticleId IdType="pubmed">24929429</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jul 24;371(4):313-325</Citation><ArticleIdList><ArticleId IdType="pubmed">24931572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Diabetes Endocrinol. 2014 Sep;2(9):701-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24943065</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2015 Feb;36(2):68-71</Citation><ArticleIdList><ArticleId IdType="pubmed">25479798</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat. 2015;4(1):59-68</Citation><ArticleIdList><ArticleId IdType="pubmed">25883393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2015 May;9(3):549-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25904142</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Inform. 2016 Jun;3(2):119-131</Citation><ArticleIdList><ArticleId IdType="pubmed">27747607</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 1998 Nov;21(11):1870-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9802735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27435068</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-0444</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Medical &amp; biological engineering &amp; computing</Title><ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation></Journal><ArticleTitle>Selection of clinical features for pattern recognition applied to gait analysis.</ArticleTitle><Pagination><MedlinePgn>685-695</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-016-1546-1</ELocationID><Abstract><AbstractText>This paper deals with the opportunity of extracting useful information from medical data retrieved directly from a stereophotogrammetric system applied to gait analysis. A feature selection method to exhaustively evaluate all the possible combinations of the gait parameters is presented, in order to find the best subset able to classify among diseased and healthy subjects. This procedure will be used for estimating the performance of widely used classification algorithms, whose performance has been ascertained in many real-world problems with respect to well-known classification benchmarks, both in terms of number of selected features and classification accuracy. Precisely, support vector machine, Naive Bayes and K nearest neighbor classifiers can obtain the lowest classification error, with an accuracy greater than 97..%. For the considered classification problem, the whole set of features will be proved to be redundant and it can be significantly pruned. Namely, groups of 3 or 5 features only are able to preserve high accuracy when the aim is to check the anomaly of a gait. The step length and the swing speed are the most informative features for the gait analysis, but also cadence and stride may add useful information for the movement evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Altilio</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, Electronics and Telecommunications (DIET), University of Rome "La Sapienza", Via Eudossiana, 18, 00184, Rome, Italy. rosa.altilio@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paoloni</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomechanics and Movement Analysis Laboratory, Physical Medicine and Rehabilitation, University of Rome "La Sapienza", Piazzale Aldo Moro, 5, 00185, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panella</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Information Engineering, Electronics and Telecommunications (DIET), University of Rome "La Sapienza", Via Eudossiana, 18, 00184, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Biol Eng Comput</MedlineTA><NlmUniqueID>7704869</NlmUniqueID><ISSNLinking>0140-0118</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006429" MajorTopicYN="N">Hemiplegia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015207" MajorTopicYN="N">Osteoarthritis, Hip</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Feature selection</Keyword><Keyword MajorTopicYN="N">Gait analysis</Keyword><Keyword MajorTopicYN="N">Pattern recognition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27435068</ArticleId><ArticleId IdType="doi">10.1007/s11517-016-1546-1</ArticleId><ArticleId IdType="pii">10.1007/s11517-016-1546-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biomed Instrum Technol. 2005 Jan-Feb;39(1):64-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15742852</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2007 Jan;88(1):115-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17207686</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 2002;13(1):143-59</Citation><ArticleIdList><ArticleId IdType="pubmed">18244416</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1994 Jun 11;308(6943):1552</Citation><ArticleIdList><ArticleId IdType="pubmed">8019315</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2016 Jun;78:65-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26341005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensors (Basel). 2014 Feb 19;14(2):3362-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24556672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mov Sci. 2007 Jun;26(3):393-411</Citation><ArticleIdList><ArticleId IdType="pubmed">17509708</ArticleId></ArticleIdList></Reference><Reference><Citation>J Electromyogr Kinesiol. 2015 Apr;25(2):413-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25725811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2011 May;34(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21377366</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Oct;54(10):1481-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26589319</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2015 Feb 5;48(3):544-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25555306</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Jul;54(7):1049-59</Citation><ArticleIdList><ArticleId IdType="pubmed">26403299</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Jul;54(7):1137-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26718556</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Sep;54(9):1399-408</Citation><ArticleIdList><ArticleId IdType="pubmed">26518306</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Dec;53(12):1345-60</Citation><ArticleIdList><ArticleId IdType="pubmed">26109519</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2015;210:850-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25991275</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Mar;54(2-3):485-96</Citation><ArticleIdList><ArticleId IdType="pubmed">26109520</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2016 May;20(3):893-901</Citation><ArticleIdList><ArticleId IdType="pubmed">25956000</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2015 Sep;53(9):815-28</Citation><ArticleIdList><ArticleId IdType="pubmed">25861746</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuromodulation. 2004 Jul;7(3):205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22151272</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2008 Aug 28;41(12):2628-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18657816</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2016 Jan;54(1):223-33</Citation><ArticleIdList><ArticleId IdType="pubmed">26429349</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Rehabil Eng. 1997 Dec;5(4):300-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9422455</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2007 Jul;38(7):2096-100</Citation><ArticleIdList><ArticleId IdType="pubmed">17510461</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2005 Mar;38(3):401-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15652537</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Biomech (Bristol, Avon). 2009 May;24(4):372-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19285768</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2014 Aug;52(8):673-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24961179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gait Posture. 2014 Jul;40(3):357-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24908195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Oct 1;23(19):2507-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17720704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27311357</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2022</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ISA transactions</Title><ISOAbbreviation>ISA Trans</ISOAbbreviation></Journal><ArticleTitle>Non-invasive hypoglycemia monitoring system using extreme learning machine for Type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>440-446</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0019-0578(16)30100-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.isatra.2016.05.008</ELocationID><Abstract><AbstractText>Hypoglycemia is a very common in type 1 diabetic persons and can occur at any age. It is always threatening to the well-being of patients with Type 1 diabetes mellitus (T1DM) since hypoglycemia leads to seizures or loss of consciousness and the possible development of permanent brain dysfunction under certain circumstances. Because of that, an accurate continuing hypoglycemia monitoring system is a very important medical device for diabetic patients. In this paper, we proposed a non-invasive hypoglycemia monitoring system using the physiological parameters of electrocardiography (ECG) signal. To enhance the detection accuracy, extreme learning machine (ELM) is developed to recognize the presence of hypoglycemia. A clinical study of 16 children with T1DM is given to illustrate the good performance of ELM. </AbstractText><CopyrightInformation>Copyright .. 2016 ISA. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Sai Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Centre for Health Technologies, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia. Electronic address: Steve.Ling@uts.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>San</LastName><ForeName>Phyo Phyo</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Institute for Infocomm Research, A(...) Star, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Hung T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Centre for Health Technologies, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ISA Trans</MedlineTA><NlmUniqueID>0374750</NlmUniqueID><ISSNLinking>0019-0578</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008133" MajorTopicYN="N">Long QT Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Extreme learning machine</Keyword><Keyword MajorTopicYN="N">Hypoglycemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27311357</ArticleId><ArticleId IdType="pii">S0019-0578(16)30100-8</ArticleId><ArticleId IdType="doi">10.1016/j.isatra.2016.05.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27207310</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1559-0089</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>10</Month></PubDate></JournalIssue><Title>Neuroinformatics</Title><ISOAbbreviation>Neuroinformatics</ISOAbbreviation></Journal><ArticleTitle>Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.</ArticleTitle><Pagination><MedlinePgn>403-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12021-016-9301-1</ELocationID><Abstract><AbstractText>Changes of white-matter lesions (WMLs) are good predictors of the progression of neurodegenerative diseases like multiple sclerosis (MS). Based on longitudinal magnetic resonance (MR) imaging the changes can be monitored, while the need for their accurate and reliable quantification led to the development of several automated MR image analysis methods. However, an objective comparison of the methods is difficult, because publicly unavailable validation datasets with ground truth and different sets of performance metrics were used. In this study, we acquired longitudinal MR datasets of 20 MS patients, in which brain regions were extracted, spatially aligned and intensity normalized. Two expert raters then delineated and jointly revised the WML changes on subtracted baseline and follow-up MR images to obtain ground truth WML segmentations. The main contribution of this paper is an objective, quantitative and systematic evaluation of two unsupervised and one supervised intensity based change detection method on the publicly available datasets with ground truth segmentations, using common pre- and post-processing steps and common evaluation metrics. Besides, different combinations of the two main steps of the studied change detection methods, i.e. dissimilarity map construction and its segmentation, were tested to identify the best performing combination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lesjak</LastName><ForeName>..iga</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>University of Ljubljana, Faculty of Electrical Engineering, Tr..a..ka 25, 1000, Ljubljana, Slovenia. ziga.lesjak@fe.uni-lj.si.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernu..</LastName><ForeName>Franjo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Ljubljana, Faculty of Electrical Engineering, Tr..a..ka 25, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likar</LastName><ForeName>Bo..tjan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Ljubljana, Faculty of Electrical Engineering, Tr..a..ka 25, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computer Vision Systems, Sensum, Tehnolo..ki Park 21, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>..piclin</LastName><ForeName>..iga</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>University of Ljubljana, Faculty of Electrical Engineering, Tr..a..ka 25, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computer Vision Systems, Sensum, Tehnolo..ki Park 21, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroinformatics</MedlineTA><NlmUniqueID>101142069</NlmUniqueID><ISSNLinking>1539-2791</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012815" MajorTopicYN="N">Signal Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Change detection</Keyword><Keyword MajorTopicYN="Y">Image segmentation</Keyword><Keyword MajorTopicYN="Y">Lesion</Keyword><Keyword MajorTopicYN="Y">Magnetic resonance</Keyword><Keyword MajorTopicYN="Y">Multiple sclerosis</Keyword><Keyword MajorTopicYN="Y">Quantitative evaluation</Keyword><Keyword MajorTopicYN="Y">Validation dataset</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27207310</ArticleId><ArticleId IdType="doi">10.1007/s12021-016-9301-1</ArticleId><ArticleId IdType="pii">10.1007/s12021-016-9301-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):195-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18202208</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2003 Oct;20(2):643-56</Citation><ArticleIdList><ArticleId IdType="pubmed">14568441</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1082-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23524331</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1165-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16775258</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Alzheimer Res. 2009 Aug;6(4):347-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19689234</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2009 Feb;250(2):506-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19037018</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2011 Apr;15(2):267-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21233004</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2012 Aug;54(8):787-807</Citation><ArticleIdList><ArticleId IdType="pubmed">22179659</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2008 Feb;29(2):340-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18272569</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiol Med. 2013 Mar;118(2):251-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22430683</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Apr 1;55(3):968-85</Citation><ArticleIdList><ArticleId IdType="pubmed">21237273</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2013 Aug;32(8):1490-503</Citation><ArticleIdList><ArticleId IdType="pubmed">23613032</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2006 May;25(5):626-39</Citation><ArticleIdList><ArticleId IdType="pubmed">16689266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2014 Aug 15;6:9-19</Citation><ArticleIdList><ArticleId IdType="pubmed">25379412</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1997 Apr;16(2):187-98</Citation><ArticleIdList><ArticleId IdType="pubmed">9101328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2015 Aug;11(8):471-82</Citation><ArticleIdList><ArticleId IdType="pubmed">26149978</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2013 Jan;17(1):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23084503</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2013 Jan;34(1):68-73</Citation><ArticleIdList><ArticleId IdType="pubmed">22766673</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7803-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22256148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Alzheimers Dis. 2015;45(1):253-68</Citation><ArticleIdList><ArticleId IdType="pubmed">25524955</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroinformatics. 2011 Dec;9(4):381-400</Citation><ArticleIdList><ArticleId IdType="pubmed">21373993</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neuroinform. 2014 Apr 28;8:44</Citation><ArticleIdList><ArticleId IdType="pubmed">24817849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2003 Sep;18(3):291-301</Citation><ArticleIdList><ArticleId IdType="pubmed">12938123</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Feb;113(2):655-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24380649</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2009 Jul 1;46(3):786-802</Citation><ArticleIdList><ArticleId IdType="pubmed">19195496</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Mar 27;10(3):e0120754</Citation><ArticleIdList><ArticleId IdType="pubmed">25816303</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2002 Jun;6(2):163-79</Citation><ArticleIdList><ArticleId IdType="pubmed">12045002</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroinformatics. 2014 Jul;12(3):365-79</Citation><ArticleIdList><ArticleId IdType="pubmed">24338728</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2013 Oct;260(10):2458-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23263472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2014 Jun;39(6):1543-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24987754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Digit Imaging. 2004 Sep;17(3):158-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15534751</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimers Res Ther. 2014 Aug 11;6(4):49</Citation><ArticleIdList><ArticleId IdType="pubmed">25478020</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2010 Apr;255(1):154-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2014 May;56(5):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24590302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2002 Nov;17(3):143-55</Citation><ArticleIdList><ArticleId IdType="pubmed">12391568</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2007;2007:2069-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18002394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Feb;20(2):214-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23877971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 May;67(5):667-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20437564</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2004 Aug;10(4):402-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15327037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27146291</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.</ArticleTitle><Pagination><MedlinePgn>754-768</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-016-9551-4</ELocationID><Abstract><AbstractText>A structural or functional pattern of neuroplasticity that could systematically discriminate between people with impaired and preserved motor performance could help us to understand the brain networks contributing to preservation or compensation of behavior in multiple sclerosis (MS). This study aimed to (1) investigate whether a machine learning-based technique could accurately classify MS participants into groups defined by upper extremity function (i.e. motor function preserved (MP) vs. motor function impaired (MI)) based on their regional grey matter measures (GMM, cortical thickness and deep grey matter volume) and inter-regional functional connection (FC), (2) investigate which features (GMM, FC, or GMM..+..FC) could classify groups more accurately, and (3) identify the multivariate patterns of GMM and FCs that are most discriminative between MP and MI participants, and between each of these groups and the healthy controls (HCs). With 26 MP, 25 MI, and 21 HCs (age and sex matched) underwent T1-weighted and resting-state functional MRI at 3..T, we applied support vector machine (SVM) based classification to learn discriminant functions indicating regions in which GMM or between which FCs were most discriminative between groups. This study demonstrates that there exist structural and FC patterns sufficient for correct classification of upper limb motor ability of people with MS. The classifier with GMM..+..FC features yielded the highest accuracy of 85.61..% (p..&lt;..0.001) to distinguish between the MS groups using leave-one-out cross-validation. It suggests that a machine-learning approach combining structural and functional features is useful for identifying the specific neural substrates that are necessary and sufficient to preserve motor function among people with MS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Jidan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute of the McGill University Health Centre, Montreal, QC, Canada. jidanz@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. jidanz@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada. jidanz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>David Qixiang</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Brain, Imaging and Behaviour-Systems, Neuroscience, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nantes</LastName><ForeName>Julia C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>Scott A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodaie</LastName><ForeName>Mojgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Brain, Imaging and Behaviour-Systems, Neuroscience, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurosurgery, Toronto Western Hospital &amp; University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koski</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Institute of the McGill University Health Centre, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007839" MajorTopicYN="N">Functional Laterality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009069" MajorTopicYN="N">Movement Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cortical thickness</Keyword><Keyword MajorTopicYN="N">Deep grey matter volume</Keyword><Keyword MajorTopicYN="N">Functional connectivity</Keyword><Keyword MajorTopicYN="N">Motor disability</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Multivariate analysis</Keyword><Keyword MajorTopicYN="N">Support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27146291</ArticleId><ArticleId IdType="doi">10.1007/s11682-016-9551-4</ArticleId><ArticleId IdType="pii">10.1007/s11682-016-9551-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27146242</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-7609</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Modern rheumatology</Title><ISOAbbreviation>Mod Rheumatol</ISOAbbreviation></Journal><ArticleTitle>A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab.</ArticleTitle><Pagination><MedlinePgn>813-816</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/14397595.2016.1168536</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the present study was to generate a novel method for predicting the clinical response to infliximab (IFX), using a machine-learning algorithm with only clinical data obtained before the treatment in rheumatoid arthritis (RA) patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We obtained 32 variables out of the clinical data on the patients from two independent hospitals. Next, we selected both clinical parameters and machine-learning algorithms and decided the candidates of prediction method. These candidates were verified by clinical variables on different patients from two other hospitals. Finally, we decided the prediction method to achieve the highest score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The combination of multilayer perceptron algorithm (neural network) and nine clinical parameters shows the best accuracy performance. This method could predict the good or moderate response to IFX with 92% accuracy. The sensitivity of this method was 96.7%, while the specificity was 75%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We have developed a novel method for predicting the clinical response using only background clinical data in RA patients before treatment with IFX. Our method for predicting the response to IFX in RA patients may have advantages over the other previous methods in several points including easy usability, cost-effectiveness and accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miyoshi</LastName><ForeName>Fumihiko</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>a Department of Rheumatology and Applied Immunology, Faculty of Medicine , Saitama Medical University , Saitama , Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honne</LastName><ForeName>Kyoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>b Division of Rheumatology and Clinical Immunology , Jichi Medical University , Tochigi , Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minota</LastName><ForeName>Seiji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>b Division of Rheumatology and Clinical Immunology , Jichi Medical University , Tochigi , Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>c Immuno-Rheumatology Center, St. Luke's International Hospital , Tokyo , Japan , and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Noriyoshi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>d Division of Immunology and Rheumatology , Internal Medicine 3, Hamamatsu University School of Medicine , Hamamatsu , Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mimura</LastName><ForeName>Toshihide</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>a Department of Rheumatology and Applied Immunology, Faculty of Medicine , Saitama Medical University , Saitama , Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mod Rheumatol</MedlineTA><NlmUniqueID>100959226</NlmUniqueID><ISSNLinking>1439-7595</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>B72HH48FLU</RegistryNumber><NameOfSubstance UI="D000069285">Infliximab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069285" MajorTopicYN="N">Infliximab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical data</Keyword><Keyword MajorTopicYN="N">Infliximab</Keyword><Keyword MajorTopicYN="N">Machine-learning</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">The prediction of clinical response</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27146242</ArticleId><ArticleId IdType="doi">10.3109/14397595.2016.1168536</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27138529</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.</ArticleTitle><Pagination><MedlinePgn>744-753</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-016-9550-5</ELocationID><Abstract><AbstractText>White matter (WM) lesions with a distinct lesion-tissue contrast are the main radiological hallmark of multiple sclerosis (MS) in standard magnetic resonance imaging (MRI). Pathological WM changes beyond lesion development lack suitable contrasts, rendering the investigation of normal appearing WM (NAWM) more challenging. In this study, repeat quantitative MRI (qMRI) was collected in 9 relapsing remitting MS patients with mild disease over nine months. The relaxation times T1 and T2, the proton density (PD), and the magnetization transfer ratio (MTR) were analysed in the NAWM. For each parameter, both the mean value and the standard deviation were determined across large NAWM regions. The resulting 8-dimensional multi-parameter space includes parameter non-uniformities as additional descriptors of NAWM inhomogeneity. The goals of the study were to investigate (1) which of the eight parameters differ significantly between NAWM and normal WM, (2) if parameter time courses differ between patients with and without radiological disease activity, and (3) if a suitable biomarker can be derived from the multi-parameter space, allowing for NAWM characterization and differentiation from controls. On a group level, all parameters investigated except mean T1 values were significantly affected in MS NAWM. Group classification accuracy using a multi-parametric support vector machine approach in NAWM was 66.7..%. In addition, mean T2 values increased significantly with time for patients with radiological disease activity, but not for patients without radiological activity. In conclusion, our data demonstrate the potential of qMRI for investigating MS pathology in NAWM. T2 measurements in NAWM may enable monitoring of disease activity outside of overt lesions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reitz</LastName><ForeName>Sarah C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany. SarahChristina.Reitz@kgu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany. SarahChristina.Reitz@kgu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hof</LastName><ForeName>Stephanie-Michelle</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischer</LastName><ForeName>Vinzenz</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg-University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodski</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MEG Unit, Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr..ger</LastName><ForeName>Adriane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg-University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gracien</LastName><ForeName>Ren..-Maxime</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droby</LastName><ForeName>Amgad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg-University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinmetz</LastName><ForeName>Helmuth</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziemann</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Eberhard Karls University, T..bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zipp</LastName><ForeName>Frauke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg-University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deichmann</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Johannes C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging Center (BIC), Goethe University, Frankfurt/Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="Y">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Multiple sclerosis (MS)</Keyword><Keyword MajorTopicYN="N">Normal appearing white matter (NAWM)</Keyword><Keyword MajorTopicYN="N">Quantitative MRI (qMRI)</Keyword><Keyword MajorTopicYN="N">Relapsing remitting multiple sclerosis (RRMS)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27138529</ArticleId><ArticleId IdType="doi">10.1007/s11682-016-9550-5</ArticleId><ArticleId IdType="pii">10.1007/s11682-016-9550-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27135409</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis.</ArticleTitle><Pagination><MedlinePgn>e0154515</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0154515</ELocationID><Abstract><AbstractText Label="OBJECTIVES">1) To use data-driven method to examine clinical codes (risk factors) of a medical condition in primary care electronic health records (EHRs) that can accurately predict a diagnosis of the condition in secondary care EHRs. 2) To develop and validate a disease phenotyping algorithm for rheumatoid arthritis using primary care EHRs.</AbstractText><AbstractText Label="METHODS">This study linked routine primary and secondary care EHRs in Wales, UK. A machine learning based scheme was used to identify patients with rheumatoid arthritis from primary care EHRs via the following steps: i) selection of variables by comparing relative frequencies of Read codes in the primary care dataset associated with disease case compared to non-disease control (disease/non-disease based on the secondary care diagnosis); ii) reduction of predictors/associated variables using a Random Forest method, iii) induction of decision rules from decision tree model. The proposed method was then extensively validated on an independent dataset, and compared for performance with two existing deterministic algorithms for RA which had been developed using expert clinical knowledge.</AbstractText><AbstractText Label="RESULTS">Primary care EHRs were available for 2,238,360 patients over the age of 16 and of these 20,667 were also linked in the secondary care rheumatology clinical system. In the linked dataset, 900 predictors (out of a total of 43,100 variables) in the primary care record were discovered more frequently in those with versus those without RA. These variables were reduced to 37 groups of related clinical codes, which were used to develop a decision tree model. The final algorithm identified 8 predictors related to diagnostic codes for RA, medication codes, such as those for disease modifying anti-rheumatic drugs, and absence of alternative diagnoses such as psoriatic arthritis. The proposed data-driven method performed as well as the expert clinical knowledge based methods.</AbstractText><AbstractText Label="CONCLUSION">Data-driven scheme, such as ensemble machine learning methods, has the potential of identifying the most informative predictors in a cost-effective and rapid way to accurately and reliably classify rheumatoid arthritis or other complex medical conditions in primary care EHRs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shang-Ming</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Gutierrez</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooksey</LastName><ForeName>Roxanne</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denaxas</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UCL Institute of Health Informatics and Farr Institute of Health Informatics Research, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebert</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixon</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Terence W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choy</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Arthritis Research UK CREATE Centre and Welsh Arthritis Research Network, School of Medicine, Cardiff University, Cardiff, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudlow</LastName><ForeName>Cathie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>UK Biobank Follow-up and Outcomes Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Brophy</LastName><ForeName>Sinead</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0902272</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K006665/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K006584/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_13043</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_13042</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U137686860</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K006525/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_QA137853</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K023233/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27135409</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0154515</ArticleId><ArticleId IdType="pii">PONE-D-16-00457</ArticleId><ArticleId IdType="pmc">PMC4852928</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Dis Child. 2013 Mar;98(3):195-202</Citation><ArticleIdList><ArticleId IdType="pubmed">23343522</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(2):e54878</Citation><ArticleIdList><ArticleId IdType="pubmed">23451024</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2013 Oct;15(10):761-71</Citation><ArticleIdList><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Dec;20(e2):e226-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23956018</ArticleId></ArticleIdList></Reference><Reference><Citation>Postgrad Med J. 2014 Jan;90(1059):13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24225940</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Dec 30;31 Suppl 10:K41-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24331074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2014 Mar-Apr;21(2):221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2014 Aug;50:196-204</Citation><ArticleIdList><ArticleId IdType="pubmed">24440148</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Med Inform. 2014 Nov;83(11):860-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25189709</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014;9(11):e113592</Citation><ArticleIdList><ArticleId IdType="pubmed">25409038</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014;9(12):e111301</Citation><ArticleIdList><ArticleId IdType="pubmed">25436638</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2015 Mar;12(3):e1001779</Citation><ArticleIdList><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015;10(5):e0127914</Citation><ArticleIdList><ArticleId IdType="pubmed">26000792</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015;10(9):e0138677</Citation><ArticleIdList><ArticleId IdType="pubmed">26413716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2002 Jul;41(7):793-800</Citation><ArticleIdList><ArticleId IdType="pubmed">12096230</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 May 24;326(7399):1130</Citation><ArticleIdList><ArticleId IdType="pubmed">12763987</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2003 Sep-Oct;29(1-2):153-67</Citation><ArticleIdList><ArticleId IdType="pubmed">12957785</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Dec 15;51(6):952-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15593102</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Stat Q. 2004 Spring;(21):5-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15615148</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Gen Pract. 2008 Mar;58(548):192-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18318973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fam Pract. 2008 Aug;25(4):213-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18694896</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Sep 15;59(9):1314-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18759262</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Inform Decis Mak. 2009;9:3</Citation><ArticleIdList><ArticleId IdType="pubmed">19149883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Mar 15;26(6):831-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20130032</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Trials. 2010 Apr;7(2):183-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20338903</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2011;13(1):R32</Citation><ArticleIdList><ArticleId IdType="pubmed">21345216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2012 Jun;13(6):395-405</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Oct;64(10):1490-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22623324</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(12):e51468</Citation><ArticleIdList><ArticleId IdType="pubmed">23272108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27080919</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1098-2272</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Genetic epidemiology</Title><ISOAbbreviation>Genet Epidemiol</ISOAbbreviation></Journal><ArticleTitle>An Object-Oriented Regression for Building Disease Predictive Models with Multiallelic HLA Genes.</ArticleTitle><Pagination><MedlinePgn>315-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/gepi.21968</ELocationID><Abstract><AbstractText>Recent genome-wide association studies confirm that human leukocyte antigen (HLA) genes have the strongest associations with several autoimmune diseases, including type 1 diabetes (T1D), providing an impetus to reduce this genetic association to practice through an HLA-based disease predictive model. However, conventional model-building methods tend to be suboptimal when predictors are highly polymorphic with many rare alleles combined with complex patterns of sequence homology within and between genes. To circumvent this challenge, we describe an alternative methodology; treating complex genotypes of HLA genes as "objects" or "exemplars," one focuses on systemic associations of disease phenotype with "objects" via similarity measurements. Conceptually, this approach assigns disease risks base on complex genotype profiles instead of specific disease-associated genotypes or alleles. Effectively, it transforms large, discrete, and sparse HLA genotypes into a matrix of similarity-based covariates. By the Kernel representative theorem and machine learning techniques, it uses a penalized likelihood method to select disease-associated exemplars in building predictive models. To illustrate this methodology, we apply it to a T1D study with eight HLA genes (HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1) to build a predictive model. The resulted predictive model has an area under curve of 0.92 in the training set, and 0.89 in the validating set, indicating that this methodology is useful to build predictive models with complex HLA genotypes.</AbstractText><CopyrightInformation>.. 2016 WILEY PERIODICALS, INC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Lue Ping</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolouri</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bellevue High School, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraghty</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lernmark</LastName><ForeName>..ke</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University/CRC, Sk..ne University Hospital, Malm.., Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Better Diabetes Diagnosis Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK026190</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK26190</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 DK053004</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK063861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK63861</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genet Epidemiol</MedlineTA><NlmUniqueID>8411723</NlmUniqueID><ISSNLinking>0741-0395</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">generalized linear model</Keyword><Keyword MajorTopicYN="N">kernel machine</Keyword><Keyword MajorTopicYN="N">multiallelic genotypes</Keyword><Keyword MajorTopicYN="N">penalized regression</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">similarity regression</Keyword><Keyword MajorTopicYN="N">statistical learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27080919</ArticleId><ArticleId IdType="doi">10.1002/gepi.21968</ArticleId><ArticleId IdType="pmc">PMC4834870</ArticleId><ArticleId IdType="mid">NIHMS766725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diabetes. 2016 Mar;65(3):710-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26740600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2011 Mar;12(3):215-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21301473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Stat Softw. 2010;33(1):1-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>J R Stat Soc Series B Stat Methodol. 2012 Mar;74(2):245-266</Citation><ArticleIdList><ArticleId IdType="pubmed">25506256</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Jun 11;86(6):929-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20560208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Bronconeumol. 2014 Oct;50(10):444-51</Citation><ArticleIdList><ArticleId IdType="pubmed">24397963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Diabetes. 2010 Dec;11(8):513-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20337975</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1997 Feb;60(2):397-407</Citation><ArticleIdList><ArticleId IdType="pubmed">9012413</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Stat Assoc. 2015 Apr 22;110(509):393-404</Citation><ArticleIdList><ArticleId IdType="pubmed">26236061</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1986 Jul-Aug;5(4):291-302</Citation><ArticleIdList><ArticleId IdType="pubmed">3532271</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Feb;82(2):386-97</Citation><ArticleIdList><ArticleId IdType="pubmed">18252219</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2006 Nov;79(5):792-806</Citation><ArticleIdList><ArticleId IdType="pubmed">17033957</ArticleId></ArticleIdList></Reference><Reference><Citation>Integr Cancer Ther. 2006 Dec;5(4):293-307</Citation><ArticleIdList><ArticleId IdType="pubmed">17101758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2004 Feb;36(2):151-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14704667</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2011 Apr;79(4):1401-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21321076</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2009 Sep;65(3):822-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19210740</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Nov;81(5):927-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17924336</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2012 Oct;61(10):2556-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22787139</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2010;43(1):53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19940542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Adh Migr. 2014;8(5):468-77</Citation><ArticleIdList><ArticleId IdType="pubmed">25482526</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2011 Jul 15;89(1):82-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21737059</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):12-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21169219</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 1968 Oct;70(4):213-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19673146</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1990 Feb;46(2):254-65</Citation><ArticleIdList><ArticleId IdType="pubmed">2301395</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2015 Nov;64:101-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26272854</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26956213</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems.</ArticleTitle><Pagination><MedlinePgn>342-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2016.02.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(16)00039-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Chronic Lymphocytic Leukemia (CLL) is a disease with highly heterogeneous clinical course. A key goal is the prediction of patients with high risk of disease progression, which could benefit from an earlier or more intense treatment. In this work we introduce a simple methodology based on machine learning methods to help physicians in their decision making in different problems related to CLL.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Clinical data belongs to a retrospective study of a cohort of 265 Caucasians who were diagnosed with CLL between 1997 and 2007 in Hospital Cabue..es (Asturias, Spain). Different machine learning methods were applied to find the shortest list of most discriminatory prognostic variables to predict the need of Chemotherapy Treatment and the development of an Autoimmune Disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Autoimmune disease occurrence was predicted with very high accuracy (&gt;90%). Autoimmune disease development is currently an unpredictable severe complication of CLL. Chemotherapy Treatment has been predicted with a lower accuracy (80%). Risk analysis showed that the number of false positives and false negatives are well balanced.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study highlights the importance of prognostic variables associated with the characteristics of platelets, reticulocytes and natural killers, which are the main targets of the autoimmune haemolytic anemia and immune thrombocytopenia for autoimmune disease development, and also, the relevance of some clinical variables related with the immune characteristics of CLL patients that are not taking into account by current prognostic markers for predicting the need of chemotherapy. Because of its simplicity, this methodology could be implemented in spreadsheets.</AbstractText><CopyrightInformation>Copyright .. 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>deAndr..s-Galiana</LastName><ForeName>Enrique J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Oviedo, Spain; Artificial Intelligence Center, University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern..ndez-Mart..nez</LastName><ForeName>Juan L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Oviedo, Spain. Electronic address: jlfm@uniovi.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luaces</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Artificial Intelligence Center, University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Coz</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Artificial Intelligence Center, University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huergo-Zapico</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Universitario Oncol..gico del Principado de Asturias (IUOPA), University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acebes-Huerta</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Universitario Oncol..gico del Principado de Asturias (IUOPA), University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz..lez</LastName><ForeName>Segundo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Universitario Oncol..gico del Principado de Asturias (IUOPA), University of Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz..lez-Rodr..guez</LastName><ForeName>Ana P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Hematology Department, Hospital Central de Asturias, Oviedo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015451" MajorTopicYN="N">Leukemia, Lymphocytic, Chronic, B-Cell</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disease development</Keyword><Keyword MajorTopicYN="N">Chemotherapy Treatment</Keyword><Keyword MajorTopicYN="N">Chronic Lymphocytic Leukemia</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26956213</ArticleId><ArticleId IdType="pii">S1532-0464(16)00039-3</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2016.02.017</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26907503</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-114X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical therapeutics</Title><ISOAbbreviation>Clin Ther</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.</ArticleTitle><Pagination><MedlinePgn>610-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinthera.2016.01.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0149-2918(16)30005-4</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The treatment of systemic lupus erythematosus (SLE) is complex, with a wide range of drugs commonly prescribed. The aims of this study were to identify longitudinal treatment patterns in patients with incident SLE and to estimate the associations of treatment patterns with clinical and economic outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective, observational cohort study used a US managed care claims database to identify patients with newly diagnosed SLE and 4-year treatment follow-up. Patients were aged ... 18 years, with continuous medical and pharmacy benefits for 12 months before and 48 months after the index date (first medical claim with a diagnosis of SLE). Longitudinal treatment patterns were grouped using a k-means cluster analysis. Therapies were included in the cluster analysis if the mean number of prescriptions in each year was ... 0.05. Clinical and economic outcomes were compared across clusters using multivariate regression analyses.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Data from 1611 patients with incident SLE were analyzed (91.4% women; mean [SD] age, 44.5 [9.5] years; 56.2% managed primarily by a specialist). Hydroxychloroquine and corticosteroids were the most commonly prescribed therapies; methotrexate, azathioprine, and mycophenolate mofetil also met the criteria for inclusion in the cluster analysis. Ten treatment clusters were identified; the most common was minimally treated patients (42.8%). Hydroxychloroquine monotherapy, corticosteroid monotherapy, and corticosteroid/hydroxychloroquine combination therapy were received by 34.0%, 11.2%, and 7.8% of patients, respectively. Methotrexate or azathioprine with a corticosteroid/hydroxychloroquine were received by 4.2% of patients. Changes in therapy, except discontinuations, were rare. Compared with the minimally treated cluster, those that received corticosteroid monotherapy (mean dose, &gt;12.0 mg/d) had poorer clinical and economic outcomes; the hydroxychloroquine-monotherapy cluster had similar or better outcomes; and patients who received a corticosteroid/hydroxychloroquine with or without methotrexate or azathioprine demonstrated outcomes that were poorer but that appeared better than those with corticosteroid monotherapy. SLE-related visits with a nonspecialist were common (~45%) and remained unchanged over time despite better clinical and economic outcomes associated with specialist visits.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">This study utilized cluster analysis, an unsupervised machine-learning method, to systematically discern treatment patterns over 4 years and to estimate outcomes associated with the identified treatment patterns. The results suggest that minimal treatment is the most common approach in patients with newly diagnosed SLE. Clinical and economic outcomes are poorest with corticosteroid monotherapy but may improve with the addition of hydroxychloroquine and/or an immunosuppressive agent. A large proportion of SLE care is provided by nonspecialists despite the potential benefits of involving a specialist.</AbstractText><CopyrightInformation>Copyright .. 2016 Elsevier HS Journals, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kan</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Research Triangle Park, North Carolina. Electronic address: hkan1@jhu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagar</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Research Triangle Park, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jeetvan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Research Triangle Park, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Medical Center, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molta</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Ther</MedlineTA><NlmUniqueID>7706726</NlmUniqueID><ISSNLinking>0149-2918</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>HU9DX48N0T</RegistryNumber><NameOfSubstance UI="D009173">Mycophenolic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>YL5FZ2Y5U1</RegistryNumber><NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008329" MajorTopicYN="N">Managed Care Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009173" MajorTopicYN="N">Mycophenolic Acid</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical outcomes</Keyword><Keyword MajorTopicYN="N">cluster analysis</Keyword><Keyword MajorTopicYN="N">economic outcomes</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">treatment patterns</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26907503</ArticleId><ArticleId IdType="pii">S0149-2918(16)30005-4</ArticleId><ArticleId IdType="doi">10.1016/j.clinthera.2016.01.016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26887447</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-9613</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine</Title><ISOAbbreviation>J Ultrasound Med</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Underlying Lymphocytic Thyroiditis With Histogram Analysis Using Grayscale Ultrasound Images.</ArticleTitle><Pagination><MedlinePgn>519-26</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7863/ultra.15.04014</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to evaluate diagnostic performance of histogram analysis using grayscale ultrasound (US) images in the diagnosis of lymphocytic thyroiditis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Three radiologists reviewed a total of 505 US images and classified the images according to the presence/existence of lymphocytic thyroiditis. After 2 months, each reviewer repeated the process with the same 505 images in a randomly mixed order. The intraobserver and interobserver variability was analyzed with a generalized .. value. Four histogram parameters (mean value, standard deviation, skewness, and kurtosis) were obtained, and an index was calculated from principal component analysis. Diagnostic performances were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 505 patients, 125 (24.8%) had lymphocytic thyroiditis, and 380 (75.2%) had normal thyroid parenchyma on pathologic analysis. The .. value for intraobserver variance ranged from -0.002 to 0.781, and the overall .. values for interobserver variance were 0.570 and 0.214 in the first and second tests, respectively. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for the 3 reviewers versus the principal component analysis index were 28.0% to 83.2%, 43.7% to 82.6%, 53.5% to 79.0%, 24.6% to 56.2%, and 75.2% to 88.9% versus 58.4%, 72.4%, 68.9%, 41.0%, and 84.1%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Histogram analysis of grayscale US images provided confirmable and quantitative information about lymphocytic thyroiditis and was comparable with performers' assessments in diagnostic performance.</AbstractText><CopyrightInformation>.. 2016 by the American Institute of Ultrasound in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ga Ram</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun-Kyung</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soo Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Eun Ju</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Jaeheung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hye Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Jung Hwa</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Jung Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Hee Jung</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea (G.R.K., E.-K.K., J.H.Y., H.J.M., J.Y.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea (S.J.K.); Department of Radiology, Ajou University School of Medicine, Suwon, Korea (E.J.H.); Yonsei University College of Medicine, Seoul, Korea (J.Y.); and Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea (H.S.L., J.H.H.). docjin@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Ultrasound Med</MedlineTA><NlmUniqueID>8211547</NlmUniqueID><ISSNLinking>0278-4297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="Y">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013967" MajorTopicYN="N">Thyroiditis, Autoimmune</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">head and neck ultrasound</Keyword><Keyword MajorTopicYN="N">histogram analysis</Keyword><Keyword MajorTopicYN="N">lymphocytic thyroiditis</Keyword><Keyword MajorTopicYN="N">thyroid gland</Keyword><Keyword MajorTopicYN="N">ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26887447</ArticleId><ArticleId IdType="pii">ultra.15.04014</ArticleId><ArticleId IdType="doi">10.7863/ultra.15.04014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26886978</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-254X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>05</Month></PubDate></JournalIssue><Title>IEEE transactions on medical imaging</Title><ISOAbbreviation>IEEE Trans Med Imaging</ISOAbbreviation></Journal><ArticleTitle>Deep 3D Convolutional Encoder Networks With Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.</ArticleTitle><Pagination><MedlinePgn>1229-1239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TMI.2016.2528821</ELocationID><Abstract><AbstractText>We propose a novel segmentation approach based on deep 3D convolutional encoder networks with shortcut connections and apply it to the segmentation of multiple sclerosis (MS) lesions in magnetic resonance images. Our model is a neural network that consists of two interconnected pathways, a convolutional pathway, which learns increasingly more abstract and higher-level image features, and a deconvolutional pathway, which predicts the final segmentation at the voxel level. The joint training of the feature extraction and prediction pathways allows for the automatic learning of features at different scales that are optimized for accuracy for any given combination of image types and segmentation task. In addition, shortcut connections between the two pathways allow high- and low-level features to be integrated, which enables the segmentation of lesions across a wide range of sizes. We have evaluated our method on two publicly available data sets (MICCAI 2008 and ISBI 2015 challenges) with the results showing that our method performs comparably to the top-ranked state-of-the-art methods, even when only relatively small data sets are available for training. In addition, we have compared our method with five freely available and widely used MS lesion segmentation methods (EMS, LST-LPA, LST-LGA, Lesion-TOADS, and SLS) on a large data set from an MS clinical trial. The results show that our method consistently outperforms these other methods across a wide range of lesion sizes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brosch</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lisa Y W</ForeName><Initials>LY</Initials></Author><Author ValidYN="Y"><LastName>Youngjin Yoo</LastName></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>David K B</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Traboulsee</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Med Imaging</MedlineTA><NlmUniqueID>8310780</NlmUniqueID><ISSNLinking>0278-0062</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26886978</ArticleId><ArticleId IdType="doi">10.1109/TMI.2016.2528821</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26867033</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>08</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.</ArticleTitle><Pagination><MedlinePgn>1955-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.39623</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The American College of Rheumatology guidelines for the treatment of lupus nephritis recommend change in induction therapy when response to therapy has not occurred within 6 months. Response is not defined, and renal fibrosis can occur while waiting for this end point. Therefore, a decision support tool to better define response is needed to guide clinicians when starting patients on therapy. This study was undertaken to identify biomarker models with sufficient predictive power to develop such a tool.</AbstractText><AbstractText Label="METHODS">Urine samples from 140 patients with biopsy-proven lupus nephritis who had not yet started induction therapy were analyzed for a panel of urinary biomarkers. Univariate receiver operating characteristic (ROC) curves were generated for each individual biomarker and compared to the ROC area under the curve values from machine learning models developed using random forest algorithms. Biomarker models of outcome developed with novel markers in addition to clinical markers were compared to those developed with traditional clinical markers alone.</AbstractText><AbstractText Label="RESULTS">Models developed with the combined traditional and novel biomarker panels demonstrated clinically meaningful predictive power. Markers most predictive of response were chemokines, cytokines, and markers of cellular damage.</AbstractText><AbstractText Label="CONCLUSION">This is the first study to demonstrate the power of low-abundance biomarker panels and machine learning algorithms for predicting lupus nephritis outcomes. This is a critical first step in research to develop clinically meaningful decision support tools.</AbstractText><CopyrightInformation>.. 2016, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Bethany J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spainhour</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston (current address: Georgia Institute of Technology and Emory University, Atlanta, Georgia).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arthur</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janech</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oates</LastName><ForeName>Jim C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00282347</AccessionNumber><AccessionNumber>NCT00430677</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK101034</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AR051719</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR025005</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 CX000218</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR045476</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR029882</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR043727</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR001070</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR069572</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR062755</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26867033</ArticleId><ArticleId IdType="doi">10.1002/art.39623</ArticleId><ArticleId IdType="pmc">PMC5201110</ArticleId><ArticleId IdType="mid">NIHMS837276</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Nephrol. 1999 Jan;19(1):57-66</Citation><ArticleIdList><ArticleId IdType="pubmed">9952281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Dec;68(6):2588-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16316334</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2005 Feb;16(2):467-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15601744</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2009 May;4(5):873-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19406962</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biol Sci. 2009;5(2):128-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19173034</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Feb;66(2):379-89</Citation><ArticleIdList><ArticleId IdType="pubmed">24504810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 2002;11(8):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12220102</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg Pathol. 2006 Aug;30(8):1030-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16861976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2012 Feb;81(4):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21993584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2009 Oct;36(10):2224-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19648301</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3652-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8170963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 1997 Apr;51(4):1188-95</Citation><ArticleIdList><ArticleId IdType="pubmed">9083285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2007 Mar;71(6):491-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17264872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab Invest. 1995 Dec;73(6):804-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8558841</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomark Insights. 2012;7:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22403482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron. 2000 Jul;85(3):207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10867535</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2009 Nov;4(11):1858-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19729426</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Apr;64(4):1215-26</Citation><ArticleIdList><ArticleId IdType="pubmed">22231479</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jan;58(1):263-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18163495</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2013 Jun;65(6):1586-91</Citation><ArticleIdList><ArticleId IdType="pubmed">23529285</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2012 Sep;39(3):130-42</Citation><ArticleIdList><ArticleId IdType="pubmed">22727560</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1988 Sep;44(3):837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 1996 Sep;60(3):365-71</Citation><ArticleIdList><ArticleId IdType="pubmed">8830793</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 1995 May;14(3):293-300</Citation><ArticleIdList><ArticleId IdType="pubmed">7641505</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 Feb 1;176(3):1889-98</Citation><ArticleIdList><ArticleId IdType="pubmed">16424220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2002 Jul;62(1):261-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12081586</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2004 Feb;15(2):241-50</Citation><ArticleIdList><ArticleId IdType="pubmed">14747370</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2000 Nov;11(11):2044-55</Citation><ArticleIdList><ArticleId IdType="pubmed">11053480</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808</Citation><ArticleIdList><ArticleId IdType="pubmed">22556106</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res. 1995 Sep;8(3):137-45</Citation><ArticleIdList><ArticleId IdType="pubmed">7654797</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Jun;58(6):1784-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18512819</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Cytokine Netw. 2002 Apr-Jun;13(2):144-53</Citation><ArticleIdList><ArticleId IdType="pubmed">12101070</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2002 Nov;17(11):1909-13</Citation><ArticleIdList><ArticleId IdType="pubmed">12401845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26830378</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>Computer-aided diagnosis of psoriasis skin images with HOS, texture and color features: A first comparative study of its kind.</ArticleTitle><Pagination><MedlinePgn>98-109</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2015.11.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(15)30069-9</ELocationID><Abstract><AbstractText>Psoriasis is an autoimmune skin disease with red and scaly plaques on skin and affecting about 125 million people worldwide. Currently, dermatologist use visual and haptic methods for diagnosis the disease severity. This does not help them in stratification and risk assessment of the lesion stage and grade. Further, current methods add complexity during monitoring and follow-up phase. The current diagnostic tools lead to subjectivity in decision making and are unreliable and laborious. This paper presents a first comparative performance study of its kind using principal component analysis (PCA) based CADx system for psoriasis risk stratification and image classification utilizing: (i) 11 higher order spectra (HOS) features, (ii) 60 texture features, and (iii) 86 color feature sets and their seven combinations. Aggregate 540 image samples (270 healthy and 270 diseased) from 30 psoriasis patients of Indian ethnic origin are used in our database. Machine learning using PCA is used for dominant feature selection which is then fed to support vector machine classifier (SVM) to obtain optimized performance. Three different protocols are implemented using three kinds of feature sets. Reliability index of the CADx is computed. Among all feature combinations, the CADx system shows optimal performance of 100% accuracy, 100% sensitivity and specificity, when all three sets of feature are combined. Further, our experimental result with increasing data size shows that all feature combinations yield high reliability index throughout the PCA-cutoffs except color feature set and combination of color and texture feature sets. HOS features are powerful in psoriasis disease classification and stratification. Even though, independently, all three set of features HOS, texture, and color perform competitively, but when combined, the machine learning system performs the best. The system is fully automated, reliable and accurate. </AbstractText><CopyrightInformation>Copyright .. 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shrivastava</LastName><ForeName>Vimal K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Electrical Engineering Department, National Institute of Technology, Raipur, India. Electronic address: lky.vml@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londhe</LastName><ForeName>Narendra D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Electrical Engineering Department, National Institute of Technology, Raipur, India; Skin Point-of-Care Division, Global Biomedical Technologies, Inc., Roseville, CA, USA. Electronic address: nlondhe.ele@nitrr.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonawane</LastName><ForeName>Rajendra S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Psoriasis Clinic and Research Centre, Psoriatreat, Pune, Maharashtra, India. Electronic address: drrajss@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suri</LastName><ForeName>Jasjit S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Skin Point-of-Care Division, Global Biomedical Technologies, Inc., Roseville, CA, USA; Electrical Engineering Department, Idaho State University (Aff.), ID, USA. Electronic address: jsuri@comcast.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003116" MajorTopicYN="N">Color</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003880" MajorTopicYN="N">Dermatology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005583" MajorTopicYN="N">Fourier Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011565" MajorTopicYN="N">Psoriasis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011857" MajorTopicYN="N">Radiographic Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Color features</Keyword><Keyword MajorTopicYN="N">Higher order spectra features</Keyword><Keyword MajorTopicYN="N">Psoriasis skin disease</Keyword><Keyword MajorTopicYN="N">Reliability</Keyword><Keyword MajorTopicYN="N">Texture features</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26830378</ArticleId><ArticleId IdType="pii">S0169-2607(15)30069-9</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2015.11.013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26737961</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Towards a predictive model for Guillain-Barr.. syndrome.</ArticleTitle><Pagination><MedlinePgn>7234-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2015.7320061</ELocationID><Abstract><AbstractText>The severity of Guillain-Barr.. Syndrome (GBS) varies among subtypes, which can be mainly Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), Acute Motor Sensory Axonal Neuropathy (AMSAN) and Miller-Fisher Syndrome (MF). In this study, we use a real dataset that contains clinical, serological, and nerve conduction tests data obtained from 129 GBS patients. We apply C4.5 decision tree, SVM (Support Vector Machines) using a Gaussian kernel, and kNN (k Nearest Neighbour) to predict four GBS subtypes. Accuracies were calculated and averaged across 30 10-fold cross-validation (10-FCV) runs. C4.5 obtained 0.9211 (..0.0109), kNN 0.9179 (..0.0041), and SVM 0.9154 (..0.0069). This is an ongoing research project and further experiments are being conducted. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hernandez-Torruco</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Canul-Reich</LastName><ForeName>Juana</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Frausto-Solis</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mendez-Castillo</LastName><ForeName>Juan Jose</ForeName><Initials>JJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="Y">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26737961</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2015.7320061</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26737281</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.</ArticleTitle><Pagination><MedlinePgn>4443-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2015.7319381</ELocationID><Abstract><AbstractText>In this work we present a machine learning pipeline for the detection of multiple sclerosis course from a collection of inexpensive and non-invasive measures such as clinical scales and patient-reported outcomes. The proposed analysis is conducted on a dataset coming from a clinical study comprising 457 patients affected by multiple sclerosis. The 91 collected variables describe patients mobility, fatigue, cognitive performance, emotional status, bladder continence and quality of life. A preliminary data exploration phase suggests that the group of patients diagnosed as Relapsing-Remitting can be isolated from other clinical courses. Supervised learning algorithms are then applied to perform feature selection and course classification. Our results confirm that clinical scales and patient-reported outcomes can be used to classify Relapsing-Remitting patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fiorini</LastName><ForeName>Samuele</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Verri</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tacchino</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ponzio</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Brichetto</LastName><ForeName>Giampaolo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Barla</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26737281</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2015.7319381</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26736988</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Online prediction of glucose concentration in type 1 diabetes using extreme learning machines.</ArticleTitle><Pagination><MedlinePgn>3262-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2015.7319088</ELocationID><Abstract><AbstractText>We propose an online machine-learning solution to the problem of nonlinear glucose time series prediction in type 1 diabetes. Recently, extreme learning machine (ELM) has been proposed for training single hidden layer feed-forward neural networks. The high accuracy and fast learning speed of ELM drive us to investigate its applicability to the glucose prediction problem. Given that diabetes self-monitoring data are received sequentially, we focus on online sequential ELM (OS-ELM) and online sequential ELM kernels (KOS-ELM). A multivariate feature set is utilized concerning subcutaneous glucose, insulin therapy, carbohydrates intake and physical activity. The dataset comes from the continuous multi-day recordings of 15 type 1 patients in free-living conditions. Assuming stationarity and evaluating the performance of the proposed method by 10-fold cross- validation, KOS-ELM were found to perform better than OS-ELM in terms of prediction error, temporal gain and regularity of predictions for a 30-min prediction horizon. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009862" MajorTopicYN="Y">Online Systems</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26736988</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2015.7319088</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26606758</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-2586</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>06</Month></PubDate></JournalIssue><Title>Journal of magnetic resonance imaging : JMRI</Title><ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation></Journal><ArticleTitle>Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>1445-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.25095</ELocationID><Abstract><AbstractText Label="PURPOSE">To develop a method to automatically detect multiple sclerosis (MS) lesions, located both in white matter (WM) and in the cortex, in patients with low disability and early disease stage.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We developed a lesion detection method, based on the k-nearest neighbor (k-NN) technique, to detect lesions as small as 0.0036...mL. This method uses the image intensity information from up to four different 3D magnetic resonance imaging (MRI) sequences (magnetization-prepared rapid gradient-echo, MPRAGE; magnetization-prepared two inversion-contrast rapid gradient-echo, MP2RAGE; 3D fluid-attenuated inversion recovery, FLAIR; and 3D double-inversion recovery, DIR), acquired on a 3T scanner. To these intensity features we added the information obtained by the spatial coordinates and tissue prior probabilities provided by the International Consortium for Brain Mapping (ICBM). Quantitative assessment was done in 39 early-stage MS patients with a "leave-one-out" cross-validation.</AbstractText><AbstractText Label="RESULTS">The best lesion detection rate (DR) performance in WM was obtained using MP2RAGE, FLAIR, and DIR intensities (77% for lesions ...0.0036...mL; 85% for lesions ...0.005...mL). Similar results were obtained excluding the DIR intensity as well as when using only MPRAGE and FLAIR (DR...=...75%, P...=...0.5720). However, the combination of FLAIR with DIR and MP2RAGE appeared to be the best for detecting cortical lesions (DR...=...62%), compared to the other combination of sequences (P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION">For WM lesion detection, similar results were observed when only conventional clinical sequences (FLAIR, MPRAGE) were used compared to a combination of conventional and "advanced" sequences (MP2RAGE, DIR). Cortical lesion detection increased significantly when "advanced" sequences were used. J. Magn. Reson. Imaging 2015. J. Magn. Reson. Imaging 2016;43:1445-1454.</AbstractText><CopyrightInformation>.. 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fartaria</LastName><ForeName>M..rio Jo..o</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnier</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Recherch.. en Neuroimag..rie (LREN), Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roche</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kober</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meuli</LastName><ForeName>Reto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rotzinger</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frackowiak</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schluep</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroimmunology Unit, Neurology, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du Pasquier</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuroimmunology Unit, Neurology, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiran</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Siemens Medical Solutions USA, Inc, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bach Cuadra</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Signal Processing Laboratory (LTS5), Ecole Polytechnique F..d..rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal Processing Core, Centre d'Imagerie BioM..dicale (CIBM), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granziera</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Advanced Clinical Imaging Technology (HC CMEA SUI DI BM PI), Siemens Healthcare AG, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Recherch.. en Neuroimag..rie (LREN), Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Chalestown, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>131914</GrantID><Acronym>SNSF_</Acronym><Agency>Swiss National Science Foundation</Agency><Country>Switzerland</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Magn Reson Imaging</MedlineTA><NlmUniqueID>9105850</NlmUniqueID><ISSNLinking>1053-1807</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">cortical lesions</Keyword><Keyword MajorTopicYN="Y">lesion detection</Keyword><Keyword MajorTopicYN="Y">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="Y">multiple sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26606758</ArticleId><ArticleId IdType="doi">10.1002/jmri.25095</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26513469</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><PubDate><Year>2015</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Automated assessment of synovitis in 0.2T magnetic resonance images of the wrist.</ArticleTitle><Pagination><MedlinePgn>116-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2015.10.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(15)00343-1</ELocationID><Abstract><AbstractText>According to the current recommendations in diagnosis of rheumatoid arthritis (RA), Magnetic Resonance (MR) images of wrist joints are used to evaluate three main types of lesions: synovitis, bone edema and bone erosions. In the clinical practice, the RA-related lesions seen in MR images are assessed manually with the semi-quantitative RAMRIS scoring system. In this paper we present an automated method for inflamed synovial membrane volume determination, based on the analysis of pre- and post-contrast MR images and segmentation of wrist bones seen in MR images. We found that the correlation between the automatically quantified volume of synovitis and RAMRIS scores was in the range from 0.76 to 0.87 for the total RAMRIS synovitis score. This can be compared with the correlation between the manually quantified volume of synovitis and RAMRIS scores which was in the range from 0.75 to 0.81 for the total synovitis score. The results of the study demonstrate that computer assisted methods for assessment of synovitis have great potential for clinical applications. </AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Czaplicka</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jagiellonian University, Prof. Stanis..awa ..ojasiewicza, 30-059 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojciechowski</LastName><ForeName>Wadim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jagiellonian University Medical College, Kopernika 19, 31-501 Krakow, Poland; Medical Center iMed24, Zyczkowskiego 29, 31-864 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W..odarczyk</LastName><ForeName>Justyna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jagiellonian University, Prof. Stanis..awa ..ojasiewicza, 30-059 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbanik</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jagiellonian University Medical College, Kopernika 19, 31-501 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabor</LastName><ForeName>Zbis..aw</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland. Electronic address: ztabor@pk.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064847" MajorTopicYN="N">Multimodal Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014955" MajorTopicYN="N">Wrist Joint</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CAD</Keyword><Keyword MajorTopicYN="N">RAMRIS</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">Synovitis</Keyword><Keyword MajorTopicYN="N">Wrist MRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>10</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26513469</ArticleId><ArticleId IdType="pii">S0010-4825(15)00343-1</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2015.10.009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26495028</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-6718</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>KIR Genes and Patterns Given by the A Priori Algorithm: Immunity for Haematological Malignancies.</ArticleTitle><Pagination><MedlinePgn>141363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/141363</ELocationID><Abstract><AbstractText>Killer-cell immunoglobulin-like receptors (KIRs) are membrane proteins expressed by cells of innate and adaptive immunity. The KIR system consists of 17 genes and 614 alleles arranged into different haplotypes. KIR genes modulate susceptibility to haematological malignancies, viral infections, and autoimmune diseases. Molecular epidemiology studies rely on traditional statistical methods to identify associations between KIR genes and disease. We have previously described our results by applying support vector machines to identify associations between KIR genes and disease. However, rules specifying which haplotypes are associated with greater susceptibility to malignancies are lacking. Here we present the results of our investigation into the rules governing haematological malignancy susceptibility. We have studied the different haplotypic combinations of 17 KIR genes in 300 healthy individuals and 43 patients with haematological malignancies (25 with leukaemia and 18 with lymphomas). We compare two machine learning algorithms against traditional statistical analysis and show that the "a priori" algorithm is capable of discovering patterns unrevealed by previous algorithms and statistical approaches. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr..guez-Escobedo</LastName><ForeName>J Gilberto</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier..a, Universidad Aut..noma de San Luis Potos.., Avenida Dr. Manuel Nava No. 8, Zona Universitaria, 78290 San Luis Potos.., ZC, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc..a-Sep..lveda</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Laboratorio de Gen..mica Viral y Humana, Facultad de Medicina, Universidad Aut..noma de San Luis Potos.., Avenida Venustiano Carranza No. 2405, Colonia Filtros las Lomas, 78210 San Luis Potos.., CP, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuevas-Tello</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier..a, Universidad Aut..noma de San Luis Potos.., Avenida Dr. Manuel Nava No. 8, Zona Universitaria, 78290 San Luis Potos.., ZC, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054340">Receptors, KIR</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019337" MajorTopicYN="N">Hematologic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008432" MajorTopicYN="N">Mathematical Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054340" MajorTopicYN="N">Receptors, KIR</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26495028</ArticleId><ArticleId IdType="doi">10.1155/2015/141363</ArticleId><ArticleId IdType="pmc">PMC4606520</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Exp Med. 2000 Feb 21;191(4):661-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10684858</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2001 Sep;15(3):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11567627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2002 Mar;63(3):164-75</Citation><ArticleIdList><ArticleId IdType="pubmed">11872234</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Rev Immunol. 2001 Jun;20(3-4):439-501</Citation><ArticleIdList><ArticleId IdType="pubmed">11878512</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Mar 15;295(5562):2097-100</Citation><ArticleIdList><ArticleId IdType="pubmed">11896281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2002 Apr;63(4):271-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12039408</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2002 Nov 15;100(10):3825-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12393440</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2002 Dec;190:40-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12493005</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2003 Aug 1;102(3):814-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12689936</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2004 May;125(3):267-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15086409</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2004 Jun;25(6):328-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15145323</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 1975 Aug 15;16(2):230-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1080480</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1975 Feb;5(2):112-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1234049</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1975 Feb;5(2):117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">1086218</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1990 Dec 1;172(6):1589-98</Citation><ArticleIdList><ArticleId IdType="pubmed">2147946</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1993 Oct 1;178(4):1321-36</Citation><ArticleIdList><ArticleId IdType="pubmed">8376937</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1999 Jul 1;94(1):333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10381530</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16864053</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007;2(5):e406</Citation><ArticleIdList><ArticleId IdType="pubmed">17476328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med. 2007 Sep-Oct;13(9-10):527-41</Citation><ArticleIdList><ArticleId IdType="pubmed">17660860</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2009 Jan 15;113(3):726-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18945962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2010 Jan;38(Database issue):D863-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19875415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Rep. 2010 Apr;37(4):1883-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19609718</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2010 Apr;16(4):533-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19961944</ArticleId></ArticleIdList></Reference><Reference><Citation>Iran J Immunol. 2010 Mar;7(1):8-17</Citation><ArticleIdList><ArticleId IdType="pubmed">20371915</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2010 Sep;16(9):1257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20302958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2010 Oct;45(10):1514-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20173784</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(12):e15115</Citation><ArticleIdList><ArticleId IdType="pubmed">21206914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2011 Aug;78(2):129-38</Citation><ArticleIdList><ArticleId IdType="pubmed">21726204</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 2011 Sep;63(9):561-75</Citation><ArticleIdList><ArticleId IdType="pubmed">21638211</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechnol J. 2012 Aug;7(8):938-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22887882</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 2012 Oct;64(10):719-37</Citation><ArticleIdList><ArticleId IdType="pubmed">22752190</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Biol Med. 2013 Dec;43(12):2053-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24290921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2014 Feb;133(2):125-38</Citation><ArticleIdList><ArticleId IdType="pubmed">24122152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Jul 31;511(7511):524-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25079538</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Netw. 2015 Jan;61:85-117</Citation><ArticleIdList><ArticleId IdType="pubmed">25462637</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Immunogenet. 2015 Aug;42(4):229-38</Citation><ArticleIdList><ArticleId IdType="pubmed">26010044</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 2015 Aug;86(2):98-113</Citation><ArticleIdList><ArticleId IdType="pubmed">26189878</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26453758</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><PubDate><Year>2015</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Patient classification and outcome prediction in IgA nephropathy.</ArticleTitle><Pagination><MedlinePgn>278-86</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2015.09.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(15)00311-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">IgA Nephropathy (IgAN) is a common kidney disease which may entail renal failure, known as End Stage Kidney Disease (ESKD). One of the major difficulties dealing with this disease is to predict the time of the long-term prognosis for a patient at the time of diagnosis. In fact, the progression of IgAN to ESKD depends on an intricate interrelationship between clinical and laboratory findings. Therefore, the objective of this work has been the selection of the best data mining tool to build a model able to predict (I) if a patient with a biopsy proven IgAN will reach ESKD and (II) if a patient will reach the ESKD before or after 5 years.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">The largest available cohort study worldwide on IgAN has been used to design and compare several data-driven models. The complete dataset was composed of 1174 records collected from Italian, Norwegian, and Japanese IgAN patients, in the last 30 years. The data mining tools considered in this work were artificial neural networks (ANNs), neuro fuzzy systems (NFSs), support vector machines (SVMs), and decision trees (DTs). A 10-fold cross validation was used to evaluate unbiased performances for all the models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An extensive model comparison based on accuracy, precision, recall, and f-measure was provided. Overall, the results indicate that ANNs can provide superior performance compared to the other models. The ANN for time-to-ESKD prediction is characterized by accuracy, precision, recall, and f-measure greater than 90%. The ANN for ESKD prediction has accuracy greater than 90% as well as precision, recall, and f-measure for the class of patients not reaching ESKD, while precision, recall, and f-measure for the class of patients reaching ESKD are slightly lower. The obtained model has been implemented in a Web-based decision support system (DSS).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The extraction of novel knowledge from clinical data and the definition of predictive models to support diagnosis, prognosis, and therapy is becoming an essential tool for researchers and clinical practitioners in medicine. The proposed comparative study of several data mining models for the outcome prediction in IgAN patients, using a large dataset of clinical records from three different countries, provides an insight into the relative prediction ability of the considered methods applied to such a disease.</AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diciolla</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Electrical and Information Engineering, Polytechnic University of Bari, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binetti</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Electrical and Information Engineering, Polytechnic University of Bari, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Noia</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Electrical and Information Engineering, Polytechnic University of Bari, Bari, Italy. Electronic address: tommaso.dinoia@poliba.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesce</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiovascular Genetics and Genomics, National Heart &amp; Lung Institute, Royal Brompton Hospital, Imperial College London, UK; Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schena</LastName><ForeName>F P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; C.A.R.S.O. Consortium, Valenzano-Casamassima, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V..gane</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Renal Research Group, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bj..rneklett</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Renal Research Group, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomino</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Juntendo University, Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naso</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Electrical and Information Engineering, Polytechnic University of Bari, Bari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="N">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017143" MajorTopicYN="N">Fuzzy Logic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005922" MajorTopicYN="N">Glomerulonephritis, IGA</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial neural network</Keyword><Keyword MajorTopicYN="N">Decision support system</Keyword><Keyword MajorTopicYN="N">Decision tree</Keyword><Keyword MajorTopicYN="N">IgA Nephropathy</Keyword><Keyword MajorTopicYN="N">Neuro fuzzy system</Keyword><Keyword MajorTopicYN="N">Support vector machine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>09</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26453758</ArticleId><ArticleId IdType="pii">S0010-4825(15)00311-X</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2015.09.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26439368</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-0371</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>10</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Biomarkers in medicine</Title><ISOAbbreviation>Biomark Med</ISOAbbreviation></Journal><ArticleTitle>New development in a blood-based diagnostic test for early-stage arthritis.</ArticleTitle><Pagination><MedlinePgn>943-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/bmm.15.77</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Usman</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham, B31 2AP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornalley</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Warwick Medical School, Clinical Sciences Research Laboratories, University of Warwick, University Hospital, Coventry, CV2 2DX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Warwick Systems Biology Centre, Senate House, University of Warwick, Coventry, CV4 7AL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabbani</LastName><ForeName>Naila</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Warwick Systems Biology Centre, Senate House, University of Warwick, Coventry, CV4 7AL, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biomark Med</MedlineTA><NlmUniqueID>101312535</NlmUniqueID><ISSNLinking>1752-0363</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001774" MajorTopicYN="Y">Blood Chemical Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">citrullination</Keyword><Keyword MajorTopicYN="N">hydroxyproline</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26439368</ArticleId><ArticleId IdType="doi">10.2217/bmm.15.77</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26340685</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Subject-Specific Sparse Dictionary Learning for Atlas-Based Brain MRI Segmentation.</ArticleTitle><Pagination><MedlinePgn>1598-609</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2015.2439242</ELocationID><Abstract><AbstractText>Quantitative measurements from segmentations of human brain magnetic resonance (MR) images provide important biomarkers for normal aging and disease progression. In this paper, we propose a patch-based tissue classification method from MR images that uses a sparse dictionary learning approach and atlas priors. Training data for the method consists of an atlas MR image, prior information maps depicting where different tissues are expected to be located, and a hard segmentation. Unlike most atlas-based classification methods that require deformable registration of the atlas priors to the subject, only affine registration is required between the subject and training atlas. A subject-specific patch dictionary is created by learning relevant patches from the atlas. Then the subject patches are modeled as sparse combinations of learned atlas patches leading to tissue memberships at each voxel. The combination of prior information in an example-based framework enables us to distinguish tissues having similar intensities but different spatial locations. We demonstrate the efficacy of the approach on the application of whole-brain tissue segmentation in subjects with healthy anatomy and normal pressure hydrocephalus, as well as lesion segmentation in multiple sclerosis patients. For each application, quantitative comparisons are made against publicly available state-of-the art approaches. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Snehashis</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Carass</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Prince</LastName><ForeName>Jerry L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Dzung L</ForeName><Initials>DL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS060910</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01EB017743</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000247</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EB017743</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32AG021334</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG021334</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS070906</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 EB012765</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS070906</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS085211</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21EB012765</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS085211</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS060910</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006850" MajorTopicYN="N">Hydrocephalus, Normal Pressure</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26340685</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2015.2439242</ArticleId><ArticleId IdType="pmc">PMC4562064</ArticleId><ArticleId IdType="mid">NIHMS695918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Med Imaging. 1999 Oct;18(10):897-908</Citation><ArticleIdList><ArticleId IdType="pubmed">10628949</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2001 Jan;20(1):45-57</Citation><ArticleIdList><ArticleId IdType="pubmed">11293691</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2001 Jun;5(2):143-56</Citation><ArticleIdList><ArticleId IdType="pubmed">11516708</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2002 Oct;21(10):1280-91</Citation><ArticleIdList><ArticleId IdType="pubmed">12585710</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2003 Apr 15;23(8):3295-301</Citation><ArticleIdList><ArticleId IdType="pubmed">12716936</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2004 Jul;23(7):903-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15250643</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2005 Jul 1;26(3):839-51</Citation><ArticleIdList><ArticleId IdType="pubmed">15955494</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2005;8(Pt 1):409-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16685872</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2006 Oct 15;33(1):115-26</Citation><ArticleIdList><ArticleId IdType="pubmed">16860573</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Radiol. 2008 Mar;15(3):300-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18280928</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2008 Oct;12(5):616-25</Citation><ArticleIdList><ArticleId IdType="pubmed">18640069</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Jan 15;49(2):1524-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19766196</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc IEEE Int Symp Biomed Imaging. 2009;5193070:406</Citation><ArticleIdList><ArticleId IdType="pubmed">20126426</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc IEEE Int Symp Biomed Imaging. 2008;4541030:452</Citation><ArticleIdList><ArticleId IdType="pubmed">20126427</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc SPIE Int Soc Opt Eng. 2010;7623:76230j</Citation><ArticleIdList><ArticleId IdType="pubmed">20431709</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Oct 1;52(4):1355-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20441794</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2010 Oct;29(10):1714-29</Citation><ArticleIdList><ArticleId IdType="pubmed">20562040</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jan 15;54(2):940-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20851199</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jun 1;56(3):1386-97</Citation><ArticleIdList><ArticleId IdType="pubmed">21316470</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jun 15;56(4):1982-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21458576</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jul 15;57(2):378-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Inf Process Med Imaging. 2011;22:1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21761641</ArticleId></ArticleIdList></Reference><Reference><Citation>Inf Process Med Imaging. 2011;22:73-84</Citation><ArticleIdList><ArticleId IdType="pubmed">21761647</ArticleId></ArticleIdList></Reference><Reference><Citation>Inf Process Med Imaging. 2011;22:371-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21761671</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2012 Feb;31(2):153-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21827972</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Feb 15;59(4):3736-47</Citation><ArticleIdList><ArticleId IdType="pubmed">22094645</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Pattern Anal Mach Intell. 1980 Jan;2(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22499617</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(5):e37049</Citation><ArticleIdList><ArticleId IdType="pubmed">22615886</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Pattern Anal Mach Intell. 2013 Mar;35(3):611-23</Citation><ArticleIdList><ArticleId IdType="pubmed">22732662</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(9):e45081</Citation><ArticleIdList><ArticleId IdType="pubmed">23028771</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2013 Aug 1;76:11-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23523774</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2013 Dec;32(12):2348-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24058022</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2013 Mar 15;2:402-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24179794</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2014 Apr 1;89:152-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24291615</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc IEEE Int Symp Biomed Imaging. 2013 Dec 31;2013:350-353</Citation><ArticleIdList><ArticleId IdType="pubmed">24443686</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2013;16(Pt 1):735-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24505733</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach Learn Med Imaging. 2014;8679:248-255</Citation><ArticleIdList><ArticleId IdType="pubmed">25383394</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc SPIE Int Soc Opt Eng. 2014 Feb 15;9034:</Citation><ArticleIdList><ArticleId IdType="pubmed">27795605</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 1995 Jun;2(2):89-101</Citation><ArticleIdList><ArticleId IdType="pubmed">9343592</ArticleId></ArticleIdList></Reference><Reference><Citation>Vision Res. 1997 Dec;37(23):3311-25</Citation><ArticleIdList><ArticleId IdType="pubmed">9425546</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 1999 Feb;9(2):179-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9931268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26336666</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1748-5673</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>International journal of data mining and bioinformatics</Title><ISOAbbreviation>Int J Data Min Bioinform</ISOAbbreviation></Journal><ArticleTitle>Patient-specific early classification of multivariate observations.</ArticleTitle><Pagination><MedlinePgn>392-411</MedlinePgn></Pagination><Abstract><AbstractText>Early classification of time series has been receiving a lot of attention recently. In this paper we present a model, which we call the Early Classification Model (ECM), that allows for early, accurate and patient-specific classification of multivariate observations. ECM is comprised of an integration of the widely used Hidden Markov Model (HMM) and Support Vector Machine (SVM) models. It attained very promising results on the datasets we tested it on: in one set of experiments based on a published dataset of response to drug therapy in Multiple Sclerosis patients, ECM used only an average of 40% of a time series and was able to outperform some of the baseline models, which needed the full time series for classification. In the set of experiments tested on a sepsis therapy dataset, ECM was able to surpass the standard threshold-based method and the state-of-the-art method for early classification of multivariate time series.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghalwash</LastName><ForeName>Mohamed F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Ramljak</LastName><ForeName>Du..an</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Obradovi..</LastName><ForeName>Zoran</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Data Min Bioinform</MedlineTA><NlmUniqueID>101279469</NlmUniqueID><ISSNLinking>1748-5673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008390" MajorTopicYN="N">Markov Chains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26336666</ArticleId><ArticleId IdType="doi">10.1504/ijdmb.2015.067955</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26227167</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1920</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neuroradiology</Title><ISOAbbreviation>Neuroradiology</ISOAbbreviation></Journal><ArticleTitle>A toolbox for multiple sclerosis lesion segmentation.</ArticleTitle><Pagination><MedlinePgn>1031-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00234-015-1552-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Lesion segmentation plays an important role in the diagnosis and follow-up of multiple sclerosis (MS). This task is very time-consuming and subject to intra- and inter-rater variability. In this paper, we present a new tool for automated MS lesion segmentation using T1w and fluid-attenuated inversion recovery (FLAIR) images.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Our approach is based on two main steps, initial brain tissue segmentation according to the gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) performed in T1w images, followed by a second step where the lesions are segmented as outliers to the normal apparent GM brain tissue on the FLAIR image.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The tool has been validated using data from more than 100 MS patients acquired with different scanners and at different magnetic field strengths. Quantitative evaluation provided a better performance in terms of precision while maintaining similar results on sensitivity and Dice similarity measures compared with those of other approaches.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our tool is implemented as a publicly available SPM8/12 extension that can be used by both the medical and research communities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roura</LastName><ForeName>Eloy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Computer Vision and Robotics Group, University of Girona, Campus Montilivi, Ed. P-IV, 17071, Girona, Spain. eloyroura@eia.udg.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Computer Vision and Robotics Group, University of Girona, Campus Montilivi, Ed. P-IV, 17071, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabezas</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Dept. of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valverde</LastName><ForeName>Sergi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computer Vision and Robotics Group, University of Girona, Campus Montilivi, Ed. P-IV, 17071, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pareto</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Dept. of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilanova</LastName><ForeName>Joan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Girona Magnetic Resonance Center, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rami..-Torrent..</LastName><ForeName>Llu..s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis and Neuroimmunology Unit, Dr. Josep Trueta University Hospital, Institut d'Investigaci.. Biom..dica de Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovira</LastName><ForeName>..lex</ForeName><Initials>..</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Dept. of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llad..</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Computer Vision and Robotics Group, University of Girona, Campus Montilivi, Ed. P-IV, 17071, Girona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neuroradiology</MedlineTA><NlmUniqueID>1302751</NlmUniqueID><ISSNLinking>0028-3940</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012986" MajorTopicYN="N">Software Validation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Automated tool</Keyword><Keyword MajorTopicYN="N">Lesion detection</Keyword><Keyword MajorTopicYN="N">Lesion segmentation</Keyword><Keyword MajorTopicYN="N">Magnetic resonance images</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26227167</ArticleId><ArticleId IdType="doi">10.1007/s00234-015-1552-2</ArticleId><ArticleId IdType="pii">10.1007/s00234-015-1552-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Med Imaging. 1998 Feb;17(1):87-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9617910</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2001 May;13(5):856-76</Citation><ArticleIdList><ArticleId IdType="pubmed">11304082</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2008 Feb 15;39(4):1752-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18063391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2013 Jan;17(1):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23084503</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Feb 15;59(4):3774-83</Citation><ArticleIdList><ArticleId IdType="pubmed">22119648</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Jul;115(3):147-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24813718</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Methods. 2014 Nov 30;237:108-17</Citation><ArticleIdList><ArticleId IdType="pubmed">25194638</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014 Feb;113(2):655-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24380649</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2015 Jan;41(1):93-101</Citation><ArticleIdList><ArticleId IdType="pubmed">24459099</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroinformatics. 2014 Jul;12(3):365-79</Citation><ArticleIdList><ArticleId IdType="pubmed">24338728</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2013 Jan 11;2:184-96</Citation><ArticleIdList><ArticleId IdType="pubmed">24179773</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jul 15;57(2):378-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21497655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2014 Jun;39(6):1543-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24987754</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 1995 Jun;2(2):89-101</Citation><ArticleIdList><ArticleId IdType="pubmed">9343592</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pathol. 2006 Nov;59(11):1151-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17071802</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2013;16(Pt 1):735-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24505733</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2005 Jul 1;26(3):839-51</Citation><ArticleIdList><ArticleId IdType="pubmed">15955494</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroradiology. 2014 May;56(5):363-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24590302</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2009 Oct 15;48(1):73-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2009;12(Pt 2):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20426159</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Jul 16;61(4):1484-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22484407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2002 Nov;17(3):143-55</Citation><ArticleIdList><ArticleId IdType="pubmed">12391568</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2004 Jul;22(3):1255-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15219597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26211811</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1361-8423</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Medical image analysis</Title><ISOAbbreviation>Med Image Anal</ISOAbbreviation></Journal><ArticleTitle>Adaptive multi-level conditional random fields for detection and segmentation of small enhanced pathology in medical images.</ArticleTitle><Pagination><MedlinePgn>17-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.media.2015.06.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1361-8415(15)00091-2</ELocationID><Abstract><AbstractText>Detection and segmentation of large structures in an image or within a region of interest have received great attention in the medical image processing domains. However, the problem of small pathology detection and segmentation still remains an unresolved challenge due to the small size of these pathologies, their low contrast and variable position, shape and texture. In many contexts, early detection of these pathologies is critical in diagnosis and assessing the outcome of treatment. In this paper, we propose a probabilistic Adaptive Multi-level Conditional Random Fields (AMCRF) with the incorporation of higher order cliques for detecting and segmenting such pathologies. In the first level of our graphical model, a voxel-based CRF is used to identify candidate lesions. In the second level, in order to further remove falsely detected regions, a new CRF is developed that incorporates higher order textural features, which are invariant to rotation and local intensity distortions. At this level, higher order textures are considered together with the voxel-wise cliques to refine boundaries and is therefore adaptive. The proposed algorithm is tested in the context of detecting enhancing Multiple Sclerosis (MS) lesions in brain MRI, where the problem is further complicated as many of the enhancing voxels are associated with normal structures (i.e. blood vessels) or noise in the MRI. The algorithm is trained and tested on large multi-center clinical trials from Relapsing-Remitting MS patients. The effect of several different parameter learning and inference techniques is further investigated. When tested on 120 cases, the proposed method reaches a lesion detection rate of 90%, with very few false positive lesion counts on average, ranging from 0.17 for very small (3-5 voxels) to 0 for very large (50+ voxels) regions. The proposed model is further tested on a very large clinical trial containing 2770 scans where a high sensitivity of 91% with an average false positive count of 0.5 is achieved. Incorporation of contextual information at different scales is also explored. Finally, superior performance is shown upon comparing with Support Vector Machine (SVM), Random Forest and variant of an MRF. </AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karimaghaloo</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Centre for Intelligent Machines, McGill University, Montreal, Canada. Electronic address: naghaloo@cim.mcgill.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Douglas L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>NeuroRx Research, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbel</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Intelligent Machines, McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Med Image Anal</MedlineTA><NlmUniqueID>9713490</NlmUniqueID><ISSNLinking>1361-8415</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012815" MajorTopicYN="N">Signal Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013382" MajorTopicYN="N">Subtraction Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Automatic detection and segmentation</Keyword><Keyword MajorTopicYN="N">CRF</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Probabilistic graphical models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26211811</ArticleId><ArticleId IdType="pii">S1361-8415(15)00091-2</ArticleId><ArticleId IdType="doi">10.1016/j.media.2015.06.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26075791</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1718</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>A method to predict the impact of regulatory variants from DNA sequence.</ArticleTitle><Pagination><MedlinePgn>955-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/ng.3331</ELocationID><Abstract><AbstractText>Most variants implicated in common human disease by genome-wide association studies (GWAS) lie in noncoding sequence intervals. Despite the suggestion that regulatory element disruption represents a common theme, identifying causal risk variants within implicated genomic regions remains a major challenge. Here we present a new sequence-based computational method to predict the effect of regulatory variation, using a classifier (gkm-SVM) that encodes cell type-specific regulatory sequence vocabularies. The induced change in the gkm-SVM score, deltaSVM, quantifies the effect of variants. We show that deltaSVM accurately predicts the impact of SNPs on DNase I sensitivity in their native genomic contexts and accurately predicts the results of dense mutagenesis of several enhancers in reporter assays. Previously validated GWAS SNPs yield large deltaSVM scores, and we predict new risk-conferring SNPs for several autoimmune diseases. Thus, deltaSVM provides a powerful computational approach to systematically identify functional regulatory variants. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dongwon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorkin</LastName><ForeName>David U</ForeName><Initials>DU</Initials><AffiliationInfo><Affiliation>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Maggie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strober</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asoni</LastName><ForeName>Alessandro L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCallion</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beer</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>1] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA. [2] Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM007814</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 GM068524</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS062972</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG007348</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS62972</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.21.1</RegistryNumber><NameOfSubstance UI="D003850">Deoxyribonuclease I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Genet. 2015 Aug;47(8):853-5</RefSource><PMID Version="1">26220134</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003850" MajorTopicYN="N">Deoxyribonuclease I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004742" MajorTopicYN="N">Enhancer Elements, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040641" MajorTopicYN="N">Quantitative Trait Loci</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012045" MajorTopicYN="N">Regulatory Sequences, Nucleic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26075791</ArticleId><ArticleId IdType="pii">ng.3331</ArticleId><ArticleId IdType="doi">10.1038/ng.3331</ArticleId><ArticleId IdType="pmc">PMC4520745</ArticleId><ArticleId IdType="mid">NIHMS689528</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pigment Cell Res. 2007 Jun;20(3):173-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17516925</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Mar;39(3):311-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17277777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Aug;40(8):955-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18587394</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008;9(9):R137</Citation><ArticleIdList><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 May 7;459(7243):108-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19295514</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9362-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19474294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Apr;42(4):295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">20190752</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2010;6(12):e1001025</Citation><ArticleIdList><ArticleId IdType="pubmed">21152010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Apr;43(4):329-32</Citation><ArticleIdList><ArticleId IdType="pubmed">21399635</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2011 Dec;43(12):1193-201</Citation><ArticleIdList><ArticleId IdType="pubmed">22057235</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2011 Dec;21(12):2167-80</Citation><ArticleIdList><ArticleId IdType="pubmed">21875935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Feb 16;482(7385):390-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22307276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2012 Mar;30(3):265-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22371081</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2012 Jun;44(6):676-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22561518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2012 Jul;13(7):469-83</Citation><ArticleIdList><ArticleId IdType="pubmed">22705667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Sep 6;489(7414):57-74</Citation><ArticleIdList><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Sep 7;337(6099):1190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22955828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2012 Oct;44(10):1137-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22961000</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2012 Nov;22(11):2290-301</Citation><ArticleIdList><ArticleId IdType="pubmed">23019145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2012 Dec 1;21(23):5202-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22922229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2012 Dec;44(12):1336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">23143596</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2013 Apr;136(Pt 4):1012-24</Citation><ArticleIdList><ArticleId IdType="pubmed">23412934</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2013 May;23(5):800-11</Citation><ArticleIdList><ArticleId IdType="pubmed">23512712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W544-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23771147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Aug;45(8):907-11</Citation><ArticleIdList><ArticleId IdType="pubmed">23817569</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Oct 11;342(6155):253-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24115442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Nov;45(11):1353-60</Citation><ArticleIdList><ArticleId IdType="pubmed">24076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2014 Feb;46(2):126-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24390282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2014 Mar;46(3):310-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24487276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2014 Mar;11(3):294-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24487584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Math Biol. 2014 Aug;69(2):469-500</Citation><ArticleIdList><ArticleId IdType="pubmed">23861010</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2014 Jul;10(7):e1003711</Citation><ArticleIdList><ArticleId IdType="pubmed">25033408</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Nov 20;515(7527):355-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25409824</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2014 Nov 6;95(5):535-52</Citation><ArticleIdList><ArticleId IdType="pubmed">25439723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2015 Feb 19;518(7539):337-43</Citation><ArticleIdList><ArticleId IdType="pubmed">25363779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Apr 1;464(7289):768-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20220758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Aug 5;466(7307):714-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20686566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2010 Oct;28(10):1045-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20944595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Oct 28;467(7319):1061-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20981092</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 Oct 27;437(7063):1299-320</Citation><ArticleIdList><ArticleId IdType="pubmed">16255080</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Jul;39(7):830-2</Citation><ArticleIdList><ArticleId IdType="pubmed">17554261</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Dec;42(12):1118-25</Citation><ArticleIdList><ArticleId IdType="pubmed">21102463</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Biol. 2006 Oct 15;298(2):644-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16934245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26055435</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0771</ISSN><JournalIssue CitedMedium="Internet"><Volume>46 Pt 1</Volume><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society</Title><ISOAbbreviation>Comput Med Imaging Graph</ISOAbbreviation></Journal><ArticleTitle>Classification of multiple sclerosis lesions using adaptive dictionary learning.</ArticleTitle><Pagination><MedlinePgn>2-10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0895-6111(15)00088-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compmedimag.2015.05.003</ELocationID><Abstract><AbstractText>This paper presents a sparse representation and an adaptive dictionary learning based method for automated classification of multiple sclerosis (MS) lesions in magnetic resonance (MR) images. Manual delineation of MS lesions is a time-consuming task, requiring neuroradiology experts to analyze huge volume of MR data. This, in addition to the high intra- and inter-observer variability necessitates the requirement of automated MS lesion classification methods. Among many image representation models and classification methods that can be used for such purpose, we investigate the use of sparse modeling. In the recent years, sparse representation has evolved as a tool in modeling data using a few basis elements of an over-complete dictionary and has found applications in many image processing tasks including classification. We propose a supervised classification approach by learning dictionaries specific to the lesions and individual healthy brain tissues, which include white matter (WM), gray matter (GM) and cerebrospinal fluid (CSF). The size of the dictionaries learned for each class plays a major role in data representation but it is an even more crucial element in the case of competitive classification. Our approach adapts the size of the dictionary for each class, depending on the complexity of the underlying data. The algorithm is validated using 52 multi-sequence MR images acquired from 13 MS patients. The results demonstrate the effectiveness of our approach in MS lesion classification.</AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deshpande</LastName><ForeName>Hrishikesh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Rennes 1, Faculty of Medicine, F-35043 Rennes, France; INSERM, U746, F-35042 Rennes, France; CNRS, IRISA, UMR 6074, F-35042 Rennes, France; Inria, VISAGES Project-Team, F-35042 Rennes, France. Electronic address: hrishikesh.deshpande@inria.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurel</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Rennes 1, Faculty of Medicine, F-35043 Rennes, France; INSERM, U746, F-35042 Rennes, France; CNRS, IRISA, UMR 6074, F-35042 Rennes, France; Inria, VISAGES Project-Team, F-35042 Rennes, France. Electronic address: pierre.maurel@irisa.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barillot</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Rennes 1, Faculty of Medicine, F-35043 Rennes, France; INSERM, U746, F-35042 Rennes, France; CNRS, IRISA, UMR 6074, F-35042 Rennes, France; Inria, VISAGES Project-Team, F-35042 Rennes, France. Electronic address: christian.barillot@irisa.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Med Imaging Graph</MedlineTA><NlmUniqueID>8806104</NlmUniqueID><ISSNLinking>0895-6111</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004014" MajorTopicYN="N">Dictionaries as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adaptive dictionary learning</Keyword><Keyword MajorTopicYN="N">Computer aided diagnosis</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Sparse representations</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26055435</ArticleId><ArticleId IdType="pii">S0895-6111(15)00088-9</ArticleId><ArticleId IdType="doi">10.1016/j.compmedimag.2015.05.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25953402</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Realization of a service for the long-term risk assessment of diabetes-related complications.</ArticleTitle><Pagination><MedlinePgn>691-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2015.03.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(15)00107-5</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We present a computerized system for the assessment of the long-term risk of developing diabetes-related complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The core of the system consists of a set of predictive models, developed through a data-mining/machine-learning approach, which are able to evaluate individual patient profiles and provide personalized risk assessments. Missing data is a common issue in (electronic) patient records, thus the models are paired with a module for the intelligent management of missing information.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The system has been deployed and made publicly available as Web service, and it has been fully integrated within the diabetes-management platform developed by the European project REACTION. Preliminary usability tests showed that the clinicians judged the models useful for risk assessment and for communicating the risk to the patient. Furthermore, the system performs as well as the United Kingdom Prospective Diabetes Study (UKPDS) Risk Engine when both systems are tested on an independent cohort of UK diabetes patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our work provides a working example of risk-stratification tool that is (a) specific for diabetes patients, (b) able to handle several different diabetes related complications, (c) performing as well as the widely known UKPDS Risk Engine on an external validation cohort.</AbstractText><CopyrightInformation>Copyright .. 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lagani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece. Electronic address: vlagani@ics.forth.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiarugi</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manousos</LastName><ForeName>Dimitris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Information Systems, Computing and Mathematics, Brunel University, Uxbridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fursse</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chorleywood Health Center, Chorleywood, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marias</LastName><ForeName>Kostas</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsamardinos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece; Department of Computer Science, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003658" MajorTopicYN="Y">Decision Making, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical decision support systems</Keyword><Keyword MajorTopicYN="N">DCCT / EDIC studies</Keyword><Keyword MajorTopicYN="N">Diabetes complications</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Risk assessment models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25953402</ArticleId><ArticleId IdType="pii">S1056-8727(15)00107-5</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2015.03.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25927832</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Heterogeneity of synovial molecular patterns in patients with arthritis.</ArticleTitle><Pagination><MedlinePgn>e0122104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0122104</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rheumatology. Previously, we performed high-density transcriptomic studies on synovial biopsies from patients with arthritis, and found that synovial gene expression profiles were significantly different according to the underlying disorder. Here, we wanted to further explore the consistency of the gene expression signals in synovial biopsies of patients with arthritis, using low-density platforms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Low-density assays (cDNA microarray and microfluidics qPCR) were designed, based on the results of the high-density microarray data. Knee synovial biopsies were obtained from patients with RA, spondyloarthropathies (SA) or osteoarthritis (OA) (n = 39), and also from patients with initial undifferentiated arthritis (UA) (n = 49).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">According to high-density microarray data, several molecular pathways are differentially expressed in patients with RA, SA and OA: T and B cell activation, chromatin remodelling, RAS GTPase activation and extracellular matrix regulation. Strikingly, disease activity (DAS28-CRP) has a significant influence on gene expression patterns in RA samples. Using the low-density assays, samples from patients with OA are easily discriminated from RA and SA samples. However, overlapping molecular patterns are found, in particular between RA and SA biopsies. Therefore, prediction of the clinical diagnosis based on gene expression data results in a diagnostic accuracy of 56.8%, which is increased up to 98.6% by the addition of specific clinical symptoms in the prediction algorithm. Similar observations are made in initial UA samples, in which overlapping molecular patterns also impact the accuracy of the diagnostic algorithm. When clinical symptoms are added, the diagnostic accuracy is strongly improved.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Gene expression signatures are overall different in patients with OA, RA and SA, but overlapping molecular signatures are found in patients with these conditions. Therefore, an accurate diagnosis in patients with UA requires a combination of gene expression and clinical data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lauwerys</LastName><ForeName>Bernard R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern..ndez-Lobato</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Machine Learning Group, ICTEAM Institute, Universit.. catholique de Louvain, Place Sainte-Barbe 2, B-1348, Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gramme</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>DNAlytics, Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducreux</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dessy</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Machine Learning Group, ICTEAM Institute, Universit.. catholique de Louvain, Place Sainte-Barbe 2, B-1348, Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Focant</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambroise</LastName><ForeName>J..r..me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre de Technologies Mol..culaires Appliqu..es, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bearzatto</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre de Technologies Mol..culaires Appliqu..es, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nzeusseu Toukap</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Eynde</LastName><ForeName>Beno..t J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Institut de Duve, Universit.. catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elewaut</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gala</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Centre de Technologies Mol..culaires Appliqu..es, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durez</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houssiau</LastName><ForeName>Fr..d..ric A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>P..le de pathologies rhumatismales, Institut de Recherche Exp..rimentale et Clinique, Universit.. catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helleputte</LastName><ForeName>Thibault</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DNAlytics, Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Machine Learning Group, ICTEAM Institute, Universit.. catholique de Louvain, Place Sainte-Barbe 2, B-1348, Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GEO</DataBankName><AccessionNumberList><AccessionNumber>GSE24742</AccessionNumber><AccessionNumber>GSE36700</AccessionNumber><AccessionNumber>GSE45867</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046210" MajorTopicYN="N">Microfluidic Analytical Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013583" MajorTopicYN="N">Synovial Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25927832</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0122104</ArticleId><ArticleId IdType="pii">PONE-D-14-47992</ArticleId><ArticleId IdType="pmc">PMC4415786</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rheumatology (Oxford). 2008 Apr;47(4):392-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18094000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 May;56(5):1579-88</Citation><ArticleIdList><ArticleId IdType="pubmed">17469140</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Mar;62(3):694-704</Citation><ArticleIdList><ArticleId IdType="pubmed">20131234</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 May;63(5):1246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">21337318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Aug;70(8):1468-70</Citation><ArticleIdList><ArticleId IdType="pubmed">21586440</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Mol Med. 2011 Nov;15(11):2335-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21129157</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2006 Jan;65(1):20-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15901632</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Feb;64(2):389-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21918954</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2003 Apr;4(2):249-64</Citation><ArticleIdList><ArticleId IdType="pubmed">12925520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Jul 22;19(11):1360-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12874047</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Nov;29(11):2278-87</Citation><ArticleIdList><ArticleId IdType="pubmed">12415582</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Apr;46(4):894-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11953964</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Feb;46(2):283-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11840429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2001 Nov;40(11):1211-20</Citation><ArticleIdList><ArticleId IdType="pubmed">11709604</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Jan;66(1):15-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24449571</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Feb;56(2):433-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17265478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2007 Mar 20;146(6):406-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17371885</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2009;11(2):R57</Citation><ArticleIdList><ArticleId IdType="pubmed">19389237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25858640</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis.</ArticleTitle><Pagination><MedlinePgn>763-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2014-206921</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">For our understanding of the pathogenesis of rheumatoid arthritis (RA), it is important to elucidate the mechanisms underlying early stages of synovitis. Here, synovial cytokine production was investigated in patients with very early arthritis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Synovial biopsies were obtained from patients with at least one clinically swollen joint within 12...weeks of symptom onset. At an 18-month follow-up visit, patients who went on to develop RA, or whose arthritis spontaneously resolved, were identified. Biopsies were also obtained from patients with RA with longer symptom duration (&gt;12...weeks) and individuals with no clinically apparent inflammation. Synovial mRNA expression of 117 cytokines was quantified using PCR techniques and analysed using standard and novel methods of data analysis. Synovial tissue sections were stained for CXCL4, CXCL7, CD41, CD68 and von Willebrand factor.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A machine learning approach identified expression of mRNA for CXCL4 and CXCL7 as potentially important in the classification of early RA versus resolving arthritis. mRNA levels for these chemokines were significantly elevated in patients with early RA compared with uninflamed controls. Significantly increased CXCL4 and CXCL7 protein expression was observed in patients with early RA compared with those with resolving arthritis or longer established disease. CXCL4 and CXCL7 co-localised with blood vessels, platelets and CD68(+) macrophages. Extravascular CXCL7 expression was significantly higher in patients with very early RA compared with longer duration RA or resolving arthritis</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Taken together, these observations suggest a transient increase in synovial CXCL4 and CXCL7 levels in early RA.</AbstractText><CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adlard</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biehl</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5148-4568</Identifier><AffiliationInfo><Affiliation>Johann Bernoulli Institute for Mathematics and Computer Science, University of Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juarez</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smallie</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snow</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buckley</LastName><ForeName>C D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raza</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filer</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheel-Toellner</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>19593</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>20088</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>20088</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>19791</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>18547</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>19791</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>19593</GrantID><Acronym>VAC_</Acronym><Agency>Versus Arthritis</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015214">Antigens, Differentiation, Myelomonocytic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C067980">CD68 antigen, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C061615">PPBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D040201">Platelet Membrane Glycoprotein IIb</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001620">beta-Thromboglobulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014841">von Willebrand Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>37270-94-3</RegistryNumber><NameOfSubstance UI="D010978">Platelet Factor 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015214" MajorTopicYN="N">Antigens, Differentiation, Myelomonocytic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010978" MajorTopicYN="N">Platelet Factor 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040201" MajorTopicYN="N">Platelet Membrane Glycoprotein IIb</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013583" MajorTopicYN="N">Synovial Membrane</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001620" MajorTopicYN="N">beta-Thromboglobulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014841" MajorTopicYN="N">von Willebrand Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Early Rheumatoid Arthritis</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Rheumatoid Arthritis</Keyword><Keyword MajorTopicYN="N">Synovitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25858640</ArticleId><ArticleId IdType="pii">annrheumdis-2014-206921</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2014-206921</ArticleId><ArticleId IdType="pmc">PMC4819606</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blood. 2000 Feb 15;95(4):1158-66</Citation><ArticleIdList><ArticleId IdType="pubmed">10666185</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2015 Jan;13(1):115-25</Citation><ArticleIdList><ArticleId IdType="pubmed">25393502</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1972 Sep-Oct;15(5):465-85</Citation><ArticleIdList><ArticleId IdType="pubmed">4117789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Mar;70(3):500-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21115552</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Jan;39(1):115-24</Citation><ArticleIdList><ArticleId IdType="pubmed">8546720</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Mar;52(3):710-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15751074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1995 Nov 10;270(45):27348-57</Citation><ArticleIdList><ArticleId IdType="pubmed">7592998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1982 Apr;41(2):177-82</Citation><ArticleIdList><ArticleId IdType="pubmed">7041832</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1992 Jul;35(7):783-93</Citation><ArticleIdList><ArticleId IdType="pubmed">1622417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2015 Mar;74(3):611-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24336336</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Dec;62(12):3537-46</Citation><ArticleIdList><ArticleId IdType="pubmed">20722031</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Aug;48(8):2155-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12905468</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2014 Aug;35(8):358-67</Citation><ArticleIdList><ArticleId IdType="pubmed">25047416</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2007;9(5):R101</Citation><ArticleIdList><ArticleId IdType="pubmed">17903238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2004 Mar;75(3):495-503</Citation><ArticleIdList><ArticleId IdType="pubmed">14673015</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2007 May;19(3):289-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17414958</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(12):e51361</Citation><ArticleIdList><ArticleId IdType="pubmed">23300543</ArticleId></ArticleIdList></Reference><Reference><Citation>Res Immunol. 1998 Sep-Oct;149(7-8):733-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9851533</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Feb;32(2):231-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15693082</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1993 Aug;36(8):1142-53</Citation><ArticleIdList><ArticleId IdType="pubmed">8343190</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Apr 6;336(6077):86-90</Citation><ArticleIdList><ArticleId IdType="pubmed">22442384</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Rheumatol. 2006 Oct;20(5):849-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16980210</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2005 Jul;78(1):202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15788441</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2004 Oct;18(13):1588-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15319366</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Feb;69(2):417-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19359260</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2001 Aug 1;98(3):610-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11468158</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2014 Feb;124(2):543-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24463452</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 2003 Aug;15(8):1007-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12882838</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Oct;66(10):2716-27</Citation><ArticleIdList><ArticleId IdType="pubmed">24943990</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Feb;40(2):217-25</Citation><ArticleIdList><ArticleId IdType="pubmed">9041933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2011 Mar;70(3):423-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21109518</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2004 Jul;43(7):906-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15113999</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 2009 Dec;21(12):3532-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19764875</ArticleId></ArticleIdList></Reference><Reference><Citation>Open Rheumatol J. 2011;5:100-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22279508</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1992 Jun 1;79(11):2896-900</Citation><ArticleIdList><ArticleId IdType="pubmed">1316786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 Jun;7(6):429-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17525752</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Jan 30;370(5):433-43</Citation><ArticleIdList><ArticleId IdType="pubmed">24350901</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1977 Apr;20(3):859-68</Citation><ArticleIdList><ArticleId IdType="pubmed">856217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25773366</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-0444</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medical &amp; biological engineering &amp; computing</Title><ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation></Journal><ArticleTitle>Evaluation of short-term predictors of glucose concentration in type 1 diabetes combining feature ranking with regression models.</ArticleTitle><Pagination><MedlinePgn>1305-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-015-1263-1</ELocationID><Abstract><AbstractText>Glucose concentration in type 1 diabetes is a function of biological and environmental factors which present high inter-patient variability. The objective of this study is to evaluate a number of features, which are extracted from medical and lifestyle self-monitoring data, with respect to their ability to predict the short-term subcutaneous (s.c.) glucose concentration of an individual. Random forests (RF) and RReliefF algorithms are first employed to rank the candidate feature set. Then, a forward selection procedure follows to build a glucose predictive model, where features are sequentially added to it in decreasing order of importance. Predictions are performed using support vector regression or Gaussian processes. The proposed method is validated on a dataset of 15 type diabetics in real-life conditions. The s.c. glucose profile along with time of the day and plasma insulin concentration are systematically highly ranked, while the effect of food intake and physical activity varies considerably among patients. Moreover, the average prediction error converges in less than d/2 iterations (d is the number of features). Our results suggest that RF and RReliefF can find the most informative features and can be successfully used to customize the input of glucose models. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering and Aeronautics, University of Patras, 26500, Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110, Ioannina, Greece. fotiadis@cc.uoi.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Biol Eng Comput</MedlineTA><NlmUniqueID>7704869</NlmUniqueID><ISSNLinking>0140-0118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feature selection</Keyword><Keyword MajorTopicYN="N">Glucose level prediction</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25773366</ArticleId><ArticleId IdType="doi">10.1007/s11517-015-1263-1</ArticleId><ArticleId IdType="pii">10.1007/s11517-015-1263-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2010 Jan 01;4(1):25-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20167164</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Jul 18;369(3):224-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23789889</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2011 Sep;58(9):2467-77</Citation><ArticleIdList><ArticleId IdType="pubmed">21622071</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1995 Aug;44(8):947-53</Citation><ArticleIdList><ArticleId IdType="pubmed">7622001</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60</Citation><ArticleIdList><ArticleId IdType="pubmed">22374344</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e32200</Citation><ArticleIdList><ArticleId IdType="pubmed">22403633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jan;2(1):158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19578532</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2014 Jan;37 Suppl 1:S14-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24357209</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2011 Jun;121(6):2133-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21633182</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2014;113(1):144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24192453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 Jul;1(4):478-86</Citation><ArticleIdList><ArticleId IdType="pubmed">19885110</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2003 Nov 06;4:54</Citation><ArticleIdList><ArticleId IdType="pubmed">14604446</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):622-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23883408</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2010 Dec;48(12):1191-201</Citation><ArticleIdList><ArticleId IdType="pubmed">20658267</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 2010 Feb;31(1):1-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19854863</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Apr 26;366(17):1616-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22533577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):617-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22768893</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2013 May 01;7(3):689-98</Citation><ArticleIdList><ArticleId IdType="pubmed">23759402</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Aug;15(8):634-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ind Eng Chem Res. 2013 Sep 4;52(35):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24187436</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Dec;57(12):3169-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19033403</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Sep 01;4(5):1146-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20920434</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5633-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19964403</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2007 May;1(3):338-47</Citation><ArticleIdList><ArticleId IdType="pubmed">19885088</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Feb 28;368(9):824-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23445093</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2010 Jan;12(1):81-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20082589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Eng. 1992 May;14(3):235-42</Citation><ArticleIdList><ArticleId IdType="pubmed">1588781</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomech. 2002 Jul;35(7):911-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12052393</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Automatica (Oxf). 2012 Aug;48(8):1892-1897</Citation><ArticleIdList><ArticleId IdType="pubmed">22865931</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2006 Jun;44(6):451-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16937196</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Biol Eng Comput. 2009 Mar;47(3):343-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19214613</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2014 Mar;61(3):883-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24557689</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Methods. 2009 Dec;14(4):323-48</Citation><ArticleIdList><ArticleId IdType="pubmed">19968396</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 May;14(3):622-33</Citation><ArticleIdList><ArticleId IdType="pubmed">20123578</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2005 Dec;52(12):1994-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16366223</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 14;99(10):6562-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11983868</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2013 Jan;15(1):66-77</Citation><ArticleIdList><ArticleId IdType="pubmed">23297671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25610791</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Predicting outcome in clinically isolated syndrome using machine learning.</ArticleTitle><Pagination><MedlinePgn>281-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2014.11.021</ELocationID><Abstract><AbstractText>We aim to determine if machine learning techniques, such as support vector machines (SVMs), can predict the occurrence of a second clinical attack, which leads to the diagnosis of clinically-definite Multiple Sclerosis (CDMS) in patients with a clinically isolated syndrome (CIS), on the basis of single patient's lesion features and clinical/demographic characteristics. Seventy-four patients at onset of CIS were scanned and clinically reviewed after one and three years. CDMS was used as the gold standard against which SVM classification accuracy was tested. Radiological features related to lesional characteristics on conventional MRI were defined a priori and used in combination with clinical/demographic features in an SVM. Forward recursive feature elimination with 100 bootstraps and a leave-one-out cross-validation was used to find the most predictive feature combinations. 30 % and 44 % of patients developed CDMS within one and three years, respectively. The SVMs correctly predicted the presence (or the absence) of CDMS in 71.4 % of patients (sensitivity/specificity: 77 %/66 %) at 1..year, and in 68 % (60 %/76 %) at 3..years on average over all bootstraps. Combinations of features consistently gave a higher accuracy in predicting outcome than any single feature. Machine-learning-based classifications can be used to provide an "individualised" prediction of conversion to MS from subjects' baseline scans and clinical characteristics, with potential to be incorporated into routine clinical practice. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wottschel</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>NMR Research Unit, UCL Institute of Neurology, Queen Square MS Centre, Queen Square, London, UK ; Department of Computer Science, Centre for Medical Imaging Computing, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>D C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Centre for Medical Imaging Computing, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>P P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Centre for Medical Imaging Computing, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chard</LastName><ForeName>D T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>NMR Research Unit, UCL Institute of Neurology, Queen Square MS Centre, Queen Square, London, UK ; National Institute for Health Research (NIHR), University College London Hospital (UCLH), Biomedical Research Centre (BRC), UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stromillo</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Stefano</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>A J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>NMR Research Unit, UCL Institute of Neurology, Queen Square MS Centre, Queen Square, London, UK ; National Institute for Health Research (NIHR), University College London Hospital (UCLH), Biomedical Research Centre (BRC), UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>D H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>NMR Research Unit, UCL Institute of Neurology, Queen Square MS Centre, Queen Square, London, UK ; National Institute for Health Research (NIHR), University College London Hospital (UCLH), Biomedical Research Centre (BRC), UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccarelli</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>NMR Research Unit, UCL Institute of Neurology, Queen Square MS Centre, Queen Square, London, UK ; National Institute for Health Research (NIHR), University College London Hospital (UCLH), Biomedical Research Centre (BRC), UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="N">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinically isolated syndrome</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Multiple Sclerosis</Keyword><Keyword MajorTopicYN="N">Support vector machines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>09</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25610791</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2014.11.021</ArticleId><ArticleId IdType="pii">S2213-1582(14)00188-0</ArticleId><ArticleId IdType="pmc">PMC4297887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain. 2008 Nov;131(Pt 11):2969-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18835868</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2010 Nov 30;75(22):1988-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21115953</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2008 Mar 25;70(13 Pt 2):1079-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17881717</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2013 Jan 15;80(3):234-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23223533</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2008 Apr;255(4):480-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18004635</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2013 May 19;2:735-45</Citation><ArticleIdList><ArticleId IdType="pubmed">24179825</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2008 Mar;131(Pt 3):681-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18202106</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2012 May;135(Pt 5):1508-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22544901</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2009 Dec 1;73(22):1837-41</Citation><ArticleIdList><ArticleId IdType="pubmed">19949029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 May;18(5):600-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21993498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):292-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Aug 1;62(1):48-58</Citation><ArticleIdList><ArticleId IdType="pubmed">22609452</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2002 Jul 9;59(1):126-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12105321</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Mar;60(1):400-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22245259</ArticleId></ArticleIdList></Reference><Reference><Citation>Comput Methods Programs Biomed. 2010 Jun;98(3):278-84</Citation><ArticleIdList><ArticleId IdType="pubmed">19818524</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2008 Mar;131(Pt 3):808-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18234696</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2010 Nov 23;75(21):1933-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21098409</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Sep 26;67(6):968-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17000962</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Apr 15;60(3):1880-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22281676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2011 Mar;17(3):312-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21071465</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2008 May;255(5):683-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18274802</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Jul 15;51(4):1405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20347044</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(6):e21138</Citation><ArticleIdList><ArticleId IdType="pubmed">21695053</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2006 Apr;129(Pt 4):1031-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16495327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Nov;20(13):1690-1</Citation><ArticleIdList><ArticleId IdType="pubmed">25326506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2012 Feb;11(2):157-69</Citation><ArticleIdList><ArticleId IdType="pubmed">22265211</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2007 Jan;254(1):78-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17508141</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2013 Jan 1;80(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23243070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2007 Aug;6(8):677-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17616439</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Jan 17;346(3):158-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11796849</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2012 Mar;60(1):59-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22166797</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 May 15;56(2):422-39</Citation><ArticleIdList><ArticleId IdType="pubmed">20347998</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1997 Nov;120 ( Pt 11):2059-69</Citation><ArticleIdList><ArticleId IdType="pubmed">9397021</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2009 Feb 3;72(5):426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19188573</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2011 Jul 19;77(3):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21613600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 1993 Jul;37(3):185-91</Citation><ArticleIdList><ArticleId IdType="pubmed">8244781</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2011 Dec;134(Pt 12):3742-54</Citation><ArticleIdList><ArticleId IdType="pubmed">22006979</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 Mar;18(3):322-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21878451</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">25569957</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2014</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>A novel extreme learning machine for hypoglycemia detection.</ArticleTitle><Pagination><MedlinePgn>302-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC.2014.6943589</ELocationID><Abstract><AbstractText>Hypoglycemia is a common side-effect of insulin therapy for patients with type 1 diabetes mellitus (T1DM) and is the major limiting factor to maintain tight glycemic control. The deficiency in glucose counter-regulation may even lead to severe hypoglycaemia. It is always threatening to the well-being of patients with T1DM since more severe hypoglycemia leads to seizures or loss of consciousness and the possible development of permanent brain dysfunction under certain circumstances. Thus, an accurate early detection on hypoglycemia is an important research topic. With the use of new emerging technology, an extreme learning machine (ELM) based hypoglycemia detection system is developed to recognize the presence of hypoglycemic episodes. From a clinical study of 16 children with T1DM, natural occurrence of nocturnal hypoglycemic episodes are associated with increased heart rates (p &lt;; 0.06) and increased corrected QT intervals (p &lt;; 0.001). The overall data were organized into a training set with 8 patients (320 data points) and a testing set with 8 patients (269 data points). By using the ELM trained feed-forward neural network (ELM-FFNN), the testing sensitivity (true positive) and specificity (true negative) for detection of hypoglycemia is 78 and 60% respectability. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>San</LastName><ForeName>Phyo Phyo</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Sai Ho</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Soe</LastName><ForeName>Ni Ni</ForeName><Initials>NN</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Hung T</ForeName><Initials>HT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017143" MajorTopicYN="N">Fuzzy Logic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25569957</ArticleId><ArticleId IdType="doi">10.1109/EMBC.2014.6943589</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25485453</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>Pt 2</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title><ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation></Journal><ArticleTitle>Spatial modeling of multiple sclerosis for disease subtype prediction.</ArticleTitle><Pagination><MedlinePgn>797-804</MedlinePgn></Pagination><Abstract><AbstractText>Magnetic resonance imaging (MRI) has become an essential tool in the diagnosis and managing of Multiple Sclerosis (MS). Currently, the assessment of MS is based on a combination of clinical scores and subjective rating of lesion images by clinicians. In this work we present an objective 5-way classification of MS disease subtype as well as a comparison between three different approaches. First we propose two spatially informed models, a Bayesian Spatial Generalized Linear Mixed Model (BSGLMM) and a Log Gaussian Cox Process (LGCP). The BSGLMM accounts for the binary nature of lesion maps and the spatial dependence between neighboring voxels, and the LGCP accounts for the random spatial variation in lesion location. Both improve upon mass univariate analyses that ignore spatial dependence and rely on some level of arbitrarily defined smoothing of the data. As a comparison, we consider a machine learning approach based on multi-class support vector machine (SVM). For the SVM classification scheme, unlike previous work, we use a large number of quantitative features derived from three MRI sequences in addition to traditional demographic and clinical measures. We show that the spatial models outperform standard approaches with average prediction accuracies of up to 85%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taschler</LastName><ForeName>Bernd</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Tian</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bendfeldt</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>M..ller-Lenke</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>100309</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0900908</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA><NlmUniqueID>101249582</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038524" MajorTopicYN="N">Diffusion Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008953" MajorTopicYN="N">Models, Anatomic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25485453</ArticleId><ArticleId IdType="doi">10.1007/978-3-319-10470-6_99</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25392319</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0970</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Multiple sclerosis (Houndmills, Basingstoke, England)</Title><ISOAbbreviation>Mult Scler</ISOAbbreviation></Journal><ArticleTitle>Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.</ArticleTitle><Pagination><MedlinePgn>894-904</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1352458514555786</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Interferon beta (IFNb) reduces relapse frequency and disability progression in patients with multiple sclerosis (MS).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Early identification of prognostic biomarkers of IFNb-treated patients will allow more effective management of MS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The IMPROVE study evaluated subcutaneous IFNb versus placebo in 180 patients with relapsing-remitting MS. Magnetic resonance imaging scans, clinical assessments, and blood samples were obtained at baseline and every 4 weeks from every participant. Thirty-nine biomarkers (32 transcripts; seven proteins) were studied in 155 patients from IMPROVE. Therapeutic response was defined by absence of new combined unique lesions, relapses, and sustained increase in Expanded Disability Status Scale over 1 year. A machine learning approach was used to examine the association between biomarker expression and treatment response.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">While baseline levels of individual genes were relatively poor predictors, combinations of three genes were able to identify subjects with sub-optimal therapeutic responses. The triplet CASP2/IRF4/IRF6, previously identified in an independent dataset, was tested among other combinations. This triplet showed acceptable predictive accuracy (0.68) and specificity (0.88), but had relatively low sensitivity (0.22) resulting in an area under the curve (AUC) of 0.63. Other combinations of biomarkers resulted in AUC of up to 0.80 (e.g. CASP2/IL10/IL12Rb1).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Baseline expression, or induction ratios, of specific gene combinations correlate with future therapeutic response to IFNb, and have the potential to be prognostically useful.</AbstractText><CopyrightInformation>.. The Author(s), 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baranzini</LastName><ForeName>Sergio E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution sebaran@cgl.ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madireddy</LastName><ForeName>Lohith R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cromer</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Merck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the company.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Antonio</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Merck Serono RBM S.p.A- Colleretto Giacosa, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehr</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Merck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the company.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beelke</LastName><ForeName>Manolo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Merck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the company.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farmer</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Merck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the company.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battaglini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caillier</LastName><ForeName>Stacy J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stromillo</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono RBM S.p.A- Colleretto Giacosa, Turin, ItalyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyUniversity of Siena, Siena, ItalyDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Stefano</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono RBM S.p.A- Colleretto Giacosa, Turin, ItalyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyUniversity of Siena, Siena, ItalyDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contributionMerck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the companyDepartment of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monnet</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Merck Serono S.A. - Geneva, Switzerland/During the completion of this study, Merck Serono closed its Geneva operations. These authors are no longer with the company.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cree</LastName><ForeName>Bruce A C</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco (UCSF), San Francisco, USA/ Equal contribution.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mult Scler</MedlineTA><NlmUniqueID>9509185</NlmUniqueID><ISSNLinking>1352-4585</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109803">IRF6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050835">Interferon Regulatory Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094531">interferon regulatory factor-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C490360">CASP2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053143">Caspase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053143" MajorTopicYN="N">Caspase 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050835" MajorTopicYN="N">Interferon Regulatory Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020529" MajorTopicYN="N">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">interferon beta</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">prognostic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25392319</ArticleId><ArticleId IdType="pii">1352458514555786</ArticleId><ArticleId IdType="doi">10.1177/1352458514555786</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25376036</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-254X</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>IEEE transactions on medical imaging</Title><ISOAbbreviation>IEEE Trans Med Imaging</ISOAbbreviation></Journal><ArticleTitle>Transfer learning improves supervised image segmentation across imaging protocols.</ArticleTitle><Pagination><MedlinePgn>1018-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TMI.2014.2366792</ELocationID><Abstract><AbstractText>The variation between images obtained with different scanners or different imaging protocols presents a major challenge in automatic segmentation of biomedical images. This variation especially hampers the application of otherwise successful supervised-learning techniques which, in order to perform well, often require a large amount of labeled training data that is exactly representative of the target data. We therefore propose to use transfer learning for image segmentation. Transfer-learning techniques can cope with differences in distributions between training and target data, and therefore may improve performance over supervised learning for segmentation across scanners and scan protocols. We present four transfer classifiers that can train a classification scheme with only a small amount of representative training data, in addition to a larger amount of other training data with slightly different characteristics. The performance of the four transfer classifiers was compared to that of standard supervised classification on two magnetic resonance imaging brain-segmentation tasks with multi-site data: white matter, gray matter, and cerebrospinal fluid segmentation; and white-matter-/MS-lesion segmentation. The experiments showed that when there is only a small amount of representative training data available, transfer learning can greatly outperform common supervised-learning approaches, minimizing classification errors by up to 60%. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Opbroek</LastName><ForeName>Annegreet</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ikram</LastName><ForeName>M Arfan</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Vernooij</LastName><ForeName>Meike W</ForeName><Initials>MW</Initials></Author><Author ValidYN="Y"><LastName>de Bruijne</LastName><ForeName>Marleen</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Med Imaging</MedlineTA><NlmUniqueID>8310780</NlmUniqueID><ISSNLinking>0278-0062</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25376036</ArticleId><ArticleId IdType="doi">10.1109/TMI.2014.2366792</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25344930</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>e1</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record.</ArticleTitle><Pagination><MedlinePgn>e151-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/amiajnl-2014-002642</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To improve the accuracy of mining structured and unstructured components of the electronic medical record (EMR) by adding temporal features to automatically identify patients with rheumatoid arthritis (RA) with methotrexate-induced liver transaminase abnormalities.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Codified information and a string-matching algorithm were applied to a RA cohort of 5903 patients from Partners HealthCare to select 1130 patients with potential liver toxicity. Supervised machine learning was applied as our key method. For features, Apache clinical Text Analysis and Knowledge Extraction System (cTAKES) was used to extract standard vocabulary from relevant sections of the unstructured clinical narrative. Temporal features were further extracted to assess the temporal relevance of event mentions with regard to the date of transaminase abnormality. All features were encapsulated in a 3-month-long episode for classification. Results were summarized at patient level in a training set (N=480 patients) and evaluated against a test set (N=120 patients).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The system achieved positive predictive value (PPV) 0.756, sensitivity 0.919, F1 score 0.829 on the test set, which was significantly better than the best baseline system (PPV 0.590, sensitivity 0.703, F1 score 0.642). Our innovations, which included framing the phenotype problem as an episode-level classification task, and adding temporal information, all proved highly effective.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Automated methotrexate-induced liver toxicity phenotype discovery for patients with RA based on structured and unstructured information in the EMR shows accurate results. Our work demonstrates that adding temporal features significantly improved classification results.</AbstractText><CopyrightInformation>.. The Author 2014. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Informatics Program, Boston, Massachusetts, USA *CL, EWK and DD are co-first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlson</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA *CL, EWK and DD are co-first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dligach</LastName><ForeName>Dmitriy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Informatics Program, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA *CL, EWK and DD are co-first authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Monica P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Informatics Program, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braggs</LastName><ForeName>Natalie S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cagan</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Computing, Partners HealthCare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Computing, Partners HealthCare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savova</LastName><ForeName>Guergana K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Informatics Program, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM103859</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR047782</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 HL065962</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR052403</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54LM008748</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01LM010090</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01GM103859-01A1</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GM092691</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR049880</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>YL5FZ2Y5U1</RegistryNumber><NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electronic medical record</Keyword><Keyword MajorTopicYN="N">liver toxicity</Keyword><Keyword MajorTopicYN="N">methotrexate</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword><Keyword MajorTopicYN="N">pharmacogenetic</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25344930</ArticleId><ArticleId IdType="pii">amiajnl-2014-002642</ArticleId><ArticleId IdType="doi">10.1136/amiajnl-2014-002642</ArticleId><ArticleId IdType="pmc">PMC5901122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Inform Assoc. 2013 Dec;20(e2):e341-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24190931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):849-58</Citation><ArticleIdList><ArticleId IdType="pubmed">23467472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):867-75</Citation><ArticleIdList><ArticleId IdType="pubmed">23686936</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 16;8(8):e69932</Citation><ArticleIdList><ArticleId IdType="pubmed">23976944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):828-35</Citation><ArticleIdList><ArticleId IdType="pubmed">23571849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2004 Sep;31(9):1727-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15338491</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2013 Jun;19(7):1411-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23567779</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Dec;20(e2):e243-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):859-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23605114</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2013 Aug;19(9):1921-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23751398</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2008 Nov 06;:328-32</Citation><ArticleIdList><ArticleId IdType="pubmed">18998945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1996 Mar;23(3):459-61</Citation><ArticleIdList><ArticleId IdType="pubmed">8832983</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2012;8(12):e1002823</Citation><ArticleIdList><ArticleId IdType="pubmed">23300414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2009 Jul;68(7):1086-93</Citation><ArticleIdList><ArticleId IdType="pubmed">19033291</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):820-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23571851</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2013 Apr;108(4):594-601</Citation><ArticleIdList><ArticleId IdType="pubmed">23337479</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Sep-Oct;17(5):568-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20819866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Apr 20;3(79):79re1</Citation><ArticleIdList><ArticleId IdType="pubmed">21508311</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliment Pharmacol Ther. 2013 Feb;37(4):445-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23289600</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2009 Nov 14;2009:497-501</Citation><ArticleIdList><ArticleId IdType="pubmed">20351906</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2011 Mar;89(3):379-86</Citation><ArticleIdList><ArticleId IdType="pubmed">21248726</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Sep-Oct;17(5):507-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2011 Jul-Aug;18(4):387-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21672908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Jan;69(1):43-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19147616</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1989 Feb;32(2):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2920047</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e162-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2013 Sep-Oct;20(5):836-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23558168</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Feb;31(2):167-75</Citation><ArticleIdList><ArticleId IdType="pubmed">3279962</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1994 Mar;37(3):316-28</Citation><ArticleIdList><ArticleId IdType="pubmed">8129787</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Ophthalmol. 2011 Nov 11;11:32</Citation><ArticleIdList><ArticleId IdType="pubmed">22078460</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25200124</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.</ArticleTitle><Pagination><MedlinePgn>3463-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.38875</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Childhood arthritis encompasses a heterogeneous family of diseases. Significant variation in clinical presentation remains despite consensus-driven diagnostic classifications. Developments in data analysis provide powerful tools for interrogating large heterogeneous data sets. We report a novel approach to integrating biologic and clinical data toward a new classification for childhood arthritis, using computational biology for data-driven pattern recognition.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Probabilistic principal components analysis was used to transform a large set of data into 4 interpretable indicators or composite variables on which patients were grouped by cluster analysis. Sensitivity analysis was conducted to determine key variables in determining indicators and cluster assignment. Results were validated against an independent validation cohort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Meaningful biologic and clinical characteristics, including levels of proinflammatory cytokines and measures of disease activity, defined axes/indicators that identified homogeneous patient subgroups by cluster analysis. The new patient classifications resolved major differences between patient subpopulations better than International League of Associations for Rheumatology subtypes. Fourteen variables were identified by sensitivity analysis to crucially determine indicators and clusters. This new schema was conserved in an independent validation cohort.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Data-driven unsupervised machine learning is a powerful approach for interrogating clinical and biologic data toward disease classification, providing insight into the biology underlying clinical heterogeneity in childhood arthritis. Our analytical framework enabled the recovery of unique patterns from small cohorts and addresses a major challenge, patient numbers, in studying rare diseases.</AbstractText><CopyrightInformation>.. 2014 The Authors. Arthritis &amp; Rheumatology is published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eng</LastName><ForeName>Simon W M</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>Trang T</ForeName><Initials>TT</Initials></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Alan M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Quaid</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Rae S M</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><CollectiveName>REACCH OUT and BBOP Research Consortia</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="N">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25200124</ArticleId><ArticleId IdType="doi">10.1002/art.38875</ArticleId><ArticleId IdType="pmc">PMC4282094</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Rheumatol. 2004 Feb;31(2):390-2</Citation><ArticleIdList><ArticleId IdType="pubmed">14760812</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1153-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19210889</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Nov 23;11:571</Citation><ArticleIdList><ArticleId IdType="pubmed">21092268</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Rheumatol Rep. 2010 Apr;12(2):87-93</Citation><ArticleIdList><ArticleId IdType="pubmed">20425016</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 May;60(5):1488-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19404961</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2008 Nov 30;339(1):82-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18771669</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Aug;63(8):2504-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21381000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2002 Jun;22(2):84-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12070682</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Jun;56(6):1954-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17530721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Jun 18;377(9783):2138-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21684384</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2010 Mar;11(2):194-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20072139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Apr;34(4):823-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17343316</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1994 Dec;37(12):1761-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7986222</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1997 Apr;24(4):738-46</Citation><ArticleIdList><ArticleId IdType="pubmed">9101511</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 May 2;201(9):1479-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15851489</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(10):e47673</Citation><ArticleIdList><ArticleId IdType="pubmed">23094074</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2005 Jan-Feb;23(1):113-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15789898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2009 Aug;48(8):899-905</Citation><ArticleIdList><ArticleId IdType="pubmed">19478039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2007 Apr;46(4):657-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17085467</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2009 Nov;5(11):593-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19865086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2001 Jul;28(7):1670-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11469477</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Jan;63(1):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20936630</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2002 Feb;29(2):369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">11838858</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2012 Jun;13(4):289-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22418018</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Mar;62(3):896-907</Citation><ArticleIdList><ArticleId IdType="pubmed">20127724</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2001 Jun 1;166(11):6899-906</Citation><ArticleIdList><ArticleId IdType="pubmed">11359851</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 Mar 1;339(6123):1084-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23328391</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1991 Sep;34(9):1158-63</Citation><ArticleIdList><ArticleId IdType="pubmed">1930333</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2009 Sep;19(9):1639-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19541911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Nov 6;456(7218):98-101</Citation><ArticleIdList><ArticleId IdType="pubmed">18758442</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Jan 22;457(7228):480-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19043404</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Oct 15;51(5):763-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15478144</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Jul;40(7):1202-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9214419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2012 Jul;71(7):1117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22294642</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2010 Oct;11(7):584-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20463745</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jul;60(7):2113-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19565504</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Nov;62(11):3249-58</Citation><ArticleIdList><ArticleId IdType="pubmed">20662067</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2000 Apr;39(4):432-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10817778</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Mar;52(3):826-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15751057</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Dec 20;367(25):2385-95</Citation><ArticleIdList><ArticleId IdType="pubmed">23252525</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2007 Sep 3;204(9):2131-44</Citation><ArticleIdList><ArticleId IdType="pubmed">17724127</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jul;60(7):2102-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19565513</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2013 Jun;42(6):597-618</Citation><ArticleIdList><ArticleId IdType="pubmed">23337074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2004 Aug;43(8):973-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15150433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 May 1;23(9):1164-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17344241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2012 Sep;71(9):1437-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22679300</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Mol Pathol. 2006 Dec;81(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">16551465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 May;66(5):589-98</Citation><ArticleIdList><ArticleId IdType="pubmed">17170049</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Aug;64(8):2781-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22354554</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 2009 Feb;28(2):129-37</Citation><ArticleIdList><ArticleId IdType="pubmed">18766426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25131220</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0542</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><Issue>2 Pt A</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Immunology letters</Title><ISOAbbreviation>Immunol Lett</ISOAbbreviation></Journal><ArticleTitle>Multi-omics analysis of inflammatory bowel disease.</ArticleTitle><Pagination><MedlinePgn>62-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imlet.2014.07.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-2478(14)00154-0</ELocationID><Abstract><AbstractText>Crohn's disease and ulcerative colitis, known together as inflammatory bowel disease (IBD), are severe autoimmune disorders now causing gut inflammation and ulceration, among other symptoms, in up to 1 in 250 people worldwide. Incidence and prevalence of IBD have been increasing dramatically over the past several decades, although the causes for this increase are still unknown. IBD has both a complex genotype and a complex phenotype, and although it has received substantial attention from the medical research community over recent years, much of the etiology remains unexplained. Genome-wide association studies have identified a rich genetic signature of disease risk in patients with IBD, consisting of at least 163 genetic loci. Many of these loci contain genes directly involved in microbial handling, indicating that the genetic architecture of the disease has been driven by host-microbe interactions. In addition, systematic shifts in gut microbiome structure (enterotype) and function have been observed in patients with IBD. Furthermore, both the host genotype and enterotype are associated with aspects of the disease phenotype, including location of the disease. This provides strong evidence of interactions between host genotype and enterotype; however, there is a lack of published multi-omics data from IBD patients, and a lack of bioinformatics tools for modeling such systems. In this article we discuss, from a computational biologist's point of view, the potential benefits of and the challenges involved in designing and analyzing such multi-omics studies of IBD. </AbstractText><CopyrightInformation>Copyright .. 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis, MN 55455, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vangay</LastName><ForeName>Pajau</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis, MN 55455, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinlay</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis, MN 55455, United States; Biotechnology Institute, University of Minnesota, Saint Paul, MN 55108, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knights</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biotechnology Institute, University of Minnesota, Saint Paul, MN 55108, United States; Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: dknights@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Immunol Lett</MedlineTA><NlmUniqueID>7910006</NlmUniqueID><ISSNLinking>0165-2478</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Immunol Lett. 2015 Jun;165(2):107-8</RefSource><PMID Version="1">25827759</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018928" MajorTopicYN="N">Immunity, Mucosal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="N">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatics</Keyword><Keyword MajorTopicYN="N">Inflammatory bowel diseases</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Metagenomics</Keyword><Keyword MajorTopicYN="N">Microbiome</Keyword><Keyword MajorTopicYN="N">Multi-omics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>06</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25131220</ArticleId><ArticleId IdType="pii">S0165-2478(14)00154-0</ArticleId><ArticleId IdType="doi">10.1016/j.imlet.2014.07.014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24932510</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Mining gene expression data of multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>e100052</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0100052</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Microarray produces a large amount of gene expression data, containing various biological implications. The challenge is to detect a panel of discriminative genes associated with disease. This study proposed a robust classification model for gene selection using gene expression data, and performed an analysis to identify disease-related genes using multiple sclerosis as an example.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Gene expression profiles based on the transcriptome of peripheral blood mononuclear cells from a total of 44 samples from 26 multiple sclerosis patients and 18 individuals with other neurological diseases (control) were analyzed. Feature selection algorithms including Support Vector Machine based on Recursive Feature Elimination, Receiver Operating Characteristic Curve, and Boruta algorithms were jointly performed to select candidate genes associating with multiple sclerosis. Multiple classification models categorized samples into two different groups based on the identified genes. Models' performance was evaluated using cross-validation methods, and an optimal classifier for gene selection was determined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An overlapping feature set was identified consisting of 8 genes that were differentially expressed between the two phenotype groups. The genes were significantly associated with the pathways of apoptosis and cytokine-cytokine receptor interaction. TNFSF10 was significantly associated with multiple sclerosis. A Support Vector Machine model was established based on the featured genes and gave a practical accuracy of ...86%. This binary classification model also outperformed the other models in terms of Sensitivity, Specificity and F1 score.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The combined analytical framework integrating feature ranking algorithms and Support Vector Machine model could be used for selecting genes for other diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Pi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health, Shantou University Medical College, Shantou City, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Good Clinical Practice Office, Cancer Hospital of Shantou University Medical College, Shantou City, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhenli</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Public Health, Shantou University Medical College, Shantou City, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhengliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Senescence, Shantou University Medical College, Shantou City, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public Health, Shantou University Medical College, Shantou City, Guangdong Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24932510</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0100052</ArticleId><ArticleId IdType="pii">PONE-D-13-54510</ArticleId><ArticleId IdType="pmc">PMC4059716</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuron. 2005 May 5;46(3):421-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15882642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2003 Sep 1;12(17):2191-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12915464</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Feb 15;31(4):e15</Citation><ArticleIdList><ArticleId IdType="pubmed">12582260</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2005 Oct;167(1-2):170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16040132</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2001 Sep 14;287(1):277-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11549287</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2010 Mar;37(3):613-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19944761</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2001 Nov;57(Pt 11):1560-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11679720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1999 Sep;46(3):425-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10482277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Oct 25;372(9648):1502-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18970977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Dec 1;22(23):2926-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17000751</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(7):e21766</Citation><ArticleIdList><ArticleId IdType="pubmed">21814551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2004 Jul;152(1-2):154-67</Citation><ArticleIdList><ArticleId IdType="pubmed">15223248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Oct;190(1-2):170-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17884184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2006 Oct;12(5):541-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17086898</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Targets. 2010 Mar;11(3):261-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20214598</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2012 Mar 30;31(7):643-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22354891</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Targets. 2010 Mar;11(3):327-34</Citation><ArticleIdList><ArticleId IdType="pubmed">20210757</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2735-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8610110</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2004;5(10):R80</Citation><ArticleIdList><ArticleId IdType="pubmed">15461798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jun 14;361(9374):2036-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12814715</ArticleId></ArticleIdList></Reference><Reference><Citation>Apoptosis. 2002 Feb;7(1):13-21</Citation><ArticleIdList><ArticleId IdType="pubmed">11773701</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2003 Mar;59(1):133-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12762450</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Today. 1999 Dec;20(12):550-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10562705</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2002 Apr 26;293(1):566-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12054639</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2004 Apr;149(1-2):195-201</Citation><ArticleIdList><ArticleId IdType="pubmed">15020080</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Med Chem. 2011;18(9):1339-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21366530</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2005 Apr;62(4):688; author reply 688-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15824275</ArticleId></ArticleIdList></Reference><Reference><Citation>Synapse. 2007 Sep;61(9):741-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17568411</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 1996 Dec;16(12):6698-706</Citation><ArticleIdList><ArticleId IdType="pubmed">8943324</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2005 Apr;18(3):537-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15755681</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2002 Oct 11;297(5):1154-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12372407</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Aug 17;5(8):e12222</Citation><ArticleIdList><ArticleId IdType="pubmed">20808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Biochem. 1997 Jan 15;243(1-2):518-26</Citation><ArticleIdList><ArticleId IdType="pubmed">9030780</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2009 Oct;5(10):e1000543</Citation><ArticleIdList><ArticleId IdType="pubmed">19876380</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 1995 Dec;3(6):673-82</Citation><ArticleIdList><ArticleId IdType="pubmed">8777713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24920114</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1742-5662</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>97</Issue><PubDate><Year>2014</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of the Royal Society, Interface</Title><ISOAbbreviation>J R Soc Interface</ISOAbbreviation></Journal><ArticleTitle>A computational method to differentiate normal individuals, osteoarthritis and rheumatoid arthritis patients using serum biomarkers.</ArticleTitle><Pagination><MedlinePgn>20140428</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsif.2014.0428</ELocationID><ELocationID EIdType="pii" ValidYN="Y">20140428</ELocationID><Abstract><AbstractText>The objective of this study was to develop a method for categorizing normal individuals (normal, n = 100) as well as patients with osteoarthritis (OA, n = 100), and rheumatoid arthritis (RA, n = 100) based on a panel of inflammatory cytokines expressed in serum samples. Two panels of inflammatory proteins were used as training sets in the construction of two separate artificial neural networks (ANNs). The first training set consisted of all proteins (38 in total) and the second consisted of only the significantly different proteins expressed (12 in total) between at least two patient groups. Both ANNs obtained high levels of sensitivity and specificity, with the first and second ANN each diagnosing 100% of test set patients correctly. These results were then verified by re-investigating the entire dataset using a decision tree algorithm. We show that ANNs can be used for the accurate differentiation between serum samples of patients with OA, a diagnosed RA patient comparator cohort and normal/control cohort. Using neural network and systems biology approaches to manage large datasets derived from high-throughput proteomics should be further explored and considered for diagnosing diseases with complex pathologies. </AbstractText><CopyrightInformation>.. 2014 The Author(s) Published by the Royal Society. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heard</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada Department of Surgery, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosvold</LastName><ForeName>Joshua M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada Department of Civil Engineering, Faculty of Engineering, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritzler</LastName><ForeName>Marvin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Gabalawy</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Arthritis Centre, University of Manitoba, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>J Preston</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Sports Medicine Centre, Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krawetz</LastName><ForeName>Roman J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada Department of Anatomy and Cell Biology, University of Calgary, Calgary, Alberta, Canada rkrawetz@ucalgary.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J R Soc Interface</MedlineTA><NlmUniqueID>101217269</NlmUniqueID><ISSNLinking>1742-5662</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial neural network</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">diagnostic</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">osteoarthritis</Keyword><Keyword MajorTopicYN="N">serum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24920114</ArticleId><ArticleId IdType="pii">rsif.2014.0428</ArticleId><ArticleId IdType="doi">10.1098/rsif.2014.0428</ArticleId><ArticleId IdType="pmc">PMC4208376</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Osteoarthritis Cartilage. 1998 May;6(3):167-76</Citation><ArticleIdList><ArticleId IdType="pubmed">9682783</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2011 Aug;63(8):2276-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21506100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1986 Aug;29(8):1039-49</Citation><ArticleIdList><ArticleId IdType="pubmed">3741515</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoarthritis Cartilage. 2007 Jan;15(1):98-103</Citation><ArticleIdList><ArticleId IdType="pubmed">16890461</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Musculoskelet Disord. 2013 Dec 13;14:349</Citation><ArticleIdList><ArticleId IdType="pubmed">24330474</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2011 Apr;40(5):371-88</Citation><ArticleIdList><ArticleId IdType="pubmed">21295822</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Exp Pathol. 2009 Apr;90(2):174-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19335556</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Rheumatol. 2011 Jan;7(1):33-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21119608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Int Med Res. 2012;40(6):2243-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23321181</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2011 Mar 24;13(2):R50</Citation><ArticleIdList><ArticleId IdType="pubmed">21435227</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2011 Nov 06;17(12):1674-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22057346</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:2207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17946097</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoarthritis Cartilage. 2010 Jun;18(6):742-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20206708</ArticleId></ArticleIdList></Reference><Reference><Citation>OMICS. 2013 Dec;17(12):595-610</Citation><ArticleIdList><ArticleId IdType="pubmed">24116388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitam Horm. 2006;74:371-403</Citation><ArticleIdList><ArticleId IdType="pubmed">17027524</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2013 Aug;40(8):1379-87</Citation><ArticleIdList><ArticleId IdType="pubmed">23678161</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chim Acta. 2006 Mar;365(1-2):68-77</Citation><ArticleIdList><ArticleId IdType="pubmed">16257399</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Phys. 2002 Mar;29(3):403-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11929022</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008 Jul 02;3(7):e2535</Citation><ArticleIdList><ArticleId IdType="pubmed">18596971</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2001 Jun;7(6):617-26</Citation><ArticleIdList><ArticleId IdType="pubmed">11439735</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2008 Jul;29(7):607-14</Citation><ArticleIdList><ArticleId IdType="pubmed">18549315</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoarthritis Cartilage. 2011 Apr;19(4):346-53</Citation><ArticleIdList><ArticleId IdType="pubmed">21320614</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Jun;64(6):1697-707</Citation><ArticleIdList><ArticleId IdType="pubmed">22392533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2010;12(6):R229</Citation><ArticleIdList><ArticleId IdType="pubmed">21194441</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24801049</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>IEEE transactions on bio-medical engineering</Title><ISOAbbreviation>IEEE Trans Biomed Eng</ISOAbbreviation></Journal><ArticleTitle>High-order statistics of microtexton for HEp-2 staining pattern classification.</ArticleTitle><Pagination><MedlinePgn>2223-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TBME.2014.2320294</ELocationID><Abstract><AbstractText>This study addresses the classification problem of the HEp-2 cell using indirect immunofluorescent (IIF) image analysis, which can indicate the presence of autoimmune diseases by finding antibodies in the patient serum. Generally, the method used for IIF analysis remains subjective, and depends too heavily on the experience and expertise of the physician. Recently, studies have shown that it is possible to identify the cell patterns using IIF image analysis and machine learning techniques. However, it still has large gap in recognition rates to the physical experts' one. This paper explores an approach in which the discriminative features of HEp-2 cell images in IIF are extracted and then, the patterns of the HEp-2 cell are identified using machine learning techniques. Motivated by the progress in the research field of computer vision, as a result of which small local pixel pattern distributions can now be highly discriminative, the proposed strategy employs a parametric probability process to model local image patches (textons: microstructures in the cell image) and extract the higher-order statistics of the model parameters for the image description. The proposed strategy can adaptively characterize the microtexton space of HEp-2 cell images as a generative probability model, and discover the parameters that yield a better fitting of the training space, which would lead to a more discriminant representation for the cell image. The simple linear support vector machine is used for cell pattern identification because of its low computational cost, in particular for large-scale datasets. Experiments using the open HEp-2 cell dataset used in the ICIP2013 contest validate that the proposed strategy can achieve a much better performance than the widely used local binary pattern (LBP) histogram and its extensions, rotation invariant co-occurrence LBP, and pairwise rotation invariant co-occurrence LBP, and that the achieved recognition error rate is even very significantly below the observed intralaboratory variability. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xian-Hua</ForeName><Initials>XH</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gang</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Wei</ForeName><Initials>YW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Biomed Eng</MedlineTA><NlmUniqueID>0012737</NlmUniqueID><ISSNLinking>0018-9294</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24801049</ArticleId><ArticleId IdType="doi">10.1109/TBME.2014.2320294</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24781953</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A comparison of supervised machine learning algorithms and feature vectors for MS lesion segmentation using multimodal structural MRI.</ArticleTitle><Pagination><MedlinePgn>e95753</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0095753</ELocationID><Abstract><AbstractText>Machine learning is a popular method for mining and analyzing large collections of medical data. We focus on a particular problem from medical research, supervised multiple sclerosis (MS) lesion segmentation in structural magnetic resonance imaging (MRI). We examine the extent to which the choice of machine learning or classification algorithm and feature extraction function impacts the performance of lesion segmentation methods. As quantitative measures derived from structural MRI are important clinical tools for research into the pathophysiology and natural history of MS, the development of automated lesion segmentation methods is an active research field. Yet, little is known about what drives performance of these methods. We evaluate the performance of automated MS lesion segmentation methods, which consist of a supervised classification algorithm composed with a feature extraction function. These feature extraction functions act on the observed T1-weighted (T1-w), T2-weighted (T2-w) and fluid-attenuated inversion recovery (FLAIR) MRI voxel intensities. Each MRI study has a manual lesion segmentation that we use to train and validate the supervised classification algorithms. Our main finding is that the differences in predictive performance are due more to differences in the feature vectors, rather than the machine learning or classification algorithms. Features that incorporate information from neighboring voxels in the brain were found to increase performance substantially. For lesion segmentation, we conclude that it is better to use simple, interpretable, and fast algorithms, such as logistic regression, linear discriminant analysis, and quadratic discriminant analysis, and to develop the features to improve performance. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, The Johns Hopkins University, Baltimore, Maryland, United States of America; Translational Neuroradiology Unit, Neuroimmunology Branch, National Institute of Neurological Disease and Stroke, National Institute of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogelstein</LastName><ForeName>Joshua T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Statistical Science, Duke University, Durham, North Carolina, United States of America; Center for the Developing Brain, Child Mind Institute, New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuzzocreo</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabresi</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, The Johns Hopkins University, Baltimore, Maryland, United States of America; Translational Neuroradiology Unit, Neuroimmunology Branch, National Institute of Neurological Disease and Stroke, National Institute of Health, Bethesda, Maryland, United States of America; Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crainiceanu</LastName><ForeName>Ciprian M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, The Johns Hopkins University, Baltimore, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinohara</LastName><ForeName>Russell T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL123407</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH095836</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS070906</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS085211</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS060910</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS08521</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24781953</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0095753</ArticleId><ArticleId IdType="pii">PONE-D-13-54497</ArticleId><ArticleId IdType="pmc">PMC4004572</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurosci Methods. 2012 Jan 15;203(1):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21920384</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2002 Oct;21(10):1280-91</Citation><ArticleIdList><ArticleId IdType="pubmed">12585710</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1998 Feb;17(1):87-97</Citation><ArticleIdList><ArticleId IdType="pubmed">9617910</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jul 15;57(2):378-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2006 Jan;34(1):142-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16525763</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 1990;1(2):239-42</Citation><ArticleIdList><ArticleId IdType="pubmed">18282841</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Aug 15;57(4):1430-46</Citation><ArticleIdList><ArticleId IdType="pubmed">21635955</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Med. 1999 Dec;42(6):1072-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10571928</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Pattern Anal Mach Intell. 1979 Mar;1(3):306-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21868861</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroinformatics. 2010 Mar;8(1):5-17</Citation><ArticleIdList><ArticleId IdType="pubmed">20077162</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2013 Jan;17(1):1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23084503</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1994;13(4):716-24</Citation><ArticleIdList><ArticleId IdType="pubmed">18218550</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Comput Comput Assist Interv. 2012;15(Pt 1):723-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23285616</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2001 Aug;23(1):89-109</Citation><ArticleIdList><ArticleId IdType="pubmed">11470218</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Image Anal. 2004 Sep;8(3):205-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15450216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Appl Genet Mol Biol. 2007;6:Article25</Citation><ArticleIdList><ArticleId IdType="pubmed">17910531</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 1994;5(6):989-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18267874</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn Reson Imaging. 1998 Apr;16(3):311-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9621972</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage Clin. 2013 Mar 15;2:402-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24179794</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2001 Sep 14;293(5537):2051-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11557883</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2011 Jun 15;56(4):1982-92</Citation><ArticleIdList><ArticleId IdType="pubmed">21458576</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1996;15(2):154-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18215898</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 1999 Jun;9(6):768-76</Citation><ArticleIdList><ArticleId IdType="pubmed">10373024</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2005 Jul 15;24(13):2025-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15900606</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 1995;14(3):442-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18215848</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2006 Feb;27(2):455-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16484429</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2006 Mar;7(1):86-112</Citation><ArticleIdList><ArticleId IdType="pubmed">16761367</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24691080</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning.</ArticleTitle><Pagination><MedlinePgn>e93024</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0093024</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">A novel characterization of Clinically Isolated Syndrome (CIS) patients according to lesion patterns is proposed. More specifically, patients are classified according to the nature of inflammatory lesions patterns. It is expected that this characterization can infer new prospective figures from the earliest imaging signs of Multiple Sclerosis (MS), since it can provide a classification of different types of lesions across patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The method is based on a two-tiered classification. Initially, the spatio-temporal lesion patterns are classified. The discovered lesion patterns are then used to characterize groups of patients. The patient groups are validated using statistical measures and by correlations at 24-month follow-up with hypointense lesion loads.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The methodology identified 3 statistically significantly different clusters of lesion patterns showing p-values smaller than 0.01. Moreover, these patterns defined at baseline correlated with chronic hypointense lesion volumes by follow-up with an R(2) score of 0.90.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The proposed methodology is capable of identifying three major different lesion patterns that are heterogeneously present in patients, allowing a patient classification using only two MRI scans. This finding may lead to more accurate prognosis and thus to more suitable treatments at early stage of MS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crimi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INRIA-Atlantique, Campus de Beaulieu, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Commowick</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>INRIA-Atlantique, Campus de Beaulieu, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maarouf</LastName><ForeName>Adil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CRMBM-CNRS-Aix-Marseille University, Marseille, France; CHU Reims, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferr..</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>CHU Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannier</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CHU Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tourbah</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Reims, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>CHU Toulouse, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranjeva</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>CRMBM-CNRS-Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edan</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CHU Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barillot</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INRIA-Atlantique, Campus de Beaulieu, Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003911">Dextrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058185">Magnetite Nanoparticles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C097921">ferumoxtran-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003911" MajorTopicYN="Y">Dextrans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="Y">Gadolinium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058185" MajorTopicYN="Y">Magnetite Nanoparticles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24691080</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0093024</ArticleId><ArticleId IdType="pii">PONE-D-13-41759</ArticleId><ArticleId IdType="pmc">PMC3972197</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Trans Med Imaging. 1997 Apr;16(2):187-98</Citation><ArticleIdList><ArticleId IdType="pubmed">9101328</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Syst Man Cybern B Cybern. 1998;28(3):301-15</Citation><ArticleIdList><ArticleId IdType="pubmed">18255949</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2006 May;27(5):1000-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16687532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Apr;49(4):470-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11310624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2001 Jul;124(Pt 7):1396-402</Citation><ArticleIdList><ArticleId IdType="pubmed">11408334</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):390-3</Citation><ArticleIdList><ArticleId IdType="pubmed">11181865</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Jan 17;346(3):158-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11796849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1993 May;33(5):480-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8498825</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1998 May;50(5):1282-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9595975</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2010 Jul;133(Pt 7):1900-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20423930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1998 Mar;43(3):332-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9506550</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 May 03;5(5):e10431</Citation><ArticleIdList><ArticleId IdType="pubmed">20454659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2002 Jan;15(1):1-25</Citation><ArticleIdList><ArticleId IdType="pubmed">11747097</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2010 May 4;74(18):1463-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20439849</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology. 2012 Jul;264(1):225-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22723563</ArticleId></ArticleIdList></Reference><Reference><Citation>J Magn Reson Imaging. 2006 May;23(5):605-18</Citation><ArticleIdList><ArticleId IdType="pubmed">16596564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2005 Dec;58(6):840-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16283615</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1995 Sep;45(9):1684-90</Citation><ArticleIdList><ArticleId IdType="pubmed">7675227</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1998 Jan 29;338(5):278-85</Citation><ArticleIdList><ArticleId IdType="pubmed">9445407</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1983 Nov;33(11):1444-52</Citation><ArticleIdList><ArticleId IdType="pubmed">6685237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2010 Jul;133(Pt 7):1914-29</Citation><ArticleIdList><ArticleId IdType="pubmed">20534650</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 1997 Dec;120 ( Pt 12):2149-57</Citation><ArticleIdList><ArticleId IdType="pubmed">9448570</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Radiol. 2002 May;9 Suppl 1:S156-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12019856</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 1999 Oct;9(4):651-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10517504</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2010 Sep;225(1):2-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19840788</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2006 Jun;111(6):539-47</Citation><ArticleIdList><ArticleId IdType="pubmed">16718350</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2008 Mar;131(Pt 3):800-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18245785</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2003 Apr;126(Pt 4):770-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12615637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2005 Jun;4(6):341-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15907738</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1996 Dec;47(6):1469-76</Citation><ArticleIdList><ArticleId IdType="pubmed">8960729</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2001 Sep;2(9):762-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11526378</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1994 Apr;44(4):635-41</Citation><ArticleIdList><ArticleId IdType="pubmed">8164816</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2000 Jun;123 ( Pt 6):1174-83</Citation><ArticleIdList><ArticleId IdType="pubmed">10825356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24462878</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2014</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8646</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Genomics</Title><ISOAbbreviation>Genomics</ISOAbbreviation></Journal><ArticleTitle>Temporal profiling of cytokine-induced genes in pancreatic ..-cells by meta-analysis and network inference.</ArticleTitle><Pagination><MedlinePgn>264-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygeno.2013.12.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0888-7543(14)00006-8</ELocationID><Abstract><AbstractText>Type 1 Diabetes (T1D) is an autoimmune disease where local release of cytokines such as IL-1.. and IFN-.. contributes to ..-cell apoptosis. To identify relevant genes regulating this process we performed a meta-analysis of 8 datasets of ..-cell gene expression after exposure to IL-1.. and IFN-... Two of these datasets are novel and contain time-series expressions in human islet cells and rat INS-1E cells. Genes were ranked according to their differential expression within and after 24 h from exposure, and characterized by function and prior knowledge in the literature. A regulatory network was then inferred from the human time expression datasets, using a time-series extension of a network inference method. The two most differentially expressed genes previously unknown in T1D literature (RIPK2 and ELF3) were found to modulate cytokine-induced apoptosis. The inferred regulatory network is thus supported by the experimental validation, providing a proof-of-concept for the proposed statistical inference approach.</AbstractText><CopyrightInformation>Copyright .. 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Machine Learning Group, Computer Science Department, Universit.. Libre de Bruxelles, Brussels, Belgium; Interuniversity Institute of Bioinformatics in Brussels (IB)(2), Brussels, Belgium. Electronic address: mlopes@ulb.ac.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutlu</LastName><ForeName>Burak</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, USA. Electronic address: burak.kutlu@systemsbiology.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miani</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine, Faculty of Medicine, Universit.. Libre de Bruxelles, Brussels, Belgium. Electronic address: mmiani@ulb.ac.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang-Berthelsen</LastName><ForeName>Claus H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Diagnostic Unit and Center for Non-Coding RNA in Technology and Health, Glostrup Research Institute, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark. Electronic address: claus.heiner.bang-berthelsen@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St..rling</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Diagnostic Unit and Center for Non-Coding RNA in Technology and Health, Glostrup Research Institute, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark. Electronic address: joachim.stoerling@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pociot</LastName><ForeName>Flemming</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Diagnostic Unit and Center for Non-Coding RNA in Technology and Health, Glostrup Research Institute, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark. Electronic address: flemming.pociot@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, USA. Electronic address: natg@shore.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hood</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, USA. Electronic address: lhood@systemsbiology.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welsh</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. Electronic address: Nils.Welsh@medcellbiol.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bontempi</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Machine Learning Group, Computer Science Department, Universit.. Libre de Bruxelles, Brussels, Belgium; Interuniversity Institute of Bioinformatics in Brussels (IB)(2), Brussels, Belgium. Electronic address: gbonte@ulb.ac.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eizirik</LastName><ForeName>Decio L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine, Faculty of Medicine, Universit.. Libre de Bruxelles, Brussels, Belgium. Electronic address: deizirik@ulb.ac.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GEO</DataBankName><AccessionNumberList><AccessionNumber>GSE53453</AccessionNumber><AccessionNumber>GSE53454</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genomics</MedlineTA><NlmUniqueID>8800135</NlmUniqueID><ISSNLinking>0888-7543</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105529">ELF3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050783">Proto-Oncogene Proteins c-ets</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C506253">RIPK2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D053475">Receptor-Interacting Protein Serine-Threonine Kinase 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="Y">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050417" MajorTopicYN="N">Insulin-Secreting Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007515" MajorTopicYN="N">Islets of Langerhans</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050783" MajorTopicYN="N">Proto-Oncogene Proteins c-ets</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053475" MajorTopicYN="N">Receptor-Interacting Protein Serine-Threonine Kinase 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Gene expression</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Network inference</Keyword><Keyword MajorTopicYN="N">Pancreatic beta cells</Keyword><Keyword MajorTopicYN="N">Time series</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24462878</ArticleId><ArticleId IdType="pii">S0888-7543(14)00006-8</ArticleId><ArticleId IdType="doi">10.1016/j.ygeno.2013.12.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24290921</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Support vector machine algorithms in the search of KIR gene associations with disease.</ArticleTitle><Pagination><MedlinePgn>2053-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2013.09.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(13)00278-3</ELocationID><Abstract><AbstractText>Killer-cell immunoglobulin-like receptors (KIR) are membrane proteins expressed by natural killer cells and CD8 lymphocytes. The KIR system consists of 17 genes and 614 alleles, some of which bind human leukocyte antigens (HLA). Both KIR and HLA modulate susceptibility to haematological malignancies, viral infections and autoimmune diseases. Molecular epidemiology studies employ traditional statistical methods to identify links between KIR genes and disease. Here we describe our results at applying artificial intelligence algorithms (support vector machines) to identify associations between KIR genes and disease. We demonstrate that these algorithms are capable of classifying samples into healthy and diseased groups based solely on KIR genotype with potential use in clinical decision support systems. </AbstractText><CopyrightInformation>.. 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cuevas Tello</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier..a, Universidad Aut..noma de San Luis Potos... Av. Dr. Manuel Nava No. 8, Zona Universitaria, ZC 78290, San Luis Potos.., M..xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern..ndez-Ram..rez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Garc..a-Sep..lveda</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054340">Receptors, KIR</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054340" MajorTopicYN="N">Receptors, KIR</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017421" MajorTopicYN="N">Sequence Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Computational biology</Keyword><Keyword MajorTopicYN="N">Immunogenetics</Keyword><Keyword MajorTopicYN="N">KIR</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>05</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24290921</ArticleId><ArticleId IdType="pii">S0010-4825(13)00278-3</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2013.09.027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24155869</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Learning to recognize phenotype candidates in the auto-immune literature using SVM re-ranking.</ArticleTitle><Pagination><MedlinePgn>e72965</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0072965</ELocationID><Abstract><AbstractText>The identification of phenotype descriptions in the scientific literature, case reports and patient records is a rewarding task for bio-medical text mining. Any progress will support knowledge discovery and linkage to other resources. However because of their wide variation a number of challenges still remain in terms of their identification and semantic normalisation before they can be fully exploited for research purposes. This paper presents novel techniques for identifying potential complex phenotype mentions by exploiting a hybrid model based on machine learning, rules and dictionary matching. A systematic study is made of how to combine sequence labels from these modules as well as the merits of various ontological resources. We evaluated our approach on a subset of Medline abstracts cited by the Online Mendelian Inheritance of Man database related to auto-immune diseases. Using partial matching the best micro-averaged F-score for phenotypes and five other entity classes was 79.9%. A best performance of 75.3% was achieved for phenotype candidates using all semantics resources. We observed the advantage of using SVM-based learn-to-rank for sequence label combination over maximum entropy and a priority list approach. The results indicate that the identification of simple entity types such as chemicals and genes are robustly supported by single semantic resources, whereas phenotypes require combinations. Altogether we conclude that our approach coped well with the compositional structure of phenotypes in the auto-immune domain. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Collier</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge, United Kingdom ; National Institute of Informatics, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Mai-vu</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Hoang-quynh</ForeName><Initials>HQ</Initials></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Quang-Thuy</ForeName><Initials>QT</Initials></Author><Author ValidYN="Y"><LastName>Oellrich</LastName><ForeName>Anika</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rebholz-Schuhmann</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019277" MajorTopicYN="N">Entropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24155869</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0072965</ArticleId><ArticleId IdType="pii">PONE-D-13-06426</ArticleId><ArticleId IdType="pmc">PMC3796529</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Med Inform Decis Mak. 2012 May 07;12:36</Citation><ArticleIdList><ArticleId IdType="pubmed">22564405</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2004;:238-49</Citation><ArticleIdList><ArticleId IdType="pubmed">14992507</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2009;2009:bap019</Citation><ArticleIdList><ArticleId IdType="pubmed">20157492</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2008;:652-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18229723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2000 May;25(1):25-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D507-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21030441</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Sep-Oct;17(5):514-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20819854</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2013 May 09;2013:bat025</Citation><ArticleIdList><ArticleId IdType="pubmed">23660285</ArticleId></ArticleIdList></Reference><Reference><Citation>Summit Transl Bioinform. 2009 Mar 01;2009:116-20</Citation><ArticleIdList><ArticleId IdType="pubmed">21347182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003;19 Suppl 1:i180-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12855455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2004;:178-89</Citation><ArticleIdList><ArticleId IdType="pubmed">14992502</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Nov;83(5):610-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18950739</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Apr;80(4):588-604</Citation><ArticleIdList><ArticleId IdType="pubmed">17357067</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2012 Oct 15;13:265</Citation><ArticleIdList><ArticleId IdType="pubmed">23061930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 1998;:707-18</Citation><ArticleIdList><ArticleId IdType="pubmed">9697224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jul 15;21(14):3191-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15860559</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013 Feb 15;14:54</Citation><ArticleIdList><ArticleId IdType="pubmed">23413997</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2005;6 Suppl 1:S14</Citation><ArticleIdList><ArticleId IdType="pubmed">15960826</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2004;107(Pt 2):758-62</Citation><ArticleIdList><ArticleId IdType="pubmed">15360914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 May;34(1):15-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12721547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2000 Dec 23;259(1-2):245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11163982</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2011 Sep-Oct;18(5):557-62</Citation><ArticleIdList><ArticleId IdType="pubmed">21565856</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2008;9 Suppl 2:S2</Citation><ArticleIdList><ArticleId IdType="pubmed">18834493</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2012 Aug 17;13:207</Citation><ArticleIdList><ArticleId IdType="pubmed">22901054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Dec 15;26(24):3112-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20971987</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Ecol Evol. 2007 Jul;22(7):345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17416439</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2003;:451-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12603049</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bioinform Comput Biol. 2010 Feb;8(1):163-79</Citation><ArticleIdList><ArticleId IdType="pubmed">20183881</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2005;6 Suppl 1:S3</Citation><ArticleIdList><ArticleId IdType="pubmed">15960837</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Genet. 2010 Jun;77(6):525-34</Citation><ArticleIdList><ArticleId IdType="pubmed">20412080</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Feb 11;11:85</Citation><ArticleIdList><ArticleId IdType="pubmed">20149233</ArticleId></ArticleIdList></Reference><Reference><Citation>Database (Oxford). 2012 Apr 18;2012:bas020</Citation><ArticleIdList><ArticleId IdType="pubmed">22513129</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2012;2012:1191-200</Citation><ArticleIdList><ArticleId IdType="pubmed">23304396</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2003 Dec;36(6):478-500</Citation><ArticleIdList><ArticleId IdType="pubmed">14759820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Jul 1;28(13):1783-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22539675</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Oct;39(18):e119</Citation><ArticleIdList><ArticleId IdType="pubmed">21737429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley Interdiscip Rev Syst Biol Med. 2009 Nov-Dec;1(3):390-399</Citation><ArticleIdList><ArticleId IdType="pubmed">20052305</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Jul 28;10:233</Citation><ArticleIdList><ArticleId IdType="pubmed">19635172</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2005;6(1):R7</Citation><ArticleIdList><ArticleId IdType="pubmed">15642099</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Semantics. 2011 Oct 06;2 Suppl 5:S11</Citation><ArticleIdList><ArticleId IdType="pubmed">22166494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24039568</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>From cellular characteristics to disease diagnosis: uncovering phenotypes with supercells.</ArticleTitle><Pagination><MedlinePgn>e1003215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1003215</ELocationID><Abstract><AbstractText>Cell heterogeneity and the inherent complexity due to the interplay of multiple molecular processes within the cell pose difficult challenges for current single-cell biology. We introduce an approach that identifies a disease phenotype from multiparameter single-cell measurements, which is based on the concept of "supercell statistics", a single-cell-based averaging procedure followed by a machine learning classification scheme. We are able to assess the optimal tradeoff between the number of single cells averaged and the number of measurements needed to capture phenotypic differences between healthy and diseased patients, as well as between different diseases that are difficult to diagnose otherwise. We apply our approach to two kinds of single-cell datasets, addressing the diagnosis of a premature aging disorder using images of cell nuclei, as well as the phenotypes of two non-infectious uveitides (the ocular manifestations of Beh..et's disease and sarcoidosis) based on multicolor flow cytometry. In the former case, one nuclear shape measurement taken over a group of 30 cells is sufficient to classify samples as healthy or diseased, in agreement with usual laboratory practice. In the latter, our method is able to identify a minimal set of 5 markers that accurately predict Beh..et's disease and sarcoidosis. This is the first time that a quantitative phenotypic distinction between these two diseases has been achieved. To obtain this clear phenotypic signature, about one hundred CD8(+) T cells need to be measured. Although the molecular markers identified have been reported to be important players in autoimmune disorders, this is the first report pointing out that CD8(+) T cells can be used to distinguish two systemic inflammatory diseases. Beyond these specific cases, the approach proposed here is applicable to datasets generated by other kinds of state-of-the-art and forthcoming single-cell technologies, such as multidimensional mass cytometry, single-cell gene expression, and single-cell full genome sequencing techniques. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Candia</LastName><ForeName>Juli..n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Maryland, College Park, Maryland, United States of America ; School of Medicine, University of Maryland, Baltimore, Maryland, United States of America ; IFLYSIB and CONICET, University of La Plata, La Plata, Argentina.candia@umd.edu          .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maunu</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driscoll</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biancotto</LastName><ForeName>Ang..lique</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health, Bethesda, Maryland, United States of America, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagur</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCoy</LastName><ForeName>J Philip</ForeName><Initials>JP</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Center for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health, Bethesda, Maryland, United States of America,; Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>H Nida</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Lai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maritan</LastName><ForeName>Amos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dipartimento di Fisica ...G. Galilei,... Universit.. di Padova, Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia and Istituto Nazionale di Fisica Nucleare, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Kan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nussenblatt</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banavar</LastName><ForeName>Jayanth R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losert</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Maryland, College Park, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM085574</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00AG029761</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA134274</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01GM085574</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 AG029761</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA154274</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5T32CA154274-03</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003933" MajorTopicYN="Y">Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24039568</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1003215</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-13-00964</ArticleId><ArticleId IdType="pmc">PMC3763994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Clin Pathol. 2012 Jan;137(1):75-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22180480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Jun 29;3(89):89ra58</Citation><ArticleIdList><ArticleId IdType="pubmed">21715679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry A. 2012 Dec;81(12):1022-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23044634</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12879-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16129833</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry B Clin Cytom. 2010;78 Suppl 1:S69-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20839340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Theor Biol. 2008 Feb 7;250(3):547-59</Citation><ArticleIdList><ArticleId IdType="pubmed">18045620</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8409-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10890920</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Jun 1;182(11):7317-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19454729</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2011 Dec;37(4):319-27</Citation><ArticleIdList><ArticleId IdType="pubmed">21959269</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(5):e37038</Citation><ArticleIdList><ArticleId IdType="pubmed">22662133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2009 May;6(5):377-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19349980</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Cell Biol. 2012 Nov;14(11):1139-47</Citation><ArticleIdList><ArticleId IdType="pubmed">23103910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Apr 1;28(7):1009-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22383736</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Apr 09;10:106</Citation><ArticleIdList><ArticleId IdType="pubmed">19358741</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging (Albany NY). 2012 Feb;4(2):119-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22354768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2012 Aug 1;28(15):2052-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22595209</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2010 May 14;141(4):559-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20478246</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4949-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17360355</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dermatol Res. 2012 Oct;304(8):639-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22310732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2011 Dec;134(Pt 12):3560-77</Citation><ArticleIdList><ArticleId IdType="pubmed">22058139</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2005 Apr 22;308(5721):523-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15845847</ArticleId></ArticleIdList></Reference><Reference><Citation>Phys Rev Lett. 2011 Jun 10;106(23):238106</Citation><ArticleIdList><ArticleId IdType="pubmed">21770549</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 May 6;332(6030):677-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21551055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2013 Mar;10(3):228-38</Citation><ArticleIdList><ArticleId IdType="pubmed">23396282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Cell. 2012 May 15;22(5):1079-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22542839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 May 22;453(7194):544-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18497826</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20667-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23188796</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 May 6;332(6030):687-96</Citation><ArticleIdList><ArticleId IdType="pubmed">21551058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Immunol. 2013 May;33(4):767-74</Citation><ArticleIdList><ArticleId IdType="pubmed">23435610</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):610-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20080726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2006 Dec;7(12):940-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17139325</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23976944</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records.</ArticleTitle><Pagination><MedlinePgn>e69932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0069932</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to mine the data in the Electronic Medical Record to automatically discover patients' Rheumatoid Arthritis disease activity at discrete rheumatology clinic visits. We cast the problem as a document classification task where the feature space includes concepts from the clinical narrative and lab values as stored in the Electronic Medical Record.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The Training Set consisted of 2792 clinical notes and associated lab values. Test Set 1 included 1749 clinical notes and associated lab values. Test Set 2 included 344 clinical notes for which there were no associated lab values. The Apache clinical Text Analysis and Knowledge Extraction System was used to analyze the text and transform it into informative features to be combined with relevant lab values.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Experiments over a range of machine learning algorithms and features were conducted. The best performing combination was linear kernel Support Vector Machines with Unified Medical Language System Concept Unique Identifier features with feature selection and lab values. The Area Under the Receiver Operating Characteristic Curve (AUC) is 0.831 (.....=...0.0317), statistically significant as compared to two baselines (AUC...=...0.758, .....=...0.0291). Algorithms demonstrated superior performance on cases clinically defined as extreme categories of disease activity (Remission and High) compared to those defined as intermediate categories (Moderate and Low) and included laboratory data on inflammatory markers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Automatic Rheumatoid Arthritis disease activity discovery from Electronic Medical Record data is a learnable task approximating human performance. As a result, this approach might have several research applications, such as the identification of patients for genome-wide pharmacogenetic studies that require large sample sizes with precise definitions of disease activity and response to therapies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Informatics Program, Boston Children's Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlson</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials></Author><Author ValidYN="Y"><LastName>Canhao</LastName><ForeName>Helena</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Dligach</LastName><ForeName>Dmitriy</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pei Jun</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Raul Natanael Guzman</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yuanyan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Weinblatt</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Shadick</LastName><ForeName>Nancy A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Plenge</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Savova</LastName><ForeName>Guergana K</ForeName><Initials>GK</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K240524030</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60477820</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GM092691</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54LM008748</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R0149880</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 LM008748</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01GM092691-01</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>06</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23976944</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0069932</ArticleId><ArticleId IdType="pii">PONE-D-13-09335</ArticleId><ArticleId IdType="pmc">PMC3745469</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Rheumatol. 1993 Mar;20(3):579-81</Citation><ArticleIdList><ArticleId IdType="pubmed">8478878</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc AMIA Symp. 1999;:67-71</Citation><ArticleIdList><ArticleId IdType="pubmed">10566322</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2012 May;64(5):625-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22473917</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Methods. 2012 Sep;17(3):399-417</Citation><ArticleIdList><ArticleId IdType="pubmed">22563845</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1996 Jan;39(1):34-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8546736</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2012 Oct;45(5):992-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22580178</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Apr 15;61(4):495-500</Citation><ArticleIdList><ArticleId IdType="pubmed">19333984</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1995 Jan;38(1):38-43</Citation><ArticleIdList><ArticleId IdType="pubmed">7818569</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Jun;19(e1):e162-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Biologics. 2012;6:429-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23269860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2007 Oct 1;23(19):2507-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17720704</ArticleId></ArticleIdList></Reference><Reference><Citation>J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18</Citation><ArticleIdList><ArticleId IdType="pubmed">22656072</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc AMIA Symp. 2001;:17-21</Citation><ArticleIdList><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2006 Dec;39(6):589-99</Citation><ArticleIdList><ArticleId IdType="pubmed">16359928</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2012 Sep-Oct;19(5):817-23</Citation><ArticleIdList><ArticleId IdType="pubmed">22539080</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2009 Jul-Aug;16(4):561-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19390096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2012 Feb;71(2):225-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21960560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1990 Nov;49(11):916-20</Citation><ArticleIdList><ArticleId IdType="pubmed">2256738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2011 Jan;50(1):40-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20847201</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Sep-Oct;17(5):507-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2008 Sep;9(5):392-403</Citation><ArticleIdList><ArticleId IdType="pubmed">18562478</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2009 Oct;42(5):760-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19683066</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2011 Dec 16;334(6062):1518-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22174245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2000 Nov-Dec;7(6):593-604</Citation><ArticleIdList><ArticleId IdType="pubmed">11062233</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2005 May-Jun;12(3):296-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1995 May 1;122(9):681-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7702231</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1988 Sep;44(3):837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint Bone Spine. 2013 Jul;80(4):386-92</Citation><ArticleIdList><ArticleId IdType="pubmed">23141718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23940698</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A novel support vector machine-based approach for rare variant detection.</ArticleTitle><Pagination><MedlinePgn>e71114</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0071114</ELocationID><Abstract><AbstractText>Advances in next-generation sequencing technologies have enabled the identification of multiple rare single nucleotide polymorphisms involved in diseases or traits. Several strategies for identifying rare variants that contribute to disease susceptibility have recently been proposed. An important feature of many of these statistical methods is the pooling or collapsing of multiple rare single nucleotide variants to achieve a reasonably high frequency and effect. However, if the pooled rare variants are associated with the trait in different directions, then the pooling may weaken the signal, thereby reducing its statistical power. In the present paper, we propose a backward support vector machine (BSVM)-based variant selection procedure to identify informative disease-associated rare variants. In the selection procedure, the rare variants are weighted and collapsed according to their positive or negative associations with the disease, which may be associated with common variants and rare variants with protective, deleterious, or neutral effects. This nonparametric variant selection procedure is able to account for confounding factors and can also be adopted in other regression frameworks. The results of a simulation study and a data example show that the proposed BSVM approach is more powerful than four other approaches under the considered scenarios, while maintaining valid type I errors. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yao-Hwei</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yen-Feng</ForeName><Initials>YF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23940698</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0071114</ArticleId><ArticleId IdType="pii">PONE-D-13-14949</ArticleId><ArticleId IdType="pmc">PMC3737136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Hum Genet. 2008 Sep;83(3):311-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18691683</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Jun 11;86(6):832-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20471002</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Nov 12;87(5):604-17</Citation><ArticleIdList><ArticleId IdType="pubmed">21070896</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1998 Jan;88(1):15-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9584027</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Feb 03;7(2):e1001289</Citation><ArticleIdList><ArticleId IdType="pubmed">21304886</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Feb;5(2):e1000384</Citation><ArticleIdList><ArticleId IdType="pubmed">19214210</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2011 Sep 9;89(3):354-67</Citation><ArticleIdList><ArticleId IdType="pubmed">21885029</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2011 Nov 29;5 Suppl 9:S61</Citation><ArticleIdList><ArticleId IdType="pubmed">22373337</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2005 Jan;85(1):16-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15607418</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2010 Feb;34(2):188-93</Citation><ArticleIdList><ArticleId IdType="pubmed">19810025</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2012 Feb;36(2):88-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22851472</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Mar;7(3):e1001322</Citation><ArticleIdList><ArticleId IdType="pubmed">21408211</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009 Oct 22;4(10):e7522</Citation><ArticleIdList><ArticleId IdType="pubmed">19847297</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Pharmacol. 2010 Jun 07;10:6</Citation><ArticleIdList><ArticleId IdType="pubmed">20529254</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1976 Sep;32(3):683-8</Citation><ArticleIdList><ArticleId IdType="pubmed">822892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Hered. 2010;70(1):42-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20413981</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2011 Jul 15;89(1):82-93</Citation><ArticleIdList><ArticleId IdType="pubmed">21737059</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2008 Feb;32(2):152-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17968988</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Apr 17;324(5925):387-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19264985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Oct 1;26(19):2375-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20693321</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23918589</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-0131</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Arthritis and rheumatism</Title><ISOAbbreviation>Arthritis Rheum</ISOAbbreviation></Journal><ArticleTitle>A genome-wide association study reveals ARL15, a novel non-HLA susceptibility gene for rheumatoid arthritis in North Indians.</ArticleTitle><Pagination><MedlinePgn>3026-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.38110</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Genome-wide association studies (GWAS) and their subsequent meta-analyses have changed the landscape of genetics in rheumatoid arthritis (RA) by uncovering several novel genes. Such studies are heavily weighted by samples from Caucasian populations, but they explain only a small proportion of total heritability. Our previous studies in genetically distinct North Indian RA cohorts have demonstrated apparent allelic/genetic heterogeneity between North Indian and Western populations, warranting GWAS in non-European populations. We undertook this study to detect additional disease-associated loci that may be collectively important in the presence or absence of genes with a major effect.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">High-quality genotypes for &gt;600,000 single-nucleotide polymorphisms (SNPs) in 706 RA patients and 761 controls from North India were generated in the discovery stage. Twelve SNPs showing suggestive association (P &lt; 5 .. 10(-5)) were then tested in an independent cohort of 927 RA patients and 1,148 controls. Additional disease-associated loci were determined using support vector machine (SVM) analyses. Fine-mapping of novel loci was performed by using imputation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In addition to the expected association of the HLA locus with RA, we identified association with a novel intronic SNP of ARL15 (rs255758) on chromosome 5 (Pcombined = 6.57 .. 10(-6); odds ratio 1.42). Genotype-phenotype correlation by assaying adiponectin levels demonstrated the functional significance of this novel gene in disease pathogenesis. SVM analysis confirmed this association along with that of a few more replication stage genes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this first GWAS of RA among North Indians, ARL15 emerged as a novel genetic risk factor in addition to the classic HLA locus, which suggests that population-specific genetic loci as well as those shared between Asian and European populations contribute to RA etiology. Furthermore, our study reveals the potential of machine learning methods in unraveling gene-gene interactions using GWAS data.</AbstractText><CopyrightInformation>Copyright .. 2013 by the American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Negi</LastName><ForeName>Sapna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juyal</LastName><ForeName>Garima</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Senapati</LastName><ForeName>Sabyasachi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Pushplata</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Aditi</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Shalini</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Sujit</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Ashok</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Uma</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rajiva</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Satbir</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Suraksha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Amita</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Jurg</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Juyal</LastName><ForeName>Ramesh C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Thelma</LastName><ForeName>B K</ForeName><Initials>BK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheum</MedlineTA><NlmUniqueID>0370605</NlmUniqueID><ISSNLinking>0004-3591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020727">ADP-Ribosylation Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="C585870">ARL15 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arthritis Rheum. 2013 Dec;65(12):3014-6</RefSource><PMID Version="1">23918636</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D020727" MajorTopicYN="N">ADP-Ribosylation Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asians</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="N">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">Whites</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23918589</ArticleId><ArticleId IdType="doi">10.1002/art.38110</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23911168</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-2968</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of diabetes science and technology</Title><ISOAbbreviation>J Diabetes Sci Technol</ISOAbbreviation></Journal><ArticleTitle>A consensus perceived glycemic variability metric.</ArticleTitle><Pagination><MedlinePgn>871-9</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Glycemic variability (GV) is an important component of overall glycemic control for patients with diabetes mellitus. Physicians are able to recognize excessive GV from continuous glucose monitoring (CGM) plots; however, there is currently no universally agreed upon GV metric. The objective of this study was to develop a consensus perceived glycemic variability (CPGV) metric that could be routinely applied to CGM data to assess diabetes mellitus control.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twelve physicians actively managing patients with type 1 diabetes mellitus rated a total of 250 24 h CGM plots as exhibiting low, borderline, high, or extremely high GV. Ratings were averaged to obtain a consensus and then input into two machine learning algorithms: multilayer perceptrons (MPs) and support vector machines for regression (SVR). In silica experiments were run using each algorithm with different combinations of 12 descriptive input features. Ten-fold cross validation was used to evaluate the performance of each model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The SVR models approximated the physician consensus ratings of unseen CGM plots better than the MP models. When judged by the root mean square error, the best SVR model performed comparably to individual physicians at matching consensus ratings. When applied to 262 different CGM plots as a screen for excessive GV, this model had accuracy, sensitivity, and specificity of 90.1%, 97.0%, and 74.1%, respectively. It significantly outperformed mean amplitude of glycemic excursion, standard deviation, distance traveled, and excursion frequency.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This new CPGV metric could be used as a routine measure of overall glucose control to supplement glycosylated hemoglobin in clinical practice.</AbstractText><CopyrightInformation>.. 2013 Diabetes Technology Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marling</LastName><ForeName>Cynthia R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>School of Electrical Engineering and Computer Science, Russ College of Engineering and Technology, Ohio University, Athens, OH 45701, USA. marling@ohio.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struble</LastName><ForeName>Nigel W</ForeName><Initials>NW</Initials></Author><Author ValidYN="Y"><LastName>Bunescu</LastName><ForeName>Razvan C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Shubrook</LastName><ForeName>Jay H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Sci Technol</MedlineTA><NlmUniqueID>101306166</NlmUniqueID><ISSNLinking>1932-2968</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="Y">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054928" MajorTopicYN="N">Validation Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014894" MajorTopicYN="N">Weights and Measures</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23911168</ArticleId><ArticleId IdType="doi">10.1177/193229681300700409</ArticleId><ArticleId IdType="pmc">PMC3879751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Diabetes Sci Technol. 2013 Mar 01;7(2):562-78</Citation><ArticleIdList><ArticleId IdType="pubmed">23567014</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Feb;35(2):409-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22179956</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 1970 Sep;19(9):644-55</Citation><ArticleIdList><ArticleId IdType="pubmed">5469118</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1814-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22923682</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Mar 01;4(2):404-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20307402</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):712-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22768904</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2008 Jul;2(4):603-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19885236</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S55-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19469679</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2012 Nov;14(11):1008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23101951</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21561372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2010 Nov 01;4(6):1563-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21129354</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 Mar;38(3):838-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20035218</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2008 Oct;10(5):385-90</Citation><ArticleIdList><ArticleId IdType="pubmed">18715215</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Sep;35(9):1897-901</Citation><ArticleIdList><ArticleId IdType="pubmed">22699297</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Oct 7;363(15):1410-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20925543</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2009 Nov;11(11):717-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19905888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2011 Jul 01;5(4):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21880228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 Jan 01;6(1):218-9; author reply 220-1</Citation><ArticleIdList><ArticleId IdType="pubmed">22401342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23883406</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>A novel adaptive-weighted-average framework for blood glucose prediction.</ArticleTitle><Pagination><MedlinePgn>792-801</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2013.0104</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Blood glucose (BG) prediction plays a very important role in daily BG management of patients with diabetes mellitus. Several algorithms, such as autoregressive (AR) models and artificial neural networks, have been proposed for BG prediction. However, every algorithm has its own subject range (i.e., one algorithm might work well for one diabetes patient but poorly for another patient). Even for one individual patient, this algorithm might perform well during the preprandial period but poorly during the postprandial period.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A novel framework was proposed to combine several BG prediction algorithms. The main idea of the novel framework is that an adaptive weight is given to each algorithm where one algorithm's weight is inversely proportional to the sum of the squared prediction errors. In general, this framework can be applied to combine any BG prediction algorithms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">As an example, the proposed framework was used to combine an AR model, extreme learning machine, and support vector regression. The new algorithm was compared with these three prediction algorithms on the continuous glucose monitoring system (CGMS) readings of 10 type 1 diabetes mellitus patients; the CGMS readings of each patient included 860 CGMS data points. For each patient, the algorithms were evaluated in terms of root-mean-square error, relative error, Clarke error-grid analysis, and J index. Of the 40 evaluations, the new adaptive-weighted algorithm achieved the best prediction performance in 37 (92.5%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Thus, we conclude that the adaptive-weighted-average framework proposed in this study can give satisfactory predictions and should be used in BG prediction. The new algorithm has great robustness with respect to variations in data characteristics, patients, and prediction horizons. At the same time, it is universal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Youqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Information Science and Technology, Beijing University of Chemical Technology , Beijing, China .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiangwei</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Xue</ForeName><Initials>X</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517652">hemoglobin A1c protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="Y">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019518" MajorTopicYN="N">Postprandial Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23883406</ArticleId><ArticleId IdType="doi">10.1089/dia.2013.0104</ArticleId><ArticleId IdType="pmc">PMC3781119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>IEEE Rev Biomed Eng. 2009 Jan 1;2:54-96</Citation><ArticleIdList><ArticleId IdType="pubmed">20936056</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:2964-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18002617</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2004 Aug;27(8):1922-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15277418</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Neural Netw. 2006 Nov;17(6):1411-23</Citation><ArticleIdList><ArticleId IdType="pubmed">17131657</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 Jun;33(6):1249-54</Citation><ArticleIdList><ArticleId IdType="pubmed">20508231</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2003 Dec;7(4):419-25</Citation><ArticleIdList><ArticleId IdType="pubmed">15000368</ArticleId></ArticleIdList></Reference><Reference><Citation>J Diabetes Sci Technol. 2012 May 01;6(3):617-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22768893</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2004 Apr;6(2):105-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15117576</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:6001-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17946733</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2010 Jan;14(1):157-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19858035</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2009 Feb;56(2):246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19272928</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:291-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19162650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Biomed Eng. 2012 Apr;40(4):934-45</Citation><ArticleIdList><ArticleId IdType="pubmed">22012087</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:7945-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22256183</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Feb;13(2):111-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21284477</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Syst Man Cybern B Cybern. 2012 Apr;42(2):513-29</Citation><ArticleIdList><ArticleId IdType="pubmed">21984515</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2008 Aug;10(4):310-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18828243</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2010 Aug;57(8):1839-46</Citation><ArticleIdList><ArticleId IdType="pubmed">20403780</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Biomed Eng. 2007 May;54(5):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2010 May;33(5):1013-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20200307</ArticleId></ArticleIdList></Reference><Reference><Citation>Conf Proc IEEE Eng Med Biol Soc. 2006;2006:71-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17945569</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2005 Feb;7(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">15738700</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Technol Ther. 2011 Aug;13(8):787-96</Citation><ArticleIdList><ArticleId IdType="pubmed">21612393</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23877232</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-0444</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medical &amp; biological engineering &amp; computing</Title><ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation></Journal><ArticleTitle>Centromere and cytoplasmic staining pattern recognition: a local approach.</ArticleTitle><Pagination><MedlinePgn>1305-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-013-1102-1</ELocationID><Abstract><AbstractText>Autoimmune diseases are very serious and also invalidating illnesses. The benchmark procedure for their diagnosis is the indirect immunofluorescence (IIF) assay performed on the HEp-2 substrate. Medical doctors first determine the fluorescence intensity exhibited by HEp-2 wells and then report the staining pattern. Despite its pivotal role, IIF is affected by inter- and intra-laboratory variabilities demanding for the development of computer-aided-diagnosis tools supporting medical doctor decisions. With reference to staining pattern recognition, state-of-the-art approaches recognize five main patterns characterized by well-defined cell edges. These approaches are based on cell segmentation, a task that recent work suggests to be harder than the classification itself. In this paper, we extend the panel of detectable HEp-2 staining patterns, introducing the recognition of centromere and cytoplasmic patterns, which have a high specific match with certain autoimmune diseases, from other stainings. Since image segmentation algorithms fail on these samples, we developed a classification system integrating local descriptors and the bag of visual word approach, which represents image contents without the burden of segmentation. We tested our approach on a large dataset of HEp-2 images with high variability in both fluorescence intensity and staining patterns correctly recognizing the 97.12..% of samples. The system has also been validated in a daily routine fashion on 108 consecutive IIF analyses of hospital outpatients and inpatients, achieving an accuracy rate of 97.22..%. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iannello</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Computer Science and Bioinformatics Laboratory, Integrated Research Centre, Universit.. Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128, Rome, Italy, g.iannello@unicampus.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onofri</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Soda</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Biol Eng Comput</MedlineTA><NlmUniqueID>7704869</NlmUniqueID><ISSNLinking>0140-0118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000941">Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000941" MajorTopicYN="N">Antigens</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002503" MajorTopicYN="N">Centromere</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>01</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23877232</ArticleId><ArticleId IdType="doi">10.1007/s11517-013-1102-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Artif Intell Med. 2011 Jan;51(1):67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20630721</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2009;11(3):229</Citation><ArticleIdList><ArticleId IdType="pubmed">19519924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2007 Aug;1109:358-71</Citation><ArticleIdList><ArticleId IdType="pubmed">17785325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Aug;69(8):1420-2</Citation><ArticleIdList><ArticleId IdType="pubmed">20511607</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2012 May;56(5):1181-1188</Citation><ArticleIdList><ArticleId IdType="pubmed">22245904</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Inf Technol Biomed. 2009 May;13(3):322-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19171521</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pathol Lab Med. 2000 Jan;124(1):71-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10629135</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2010;12(2):R40</Citation><ArticleIdList><ArticleId IdType="pubmed">20214808</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol Immunopathol. 1997 Sep;84(3):223-43</Citation><ArticleIdList><ArticleId IdType="pubmed">9281381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry A. 2006 Mar;69(3):182-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16496376</ArticleId></ArticleIdList></Reference><Reference><Citation>Artif Intell Med. 2002 Sep-Oct;26(1-2):161-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12234722</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:3110-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19163365</ArticleId></ArticleIdList></Reference><Reference><Citation>Biophys J. 1995 Jun;68(6):2588-600</Citation><ArticleIdList><ArticleId IdType="pubmed">7647262</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 2008 Feb;37(4):223-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17692364</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2009 Sep;9(1):17-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19245860</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytometry B Clin Cytom. 2007 Nov;72(6):472-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17549740</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2003 Sep;2(5):298-304</Citation><ArticleIdList><ArticleId IdType="pubmed">12965182</ArticleId></ArticleIdList></Reference><Reference><Citation>Neural Comput. 2003 Jul;15(7):1667-89</Citation><ArticleIdList><ArticleId IdType="pubmed">12816571</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 1998 Oct 1;219(1-2):99-107</Citation><ArticleIdList><ArticleId IdType="pubmed">9831391</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23856916</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-2281</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2013</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of biomedical optics</Title><ISOAbbreviation>J Biomed Opt</ISOAbbreviation></Journal><ArticleTitle>Computer-aided diagnosis of rheumatoid arthritis with optical tomography, Part 2: image classification.</ArticleTitle><Pagination><MedlinePgn>076002</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1117/1.JBO.18.7.076002</ELocationID><Abstract><AbstractText>This is the second part of a two-part paper on the application of computer-aided diagnosis to diffuse optical tomography (DOT) for diagnosing rheumatoid arthritis (RA). A comprehensive analysis of techniques for the classification of DOT images of proximal interphalangeal joints of subjects with and without RA is presented. A method for extracting heuristic features from DOT images was presented in Part 1. The ability of five classification algorithms to accurately label each DOT image as belonging to a subject with or without RA is analyzed here. The algorithms of interest are the k-nearest-neighbors, linear and quadratic discriminant analysis, self-organizing maps, and support vector machines (SVM). With a polynomial SVM classifier, we achieve 100.0% sensitivity and 97.8% specificity. Lower bounds for these results (at 95.0% confidence level) are 96.4% and 93.8%, respectively. Image features most predictive of RA are from the spatial variation of optical properties and the absolute range in feature values. The optimal classifiers are low-dimensional combinations (&lt;7 features). These results underscore the high potential for DOT to become a clinically useful diagnostic tool and warrant larger prospective clinical trials to conclusively demonstrate the ultimate clinical utility of this approach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Montejo</LastName><ForeName>Ludguier D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Columbia University, New York, New York 10025, USA. ldm2106@columbia.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Jingfei</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun K</ForeName><Initials>HK</Initials></Author><Author ValidYN="Y"><LastName>Netz</LastName><ForeName>Uwe J</ForeName><Initials>UJ</Initials></Author><Author ValidYN="Y"><LastName>Blaschke</LastName><ForeName>Sabine</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>M..ller</LastName><ForeName>Gerhard A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Hielscher</LastName><ForeName>Andreas H</ForeName><Initials>AH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR046255</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR059038</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5R01AR046255</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5T32AR059038 02</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Opt</MedlineTA><NlmUniqueID>9605853</NlmUniqueID><ISSNLinking>1083-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016002" MajorTopicYN="N">Discriminant Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041622" MajorTopicYN="N">Tomography, Optical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23856916</ArticleId><ArticleId IdType="pii">1713782</ArticleId><ArticleId IdType="doi">10.1117/1.JBO.18.7.076002</ArticleId><ArticleId IdType="pmc">PMC3710916</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acta Orthop Scand. 1992 Aug;63(4):417-23</Citation><ArticleIdList><ArticleId IdType="pubmed">1529693</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2010 Nov-Dec;15(6):066020</Citation><ArticleIdList><ArticleId IdType="pubmed">21198194</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Med Imaging. 2011 Oct;30(10):1725-36</Citation><ArticleIdList><ArticleId IdType="pubmed">21964730</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2010 May;22(3):299-306</Citation><ArticleIdList><ArticleId IdType="pubmed">20305562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2008 Sep-Oct;13(5):050503</Citation><ArticleIdList><ArticleId IdType="pubmed">19021375</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Tech (Berl). 1997 Nov;42(11):319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">9490122</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Rheumatol. 1991 Mar-Apr;50(2):74-81</Citation><ArticleIdList><ArticleId IdType="pubmed">1872045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Opt. 2013 Jul;18(7):076001</Citation><ArticleIdList><ArticleId IdType="pubmed">23856915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23848178</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8593</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Diabetes technology &amp; therapeutics</Title><ISOAbbreviation>Diabetes Technol Ther</ISOAbbreviation></Journal><ArticleTitle>A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions.</ArticleTitle><Pagination><MedlinePgn>634-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/dia.2012.0285</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prevention of hypoglycemic events is of paramount importance in the daily management of insulin-treated diabetes. The use of short-term prediction algorithms of the subcutaneous (s.c.) glucose concentration may contribute significantly toward this direction. The literature suggests that, although the recent glucose profile is a prominent predictor of hypoglycemia, the overall patient's context greatly impacts its accurate estimation. The objective of this study is to evaluate the performance of a support vector for regression (SVR) s.c. glucose method on hypoglycemia prediction.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We extend our SVR model to predict separately the nocturnal events during sleep and the non-nocturnal (i.e., diurnal) ones over 30-min and 60-min horizons using information on recent glucose profile, meals, insulin intake, and physical activities for a hypoglycemic threshold of 70...mg/dL. We also introduce herein additional variables accounting for recurrent nocturnal hypoglycemia due to antecedent hypoglycemia, exercise, and sleep. SVR predictions are compared with those from two other machine learning techniques.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The method is assessed on a dataset of 15 patients with type 1 diabetes under free-living conditions. Nocturnal hypoglycemic events are predicted with 94% sensitivity for both horizons and with time lags of 5.43...min and 4.57...min, respectively. As concerns the diurnal events, when physical activities are not considered, the sensitivity is 92% and 96% for a 30-min and 60-min horizon, respectively, with both time lags being less than 5...min. However, when such information is introduced, the diurnal sensitivity decreases by 8% and 3%, respectively. Both nocturnal and diurnal predictions show a high (&gt;90%) precision.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Results suggest that hypoglycemia prediction using SVR can be accurate and performs better in most diurnal and nocturnal cases compared with other techniques. It is advised that the problem of hypoglycemia prediction should be handled differently for nocturnal and diurnal periods as regards input variables and interpretation of results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>Eleni I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>Vasilios C</ForeName><Initials>VC</Initials></Author><Author ValidYN="Y"><LastName>Ardig..</LastName><ForeName>Diego</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>Demosthenes</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>Dimitrios I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes Technol Ther</MedlineTA><NlmUniqueID>100889084</NlmUniqueID><ISSNLinking>1520-9156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="Y">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040521" MajorTopicYN="N">Subcutaneous Tissue</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23848178</ArticleId><ArticleId IdType="doi">10.1089/dia.2012.0285</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">23740754</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2272</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Genetic epidemiology</Title><ISOAbbreviation>Genet Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Encore: Genetic Association Interaction Network centrality pipeline and application to SLE exome data.</ArticleTitle><Pagination><MedlinePgn>614-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/gepi.21739</ELocationID><Abstract><AbstractText>Open source tools are needed to facilitate the construction, analysis, and visualization of gene-gene interaction networks for sequencing data. To address this need, we present Encore, an open source network analysis pipeline for genome-wide association studies and rare variant data. Encore constructs Genetic Association Interaction Networks or epistasis networks using two optional approaches: our previous information-theory method or a generalized linear model approach. Additionally, Encore includes multiple data filtering options, including Random Forest/Random Jungle for main effect enrichment and Evaporative Cooling and Relief-F filters for enrichment of interaction effects. Encore implements SNPrank network centrality for identifying susceptibility hubs (nodes containing a large amount of disease susceptibility information through the combination of multivariate main effects and multiple gene-gene interactions in the network), and it provides appropriate files for interactive visualization of a network using tools from our online Galaxy instance. We implemented these algorithms in C++ using OpenMP for shared-memory parallel analysis on a server or desktop. To demonstrate Encore's utility in analysis of genetic sequencing data, we present an analysis of exome resequencing data from healthy individuals and those with Systemic Lupus Erythematous (SLE). Our results verify the importance of the previously associated SLE genes HLA-DRB and NCF2, and these two genes had the highest gene-gene interaction degrees among the susceptibility hubs. An additional 14 genes previously associated with SLE emerged in our epistasis network model of the exome data, and three novel candidate genes, ST8SIA4, CMTM4, and C2CD4B, were implicated in the model. In summary, we present a comprehensive tool for epistasis network analysis and the first such analysis of exome data from a genetic study of SLE. </AbstractText><CopyrightInformation>.. 2013 WILEY PERIODICALS, INC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Tandy School of Computer Science, University of Tulsa, Tulsa, Oklahoma 74104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lareau</LastName><ForeName>Caleb A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Bill C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Ahwan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Courtney G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Gaffney</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>McKinney</LastName><ForeName>B A</ForeName><Initials>BA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL113326</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI-80932</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC2 AR058959</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 RR020143</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI080932</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI063274</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM103456</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genet Epidemiol</MedlineTA><NlmUniqueID>8411723</NlmUniqueID><ISSNLinking>0741-0395</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059806">HLA-DR beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.3.-</RegistryNumber><NameOfSubstance UI="D019255">NADPH Oxidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.3.1</RegistryNumber><NameOfSubstance UI="C527764">NCF2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.99.-</RegistryNumber><NameOfSubstance UI="D012799">Sialyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.99.-</RegistryNumber><NameOfSubstance UI="C515117">ST8SIA4 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="Y">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="Y">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059806" MajorTopicYN="N">HLA-DR beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019255" MajorTopicYN="N">NADPH Oxidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012799" MajorTopicYN="N">Sialyltransferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Systemic Lupus Erythematous</Keyword><Keyword MajorTopicYN="N">epistasis network</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">network analysis</Keyword><Keyword MajorTopicYN="N">network centrality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>03</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23740754</ArticleId><ArticleId IdType="doi">10.1002/gepi.21739</ArticleId><ArticleId IdType="pmc">PMC3955726</ArticleId><ArticleId IdType="mid">NIHMS558444</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Transl Psychiatry. 2012 Aug 14;2:e154</Citation><ArticleIdList><ArticleId IdType="pubmed">22892719</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2004 Nov 10;342(1):85-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15527968</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Feb;62(2):553-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20112359</ArticleId></ArticleIdList></Reference><Reference><Citation>Antioxid Redox Signal. 2010 Oct;13(8):1145-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20367281</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2010 Sep;20(9):1297-303</Citation><ArticleIdList><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Mar;5(3):e1000432</Citation><ArticleIdList><ArticleId IdType="pubmed">19300503</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Nov 15;181(10):6850-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18981104</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Sep 12;12:364</Citation><ArticleIdList><ArticleId IdType="pubmed">21910885</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Oct;7(10):e1002341</Citation><ArticleIdList><ArticleId IdType="pubmed">22046141</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jun 13;30(28):4182-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22542470</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Nov 6;456(7218):18-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18987709</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2009 Aug;127(4):549-57</Citation><ArticleIdList><ArticleId IdType="pubmed">19604305</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Protoc Mol Biol. 2010 Jan;Chapter 19:Unit 19.10.1-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20069535</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Jul 15;25(14):1754-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2010 Jun;11(6):446-50</Citation><ArticleIdList><ArticleId IdType="pubmed">20479774</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2004 Dec;202:139-56</Citation><ArticleIdList><ArticleId IdType="pubmed">15546391</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2007;376:71-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17984539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Jan 15;27(2):284-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21115438</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Res. 1996 Jul 15;45(2):143-52</Citation><ArticleIdList><ArticleId IdType="pubmed">8843031</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2004;22:55-79</Citation><ArticleIdList><ArticleId IdType="pubmed">15032574</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Genet. 2012 Jan 12;2:109</Citation><ArticleIdList><ArticleId IdType="pubmed">22303403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jul 15;26(14):1752-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20505004</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation><ArticleIdList><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2010 Dec;11(8):630-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20613780</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14747-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17804789</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Rheumatol. 2010 May;39(3):254-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20429676</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">23674378</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-108X</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>8</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The International journal of eating disorders</Title><ISOAbbreviation>Int J Eat Disord</ISOAbbreviation></Journal><ArticleTitle>Detecting intentional insulin omission for weight loss in girls with type 1 diabetes mellitus.</ArticleTitle><Pagination><MedlinePgn>819-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/eat.22138</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Intentional insulin omission is a unique inappropriate compensatory behavior that occurs in patients with type 1 diabetes mellitus, mostly in females, who omit or restrict their required insulin doses in order to lose weight. Diagnosis of this underlying disorder is difficult. We aimed to use clinical and laboratory criteria to create an algorithm to assist in the detection of intentional insulin omission.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The distribution of HbA1c levels from 287 (181 females) patients with type 1 diabetes were used as reference. Data from 26 patients with type 1 diabetes and intentional insulin omission were analysed. The Weka (Waikato Environment for Knowledge Analysis) machine learning software, decision tree classifier with 10-fold cross validation was used to developed prediction models. Model performance was assessed by cross-validation in a further 43 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adolescents with intentional insulin omission were discriminated by: female sex, HbA1c&gt;9.2%, more than 20% of HbA1c measurements above the 90th percentile, the mean of 3 highest delta HbA1c z-scores&gt;1.28, current age and age at diagnosis. The models developed showed good discrimination (sensitivity and specificity 0.88 and 0.74, respectively). The external test dataset revealed good performance of the model with a sensitivity and specificity of 1.00 and 0.97, respectively.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Using data mining methods we developed a clinical prediction model to determine an individual's probability of intentionally omitting insulin. This model provides a decision support system for the detection of intentional insulin omission for weight loss in adolescent females with type 1 diabetes mellitus.</AbstractText><CopyrightInformation>Copyright .. 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinhas-Hamiel</LastName><ForeName>Orit</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Maccabi Health Care Services, Juvenile Diabetes Center, Raanana, Israel; Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamiel</LastName><ForeName>Uri</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Boyko</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Graph-Barel</LastName><ForeName>Chana</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rachmiel</LastName><ForeName>Marianna</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lerner-Geva</LastName><ForeName>Liat</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Reichman</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Eat Disord</MedlineTA><NlmUniqueID>8111226</NlmUniqueID><ISSNLinking>0276-3478</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001068" MajorTopicYN="N">Feeding and Eating Disorders</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033182" MajorTopicYN="N">Intention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="Y">Weight Loss</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hemoglobin A1c</Keyword><Keyword MajorTopicYN="N">Insulin omission</Keyword><Keyword MajorTopicYN="N">data mining</Keyword><Keyword MajorTopicYN="N">decision tree</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23674378</ArticleId><ArticleId IdType="doi">10.1002/eat.22138</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23402937</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method.</ArticleTitle><Pagination><MedlinePgn>395-404</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2013.01.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(13)00029-2</ELocationID><Abstract><AbstractText>We tested four machine learning methods, support vector machine (SVM), k-nearest neighbor, back-propagation neural network and C4.5 decision tree for their capability in predicting spleen tyrosine kinase (Syk) inhibitors by using 2592 compounds which are more diverse than those in other studies. The recursive feature elimination method was used for improving prediction performance and selecting molecular descriptors responsible for distinguishing Syk inhibitors and non-inhibitors. Among four machine learning models, SVM produces the best performance at 99.18% for inhibitors and 98.82% for non-inhibitors, respectively, indicating that the SVM is potentially useful for facilitating the discovery of Syk inhibitors.</AbstractText><CopyrightInformation>Copyright .. 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bing-Ke</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>College of Chemistry, Key Laboratory of Green Chemistry and Technology in Ministry of Education, Sichuan University, Chengdu 610064, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xue-Gang</ForeName><Initials>XG</Initials></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Zong</ForeName><Initials>YZ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C000606896">SYK protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D000072377">Syk Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072377" MajorTopicYN="N">Syk Kinase</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23402937</ArticleId><ArticleId IdType="pii">S0010-4825(13)00029-2</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2013.01.015</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23378606</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-327X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Diabetes</Title><ISOAbbreviation>Diabetes</ISOAbbreviation></Journal><ArticleTitle>Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.</ArticleTitle><Pagination><MedlinePgn>2135-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2337/db12-1398</ELocationID><Abstract><AbstractText>Evaluating risk of developing type 1 diabetes (T1D) depends on determining an individual's HLA type, especially of the HLA DRB1 and DQB1 alleles. Individuals positive for HLA-DRB1*03 (DR3) or HLA-DRB1*04 (DR4) with DQB1*03:02 (DQ8) have the highest risk of developing T1D. Currently, HLA typing methods are relatively expensive and time consuming. We sought to determine the minimum number of single nucleotide polymorphisms (SNPs) that could rapidly define the HLA-DR types relevant to T1D, namely, DR3/4, DR3/3, DR4/4, DR3/X, DR4/X, and DRX/X (where X is neither DR3 nor DR4), and could distinguish the highest-risk DR4 type (DR4-DQ8) as well as the non-T1D-associated DR4-DQB1*03:01 type. We analyzed 19,035 SNPs of 10,579 subjects (7,405 from a discovery set and 3,174 from a validation set) from the Type 1 Diabetes Genetics Consortium and developed a novel machine learning method to select as few as three SNPs that could define the HLA-DR and HLA-DQ types accurately. The overall accuracy was 99.3%, area under curve was 0.997, true-positive rates were &gt;0.99, and false-positive rates were &lt;0.001. We confirmed the reliability of these SNPs by 10-fold cross-validation. Our approach predicts HLA-DR/DQ types relevant to T1D more accurately than existing methods and is rapid and cost-effective.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Cao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Diabetes Research, The Western Australian Institute for Medical Research, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varney</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Leonard C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Morahan</LastName><ForeName>Grant</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP3 DK085678</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK062418</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1DP3DK085678-01</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diabetes</MedlineTA><NlmUniqueID>0372763</NlmUniqueID><ISSNLinking>0012-1797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006683">HLA-DQ Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006683" MajorTopicYN="N">HLA-DQ Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23378606</ArticleId><ArticleId IdType="pii">db12-1398</ArticleId><ArticleId IdType="doi">10.2337/db12-1398</ArticleId><ArticleId IdType="pmc">PMC3661605</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Genet. 2012 Jan;8(1):e1002476</Citation><ArticleIdList><ArticleId IdType="pubmed">22291608</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rev. 2011 Jan;91(1):79-118</Citation><ArticleIdList><ArticleId IdType="pubmed">21248163</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2003 Sep;73(3):580-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12920676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 Apr 1;27(7):968-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21300701</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2011 Mar;60(3):1030-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21266329</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Trials. 2010;7(1 Suppl):S75-87</Citation><ArticleIdList><ArticleId IdType="pubmed">20595243</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22732486</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2002 Jan;30(1):97-101</Citation><ArticleIdList><ArticleId IdType="pubmed">11731797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Jul 21;358(9277):221-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11476858</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2009 Dec;10 Suppl 1:S1-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19956093</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14074-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16966600</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3152-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18694972</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Jan;82(1):48-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18179884</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Nucl Med. 1978 Oct;8(4):283-98</Citation><ArticleIdList><ArticleId IdType="pubmed">112681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Antigens. 1996 Apr;47(4):275-83</Citation><ArticleIdList><ArticleId IdType="pubmed">8773316</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Apr;57(4):1084-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18252895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23008265</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jan</Month></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Multivariate prediction of subcutaneous glucose concentration in type 1 diabetes patients based on support vector regression.</ArticleTitle><Pagination><MedlinePgn>71-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TITB.2012.2219876</ELocationID><Abstract><AbstractText>Data-driven techniques have recently drawn significant interest in the predictive modeling of subcutaneous (s.c.) glucose concentration in type 1 diabetes. In this study, the s.c. glucose prediction is treated as a multivariate regression problem, which is addressed using support vector regression (SVR). The proposed method is based on variables concerning: (i) the s.c. glucose profile, (ii) the plasma insulin concentration, (iii) the appearance of meal-derived glucose in the systemic circulation, and (iv) the energy expenditure during physical activities. Six cases corresponding to different combinations of the aforementioned variables are used to investigate the influence of the input on the daily glucose prediction. The proposed method is evaluated using a dataset of 27 patients in free-living conditions. 10-fold cross validation is applied to each dataset individually to both optimize and test the SVR model. In the case where all the input variables are considered, the average prediction errors are 5.21, 6.03, 7.14 and 7.62 mg/dl for 15, 30, 60 and 120 min prediction horizons, respectively. The results clearly indicate that the availability of multivariable data and their effective combination can significantly increase the accuracy of both short-term and long-term predictions. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georga</LastName><ForeName>E I</ForeName><Initials>EI</Initials></Author><Author ValidYN="Y"><LastName>Protopappas</LastName><ForeName>V C</ForeName><Initials>VC</Initials></Author><Author ValidYN="Y"><LastName>Ardigo</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Marina</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zavaroni</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Polyzos</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fotiadis</LastName><ForeName>D I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015190" MajorTopicYN="N">Blood Glucose Self-Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040521" MajorTopicYN="N">Subcutaneous Tissue</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23008265</ArticleId><ArticleId IdType="doi">10.1109/TITB.2012.2219876</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22902400</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0542</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>1</Issue><PubDate><MedlineDate>2012 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>Immunology letters</Title><ISOAbbreviation>Immunol Lett</ISOAbbreviation></Journal><ArticleTitle>Models and methods for analysis of lymphocyte repertoire generation, development, selection and evolution.</ArticleTitle><Pagination><MedlinePgn>11-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imlet.2012.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-2478(12)00187-3</ELocationID><Abstract><AbstractText>T and B cell receptor repertoires are diversified by variable region gene rearrangement and selected based on functionality and lack of self-reactivity. Repertoires can also be defined based on phenotype and function rather than receptor specificity - such as the diversity of T helper cell subsets. Natural killer (NK) cell repertoires, in which each cell expresses a randomly chosen subset of its inhibitory receptor genes, and is educated based on self-MHC recognition by yet unknown mechanisms, are also phenotypic repertoires. Studying the generation, development and selection of lymphocyte repertoires, and their functions during immune responses, is essential for understanding the function of the immune system in healthy individuals and in immune deficient, autoimmune or cancer patients. The study of lymphocyte repertoires will enable clinical immunologists to develop better therapeutic monoclonal antibodies, vaccines, transplantation donor-recipient matching protocols, and other immune intervention strategies. The recent development of high-throughput methods for repertoire data collection - from multicolor flow cytometry through single-cell imaging to deep sequencing - presents us now, for the first time, with the ability to analyze and compare large samples of lymphocyte repertoires in health, aging and disease. The exponential growth of these datasets, however, challenges the theoretical immunology community to develop methods for data organization and analysis. Furthermore, the need to test hypotheses regarding immune function, and generate predictions regarding the outcomes of medical interventions, necessitates the development of complex mathematical and computational models, covering processes on multiple scales, from the genetic and molecular to the cellular and system scales.</AbstractText><CopyrightInformation>Copyright .. 2012 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mehr</LastName><ForeName>Ramit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel. Electronic address: ramit.mehr@biu.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sternberg-Simon</LastName><ForeName>Michal</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Michaeli</LastName><ForeName>Miri</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pickman</LastName><ForeName>Yishai</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Immunol Lett</MedlineTA><NlmUniqueID>7910006</NlmUniqueID><ISSNLinking>0165-2478</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011946">Receptors, Antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060965" MajorTopicYN="N">Clonal Evolution</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060966" MajorTopicYN="N">Clonal Selection, Antigen-Mediated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018448" MajorTopicYN="Y">Models, Immunological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011946" MajorTopicYN="N">Receptors, Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22902400</ArticleId><ArticleId IdType="pii">S0165-2478(12)00187-3</ArticleId><ArticleId IdType="doi">10.1016/j.imlet.2012.08.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22831459</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-0254</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Journal of biomolecular structure &amp; dynamics</Title><ISOAbbreviation>J Biomol Struct Dyn</ISOAbbreviation></Journal><ArticleTitle>Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.</ArticleTitle><Pagination><MedlinePgn>215-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2012.698245</ELocationID><Abstract><AbstractText>C5aR antagonists have been thought as potential immune mediators in various inflammatory and autoimmune diseases, and discovery of C5aR antagonists has attracted much attention in recent years. The discovery of C5aR antagonists was usually achieved through high-throughput screening, which usually suffered a high cost and a low success rate. Currently, the fast developing computer-aided virtual screening (VS) methods provide economic and rapid approaches to the lead discovery. In this account, we proposed a hybrid ligand-based VS protocol that is based on support vector machine (SVM) classification and pharmacophore models for retrieving novel C5aR antagonists. Performance evaluation of this hybrid VS protocol in virtual screening against a large independent test set, T-CHEM, showed that the hybrid VS approach significantly increased the hit rate and enrichment factor compared with the individual SVM classification model-based VS and pharmacophore model-based VS, as well as molecular docking-based VS in that the receptor structure was created by homology modeling. The hybrid VS approach was then used to screen several large chemical libraries including PubChem, Specs, and Enamine. Finally, a total of 20 compounds were selected from the top ranking hits, and shifted to the subsequent in vitro and in vivo studies, which results will be reported in the near future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chun-Hui</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lin-Li</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Pan</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shuang</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Hua-Lin</ForeName><Initials>HL</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ze-Rong</ForeName><Initials>ZR</Initials></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sheng-Yong</ForeName><Initials>SY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomol Struct Dyn</MedlineTA><NlmUniqueID>8404176</NlmUniqueID><ISSNLinking>0739-1102</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C488033">C5AR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051056">Complement Inactivating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044087">Receptor, Anaphylatoxin C5a</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011951">Receptors, Complement</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051056" MajorTopicYN="N">Complement Inactivating Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008956" MajorTopicYN="N">Models, Chemical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044087" MajorTopicYN="N">Receptor, Anaphylatoxin C5a</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011951" MajorTopicYN="N">Receptors, Complement</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040681" MajorTopicYN="N">Structural Homology, Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22831459</ArticleId><ArticleId IdType="doi">10.1080/07391102.2012.698245</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22777693</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1004</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>12</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Human mutation</Title><ISOAbbreviation>Hum Mutat</ISOAbbreviation></Journal><ArticleTitle>Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities.</ArticleTitle><Pagination><MedlinePgn>1708-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/humu.22161</ELocationID><Abstract><AbstractText>The success of genome-wide association studies (GWAS) in deciphering the genetic architecture of complex diseases has fueled the expectations whether the individual risk can also be quantified based on the genetic architecture. So far, disease risk prediction based on top-validated single-nucleotide polymorphisms (SNPs) showed little predictive value. Here, we applied a support vector machine (SVM) to Parkinson disease (PD) and type 1 diabetes (T1D), to show that apart from magnitude of effect size of risk variants, heritability of the disease also plays an important role in disease risk prediction. Furthermore, we performed a simulation study to show the role of uncommon (frequency 1-5%) as well as rare variants (frequency &lt;1%) in disease etiology of complex diseases. Using a cross-validation model, we were able to achieve predictions with an area under the receiver operating characteristic curve (AUC) of ~0.88 for T1D, highlighting the strong heritable component (...90%). This is in contrast to PD, where we were unable to achieve a satisfactory prediction (AUC ~0.56; heritability ~38%). Our simulations showed that simultaneous inclusion of uncommon and rare variants in GWAS would eventually lead to feasible disease risk prediction for complex diseases such as PD. The used software is available at http://www.ra.cs.uni-tuebingen.de/software/MACLEAPS/.</AbstractText><CopyrightInformation>.. 2012 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mittag</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, T..bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B..chel</LastName><ForeName>Finja</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Jahn</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bochdanovits</LastName><ForeName>Zoltan</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Sim..n-S..nchez</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Nalls</LastName><ForeName>Mike A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Margaux</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Dena G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>Gibbs</LastName><ForeName>J Raphael</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Lesage</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Brice</LastName><ForeName>Alexis</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Heutink</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Nicholas W</ForeName><Initials>NW</Initials></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Singleton</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials></Author><Author ValidYN="Y"><LastName>Zell</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gasser</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Manu</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><CollectiveName>International Parkinson...s Disease Genomics Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 NS082151</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z99 AG999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>076113</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_G0901330</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Z01 AG000949-02</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>085475</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_09003</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1100479</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Mutat</MedlineTA><NlmUniqueID>9215429</NlmUniqueID><ISSNLinking>1059-7794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Nalls</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plagnol</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Dena G</ForeName><Initials>DG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Manu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheerin</LastName><ForeName>Una-Marie</ForeName><Initials>UM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saad</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sim..n-S..nchez</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulte</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lesage</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sveinbj..rnsd..ttir</LastName><ForeName>Sigurlaug</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arepalli</LastName><ForeName>Sampath</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barker</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ben-Shlomo</LastName><ForeName>Yoav</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berendse</LastName><ForeName>Henk W</ForeName><Initials>HW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berg</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Kailash</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Bie</LastName><ForeName>Rob M  A</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biffi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bloem</LastName><ForeName>Bas</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bochdanovits</LastName><ForeName>Zoltan</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bras</LastName><ForeName>Jose M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brockmann</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>Janet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burn</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charlesworth</LastName><ForeName>Gavin</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Honglei</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chinnery</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chong</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>Carl E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cookson</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cooper</LastName><ForeName>J  Mark</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corvol</LastName><ForeName>Jean Christophe</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Counsell</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dartigues</LastName><ForeName>Jean-Fran..ois</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deloukas</LastName><ForeName>Panos</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deuschl</LastName><ForeName>G..nther</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dexter</LastName><ForeName>David T</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Karin D</ForeName><Initials>KD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillman</LastName><ForeName>Allissa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Durif</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>D..rr</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edkins</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foltynie</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gardner</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gibbs</LastName><ForeName>J  Raphael</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goate</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gray</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerreiro</LastName><ForeName>Rita</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>G..stafsson</LastName><ForeName>..mar</ForeName><Initials>..</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Hilten</LastName><ForeName>Jacobus J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofman</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollenbeck</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holton</LastName><ForeName>Janice</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hershey</LastName><ForeName>Milton S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huber</LastName><ForeName>Heiko</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hudson</LastName><ForeName>Gavin</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hunt</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huttenlocher</LastName><ForeName>Johanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Illig</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>J..nsson</LastName><ForeName>P..lmi V</ForeName><Initials>PV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lambert</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langford</LastName><ForeName>Cordelia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lees</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lichtner</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>M..nchen</LastName><ForeName>Helmholtz Zentrum</ForeName><Initials>HZ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Limousin</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Grisel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorenz</LastName><ForeName>Delia</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNeill</LastName><ForeName>Alisdair</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moorby</LastName><ForeName>Catriona</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Huw R</ForeName><Initials>HR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morrison</LastName><ForeName>Karen E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Sullivan</LastName><ForeName>Sean S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearson</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perlmutter</LastName><ForeName>Joel S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>P..tursson</LastName><ForeName>Hj..rvar</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollak</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potter</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravina</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Revesz</LastName><ForeName>Tamas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riess</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivadeneira</LastName><ForeName>Fernando</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizzu</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryten</LastName><ForeName>Mina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sawcer</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schapira</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scheffer</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidransky</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Colin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spencer</LastName><ForeName>Chris C  A</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stef..nsson</LastName><ForeName>Hreinn</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steinberg</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stockton</LastName><ForeName>Joanna D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strange</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Talbot</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tanner</LastName><ForeName>Carlie M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tashakkori-Ghanbaria</LastName><ForeName>Avazeh</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tison</LastName><ForeName>Fran..ois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trabzuni</LastName><ForeName>Daniah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uitterlinden</LastName><ForeName>Andr.. G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velseboer</LastName><ForeName>Daan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidailhet</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>van de Warrenburg</LastName><ForeName>Bart</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wickremaratchi</LastName><ForeName>Mirdhu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Nigel</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams-Gray</LastName><ForeName>Caroline H</ForeName><Initials>CH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winder-Rhodes</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stef..nsson</LastName><ForeName>K..ri</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heutink</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brice</LastName><ForeName>Alexis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gasser</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singleton</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Nicholas W</ForeName><Initials>NW</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22777693</ArticleId><ArticleId IdType="doi">10.1002/humu.22161</ArticleId><ArticleId IdType="pmc">PMC5968822</ArticleId><ArticleId IdType="mid">NIHMS968001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Epidemiol. 2006;21(12):869-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17160427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 May;10(5):318-29</Citation><ArticleIdList><ArticleId IdType="pubmed">19373277</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2006 Jul;8(7):395-400</Citation><ArticleIdList><ArticleId IdType="pubmed">16845271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2005 Feb;6(2):95-108</Citation><ArticleIdList><ArticleId IdType="pubmed">15716906</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Sep 15;18(18):3525-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19553258</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Jul 8;363(2):166-76</Citation><ArticleIdList><ArticleId IdType="pubmed">20647212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Feb 19;377(9766):641-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21292315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2011 Feb 1;20(3):615-27</Citation><ArticleIdList><ArticleId IdType="pubmed">21084426</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Protoc. 2007;2(10):2492-501</Citation><ArticleIdList><ArticleId IdType="pubmed">17947991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Oct 15;17(R2):R166-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18852206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18372903</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2011 Jun;19(6):655-61</Citation><ArticleIdList><ArticleId IdType="pubmed">21248740</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Sep 2;467(7311):52-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20811451</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Feb;5(2):e1000337</Citation><ArticleIdList><ArticleId IdType="pubmed">19197355</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2010 Oct;26(10):438-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20813421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 Apr;9(4):255-66</Citation><ArticleIdList><ArticleId IdType="pubmed">18319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Dec;41(12):1308-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2008 Oct;4(10):e1000173</Citation><ArticleIdList><ArticleId IdType="pubmed">18974822</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Oct;5(10):e1000678</Citation><ArticleIdList><ArticleId IdType="pubmed">19816555</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2009;33 Suppl 1:S51-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19924717</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2011 Jan 7;88(1):76-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2010 Feb 26;6(2):e1000864</Citation><ArticleIdList><ArticleId IdType="pubmed">20195508</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2011 Jun;7(6):e1002141</Citation><ArticleIdList><ArticleId IdType="pubmed">21738487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2011 Jul;35(5):310-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21374718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2009 Jan;124(6):593-605</Citation><ArticleIdList><ArticleId IdType="pubmed">18985386</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2011 Nov 29;5 Suppl 9:S61</Citation><ArticleIdList><ArticleId IdType="pubmed">22373337</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22752090</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1203</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>10</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Human genetics</Title><ISOAbbreviation>Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Risk estimation and risk prediction using machine-learning methods.</ArticleTitle><Pagination><MedlinePgn>1639-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00439-012-1194-y</ELocationID><Abstract><AbstractText>After an association between genetic variants and a phenotype has been established, further study goals comprise the classification of patients according to disease risk or the estimation of disease probability. To accomplish this, different statistical methods are required, and specifically machine-learning approaches may offer advantages over classical techniques. In this paper, we describe methods for the construction and evaluation of classification and probability estimation rules. We review the use of machine-learning approaches in this context and explain some of the machine-learning algorithms in detail. Finally, we illustrate the methodology through application to a genome-wide association analysis on rheumatoid arthritis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kruppa</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut f..r Medizininsche Biometrie und Statistik, Universit..t zu L..beck, Universit..tsklinikum Schleswig-Holstein, Campus L..beck, Maria-Goeppert-Str. 1, 23562 L..beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>K..nig</LastName><ForeName>Inke R</ForeName><Initials>IR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR044422</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Hum Genet</MedlineTA><NlmUniqueID>7613873</NlmUniqueID><ISSNLinking>0340-6717</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>02</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22752090</ArticleId><ArticleId IdType="doi">10.1007/s00439-012-1194-y</ArticleId><ArticleId IdType="pmc">PMC3432206</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genet Epidemiol. 2010 Sep;34(6):575-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20568290</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S69</Citation><ArticleIdList><ArticleId IdType="pubmed">20018063</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Jan 30;10 Suppl 1:S74</Citation><ArticleIdList><ArticleId IdType="pubmed">19208179</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2008 Jul 16;100(14):978-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18612128</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Oct;5(10):e1000678</Citation><ArticleIdList><ArticleId IdType="pubmed">19816555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2011 May 15;27(10):1384-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21450715</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4168-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12642676</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2010 Sep 30;29(22):2359-68</Citation><ArticleIdList><ArticleId IdType="pubmed">20623818</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Genet. 2010;72:25-45</Citation><ArticleIdList><ArticleId IdType="pubmed">21029847</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2009;33 Suppl 1:S45-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19924716</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1988 Sep;44(3):837-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Jan 30;10 Suppl 1:S65</Citation><ArticleIdList><ArticleId IdType="pubmed">19208169</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2003 Jan 1;95(1):14-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12509396</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S65</Citation><ArticleIdList><ArticleId IdType="pubmed">20018059</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S2</Citation><ArticleIdList><ArticleId IdType="pubmed">20018009</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2008 Feb 1;167(3):362-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17982157</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2009;48(3):306-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19387509</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S83</Citation><ArticleIdList><ArticleId IdType="pubmed">20018079</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2012;51(1):74-81</Citation><ArticleIdList><ArticleId IdType="pubmed">21915433</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2007 Feb 20;115(7):928-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17309939</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2010 Feb 27;11:110</Citation><ArticleIdList><ArticleId IdType="pubmed">20187966</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2008;458:15-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19065803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Oct 15;17(R2):R166-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18852206</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12</Citation><ArticleIdList><ArticleId IdType="pubmed">17569110</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S58</Citation><ArticleIdList><ArticleId IdType="pubmed">20018051</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Data Min Bioinform. 2008;2(4):289-341</Citation><ArticleIdList><ArticleId IdType="pubmed">19216340</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2011 Feb 15;12 Suppl 1:S26</Citation><ArticleIdList><ArticleId IdType="pubmed">21342556</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:3573-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22255111</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Genet. 2010 Oct;3(5):468-74</Citation><ArticleIdList><ArticleId IdType="pubmed">20729558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Apr 15;21(8):1509-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15572470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Mar 1;26(5):694-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20081222</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE Trans Pattern Anal Mach Intell. 1980 Mar;2(3):242-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21868897</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Genet. 2010;72:101-16</Citation><ArticleIdList><ArticleId IdType="pubmed">21029850</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jan 21;5(1):e8830</Citation><ArticleIdList><ArticleId IdType="pubmed">20098615</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2004 May 1;159(9):882-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15105181</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2009;33 Suppl 1:S88-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19924707</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2010 Sep 30;6(9):e1001146</Citation><ArticleIdList><ArticleId IdType="pubmed">20941391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 Jul 15;26(14):1752-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20505004</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2010 Nov;34(7):643-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20842684</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 May;39(9):e62</Citation><ArticleIdList><ArticleId IdType="pubmed">21317188</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2008 Jul 16;100(14):1037-41</Citation><ArticleIdList><ArticleId IdType="pubmed">18612136</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Sep 23;5(9):e12952</Citation><ArticleIdList><ArticleId IdType="pubmed">20886065</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2007 Jan;8(1):86-100</Citation><ArticleIdList><ArticleId IdType="pubmed">16603682</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2009 Jan;11(1):3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">18813139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2006 Dec;24(12):1565-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17160063</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2012 Jul 10;31(15):1601-16</Citation><ArticleIdList><ArticleId IdType="pubmed">22302520</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Jan 09;10:13</Citation><ArticleIdList><ArticleId IdType="pubmed">19134182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2011 May;129(5):473-85</Citation><ArticleIdList><ArticleId IdType="pubmed">21210282</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S60</Citation><ArticleIdList><ArticleId IdType="pubmed">20018054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Aug 1;21(15):3301-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15905277</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2007 Dec;40(6):750-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17625973</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>IEEE/ACM Trans Comput Biol Bioinform. 2011 Nov-Dec;8(6):1580-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21383421</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2011 May;12(3):253-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21546448</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:6182-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21097154</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc IEEE Comput Syst Bioinform Conf. 2005;:301-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16447987</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2010 Jun 14;11:49</Citation><ArticleIdList><ArticleId IdType="pubmed">20546594</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Sep 15;18(18):3525-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19553258</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics Proteomics Bioinformatics. 2007 Dec;5(3-4):242-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18267305</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1999 Dec 11;319(7224):1562-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10591726</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22594639</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1747-0285</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Chemical biology &amp; drug design</Title><ISOAbbreviation>Chem Biol Drug Des</ISOAbbreviation></Journal><ArticleTitle>Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.</ArticleTitle><Pagination><MedlinePgn>366-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1747-0285.2012.01415.x</ELocationID><Abstract><AbstractText>Bruton's tyrosine kinase has emerged as a potential target for the treatment for B-cell malignancies and autoimmune diseases. Discovery of Bruton's tyrosine kinase inhibitors has thus attracted much attention recently. In this investigation, we introduced a hybrid protocol of virtual screening methods including support vector machine model-based virtual screening, pharmacophore model-based virtual screening and docking-based virtual screening for retrieving new Bruton's tyrosine kinase inhibitors from commercially available chemical databases. Performances of the hybrid virtual screening approach were evaluated against a test set, which results showed that the hybrid virtual screening approach significantly shortened the overall screening time, and considerably increased the hit rate and enrichment factor compared with the individual method (SB-VS, PB-VS and DB-VS) or their combinations by twos. This hybrid virtual screening approach was then applied to screen several chemical databases including Specs (202,408 compounds) and Enamine (980,000 compounds) databases. Thirty-nine compounds were selected from the final hits and have been shifted to experimental studies.</AbstractText><CopyrightInformation>.. 2012 John Wiley &amp; Sons A/S.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Hua-Lin</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ze-Rong</ForeName><Initials>ZR</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lin-Li</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Pan</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jing-Jing</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sheng-Yong</ForeName><Initials>SY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Biol Drug Des</MedlineTA><NlmUniqueID>101262549</NlmUniqueID><ISSNLinking>1747-0277</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D000077329">Agammaglobulinaemia Tyrosine Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077329" MajorTopicYN="N">Agammaglobulinaemia Tyrosine Kinase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="Y">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22594639</ArticleId><ArticleId IdType="doi">10.1111/j.1747-0285.2012.01415.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22547455</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2012</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-254X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>9</Issue><PubDate><Year>2012</Year><Month>Sep</Month></PubDate></JournalIssue><Title>IEEE transactions on medical imaging</Title><ISOAbbreviation>IEEE Trans Med Imaging</ISOAbbreviation></Journal><ArticleTitle>Interactive lesion segmentation with shape priors from offline and online learning.</ArticleTitle><Pagination><MedlinePgn>1698-712</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TMI.2012.2196285</ELocationID><Abstract><AbstractText>In medical image segmentation, tumors and other lesions demand the highest levels of accuracy but still call for the highest levels of manual delineation. One factor holding back automatic segmentation is the exemption of pathological regions from shape modelling techniques that rely on high-level shape information not offered by lesions. This paper introduces two new statistical shape models (SSMs) that combine radial shape parameterization with machine learning techniques from the field of nonlinear time series analysis. We then develop two dynamic contour models (DCMs) using the new SSMs as shape priors for tumor and lesion segmentation. From training data, the SSMs learn the lower level shape information of boundary fluctuations, which we prove to be nevertheless highly discriminant. One of the new DCMs also uses online learning to refine the shape prior for the lesion of interest based on user interactions. Classification experiments reveal superior sensitivity and specificity of the new shape priors over those previously used to constrain DCMs. User trials with the new interactive algorithms show that the shape priors are directly responsible for improvements in accuracy and reductions in user demand.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shepherd</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Turku PET Centre and Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland. tony.shepherd@tyks.fi</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prince</LastName><ForeName>Simon J D</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Med Imaging</MedlineTA><NlmUniqueID>8310780</NlmUniqueID><ISSNLinking>0278-0062</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013269" MajorTopicYN="N">Stochastic Processes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22547455</ArticleId><ArticleId IdType="doi">10.1109/TMI.2012.2196285</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22532634</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.</ArticleTitle><Pagination><MedlinePgn>1374-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2011-200968</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought clinically relevant predictive biomarkers present in CD4 T-cells, or in serum, that identified those patients with undifferentiated arthritis (UA) who subsequently develop rheumatoid arthritis (RA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Total RNA was isolated from highly purified peripheral blood CD4 T cells of 173 early arthritis clinic patients. Paired serum samples were also stored. Microarray analysis of RNA samples was performed and differential transcript expression among 111 'training cohort' patients confirmed using real-time quantitative PCR. Machine learning approaches tested the utility of a classification model among an independent validation cohort presenting with UA (62 patients). Cytokine measurements were performed using a highly sensitive electrochemiluminescence detection system.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A 12-gene transcriptional 'signature' identified RA patients in the training cohort and predicted the subsequent development of RA among UA patients in the validation cohort (sensitivity 68%, specificity 70%). STAT3-inducible genes were over-represented in the signature, particularly in anti-citrullinated peptide antibody-negative disease, providing a risk metric of similar predictive value to the Leiden score in seronegative UA (sensitivity 85%, specificity 75%). Baseline levels of serum interleukin 6 (IL-6) (which signals via STAT3) were highest in anti-citrullinated peptide antibodies-negative RA and distinguished this subgroup from non-RA inflammatory synovitis (corrected p&lt;0.05).Paired serum IL-6 measurements correlated strongly with STAT3-inducible gene expression.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The authors have identified IL-6-mediated STAT-3 signalling in CD4 T cells during the earliest clinical phase of RA, which is most prominent in seronegative disease. While highlighting potential biomarker(s) for early RA, the role of this pathway in disease pathogenesis awaits clarification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Arthur G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine (Musculoskeletal Research Group), Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swan</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Gillian</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hilkens</LastName><ForeName>Catharien M U</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Isaacs</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G1001518</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>17983</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010456">Peptides, Cyclic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494086">STAT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C487763">cyclic citrullinated peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010456" MajorTopicYN="N">Peptides, Cyclic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22532634</ArticleId><ArticleId IdType="pii">annrheumdis-2011-200968</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2011-200968</ArticleId><ArticleId IdType="pmc">PMC3396452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Opin Rheumatol. 2010 May;22(3):330-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20164774</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2010 Jan 6;29(1):55-67</Citation><ArticleIdList><ArticleId IdType="pubmed">19851287</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Dec 1;179(11):7215-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18025162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2007 Jan;66(1):34-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16396980</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1999 Jun 15;93(12):4318-27</Citation><ArticleIdList><ArticleId IdType="pubmed">10361130</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1994 Jul 9;309(6947):102</Citation><ArticleIdList><ArticleId IdType="pubmed">8038641</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Mar;60(3):641-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19248103</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2002 Dec 15;100(13):4550-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12393721</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genomics. 2007 Mar 05;8:64</Citation><ArticleIdList><ArticleId IdType="pubmed">17338817</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2010;28:535-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20192809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2010 Nov;69(11):1898-906</Citation><ArticleIdList><ArticleId IdType="pubmed">20959326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Feb 21;373(9664):659-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19157532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2009 Oct;68(10):1580-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19019888</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Oncol. 2009 Aug;35(2):337-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19578748</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2008 Dec 15;112(13):5193-201</Citation><ArticleIdList><ArticleId IdType="pubmed">18824600</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2009 Jun;8(7):538-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19189867</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Mar;62(3):694-704</Citation><ArticleIdList><ArticleId IdType="pubmed">20131234</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2002 May;109(9):1133-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11994400</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Jan 1;182(1):613-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19109195</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2004 Mar;50(3):709-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15022309</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2006 Aug;80(2):227-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16707558</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1999 Mar 15;93(6):1980-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10068671</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2000 May 15;19(21):2548-56</Citation><ArticleIdList><ArticleId IdType="pubmed">10851053</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2007 Jan;8(1):118-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16632515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Jun 26;387(6636):917-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9202125</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jul;60(7):1906-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19565493</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Aug;6(5):388-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15973463</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2008 Aug;58(8):2241-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18668546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2007 Jun 5;146(11):797-808</Citation><ArticleIdList><ArticleId IdType="pubmed">17548411</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2006 Nov 23;25(55):7297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">16732314</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1998 Nov;10(11):1747-51</Citation><ArticleIdList><ArticleId IdType="pubmed">9846704</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Rev. 2005 Apr;204:55-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15790350</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Feb;62(2):383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20112361</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods. 2001 Dec;25(4):402-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Mar 1;180(5):2903-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18292512</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2569-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20872595</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Mar;60(3):905; author reply 906</Citation><ArticleIdList><ArticleId IdType="pubmed">19248101</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2010 May;16(5):586-91, 1p following 591</Citation><ArticleIdList><ArticleId IdType="pubmed">20400961</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Mol Biol. 2006 Jan 31;7:3</Citation><ArticleIdList><ArticleId IdType="pubmed">16448564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22515101</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1550-7033</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of biomedical nanotechnology</Title><ISOAbbreviation>J Biomed Nanotechnol</ISOAbbreviation></Journal><ArticleTitle>Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.</ArticleTitle><Pagination><MedlinePgn>133-9</MedlinePgn></Pagination><Abstract><AbstractText>IgA nephropathy is the most common type of chronic glomerulonephritis which leads eventually to end-stage renal disease (ESRD). The duration of clinical early stage IgA nephropathy to ESRD varies a lot. The pathologic presentation may have detrimental effect on outcome. But the renal biopsy is a high-risk invasive operation not able to be accepted by all patients. In this study, we tried to find biomarkers in urine as a non-invasive approach to diagnose different pathologic presentations of clinical early stage IgA nephropathy. A total of 56 patients with IgA nephropathy were included in this study, with 23 patients having severe pathologic presentation and the other 33 having mild ones. The control group consisted of 14 normal subjects. The urinary proteomic spectra from those three groups were generated by Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with weak cationic exchange magnetic beads. The total experiment data was handled by the Zhejiang University ProteinChip Data Analysis System. We found that the urine protein/peptide spectra patterns could be established to distinguish severe IgA nephropathy from the mild IgA nephropathy group and the normal group. Several potential biomarkers were found and the diagnostic system could distinguish between severe IgA nephropathy from the mild IgA nephropathy with a sensitivity of 90.48% and specificity of 96.77%. We conclude that, using MALDI-TOF-MS with magnetic beads to detect urine proteomic patterns shows great potential in identifying early IgA nephropathy with different pathologic prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Kidney Disease Center the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jiekai</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Shunxian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiping</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Youying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianghua</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Nanotechnol</MedlineTA><NlmUniqueID>101230869</NlmUniqueID><ISSNLinking>1550-7033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005922" MajorTopicYN="N">Glomerulonephritis, IGA</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059346" MajorTopicYN="N">Magnets</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008863" MajorTopicYN="N">Microspheres</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010449" MajorTopicYN="N">Peptide Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040081" MajorTopicYN="N">Protein Array Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22515101</ArticleId><ArticleId IdType="doi">10.1166/jbn.2012.1364</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22441377</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Supporting diagnostic decisions using hybrid and complementary data mining applications: a pilot study in the pediatric emergency department.</ArticleTitle><Pagination><MedlinePgn>725-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/pr.2012.34</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">This article demonstrates the capacity of a combination of different data mining (DM) methods to support diagnosis in pediatric emergency patients. By using a novel combination of these DM procedures, a computer-based diagnosis was created.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A support vector machine (SVM), artificial neural networks (ANNs), fuzzy logics, and a voting algorithm were simultaneously used to allocate a patient to one of 18 diagnoses (e.g., pneumonia, appendicitis). Anonymized data sets of patients who presented in the emergency department (ED) of a pediatric care clinic were chosen. For each patient, 26 identical clinical and laboratory parameters were used (e.g., blood count, C-reactive protein) to finally develop the program.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The combination of four DM operations arrived at a correct diagnosis in 98% of the cases, retrospectively. A subgroup analysis showed that the highest diagnostic accuracy was for appendicitis (97% correct diagnoses) and idiopathic thrombocytopenic purpura or erythroblastopenia (100% correct diagnoses). During the prospective testing, 81% of the patients were correctly diagnosed by the system.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The combination of these DM methods was suitable for proposing a diagnosis using both laboratory and clinical parameters. We conclude that an optimized combination of different but complementary DM methods might serve to assist medical decisions in the ED.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grigull</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Haematology and Oncology, Medical University, Hannover, Germany. grigull.lorenz@mh-hannover.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechner</LastName><ForeName>Werner M</ForeName><Initials>WM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001064" MajorTopicYN="N">Appendicitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017143" MajorTopicYN="N">Fuzzy Logic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016553" MajorTopicYN="N">Purpura, Thrombocytopenic, Idiopathic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22441377</ArticleId><ArticleId IdType="pii">pr201234</ArticleId><ArticleId IdType="doi">10.1038/pr.2012.34</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22423970</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1934-6069</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell host &amp; microbe</Title><ISOAbbreviation>Cell Host Microbe</ISOAbbreviation></Journal><ArticleTitle>Cofactors required for TLR7- and TLR9-dependent innate immune responses.</ArticleTitle><Pagination><MedlinePgn>306-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chom.2012.02.002</ELocationID><Abstract><AbstractText>Pathogens commonly utilize endocytic pathways to..gain cellular access. The endosomal pattern recognition receptors TLR7 and TLR9 detect pathogen-encoded nucleic acids to initiate MyD88-dependent proinflammatory responses to microbial infection. Using genome-wide RNAi screening and integrative systems-based analysis, we identify 190 cofactors required for TLR7- and TLR9-directed signaling responses. A set of cofactors were crossprofiled for their activities downstream of several immunoreceptors and then functionally mapped based on the known architecture of NF-..B signaling pathways. Protein complexes and pathways involved in ubiquitin-protein ligase activities, sphingolipid metabolism, chromatin modifications, and ancient stress responses were found to modulate innate recognition of endosomal nucleic acids. Additionally, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) was characterized as necessary for ubiquitin-dependent TLR9 targeting to the endolysosome. Proteins and pathways identified here should prove useful in delineating strategies to manipulate innate responses for treatment of autoimmune disorders and microbial infection.</AbstractText><CopyrightInformation>Copyright .... 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Chih-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Opaluch</LastName><ForeName>Amanda M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Maestre</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Secundino</LastName><ForeName>Ismael</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>De Jesus</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Quy T</ForeName><Initials>QT</Initials></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Genevieve</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Bonamy</LastName><ForeName>Ghislain M C</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Miraglia</LastName><ForeName>Loren J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Orth</LastName><ForeName>Anthony P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Nizet</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Fernandez-Sesma</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yingyao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Gregory M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Chanda</LastName><ForeName>Sumit K</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI090935-01</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI077780</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI77780</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG032171</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI073450</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM085764</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50GM085764</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM085764-01A2</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI090935-02</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI072429</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI090935</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Host Microbe</MedlineTA><NlmUniqueID>101302316</NlmUniqueID><ISSNLinking>1931-3128</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056827">Endosomal Sorting Complexes Required for Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507779">MYD88 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495348">TLR7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495371">TLR9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C096164">hepatocyte growth factor-regulated tyrosine kinase substrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056827" MajorTopicYN="N">Endosomal Sorting Complexes Required for Transport</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="N">Toll-Like Receptor 7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051217" MajorTopicYN="N">Toll-Like Receptor 9</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22423970</ArticleId><ArticleId IdType="pii">S1931-3128(12)00062-5</ArticleId><ArticleId IdType="doi">10.1016/j.chom.2012.02.002</ArticleId><ArticleId IdType="pmc">PMC3310399</ArticleId><ArticleId IdType="mid">NIHMS361160</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int Rev Immunol. 2011 Feb;30(1):16-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21235323</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Oct;79(20):12944-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16188996</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2003 Sep;2(5):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">12965173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 2008 May;28(10):3538-47</Citation><ArticleIdList><ArticleId IdType="pubmed">18347055</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 2003 Aug 4;162(3):435-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12900395</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Mar 13;452(7184):234-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18305481</ArticleId></ArticleIdList></Reference><Reference><Citation>Traffic. 2009 Sep;10(9):1318-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19624486</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 May 4;107(18):8322-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20404143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Death Differ. 2006 May;13(5):816-25</Citation><ArticleIdList><ArticleId IdType="pubmed">16410796</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2008 May 23;283(21):14295-308</Citation><ArticleIdList><ArticleId IdType="pubmed">18332133</ArticleId></ArticleIdList></Reference><Reference><Citation>Traffic. 2011 Oct;12(10):1291-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21518165</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2006 Jan;7(1):49-56</Citation><ArticleIdList><ArticleId IdType="pubmed">16341217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2007 Feb 23;128(4):693-705</Citation><ArticleIdList><ArticleId IdType="pubmed">17320507</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2009 Nov 20;31(5):737-48</Citation><ArticleIdList><ArticleId IdType="pubmed">19879164</ArticleId></ArticleIdList></Reference><Reference><Citation>J Innate Immun. 2012;4(2):213-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21860217</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2011 Jun 6;585(11):1568-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21565193</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2006 Feb 22;25(4):683-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16467847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2007 Oct;4(10):847-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17828270</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1999 May 20;399(6733):271-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Feb;62(2):553-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20112359</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Cell Biol. 2009 Aug;21(4):568-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19560911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2008 Dec 4;456(7222):658-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18820679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2010 Mar 19;140(6):805-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2011 Nov 23;35(5):721-32</Citation><ArticleIdList><ArticleId IdType="pubmed">22078797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2005 Sep 9;122(5):669-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Apr 1;21(7):1237-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15531612</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2011 Nov 11;147(4):853-67</Citation><ArticleIdList><ArticleId IdType="pubmed">22078882</ArticleId></ArticleIdList></Reference><Reference><Citation>Development. 2010 Jun;137(11):1825-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20460366</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2010 Mar 26;32(3):305-15</Citation><ArticleIdList><ArticleId IdType="pubmed">20346772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Feb;40(2):204-10</Citation><ArticleIdList><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res. 2003 May;47(5):421-37</Citation><ArticleIdList><ArticleId IdType="pubmed">12676516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2006 Feb 24;124(4):783-801</Citation><ArticleIdList><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19973-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21045126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2008 Dec;9(12):1407-14</Citation><ArticleIdList><ArticleId IdType="pubmed">18931679</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Microbiol Lett. 1991 Aug 1;66(2):219-24</Citation><ArticleIdList><ArticleId IdType="pubmed">1936949</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2011 Mar 4;144(5):675-88</Citation><ArticleIdList><ArticleId IdType="pubmed">21376231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2004 Jul;5(7):730-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Feb 11;463(7282):813-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20027183</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biochem Sci. 2007 Dec;32(12):561-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17988873</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2009 Mar;8(5):400-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19162250</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2010 Sep 17;329(5998):1530-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20847273</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2005 Jul 6;24(13):2265-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15944737</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1996 Aug 1;184(2):725-33</Citation><ArticleIdList><ArticleId IdType="pubmed">8760826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1998 Jul 30;394(6692):485-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9697772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2004 May;5(5):495-502</Citation><ArticleIdList><ArticleId IdType="pubmed">15107846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Clin Pract Rheumatol. 2006 Jun;2(6):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16932712</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4465-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11904358</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22254346</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2011</Volume><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Automatic classification of pathological gait patterns using ground reaction forces and machine learning algorithms.</ArticleTitle><Pagination><MedlinePgn>453-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/IEMBS.2011.6090063</ELocationID><Abstract><AbstractText>An automated gait classification method is developed in this study, which can be applied to analysis and to classify pathological gait patterns using 3D ground reaction force (GRFs) data. The study involved the discrimination of gait patterns of healthy, cerebral palsy (CP) and multiple sclerosis subjects. The acquired 3D GRFs data were categorized into three groups. Two different algorithms were used to extract the gait features; the GRFs parameters and the discrete wavelet transform (DWT), respectively. Nearest neighbor classifier (NNC) and artificial neural networks (ANN) were also investigated for the classification of gait features in this study. Furthermore, different feature sets were formed using a combination of the 3D GRFs components (mediolateral, anterioposterior, and vertical) and their various impacts on the acquired results were evaluated. The best leave-one-out (LOO) classification accuracy 85% was achieved. The results showed some improvement through the application of a features selection algorithm based on M-shaped value of vertical force and the statistical test ANOVA of mediolateral and anterioposterior forces. The optimal feature set of six features enhanced the accuracy to 95%. This work can provide an automated gait classification tool that may be useful to the clinician in the diagnosis and identification of pathological gait impairments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alaqtash</LastName><ForeName>Murad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computer Engineering Department, The University of Texas at El Paso, El Paso, TX 79968, USA. msalaqtash@miners.utep.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkodie-Gyan</LastName><ForeName>Thompson</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Huiying</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Olac</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Brower</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Abdelgawad</LastName><ForeName>Amr</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002547" MajorTopicYN="N">Cerebral Palsy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="N">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005528" MajorTopicYN="N">Foot</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010363" MajorTopicYN="N">Pattern Recognition, Automated</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013314" MajorTopicYN="N">Stress, Mechanical</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22254346</ArticleId><ArticleId IdType="doi">10.1109/IEMBS.2011.6090063</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22245259</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9572</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>NeuroImage</Title><ISOAbbreviation>Neuroimage</ISOAbbreviation></Journal><ArticleTitle>Multivariate pattern classification of gray matter pathology in multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>400-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroimage.2011.12.070</ELocationID><Abstract><AbstractText>Univariate analyses have identified gray matter (GM) alterations in different groups of MS patients. While these methods detect differences on the basis of the single voxel or cluster, multivariate methods like support vector machines (SVM) identify the complex neuroanatomical patterns of GM differences. Using multivariate linear SVM analysis and leave-one-out cross-validation, we aimed at identifying neuroanatomical GM patterns relevant for individual classification of MS patients. We used SVM to separate GM segmentations of T1-weighted three-dimensional magnetic resonance (MR) imaging scans within different age- and sex-matched groups of MS patients with either early (n=17) or late MS (n=17) (contrast I), low (n=20) or high (n=20) white matter lesion load (contrast II), and benign MS (BMS, n=13) or non-benign MS (NBMS, n=13) (contrast III) scanned on a single 1.5 T MR scanner. GM patterns most relevant for individual separation of MS patients comprised cortical areas of all the cerebral lobes as well as deep GM structures, including the thalamus and caudate. The patterns detected were sufficiently informative to separate individuals of the respective groups with high sensitivity and specificity in 85% (contrast I), 83% (contrast II) and 77% (contrast III) of cases. The study demonstrates that neuroanatomical spatial patterns of GM segmentations contain information sufficient for correct classification of MS patients at the single case level, thus making multivariate SVM analysis a promising clinical application.</AbstractText><CopyrightInformation>Copyright .. 2011 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bendfeldt</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Image Analysis Center (MIAC), University Hospital Basel, CH-4031 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kl..ppel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Smieskova</LastName><ForeName>Renata</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Traud</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mueller-Lenke</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Naegelin</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kappos</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Radue</LastName><ForeName>Ernst-Wilhelm</ForeName><Initials>EW</Initials></Author><Author ValidYN="Y"><LastName>Borgwardt</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G0900908</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroimage</MedlineTA><NlmUniqueID>9215515</NlmUniqueID><ISSNLinking>1053-8119</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>11</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22245259</ArticleId><ArticleId IdType="pii">S1053-8119(11)01472-8</ArticleId><ArticleId IdType="doi">10.1016/j.neuroimage.2011.12.070</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22222338</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-2990</ISSN><JournalIssue CitedMedium="Internet"><Volume>344</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The American journal of the medical sciences</Title><ISOAbbreviation>Am J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients.</ArticleTitle><Pagination><MedlinePgn>268-73</MedlinePgn></Pagination><Abstract><AbstractText>The ultimate goal is to identify and target modifiable risk factors that will reduce major cardiovascular events in African American lupus patients. As a first step toward achieving this goal, this study was designed to explore risk factor models of preclinical atherosclerosis in a predominantly African American group of patients with systemic lupus erythematosus (SLE) using variables historically associated with endothelial function in nonlupus populations. Fifty-one subjects with SLE but without a history of clinical cardiovascular events were enrolled. At entry, a Framingham risk factor history and medication list were recorded. Sera and plasma samples were analyzed for lipids, lupus activity markers and total 25-hydroxyvitamin D (25 OH)D) levels. Carotid ultrasound measurements were performed to determine total plaque area (TPA) in both carotids. Cases had TPA values above age-matched controls from a vascular prevention clinic population. Logistic regression and machine learning analyses were performed to create predictive models. 25(OH)D levels were significantly lower, and SLE disease duration was significantly higher in cases. 25(OH)D levels inversely correlated with age-adjusted TPA. Angiotensin-converting enzyme (ACE) inhibitor nonuse associated with case status. Logistic regression models containing ACE inhibitor use, 25(OH)D levels and low-density lipoprotein levels had a diagnostic accuracy of 84% for predicting accelerated atherosclerosis. Similar results were obtained with machine learning models, but hydroxychlo-roquine use associated with controls in these models. This is the first study to demonstrate an association between atherosclerotic burden and 25(OH)D insufficiency or ACE inhibitor nonuse in lupus patients. These findings provide strong rationale for the study of ACE inhibitors and vitamin D replenishment as preventive therapies in this high-risk population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravenell</LastName><ForeName>Roneka L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamen</LastName><ForeName>Diane L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>J David</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Hollis</LastName><ForeName>Bruce W</ForeName><Initials>BW</Initials></Author><Author ValidYN="Y"><LastName>Fleury</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Janech</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Jonas S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Shaftman</LastName><ForeName>Stephanie R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Oates</LastName><ForeName>Jim C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AR052364</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AR052364-01A2</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01RR001070</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR029882-01</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR029882</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR001070-23</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR001070</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Sci</MedlineTA><NlmUniqueID>0370506</NlmUniqueID><ISSNLinking>0002-9629</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>A288AR3C9H</RegistryNumber><NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">African Americans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="N">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22222338</ArticleId><ArticleId IdType="doi">10.1097/MAJ.0b013e31823fa7d9</ArticleId><ArticleId IdType="pii">S0002-9629(15)30827-2</ArticleId><ArticleId IdType="pmc">PMC3323721</ArticleId><ArticleId IdType="mid">NIHMS341967</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stroke. 2002 Dec;33(12):2916-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12468791</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2006 Feb;5(2):114-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16431339</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2010 Jun;41(6):1193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20413738</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Oct 15;61(10):1387-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19790113</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2007 Nov;38(11):2873-80</Citation><ArticleIdList><ArticleId IdType="pubmed">17901390</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1997 Sep;40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupus. 1999;8(8):632-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10568900</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis. 2009 May;204(1):85-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18834982</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Cardiol Rep. 2009 Jan;11(1):21-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19091171</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Jan;34(1):70-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17117488</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2012 Apr;51(4):644-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21719424</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2003 Dec 8;115 Suppl 8A:99S-106S</Citation><ArticleIdList><ArticleId IdType="pubmed">14678874</ArticleId></ArticleIdList></Reference><Reference><Citation>Atherosclerosis. 2005 Feb;178(2):319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">15694940</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2008 Jun 9;168(11):1174-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18541825</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nutr. 2005 Feb;135(2):317-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15671234</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2399-406</Citation><ArticleIdList><ArticleId IdType="pubmed">14681505</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Cardiol. 2002 Feb 21;89(4A):10B-15B; discussion 15B-16B</Citation><ArticleIdList><ArticleId IdType="pubmed">11879661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2005 Jun 21;142(12 Pt 1):953-62</Citation><ArticleIdList><ArticleId IdType="pubmed">15968009</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1996 Aug 1;94(3):258-65</Citation><ArticleIdList><ArticleId IdType="pubmed">8759064</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2002 Jan 22;105(3):393-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11804998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Endocrinol Metab. 2009 Oct;94(10):4023-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19584181</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2010 Sep;62(9):2767-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20506536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Dec;68(6):2588-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16316334</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Biotechnol. 2002 Feb;13(1):72-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11849962</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Jan 20;342(3):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">10639539</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2000 Oct;46(10):1657-61</Citation><ArticleIdList><ArticleId IdType="pubmed">11017946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22195070</PMID><DateCompleted><Year>2013</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2011</Volume><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Na..ve Electronic Health Record phenotype identification for Rheumatoid arthritis.</ArticleTitle><Pagination><MedlinePgn>189-96</MedlinePgn></Pagination><Abstract><AbstractText>Electronic Health Records (EHRs) provide a real-world patient cohort for clinical and genomic research. Phenotype identification using informatics algorithms has been shown to replicate known genetic associations found in clinical trials and observational cohorts. However, development of accurate phenotype identification methods can be challenging, requiring significant time and effort. We applied Support Vector Machines (SVMs) to both na..ve (i.e., non-curated) and expert-defined collections of EHR features to identify Rheumatoid Arthritis cases using billing codes, medication exposures, and natural language processing-derived concepts. SVMs trained on na..ve and expert-defined data outperformed an existing deterministic algorithm; the best performing na..ve system had precision of 0.94 and recall of 0.87, compared to precision of 0.75 and recall of 0.51 for the deterministic algorithm. We show that with an expert defined feature set as few as 50-100 training samples are required. This study demonstrates that SVMs operating on non-curated sets of attributes can accurately identify cases from an EHR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eyler</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007450</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM010685</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GM092691</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>3T15LM007450-08S1</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1 U01 GM092691-01</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="Y">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22195070</ArticleId><ArticleId IdType="pmc">PMC3243261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Inform Assoc. 2009 Nov-Dec;16(6):806-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19717800</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2001 Oct;34(5):301-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2005 Oct;20(10):943-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16191143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2010 May 1;26(9):1205-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20335276</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2003 Jul-Aug;10(4):351-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12668688</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2011 Feb;8(2):271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21044898</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2008 Sep;84(3):362-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18500243</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Apr 9;86(4):560-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20362271</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2010 Jan-Feb;17(1):19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20064797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21910999</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8541</ISSN><JournalIssue CitedMedium="Internet"><Volume>289</Volume><PubDate><Year>2011</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of theoretical biology</Title><ISOAbbreviation>J Theor Biol</ISOAbbreviation></Journal><ArticleTitle>Mining susceptibility gene modules and disease risk genes from SNP data by combining network topological properties with support vector regression.</ArticleTitle><Pagination><MedlinePgn>225-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtbi.2011.08.040</ELocationID><Abstract><AbstractText>Genome-wide association study is a powerful approach to identify disease risk loci. However, the molecular regulatory mechanisms for most complex diseases are still not well understood. Therefore, further investigating the interplay between genetic factors and biological networks is important for elucidating the molecular mechanisms of complex diseases. Here, we proposed a novel framework to identify susceptibility gene modules and disease risk genes by combining network topological properties with support vector regression from single nucleotide polymorphism (SNP) level. We assigned risk SNPs to genes using the University of California at Santa Cruz (UCSC) genome database, and then mapped these genes to protein-protein interaction (PPI) networks. The gene modules implicated by hub genes were extracted using the PPI networks and the topological property was analyzed for these gene modules. For each gene module, risk feature genes were determined by topological property analysis and support vector regression. As a result, five shared risk feature genes, CD80, EGFR, FN1, GSK3B and TRAF6 were found and proven to be associated with rheumatoid arthritis by previous reports. Our approach showed a good performance in comparison with other approaches and can be used for prioritizing candidate genes associated with complex diseases.</AbstractText><CopyrightInformation>Copyright .. 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Institute of Capital Medical University, Beijing 100069, China. hualin7750@yahoo.com.cn</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ping</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi-cheng</ForeName><Initials>ZC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Theor Biol</MedlineTA><NlmUniqueID>0376342</NlmUniqueID><ISSNLinking>0022-5193</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060388" MajorTopicYN="N">Support Vector Machine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>08</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21910999</ArticleId><ArticleId IdType="pii">S0022-5193(11)00443-7</ArticleId><ArticleId IdType="doi">10.1016/j.jtbi.2011.08.040</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21701272</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>4</Issue><PubDate><MedlineDate>2011 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Predicting three-year kidney graft survival in recipients with systemic lupus erythematosus.</ArticleTitle><Pagination><MedlinePgn>300-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0b013e318222db30</ELocationID><Abstract><AbstractText>Predicting the outcome of kidney transplantation is important in optimizing transplantation parameters and modifying factors related to the recipient, donor, and transplant procedure. As patients with end-stage renal disease (ESRD) secondary to lupus nephropathy are generally younger than the typical ESRD patients and also seem to have inferior transplant outcome, developing an outcome prediction model in this patient category has high clinical relevance. The goal of this study was to compare methods of building prediction models of kidney transplant outcome that potentially can be useful for clinical decision support. We applied three well-known data mining methods (classification trees, logistic regression, and artificial neural networks) to the data describing recipients with systemic lupus erythematosus (SLE) in the US Renal Data System (USRDS) database. The 95% confidence interval (CI) of the area under the receiver-operator characteristic curves (AUC) was used to measure the discrimination ability of the prediction models. Two groups of predictors were selected to build the prediction models. Using input variables based on Weka (a open source machine learning software) supplemented with additional variables of known clinical relevance (38 total predictors), the logistic regression performed the best overall (AUC: 0.74, 95% CI: 0.72-0.77)-significantly better (p &lt; 0.05) than the classification trees (AUC: 0.70, 95% CI: 0.67-0.72) but not significantly better (p = 0.218) than the artificial neural networks (AUC: 0.71, 95% CI: 0.69-0.73). The performance of the artificial neural networks was not significantly better than that of the classification trees (p = 0.693). Using the more parsimonious subset of variables (six variables), the logistic regression (AUC: 0.73, 95% CI: 0.71-0.75) did not perform significantly better than either the classification tree (AUC: 0.70, 95% CI: 0.68-0.73) or the artificial neural network (AUC: 0.73, 95% CI: 0.70-0.75) models. We generated several models predicting 3-year allograft survival in kidney transplant recipients with SLE that potentially can be used in practice. The performance of logistic regression and classification tree was not inferior to more complex artificial neural network. Prediction models may be used in clinical practice to identify patients at risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hongying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Transplant Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poynton</LastName><ForeName>Mollie R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Hurdle</LastName><ForeName>John F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Baird</LastName><ForeName>Bradley C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Koford</LastName><ForeName>James K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Goldfarb-Rumyantzev</LastName><ForeName>Alexander S</ForeName><Initials>AS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006085" MajorTopicYN="N">Graft Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="N">Kidney Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009927" MajorTopicYN="N">Tissue and Organ Procurement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21701272</ArticleId><ArticleId IdType="doi">10.1097/MAT.0b013e318222db30</ArticleId><ArticleId IdType="pii">00002480-201107000-00010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21210282</PMID><DateCompleted><Year>2011</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1203</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Human genetics</Title><ISOAbbreviation>Hum Genet</ISOAbbreviation></Journal><ArticleTitle>A genome-wide screen of gene-gene interactions for rheumatoid arthritis susceptibility.</ArticleTitle><Pagination><MedlinePgn>473-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00439-010-0943-z</ELocationID><Abstract><AbstractText>The objective of the study was to identify interacting genes contributing to rheumatoid arthritis (RA) susceptibility and identify SNPs that discriminate between RA patients who were anti-cyclic citrullinated protein positive and healthy controls. We analyzed two independent cohorts from the North American Rheumatoid Arthritis Consortium. A cohort of 908 RA cases and 1,260 controls was used to discover pairwise interactions among SNPs and to identify a set of single nucleotide polymorphisms (SNPs) that predict RA status, and a second cohort of 952 cases and 1,760 controls was used to validate the findings. After adjusting for HLA-shared epitope alleles, we identified and replicated seven SNP pairs within the HLA class II locus with significant interaction effects. We failed to replicate significant pairwise interactions among non-HLA SNPs. The machine learning approach "random forest" applied to a set of SNPs selected from single-SNP and pairwise interaction tests identified 93 SNPs that distinguish RA cases from controls with 70% accuracy. HLA SNPs provide the most classification information, and inclusion of non-HLA SNPs improved classification. While specific gene-gene interactions are difficult to validate using genome-wide SNP data, a stepwise approach combining association and classification methods identifies candidate interacting SNPs that distinguish RA cases from healthy controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Population Studies and the Framingham Heart Study, National Heart, Lung, and Blood Institute/NIH, 73 Mt. Wayte Avenue, Framingham, MA 01702, USA. liuchunyu2002@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackerman</LastName><ForeName>H Hoxie</ForeName><Initials>HH</Initials></Author><Author ValidYN="Y"><LastName>Carulli</LastName><ForeName>John P</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Hum Genet</MedlineTA><NlmUniqueID>7613873</NlmUniqueID><ISSNLinking>0340-6717</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="Y">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21210282</ArticleId><ArticleId IdType="doi">10.1007/s00439-010-0943-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Opin Rheumatol. 2010 Mar;22(2):109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">20075733</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2010 Jun;42(6):508-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20453842</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2007 Sep;4(9):e278</Citation><ArticleIdList><ArticleId IdType="pubmed">17880261</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jan;60(1):30-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19116921</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 May;80(5):867-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17436241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Aug;60(8):2242-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19644859</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Apr;60(4):931-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19333938</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2009 Dec 15;3 Suppl 7:S81</Citation><ArticleIdList><ArticleId IdType="pubmed">20018077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Hered. 2003;56(1-3):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">14614241</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Oct;40(10):1216-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18794853</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2010 Apr;11(3):199-208</Citation><ArticleIdList><ArticleId IdType="pubmed">20090771</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1987 Nov;30(11):1205-13</Citation><ArticleIdList><ArticleId IdType="pubmed">2446635</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2000 Jan;43(1):30-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10643697</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Jun;10(6):392-404</Citation><ArticleIdList><ArticleId IdType="pubmed">19434077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1991 Jun;50(6):343-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2059076</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2008 Mar 19;299(11):1335-44</Citation><ArticleIdList><ArticleId IdType="pubmed">18349094</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2008 Apr;32(3):255-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18200600</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med. 2008 May-Jun;14(5-6):293-300</Citation><ArticleIdList><ArticleId IdType="pubmed">18309376</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 20;357(12):1199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2006 Sep 22;2(9):e157</Citation><ArticleIdList><ArticleId IdType="pubmed">17002500</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Jan;82(1):48-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18179884</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2004 Dec 10;5:32</Citation><ArticleIdList><ArticleId IdType="pubmed">15588316</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2003 Dec;25(4):327-38</Citation><ArticleIdList><ArticleId IdType="pubmed">14639702</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 Aug;34(4):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">12833157</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2005;7(5):R949-58</Citation><ArticleIdList><ArticleId IdType="pubmed">16207336</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Mar;6(2):129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15674368</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 6;357(10):977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17804842</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1993 Aug 13;261(5123):921-3</Citation><ArticleIdList><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2005 Nov;52(11):3433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16255021</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2005 Dec;77(6):1044-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16380915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Feb 15;361(9357):598-604</Citation><ArticleIdList><ArticleId IdType="pubmed">12598158</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2007 Nov;120(11):936-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17976416</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2007 Nov;31(7):776-88</Citation><ArticleIdList><ArticleId IdType="pubmed">17549752</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Apr;37(4):413-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15793588</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2006 Jan 06;7:3</Citation><ArticleIdList><ArticleId IdType="pubmed">16398926</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Aug;75(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15208781</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Feb;46(2):328-46</Citation><ArticleIdList><ArticleId IdType="pubmed">11840435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Nov;37(11):1217-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16244653</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Feb 28;358(9):900-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18204098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jan 15;21(2):263-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jul;41(7):820-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19503088</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2010 Dec;49(12):2298-304</Citation><ArticleIdList><ArticleId IdType="pubmed">20833643</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2002 Jan 15;21(1):35-50</Citation><ArticleIdList><ArticleId IdType="pubmed">11782049</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1986 Dec;83(23):9149-53</Citation><ArticleIdList><ArticleId IdType="pubmed">3466180</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2007 Mar-Apr;25(2):219-24</Citation><ArticleIdList><ArticleId IdType="pubmed">17543145</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Oct;38(10):1166-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16998491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med. 2007 Sep-Oct;13(9-10):455-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17932559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Aug;38(8):904-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Hum Genet. 2000 Sep;64(Pt 5):413-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11281279</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1999 Jun;42(6):1071-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10366098</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2002 Mar 1;155(5):478-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11867360</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1986 Apr;83(8):2642-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3458223</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20699326</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>21</Issue><PubDate><Year>2010</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals.</ArticleTitle><Pagination><MedlinePgn>4286-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddq328</ELocationID><Abstract><AbstractText>The primary genetic risk factor in multiple sclerosis (MS) is the HLA-DRB1*1501 allele; however, much of the remaining genetic contribution to MS has yet to be elucidated. Several lines of evidence support a role for neuroendocrine system involvement in autoimmunity which may, in part, be genetically determined. Here, we comprehensively investigated variation within eight candidate hypothalamic-pituitary-adrenal (HPA) axis genes and susceptibility to MS. A total of 326 SNPs were investigated in a discovery dataset of 1343 MS cases and 1379 healthy controls of European ancestry using a multi-analytical strategy. Random Forests, a supervised machine-learning algorithm, identified eight intronic SNPs within the corticotrophin-releasing hormone receptor 1 or CRHR1 locus on 17q21.31 as important predictors of MS. On the basis of univariate analyses, six CRHR1 variants were associated with decreased risk for disease following a conservative correction for multiple tests. Independent replication was observed for CRHR1 in a large meta-analysis comprising 2624 MS cases and 7220 healthy controls of European ancestry. Results from a combined meta-analysis of all 3967 MS cases and 8599 controls provide strong evidence for the involvement of CRHR1 in MS. The strongest association was observed for rs242936 (OR = 0.82, 95% CI = 0.74-0.90, P = 9.7 .. 10(-5)). Replicated CRHR1 variants appear to exist on a single associated haplotype. Further investigation of mechanisms involved in HPA axis regulation and response to stress in MS pathogenesis is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Farren B S</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Laboratory, Division of Epidemiology, School of Public Health, CA 94720-7356, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Selena E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>McCauley</LastName><ForeName>Jacob L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Zuvich</LastName><ForeName>Rebecca L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>De Jager</LastName><ForeName>Philip L</ForeName><Initials>PL</Initials></Author><Author ValidYN="Y"><LastName>Rioux</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Ivinson</LastName><ForeName>Adrian J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Compston</LastName><ForeName>Alastair</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hafler</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Stephen L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Oksenberg</LastName><ForeName>Jorge R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Sawcer</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Pericak-Vance</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><CollectiveName>International Multiple Sclerosis Genetics Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G0700061</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U19 AI067152</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI059829</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018019">Receptors, Corticotropin-Releasing Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>5CLY6W2H1M</RegistryNumber><NameOfSubstance UI="C101530">CRF receptor type 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018019" MajorTopicYN="N">Receptors, Corticotropin-Releasing Hormone</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20699326</ArticleId><ArticleId IdType="pii">ddq328</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddq328</ArticleId><ArticleId IdType="pmc">PMC2951862</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Bioinformatics. 2010 Feb 27;11:110</Citation><ArticleIdList><ArticleId IdType="pubmed">20187966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2000 Jun;47(6):831-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10852554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Jun 1;18(11):2078-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19286671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain. 2003 Dec;106(3):297-307</Citation><ArticleIdList><ArticleId IdType="pubmed">14659512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2008 Nov;1144:56-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19076364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2005 Jul 15;14(14):2019-26</Citation><ArticleIdList><ArticleId IdType="pubmed">15930013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 1998 Jun;19(2):108-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9620759</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 2009;26(11):984-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19750552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2009 Jan;68(1):40-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18276740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">2709039</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2006 Oct 5;52(1):61-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17015227</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neurol. 2009;62(3):130-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19571540</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolism. 2002 Jun;51(6 Suppl 1):5-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12040534</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2004 Aug;10(8):409-15</Citation><ArticleIdList><ArticleId IdType="pubmed">15310462</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology. 2010 Mar;151(3):1221-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20032050</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jul;41(7):824-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19525955</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Nov;81(5):1084-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17924348</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2008 Jan;7(3):209-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18190880</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimmunomodulation. 2006;13(5-6):277-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17709949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2008 Nov;14(9):1262-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2001 Aug;44(8):1761-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11508426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2006 Sep 15;15(18):2813-24</Citation><ArticleIdList><ArticleId IdType="pubmed">16905561</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Mar 05;10:78</Citation><ArticleIdList><ArticleId IdType="pubmed">19265542</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2007 Jul;32(6):604-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17602841</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2008 Dec 9;71(24):1948-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19064876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1991 Apr 15;134(1):77-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1672837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jun 15;174(12):7665-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15944267</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Aug;6(5):375-87</Citation><ArticleIdList><ArticleId IdType="pubmed">15973459</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Jun 21;296(5576):2225-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12029063</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2008 Nov 7;322(5903):881-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18988837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2010 Mar 1;19(5):953-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20007504</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimmunomodulation. 2009;16(5):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19571587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2008 Jul;7(7):567-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18565446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2006 Jun;1069:62-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16855135</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2006 Sep 1;404(3):358-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16815632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroendocrinol. 2003 Nov;15(11):1070-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14622437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2009 Aug 1;25(15):1884-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19460890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2007 Nov;21(8):1009-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17889502</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Biochem. 2004 Jul;271(13):2821-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15206947</ArticleId></ArticleIdList></Reference><Reference><Citation>J Chronic Dis. 1982;35(11):821-31</Citation><ArticleIdList><ArticleId IdType="pubmed">7142361</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19380721</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2008 Oct;9(7):624-30</Citation><ArticleIdList><ArticleId IdType="pubmed">18650830</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2008 Jul 11;9:307</Citation><ArticleIdList><ArticleId IdType="pubmed">18620558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology. 1998 Jan;139(1):403-13</Citation><ArticleIdList><ArticleId IdType="pubmed">9421440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Feb 15;18(4):767-78</Citation><ArticleIdList><ArticleId IdType="pubmed">19010793</ArticleId></ArticleIdList></Reference><Reference><Citation>J Autoimmun. 2009 May-Jun;32(3-4):231-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19307103</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2003 Sep 20;327(7416):646</Citation><ArticleIdList><ArticleId IdType="pubmed">14500435</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2006 Oct;14(10):1064</Citation><ArticleIdList><ArticleId IdType="pubmed">16736032</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jul;41(7):776-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19525953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Methods. 2006 Jan;3(1):31-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16369550</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 2009 Feb;71(2):243-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19188532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2009 Jun 25;211(1-2):105-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19375175</ArticleId></ArticleIdList></Reference><Reference><Citation>Peptides. 2001 May;22(5):809-20</Citation><ArticleIdList><ArticleId IdType="pubmed">11337095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):557-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15767327</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Mol Med. 2008 Jun;8(4):247-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18537632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2008 Aug;64(2):143-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18570326</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2001 Dec;15(14):2754-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11606483</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Rev. 2006 May;27(3):260-86</Citation><ArticleIdList><ArticleId IdType="pubmed">16484629</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Oct 15;181(8):5473-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18832704</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 1988 May;18(1):5-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2837436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2005 Jan 15;21(2):263-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Dermatol. 2007 Feb;16(2):104-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17222223</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5264-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19237575</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Jan;74(1):160-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14669136</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1999 Jun 10;52(9):1737-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10371517</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2004 Nov;25(11):563-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15491778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2006 Aug;12(4):465-75</Citation><ArticleIdList><ArticleId IdType="pubmed">16900760</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Feb 12;86(2):161-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20116045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2003 Oct;143(1-2):39-46</Citation><ArticleIdList><ArticleId IdType="pubmed">14575912</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Feb;37(2):129-37</Citation><ArticleIdList><ArticleId IdType="pubmed">15654335</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Aug 30;357(9):851-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17660530</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2000 Jul 12;55(1):55-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10891906</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Oct;38(10):1166-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16998491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Aug;38(8):904-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2000 Jun;155(2):945-59</Citation><ArticleIdList><ArticleId IdType="pubmed">10835412</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 2002 Nov-Dec;64(6):916-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12461197</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrinology. 2009 Dec;150(12):5428-37</Citation><ArticleIdList><ArticleId IdType="pubmed">19819946</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2008 Jan;14(1):6-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17881389</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2008 Feb;7(1):14-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17376150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 2008 Mar-Apr;252(1-2):16-26</Citation><ArticleIdList><ArticleId IdType="pubmed">18279846</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2002 Nov;70(11):6068-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12379683</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2010 Jun 14;11:49</Citation><ArticleIdList><ArticleId IdType="pubmed">20546594</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2008 Oct;23(7):497-504</Citation><ArticleIdList><ArticleId IdType="pubmed">18778921</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2010 Apr 9;86(4):621-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20362272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20546594</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2010</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC genetics</Title><ISOAbbreviation>BMC Genet</ISOAbbreviation></Journal><ArticleTitle>An application of Random Forests to a genome-wide association dataset: methodological considerations &amp; new findings.</ArticleTitle><Pagination><MedlinePgn>49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2156-11-49</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">As computational power improves, the application of more advanced machine learning techniques to the analysis of large genome-wide association (GWA) datasets becomes possible. While most traditional statistical methods can only elucidate main effects of genetic variants on risk for disease, certain machine learning approaches are particularly suited to discover higher order and non-linear effects. One such approach is the Random Forests (RF) algorithm. The use of RF for SNP discovery related to human disease has grown in recent years; however, most work has focused on small datasets or simulation studies which are limited.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using a multiple sclerosis (MS) case-control dataset comprised of 300 K SNP genotypes across the genome, we outline an approach and some considerations for optimally tuning the RF algorithm based on the empirical dataset. Importantly, results show that typical default parameter values are not appropriate for large GWA datasets. Furthermore, gains can be made by sub-sampling the data, pruning based on linkage disequilibrium (LD), and removing strong effects from RF analyses. The new RF results are compared to findings from the original MS GWA study and demonstrate overlap. In addition, four new interesting candidate MS genes are identified, MPHOSPH9, CTNNA3, PHACTR2 and IL7, by RF analysis and warrant further follow-up in independent studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study presents one of the first illustrations of successfully analyzing GWA data with a machine learning algorithm. It is shown that RF is computationally feasible for GWA data and the results obtained make biologic sense based on previous studies. More importantly, new genes were identified as potentially being associated with MS, suggesting new avenues of investigation for this complex disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, School of Public Health, University of California, Berkeley, CA, USA. bgoldstein@genepi.berkeley.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubbard</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Cutler</LastName><ForeName>Adele</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH 63420</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH60870</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH59586</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH059571</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH067257</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS049510</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>076113</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01AI076544</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH059565</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH059588</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HG 00047</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS032830</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH59566</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS049477</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH060879</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH59587</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G0700061</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Genet</MedlineTA><NlmUniqueID>100966978</NlmUniqueID><ISSNLinking>1471-2156</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>06</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20546594</ArticleId><ArticleId IdType="pii">1471-2156-11-49</ArticleId><ArticleId IdType="doi">10.1186/1471-2156-11-49</ArticleId><ArticleId IdType="pmc">PMC2896336</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Genet. 2009 Jul;41(7):824-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19525955</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Nov;81(5):1084-97</Citation><ArticleIdList><ArticleId IdType="pubmed">17924348</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Aug;6(5):375-87</Citation><ArticleIdList><ArticleId IdType="pubmed">15973459</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2003 Apr;41(4):529-34</Citation><ArticleIdList><ArticleId IdType="pubmed">12747598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jul;41(7):776-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19525953</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2009 Mar 27;453(1):9-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19429005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genomics. 2006 Mar;2(5):318-28</Citation><ArticleIdList><ArticleId IdType="pubmed">16595076</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S62</Citation><ArticleIdList><ArticleId IdType="pubmed">18466563</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2008 Nov 14;9:71</Citation><ArticleIdList><ArticleId IdType="pubmed">19014573</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2005 Feb;28(2):171-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15593090</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2008 Mar 19;299(11):1335-44</Citation><ArticleIdList><ArticleId IdType="pubmed">18349094</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2009 Mar 05;10:78</Citation><ArticleIdList><ArticleId IdType="pubmed">19265542</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2004 Dec 10;5:32</Citation><ArticleIdList><ArticleId IdType="pubmed">15588316</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Genet. 2006 Apr 21;7:23</Citation><ArticleIdList><ArticleId IdType="pubmed">16630340</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2005 Feb;28(2):157-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15532037</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2006 Jan 06;7:3</Citation><ArticleIdList><ArticleId IdType="pubmed">16398926</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2007 Jan 25;8:25</Citation><ArticleIdList><ArticleId IdType="pubmed">17254353</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Neurobiol. 2007 Aug;27(5):651-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17554624</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Aug 30;357(9):851-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17660530</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S54</Citation><ArticleIdList><ArticleId IdType="pubmed">18466554</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2008;10(2):107</Citation><ArticleIdList><ArticleId IdType="pubmed">18466642</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):727-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18163421</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20497952</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2010</Year><Month>Jul</Month></PubDate></JournalIssue><Title>International immunology</Title><ISOAbbreviation>Int Immunol</ISOAbbreviation></Journal><ArticleTitle>Specific serum protein biomarkers of rheumatoid arthritis detected by MALDI-TOF-MS combined with magnetic beads.</ArticleTitle><Pagination><MedlinePgn>611-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/intimm/dxq043</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To identify novel serum protein biomarkers and establish diagnostic pattern for rheumatoid arthritis (RA) by using proteomic technology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Serum proteomic spectra were generated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) combined with weak cationic exchange magnetic beads. A training set of spectra, derived from analyzing sera from 22 patients with RA, 26 patients with other autoimmune diseases and 25 age- and sex-matched healthy volunteers, was used to train and develop a decision tree model with a machine learning algorithm called decision boosting. A blinded testing set, including 21 patients with RA, 24 patients with other autoimmune diseases and 25 healthy people, was used to examine the accuracy of the model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A decision tree model was established, consisting of four potential protein biomarkers whose m/z values were 4966.88, 5065.3, 5636.97 and 7766.87, respectively. In validation test, the decision tree model could differentiate RA from other autoimmune diseases and healthy people with the sensitivity of 85.71% and specificity of 87.76%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present data suggested that MALDI-TOF-MS combined with magnetic beads could screen and identify some novel serum protein biomarkers related to RA. The proteomic pattern based on the four candidate biomarkers is of value for laboratory diagnosis of RA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, No. 37, Guo Xue Xiang, Chengdu 610041, The People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhuochun</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yunying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lanlan</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xiaofu</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chaojun</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int Immunol</MedlineTA><NlmUniqueID>8916182</NlmUniqueID><ISSNLinking>0953-8178</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008280" MajorTopicYN="Y">Magnetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008863" MajorTopicYN="Y">Microspheres</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="N">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20497952</ArticleId><ArticleId IdType="pii">dxq043</ArticleId><ArticleId IdType="doi">10.1093/intimm/dxq043</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20090771</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5470</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2010</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Genes and immunity</Title><ISOAbbreviation>Genes Immun</ISOAbbreviation></Journal><ArticleTitle>Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.</ArticleTitle><Pagination><MedlinePgn>199-208</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/gene.2009.110</ELocationID><Abstract><AbstractText>Investigating genetic interactions (epistasis) has proven difficult despite the recent advances of both laboratory methods and statistical developments. With no 'best' statistical approach available, combining several analytical methods may be optimal for detecting epistatic interactions. Using a multi-stage analysis that incorporated supervised machine learning and methods of association testing, we investigated epistatic interactions with a well-established genetic factor (PTPN22 1858T) in a complex autoimmune disease (rheumatoid arthritis (RA)). Our analysis consisted of four principal stages: Stage I (data reduction)-identifying candidate chromosomal regions in 292 affected sibling pairs, by predicting PTPN22 concordance using multipoint identity-by-descent probabilities and a supervised machine learning algorithm (Random Forests); Stage II (extension analysis)-testing detailed genetic data within candidate chromosomal regions for epistasis with PTPN22 1858T in 677 cases and 750 controls using logistic regression; Stage III (replication analysis)-confirmation of epistatic interactions in 947 cases and 1756 controls; Stage IV (combined analysis)-a pooled analysis including all 1624 RA cases and 2506 control subjects for final estimates of effect size. A total of seven replicating epistatic interactions were identified. SNP variants within CDH13, MYO3A, CEP72 and near WFDC1 showed significant evidence for interaction with PTPN22, affecting susceptibility to RA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>F B S</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>University of California, Berkeley, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsay</LastName><ForeName>P P</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Madden</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Holers</LastName><ForeName>V M</ForeName><Initials>VM</Initials></Author><Author ValidYN="Y"><LastName>Mikuls</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Sokka</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Seldin</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Gregersen</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Author><Author ValidYN="Y"><LastName>Criswell</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>L F</ForeName><Initials>LF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR044422</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5 MO1 RR-00079</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR02175</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR44422</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR051394</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-AR-2-2263</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR 20684</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR002175</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR044422-10</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR044422-13</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000079</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Immun</MedlineTA><NlmUniqueID>100953417</NlmUniqueID><ISSNLinking>1466-4879</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="C516765">PTPN22 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.48</RegistryNumber><NameOfSubstance UI="D054596">Protein Tyrosine Phosphatase, Non-Receptor Type 22</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="Y">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054596" MajorTopicYN="N">Protein Tyrosine Phosphatase, Non-Receptor Type 22</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035781" MajorTopicYN="N">Siblings</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20090771</ArticleId><ArticleId IdType="pii">gene2009110</ArticleId><ArticleId IdType="doi">10.1038/gene.2009.110</ArticleId><ArticleId IdType="pmc">PMC3118040</ArticleId><ArticleId IdType="mid">NIHMS214790</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S127</Citation><ArticleIdList><ArticleId IdType="pubmed">18466469</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2005 Apr;19(6):588-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15703273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Hered. 2007;63(2):67-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17283436</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2000 Jul;67(1):170-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10827107</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2005 Apr;76(4):561-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15719322</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Mar 15;182(6):3343-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19265110</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2000 Jan;43(1):155-63</Citation><ArticleIdList><ArticleId IdType="pubmed">10643712</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Jan;82(1):471-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17942534</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2000 Jan;43(1):30-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10643697</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1986 Oct;13(5):878-81</Citation><ArticleIdList><ArticleId IdType="pubmed">3820196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2006 Aug;45(8):1009-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16490755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2009 Jun;10(6):392-404</Citation><ArticleIdList><ArticleId IdType="pubmed">19434077</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2002 Sep;71(3):585-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12181776</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2002 May 28;99(11):7518-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12032315</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2001 Apr;68(4):963-77</Citation><ArticleIdList><ArticleId IdType="pubmed">11254453</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 20;357(12):1199-209</Citation><ArticleIdList><ArticleId IdType="pubmed">17804836</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S178-81</Citation><ArticleIdList><ArticleId IdType="pubmed">16273804</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rheumatol. 2008 May;27(5):637-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18071780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2005 Dec;37(12):1317-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16273109</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2008;10(3):R52</Citation><ArticleIdList><ArticleId IdType="pubmed">18462498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2009 Sep;126(3):457-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19466457</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2002 Jan;63(1):76-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11916172</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2009 Jul 22;28(14):2066-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19536135</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2006 Sep 15;2(9):e143</Citation><ArticleIdList><ArticleId IdType="pubmed">17044734</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunol. 2006 Aug;18(4):214-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16731003</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2008 Nov 7;322(5903):881-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18988837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Dec;39(12):1431-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17982455</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S70</Citation><ArticleIdList><ArticleId IdType="pubmed">18466572</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 2009 Jan 22;583(2):430-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19116147</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Jan;60(1):30-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19116921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamm Genome. 2000 Sep;11(9):767-73</Citation><ArticleIdList><ArticleId IdType="pubmed">10967136</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urban Health. 2004 Jun;81(2):301-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15136663</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S63</Citation><ArticleIdList><ArticleId IdType="pubmed">18466564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2009 Dec 15;61(12):1735-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19950324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2003 Aug;34(4):395-402</Citation><ArticleIdList><ArticleId IdType="pubmed">12833157</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2005 Mar;6(2):129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15674368</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Sep 6;357(10):977-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17804842</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 May;80(5):867-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17436241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2002 Sep;46(9):2320-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12355479</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2006 Apr 21;281(16):11002-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16461343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Cell. 2003 Mar;14(3):1058-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12631723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigment Cell Melanoma Res. 2009 Jun;22(3):296-306</Citation><ArticleIdList><ArticleId IdType="pubmed">19368692</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2005 Aug;32(8):1488-94</Citation><ArticleIdList><ArticleId IdType="pubmed">16078324</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Jun;48(6):1530-42</Citation><ArticleIdList><ArticleId IdType="pubmed">12794820</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2003 Apr;48(4):906-16</Citation><ArticleIdList><ArticleId IdType="pubmed">12687532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Aug 1;17(15):2274-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18434327</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Nov 1;179(9):6359-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17947714</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Hematol. 2002 Mar;30(3):237-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11882361</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Nov;34(11):2253-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17937465</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Dec;54(12):3820-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17133579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Genet. 2009 Jul;126(1):13-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19384554</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Oct 1;179(7):4704-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17878369</ArticleId></ArticleIdList></Reference><Reference><Citation>FEBS Lett. 1998 Jun 12;429(2):207-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9650591</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2222-30</Citation><ArticleIdList><ArticleId IdType="pubmed">16873731</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2007;9(3):R56</Citation><ArticleIdList><ArticleId IdType="pubmed">17553139</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Aug;75(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15208781</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 1988 Mar;31(3):315-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2006 Dec;7(12):917-28</Citation><ArticleIdList><ArticleId IdType="pubmed">17139323</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 Jan;54(1):38-46</Citation><ArticleIdList><ArticleId IdType="pubmed">16385494</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S17</Citation><ArticleIdList><ArticleId IdType="pubmed">18466513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Jun 15;18(12):2288-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19304780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Oct;40(10):1156-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18794857</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2008;26:29-55</Citation><ArticleIdList><ArticleId IdType="pubmed">18303998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2007 Jul;34(7):1480-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17552044</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jul;41(7):820-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19503088</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Apr 1;182(7):4093-106</Citation><ArticleIdList><ArticleId IdType="pubmed">19299707</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Immun. 2006 Jun;7(4):277-86</Citation><ArticleIdList><ArticleId IdType="pubmed">16691188</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 May;9(5):356-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18398418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mutat. 2009 Jan;30(1):69-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18683858</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2009;27:363-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19302045</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2007 Jul;90(1):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17482423</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinogenesis. 2009 Jan;30(1):20-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18842679</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2008 Aug 22;283(34):23485-95</Citation><ArticleIdList><ArticleId IdType="pubmed">18550521</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Res Ther. 2007;9(1):R5</Citation><ArticleIdList><ArticleId IdType="pubmed">17254342</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2006 Oct 4;26(40):10243-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17021180</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S13</Citation><ArticleIdList><ArticleId IdType="pubmed">18466472</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Rev Allergy Immunol. 2007 Feb;32(1):47-56</Citation><ArticleIdList><ArticleId IdType="pubmed">17426360</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Proc. 2007;1 Suppl 1:S54</Citation><ArticleIdList><ArticleId IdType="pubmed">18466554</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2006 May;54(5):1482-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16646029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Feb 15;182(4):2041-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19201857</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2001 Apr;68(4):927-36</Citation><ArticleIdList><ArticleId IdType="pubmed">11254450</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2007 Nov;19(6):580-91</Citation><ArticleIdList><ArticleId IdType="pubmed">17917539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2003 Sep 15;63(18):5859-65</Citation><ArticleIdList><ArticleId IdType="pubmed">14522910</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2005 Oct;19(12):1737-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16099944</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2002 May;22(1):16-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12120906</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19816555</PMID><DateCompleted><Year>2010</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet</ISOAbbreviation></Journal><ArticleTitle>From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes.</ArticleTitle><Pagination><MedlinePgn>e1000678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1000678</ELocationID><Abstract><AbstractText>Genome-wide association studies (GWAS) have been fruitful in identifying disease susceptibility loci for common and complex diseases. A remaining question is whether we can quantify individual disease risk based on genotype data, in order to facilitate personalized prevention and treatment for complex diseases. Previous studies have typically failed to achieve satisfactory performance, primarily due to the use of only a limited number of confirmed susceptibility loci. Here we propose that sophisticated machine-learning approaches with a large ensemble of markers may improve the performance of disease risk assessment. We applied a Support Vector Machine (SVM) algorithm on a GWAS dataset generated on the Affymetrix genotyping platform for type 1 diabetes (T1D) and optimized a risk assessment model with hundreds of markers. We subsequently tested this model on an independent Illumina-genotyped dataset with imputed genotypes (1,008 cases and 1,000 controls), as well as a separate Affymetrix-genotyped dataset (1,529 cases and 1,458 controls), resulting in area under ROC curve (AUC) of approximately 0.84 in both datasets. In contrast, poor performance was achieved when limited to dozens of known susceptibility loci in the SVM model or logistic regression model. Our study suggests that improved disease risk assessment can be achieved by using algorithms that take into account interactions between a large ensemble of markers. We are optimistic that genotype-based disease risk assessment may be feasible for diseases where a notable proportion of the risk has already been captured by SNP arrays.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Computer Science, New Jersey Institute of Technology, Newark, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Hui-Qi</ForeName><Initials>HQ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haitao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Bradfield</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Frackleton</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Cuiping</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Glessner</LastName><ForeName>Joseph T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Chiavacci</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Stanley</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Monos</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Struan F A</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Polychronakos</LastName><ForeName>Constantin</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hakonarson</LastName><ForeName>Hakon</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>076113</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19816555</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1000678</ArticleId><ArticleId IdType="pmc">PMC2748686</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS Med. 2006 Oct;3(10):e374</Citation><ArticleIdList><ArticleId IdType="pubmed">17020404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Apr 9-15;365(9467):1333-46</Citation><ArticleIdList><ArticleId IdType="pubmed">15823385</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 May 11;316(5826):889-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17434869</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3129-35</Citation><ArticleIdList><ArticleId IdType="pubmed">18591388</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2009 Feb;5(2):e1000337</Citation><ArticleIdList><ArticleId IdType="pubmed">19197355</ArticleId></ArticleIdList></Reference><Reference><Citation>Invest Ophthalmol Vis Sci. 2009 May;50(5):2044-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19117936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Aug;40(8):955-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18587394</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Aug;75(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15208781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2006 Dec;24(12):1565-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17160063</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2003 Apr;52(4):1052-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12663480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):609-15</Citation><ArticleIdList><ArticleId IdType="pubmed">18391951</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2009 Sep 15;18(18):3525-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19553258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Sep;39(9):1045-51</Citation><ArticleIdList><ArticleId IdType="pubmed">17728769</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jun;41(6):703-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2008;3(10):e3395</Citation><ArticleIdList><ArticleId IdType="pubmed">18852893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2007 Oct;39(10):1181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17898773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2008 Oct 15;17(R2):R166-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18852206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18372903</ArticleId></ArticleIdList></Reference><Reference><Citation>Biostatistics. 2008 Jan;9(1):30-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17429103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):575-83</Citation><ArticleIdList><ArticleId IdType="pubmed">18391952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jan;41(1):56-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19060906</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2007 May 18;3(5):e74</Citation><ArticleIdList><ArticleId IdType="pubmed">17511519</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Genet. 2008 Oct;4(10):e1000231</Citation><ArticleIdList><ArticleId IdType="pubmed">18949033</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Med. 2006 Mar;8(3):191-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16540755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Aug 2;448(7153):591-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17632545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Jan 20;150(2):65-72</Citation><ArticleIdList><ArticleId IdType="pubmed">19153409</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2009 Aug;17(8):1070-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19223933</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2009 Jul;158(1):105-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19540399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):584-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18391950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Feb 15;361(9357):598-604</Citation><ArticleIdList><ArticleId IdType="pubmed">12598158</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 2008 Jun;18(3):257-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18682292</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Nov;57(11):3122-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18694974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2009 Jan;41(1):25-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19079261</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes. 2008 Jan;57(1):244-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17977958</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):262-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10618406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Dec;40(12):1399-401</Citation><ArticleIdList><ArticleId IdType="pubmed">18978792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2006 Jul;17(7):1782-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16775037</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 1987 Jan;40(1):1-14</Citation><ArticleIdList><ArticleId IdType="pubmed">3468804</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2008 Jun;14(6):268-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18482868</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Sep;81(3):559-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 May;9(5):356-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18398418</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Apr 23;360(17):1701-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19369656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2006 Aug;38(8):904-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2007 Oct;17(10):1520-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17785532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2004 Apr;36(4):337-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15004560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19627014</PMID><DateCompleted><Year>2010</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1672-173X</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition</Title><ISOAbbreviation>Sichuan Da Xue Xue Bao Yi Xue Ban</ISOAbbreviation></Journal><ArticleTitle>[Promising diagnostic model for systemic lupus erythematosus using proteomic fingerprint technology].</ArticleTitle><Pagination><MedlinePgn>499-503</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To establish a diagnostic model for systemic lupus erythematosus (SLE) using proteiomic fingerprint techology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Blood samples were collected from 64 cases of SLE, 30 cases of rheumatoid arthritis (RA), 30 cases of Sjogren's syndrome (SS), 25 cases of systemic sclerosis (SSc), as well as 83 healthy controls. Proteomic spectra of these 232 serum samples were generated by proteomic fingerprint technology. Diagnostic model was established by a machine learning algorithm called decision boosting. The sensitivity and specificity of the diagnostic model was validated with a blinded testing set.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty differential protein peaks (P&lt;0.05) between SLE and control subjects were indicated, 28 of them were up regulated and 32 were down regulated in SLE patients. The algorithm identified a cluster pattern segregating SLE from non-SLE with sensitivity of 91% and specificity of 92%. The discriminatory diagnostic pattern correctly identified SLE. A sensitivity of 78% and specificity of 96% for the blinded test were obtained when comparing SLE vs non-SLE.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This diagnostic model using proteiomic fingerprint techology appears to be a promising tools with high sensitivity and specificity in diagnosis of SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhuo-chun</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yun-ying</ForeName><Initials>YY</Initials></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Bei</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lan-lan</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yong-kang</ForeName><Initials>YK</Initials></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Bin-wu</ForeName><Initials>BW</Initials></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Wei-hua</ForeName><Initials>WH</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chao-jun</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yong-zhe</ForeName><Initials>YZ</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Sichuan Da Xue Xue Bao Yi Xue Ban</MedlineTA><NlmUniqueID>101162609</NlmUniqueID><ISSNLinking>1672-173X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19627014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19423430</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2009</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-0032</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society</Title><ISOAbbreviation>IEEE Trans Inf Technol Biomed</ISOAbbreviation></Journal><ArticleTitle>Microarray analysis of autoimmune diseases by machine learning procedures.</ArticleTitle><Pagination><MedlinePgn>341-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/TITB.2008.2011984</ELocationID><Abstract><AbstractText>Microarray-based global gene expression profiling, with the use of sophisticated statistical algorithms is providing new insights into the pathogenesis of autoimmune diseases. We have applied a novel statistical technique for gene selection based on machine learning approaches to analyze microarray expression data gathered from patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (PAPS), two autoimmune diseases of unknown genetic origin that share many common features. The methodology included a combination of three data discretization policies, a consensus gene selection method, and a multivariate correlation measurement. A set of 150 genes was found to discriminate SLE and PAPS patients from healthy individuals. Statistical validations demonstrate the relevance of this gene set from an univariate and multivariate perspective. Moreover, functional characterization of these genes identified an interferon-regulated gene signature, consistent with previous reports. It also revealed the existence of other regulatory pathways, including those regulated by PTEN, TNF, and BCL-2, which are altered in SLE and PAPS. Remarkably, a significant number of these genes carry E2F binding motifs in their promoters, projecting a role for E2F in the regulation of autoimmunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arma..anzas</LastName><ForeName>Rub..n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Artificial Intelligence, University of the Basque Country, 20080 San Sebastian, Spain. ruben@si.ehu.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Borja</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Inza</LastName><ForeName>I..aki</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>L..pez-Hoyos</LastName><ForeName>Marcos</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mart..nez-Taboada</LastName><ForeName>V..ctor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ucar</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bernales</LastName><ForeName>Irantzu</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Fullaondo</LastName><ForeName>Asier</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Larra..aga</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Zubiaga</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE Trans Inf Technol Biomed</MedlineTA><NlmUniqueID>9712259</NlmUniqueID><ISSNLinking>1089-7771</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="N">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19423430</ArticleId><ArticleId IdType="doi">10.1109/TITB.2008.2011984</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19389822</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1462-0332</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2009</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Rheumatology (Oxford, England)</Title><ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation></Journal><ArticleTitle>MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.</ArticleTitle><Pagination><MedlinePgn>626-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/kep058</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To discover novel potential biomarkers and establish a diagnostic pattern for SLE by using proteomic technology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Serum proteomic spectra were generated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) combined with weak cationic exchange magnetic beads. A training set of spectra, derived from analysing sera from 32 patients with SLE, 43 patients with other autoimmune diseases and 43 age- and sex-matched healthy volunteers, was used to train and develop a decision tree model with a machine learning algorithm called decision boosting. A blinded testing set, including 32 patients with SLE, 42 patients with other autoimmune diseases and 40 healthy people, was used to determine the accuracy of the model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The diagnostic pattern with a panel of four potential protein biomarkers of mass-to-charge (m/z) ratio 4070.09, 7770.45, 28 045.1 and 3376.02 could accurately recognize 25 of 32 patients with SLE, 36 of 42 patients with other autoimmune diseases and 36 of 40 healthy people.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The preliminary data suggested a potential application of MALDI-TOF MS combined with magnetic beads as an effective technology to profile serum proteome, and with pattern analysis, a diagnostic model comprising four potential biomarkers was indicated to differentiate individuals with SLE from RA, SS, SSc and healthy controls rapidly and precisely.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhuochun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yunying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Bei</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lanlan</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Binwu</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chaojun</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongzhe</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rheumatology (Oxford)</MedlineTA><NlmUniqueID>100883501</NlmUniqueID><ISSNLinking>1462-0324</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002412">Cations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002412" MajorTopicYN="N">Cations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="Y">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008280" MajorTopicYN="N">Magnetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008863" MajorTopicYN="N">Microspheres</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>4</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>4</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19389822</ArticleId><ArticleId IdType="pii">kep058</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/kep058</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19183246</PMID><DateCompleted><Year>2011</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1582-4934</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1-2</Issue><PubDate><Year>2010</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cellular and molecular medicine</Title><ISOAbbreviation>J Cell Mol Med</ISOAbbreviation></Journal><ArticleTitle>Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis.</ArticleTitle><Pagination><MedlinePgn>434-48</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1582-4934.2008.00646.x</ELocationID><Abstract><AbstractText>Theiler's murine encephalomyelitis is an experimentally virus-induced inflammatory demyelinating disease of the spinal cord, displaying clinical and pathological similarities to chronic progressive multiple sclerosis. The aim of this study was to identify pathways associated with chronic demyelination using an assumption-free combined microarray and immunohistology approach. Movement control as determined by rotarod assay significantly worsened in Theiler's murine encephalomyelitis -virus-infected SJL/J mice from 42 to 196 days after infection (dpi). In the spinal cords, inflammatory changes were detected 14 to 196 dpi, and demyelination progressively increased from 42 to 196 dpi. Microarray analysis revealed 1001 differentially expressed genes over the study period. The dominating changes as revealed by k-means and functional annotation clustering included up-regulations related to intrathecal antibody production and antigen processing and presentation via major histocompatibility class II molecules. A random forest machine learning algorithm revealed that down-regulated lipid and cholesterol biosynthesis, differentially expressed neurite morphogenesis and up-regulated toll-like receptor-4-induced pathways were intimately associated with demyelination as measured by immunohistology. Conclusively, although transcriptional changes were dominated by the adaptive immune response, the main pathways associated with demyelination included up-regulation of toll-like receptor 4 and down-regulation of cholesterol biosynthesis. Cholesterol biosynthesis is a rate limiting step of myelination and its down-regulation is suggested to be involved in chronic demyelination by an inhibition of remyelination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Reiner</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Veterinary Medicine Hannover, B..nteweg, Hannover, Germany. reiner.ulrich@tiho-hannover.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalkuhl</LastName><ForeName>Arno</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Deschl</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Baumg..rtner</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cell Mol Med</MedlineTA><NlmUniqueID>101083777</NlmUniqueID><ISSNLinking>1582-1838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018188" MajorTopicYN="N">Cardiovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003711" MajorTopicYN="Y">Demyelinating Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046228" MajorTopicYN="N">Microarray Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045442" MajorTopicYN="N">Rotarod Performance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017945" MajorTopicYN="Y">Theilovirus</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19183246</ArticleId><ArticleId IdType="pii">JCMM646</ArticleId><ArticleId IdType="doi">10.1111/j.1582-4934.2008.00646.x</ArticleId><ArticleId IdType="pmc">PMC3837619</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Pathol. 1979 Apr;95(1):99-116</Citation><ArticleIdList><ArticleId IdType="pubmed">434114</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 1995 Oct;62(1):91-102</Citation><ArticleIdList><ArticleId IdType="pubmed">7499498</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 2007 Jan 15;55(2):130-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17078030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2007 Jul;133(1):150-163.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">17631139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21</Citation><ArticleIdList><ArticleId IdType="pubmed">12430718</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2007 Nov;171(5):1563-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17823280</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2008 Feb;38(2):565-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18203139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2003 Jul;13(3):291-308</Citation><ArticleIdList><ArticleId IdType="pubmed">12946019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Feb 15;22(4):507-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16357033</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2006 Aug;65(8):783-93</Citation><ArticleIdList><ArticleId IdType="pubmed">16896312</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1998 Sep;153(3):801-13</Citation><ArticleIdList><ArticleId IdType="pubmed">9736029</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2002 May;8(5):500-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11984595</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1983 Jan 10;258(1):636-42</Citation><ArticleIdList><ArticleId IdType="pubmed">6336756</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2007;8(9):R187</Citation><ArticleIdList><ArticleId IdType="pubmed">17845722</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rev. 2001 Apr;81(2):871-927</Citation><ArticleIdList><ArticleId IdType="pubmed">11274346</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jun 1;174(11):6639-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15905502</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 1989;2(5):318-29</Citation><ArticleIdList><ArticleId IdType="pubmed">2478465</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1996 Jul;8(7):1001-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8757945</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12824464</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 1998 Mar 15;212(2):187-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9672206</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2005 Sep;19(11):1407-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16126908</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1987 Jun;68 ( Pt 6):1659-67</Citation><ArticleIdList><ArticleId IdType="pubmed">2953860</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2007 Apr;17(2):219-29</Citation><ArticleIdList><ArticleId IdType="pubmed">17388953</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2004 Apr;14(2):164-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15193029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1990 Jun 1;171(6):1893-907</Citation><ArticleIdList><ArticleId IdType="pubmed">1693653</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurotherapeutics. 2007 Oct;4(4):693-700</Citation><ArticleIdList><ArticleId IdType="pubmed">17920550</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Neurosci. 2005;27(6):378-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16280635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Jul;187(1-2):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17400297</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2008 Mar;255 Suppl 1:19-25</Citation><ArticleIdList><ArticleId IdType="pubmed">18317673</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropathol Appl Neurobiol. 2008 Dec;34(6):603-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18466224</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2002 Jan 7;195(1):99-111</Citation><ArticleIdList><ArticleId IdType="pubmed">11781369</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2000 May;25(1):25-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2004 Nov 22;20(17):3246-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15180930</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1997 Apr;71(4):3336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9060706</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2003;4(4):R27</Citation><ArticleIdList><ArticleId IdType="pubmed">12702208</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1999 Sep;104(5):599-610</Citation><ArticleIdList><ArticleId IdType="pubmed">10487774</ArticleId></ArticleIdList></Reference><Reference><Citation>Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):233-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8717165</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Oct;190(1-2):112-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17919740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Mar;70(3):1729-37</Citation><ArticleIdList><ArticleId IdType="pubmed">8627694</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Biol. 2003;4(5):P3</Citation><ArticleIdList><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2004 Jul;152(1-2):154-67</Citation><ArticleIdList><ArticleId IdType="pubmed">15223248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1985 Jul;101(1):85-95</Citation><ArticleIdList><ArticleId IdType="pubmed">2409098</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropathol Appl Neurobiol. 2008 Feb;34(1):105-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17961136</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12837-42</Citation><ArticleIdList><ArticleId IdType="pubmed">16141318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1985 Aug;135(2):1408-14</Citation><ArticleIdList><ArticleId IdType="pubmed">3925009</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurocytol. 1999 Apr-May;28(4-5):365-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10739577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Sep 15;173(6):3916-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15356140</ArticleId></ArticleIdList></Reference><Reference><Citation>Subcell Biochem. 2008;49:241-68</Citation><ArticleIdList><ArticleId IdType="pubmed">18751914</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2002 Feb;125(Pt 2):338-49</Citation><ArticleIdList><ArticleId IdType="pubmed">11844734</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1990 Dec;137(6):1467-79</Citation><ArticleIdList><ArticleId IdType="pubmed">2260633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1978 Feb;137(2):145-51</Citation><ArticleIdList><ArticleId IdType="pubmed">203636</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 1999 Jul;158(1):171-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10448429</ArticleId></ArticleIdList></Reference><Reference><Citation>J Histochem Cytochem. 1995 Mar;43(3):313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">7868861</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2005 Apr;8(4):468-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15793579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2000 Jun;47(6):707-17</Citation><ArticleIdList><ArticleId IdType="pubmed">10852536</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2005 Jul;128(Pt 7):1649-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15872019</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2005 Nov;128(Pt 11):2705-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16230320</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 1998 Apr;22(4):348-59</Citation><ArticleIdList><ArticleId IdType="pubmed">9517567</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 1989;29(2):92-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2563358</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9843981</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Dec 1;173(11):7070-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15557205</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2006 Apr;20(6):750-2</Citation><ArticleIdList><ArticleId IdType="pubmed">16464958</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Virol. 2008;3(6):579-593</Citation><ArticleIdList><ArticleId IdType="pubmed">19079794</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2007 Jul;102(1):37-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17403033</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Neurosci. 2008;31:247-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18558855</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1983 Apr;111(1):112-24</Citation><ArticleIdList><ArticleId IdType="pubmed">6340516</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Cell Physiol. 2001 Jun;280(6):C1422-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11350737</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2001 Jan;15(1):155-163</Citation><ArticleIdList><ArticleId IdType="pubmed">11149903</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Aug;188(1-2):86-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17599467</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Biol. 2000 Feb-Apr;7(1-2):203-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10890397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jan;36(Database issue):D480-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18077471</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2007 Sep;66(9):809-18</Citation><ArticleIdList><ArticleId IdType="pubmed">17805011</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2007 Apr;17(2):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17388952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2002 Sep;3(9):705-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12209119</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2003 Apr;162(4):1259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">12651618</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 1999 Feb 1;25(3):216-28</Citation><ArticleIdList><ArticleId IdType="pubmed">9932868</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2006 Aug 15;22(16):2028-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16809386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci Res. 1999 Nov 15;58(4):492-504</Citation><ArticleIdList><ArticleId IdType="pubmed">10533042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioinformatics. 2003 Jan 22;19(2):185-93</Citation><ArticleIdList><ArticleId IdType="pubmed">12538238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Nov 1;165(9):5304-14</Citation><ArticleIdList><ArticleId IdType="pubmed">11046065</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Res. 2005;31(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15591618</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2005 Aug;111(2):214-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15893838</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1998 Oct;72(10):7762-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9733812</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Neurol Neurosci Rep. 2007 May;7(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">17488590</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1979 Jun 8;204(4397):1103-6</Citation><ArticleIdList><ArticleId IdType="pubmed">451555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18689680</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>33</Issue><PubDate><Year>2008</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.</ArticleTitle><Pagination><MedlinePgn>11839-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.0805065105</ELocationID><Abstract><AbstractText>Clinically isolated syndrome (CIS) refers to the earliest clinical manifestation of multiple sclerosis (MS). Currently there are no prognostic biological markers that accurately predict conversion of CIS to clinically definite MS (CDMS). Furthermore, the earliest molecular events in MS are still unknown. We used microarrays to study gene expression in na..ve CD4(+) T cells from 37 CIS patients at time of diagnosis and after 1 year. Supervised machine-learning methods were used to build predictive models of disease conversion. We identified 975 genes whose expression segregated CIS patients into four distinct subgroups. A subset of 108 genes further discriminated patients in one of these (group 1) from other CIS patients. Remarkably, 92% of patients in group 1 converted to CDMS within 9 months. Consistent down-regulation of TOB1, a critical regulator of cell proliferation, was characteristic of group 1 patients. Decreased TOB1 expression at the RNA and protein levels also was confirmed in experimental autoimmune encephalomyelitis. Finally, a genetic association was observed between TOB1 variation and MS progression in an independent cohort. These results indicate that CIS patients at high risk of conversion have impaired regulation of T cell quiescence, possibly resulting in earlier activation of pathogenic CD4(+) cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corvol</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Radiology, University of California, San Francisco, CA 94143-0435, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelletier</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Roland G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Caillier</LastName><ForeName>Stacy J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Pappas</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Casazza</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Okuda</LastName><ForeName>Darin T</ForeName><Initials>DT</Initials></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Stephen L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Oksenberg</LastName><ForeName>Jorge R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Baranzini</LastName><ForeName>Sergio E</ForeName><Initials>SE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098669">TOB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18689680</ArticleId><ArticleId IdType="pii">0805065105</ArticleId><ArticleId IdType="doi">10.1073/pnas.0805065105</ArticleId><ArticleId IdType="pmc">PMC2504481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Autoimmun. 2007 Jun;28(4):177-87</Citation><ArticleIdList><ArticleId IdType="pubmed">17320348</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Cogn. 2002 Oct;50(1):51-61</Citation><ArticleIdList><ArticleId IdType="pubmed">12372351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2006 Mar;5(3):221-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16488377</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2007 Aug;188(1-2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17614141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2003 Feb 15;31(4):e15</Citation><ArticleIdList><ArticleId IdType="pubmed">12582260</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2001 Nov 23;294(5547):1731-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11721059</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2002 Jan 17;346(3):158-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11796849</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Sep 15;179(6):4074-82</Citation><ArticleIdList><ArticleId IdType="pubmed">17785846</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Jan 25;356(4):371-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17251533</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Jul 10;349(2):139-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12853586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2001 Dec;7(6):359-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11795456</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2003 Jul;24(7):380-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12860529</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2004 Apr;2(4):E108</Citation><ArticleIdList><ArticleId IdType="pubmed">15094809</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuk Lymphoma. 2004 Oct;45(10):1959-67</Citation><ArticleIdList><ArticleId IdType="pubmed">15370239</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2006 Oct 10;67(7):1242-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16914693</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2005 Jan;3(1):e2</Citation><ArticleIdList><ArticleId IdType="pubmed">15630474</ArticleId></ArticleIdList></Reference><Reference><Citation>J Comput Assist Tomogr. 2001 May-Jun;25(3):466-75</Citation><ArticleIdList><ArticleId IdType="pubmed">11351200</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2007 Jan;8(1):74-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17143274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2003 Jun;53(6):819-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12783433</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2001 Dec;2(12):1174-82</Citation><ArticleIdList><ArticleId IdType="pubmed">11694881</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2001 Jul;50(1):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11456302</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2006 May;174(1-2):108-18</Citation><ArticleIdList><ArticleId IdType="pubmed">16564577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jul 26;448(7152):474-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17568699</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 1995 Mar 15;9(6):650-62</Citation><ArticleIdList><ArticleId IdType="pubmed">7729684</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jun 1;174(11):7412-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15905590</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2005 Apr;18(3):537-50</Citation><ArticleIdList><ArticleId IdType="pubmed">15755681</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10484-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8248134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18046754</PMID><DateCompleted><Year>2008</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0741-0395</ISSN><JournalIssue CitedMedium="Print"><Volume>31 Suppl 1</Volume><PubDate><Year>2007</Year></PubDate></JournalIssue><Title>Genetic epidemiology</Title><ISOAbbreviation>Genet Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Summary of contributions to GAW15 Group 13: candidate gene association studies.</ArticleTitle><Pagination><MedlinePgn>S110-7</MedlinePgn></Pagination><Abstract><AbstractText>Here we summarize the contributions to Group 13 of the Genetic Analysis Workshop 15 held in St. Pete Beach, Florida, on November 12-14, 2006. The focus of this group was to identify candidate genes associated with rheumatoid arthritis or surrogate outcomes. The association methods proposed in this group were diverse, from better known approaches, such as logistic regression for single nucleotide polymorphism (SNP) analysis and haplotype sharing tests to methods less familiar to genetic epidemiologists, such as machine learning and visualization methods. The majority of papers analyzed Genetic Analysis Workshop 15 Problems 2 (rheumatoid arthritis data) and 3 (simulated data). The highlighted points of this group analyses were: (1) haplotype-based statistics can be more powerful than single SNP analysis for risk-locus localization; (2) considering linkage disequilibrium block structure in haplotype analysis may reduce the likelihood of false-positive results; and (3) visual representation of genetic models for continuous covariates may help identify SNPs associated with the underlying quantitative trait loci.</AbstractText><CopyrightInformation>(c) 2007 Wiley-Liss, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Andrade</LastName><ForeName>Mariza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Department of Health Science Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. mandrade@mayo.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials></Author><Author ValidYN="Y"><LastName>Brinza</LastName><ForeName>Dimitru</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Rong</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Da</LastName><ForeName>Yang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Andr.. R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Ewhida</LastName><ForeName>Adel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zeny</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Hsuan</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Hsin-Ju</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>K..hler</LastName><ForeName>Karola</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Youfang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liu-Mares</LastName><ForeName>Wen</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Jian'an</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Marquard</LastName><ForeName>Vivien</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Nolte</LastName><ForeName>Ilja M</ForeName><Initials>IM</Initials></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Sohee</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Platt</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Joo</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ao</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Won</LastName><ForeName>Sungho</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 CA092049</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genet Epidemiol</MedlineTA><NlmUniqueID>8411723</NlmUniqueID><ISSNLinking>0741-0395</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>44</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>4</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18046754</ArticleId><ArticleId IdType="doi">10.1002/gepi.20287</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16320331</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0004-3591</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>12</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Arthritis and rheumatism</Title><ISOAbbreviation>Arthritis Rheum</ISOAbbreviation></Journal><ArticleTitle>Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.</ArticleTitle><Pagination><MedlinePgn>3801-12</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify serum protein biomarkers specific for rheumatoid arthritis (RA), using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 103 serum samples from patients and healthy controls were analyzed. Thirty-four of the patients had a diagnosis of RA, based on the American College of Rheumatology criteria. The inflammation control group comprised 20 patients with psoriatic arthritis (PsA), 9 with asthma, and 10 with Crohn's disease. The noninflammation control group comprised 14 patients with knee osteoarthritis and 16 healthy control subjects. Serum protein profiles were obtained by SELDI-TOF-MS and compared in order to identify new biomarkers specific for RA. Data were analyzed by a machine learning algorithm called decision tree boosting, according to different preprocessing steps.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The most discriminative mass/charge (m/z) values serving as potential biomarkers for RA were identified on arrays for both patients with RA versus controls and patients with RA versus patients with PsA. From among several candidates, the following peaks were highlighted: m/z values of 2,924 (RA versus controls on H4 arrays), 10,832 and 11,632 (RA versus controls on CM10 arrays), 4,824 (RA versus PsA on H4 arrays), and 4,666 (RA versus PsA on CM10 arrays). Positive results of proteomic analysis were associated with positive results of the anti-cyclic citrullinated peptide test. Our observations suggested that the 10,832 peak could represent myeloid-related protein 8.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SELDI-TOF-MS technology allows rapid analysis of many serum samples, and use of decision tree boosting analysis as the main statistical method allowed us to propose a pattern of protein peaks specific for RA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Seny</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Li..ge, Centre Hospitalier Universitaire, Liege, Belgium. ddeseny@chu.ulg.ac.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fillet</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Meuwis</LastName><ForeName>Marie-Alice</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Geurts</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Lutteri</LastName><ForeName>Laurence</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ribbens</LastName><ForeName>Clio</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bours</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Wehenkel</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Piette</LastName><ForeName>Jacques</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Malaise</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Merville</LastName><ForeName>Marie-Paule</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheum</MedlineTA><NlmUniqueID>0370605</NlmUniqueID><ISSNLinking>0004-3591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010456">Peptides, Cyclic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C487763">cyclic citrullinated peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015535" MajorTopicYN="N">Arthritis, Psoriatic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="N">Crohn Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010456" MajorTopicYN="N">Peptides, Cyclic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040081" MajorTopicYN="N">Protein Array Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16320331</ArticleId><ArticleId IdType="doi">10.1002/art.21607</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15134529</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1386-2073</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>Combinatorial chemistry &amp; high throughput screening</Title><ISOAbbreviation>Comb Chem High Throughput Screen</ISOAbbreviation></Journal><ArticleTitle>Making sense of molecular signatures in the immune system.</ArticleTitle><Pagination><MedlinePgn>231-8</MedlinePgn></Pagination><Abstract><AbstractText>The development of Functional Genomics technologies has opened new avenues to investigate the complexity of the immune system. Microarray technology has been particularly successful because of its relatively low cost and high genome coverage. Consequently to our ability to monitor the expression of a significant proportion of an organism genome, our understanding of the molecular dynamics behind cell differentiation and cell response has greatly improved. Molecular signatures associated to immune cells have provided important tools to investigate the molecular basis of diseases and have been often associated to diagnostic and prognostic markers. The availability of such large collection of data has stimulated the application of complex machine learning techniques in the attempt to link molecular signatures and cell physiology. Here we review the most recent developments in the analysis of molecular signatures in the immune system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK. f.falciani@bham.ac.at</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadesse</LastName><ForeName>Mahlet G T</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Vannucci</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kikuchi</LastName><ForeName>Hugh</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Trevino</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Sarti</LastName><ForeName>Donatella</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Dragoni</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Contestabile</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zanders</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Falciani</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Comb Chem High Throughput Screen</MedlineTA><NlmUniqueID>9810948</NlmUniqueID><ISSNLinking>1386-2073</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007938" MajorTopicYN="N">Leukemia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040081" MajorTopicYN="N">Protein Array Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017154" MajorTopicYN="N">Stromal Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>38</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>17</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15134529</ArticleId><ArticleId IdType="doi">10.2174/1386207043328805</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14768006</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0270-9139</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Hepatology (Baltimore, Md.)</Title><ISOAbbreviation>Hepatology</ISOAbbreviation></Journal><ArticleTitle>Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.</ArticleTitle><Pagination><MedlinePgn>518-27</MedlinePgn></Pagination><Abstract><AbstractText>Several types of aggressive cancers, including hepatocellular carcinoma (HCC), often arise as a multifocal primary tumor. This suggests a high rate of premalignant changes in noncancerous tissue before the formation of a solitary tumor. Examination of the messenger RNA expression profiles of tissue samples derived from patients with cirrhosis of various etiologies by complementary DNA (cDNA) microarray indicated that they can be grossly separated into two main groups. One group included hepatitis B and C virus infections, hemochromatosis, and Wilson's disease. The other group contained mainly alcoholic liver disease, autoimmune hepatitis, and primary biliary cirrhosis. Analysis of these two groups by the cross-validated leave-one-out machine-learning algorithms revealed a molecular signature containing 556 discriminative genes (P &lt;.001). It is noteworthy that 273 genes in this signature (49%) were also significantly altered in HCC (P &lt;.001). Many genes were previously known to be related to HCC. The 273-gene signature was validated as cancer-associated genes by matching this set to additional independent tumor tissue samples from 163 patients with HCC, 56 patients with lung carcinoma, and 38 patients with breast carcinoma. From this signature, 30 genes were altered most significantly in tissue samples from high-risk individuals with cirrhosis and from patients with HCC. Among them, 12 genes encoded secretory proteins found in sera. In conclusion, we identified a unique gene signature in the tissue samples of patients with cirrhosis, which may be used as candidate markers for diagnosing the early onset of HCC in high-risk populations and may guide new strategies for chemoprevention. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qinghai</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Forgues</LastName><ForeName>Marshonna</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yidong</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Budhu</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sime</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hofseth</LastName><ForeName>Lorne J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Kaul</LastName><ForeName>Rashmi</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin Wei</ForeName><Initials>XW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hepatology</MedlineTA><NlmUniqueID>8302946</NlmUniqueID><ISSNLinking>0270-9139</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015815">Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071858">Epithelial Cell Adhesion Molecule</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015815" MajorTopicYN="N">Cell Adhesion Molecules</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071858" MajorTopicYN="N">Epithelial Cell Adhesion Molecule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="Y">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14768006</ArticleId><ArticleId IdType="doi">10.1002/hep.20053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12965182</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1568-9972</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Autoimmunity reviews</Title><ISOAbbreviation>Autoimmun Rev</ISOAbbreviation></Journal><ArticleTitle>Computer-assisted classification of HEp-2 immunofluorescence patterns in autoimmune diagnostics.</ArticleTitle><Pagination><MedlinePgn>298-304</MedlinePgn></Pagination><Abstract><AbstractText>Indirect immunofluorescence with HEp-2 cells presents the major screening method for detection of autoantibodies in systemic autoimmune diseases. Hereby, a large variety of autoantibody entities can be detected and recognized by at least partially typic fluorescence patterns. Currently, this method requires highly specialized technicians and resists automatization. Nevertheless, requirements of good laboratory practice, especially standardization and documentation are hampered by the common microscopic technique. Here, we present a computer-assisted system for classification of interphase HEp-2 immunofluorescence patterns in autoimmune diagnostics. Designed as an assisting system, representative patterns are acquired by an operator with a digital microscope camera and transferred to a personal computer. By use of a novel software package based on image analysis, feature extraction and machine learning algorithms, relevant characteristics describing patterns could be found out. Our results show that identification of positive fluorescence and pre-differentiation between most important HEp-2 staining patterns can be performed by this system. Results and documentation of fluorescence patterns can be integrated into the laboratory system. To enable the usage of such a system in routine diagnostics, accuracy of this system and correct recognition of interferring patterns must be further improved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sack</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany. mail@ulrichsack.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoechner</LastName><ForeName>Stephan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Warschkau</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Pigla</LastName><ForeName>Ullrich</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Emmrich</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kamprad</LastName><ForeName>Manja</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Autoimmun Rev</MedlineTA><NlmUniqueID>101128967</NlmUniqueID><ISSNLinking>1568-9972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="Y">Fluorescent Antibody Technique</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="Y">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>28</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12965182</ArticleId><ArticleId IdType="pii">S1568997203000673</ArticleId><ArticleId IdType="doi">10.1016/s1568-9972(03)00067-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11185419</PMID><DateCompleted><Year>2000</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0933-3657</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2000</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>Intelligent analysis of clinical time series: an application in the diabetes mellitus domain.</ArticleTitle><Pagination><MedlinePgn>37-57</MedlinePgn></Pagination><Abstract><AbstractText>This paper describes the application of a method for the intelligent analysis of clinical time series in the diabetes mellitus domain. Such a method is based on temporal abstractions and relies on the following steps: (i) 'pre-processing' of raw data through the application of suitable filtering techniques: (ii) 'extraction' from the pre-processed data of a set of abstract episodes (temporal abstractions); and (iii) 'post-processing' of temporal abstractions; the post-processing phase results in a new set of features that embeds high level information on the patient dynamics. The derived features set is used to obtain new knowledge through the application of machine learning algorithms. The paper describes in detail the application of this methodology and presents some results obtained on simulated data and on a data-set of four diabetic patients monitored for &gt; 1 year.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellazzi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento di Informatica e Sistemistica, Universit.. di Pavia, Italy. ric@aim.unipv.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larizza</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Magni</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Montani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Stefanelli</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="Y">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11185419</ArticleId><ArticleId IdType="pii">S0933-3657(00)00052-X</ArticleId><ArticleId IdType="doi">10.1016/s0933-3657(00)00052-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
